Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABHD8 "FLJ11743, MGC14280, MGC2512" ENSG00000127220 "Abhydrolase domain containing 8" Q96I13 19 17292131-17310236 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.8" "Cell type enhanced" "Detected in many" "Early spermatids: 146.2;Horizontal cells: 72.3;Late spermatids: 314.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "PC-3: 53.9;U-266/70: 40.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037658, HPA058209" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA037658: AB_10672602, HPA058209: AB_2683638" "unprognostic (4.71e-3)" "unprognostic (5.06e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (7.45e-3)" "unprognostic (7.09e-2)" "unprognostic (1.96e-2)" "unprognostic (5.61e-2)" "unprognostic (9.62e-3)" "unprognostic (1.25e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.04e-5)" "unprognostic (3.77e-1)" "unprognostic (6.36e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-1)" "unprognostic (1.50e-1)" "unprognostic (9.24e-2)" 7.4 26.0 32.3 3.9 37.2 4.5 8.8 20.6 57.8 12.0 14.3 16.7 2.7 11.5 1.7 5.7 11.2 2.9 12.4 36.3 23.8 11.6 28.2 9.6 4.5 19.2 26.5 14.2 11.6 8.9 24.6 5.6 19.5 14.6 0.6 6.1 10.5 6.7 13.8 11.3 7.8 2.7 16.1 11.4 11.1 45.7 30.0 4.7 12.1 3.9 2.2 10.2 8.8 27.0 22.5 6.4 3.2 12.6 4.1 1.4 34.2 4.5 6.0 4.8 6.1 5.6 15.0 1.6 6.1 3.5 7.4 3.1 3.2 7.8 1.0 26.6 21.1 7.3 9.6 9.7 13.4 0.5 9.9 3.8 4.7 8.2 1.0 7.4 3.5 12.5 6.6 12.4 1.9 1.2 9.0 1.3 6.0 3.8 53.9 13.3 9.9 6.5 4.3 2.1 3.9 21.3 10.0 3.3 14.6 2.8 13.6 12.6 2.1 4.4 9.6 22.7 8.1 40.6 33.0 7.9 14.9 8.7 4.1 0.0 2.4 3.0 1.1 1.9 0.7 0.3 1.6 0.9 2.9 0.5 1.3 1.2 1.3 1.7 1.9 1.3 1.2 1.0 32.3 37.2 20.6 57.8 36.3 23.8 19.2 26.5 19.5 16.1 30.0 27.0 5.9 0.0 1.3 20.9 5.0 3.8 4.7 8.0 8.6 56.9 9.6 14.4 2.0 7.2 4.8 7.3 18.8 20.6 4.0 0.8 7.9 13.1 146.2 3.0 3.7 4.3 7.2 0.8 22.7 8.5 9.0 7.7 2.6 2.5 4.5 12.3 4.2 13.5 22.5 72.3 19.4 3.3 12.2 8.1 6.9 314.2 12.5 11.1 1.8 8.4 18.4 36.1 7.2 2.5 1.4 8.4 4.3 25.6 9.2 6.3 0.4 9.7 1.7 38.2 6.6 13.6 5.6 64.3 1.5 3.0 4.1 24.8 4.8 10.8 1.3 4.3 ABL1 "ABL, c-ABL, JTK7, p150" ENSG00000097007 "ABL proto-oncogene 1, non-receptor tyrosine kinase" P00519 9 130713016-130887675 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 71.2;Oligodendrocytes: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002686, HPA027251, HPA027280, HPA028409" Supported Enhanced "Nucleoplasm,Nuclear bodies" Yes No "Cluster 37: B-cells - Transcription" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear bodies" "CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011" "unprognostic (4.82e-2)" "unprognostic (3.99e-2)" "unprognostic (5.55e-2)" "unprognostic (4.72e-2)" "unprognostic (1.16e-1)" "unprognostic (1.46e-1)" "unprognostic (3.75e-3)" "unprognostic (1.89e-3)" "unprognostic (2.34e-1)" "unprognostic (2.54e-2)" "unprognostic (1.09e-2)" "unprognostic (1.48e-1)" "unprognostic (3.96e-3)" "unprognostic (1.10e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 50.9 30.7 27.4 25.3 38.9 23.4 45.8 33.6 31.4 60.5 40.4 96.4 23.1 63.0 11.6 33.8 55.6 35.7 36.1 26.6 28.3 23.1 17.5 37.3 16.3 39.3 38.5 56.0 24.9 32.5 34.9 26.5 35.8 43.5 26.7 14.2 32.4 33.6 29.4 36.3 45.2 41.2 31.3 23.3 51.6 20.1 34.9 22.4 46.7 30.8 15.4 79.3 42.7 41.3 22.5 48.3 53.6 62.9 76.5 93.3 18.8 38.8 60.4 44.8 38.1 36.4 28.3 32.3 22.3 52.0 47.6 42.5 23.5 36.0 30.7 20.6 16.3 23.7 84.1 33.4 51.8 36.5 32.3 68.8 37.2 80.6 50.0 64.1 61.0 47.9 135.8 26.5 54.9 42.0 49.2 30.5 57.9 34.3 33.8 55.9 67.9 35.9 45.0 25.7 47.9 60.1 66.1 23.5 29.2 31.0 46.2 33.1 71.1 170.7 44.1 66.3 62.6 8.4 20.3 47.9 72.1 27.6 55.1 0.0 0.7 0.3 0.6 0.4 0.8 1.3 0.6 0.6 0.7 0.4 0.6 0.5 0.0 0.8 1.9 1.0 0.3 0.6 27.4 38.9 33.6 31.4 26.6 28.3 39.3 38.5 35.8 31.3 34.9 41.3 16.2 9.6 13.6 54.9 4.7 9.2 7.3 9.8 5.2 8.2 11.6 10.2 6.2 7.2 7.2 14.7 12.5 13.6 12.1 21.2 1.9 14.4 5.9 8.6 29.7 18.1 22.1 4.6 52.5 11.1 4.3 36.7 5.6 12.4 2.5 22.1 20.3 15.9 16.6 10.1 63.7 17.5 6.1 16.4 11.7 8.8 28.0 10.2 5.4 71.2 6.6 19.2 6.2 66.9 116.0 17.9 18.3 25.6 5.6 8.6 11.6 10.3 7.8 9.1 19.7 29.5 19.8 16.9 16.5 6.6 6.8 15.2 7.9 20.1 21.4 7.2 ABRAXAS1 "ABRA1, ABRAXAS, CCDC98, FAM175A, FLJ13614" ENSG00000163322 "Abraxas 1, BRCA1 A complex subunit" Q6UWZ7 4 83459517-83523348 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Endometrial stromal cells: 20.7;Proximal tubular cells: 30.1;Respiratory ciliated cells: 21.9;Theca cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037654 Uncertain Supported "Nuclear bodies" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" "HPA037654: AB_2675588" "unprognostic (1.44e-1)" "unprognostic (2.46e-2)" "unprognostic (2.42e-2)" "unprognostic (1.81e-1)" "unprognostic (8.57e-3)" "unprognostic (6.99e-2)" "unprognostic (4.98e-4)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (2.73e-1)" "unprognostic (2.35e-1)" "unprognostic (6.98e-2)" "prognostic favorable (1.53e-4)" "unprognostic (2.24e-3)" "unprognostic (9.34e-3)" "unprognostic (5.58e-2)" "unprognostic (6.57e-2)" 4.4 3.9 2.9 3.9 2.0 7.9 3.8 7.7 3.0 5.1 12.0 3.3 3.7 6.4 2.1 5.2 4.8 5.7 3.7 2.4 1.4 4.1 2.2 3.8 8.0 2.2 2.2 14.8 3.4 2.2 1.1 2.9 2.4 2.7 2.8 3.6 3.5 2.2 6.4 5.7 3.1 2.9 0.5 4.1 3.6 10.8 2.6 4.8 7.4 2.0 3.8 3.8 3.5 5.1 5.6 3.4 6.8 8.2 6.1 25.2 3.6 4.1 5.1 1.9 2.9 7.6 9.0 22.1 3.3 4.3 4.2 2.9 3.7 2.9 3.5 8.8 2.4 12.9 4.6 9.1 4.9 15.3 11.1 10.9 2.5 2.7 2.4 10.2 8.7 12.9 36.7 13.2 4.7 3.7 17.2 5.6 11.5 6.3 5.0 9.3 7.6 5.5 4.2 4.6 6.3 5.1 5.3 2.2 9.6 5.5 6.3 6.3 11.5 7.4 7.6 7.4 6.0 11.5 8.4 16.1 6.7 12.8 5.3 4.0 2.5 2.1 2.0 2.3 2.6 2.1 3.5 2.4 1.9 3.3 5.4 4.2 3.2 5.0 2.3 1.5 3.2 1.9 2.9 2.0 7.7 3.0 2.4 1.4 2.2 2.2 2.4 0.5 2.6 5.1 14.3 16.0 12.4 0.0 4.6 0.0 0.0 0.0 0.0 0.0 11.4 13.0 0.0 0.0 8.6 12.9 0.0 5.2 8.8 0.0 43.0 9.2 0.0 11.9 20.7 5.7 0.0 0.0 0.0 6.5 6.9 9.1 0.0 5.9 6.3 12.3 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 7.4 0.0 0.0 1.7 0.0 0.0 30.1 21.9 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 2.9 6.2 26.8 0.0 0.0 AC004593.2 ENSG00000285162 "Chimerin 2" 7 29122340-29514667 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 3.3" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 3.3" "Group enriched" "Detected in some" 32 "classical monocyte: 4.1;intermediate monocyte: 3.4;myeloid DC: 4.3;non-classical monocyte: 1.8" "Group enriched" "Detected in many" 42 "dendritic cells: 4.3;monocytes: 4.1" "Cell line enhanced" "Detected in some" "GAMG: 1.0;HaCaT: 1.1;U-266/84: 1.4" HPA019026 Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 16: U-266 - Nucleosome" Nucleoplasm "Nuclear bodies" "HPA019026: " 0.0 0.1 0.2 0.1 0.2 0.1 0.0 3.3 0.3 0.0 0.4 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.3 0.1 0.5 0.2 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.5 0.8 0.2 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.8 0.0 1.0 1.1 0.0 0.0 0.0 0.0 0.3 0.8 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.3 0.4 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.5 0.0 4.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 1.9 0.2 0.2 3.3 0.3 0.1 0.5 0.2 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC073610.1 ENSG00000272822 "Novel protein" 12 48903503-48957365 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.7;hTERT-RPE1: 4.4" HPA068942 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 33: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear bodies" "HPA068942: AB_2732124" "unprognostic (7.48e-2)" "unprognostic (6.47e-2)" "unprognostic (7.52e-2)" "unprognostic (1.05e-1)" "unprognostic (1.64e-1)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (7.66e-2)" "unprognostic (7.25e-2)" "unprognostic (1.01e-2)" "unprognostic (6.24e-2)" "unprognostic (5.78e-2)" "unprognostic (1.01e-12)" "unprognostic (1.92e-2)" "unprognostic (1.33e-1)" "unprognostic (2.84e-1)" "unprognostic (9.06e-2)" 0.8 0.3 0.9 0.0 1.3 0.1 0.6 0.1 1.9 0.9 0.0 0.9 0.0 0.8 0.5 0.3 0.8 0.6 1.0 1.1 0.6 0.3 0.6 1.1 0.4 0.0 0.0 0.8 0.6 0.0 0.8 0.1 0.1 0.6 0.2 1.4 0.4 0.2 0.4 0.7 0.2 0.9 0.0 0.3 0.4 1.1 1.0 0.2 0.3 0.8 0.2 0.6 0.5 0.1 0.5 0.2 2.1 1.6 2.2 0.9 0.0 0.9 4.7 1.2 0.5 0.0 0.6 0.6 1.3 0.8 1.4 0.1 0.8 0.0 1.2 2.8 0.3 0.6 0.3 0.0 1.5 0.0 0.6 0.2 1.1 0.3 0.7 4.4 0.5 1.1 0.0 0.8 0.7 0.2 0.3 0.5 0.0 1.2 0.6 1.3 0.3 0.1 0.1 0.1 0.9 0.3 0.5 0.4 0.4 0.4 0.1 0.3 2.4 0.4 0.3 0.3 0.3 1.1 0.1 0.4 1.0 0.6 0.2 0.3 0.3 0.1 0.6 0.1 0.7 0.2 0.2 0.5 0.2 0.2 0.6 0.6 0.2 0.3 0.1 0.5 0.2 0.7 0.9 1.3 0.1 1.9 1.1 0.6 0.0 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 ACD "Pip1, Ptop, Tint1, Tpp1" ENSG00000102977 "ACD shelterin complex subunit and telomerase recruitment factor" Q96AP0 16 67657512-67660815 "Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049411, HPA057660" Approved Enhanced "Nuclear bodies" NA Yes "Cluster 6: Non-specific - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" "HPA049411: AB_2680752, HPA057660: AB_2683493" "unprognostic (1.47e-1)" "unprognostic (3.77e-2)" "unprognostic (1.09e-2)" "unprognostic (7.15e-3)" "unprognostic (2.22e-1)" "unprognostic (4.24e-3)" "prognostic unfavorable (2.42e-6)" "unprognostic (1.50e-2)" "unprognostic (4.75e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-3)" "unprognostic (3.27e-2)" "unprognostic (8.88e-2)" "unprognostic (6.34e-2)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.30e-1)" 13.0 9.9 14.2 7.3 14.4 10.1 12.9 14.4 17.7 17.1 12.0 14.8 4.2 16.4 4.0 9.1 15.6 5.2 11.2 14.6 14.2 10.8 6.7 9.9 10.1 14.6 14.2 19.9 12.4 6.3 13.7 4.7 15.0 12.2 2.3 2.7 9.4 6.3 9.8 11.4 12.1 4.6 14.1 14.9 11.2 23.7 14.6 5.5 10.0 3.2 5.6 15.5 12.2 14.6 42.1 32.3 18.4 19.2 8.3 5.8 39.5 17.1 11.3 25.0 30.3 42.0 20.3 11.6 19.4 9.4 22.5 32.7 11.3 32.8 8.2 12.6 37.4 24.9 13.4 42.4 5.8 32.5 37.6 8.3 10.0 33.7 17.7 9.4 15.9 34.3 15.7 8.1 12.6 45.2 31.8 31.8 23.5 16.3 21.5 44.1 19.8 48.0 10.5 16.6 26.3 23.1 64.0 6.7 14.5 5.3 15.8 17.9 13.8 26.6 22.4 31.9 26.1 21.7 28.6 35.9 24.7 20.5 23.3 34.5 18.2 22.8 40.2 22.2 34.1 46.4 36.7 34.8 21.0 37.7 28.5 30.3 25.9 43.5 25.8 22.9 39.5 24.7 14.2 14.4 14.4 17.7 14.6 14.2 14.6 14.2 15.0 14.1 14.6 14.6 19.4 6.4 11.9 5.5 22.3 14.4 15.9 22.6 21.6 14.7 13.7 16.0 2.8 8.6 12.6 11.0 4.2 25.1 22.5 5.5 9.8 21.3 59.3 6.6 7.7 15.4 12.5 11.6 6.2 19.6 22.8 14.1 9.7 6.8 27.9 13.6 12.8 4.7 15.5 13.5 6.1 6.4 6.1 7.6 20.6 71.4 15.2 13.4 23.2 4.7 19.3 14.3 30.9 4.0 3.6 18.4 9.2 11.7 17.0 9.9 10.2 13.2 16.1 10.8 6.6 11.8 14.8 58.1 24.1 7.1 9.7 11.4 27.0 6.9 9.0 10.0 ACTN4 FSGS1 ENSG00000130402 "Actinin alpha 4" O43707 19 38647649-38731589 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 626.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 947.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001873, HPA006035" Supported Approved "Nuclear bodies,Actin filaments,Cytosol" NA NA 71000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies, Actin filaments" Cytosol "HPA001873: AB_1078096, HPA006035: AB_1078095" "unprognostic (1.03e-1)" "unprognostic (6.34e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-2)" "unprognostic (2.37e-1)" "unprognostic (3.34e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.70e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.99e-1)" "prognostic favorable (5.25e-5)" "unprognostic (6.59e-2)" "unprognostic (1.91e-1)" "unprognostic (6.75e-3)" "unprognostic (6.52e-2)" 176.5 160.8 22.9 63.9 42.0 74.2 151.4 42.9 42.2 165.2 58.5 168.5 128.7 269.4 11.8 232.8 163.2 46.8 89.0 19.5 27.8 166.7 85.0 174.7 37.5 45.9 42.4 102.5 90.6 42.2 80.0 85.7 44.8 115.6 42.2 26.0 148.1 59.0 52.2 183.4 150.3 73.1 30.2 118.1 120.9 23.6 38.1 18.5 105.4 18.8 24.2 150.2 181.3 63.4 364.6 947.0 92.9 48.6 37.7 50.6 237.2 198.7 162.5 178.8 143.9 335.9 265.1 99.0 409.1 260.6 117.4 185.1 57.4 203.8 38.3 238.3 69.5 139.7 356.1 240.4 103.4 101.7 145.2 95.3 63.4 157.5 79.6 146.9 116.4 26.3 165.0 71.8 127.5 221.2 27.2 44.1 78.4 197.8 177.3 89.5 109.4 43.8 174.6 396.3 83.0 49.8 366.3 210.5 94.7 64.0 94.5 78.8 309.7 249.3 138.7 135.3 476.1 44.1 84.5 67.8 231.7 90.6 476.7 7.6 8.1 17.8 13.2 7.7 9.8 3.2 5.7 13.2 7.0 3.0 0.9 4.4 16.9 24.8 6.7 10.8 9.5 10.6 22.9 42.0 42.9 42.2 19.5 27.8 45.9 42.4 44.8 30.2 38.1 63.4 315.2 179.5 120.0 21.5 45.8 234.8 266.4 155.1 153.7 25.6 134.0 148.1 9.2 143.0 119.4 152.6 14.6 123.7 150.7 626.1 19.6 413.5 2.5 272.0 145.7 206.2 162.0 59.3 46.0 419.3 256.7 77.3 219.7 346.4 73.5 75.9 130.6 108.5 72.6 23.5 22.6 365.5 73.2 65.9 103.7 4.5 41.3 75.4 46.2 48.7 162.2 122.4 120.5 35.2 83.6 532.3 425.2 71.5 91.2 322.1 315.5 104.0 122.1 32.3 190.7 97.2 251.0 36.2 23.7 189.3 202.7 168.0 119.4 115.3 280.6 284.7 AGL ENSG00000162688 "Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase" P35573 1 99850361-99924023 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycogen biosynthesis" "Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 257.6;tongue: 212.0" "Cell type enhanced" "Detected in all" "Muller glia cells: 160.5;Theca cells: 159.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028498, HPA054340" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 450000 "Cluster 15: NK-cells - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "Nuclear bodies, Cytosol" "HPA028498: AB_10600975, HPA054340: AB_2682455" "unprognostic (2.90e-1)" "unprognostic (5.34e-2)" "unprognostic (3.99e-3)" "unprognostic (2.18e-2)" "unprognostic (6.46e-3)" "unprognostic (5.13e-2)" "unprognostic (1.12e-1)" "unprognostic (1.92e-2)" "unprognostic (9.37e-3)" "unprognostic (1.11e-1)" "unprognostic (8.10e-3)" "unprognostic (7.61e-2)" "prognostic favorable (1.73e-10)" "unprognostic (6.38e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" "unprognostic (7.13e-2)" 11.9 6.7 4.1 7.1 4.9 6.1 9.1 6.9 5.6 6.1 6.0 10.0 8.8 7.3 7.6 16.4 5.4 5.2 22.8 3.7 5.1 13.3 42.8 5.9 7.3 4.7 5.6 5.9 4.3 17.6 4.5 11.7 4.4 13.8 10.6 23.3 7.7 9.6 257.6 5.3 7.1 9.7 4.9 8.0 7.7 4.7 4.8 7.9 10.5 212.0 8.5 8.9 5.0 5.6 20.4 5.9 7.0 11.4 11.0 10.4 23.4 6.3 9.2 5.5 9.8 22.3 6.8 26.4 11.7 10.8 4.9 11.3 40.5 12.4 10.2 14.2 12.9 15.5 18.9 12.4 7.3 13.7 8.9 12.8 7.9 7.5 6.2 7.5 8.5 9.2 26.3 2.0 5.5 6.2 16.3 4.3 10.9 8.9 7.7 0.0 2.3 1.3 16.3 26.7 17.2 12.1 18.2 17.3 9.9 12.8 12.6 9.0 9.4 6.6 9.3 8.9 6.3 7.3 6.1 30.5 11.7 3.6 3.5 0.0 0.4 1.4 1.5 0.6 1.4 1.0 1.1 1.0 0.9 1.0 1.1 1.1 0.5 2.4 0.3 0.8 1.3 0.8 4.1 4.9 6.9 5.6 3.7 5.1 4.7 5.6 4.4 4.9 4.8 5.6 12.8 22.4 26.8 96.6 28.5 10.6 18.1 24.6 18.2 34.6 18.8 18.0 119.6 18.6 25.8 16.5 54.2 107.9 18.8 23.2 23.5 13.7 1.2 18.8 23.6 13.9 16.8 15.6 45.6 12.9 20.3 28.5 31.1 18.6 10.8 45.0 14.6 111.0 17.9 52.2 56.0 15.8 12.2 19.1 8.8 2.5 10.2 13.5 16.0 23.4 14.1 160.5 21.6 36.2 34.4 17.7 14.3 21.4 20.4 13.0 15.2 19.2 26.0 46.9 6.6 41.4 18.4 8.7 11.9 40.0 9.2 29.1 25.7 159.1 23.5 20.1 AL031681.2 ENSG00000288000 "Novel protein" 20 43458054-43541881 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059648 Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA Nucleoplasm "Nuclear bodies, Midbody ring" "HPA059648: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALKBH8 "MGC10235, TRM9, TRMT9A" ENSG00000137760 "AlkB homolog 8, tRNA methyltransferase" Q96BT7 11 107502727-107565742 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038724, HPA038725, HPA061514" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies" Nucleoplasm "HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547" "unprognostic (2.66e-2)" "unprognostic (3.82e-1)" "unprognostic (8.19e-2)" "unprognostic (3.76e-1)" "unprognostic (4.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (1.95e-1)" "unprognostic (4.45e-2)" "unprognostic (7.67e-2)" "unprognostic (1.89e-2)" "unprognostic (7.95e-2)" "unprognostic (2.81e-1)" "unprognostic (2.03e-1)" "unprognostic (2.04e-1)" "unprognostic (2.34e-3)" "unprognostic (1.01e-1)" 3.1 2.9 2.4 4.0 3.0 3.3 5.0 2.6 2.8 2.9 1.7 3.0 3.2 3.8 3.2 3.1 2.9 2.8 3.8 2.4 2.6 3.9 4.5 3.6 6.0 2.2 2.6 4.4 2.3 4.1 1.7 3.3 2.5 3.5 3.6 3.3 2.9 3.3 5.1 4.6 2.6 3.6 2.2 4.6 3.3 2.8 2.3 4.6 5.2 4.7 5.9 3.5 2.8 2.3 5.4 6.5 6.6 7.2 3.6 7.9 5.4 10.2 7.5 7.4 8.0 12.1 9.7 12.6 5.8 10.0 10.2 9.6 9.9 8.5 9.6 11.4 6.6 10.6 2.5 5.6 5.3 13.7 12.6 4.9 9.2 9.5 12.0 3.8 9.3 9.9 15.2 4.1 5.9 4.9 12.4 6.8 8.7 10.5 10.6 11.1 10.2 8.7 5.9 5.8 6.0 6.7 5.9 4.4 4.5 4.0 7.2 4.1 8.8 16.1 9.6 5.3 12.9 3.8 4.3 9.7 4.5 9.0 16.1 0.0 1.1 0.3 2.2 2.1 2.1 0.9 1.6 1.9 1.7 1.9 3.0 2.6 0.0 2.8 1.5 1.0 1.8 1.1 2.4 3.0 2.6 2.8 2.4 2.6 2.2 2.6 2.5 2.2 2.3 2.3 4.4 0.0 5.3 4.6 8.5 2.0 1.7 1.5 7.4 5.7 3.2 3.0 11.2 5.7 3.5 1.8 6.2 2.3 3.0 1.3 0.0 1.9 0.4 2.4 4.6 4.2 1.2 4.6 25.2 3.3 2.7 4.3 7.7 2.3 10.1 5.1 2.9 6.6 2.8 1.7 27.4 2.8 2.0 3.8 2.2 0.2 2.8 4.1 3.6 14.0 4.7 3.0 3.1 23.1 14.3 2.7 5.2 4.1 3.8 1.3 1.3 3.6 0.8 3.8 0.0 4.0 3.0 1.8 3.2 6.9 4.1 0.8 6.6 5.2 3.5 0.6 ALX1 CART1 ENSG00000180318 "ALX homeobox 1" Q15699 12 85280220-85301784 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 3.9;kidney: 6.1" "Cell type enriched" "Detected in some" 5 "Melanocytes: 32.0" "Cancer enriched" "Detected in some" 10 "melanoma: 16.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001598, HPA018905" Uncertain Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" "Nucleoplasm, Golgi apparatus" "HPA001598: AB_1078400, HPA018905: AB_1844783" "unprognostic (4.92e-3)" "unprognostic (8.09e-2)" "unprognostic (1.09e-3)" "unprognostic (1.84e-1)" "unprognostic (6.24e-2)" "unprognostic (2.05e-2)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (3.57e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-5)" "unprognostic (8.97e-2)" "unprognostic (1.43e-1)" 0.2 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.3 1.0 0.4 0.0 0.0 0.7 3.9 0.0 2.3 0.0 0.0 0.2 0.3 6.1 0.0 0.0 0.0 0.2 0.2 1.6 0.0 0.0 0.7 0.0 0.2 0.1 0.0 0.2 1.9 0.9 0.0 1.6 0.0 0.3 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.8 0.0 0.4 0.3 0.2 0.0 6.0 0.0 0.0 0.7 0.7 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 3.6 0.0 10.4 0.5 0.0 0.0 23.3 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.0 9.3 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 2.7 5.8 0.0 0.0 29.5 4.1 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.3 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 5.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 2.2 0.2 1.0 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 AMER1 "FAM123B, FLJ39827, RP11-403E24.2, WTX" ENSG00000184675 "APC membrane recruitment protein 1" Q5JTC6 X 64185117-64205708 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "tongue: 15.3" "Cell type enhanced" "Detected in many" "Sertoli cells: 6.6;Theca cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065214, HPA065265" Approved Supported "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" "Vesicles, Plasma membrane" "HPA065214: AB_2685435, HPA065265: AB_2685450" "unprognostic (1.56e-2)" "unprognostic (8.85e-2)" "unprognostic (6.86e-2)" "unprognostic (2.74e-1)" "unprognostic (2.12e-2)" "unprognostic (1.86e-1)" "unprognostic (3.57e-2)" "unprognostic (1.48e-1)" "unprognostic (8.02e-2)" "unprognostic (1.75e-1)" "unprognostic (6.31e-2)" "unprognostic (3.43e-1)" "unprognostic (4.69e-4)" "unprognostic (1.26e-1)" "unprognostic (1.13e-1)" "unprognostic (6.19e-2)" "unprognostic (2.89e-1)" 1.1 1.4 1.6 1.3 1.5 1.2 1.3 1.8 1.6 1.9 0.1 1.5 1.5 1.9 4.0 2.8 2.2 1.0 1.3 1.0 1.6 1.8 2.1 1.2 1.2 1.5 1.4 6.3 2.0 1.6 0.7 0.8 1.5 1.7 1.3 1.3 2.2 2.2 4.1 2.2 1.3 2.8 0.7 1.3 1.6 0.4 1.9 1.6 1.4 15.3 1.6 1.3 1.3 1.0 3.1 2.2 5.8 4.6 2.2 2.1 4.7 1.4 1.2 2.1 1.3 7.3 1.1 5.9 1.8 3.0 1.6 4.3 12.5 4.1 2.0 2.5 2.5 3.7 4.9 4.9 1.6 7.7 0.9 3.0 5.3 1.6 3.2 1.7 1.2 4.6 5.6 5.9 1.1 3.7 5.2 4.0 15.6 4.0 4.4 11.7 9.4 4.3 0.9 1.0 2.6 3.9 3.7 5.0 1.9 4.8 1.6 2.1 0.8 2.5 5.8 6.7 1.9 3.0 2.2 4.4 1.2 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 1.5 1.8 1.6 1.0 1.6 1.5 1.4 1.5 0.7 1.9 1.0 0.9 0.0 0.0 1.0 1.5 2.2 0.6 0.9 2.8 5.0 1.7 1.5 2.6 4.3 0.3 0.0 2.1 1.1 3.4 1.1 0.0 1.2 0.1 3.3 2.6 1.5 1.2 0.8 0.8 1.6 0.8 1.8 3.6 2.0 0.0 3.9 1.4 2.6 0.4 0.0 1.3 1.0 0.0 1.0 0.3 0.2 2.5 0.5 1.8 1.0 1.2 0.2 0.0 1.0 0.6 0.7 0.5 4.1 2.4 1.2 0.8 0.8 0.0 1.0 6.6 2.3 4.4 0.0 0.2 3.6 2.6 0.7 0.9 6.4 1.6 0.7 AMER3 "FAM123C, FLJ38377" ENSG00000178171 "APC membrane recruitment protein 3" Q8N944 2 130755540-130768134 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 14.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA045593, HPA054230" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 6: Brain - Smell perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA045593: AB_10965021, HPA054230: AB_2682423" "unprognostic (6.68e-2)" "unprognostic (3.73e-1)" "unprognostic (2.17e-2)" "unprognostic (1.83e-1)" "unprognostic (2.71e-1)" "unprognostic (5.33e-3)" "unprognostic (1.51e-1)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (6.46e-3)" 0.0 0.6 4.0 0.0 4.5 0.1 0.0 14.6 8.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.7 3.2 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.9 0.0 2.8 0.0 1.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.3 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 4.5 14.6 8.1 3.7 3.2 1.2 0.2 1.0 0.0 1.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.6 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.1 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 5.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AMIGO1 "AMIGO, KIAA1163" ENSG00000181754 "Adhesion molecule with Ig like domain 1" Q86WK6 1 109504178-109509738 "Predicted membrane proteins, Transporters" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 33.6;Excitatory neurons: 9.6;Inhibitory neurons: 15.9;Rod photoreceptor cells: 9.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Lineage enhanced" "Detected in single" "T-cells: 2.3" "Cell line enhanced" "Detected in many" "SK-BR-3: 11.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046152 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Nucleoplasm, Nuclear bodies" "HPA046152: AB_2679559" "unprognostic (1.35e-1)" "unprognostic (3.94e-1)" "unprognostic (2.32e-2)" "unprognostic (4.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.44e-2)" "unprognostic (9.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.16e-3)" "unprognostic (3.11e-1)" "unprognostic (9.06e-3)" "unprognostic (1.82e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" 3.8 10.7 12.7 2.7 13.8 0.4 3.2 11.7 20.0 3.6 8.2 6.9 2.1 4.3 11.7 2.8 3.3 2.8 8.6 14.3 12.6 5.2 2.8 4.6 4.1 11.5 10.7 8.8 6.8 12.4 7.4 1.9 12.5 6.3 2.4 23.4 7.6 7.7 19.3 2.4 3.8 4.5 7.9 3.3 4.6 2.9 12.6 2.7 6.5 11.9 3.3 3.9 2.8 11.8 2.3 1.1 2.4 8.3 3.0 1.3 2.9 3.6 2.0 4.4 2.1 0.5 0.1 0.1 1.0 2.5 1.0 1.2 6.5 0.2 3.7 0.9 0.5 0.0 1.6 0.7 2.5 1.9 4.6 0.6 2.8 1.5 0.0 0.4 1.1 1.3 1.9 0.0 0.1 4.1 0.4 3.9 1.3 2.0 2.5 0.6 0.0 0.3 5.1 1.1 8.1 2.7 0.9 11.0 3.2 1.0 3.2 2.8 1.0 0.1 4.8 3.0 1.5 0.2 0.0 0.0 1.6 0.0 2.4 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.9 1.1 0.0 0.0 2.3 1.7 0.0 0.9 0.0 0.0 0.7 0.4 12.7 13.8 11.7 20.0 14.3 12.6 11.5 10.7 12.5 7.9 12.6 11.8 0.6 3.2 2.0 5.9 0.2 0.6 0.4 0.3 0.6 33.6 2.4 1.4 8.9 1.5 0.3 3.7 4.2 1.3 0.6 1.5 0.0 1.2 0.0 0.4 0.4 1.6 4.8 0.0 9.6 0.9 0.2 1.9 0.0 0.7 0.0 1.4 1.1 1.0 0.2 5.0 15.9 1.0 2.0 0.6 0.0 0.1 2.1 0.2 0.0 2.8 0.8 6.7 0.0 3.0 2.1 0.8 1.6 5.7 0.1 1.1 2.3 0.8 0.1 9.4 0.0 4.3 1.5 1.2 1.4 0.2 0.4 0.3 1.8 0.9 1.5 0.3 AMZ2 ENSG00000196704 "Archaelysin family metallopeptidase 2" Q86W34 17 68205481-68257712 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 477.3;Early spermatids: 736.8;Late spermatids: 1665.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023299, HPA052406" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies, Cytosol" "HPA023299: AB_2226909, HPA052406: AB_2681818" "unprognostic (3.04e-1)" "unprognostic (3.68e-2)" "unprognostic (3.93e-2)" "unprognostic (3.27e-3)" "unprognostic (3.32e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.43e-1)" "unprognostic (3.92e-2)" "unprognostic (2.83e-3)" "unprognostic (3.59e-3)" "unprognostic (3.37e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.37e-1)" "unprognostic (2.95e-1)" "unprognostic (3.28e-1)" "unprognostic (7.62e-2)" 52.3 51.8 54.5 32.6 66.4 36.4 45.0 57.1 87.2 41.2 50.0 57.8 26.2 44.5 53.4 38.4 52.5 37.9 77.0 59.5 56.6 59.2 38.1 32.9 54.0 58.8 56.7 48.7 45.3 64.4 59.1 29.5 58.0 41.6 32.9 78.5 40.0 51.2 95.6 43.1 36.9 41.7 55.3 43.3 39.7 194.4 60.0 53.2 53.3 86.8 51.7 48.5 36.5 61.4 94.6 98.9 87.5 72.9 65.6 113.4 140.0 71.0 88.3 116.1 93.7 42.3 60.4 142.6 74.9 104.8 107.0 46.0 68.6 198.5 154.0 50.2 67.7 52.8 38.6 83.1 124.9 49.8 86.9 96.9 213.9 107.5 206.2 113.0 118.9 121.7 54.6 86.5 150.9 67.3 110.2 45.4 43.5 51.1 98.5 41.3 238.9 106.7 71.2 50.1 85.7 67.2 64.8 125.5 130.9 184.6 100.7 33.5 65.2 143.8 72.0 55.8 74.8 121.9 121.9 255.7 105.1 69.0 79.1 76.6 25.2 35.3 34.8 30.3 46.2 30.7 43.2 46.0 30.3 41.3 37.8 40.4 45.1 63.7 40.9 28.1 58.3 36.9 54.5 66.4 57.1 87.2 59.5 56.6 58.8 56.7 58.0 55.3 60.0 61.4 18.5 12.8 15.6 477.3 38.7 18.6 31.6 58.4 30.1 13.8 29.7 34.3 81.4 21.5 32.8 23.9 8.4 64.0 58.0 9.4 109.5 28.8 736.8 28.4 17.2 24.4 21.1 21.0 36.4 26.0 66.9 28.2 14.8 18.5 34.1 28.9 21.4 15.5 41.8 18.5 30.0 16.7 40.7 26.1 71.0 1665.0 36.1 39.0 56.9 27.2 46.4 65.7 69.0 56.8 47.7 25.4 10.8 32.7 46.2 17.7 15.2 69.0 61.8 12.8 19.7 26.5 26.8 274.4 59.4 26.4 22.6 34.2 49.3 26.1 15.1 24.5 ANGEL2 "Ccr4d, FLJ12793, KIAA0759L" ENSG00000174606 "Angel homolog 2" Q5VTE6 1 212992182-213015867 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030795, HPA030796" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Mitochondria" "HPA030795: , HPA030796: AB_10600979" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (8.73e-2)" "unprognostic (2.76e-1)" "unprognostic (2.04e-2)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (2.70e-3)" "unprognostic (6.46e-2)" "prognostic unfavorable (8.39e-6)" "unprognostic (9.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.20e-4)" 7.5 6.6 13.1 6.9 14.9 6.4 10.4 11.1 14.7 7.9 9.2 6.6 5.2 8.6 8.1 5.9 7.4 6.1 5.8 12.8 11.1 7.7 8.0 6.6 10.5 10.6 10.8 10.8 6.7 7.8 6.2 6.5 10.1 8.2 6.4 9.2 6.0 6.2 7.3 9.1 7.2 7.1 10.1 9.8 6.3 5.5 13.1 10.2 8.1 7.1 9.2 7.1 6.3 11.6 12.2 9.6 15.2 13.2 11.5 16.8 13.6 9.8 16.3 15.4 15.3 6.3 8.9 11.8 8.8 9.7 8.5 9.4 17.8 9.4 15.5 22.3 10.6 11.9 7.4 6.3 12.5 11.8 13.6 10.4 11.9 12.1 12.2 13.1 13.2 10.4 13.9 11.8 18.0 4.0 13.6 7.9 36.4 6.6 6.8 6.9 27.4 12.4 12.1 8.2 7.5 21.7 11.9 15.7 18.3 16.2 12.2 8.6 9.8 12.7 6.7 15.7 15.1 8.6 8.9 7.9 14.2 8.7 11.9 6.6 4.4 5.9 5.1 4.3 6.5 5.7 6.4 5.4 5.5 3.5 6.7 5.7 2.7 10.9 3.5 3.3 8.9 5.2 13.1 14.9 11.1 14.7 12.8 11.1 10.6 10.8 10.1 10.1 13.1 11.6 23.1 48.1 9.8 26.8 23.8 6.9 8.5 11.7 12.5 21.2 14.6 10.2 15.2 17.2 14.5 12.9 10.4 14.8 26.2 7.6 11.7 10.3 1.5 11.3 19.8 15.9 6.7 18.1 33.2 10.5 15.0 18.0 14.3 11.7 17.1 28.8 16.1 12.5 11.8 28.6 26.3 8.4 14.2 20.4 10.5 2.6 15.5 17.1 3.6 30.0 17.3 11.6 16.5 30.2 49.3 10.2 6.4 13.9 24.2 10.8 10.7 16.9 22.5 17.8 19.7 21.7 16.1 9.5 16.6 12.7 7.0 10.9 25.8 17.9 8.0 7.4 ANKMY1 "FLJ20499, ZMYND13" ENSG00000144504 "Ankyrin repeat and MYND domain containing 1" Q9P2S6 2 240479422-240569209 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 67.9" "Cell type enhanced" "Detected in many" "Early spermatids: 187.5;Late spermatids: 213.1;Respiratory ciliated cells: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA026620, HPA048869" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026620: AB_1844834, HPA048869: " "unprognostic (2.89e-3)" "unprognostic (1.03e-1)" "unprognostic (3.83e-2)" "unprognostic (3.22e-3)" "unprognostic (3.46e-1)" "unprognostic (3.97e-5)" "unprognostic (8.32e-2)" "unprognostic (1.19e-1)" "unprognostic (4.40e-3)" "unprognostic (1.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.36e-2)" "unprognostic (2.59e-5)" "unprognostic (2.01e-1)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "prognostic favorable (3.20e-4)" 4.9 4.4 6.4 5.7 7.6 12.5 6.3 6.0 7.3 7.5 6.1 6.0 6.5 5.4 8.7 5.8 24.6 4.7 3.4 5.4 4.9 5.0 6.2 6.9 9.0 8.1 12.3 7.4 8.6 6.2 4.5 3.9 8.0 6.6 5.5 3.8 5.1 5.2 3.5 8.2 7.2 3.0 8.0 8.2 9.6 67.9 7.1 7.1 6.5 2.1 6.7 5.7 6.4 11.1 7.0 15.2 3.2 6.0 2.9 4.1 13.4 3.3 5.0 2.7 3.6 4.9 14.2 7.0 0.6 3.7 4.1 7.6 6.2 7.8 3.2 12.9 5.2 13.9 8.6 13.0 2.4 7.8 12.8 6.6 18.7 2.5 17.7 8.2 2.8 11.0 13.2 8.8 4.6 6.7 7.2 12.8 2.7 12.1 9.0 20.1 9.8 11.1 4.1 15.0 7.5 5.6 2.7 7.2 10.0 3.9 6.2 11.9 3.6 10.0 3.3 4.0 5.9 20.0 5.5 7.0 5.7 11.8 7.9 0.0 2.1 4.5 4.6 1.8 2.7 2.8 2.8 2.9 2.7 4.1 4.1 3.0 0.9 1.3 2.3 1.8 0.9 2.4 6.4 7.6 6.0 7.3 5.4 4.9 8.1 12.3 8.0 8.0 7.1 11.1 3.0 0.0 8.1 23.8 7.2 0.9 1.8 5.3 13.1 3.5 4.3 3.7 2.2 1.5 10.1 3.7 4.2 3.0 8.1 4.8 1.9 2.7 187.5 40.8 3.6 3.5 4.2 6.5 17.0 4.3 1.7 2.8 16.8 4.5 5.7 4.8 2.9 6.4 2.7 3.3 25.4 4.5 6.1 7.6 2.0 213.1 4.1 6.7 0.0 38.4 5.5 2.6 7.2 21.1 42.9 3.2 2.2 3.0 3.4 2.8 5.7 2.9 62.6 4.0 0.0 2.2 3.5 28.8 8.9 5.0 2.3 2.9 8.6 2.9 4.7 2.0 ANKRD29 FLJ25053 ENSG00000154065 "Ankyrin repeat domain 29" Q8N6D5 18 23598926-23662911 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 163.8;Alveolar cells type 1: 218.0;Cone photoreceptor cells: 66.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.7;BJ hTERT+: 16.6;hTCEpi: 16.2;PC-3: 15.5;U-2197: 20.5;U-87 MG: 21.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041272, HPA049419" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA041272: AB_2677387, HPA049419: AB_2680757" "unprognostic (4.52e-3)" "unprognostic (8.37e-2)" "unprognostic (7.04e-2)" "unprognostic (1.78e-1)" "unprognostic (2.01e-3)" "prognostic favorable (1.92e-5)" "unprognostic (3.29e-2)" "prognostic favorable (5.98e-5)" "unprognostic (1.11e-1)" "unprognostic (1.93e-2)" "unprognostic (3.83e-2)" "unprognostic (3.54e-1)" "prognostic favorable (7.20e-5)" "unprognostic (1.10e-2)" "unprognostic (9.46e-2)" "unprognostic (7.36e-2)" "unprognostic (1.64e-5)" 17.8 7.2 14.1 3.6 6.4 0.2 15.8 9.1 13.5 12.9 10.7 4.7 1.5 15.7 5.3 9.4 13.8 5.6 6.8 13.5 10.4 3.6 1.9 31.3 20.1 11.6 14.8 14.5 1.0 24.8 8.1 0.1 11.5 8.3 2.2 4.9 7.5 8.8 4.4 4.4 6.6 11.7 6.8 2.6 15.1 3.7 9.4 3.8 3.3 3.9 14.3 6.6 13.0 10.1 2.4 6.7 0.0 0.0 1.6 16.7 0.1 6.6 16.6 2.6 3.3 3.0 0.6 0.0 0.9 3.2 12.9 3.4 0.0 8.7 0.6 0.2 5.9 0.0 4.3 0.2 0.3 0.0 0.5 4.4 16.2 2.6 4.4 2.4 1.7 0.0 0.0 0.4 4.4 0.7 0.0 0.0 1.2 5.7 15.5 0.0 0.4 1.5 4.1 2.4 1.0 8.0 1.7 0.3 0.1 0.3 1.9 0.1 3.9 0.4 2.3 20.5 6.0 0.0 0.0 0.0 21.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 14.1 6.4 9.1 13.5 13.5 10.4 11.6 14.8 11.5 6.8 9.4 10.1 163.8 218.0 38.7 27.4 0.2 5.1 10.1 5.0 5.2 6.0 5.1 16.6 9.7 8.6 6.3 1.8 66.7 0.0 1.1 0.3 5.9 2.5 40.0 10.2 18.7 39.0 1.8 0.4 22.1 1.1 0.0 6.6 25.5 0.8 3.8 9.7 15.4 0.9 2.3 42.1 27.6 1.7 0.0 0.8 3.3 25.2 7.2 3.6 7.2 22.5 0.2 1.3 0.0 8.5 1.3 11.4 1.2 20.3 1.5 5.1 11.5 10.1 1.6 4.3 13.1 12.1 40.6 2.3 2.6 20.1 2.8 0.0 0.8 21.5 2.5 3.6 ANKRD62 DKFZp779B1634 ENSG00000181626 "Ankyrin repeat domain 62" A6NC57 18 12093843-12129764 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 1.1;pancreas: 1.0;testis: 1.6" "Cell type enriched" "Detected in some" 5 "Spermatocytes: 92.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059835 Enhanced Uncertain "Nucleoplasm,Nuclear bodies,Actin filaments" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "Actin filaments" "HPA059835: AB_2684136" "unprognostic (2.45e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-3)" "unprognostic (9.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (6.61e-2)" "unprognostic (7.95e-2)" "unprognostic (3.27e-1)" "unprognostic (2.55e-4)" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (4.52e-3)" "unprognostic (8.70e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.4 0.0 0.6 0.0 0.7 0.0 0.0 0.4 0.1 0.0 1.3 0.3 0.1 0.4 0.3 0.0 0.0 1.7 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.2 0.1 0.2 0.5 0.0 0.0 16.5 1.7 0.6 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.6 0.8 2.6 0.6 0.2 0.0 1.0 0.0 0.1 1.0 1.0 0.2 0.5 1.1 0.4 0.0 0.8 0.2 0.0 0.0 0.9 0.0 1.3 0.3 92.8 15.8 0.5 1.1 0.0 0.2 0.1 0.2 0.5 ANKZF1 "FLJ10415, Vms1, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1" Q9H8Y5 2 219229783-219236679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 9.1 9.2 7.8 8.8 8.6 7.8 10.8 9.9 9.8 13.8 9.6 13.1 9.6 10.1 3.2 15.2 13.5 6.1 14.1 7.9 8.0 13.9 14.4 10.7 13.7 10.1 8.5 16.0 15.6 6.4 12.5 5.9 9.3 15.1 5.2 8.2 15.3 5.6 16.9 17.3 15.2 4.6 7.9 18.1 14.2 7.9 8.7 11.9 11.9 8.1 8.3 12.4 15.0 10.5 31.6 6.1 8.1 11.8 10.6 8.8 32.5 10.1 10.0 13.6 17.2 14.9 13.2 6.6 18.0 4.3 15.3 22.7 10.5 17.5 10.0 13.9 11.0 14.6 19.1 13.9 10.6 9.6 13.7 8.9 33.1 10.1 15.9 22.6 9.4 17.0 24.8 14.9 6.9 13.6 14.1 24.1 13.5 13.7 10.9 14.3 9.9 21.4 7.6 7.9 10.3 10.5 11.9 23.9 19.8 19.5 6.4 23.7 10.3 11.4 8.7 10.1 13.3 31.6 19.9 12.9 19.4 13.8 5.1 9.9 9.1 11.0 16.1 9.0 17.4 13.0 16.3 16.2 9.4 13.3 19.0 18.0 12.3 24.4 14.0 9.8 17.1 13.6 7.8 8.6 9.9 9.8 7.9 8.0 10.1 8.5 9.3 7.9 8.7 10.5 10.2 16.0 17.2 24.2 28.0 9.3 14.5 28.9 9.6 39.8 14.4 13.6 9.2 11.5 24.8 12.9 31.3 10.5 32.7 17.3 13.7 20.5 4.4 28.2 9.7 11.8 9.6 19.6 19.0 12.6 27.2 8.9 17.9 13.0 21.6 21.4 8.6 13.1 7.7 32.0 21.0 19.1 20.3 8.2 5.3 4.0 23.9 10.9 10.6 6.5 15.6 18.0 43.3 13.6 25.3 14.2 16.0 16.6 17.7 13.6 25.2 16.5 65.1 55.4 6.6 13.2 12.8 10.1 17.0 8.3 9.9 11.6 30.0 21.3 17.6 11.1 APOL6 "APOL-VI, APOLVI" ENSG00000221963 "Apolipoprotein L6" Q9BWW8 22 35648446-35668404 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 46.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 135.9;NK-cells: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB028574, HPA029165, HPA029167" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 85: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" Cytosol "CAB028574: , HPA029165: AB_10670037, HPA029167: AB_10670832" "unprognostic (7.25e-3)" "unprognostic (2.67e-2)" "unprognostic (1.09e-2)" "unprognostic (1.07e-1)" "unprognostic (2.76e-1)" "unprognostic (1.55e-1)" "unprognostic (2.32e-2)" "unprognostic (8.29e-2)" "unprognostic (3.76e-2)" "unprognostic (6.26e-3)" "unprognostic (1.46e-3)" "unprognostic (1.46e-1)" "unprognostic (6.65e-3)" "unprognostic (2.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.71e-2)" "prognostic favorable (6.61e-4)" 23.4 7.3 4.1 15.8 4.3 16.1 10.0 3.4 4.0 6.8 3.3 13.2 19.2 5.5 5.5 5.9 6.6 9.1 4.2 3.9 5.1 6.4 46.5 15.5 15.5 8.7 5.0 12.2 2.9 2.6 2.4 7.8 5.8 7.9 11.8 2.6 14.0 5.1 3.1 4.5 19.7 7.4 6.7 18.2 14.0 2.3 4.9 10.1 8.5 3.9 10.4 13.2 3.7 5.4 12.8 4.1 0.3 1.5 30.1 15.0 17.3 5.3 14.2 17.3 21.7 2.0 14.2 17.7 2.6 14.0 12.6 16.2 0.1 8.6 4.5 33.6 0.1 7.4 2.6 4.0 23.7 10.4 12.4 19.3 5.7 5.9 3.3 3.9 3.6 8.0 0.8 31.2 3.2 1.3 14.6 3.2 0.5 0.9 5.3 6.1 6.8 8.7 7.6 28.9 0.4 0.2 8.5 7.2 10.0 1.1 1.2 12.1 3.9 4.3 2.6 3.0 2.8 16.4 14.2 1.7 8.1 16.2 6.1 7.5 4.8 2.6 7.3 7.6 6.1 1.0 4.8 5.8 2.4 0.7 4.6 5.3 7.5 5.0 8.5 0.3 5.5 4.2 4.1 4.3 3.4 4.0 3.9 5.1 8.7 5.0 5.8 6.7 4.9 5.4 58.6 70.5 34.3 6.8 15.7 8.0 10.8 14.7 13.6 0.2 16.8 10.8 7.3 34.3 38.6 12.9 0.0 8.3 79.1 101.1 9.8 33.6 10.5 18.4 48.9 33.4 47.3 11.6 0.2 41.9 35.6 33.4 41.8 17.2 36.8 12.2 39.3 135.9 34.9 0.0 1.3 55.3 20.3 58.1 19.9 7.4 26.1 50.5 8.8 17.8 68.5 3.8 126.7 9.5 2.1 45.7 43.7 18.8 51.0 43.2 88.6 31.6 47.4 0.0 0.0 25.3 22.0 0.5 0.2 15.6 5.3 2.5 67.7 6.0 35.9 62.0 ARHGAP35 "GRF-1, GRLF1, KIAA1722, P190A, p190ARhoGAP, p190RhoGAP" ENSG00000160007 "Rho GTPase activating protein 35" Q9NRY4 19 46860997-47005077 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, GTPase activation, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 186.4;Late spermatids: 651.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037311, HPA055184, HPA056470" Approved Supported "Nuclear bodies,Aggresome" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 15: RT4 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" Aggresome "CAB037311: AB_477435, HPA055184: AB_2682730, HPA056470: AB_2683142" "unprognostic (5.47e-3)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (2.40e-2)" "unprognostic (2.01e-2)" "unprognostic (7.78e-3)" "unprognostic (9.82e-3)" "unprognostic (4.41e-2)" "unprognostic (2.71e-1)" "unprognostic (2.73e-2)" "unprognostic (3.25e-2)" "unprognostic (1.92e-1)" "prognostic favorable (5.55e-8)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (1.04e-1)" "unprognostic (1.16e-1)" 13.6 10.1 35.7 8.0 31.5 5.3 16.1 16.8 31.1 12.9 9.2 14.8 12.9 12.8 10.6 15.7 12.8 9.1 25.8 37.0 27.3 19.1 22.3 14.9 8.7 26.0 32.3 17.3 13.6 31.3 14.1 7.8 34.5 13.4 12.3 16.6 15.7 15.7 29.4 11.6 16.3 12.9 19.8 8.8 10.9 40.3 33.3 10.8 20.2 24.2 9.0 13.1 9.0 25.1 52.0 56.7 37.9 34.0 33.9 27.9 6.4 27.3 38.7 27.1 31.0 30.6 18.0 27.4 19.1 112.0 41.2 30.8 34.8 35.3 36.9 19.3 14.7 37.2 40.1 24.1 31.7 22.3 30.4 28.3 35.1 30.6 32.5 37.9 24.7 18.2 25.2 9.9 31.4 30.3 21.8 35.4 19.9 37.4 20.8 24.1 26.0 8.5 23.0 100.0 37.9 36.1 50.5 47.5 20.0 23.4 44.6 27.1 31.3 23.9 18.9 26.2 33.0 10.1 19.6 21.7 53.6 22.8 59.7 0.3 0.2 0.2 0.6 0.2 0.6 0.1 0.6 0.7 0.3 0.2 0.2 0.2 0.1 0.2 0.3 0.3 0.2 0.3 35.7 31.5 16.8 31.1 37.0 27.3 26.0 32.3 34.5 19.8 33.3 25.1 15.7 44.8 38.4 47.7 8.6 15.2 13.9 20.1 19.4 31.9 35.2 23.0 58.2 27.1 21.4 25.8 25.0 3.7 14.8 61.0 7.9 14.6 186.4 17.8 19.0 19.5 31.2 16.6 42.4 20.0 1.0 19.1 19.9 34.1 9.5 30.9 27.8 89.7 15.0 69.0 48.8 18.5 14.2 19.5 7.8 651.3 23.3 11.0 21.4 32.8 14.2 28.2 18.6 37.2 58.2 20.9 21.4 25.6 6.7 23.3 44.5 22.6 10.4 22.0 19.7 22.6 24.9 45.9 23.5 24.4 16.6 1.6 16.1 29.5 25.7 17.0 ARHGEF19 "FLJ33962, WGEF" ENSG00000142632 "Rho guanine nucleotide exchange factor 19" Q8IW93 1 16197854-16212652 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 26.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 17.6;HaCaT: 14.4;T-47d: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA068108 Approved "Nuclear bodies" No No "Cluster 22: NK-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 33: Fibroblasts - ECM organization" "Nuclear bodies" "HPA068108: AB_2685956" "unprognostic (2.19e-2)" "unprognostic (1.85e-3)" "unprognostic (1.33e-1)" "unprognostic (3.52e-2)" "unprognostic (1.27e-1)" "unprognostic (1.74e-2)" "unprognostic (9.45e-2)" "prognostic favorable (6.53e-4)" "unprognostic (4.01e-2)" "unprognostic (2.43e-2)" "unprognostic (2.07e-2)" "unprognostic (1.65e-2)" "prognostic unfavorable (8.88e-5)" "unprognostic (3.72e-2)" "unprognostic (2.84e-1)" "unprognostic (1.26e-1)" "unprognostic (1.80e-1)" 2.9 10.1 0.9 2.7 0.7 0.9 5.0 0.7 1.3 8.7 0.8 2.8 2.3 6.0 1.1 15.9 6.4 2.1 2.2 0.7 0.9 4.2 1.5 3.2 1.6 0.9 0.8 6.9 7.9 2.1 1.8 3.1 0.7 8.4 0.9 0.2 17.2 4.5 0.8 26.3 3.0 1.5 0.7 2.8 6.2 1.5 0.8 1.8 12.0 0.4 2.3 6.1 11.4 0.7 17.6 4.6 2.4 4.9 0.3 1.4 0.9 4.3 4.1 2.4 3.3 6.9 2.7 0.0 3.4 3.9 1.8 14.4 1.0 1.6 0.6 2.9 0.4 1.4 11.7 0.5 5.7 0.8 5.6 4.4 0.9 6.3 1.8 0.5 0.7 5.5 3.2 3.8 1.0 3.7 2.0 2.0 0.7 2.5 4.9 6.8 2.2 4.1 0.9 1.3 1.7 2.9 3.3 2.0 0.8 0.2 25.7 2.9 1.8 0.0 7.6 3.9 0.0 4.1 6.7 1.0 0.0 4.3 6.6 0.0 0.5 0.4 0.9 0.2 0.9 0.7 0.8 0.7 0.6 0.5 0.8 0.4 0.0 0.8 0.0 0.6 0.5 0.5 0.9 0.7 0.7 1.3 0.7 0.9 0.9 0.8 0.7 0.7 0.8 0.7 6.1 6.4 6.0 1.3 3.9 4.7 9.3 8.8 14.2 0.5 8.6 8.0 0.5 2.8 8.8 0.0 0.0 1.7 6.5 3.8 0.0 5.7 0.2 7.0 4.5 4.6 0.0 4.2 0.0 5.7 4.9 4.5 3.6 7.8 9.5 2.1 7.5 1.0 2.6 0.0 0.1 5.2 8.2 4.4 1.4 0.0 7.8 1.9 3.6 2.8 2.4 5.3 7.2 1.0 0.0 4.7 5.2 3.4 3.1 2.3 2.5 1.6 4.0 0.3 0.0 4.7 3.9 1.8 6.8 10.7 7.7 1.2 5.4 3.0 4.7 6.4 ARMT1 "C6orf211, FLJ12910" ENSG00000146476 "Acidic residue methyltransferase 1" Q9H993 6 151452258-151470101 "Predicted intracellular proteins" "DNA damage" "Hydrolase, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003004, HPA005819" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 410000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA003004: AB_1078358, HPA005819: AB_1845741" "unprognostic (5.16e-3)" "prognostic unfavorable (7.09e-4)" "prognostic favorable (4.14e-4)" "unprognostic (6.39e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (1.37e-2)" "unprognostic (9.47e-2)" "unprognostic (2.33e-2)" "unprognostic (2.16e-1)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.16e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-2)" "unprognostic (4.12e-1)" "unprognostic (1.22e-1)" 17.1 16.0 8.5 15.3 9.5 5.5 25.0 9.6 12.2 16.1 8.3 16.6 18.9 16.0 16.1 12.0 12.6 11.3 16.8 8.6 10.0 41.5 37.6 19.5 21.0 9.0 9.1 11.9 6.8 11.6 5.3 22.2 9.1 12.2 17.6 16.4 7.6 11.1 19.0 8.8 14.5 14.9 9.6 12.8 14.1 14.1 9.8 15.6 27.7 22.6 18.5 17.3 8.1 9.0 24.6 18.4 37.9 34.2 30.3 47.4 60.9 44.8 39.1 36.9 48.4 47.8 19.7 36.2 29.5 31.8 33.7 24.2 112.7 33.5 61.7 40.6 34.9 26.0 21.7 55.9 37.8 50.1 31.7 38.2 23.3 49.3 29.2 30.6 52.8 27.0 38.5 44.3 46.4 101.8 31.7 47.4 64.4 23.7 15.3 41.0 32.7 28.6 112.6 31.2 15.6 10.2 37.5 34.9 23.8 67.4 98.9 38.6 44.6 17.9 25.0 66.8 36.3 21.1 28.5 43.7 31.7 60.7 21.6 53.8 26.9 52.0 13.5 34.5 18.1 17.5 17.4 14.5 22.9 14.7 15.9 14.8 22.1 21.0 33.4 8.5 25.1 21.1 8.5 9.5 9.6 12.2 8.6 10.0 9.0 9.1 9.1 9.6 9.8 9.0 16.3 25.6 40.4 6.5 13.2 0.0 8.4 0.0 11.4 10.0 33.5 16.3 18.6 14.3 6.2 23.9 8.4 31.7 12.6 10.6 45.0 19.5 1.4 19.4 29.3 10.6 4.9 6.5 11.4 17.8 39.0 14.2 12.2 23.3 3.8 7.7 15.4 48.7 35.4 8.4 9.8 8.9 0.0 34.0 0.0 3.1 19.3 23.6 0.0 5.6 36.0 17.3 18.6 6.6 8.9 19.5 7.2 14.7 15.2 5.4 18.6 79.3 10.9 20.9 0.0 6.7 14.3 25.2 14.8 11.1 0.0 36.0 14.0 15.5 10.7 9.6 ARNT "bHLHe2, HIF-1beta" ENSG00000143437 "Aryl hydrocarbon receptor nuclear translocator" P27540 1 150809713-150876708 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 7 "U-698: 397.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001759, CAB004318" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 85: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 2: Hepatocytes - Metabolism" "Nucleoplasm, Nuclear bodies" "CAB004318: AB_626698, HPA001759: AB_1078213" "unprognostic (1.81e-1)" "unprognostic (8.14e-2)" "unprognostic (6.87e-2)" "unprognostic (5.76e-2)" "unprognostic (1.86e-1)" "unprognostic (4.10e-2)" "unprognostic (9.43e-2)" "unprognostic (5.27e-3)" "unprognostic (5.05e-1)" "unprognostic (3.42e-2)" "unprognostic (1.22e-1)" "unprognostic (9.52e-2)" "unprognostic (1.85e-3)" "unprognostic (2.68e-1)" "unprognostic (4.67e-1)" "unprognostic (6.45e-2)" "unprognostic (6.92e-2)" 25.8 20.4 9.6 18.1 9.6 17.1 22.7 16.2 12.2 31.8 16.5 19.5 15.0 27.4 14.8 19.2 25.0 20.5 20.7 8.9 10.7 17.8 42.9 24.7 17.5 10.4 9.5 37.7 28.6 19.6 12.5 31.2 10.2 16.3 21.2 39.1 15.5 17.6 32.3 23.9 17.0 29.0 8.0 19.5 19.0 17.3 10.9 20.4 19.6 28.1 22.4 21.3 24.0 11.2 17.1 17.2 25.6 19.5 53.4 50.9 34.2 19.0 36.9 25.2 22.7 15.1 17.0 18.3 16.5 34.0 12.4 19.1 24.2 21.3 21.9 29.3 13.8 21.4 28.7 17.6 31.0 26.4 24.7 39.9 20.0 30.7 26.9 30.6 31.3 24.4 27.9 34.9 26.3 33.8 21.1 15.0 21.2 30.9 13.0 26.1 30.8 25.5 20.6 17.4 17.6 25.1 36.6 25.3 15.2 34.4 32.6 59.4 22.6 20.9 18.8 16.8 16.8 39.8 30.8 397.5 25.5 0.9 14.4 46.6 23.6 21.2 12.1 21.6 11.1 8.7 10.0 11.7 18.7 8.7 9.5 9.8 11.9 12.0 23.4 7.8 11.1 16.2 9.6 9.6 16.2 12.2 8.9 10.7 10.4 9.5 10.2 8.0 10.9 11.2 14.8 12.8 10.3 28.1 14.9 14.1 9.9 11.0 8.0 23.6 10.2 6.9 12.8 24.3 11.6 11.0 54.2 24.5 12.6 13.3 3.9 11.2 5.0 10.3 23.3 14.8 20.4 16.6 41.6 9.7 37.1 25.4 8.6 20.6 3.8 17.1 30.0 47.7 20.3 6.7 47.5 16.5 8.2 39.1 20.1 4.3 32.3 20.0 10.6 39.4 27.9 7.9 13.4 41.7 50.9 9.6 8.1 32.7 13.0 8.8 10.1 13.1 9.7 38.3 13.1 17.0 19.4 18.4 16.7 11.0 15.3 29.6 12.7 20.7 9.0 10.0 ATF7IP "FLJ10688, p621" ENSG00000171681 "Activating transcription factor 7 interacting protein" Q6VMQ6 12 14365632-14502935 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016578, HPA023505" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" "HPA016578: AB_1845147, HPA023505: AB_1845148" "unprognostic (2.06e-2)" "unprognostic (3.12e-2)" "unprognostic (1.25e-1)" "unprognostic (6.25e-3)" "unprognostic (1.20e-3)" "unprognostic (2.48e-2)" "unprognostic (5.84e-2)" "unprognostic (8.56e-3)" "unprognostic (7.36e-2)" "unprognostic (3.05e-2)" "unprognostic (3.62e-2)" "unprognostic (1.86e-1)" "unprognostic (7.90e-3)" "unprognostic (2.88e-1)" "unprognostic (7.64e-2)" "unprognostic (1.14e-2)" "unprognostic (3.78e-2)" 12.4 10.4 12.1 16.8 18.8 30.9 14.7 32.8 11.7 12.8 21.7 11.2 8.3 15.6 13.7 14.3 13.4 11.8 16.3 9.9 14.1 11.0 14.4 13.3 28.2 16.9 15.5 17.9 11.5 17.2 8.5 14.2 15.8 13.4 13.0 17.1 20.6 12.0 16.4 16.7 11.9 16.4 11.2 20.8 14.2 33.8 18.8 32.5 21.7 21.2 28.1 12.6 11.4 21.3 23.2 13.8 54.3 31.7 27.9 35.2 11.4 24.4 13.7 18.8 28.6 31.4 23.9 38.5 16.2 16.6 34.3 23.0 34.3 22.4 42.3 27.5 20.1 25.8 23.3 6.5 16.6 17.7 15.1 19.0 18.3 23.2 23.9 29.3 41.5 13.6 15.6 19.7 29.9 21.7 25.5 15.4 35.1 11.9 12.7 52.3 60.3 21.0 16.2 44.6 17.4 14.2 27.7 16.0 15.4 44.0 16.2 20.5 19.2 26.3 16.7 14.9 20.3 13.2 13.9 53.1 16.7 16.5 29.0 29.2 11.6 19.4 16.2 8.3 16.8 23.1 13.6 16.0 9.8 30.9 10.9 15.5 17.8 11.4 14.2 12.9 18.7 11.0 12.1 18.8 32.8 11.7 9.9 14.1 16.9 15.5 15.8 11.2 18.8 21.3 46.6 67.3 42.5 67.9 121.2 6.6 12.8 9.7 75.1 50.2 31.6 24.6 73.0 20.0 26.6 35.0 68.8 17.2 112.1 13.2 7.9 16.6 79.6 31.1 34.7 40.3 28.1 55.1 62.6 12.2 10.9 32.0 41.8 31.9 25.9 34.8 30.0 31.3 20.5 63.9 73.9 19.6 10.2 48.4 11.2 19.6 29.2 46.3 5.4 107.7 47.9 23.5 64.9 136.7 147.9 14.5 13.5 29.3 85.9 13.6 12.0 16.4 24.3 39.8 13.1 40.0 33.3 42.4 25.0 62.7 6.7 15.5 98.5 35.1 18.3 12.1 ATMIN "ASCIZ, KIAA0431, ZNF822" ENSG00000166454 "ATM interactor" O43313 16 81035842-81047350 "Predicted intracellular proteins" "DNA damage, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 180.6;Late spermatids: 288.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054967, HPA066900" Approved Supported "Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "HPA054967: AB_2682654, HPA066900: AB_2685744" "unprognostic (9.92e-2)" "unprognostic (3.31e-1)" "unprognostic (4.47e-2)" "unprognostic (1.63e-1)" "unprognostic (1.23e-1)" "unprognostic (9.32e-2)" "unprognostic (4.69e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" "unprognostic (6.51e-3)" "unprognostic (1.48e-1)" "unprognostic (4.26e-2)" "prognostic favorable (6.80e-4)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (1.24e-1)" "unprognostic (4.60e-1)" 15.9 12.7 18.9 11.4 19.6 7.9 14.4 18.2 23.5 13.5 14.6 12.9 12.8 13.8 18.0 18.9 11.4 11.5 14.2 19.6 21.6 19.7 17.9 10.7 13.9 19.6 21.7 14.3 16.1 27.0 13.1 20.4 22.8 17.6 13.7 10.3 12.8 14.8 16.0 17.6 12.9 13.7 17.6 12.9 12.7 22.6 21.5 15.6 20.6 17.0 15.0 14.2 12.0 18.4 26.7 22.0 28.6 33.7 30.6 21.3 42.8 17.1 24.8 15.9 8.8 14.9 14.9 20.8 21.8 25.6 18.3 25.3 28.1 14.7 20.3 13.8 15.6 14.3 13.3 17.4 28.3 24.7 21.6 22.7 24.7 15.4 24.7 26.7 16.6 20.0 22.8 12.4 22.9 42.9 19.9 18.0 33.6 16.6 16.3 34.5 13.8 12.2 25.0 27.5 22.8 29.5 54.3 16.8 14.3 23.7 28.5 22.0 22.0 20.3 20.6 19.9 16.2 19.7 31.6 50.4 18.7 16.1 19.3 0.5 0.8 0.5 1.9 0.6 1.4 1.5 2.0 1.7 0.8 1.6 1.7 1.9 0.2 1.9 0.6 1.0 2.2 0.6 18.9 19.6 18.2 23.5 19.6 21.6 19.6 21.7 22.8 17.6 21.5 18.4 38.6 9.6 19.2 10.7 11.7 12.0 16.3 10.0 10.2 24.9 20.7 16.9 18.6 20.0 15.5 23.9 20.9 42.3 25.8 21.4 11.7 12.6 180.6 13.3 37.2 19.3 11.5 7.4 16.1 14.0 38.4 17.9 15.8 22.4 16.5 15.2 22.9 21.6 29.7 13.5 17.7 13.7 6.1 23.9 6.0 288.9 19.9 14.3 14.2 3.7 19.2 32.5 12.3 8.0 16.9 18.5 11.2 19.5 15.0 15.1 19.9 20.8 7.5 16.6 13.1 24.2 18.0 28.6 25.4 17.2 15.3 30.1 15.5 21.6 16.0 18.4 ATP8B1 "ATPIC, BRIC, FIC1, PFIC, PFIC1" ENSG00000081923 "ATPase phospholipid transporting 8B1" O43520 18 57646426-57803315 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Lipid transport, Transport" Translocase "Disease variant, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 90.2;RT4: 168.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018673, HPA018674" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 37: Intestine - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA018673: AB_1845207, HPA018674: AB_1845208" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "prognostic favorable (2.60e-4)" "unprognostic (8.81e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-1)" "unprognostic (1.39e-1)" "unprognostic (1.02e-1)" "unprognostic (9.62e-3)" "unprognostic (1.97e-1)" "unprognostic (3.30e-3)" "unprognostic (4.55e-3)" "prognostic favorable (6.35e-4)" "unprognostic (1.88e-1)" "unprognostic (2.22e-1)" "unprognostic (3.25e-1)" "unprognostic (8.60e-3)" 9.1 5.4 1.3 8.5 2.0 1.2 9.5 3.6 3.9 16.3 3.0 76.2 30.3 5.9 3.5 14.8 10.6 18.0 4.4 1.7 1.1 6.6 7.7 8.3 2.2 2.1 1.1 2.1 23.3 9.7 2.7 6.9 2.0 17.6 61.7 0.6 20.6 11.5 1.9 8.4 38.2 8.3 1.0 4.6 46.1 0.6 1.9 1.5 22.0 1.8 3.6 30.0 13.0 3.0 32.0 10.7 0.1 0.6 10.5 19.2 11.9 62.6 63.6 67.4 40.4 8.0 24.3 1.5 19.3 90.2 22.3 44.9 0.2 13.9 64.3 0.2 1.1 0.2 2.6 2.5 2.2 0.4 0.6 2.9 12.6 20.8 34.0 39.5 33.0 0.3 0.3 0.7 34.1 15.6 0.1 0.3 0.3 35.5 3.3 0.3 0.2 0.0 7.9 168.1 0.8 0.7 1.3 32.5 0.1 0.5 10.3 0.6 35.3 48.3 2.0 7.7 14.2 0.4 0.4 0.5 1.1 0.4 2.8 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.2 0.6 0.0 0.2 0.1 0.0 0.0 1.3 2.0 3.6 3.9 1.7 1.1 2.1 1.1 2.0 1.0 1.9 3.0 25.9 19.2 27.0 11.1 4.1 7.8 66.7 20.6 10.2 0.7 28.4 10.4 5.4 27.1 48.9 40.5 0.0 25.6 0.6 279.7 0.0 27.0 2.8 26.3 4.0 30.8 68.4 0.4 61.2 53.1 2.7 7.1 98.4 40.1 4.5 0.9 33.2 19.1 2.4 6.7 11.7 180.5 22.4 2.8 4.0 0.4 0.3 1.0 7.2 37.5 0.9 0.1 0.0 20.6 10.7 38.5 116.7 0.0 0.9 70.8 58.2 0.2 44.7 1.2 13.1 2.8 20.7 0.3 1.5 28.0 16.3 10.9 1.7 2.3 185.7 119.2 ATRX "JMS, MRX52, RAD54, XH2, XNP" ENSG00000085224 "ATRX chromatin remodeler" P46100 X 77504880-77786233 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001906, CAB009372, HPA064684, CAB068176" Supported Supported "Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321" "unprognostic (1.77e-2)" "unprognostic (1.55e-1)" "unprognostic (6.65e-2)" "unprognostic (4.37e-2)" "unprognostic (1.67e-1)" "unprognostic (9.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.15e-2)" "unprognostic (6.04e-2)" "unprognostic (2.35e-2)" "unprognostic (1.09e-1)" "unprognostic (5.80e-2)" "unprognostic (5.14e-3)" "unprognostic (1.50e-1)" "unprognostic (6.19e-2)" "unprognostic (1.76e-2)" "unprognostic (2.24e-1)" 18.0 15.9 17.3 17.6 20.4 29.9 18.1 32.9 20.4 18.0 21.4 12.7 11.2 21.2 14.8 13.3 11.8 14.7 15.5 19.2 19.8 16.9 13.2 13.4 22.6 15.0 20.1 24.9 13.4 23.2 8.5 16.6 16.6 19.2 13.5 26.8 14.0 14.8 19.1 15.6 10.9 15.6 16.4 22.8 16.5 6.6 22.6 25.7 20.0 26.9 18.6 14.1 9.9 19.7 36.0 55.1 60.1 45.0 31.8 38.1 21.2 29.4 27.3 21.8 25.9 19.6 30.7 48.5 29.9 32.5 39.9 30.0 44.6 18.1 37.5 27.3 30.8 29.3 67.2 16.2 16.1 38.4 10.2 25.5 20.2 32.2 30.4 29.4 41.9 30.3 34.9 53.3 29.3 27.6 30.2 25.0 42.0 17.6 42.5 48.6 76.3 26.0 25.6 46.4 33.1 55.5 60.5 23.1 21.9 37.2 18.6 20.8 55.8 32.8 76.1 34.4 21.0 16.3 52.9 42.1 23.0 30.9 27.8 44.0 10.5 22.7 26.0 13.3 25.2 31.2 24.0 20.9 8.1 32.4 24.6 20.1 33.2 23.2 20.0 20.7 22.2 9.7 17.3 20.4 32.9 20.4 19.2 19.8 15.0 20.1 16.6 16.4 22.6 19.7 201.0 160.3 230.1 157.4 176.6 92.4 112.2 71.3 114.9 220.1 87.8 86.7 277.8 60.1 101.5 71.7 212.7 72.2 176.9 49.0 23.5 91.8 4.7 103.1 195.5 162.8 126.8 105.8 197.8 83.1 51.0 134.3 114.2 137.3 113.1 261.4 97.8 56.7 70.9 158.2 246.9 78.0 69.2 87.0 101.6 12.7 162.4 113.1 62.2 195.8 149.0 112.3 183.4 202.5 237.1 92.0 47.6 208.0 183.9 120.8 49.2 37.2 102.6 245.4 92.1 174.7 160.0 19.8 52.8 78.7 84.4 59.8 158.0 312.4 73.3 112.0 BABAM1 "C19orf62, FLJ20571, HSPC142, MERIT40, NBA1" ENSG00000105393 "BRISC and BRCA1 A complex member 1" Q9NWV8 19 17267376-17281249 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054386, HPA068786, HPA077609" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 47: Non-specific - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: " "unprognostic (5.60e-2)" "unprognostic (1.08e-3)" "unprognostic (6.77e-2)" "unprognostic (1.06e-1)" "unprognostic (1.44e-1)" "unprognostic (2.18e-2)" "unprognostic (9.45e-3)" "unprognostic (2.05e-2)" "unprognostic (7.30e-2)" "unprognostic (2.03e-2)" "unprognostic (5.12e-2)" "unprognostic (7.21e-2)" "unprognostic (3.31e-3)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.79e-1)" "unprognostic (5.74e-2)" 45.8 54.1 51.9 40.0 55.4 70.4 46.8 44.7 66.7 49.9 39.4 60.6 41.6 50.3 28.7 48.3 44.5 28.9 72.1 58.3 53.9 53.3 55.3 42.8 55.4 50.4 51.5 44.2 49.9 46.8 32.2 46.7 54.1 48.0 36.3 26.4 50.2 37.1 134.1 46.1 50.6 37.3 44.0 60.7 54.2 41.6 51.4 51.3 37.3 96.9 51.3 49.2 43.4 54.7 126.8 69.5 68.8 66.0 72.9 51.9 154.9 73.5 96.0 143.2 142.1 78.2 146.5 87.8 172.1 102.2 64.9 61.2 79.7 102.2 89.1 127.5 130.9 78.6 91.6 99.0 60.4 142.4 96.0 79.6 68.3 96.4 56.1 79.3 122.5 123.9 132.9 101.1 103.3 104.1 138.7 135.8 182.0 106.3 147.0 95.5 92.2 119.4 104.1 62.1 66.3 120.3 90.5 92.8 84.6 77.2 81.4 115.2 91.7 87.8 55.7 108.8 124.3 133.1 172.5 119.7 125.6 187.0 85.5 201.3 154.3 167.7 132.9 148.1 128.3 141.9 121.7 129.2 161.3 143.4 111.8 109.9 37.9 114.3 147.8 134.3 180.2 214.1 51.9 55.4 44.7 66.7 58.3 53.9 50.4 51.5 54.1 44.0 51.4 54.7 40.8 12.8 29.7 11.1 45.0 34.9 41.5 63.4 19.4 21.9 53.9 60.7 37.8 41.5 44.9 35.0 14.6 172.4 51.0 51.1 101.8 70.1 65.8 18.4 30.4 39.9 43.8 78.5 18.6 72.4 155.4 41.4 26.0 28.1 46.3 54.3 40.0 50.4 98.7 16.8 16.2 60.6 48.8 46.8 45.6 106.3 36.7 43.2 65.8 8.4 80.4 35.3 68.0 8.5 12.3 69.8 63.8 44.4 51.7 44.6 68.1 89.3 23.5 18.5 39.5 34.7 52.5 57.8 74.2 27.9 41.3 158.0 46.4 43.0 64.7 45.5 BANP "BEND1, DKFZp761H172, FLJ10177, FLJ20538, SMAR1, SMARBP1" ENSG00000172530 "BTG3 associated nuclear protein" Q8N9N5 16 87949244-88077318 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, DNA-binding, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047164 Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "HPA047164: AB_2679964" "unprognostic (1.82e-1)" "unprognostic (7.84e-3)" "unprognostic (4.73e-2)" "unprognostic (2.14e-1)" "unprognostic (1.55e-1)" "unprognostic (3.35e-2)" "unprognostic (4.95e-2)" "unprognostic (1.47e-1)" "unprognostic (1.19e-1)" "unprognostic (8.17e-2)" "unprognostic (3.53e-3)" "unprognostic (1.68e-3)" "unprognostic (4.98e-2)" "unprognostic (2.05e-1)" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (5.89e-2)" 8.8 9.3 8.1 9.5 8.8 12.1 7.8 16.0 9.5 10.2 11.3 8.8 5.1 9.6 3.3 7.5 9.6 4.9 8.0 9.1 8.9 9.0 13.9 7.4 9.6 10.6 9.0 12.3 8.7 6.2 9.9 7.7 9.8 8.1 3.6 6.4 7.9 5.1 10.2 8.0 8.7 4.3 7.3 12.1 7.5 11.0 10.3 10.4 8.0 5.1 6.4 9.3 8.3 12.1 12.5 19.7 9.6 14.4 8.4 10.1 32.2 14.8 7.4 14.3 9.7 21.6 17.0 16.8 19.6 3.5 13.0 14.2 14.4 6.7 5.2 13.1 15.5 10.5 12.9 18.0 7.1 11.2 8.3 3.0 10.7 8.8 6.3 12.9 8.9 10.9 17.9 9.3 8.8 14.5 15.5 14.6 16.5 9.7 23.6 16.4 11.1 12.4 8.5 5.9 14.2 11.7 18.8 11.0 13.8 14.1 13.5 14.3 11.0 15.4 10.7 9.1 14.8 7.6 13.9 25.7 9.2 17.2 15.1 22.9 19.9 40.7 22.2 18.2 18.7 25.1 23.5 19.9 24.7 21.5 24.9 22.3 64.5 24.5 22.5 29.7 23.0 19.5 8.1 8.8 16.0 9.5 9.1 8.9 10.6 9.0 9.8 7.3 10.3 12.1 12.0 9.6 8.3 15.0 28.6 14.9 11.8 7.4 6.2 14.2 14.1 13.2 5.8 10.0 5.1 16.5 4.2 19.4 42.2 9.2 3.9 12.5 5.8 10.7 9.7 13.6 12.1 4.4 32.7 8.0 27.3 16.3 4.1 13.4 8.2 17.9 5.3 10.3 12.4 26.9 28.3 8.9 2.0 11.1 48.3 8.2 10.8 22.6 19.6 20.6 16.0 11.6 22.6 23.1 28.6 11.0 8.6 10.9 21.2 16.2 10.0 7.8 6.3 17.2 13.1 10.8 22.7 33.7 22.7 6.2 21.3 56.6 19.1 10.2 8.9 17.2 BCL11A "BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856" ENSG00000119866 "BAF chromatin remodeling complex subunit BCL11A" Q9H165 2 60450520-60554467 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.8;lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" "B-cells: 149.0;Basal squamous epithelial cells: 118.4;dendritic cells: 140.3;Excitatory neurons: 180.8;Inhibitory neurons: 153.2;Squamous epithelial cells: 120.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 312.7;naive B-cell: 415.7;plasmacytoid DC: 899.0" "Group enriched" "Detected in all" 15 "B-cells: 415.7;dendritic cells: 899.0" "Cell line enhanced" "Detected in many" "Daudi: 51.1;MOLT-4: 49.0;REH: 48.3;U-698: 106.7;U-937: 34.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 52.5;cerebral cortex: 82.3;hippocampal formation: 69.2;olfactory bulb: 66.7" "CAB014891, HPA029003, HPA075941" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "CAB014891: , HPA029003: AB_2672863, HPA075941: " "unprognostic (4.10e-3)" "unprognostic (6.72e-2)" "unprognostic (4.50e-2)" "unprognostic (9.41e-3)" "unprognostic (2.37e-1)" "unprognostic (4.47e-3)" "unprognostic (2.53e-2)" "unprognostic (1.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.45e-1)" "unprognostic (4.27e-4)" "unprognostic (1.23e-2)" "unprognostic (2.35e-2)" "unprognostic (3.59e-2)" "unprognostic (2.26e-1)" "unprognostic (4.40e-2)" "unprognostic (2.99e-2)" 0.7 2.1 31.4 11.3 34.7 25.3 7.1 10.5 47.8 5.2 9.7 18.4 9.7 2.1 1.4 18.4 5.7 2.5 8.0 38.7 15.5 1.0 0.5 2.1 29.2 31.6 15.3 0.6 10.8 1.7 3.0 0.9 31.0 7.8 6.1 1.7 13.8 1.9 1.7 33.2 13.9 3.4 15.9 19.6 4.8 2.0 15.9 33.9 2.3 0.2 40.9 3.3 11.5 38.7 0.6 0.0 4.2 0.1 0.8 0.8 0.3 1.5 0.0 0.1 0.0 0.0 0.2 51.1 0.2 0.2 0.0 10.5 15.4 7.4 0.2 0.9 15.2 0.1 0.6 0.2 0.0 18.7 0.1 1.7 4.1 0.0 2.5 4.0 2.6 17.1 0.8 0.3 0.1 0.1 49.0 19.9 28.6 7.7 0.2 48.3 1.3 19.7 0.0 0.9 20.1 4.8 0.3 0.4 0.3 8.0 0.3 9.1 1.0 0.3 11.6 0.3 0.1 0.8 0.2 106.7 0.1 34.0 1.6 4.5 23.8 5.1 0.5 44.1 1.1 312.7 0.5 0.5 89.9 415.7 1.3 1.1 11.0 8.4 33.7 899.0 1.1 11.4 31.4 34.7 10.5 47.8 38.7 15.5 31.6 15.3 31.0 15.9 15.9 38.7 0.6 0.0 7.4 3.6 149.0 46.3 16.0 34.0 118.4 2.5 31.6 28.6 18.2 4.3 11.7 1.8 0.0 0.6 140.3 7.5 5.9 9.5 12.0 3.9 2.0 1.4 19.8 69.6 180.8 6.4 0.5 3.6 5.1 4.8 10.1 67.4 0.7 0.1 43.2 52.2 153.2 13.6 6.1 7.0 86.1 5.0 0.3 20.5 16.0 11.2 16.0 0.3 0.0 3.5 4.6 4.7 12.5 0.0 6.0 11.7 16.2 0.5 5.5 0.3 0.0 0.2 2.0 2.9 6.9 120.3 69.9 0.8 4.6 1.0 28.9 5.8 BCL9 ENSG00000116128 "BCL9 transcription coactivator" O00512 1 147541501-147626216 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Oligodendrocyte precursor cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "NTERA-2: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020274 Approved Approved "Nucleoplasm,Nuclear bodies" No No "Cluster 32: T-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear bodies" "HPA020274: AB_2670400" "unprognostic (2.31e-1)" "unprognostic (1.52e-2)" "unprognostic (5.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (6.74e-4)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.29e-1)" "unprognostic (4.78e-3)" "unprognostic (3.92e-2)" "unprognostic (1.64e-3)" "unprognostic (2.58e-1)" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" 3.7 6.2 6.1 4.5 5.6 3.2 3.9 7.6 5.8 10.8 1.1 8.6 4.8 14.4 13.7 4.9 16.4 4.6 7.7 5.6 7.1 6.8 3.5 4.5 3.9 6.0 5.2 14.6 5.0 10.8 7.2 4.1 4.1 9.1 6.9 7.4 7.5 11.1 8.1 7.1 4.7 13.9 4.1 3.1 6.2 5.5 4.9 11.1 6.8 6.2 4.4 7.1 6.5 4.8 5.5 5.3 36.4 27.2 4.1 4.8 7.1 4.4 6.9 4.7 4.6 6.9 8.1 5.2 9.6 4.1 7.9 4.3 23.3 8.0 4.4 12.4 6.5 2.5 5.7 4.6 3.5 1.6 7.2 4.8 6.7 5.6 4.1 8.4 7.4 16.8 4.9 8.3 4.2 12.4 13.1 1.2 43.2 11.0 11.5 13.8 9.2 10.1 18.4 6.0 10.0 21.4 4.9 9.0 8.6 33.3 11.4 2.5 5.5 3.3 15.5 9.4 7.1 36.6 10.0 9.7 8.4 1.4 16.3 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.2 6.1 5.6 7.6 5.8 5.6 7.1 6.0 5.2 4.1 4.1 4.9 4.8 4.6 0.0 2.2 39.5 2.1 3.1 6.0 2.8 14.8 12.1 10.1 5.0 7.4 7.2 2.9 12.9 2.1 2.1 1.2 3.2 11.7 4.4 10.5 21.0 17.5 4.1 28.3 0.0 12.9 4.7 2.5 7.5 2.6 24.6 8.8 12.8 5.7 3.7 1.3 6.7 20.7 7.9 4.1 1.9 1.4 5.3 9.6 1.9 0.0 8.4 1.1 4.8 4.1 31.2 24.2 4.5 1.4 7.9 4.4 6.1 1.3 7.0 4.8 3.1 0.0 6.8 7.3 4.0 8.6 9.7 3.7 2.1 3.6 4.8 6.6 3.3 BECN1 "ATG6, VPS30" ENSG00000126581 "Beclin 1" Q14457 17 42810134-42833350 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Autophagy, Cell cycle, Cell division, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003949, CAB010143, HPA028949" Supported Supported "Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol "Nuclear bodies" "CAB010143: AB_626746, HPA003949: , HPA028949: AB_2672839" "unprognostic (1.97e-1)" "unprognostic (2.66e-2)" "unprognostic (9.97e-2)" "unprognostic (3.80e-3)" "unprognostic (1.46e-1)" "unprognostic (2.01e-2)" "unprognostic (5.16e-3)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.59e-2)" "unprognostic (4.33e-2)" "unprognostic (1.81e-1)" "unprognostic (2.34e-1)" "unprognostic (1.02e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" 45.3 41.4 26.9 41.8 27.7 50.7 43.9 27.4 37.8 35.7 30.9 70.3 56.6 31.5 47.7 49.5 36.1 34.4 58.9 28.5 29.1 47.9 43.7 39.6 47.9 27.4 27.9 26.7 39.5 41.7 20.5 26.2 27.8 42.3 64.8 26.5 36.0 41.3 95.8 36.4 50.1 44.4 28.4 39.8 53.0 24.2 28.3 41.4 36.7 77.6 56.2 49.2 29.7 28.5 47.4 79.0 27.9 48.7 95.7 56.8 54.9 95.1 104.2 69.5 73.8 61.4 61.9 68.9 69.3 118.9 70.0 52.7 48.9 85.3 123.4 105.0 59.4 58.0 74.9 105.5 71.4 111.0 114.3 76.8 99.1 69.4 66.0 61.8 90.2 75.4 50.5 67.1 86.4 40.1 66.1 61.1 29.0 88.5 40.6 56.3 100.6 69.3 74.1 88.6 33.5 34.9 52.0 43.5 100.7 61.4 72.0 92.9 121.6 82.8 38.8 57.0 99.7 103.8 84.8 57.4 84.3 54.0 106.7 154.1 133.2 122.1 103.1 152.1 105.1 112.6 114.4 111.6 120.2 123.7 96.4 100.2 191.0 107.8 144.2 75.7 180.1 171.8 26.9 27.7 27.4 37.8 28.5 29.1 27.4 27.9 27.8 28.4 28.3 28.5 43.7 38.5 46.1 11.8 38.7 29.7 26.7 40.1 39.3 12.3 38.3 22.7 6.0 30.0 39.1 12.9 10.4 23.5 37.8 59.5 58.7 46.2 18.2 35.0 28.3 33.9 28.3 36.2 12.1 69.6 32.3 23.1 42.3 31.5 43.1 20.5 31.4 46.2 38.8 21.9 11.7 60.2 30.5 65.4 36.8 11.9 21.5 43.1 42.7 3.7 67.2 26.9 50.4 5.5 9.8 53.6 45.4 26.7 51.2 37.8 49.1 40.3 51.7 13.4 26.3 25.6 36.0 31.6 14.9 44.9 37.6 38.0 39.8 33.8 51.1 46.7 BHLHE40 "BHLHB2, Clast5, DEC1, SHARP2, STRA13" ENSG00000134107 "Basic helix-loop-helix family member e40" O14503 3 4979437-4985323 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 386.7;granulocytes: 439.2;Squamous epithelial cells: 517.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 101.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 488.2;Karpas-707: 228.4;U-87 MG: 218.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028922 Uncertain Supported "Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Nuclear bodies" "HPA028922: AB_2672828" "unprognostic (8.64e-3)" "unprognostic (5.21e-2)" "unprognostic (1.03e-2)" "unprognostic (1.39e-1)" "unprognostic (8.58e-3)" "unprognostic (7.95e-2)" "unprognostic (2.90e-1)" "unprognostic (2.88e-3)" "unprognostic (1.31e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (5.45e-2)" "unprognostic (3.36e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (5.95e-2)" "unprognostic (7.03e-3)" 154.1 99.0 38.5 52.9 38.4 188.2 200.0 36.1 48.7 141.6 41.4 67.9 30.8 67.6 34.6 353.2 61.5 100.4 153.4 38.1 32.8 151.4 187.9 112.1 52.4 52.0 47.5 76.0 79.8 67.5 92.6 72.2 39.3 98.1 47.4 118.3 117.3 32.5 251.7 207.2 42.6 65.2 40.5 26.9 43.5 14.1 49.6 40.6 82.7 46.8 50.7 172.1 272.3 37.0 40.4 53.4 0.1 14.7 30.8 23.8 78.6 7.5 19.7 7.7 30.2 3.4 39.7 0.2 19.6 14.2 118.9 31.5 6.6 108.0 13.2 488.2 4.7 9.8 39.6 11.9 29.7 25.5 192.8 55.1 63.3 88.9 25.4 53.4 30.0 1.7 53.9 228.4 20.3 28.4 3.9 10.8 2.9 45.6 87.1 0.7 17.6 23.0 74.4 7.9 0.8 1.7 132.6 34.2 40.0 45.9 78.6 38.8 39.7 30.4 29.3 28.9 50.0 175.9 82.8 1.6 218.0 19.8 15.3 101.4 9.7 54.5 24.7 4.9 24.9 7.7 13.1 16.6 15.2 4.5 2.9 10.1 14.3 54.9 0.5 19.9 0.9 11.9 38.5 38.4 36.1 48.7 38.1 32.8 52.0 47.5 39.3 40.5 49.6 37.0 172.5 67.3 191.3 32.3 24.9 165.4 112.8 330.5 373.3 15.4 136.6 74.7 65.0 40.0 297.7 46.0 0.0 32.0 159.8 52.9 11.7 75.2 0.3 210.2 69.6 161.6 10.7 2.5 36.6 72.5 89.3 102.6 68.3 386.7 439.2 0.5 75.0 56.5 38.3 10.1 4.5 32.6 136.3 52.1 354.0 1.7 7.2 117.9 108.5 27.2 42.9 95.1 44.3 11.1 3.3 138.8 37.9 3.8 38.0 61.1 8.8 23.1 102.1 11.5 6.6 55.3 94.4 0.2 0.4 517.2 262.0 158.4 97.8 0.3 24.4 129.4 BLMH BH ENSG00000108578 "Bleomycin hydrolase" Q13867 17 30248203-30292056 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 130.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039548, HPA064307" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 42000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA039548: AB_10805479, HPA064307: AB_2685241" "unprognostic (6.85e-2)" "unprognostic (2.79e-1)" "unprognostic (1.48e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (2.54e-2)" "unprognostic (3.91e-3)" "unprognostic (2.07e-1)" "unprognostic (2.05e-3)" "unprognostic (6.69e-3)" "unprognostic (1.95e-3)" "unprognostic (2.14e-2)" "unprognostic (2.14e-2)" "unprognostic (1.22e-3)" "unprognostic (1.05e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" 20.6 13.5 13.4 18.2 15.0 18.1 20.4 15.9 17.6 19.1 14.5 18.8 12.4 21.2 21.1 28.3 14.7 18.4 15.6 13.5 15.2 22.0 14.0 16.0 26.0 15.6 14.1 13.9 26.8 21.7 9.7 27.4 15.4 14.4 15.4 14.7 15.6 14.4 28.8 130.3 18.3 22.4 14.7 20.6 16.2 15.9 14.2 36.3 16.5 19.0 26.9 17.9 21.5 16.2 40.3 62.9 61.5 41.6 40.6 43.8 27.8 36.5 24.0 59.1 50.8 93.2 11.9 119.5 63.3 31.1 26.1 27.1 135.5 52.8 50.1 31.5 101.4 73.5 54.6 80.0 58.3 136.1 43.2 50.5 3.5 46.5 26.5 47.1 87.2 98.2 157.9 47.6 24.6 31.0 168.1 98.6 57.2 0.0 29.2 143.0 154.5 78.9 46.8 35.6 135.1 48.4 32.6 63.2 42.2 106.6 42.9 68.5 54.5 35.0 69.2 16.0 66.0 55.8 124.1 159.3 26.7 0.2 47.6 0.0 8.8 1.5 15.3 6.2 25.3 6.5 18.2 20.2 10.1 7.3 16.4 17.8 1.2 16.3 3.3 10.1 20.0 9.9 13.4 15.0 15.9 17.6 13.5 15.2 15.6 14.1 15.4 14.7 14.2 16.2 21.0 3.2 12.6 13.4 8.8 15.9 16.7 10.6 19.4 20.2 10.3 6.6 17.8 12.8 4.0 11.0 12.5 49.6 15.6 7.6 7.9 17.4 8.4 7.4 28.2 24.0 18.0 22.5 19.0 14.2 38.0 18.3 11.2 7.0 43.8 30.5 25.7 6.9 25.0 13.5 20.9 8.4 6.1 18.9 7.1 6.6 16.1 13.0 10.6 18.7 12.2 9.9 22.6 29.1 22.6 7.2 9.6 24.8 20.0 13.0 11.5 20.0 5.5 15.7 6.6 12.9 19.7 14.9 29.1 24.0 12.6 27.5 20.9 34.8 11.5 7.6 BMI1 "PCGF4, RNF51" ENSG00000168283 "BMI1 proto-oncogene, polycomb ring finger" P35226 10 22321099-22331484 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 134.0;Late spermatids: 165.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 508.3;U-937: 583.9" "CAB011120, HPA030471, HPA030472" Supported Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "Nucleoli, Cytosol" "CAB011120: , HPA030471: AB_2673491, HPA030472: AB_10601090" "unprognostic (5.44e-1)" "unprognostic (2.98e-1)" "unprognostic (4.24e-2)" "unprognostic (4.37e-2)" "unprognostic (2.76e-3)" "unprognostic (6.93e-2)" "prognostic unfavorable (2.60e-8)" "unprognostic (9.43e-2)" "unprognostic (7.95e-2)" "unprognostic (7.84e-2)" "unprognostic (8.23e-2)" "unprognostic (1.56e-1)" "unprognostic (7.44e-2)" "unprognostic (9.73e-2)" "unprognostic (8.56e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-2)" 29.0 31.1 26.6 25.1 35.1 21.9 36.0 29.9 42.4 27.6 28.2 26.2 19.7 30.7 29.7 21.9 22.6 23.9 20.5 25.0 27.8 26.0 35.6 23.4 27.7 29.5 30.1 21.7 25.7 56.9 25.0 28.7 31.6 33.7 21.5 40.4 19.9 26.1 44.4 14.4 20.8 36.2 29.9 36.2 22.5 35.3 28.1 24.9 23.9 35.5 27.0 23.8 14.8 45.4 74.9 36.1 41.2 12.7 68.9 54.6 40.5 49.7 22.2 37.3 43.5 37.6 93.4 38.1 32.8 45.6 42.2 26.1 59.1 35.0 45.4 508.3 72.8 104.7 28.7 42.9 41.1 39.8 55.7 35.5 58.8 41.2 45.3 47.0 26.2 62.1 105.4 63.3 48.6 30.2 106.9 11.4 9.3 36.3 83.4 79.6 57.1 37.3 35.3 25.2 33.8 66.0 32.7 42.5 57.3 17.8 38.5 153.8 56.4 41.4 122.6 99.6 67.6 76.1 110.8 83.1 59.5 583.9 27.4 15.1 1.3 2.5 5.2 3.0 7.0 4.4 5.3 5.0 0.9 2.2 4.4 4.3 0.6 5.2 2.1 1.6 4.1 2.0 26.6 35.1 29.9 42.4 25.0 27.8 29.5 30.1 31.6 29.9 28.1 45.4 18.9 25.6 24.0 0.0 23.1 15.9 20.5 12.4 22.8 20.9 24.4 20.3 19.0 22.8 19.8 12.9 8.4 12.7 14.2 5.6 13.7 16.3 134.0 12.1 25.3 24.0 13.2 19.1 0.0 18.2 22.2 19.8 7.7 9.8 12.0 12.6 28.5 30.7 9.9 30.3 0.0 9.9 14.2 19.7 25.6 165.1 36.1 13.8 37.4 0.0 17.5 13.9 15.5 0.0 0.0 22.9 7.3 36.5 33.9 29.1 4.6 13.0 16.9 15.2 19.7 26.5 28.6 19.8 22.2 11.2 14.6 6.7 22.4 17.0 10.3 20.4 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 7900000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 41.6 5.8 15.8 10.4 15.5 0.2 29.8 13.1 12.1 26.0 33.2 49.1 4.9 46.6 10.1 24.9 63.2 19.3 14.3 17.1 15.2 9.7 1.0 6.6 3.6 53.2 30.1 35.2 16.1 2.7 20.8 2.2 23.2 33.8 4.6 3.2 23.8 21.3 6.3 34.9 18.3 32.6 32.3 4.6 19.0 5.0 26.3 5.7 24.6 9.0 3.1 32.5 25.8 23.4 0.0 7.6 27.6 79.2 113.6 6.0 0.9 12.8 41.9 3.2 2.7 0.0 0.0 0.1 7.8 21.8 1.7 0.0 5.6 2.7 1.1 0.0 3.4 0.0 2.3 0.0 0.6 0.3 0.2 19.7 1.8 1.7 0.2 25.7 0.0 0.0 0.1 0.0 0.6 2.1 0.2 1.4 7.0 0.0 6.9 0.2 12.3 0.0 0.7 0.1 8.2 11.7 0.1 0.5 0.3 8.1 3.4 0.4 0.0 4.5 7.3 0.1 4.2 0.0 0.0 0.0 9.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 15.5 13.1 12.1 17.1 15.2 53.2 30.1 23.2 32.3 26.3 23.4 9.6 0.0 0.5 71.8 0.0 21.2 3.1 3.6 112.1 0.6 3.7 17.3 1.1 1.5 0.7 5.5 0.0 4.8 0.2 0.0 0.0 0.1 1.4 12.6 10.5 5.6 1.8 0.0 8.8 0.0 4.3 55.4 0.5 11.7 0.0 5.7 3.3 0.1 0.8 0.0 2.5 0.0 0.0 0.3 5.5 3.3 84.8 1.0 10.6 6.5 0.0 12.2 0.0 24.1 0.7 0.3 0.0 47.8 0.6 3.3 0.0 0.0 0.3 0.5 0.0 18.0 13.5 1.5 3.2 11.5 11.1 1.9 0.8 1.1 0.0 0.9 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135400-74147912 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 173.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 313.2;Distal tubular cells: 352.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: AB_2682063" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 35.6 39.3 52.1 22.6 54.3 40.8 31.4 58.9 66.1 20.2 55.0 46.5 33.8 24.5 25.1 31.7 20.8 11.9 101.0 52.7 56.5 59.8 33.7 23.5 22.2 57.0 53.8 16.6 44.7 56.2 29.6 14.2 56.0 25.4 37.6 35.7 39.7 23.7 117.8 16.6 28.9 22.6 54.7 21.9 41.1 15.8 53.7 24.8 28.8 173.9 21.6 27.1 24.3 55.3 102.8 134.0 44.8 46.2 81.5 78.3 113.9 92.5 54.5 104.0 72.0 176.6 45.4 67.2 79.7 82.4 99.3 53.2 107.9 135.4 95.8 126.5 172.8 85.4 88.3 269.8 76.1 167.3 39.0 62.2 96.6 100.9 124.2 45.9 79.4 144.3 183.2 73.7 116.0 163.6 136.4 123.1 66.9 196.8 198.6 88.5 120.1 132.0 138.8 106.2 70.4 40.7 68.3 106.8 123.3 62.0 62.6 102.8 42.6 83.9 142.9 93.8 185.4 67.5 135.3 92.7 87.6 131.8 73.8 14.7 14.2 3.9 68.3 29.9 75.7 45.4 92.7 72.6 37.8 44.5 79.3 68.7 3.0 51.7 33.5 65.1 91.2 40.6 52.1 54.3 58.9 66.1 52.7 56.5 57.0 53.8 56.0 54.7 53.7 55.3 54.7 9.6 29.8 8.5 33.2 22.7 44.5 111.8 43.3 29.9 82.0 109.5 313.2 44.3 50.1 84.6 16.7 54.9 42.8 125.4 352.1 93.2 20.0 67.0 46.2 45.5 76.1 138.2 14.3 111.4 167.5 48.6 58.1 61.5 25.4 31.9 36.4 113.3 113.9 26.9 15.0 128.3 83.4 32.1 28.9 10.2 32.9 32.2 99.6 3.7 59.4 61.8 62.8 7.5 7.7 95.0 70.9 46.3 76.1 50.9 85.6 266.4 51.2 52.6 19.7 39.6 64.4 66.8 80.5 101.0 16.9 22.3 45.1 83.0 176.2 52.0 BRCA1 "BRCC1, FANCS, PPP1R53, RNF53" ENSG00000012048 "BRCA1 DNA repair associated" P38398 17 43044295-43170245 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3" "Group enriched" "Detected in all" 6 "dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001946, HPA004840, HPA034966, HPA057371" Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" "CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611" "unprognostic (7.87e-3)" "unprognostic (6.97e-2)" "unprognostic (3.53e-3)" "unprognostic (2.39e-1)" "unprognostic (5.42e-2)" "unprognostic (7.07e-3)" "unprognostic (1.56e-3)" "unprognostic (4.14e-3)" "unprognostic (9.62e-3)" "unprognostic (2.47e-1)" "unprognostic (5.53e-3)" "unprognostic (1.28e-1)" "unprognostic (1.08e-4)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.31e-2)" 3.1 1.8 4.2 7.5 7.2 13.0 3.6 4.7 5.2 2.7 2.7 6.8 3.2 3.1 2.2 4.0 3.7 1.9 3.0 3.6 4.1 2.0 5.6 3.2 10.3 5.6 5.0 2.8 2.8 5.9 2.8 3.8 6.0 2.4 7.4 8.2 3.2 1.6 4.2 6.0 5.1 3.9 3.7 3.9 3.6 13.0 5.5 14.5 7.8 3.7 11.2 2.8 2.4 10.8 44.1 69.1 37.8 30.1 6.0 13.4 36.6 50.6 21.5 41.9 39.3 42.3 33.4 100.8 9.1 19.0 49.0 49.5 51.9 28.3 69.5 46.9 38.0 48.1 54.0 37.1 1.3 86.0 39.9 3.8 4.5 63.1 20.0 10.6 22.3 46.6 73.7 42.2 39.7 30.0 72.0 27.8 20.5 29.1 18.7 49.0 79.8 40.8 15.4 42.1 25.8 27.4 38.8 12.5 19.4 25.5 33.9 39.6 13.8 37.2 29.6 49.0 53.2 20.1 51.2 75.5 29.6 49.6 39.4 6.8 14.7 2.2 1.5 4.7 1.5 1.2 1.5 1.2 10.9 2.1 1.3 1.5 11.3 1.5 2.0 1.7 0.5 17.5 4.2 7.2 4.7 5.2 3.6 4.1 5.6 5.0 6.0 3.7 5.5 10.8 5.0 0.0 2.8 9.4 5.8 2.9 4.5 1.9 1.2 10.3 4.4 5.2 10.1 5.7 3.5 1.8 22.9 12.8 8.1 6.2 0.0 3.0 11.9 14.0 6.3 4.7 0.0 42.5 3.0 1.1 18.2 7.4 6.1 4.2 8.2 38.2 5.3 18.3 10.1 11.8 4.4 7.5 0.0 3.9 2.8 8.0 2.5 6.4 0.0 4.7 4.9 2.4 5.2 3.0 18.7 1.7 2.4 1.5 16.6 2.3 1.1 1.0 10.0 22.8 6.6 13.7 5.5 105.8 73.5 8.2 2.3 4.0 4.7 9.7 12.7 3.4 BRD3 "KIAA0043, ORFX, RING3L" ENSG00000169925 "Bromodomain containing 3" Q15059 9 134030305-134068535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051830 Approved Approved "Nuclear bodies" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "HPA051830: AB_2681627" "unprognostic (3.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-1)" "unprognostic (6.20e-2)" "unprognostic (2.60e-2)" "unprognostic (2.98e-2)" "unprognostic (3.48e-2)" "unprognostic (1.11e-2)" "unprognostic (6.75e-2)" "unprognostic (2.79e-1)" "unprognostic (1.98e-1)" "prognostic favorable (2.71e-7)" "unprognostic (1.00e-1)" "unprognostic (4.71e-2)" "unprognostic (2.57e-2)" "unprognostic (1.42e-1)" 10.6 10.3 14.2 7.3 14.7 8.2 10.2 13.0 13.6 12.9 6.4 16.1 7.9 14.6 9.4 8.6 12.5 6.9 9.5 11.6 14.6 7.8 11.0 9.2 7.5 13.9 12.6 11.6 10.7 10.1 9.2 9.0 11.7 11.8 5.6 10.6 9.6 11.6 19.3 12.6 9.6 9.0 10.4 12.4 9.9 13.0 13.5 13.4 11.8 11.5 5.8 11.8 10.3 15.9 8.5 25.3 31.4 24.6 17.1 13.8 28.7 8.4 9.5 9.2 9.3 21.2 13.7 3.2 8.7 7.7 10.4 28.7 29.4 11.7 7.2 20.1 16.5 18.2 29.1 24.1 15.3 24.1 15.7 14.8 14.1 10.6 12.0 14.9 15.2 30.0 16.7 9.3 9.5 28.4 44.9 32.2 42.0 21.9 19.2 32.8 45.3 16.1 13.1 8.9 45.8 42.3 37.7 14.1 10.1 18.7 20.3 39.6 19.5 22.3 12.3 14.6 7.6 5.0 5.6 3.0 11.2 16.4 15.1 6.6 12.9 15.8 11.4 10.1 9.6 6.9 9.1 10.2 12.9 6.7 8.6 9.1 15.0 16.3 8.6 17.1 4.6 9.4 14.2 14.7 13.0 13.6 11.6 14.6 13.9 12.6 11.7 10.4 13.5 15.9 27.6 32.1 21.9 13.1 18.3 32.4 21.2 19.8 42.1 60.9 32.8 24.3 24.3 28.6 25.7 23.9 37.5 26.0 31.8 22.6 19.6 42.7 49.2 22.9 37.9 32.1 54.0 70.1 13.4 24.4 20.5 32.4 21.9 25.3 15.9 53.2 35.7 34.0 18.7 57.2 16.8 26.6 14.2 27.9 22.8 20.7 57.2 33.6 23.2 10.3 33.6 45.6 30.9 12.5 19.3 27.7 21.4 67.4 9.1 51.0 19.2 15.7 20.1 58.0 59.2 55.8 40.0 20.7 53.1 31.9 35.7 32.7 26.4 178.7 30.8 22.3 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1 RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "HPA051918: AB_2681663, HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favorable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favorable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 10.5 11.4 19.7 5.5 22.2 6.5 10.5 23.1 23.6 12.5 12.9 11.1 7.6 12.1 4.2 10.4 12.8 6.0 12.2 17.1 19.2 11.6 13.1 8.4 8.1 31.8 24.9 13.0 15.1 10.3 20.4 6.0 29.7 12.0 4.2 7.5 10.1 6.3 17.7 11.2 10.3 4.6 18.7 12.6 11.2 14.6 25.4 7.3 10.5 9.6 5.8 11.5 9.9 37.4 12.6 28.0 11.8 25.3 10.3 11.4 11.9 17.4 11.2 15.4 12.2 20.2 18.8 9.4 16.9 12.0 7.5 24.2 14.4 11.7 8.4 25.2 14.2 11.5 15.1 9.9 11.5 13.7 24.3 11.3 10.1 9.3 11.5 7.8 11.3 19.7 13.1 7.5 7.6 40.9 16.2 17.1 8.6 20.7 27.7 28.2 8.1 9.6 7.6 29.9 37.5 27.8 18.4 14.0 16.0 5.4 33.4 18.9 16.8 12.1 9.6 22.7 14.2 13.8 11.5 8.9 14.5 11.3 16.9 0.4 1.2 2.0 1.6 1.0 1.1 1.5 1.1 1.6 1.2 1.4 1.4 1.3 0.5 2.5 4.0 3.1 1.6 1.6 19.7 22.2 23.1 23.6 17.1 19.2 31.8 24.9 29.7 18.7 25.4 37.4 11.5 3.2 5.9 17.6 11.4 7.5 7.1 4.5 8.6 18.8 10.7 9.0 8.5 2.8 6.3 3.7 16.7 11.4 15.5 16.2 3.9 5.8 2.3 26.5 10.9 9.5 9.6 6.3 18.3 7.1 8.9 7.7 14.8 16.5 2.5 16.0 8.9 11.3 7.2 30.3 20.8 11.7 4.1 6.7 10.3 1.4 6.5 7.8 8.8 10.3 5.3 7.1 4.1 15.1 34.2 4.8 6.5 4.5 13.4 7.7 8.9 6.1 12.4 20.0 0.0 9.6 8.2 9.2 12.7 7.7 8.8 9.3 11.6 13.2 12.5 5.1 C11orf54 PTD012 ENSG00000182919 "Chromosome 11 open reading frame 54" Q9H0W9 11 93741591-93764749 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "kidney: 569.9;liver: 258.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 370.4;Proximal tubular cells: 1136.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040088, HPA040511" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA 1300000 "Cluster 5: Granulocytes - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear bodies" Nucleoplasm "HPA040088: AB_10795518, HPA040511: AB_10795369" "unprognostic (3.32e-2)" "unprognostic (3.51e-1)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.82e-2)" "unprognostic (1.90e-2)" "unprognostic (2.81e-2)" "unprognostic (1.01e-1)" "unprognostic (2.46e-2)" "unprognostic (2.87e-1)" "unprognostic (2.10e-3)" "unprognostic (1.58e-1)" "prognostic favorable (5.06e-6)" "unprognostic (2.19e-1)" "unprognostic (6.10e-2)" "unprognostic (2.41e-2)" "unprognostic (6.53e-3)" 20.1 24.6 10.2 19.1 16.4 7.4 31.4 15.2 14.8 20.7 18.0 40.8 53.0 21.7 19.6 17.6 32.3 47.2 21.5 9.5 14.8 569.9 258.8 30.3 21.5 18.3 12.9 30.1 51.6 20.9 16.7 25.3 16.5 39.6 43.8 20.7 28.9 25.0 41.8 21.2 51.5 20.8 13.0 17.3 37.9 19.8 12.9 28.1 35.9 54.7 23.4 17.0 12.9 25.2 9.4 13.5 30.9 18.3 23.5 26.8 36.1 13.8 23.6 13.8 19.0 5.6 52.9 39.4 85.5 25.6 14.4 22.2 37.5 10.0 19.4 39.9 11.4 21.7 34.9 26.5 27.7 20.7 11.0 24.7 17.0 24.7 16.6 34.8 21.6 26.2 29.6 26.6 12.8 8.0 33.0 23.7 10.5 64.9 22.1 31.4 40.8 62.2 74.6 19.6 15.2 20.2 23.0 28.2 27.7 22.7 65.9 13.4 13.5 13.0 10.0 22.5 6.6 12.0 38.2 37.8 9.8 29.2 23.3 75.0 30.0 74.0 21.7 21.5 22.3 27.1 22.1 24.7 23.0 23.0 27.0 23.7 100.9 24.8 19.0 31.9 31.5 18.8 10.2 16.4 15.2 14.8 9.5 14.8 18.3 12.9 16.5 13.0 12.9 25.2 25.1 64.1 54.7 28.1 27.4 5.5 10.6 18.4 21.1 18.0 21.6 14.6 34.7 190.1 33.5 47.8 16.7 51.4 21.6 53.6 178.1 17.4 14.4 34.2 20.5 18.3 22.2 23.1 23.7 13.9 14.8 23.9 32.6 43.6 15.2 40.2 29.6 370.4 17.5 15.2 27.8 37.1 28.5 29.2 7.2 6.4 25.7 22.2 8.8 15.9 18.2 17.0 10.3 25.6 37.8 13.1 38.4 23.0 25.7 29.0 75.0 1136.3 36.2 19.7 6.6 28.9 17.0 38.6 17.4 17.6 9.9 62.0 21.1 16.3 35.6 22.9 C11orf71 FLJ20010 ENSG00000180425 "Chromosome 11 open reading frame 71" Q6IPW1 11 114391443-114400511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 139.0" "Cell type enriched" "Detected in many" 4 "Late spermatids: 2360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063943, HPA074787" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA063943: AB_2685157, HPA074787: AB_2686712" "unprognostic (1.24e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-2)" "prognostic favorable (6.94e-4)" "unprognostic (7.35e-2)" "unprognostic (4.53e-2)" "unprognostic (1.83e-1)" "unprognostic (2.30e-3)" "unprognostic (1.58e-1)" "unprognostic (3.04e-3)" "unprognostic (1.39e-2)" "unprognostic (2.85e-2)" "prognostic favorable (7.01e-9)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.17e-2)" 5.8 10.7 11.8 5.1 13.7 3.7 7.6 12.3 13.8 5.5 10.8 6.9 7.6 5.1 22.6 4.3 7.1 4.4 9.3 11.7 13.9 13.9 22.1 5.9 6.7 14.0 16.7 7.2 8.7 8.9 13.4 3.7 13.2 8.5 6.2 15.9 9.8 5.7 15.0 9.4 7.5 2.9 12.2 9.4 7.3 139.0 12.7 8.9 12.4 15.2 4.7 4.6 4.1 16.0 1.2 3.9 4.2 13.6 6.2 3.6 2.9 0.6 1.7 1.7 1.5 3.0 23.6 6.8 7.8 1.0 8.1 6.3 2.8 2.9 2.1 7.5 1.6 5.1 3.2 6.9 5.9 3.0 5.5 5.9 3.2 2.2 6.7 1.9 2.1 10.8 5.1 6.0 3.2 5.5 5.5 4.6 2.2 5.5 2.5 3.9 3.4 17.3 3.8 3.0 11.6 4.6 15.3 1.8 2.4 4.4 11.5 1.6 2.1 0.4 5.9 4.6 1.2 5.8 10.1 5.2 0.9 6.9 1.7 15.9 15.4 10.3 8.8 9.8 5.5 5.9 5.7 6.0 9.3 8.3 9.5 9.9 12.3 12.1 11.9 12.0 7.1 10.1 11.8 13.7 12.3 13.8 11.7 13.9 14.0 16.7 13.2 12.2 12.7 16.0 12.7 3.2 13.4 5.2 8.0 2.7 15.7 6.3 8.6 10.3 18.3 15.9 19.0 0.0 6.2 5.5 4.2 16.1 6.4 15.0 82.2 15.7 589.6 21.2 8.1 8.7 18.1 7.2 4.7 18.9 3.4 9.5 18.8 12.8 6.3 14.1 0.0 0.0 11.5 13.5 5.6 16.7 10.2 0.0 4.1 2360.8 13.1 13.6 5.4 2.8 11.2 31.5 7.2 4.0 18.5 10.5 15.5 9.1 17.2 9.2 33.0 78.6 18.9 14.1 6.6 7.6 8.0 70.6 9.9 10.4 2.6 14.6 7.4 19.6 12.7 11.4 C12orf4 ENSG00000047621 "Chromosome 12 open reading frame 4" Q9NQ89 12 4487735-4538508 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037871 Uncertain Approved "Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "HPA037871: AB_10670531" "unprognostic (5.88e-2)" "unprognostic (2.81e-1)" "unprognostic (5.64e-2)" "unprognostic (2.51e-2)" "unprognostic (3.07e-2)" "unprognostic (6.69e-2)" "unprognostic (2.96e-3)" "unprognostic (8.59e-2)" "unprognostic (6.85e-2)" "unprognostic (2.75e-2)" "unprognostic (2.26e-2)" "unprognostic (5.93e-2)" "unprognostic (1.26e-2)" "unprognostic (7.83e-2)" "unprognostic (2.74e-1)" "unprognostic (5.02e-2)" "unprognostic (3.92e-1)" 7.5 5.4 6.6 8.9 7.6 9.2 7.3 7.7 9.1 6.6 5.6 7.0 4.3 6.6 5.3 7.1 5.5 6.5 7.4 7.8 6.0 6.0 5.9 6.7 10.1 5.6 6.3 5.3 4.7 6.2 4.7 9.6 6.0 7.4 8.1 10.0 4.9 6.6 10.5 5.9 5.1 9.4 5.9 7.9 5.7 9.2 7.0 9.2 7.9 10.8 10.2 8.6 5.0 7.6 14.6 11.0 13.4 15.9 13.1 19.5 28.4 27.6 11.4 24.9 30.3 19.5 11.8 12.4 5.6 17.9 20.5 10.6 19.0 15.9 33.6 37.1 13.0 21.5 10.3 9.6 19.0 18.7 19.4 17.4 8.8 29.9 33.4 15.6 14.4 15.1 12.8 20.9 23.5 7.0 14.9 7.9 19.8 12.6 10.4 16.0 21.1 7.9 15.3 15.1 5.3 10.4 18.9 13.6 11.9 36.4 5.7 15.9 15.0 21.6 19.9 23.8 29.3 4.8 6.8 30.2 16.0 15.1 20.4 0.0 7.5 2.8 4.2 12.7 4.6 4.7 4.1 4.3 6.6 5.2 4.5 4.0 2.4 4.4 15.1 6.9 6.9 4.3 6.6 7.6 7.7 9.1 7.8 6.0 5.6 6.3 6.0 5.9 7.0 7.6 9.8 16.0 12.0 21.5 9.2 2.9 3.0 5.5 7.4 11.8 5.2 5.3 14.3 2.8 8.9 3.7 29.2 7.4 11.4 5.2 3.9 7.6 40.9 7.3 11.8 8.2 6.0 16.0 43.0 8.2 8.5 8.1 1.5 4.4 1.3 9.7 7.5 5.4 28.2 8.4 32.4 5.3 4.1 13.3 4.7 29.9 8.1 11.4 1.8 30.0 8.5 6.8 8.2 32.6 39.2 8.3 3.2 6.8 15.5 2.2 4.6 5.4 8.6 12.3 6.6 9.7 9.6 22.0 16.2 6.4 3.3 6.2 8.2 8.0 6.0 1.9 C19orf44 FLJ21742 ENSG00000105072 "Chromosome 19 open reading frame 44" Q9H6X5 19 16496394-16521352 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 46.7;Late spermatids: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041683, HPA049414" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA041683: AB_10793929, HPA049414: AB_2680754" "unprognostic (2.16e-1)" "unprognostic (2.16e-2)" "unprognostic (1.25e-1)" "unprognostic (8.52e-2)" "unprognostic (2.05e-1)" "unprognostic (8.38e-3)" "unprognostic (1.83e-1)" "unprognostic (4.19e-2)" "unprognostic (6.45e-2)" "unprognostic (1.36e-1)" "unprognostic (2.32e-3)" "unprognostic (3.73e-1)" "unprognostic (1.04e-1)" "unprognostic (7.02e-2)" "unprognostic (7.88e-2)" "unprognostic (1.06e-1)" "unprognostic (1.90e-1)" 3.2 2.7 3.9 1.8 4.1 3.2 3.4 3.7 5.4 5.7 5.9 5.3 1.9 4.9 2.8 2.8 6.0 3.7 3.3 3.9 4.2 4.5 2.7 2.6 2.2 4.7 5.0 8.1 4.1 5.6 5.2 2.1 3.5 4.8 1.5 3.7 5.8 4.4 4.6 4.3 2.3 3.4 2.9 2.4 3.3 14.5 4.1 3.5 4.8 2.7 1.9 4.4 3.7 3.8 4.7 4.9 5.1 6.4 3.3 6.1 5.4 3.6 3.5 4.5 6.6 3.0 6.5 3.6 6.9 2.9 3.0 3.9 3.9 3.1 3.4 2.5 10.0 1.4 8.0 4.6 4.4 2.0 2.2 3.3 3.1 5.7 4.3 8.8 2.5 5.5 5.7 1.5 2.9 6.6 3.6 5.7 3.0 6.3 7.3 3.5 2.3 5.9 4.7 1.8 5.9 3.2 4.1 5.6 3.3 4.4 5.7 2.9 4.4 6.2 3.5 5.9 5.7 4.3 3.3 2.5 4.6 2.0 5.4 3.5 0.5 0.1 0.5 0.3 0.1 1.5 0.6 0.2 0.2 1.1 0.6 1.0 1.0 0.3 0.8 0.4 0.2 0.4 3.9 4.1 3.7 5.4 3.9 4.2 4.7 5.0 3.5 2.9 4.1 3.8 1.7 0.0 5.6 9.4 2.5 0.4 1.0 1.3 1.2 3.4 2.1 2.3 3.7 2.8 4.8 7.3 12.5 1.9 1.1 0.8 0.0 1.8 46.7 9.9 6.0 2.5 7.2 2.1 3.9 1.2 1.8 3.1 2.6 5.4 0.0 6.7 1.4 1.7 0.8 0.0 4.8 1.6 0.0 0.6 1.0 72.6 3.1 0.9 0.0 5.6 1.3 2.7 0.0 0.5 2.9 1.1 1.6 5.3 1.2 0.7 0.4 3.4 6.6 8.4 0.0 3.7 2.9 10.9 2.1 1.6 0.4 0.5 0.9 4.1 1.2 0.3 C1GALT1 "C1GALT, T-synthase" ENSG00000106392 "Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1" Q9NS00 7 7156934-7248616 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 204.3;Syncytiotrophoblasts: 204.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "LHCN-M2: 288.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011294, HPA012819" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 43000 "Cluster 2: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear bodies, Cytosol" "HPA011294: AB_1845623, HPA012819: AB_1845624" "unprognostic (1.52e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.38e-2)" "unprognostic (8.78e-2)" "unprognostic (2.97e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (2.03e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-1)" "unprognostic (3.28e-1)" "unprognostic (8.28e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-1)" 12.9 7.2 12.8 14.2 17.7 37.7 16.6 16.1 15.5 18.5 25.0 15.2 29.4 5.6 6.4 21.6 16.2 16.6 12.6 11.3 13.7 30.8 22.0 15.0 19.1 17.7 15.6 4.6 6.1 45.8 8.6 27.0 17.7 5.1 18.0 23.6 23.3 6.8 7.5 8.8 19.3 7.3 17.9 15.5 22.4 7.3 14.2 14.3 12.5 11.3 14.0 13.0 7.3 24.6 63.5 25.9 9.6 16.0 28.1 57.0 28.0 71.5 60.7 32.4 51.1 20.0 63.9 33.4 17.0 31.7 93.5 18.3 14.0 27.5 58.3 15.1 8.1 31.1 15.9 62.3 28.1 34.3 13.2 44.0 20.0 75.7 70.0 47.4 30.3 29.9 61.0 19.9 288.7 10.5 8.8 22.8 51.7 47.8 20.3 29.6 53.1 19.3 46.6 32.4 9.9 27.2 46.9 57.0 52.8 57.5 15.6 19.6 30.4 55.2 76.7 74.7 31.3 34.4 28.7 32.9 36.9 42.9 55.8 56.0 12.9 38.4 17.7 20.2 19.7 20.4 16.6 20.6 15.1 16.6 17.7 19.4 29.1 22.7 34.0 16.4 16.2 14.1 12.8 17.7 16.1 15.5 11.3 13.7 17.7 15.6 17.7 17.9 14.2 24.6 23.2 41.7 54.2 32.3 57.1 26.3 17.0 48.4 29.0 28.1 24.5 10.8 24.0 25.8 40.6 18.4 33.3 91.9 44.8 29.9 5.9 29.1 17.2 28.4 8.7 12.7 15.6 49.7 44.3 25.3 81.1 26.0 41.3 31.7 12.0 36.2 13.9 23.5 38.2 47.1 42.5 18.8 30.5 21.1 20.5 19.9 6.5 33.0 23.2 65.6 21.9 22.9 49.4 52.3 204.3 46.2 22.6 6.4 43.2 14.5 27.7 40.0 29.7 34.8 6.6 17.2 15.3 16.6 35.6 46.4 19.5 204.8 39.6 8.9 26.7 25.7 C1orf100 ENSG00000173728 "Chromosome 1 open reading frame 100" Q5SVJ3 1 244352635-244389663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 63 "testis: 35.0" "Group enriched" "Detected in some" 151 "Early spermatids: 1207.7;Late spermatids: 851.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 41 "K-562: 5.9" "Not detected" "Not detected" "HPA031179, HPA031180" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA031179: AB_10599995, HPA031180: AB_10599026" "unprognostic (9.84e-2)" "unprognostic (2.14e-3)" "unprognostic (3.37e-2)" "unprognostic (9.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.49e-2)" "unprognostic (5.45e-3)" "unprognostic (2.17e-2)" "unprognostic (4.00e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-5)" "unprognostic (1.85e-2)" "unprognostic (2.08e-3)" "unprognostic (2.53e-2)" "unprognostic (1.79e-1)" "unprognostic (2.85e-1)" "unprognostic (1.27e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1207.7 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 851.9 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C21orf58 ENSG00000160298 "Chromosome 21 open reading frame 58" P58505 21 46300181-46323875 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.4;pituitary gland: 20.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 141.9;Enteroendocrine cells: 69.4;Erythroid cells: 80.2;Respiratory ciliated cells: 164.1;Spermatocytes: 80.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "basophil: 4.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "REH: 62.0" "Not detected" "Not detected" "HPA035110, HPA035111" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 14: REH - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nuclear bodies" "HPA035110: AB_10603683, HPA035111: AB_2674468" "unprognostic (2.19e-1)" "unprognostic (6.74e-3)" "unprognostic (2.51e-1)" "unprognostic (6.31e-3)" "unprognostic (1.08e-2)" "prognostic favorable (7.00e-4)" "unprognostic (4.74e-3)" "unprognostic (6.14e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (1.38e-1)" "prognostic favorable (4.20e-4)" "unprognostic (1.27e-1)" "unprognostic (1.01e-10)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (6.07e-2)" 1.5 1.7 1.9 3.6 2.4 13.1 2.0 2.6 2.3 3.5 3.0 3.2 4.7 2.0 0.7 3.9 26.4 1.0 1.3 1.8 1.9 1.5 1.7 4.8 6.3 2.8 4.6 2.6 2.5 1.2 20.7 2.0 2.0 2.9 2.6 2.5 2.3 1.5 1.7 5.3 4.4 1.3 1.8 3.4 3.5 7.1 2.5 12.8 2.1 0.7 3.8 2.1 2.7 3.2 26.0 11.6 30.2 19.0 2.9 4.0 16.7 15.7 5.7 10.8 10.5 5.4 18.6 18.6 3.8 4.4 12.5 20.3 8.1 6.7 3.2 19.9 17.8 29.9 35.2 3.1 0.7 8.6 16.6 1.7 1.4 7.7 1.9 4.0 6.8 45.4 17.4 48.1 8.9 10.6 42.7 11.6 13.0 7.2 5.7 62.0 13.6 16.6 3.4 4.8 24.7 15.4 11.7 8.3 3.7 6.4 20.5 17.1 4.7 6.6 18.4 6.6 9.6 19.3 9.3 8.8 11.6 37.1 17.4 4.4 0.2 0.6 0.4 0.1 0.2 0.1 0.5 0.6 0.0 0.9 0.9 0.7 0.3 0.3 0.1 1.0 0.8 0.5 1.9 2.4 2.6 2.3 1.8 1.9 2.8 4.6 2.0 1.8 2.5 3.2 2.1 3.2 2.6 4.2 3.1 0.9 1.6 7.0 2.8 19.5 6.2 8.8 3.0 0.0 16.6 1.8 27.1 7.7 9.4 13.9 0.0 1.7 17.3 141.9 7.7 2.3 69.4 80.2 2.7 1.0 5.9 5.9 11.7 4.5 2.5 21.4 2.2 1.5 4.0 5.0 2.5 12.8 14.2 1.6 1.9 32.5 5.3 6.2 0.0 0.0 1.3 5.9 5.2 1.5 4.2 1.2 4.1 2.6 4.8 2.0 3.0 0.7 164.1 28.2 0.0 2.6 5.5 80.8 45.3 8.5 1.4 1.4 3.7 3.9 16.8 0.9 C2orf16 DKFZp434G118 ENSG00000221843 "Chromosome 2 open reading frame 16" Q68DN1 2 27537386-27582721 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 21.4" "Cell type enriched" "Detected in some" 6 "Early spermatids: 94.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.4;SiHa: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052136, HPA056962" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 74: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA052136: AB_2681742, HPA056962: AB_2683290" "unprognostic (4.32e-2)" "unprognostic (1.08e-2)" "unprognostic (8.36e-2)" "unprognostic (3.40e-3)" "unprognostic (6.36e-2)" "unprognostic (6.17e-2)" "unprognostic (6.15e-2)" "unprognostic (3.07e-1)" "unprognostic (9.35e-2)" "unprognostic (3.79e-3)" "unprognostic (4.59e-1)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (8.00e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-2)" "unprognostic (8.53e-3)" 0.1 0.4 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.2 0.0 0.3 0.2 0.2 0.3 0.1 0.2 0.2 1.2 0.1 0.1 0.3 0.1 0.5 0.3 0.0 0.5 0.0 0.3 0.2 0.0 1.5 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.4 21.4 0.3 0.0 0.4 0.0 0.0 0.2 0.2 0.2 0.6 0.6 0.9 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.8 0.3 0.8 0.0 0.6 0.2 0.0 0.0 0.0 0.6 0.1 1.2 0.5 0.6 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.5 0.8 0.0 0.1 0.0 0.3 0.1 0.3 0.0 0.5 0.5 0.2 0.0 0.6 2.4 0.4 1.8 0.4 0.2 0.1 0.4 0.4 1.1 0.5 0.8 0.3 0.4 0.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.4 94.1 0.3 0.2 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 0.0 14.4 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.1 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 17.4;skin 1: 26.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 26.4;U-698: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 31: Skin - Epidermis development" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.2 1.0 0.1 1.2 0.2 0.6 2.7 0.2 0.3 0.7 0.2 7.5 3.3 0.9 0.0 2.6 0.7 5.0 4.0 0.2 0.1 4.8 0.3 3.8 1.2 0.0 0.1 0.2 17.4 0.0 2.0 3.3 0.1 1.7 13.7 0.1 3.8 3.4 0.5 26.3 5.2 0.9 0.1 0.7 13.7 0.9 0.3 6.6 7.6 0.1 2.0 5.8 1.6 0.1 11.0 2.0 4.2 0.0 0.6 0.0 1.8 15.5 6.7 10.1 11.3 26.4 10.1 0.4 1.9 3.1 4.4 8.7 6.1 0.3 19.4 0.0 2.8 7.9 1.8 1.9 4.6 0.0 0.1 0.6 8.7 5.2 15.0 5.4 2.2 0.0 2.8 2.8 7.5 1.7 0.3 0.0 12.3 7.9 0.6 0.3 13.2 0.0 18.1 16.5 0.5 0.9 2.4 5.2 6.3 6.8 9.5 0.0 5.8 3.6 5.5 0.0 0.0 3.9 0.0 30.1 2.7 0.1 3.6 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.8 16.0 10.0 0.3 1.6 32.5 129.6 10.0 45.5 0.0 14.8 3.3 2.1 4.3 19.3 18.4 0.0 18.1 0.7 30.4 0.0 26.3 24.2 24.8 3.1 3.5 11.9 0.0 3.2 35.9 25.6 4.7 64.2 44.1 0.0 0.4 0.4 0.0 1.9 0.0 0.6 56.6 8.2 0.3 2.7 23.3 0.3 1.0 1.8 1.0 2.6 0.0 0.0 0.5 0.3 82.8 30.7 0.4 4.6 75.6 7.8 2.1 14.8 0.0 0.0 4.6 4.7 3.2 5.3 44.0 33.5 75.0 2.0 3.0 8.9 132.5 C4orf33 FLJ33703 ENSG00000151470 "Chromosome 4 open reading frame 33" Q8N1A6 4 129093317-129116640 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA061199 Uncertain Approved "Nuclear bodies,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus" "Nuclear bodies" "HPA061199: AB_2684450" "unprognostic (7.27e-2)" "unprognostic (8.84e-2)" "unprognostic (3.50e-2)" "unprognostic (3.12e-2)" "unprognostic (3.14e-1)" "unprognostic (4.07e-2)" "unprognostic (5.82e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (1.34e-2)" "unprognostic (3.55e-2)" "unprognostic (5.14e-2)" "prognostic favorable (3.04e-4)" "unprognostic (2.09e-2)" "unprognostic (2.54e-1)" "unprognostic (9.89e-2)" "prognostic favorable (2.49e-5)" 7.8 10.3 4.6 6.4 5.2 16.1 9.5 11.6 5.6 5.5 3.9 20.5 17.0 4.8 9.4 9.1 8.4 9.2 5.8 4.7 5.4 14.2 9.9 8.4 6.5 6.3 6.5 11.1 9.4 6.0 12.2 9.4 7.0 4.6 16.7 13.4 6.7 4.1 2.6 6.8 15.1 5.7 6.2 7.9 16.2 5.6 5.5 8.9 12.0 2.7 5.8 9.9 5.8 7.0 7.7 4.3 9.7 9.8 7.8 7.5 15.7 7.2 10.0 8.4 10.8 2.2 36.1 6.4 17.8 10.4 13.0 4.8 11.2 11.5 6.8 38.3 8.6 15.7 11.4 3.0 9.5 7.8 16.0 7.6 10.2 10.0 4.0 15.5 6.9 22.9 20.5 26.9 8.6 3.1 12.7 6.2 0.5 16.2 5.4 5.3 10.3 8.3 23.7 8.7 12.4 2.8 5.5 13.1 8.7 2.2 12.2 5.9 5.0 7.4 2.7 5.5 5.8 14.4 6.8 11.3 15.4 20.4 6.4 18.7 11.7 30.3 3.3 11.6 2.5 5.6 2.6 4.0 11.8 2.7 2.7 4.3 5.7 9.3 12.3 6.4 4.8 4.9 4.6 5.2 11.6 5.6 4.7 5.4 6.3 6.5 7.0 6.2 5.5 7.0 10.7 6.4 14.1 11.8 9.2 10.5 7.4 22.9 10.8 15.1 13.4 8.3 4.2 18.6 16.3 12.9 8.4 21.5 19.8 24.7 50.9 10.4 6.9 34.8 7.4 7.9 4.9 8.2 12.8 9.3 18.9 8.3 18.8 17.5 14.5 5.9 8.6 5.2 14.2 1.7 11.2 14.7 22.4 18.1 16.7 3.0 2.1 18.6 12.4 10.3 13.3 11.8 7.2 12.1 21.5 8.1 17.9 2.2 9.6 2.7 25.6 30.9 36.9 11.5 0.0 5.0 12.9 4.6 5.4 13.5 9.2 18.9 12.2 15.5 16.4 8.9 C4orf54 "FOPV, LOC285556" ENSG00000248713 "Chromosome 4 open reading frame 54" D6RIA3 4 99636529-99654648 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skeletal muscle: 72.7" "Cell type enriched" "Detected in single" 17 "Endometrial ciliated cells: 14.3" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 1.6;SK-BR-3: 1.1" "Low region specificity" "Detected in single" HPA079091 Approved "Nuclear bodies,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear bodies" Cytosol "HPA079091: " "unprognostic (3.91e-2)" "unprognostic (3.76e-1)" "unprognostic (4.27e-2)" "unprognostic (1.81e-2)" "unprognostic (1.76e-2)" "unprognostic (4.00e-3)" "unprognostic (2.31e-3)" "unprognostic (1.50e-1)" "unprognostic (4.31e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" "unprognostic (2.20e-1)" "unprognostic (2.42e-3)" "unprognostic (1.89e-2)" "unprognostic (2.10e-2)" "unprognostic (1.20e-3)" 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 6.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 72.7 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.7 0.0 14.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 C8orf58 FLJ34715 ENSG00000241852 "Chromosome 8 open reading frame 58" Q8NAV2 8 22599599-22604150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 28.1;Extravillous trophoblasts: 30.4;Sertoli cells: 26.3;Syncytiotrophoblasts: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024667, HPA028286" Uncertain Approved "Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 12: NES - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear bodies" "HPA024667: AB_1845783, HPA028286: AB_1845784" "unprognostic (8.88e-3)" "unprognostic (4.58e-2)" "unprognostic (1.99e-1)" "unprognostic (1.69e-2)" "unprognostic (6.72e-2)" "unprognostic (9.68e-2)" "unprognostic (2.60e-1)" "unprognostic (1.17e-1)" "unprognostic (1.22e-1)" "unprognostic (8.70e-2)" "unprognostic (2.40e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.58e-6)" "unprognostic (1.67e-1)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" 11.1 7.1 8.8 4.3 8.3 4.5 10.8 13.5 9.9 10.6 8.5 7.7 3.5 9.2 4.9 9.8 8.9 7.2 9.9 8.4 8.9 13.3 7.9 10.6 5.5 9.5 8.4 9.3 6.2 4.9 5.5 16.6 8.9 8.3 3.2 5.9 7.1 5.5 9.0 13.6 7.2 4.8 8.7 25.7 6.3 16.5 8.9 3.5 8.1 4.8 3.5 8.6 9.9 8.6 7.7 11.4 30.8 18.2 8.3 9.5 8.4 16.9 14.2 20.9 15.0 2.2 6.4 1.5 8.0 18.7 14.2 7.5 5.6 15.9 13.4 2.3 2.6 4.5 12.0 1.2 14.5 1.6 6.7 13.7 13.5 12.4 7.8 18.7 12.2 5.9 2.8 2.2 16.8 5.5 3.4 8.4 18.8 6.3 7.5 5.6 7.7 1.8 12.8 7.0 3.2 10.0 8.3 5.9 20.0 31.8 5.6 3.6 17.0 22.7 18.1 15.9 15.7 2.7 1.8 1.5 11.7 3.3 18.6 0.0 0.2 1.2 0.1 0.5 0.1 0.4 0.1 0.3 0.1 0.4 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.1 8.8 8.3 13.5 9.9 8.4 8.9 9.5 8.4 8.9 8.7 8.9 8.6 9.8 3.2 2.0 3.9 5.0 10.3 3.8 7.0 2.8 2.9 4.2 5.0 2.4 0.0 4.9 0.0 0.0 28.1 3.6 3.4 0.0 11.5 1.2 1.4 6.4 12.1 4.2 0.8 1.0 6.7 30.4 6.1 2.0 3.2 1.3 5.4 15.7 0.8 9.5 1.7 1.1 1.7 6.1 3.1 5.4 2.3 8.7 2.9 3.6 1.9 7.9 6.5 1.0 1.0 0.3 12.5 3.3 6.4 2.8 5.1 3.9 2.3 2.4 4.8 26.3 3.1 6.7 1.8 2.9 4.1 9.7 55.8 3.8 4.6 2.2 2.8 C9orf153 bA507D14.1 ENSG00000187753 "Chromosome 9 open reading frame 153" Q5TBE3 9 86220265-86259657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 20.8" "Group enriched" "Detected in some" 26 "Early spermatids: 268.6;Late spermatids: 244.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.3" "Not detected" "Not detected" HPA079466 Approved "Nucleoplasm,Nuclear bodies,Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies, Plasma membrane" "Nucleoplasm, Vesicles" "HPA079466: " "unprognostic (2.03e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.30e-3)" "unprognostic (7.49e-2)" "unprognostic (2.75e-2)" "unprognostic (3.37e-1)" "unprognostic (6.85e-2)" "unprognostic (9.70e-2)" "unprognostic (1.49e-1)" "unprognostic (2.01e-6)" "unprognostic (9.43e-2)" "unprognostic (1.92e-1)" "unprognostic (9.64e-2)" "unprognostic (2.10e-1)" 0.1 0.4 0.3 0.4 0.2 2.6 0.2 1.4 0.9 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.4 0.1 0.2 0.2 0.1 0.1 0.2 0.5 0.5 0.6 0.2 0.1 0.1 0.0 0.9 0.6 0.1 0.1 0.6 0.2 0.2 0.0 0.3 0.2 0.1 0.0 0.2 0.3 20.8 0.5 0.1 0.2 0.1 0.0 0.0 0.0 1.3 0.2 0.8 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.2 0.0 0.6 0.8 0.2 0.2 0.5 0.2 0.0 0.0 0.1 0.1 0.3 0.0 1.3 0.2 0.1 0.2 0.2 0.1 0.6 0.1 0.0 0.0 0.3 0.9 0.0 0.5 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.7 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.6 0.1 0.2 0.4 0.1 0.3 0.0 0.1 0.4 0.8 1.6 0.2 0.3 0.6 0.1 0.1 0.1 0.1 1.2 0.2 0.1 0.1 0.5 0.3 0.2 0.2 0.1 1.5 0.3 0.2 1.4 0.9 0.2 0.2 0.5 0.6 0.6 0.0 0.5 1.3 0.3 0.0 0.0 9.8 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 268.6 0.4 0.5 0.7 0.0 0.0 4.8 0.0 0.1 0.4 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.4 244.8 2.8 0.1 1.8 1.0 0.1 0.4 2.1 6.6 9.7 0.1 0.0 0.7 0.4 0.3 0.0 0.1 0.0 0.1 0.0 1.3 0.7 1.8 1.9 0.0 0.1 0.1 0.2 0.3 0.1 0.2 CABLES1 "FLJ35924, HsT2563" ENSG00000134508 "Cdk5 and Abl enzyme substrate 1" Q8TDN4 18 23134564-23260467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 70.2" "Cell type enhanced" "Detected in many" "Astrocytes: 258.2;Glandular and luminal cells: 54.3;Oligodendrocyte precursor cells: 163.3" "Cancer enriched" "Detected in all" 5 "melanoma: 38.7" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 8 "NK-cells: 1.2" "Cell line enhanced" "Detected in many" "SK-MEL-30: 154.3;U-266/70: 216.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073649 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear bodies" "HPA073649: AB_2732233" "unprognostic (1.27e-1)" "unprognostic (2.03e-1)" "unprognostic (1.97e-1)" "unprognostic (4.24e-3)" "unprognostic (1.56e-1)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (1.01e-1)" "prognostic favorable (4.71e-6)" "unprognostic (1.00e-1)" "unprognostic (1.60e-1)" "unprognostic (4.80e-2)" "unprognostic (7.81e-2)" 17.1 3.3 63.9 2.1 67.9 2.6 13.8 36.8 54.8 6.9 17.1 5.2 7.5 9.4 3.2 6.9 10.9 5.2 4.6 44.9 53.5 13.1 9.9 21.5 2.8 39.6 59.0 3.7 3.0 21.9 4.0 10.4 40.8 3.7 5.1 8.0 22.3 4.5 1.5 17.2 6.7 6.6 31.2 3.7 14.5 3.5 70.2 4.9 15.0 1.8 2.3 5.4 7.8 33.3 13.1 14.4 11.8 0.9 7.1 0.3 20.4 3.1 17.3 4.2 2.5 9.5 23.0 0.7 13.3 14.9 42.3 11.4 9.0 2.3 3.2 0.3 19.4 1.0 38.7 37.1 6.2 2.5 1.0 4.2 2.1 5.3 6.1 26.8 47.1 2.3 0.5 16.2 11.7 30.2 0.1 8.8 7.5 64.5 46.6 3.1 42.2 50.6 21.2 31.5 11.2 8.2 26.1 32.5 154.3 8.3 52.4 7.2 79.3 47.9 0.5 1.6 3.8 216.0 88.9 27.4 0.2 19.2 16.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.1 0.0 0.0 63.9 67.9 36.8 54.8 44.9 53.5 39.6 59.0 40.8 31.2 70.2 33.3 2.9 22.4 27.4 258.2 3.8 5.1 2.0 1.4 5.2 4.1 9.2 6.7 1.4 7.2 2.3 3.7 29.2 0.9 1.3 8.5 1.9 1.1 2.0 11.6 4.4 6.0 3.5 1.3 19.2 2.3 1.1 4.1 10.2 54.3 0.0 14.8 25.0 9.3 16.6 0.0 22.2 4.6 0.0 3.5 3.1 3.5 0.0 4.7 28.4 41.2 0.0 1.4 0.0 163.3 1.4 2.4 5.2 6.0 3.6 0.6 6.7 14.3 1.8 18.7 0.0 5.0 2.1 0.2 3.2 1.6 6.7 0.3 1.4 0.5 2.1 2.2 CABLES2 "C20orf150, dJ908M14.2, ik3-2" ENSG00000149679 "Cdk5 and Abl enzyme substrate 2" Q9BTV7 20 62388632-62407285 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.0" "Cell type enhanced" "Detected in many" "Early spermatids: 51.3;Late spermatids: 25.6;Spermatocytes: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052138 Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear bodies" "Nucleoplasm, Cell Junctions" "HPA052138: AB_2681743" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (5.26e-5)" "unprognostic (1.45e-2)" "unprognostic (1.51e-1)" "unprognostic (2.71e-2)" "unprognostic (5.07e-2)" "unprognostic (5.37e-3)" "unprognostic (6.05e-2)" "unprognostic (1.40e-3)" "unprognostic (3.09e-2)" "prognostic unfavorable (1.24e-6)" "unprognostic (1.99e-2)" "unprognostic (3.87e-1)" "unprognostic (1.67e-1)" "unprognostic (2.94e-2)" 2.4 3.0 6.8 4.2 7.2 8.1 2.8 11.5 9.1 3.9 3.5 4.4 2.9 3.5 2.6 3.2 4.8 2.2 10.6 7.1 7.4 2.6 4.0 2.9 5.1 7.9 6.6 4.3 3.2 3.9 5.9 2.8 7.8 4.3 3.2 5.6 3.3 3.1 5.8 4.3 4.4 3.3 5.9 4.2 4.0 31.0 7.5 5.3 5.1 4.1 4.4 3.7 3.3 7.2 16.3 12.0 20.4 20.9 3.1 4.4 2.8 9.2 8.9 24.8 11.4 43.6 9.1 16.3 7.6 5.9 33.9 10.1 12.6 6.0 9.6 7.3 6.9 19.0 6.3 10.6 5.5 7.8 9.4 2.7 6.7 7.1 2.6 4.4 5.8 20.8 4.9 13.9 5.6 20.0 20.6 6.2 6.8 16.4 13.7 28.1 17.2 7.1 3.7 10.6 11.1 16.8 13.3 17.4 3.6 7.6 11.9 11.7 6.0 22.7 6.8 30.3 9.5 13.3 11.7 19.4 20.4 8.8 12.1 0.0 0.2 0.0 0.7 0.3 0.4 0.5 0.4 0.5 0.3 0.2 0.2 0.3 0.2 0.4 0.3 0.2 1.3 0.1 6.8 7.2 11.5 9.1 7.1 7.4 7.9 6.6 7.8 5.9 7.5 7.2 1.5 3.2 1.7 2.0 2.1 0.9 0.5 1.7 2.8 6.0 2.9 2.4 10.7 2.8 2.5 0.0 4.2 1.3 3.1 3.5 1.9 2.2 51.3 1.1 1.2 1.6 3.5 1.7 4.4 2.4 0.7 2.6 3.6 2.2 0.0 5.3 2.2 1.4 2.1 13.5 5.2 4.1 0.0 1.6 3.0 25.6 1.8 2.0 0.0 1.0 1.0 1.9 1.0 3.5 3.3 2.1 2.3 3.4 2.5 0.7 1.8 0.7 0.2 3.4 0.0 3.0 1.3 21.8 6.9 1.3 2.0 2.3 2.0 1.0 2.8 0.6 CAND2 "KIAA0667, TIP120B, Tp120b" ENSG00000144712 "Cullin associated and neddylation dissociated 2 (putative)" O75155 3 12796472-12871916 "Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 135.0" "Cell type enriched" "Detected in many" 4 "Early spermatids: 120.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 19.4;REH: 12.4;U-266/84: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005777 Approved Approved "Nuclear bodies,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" Cytosol "HPA005777: AB_2667431" "unprognostic (6.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.52e-3)" "unprognostic (6.09e-2)" "unprognostic (4.22e-1)" "unprognostic (2.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.67e-2)" "unprognostic (2.00e-2)" "unprognostic (9.03e-2)" "unprognostic (6.36e-3)" "unprognostic (1.03e-1)" "unprognostic (4.78e-5)" "unprognostic (1.31e-2)" "unprognostic (2.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.96e-3)" 3.0 3.2 7.9 0.5 7.9 1.0 1.9 6.4 8.7 4.8 7.6 6.5 0.9 6.4 2.2 2.4 6.2 1.7 25.3 8.0 9.6 2.4 1.6 2.4 0.8 8.0 7.4 5.0 2.4 5.4 8.3 0.8 8.3 3.6 0.7 2.2 3.3 3.0 135.0 1.4 2.3 3.4 6.6 2.2 3.3 15.7 8.8 0.8 3.1 36.2 0.6 4.4 2.7 8.6 0.8 1.6 5.6 0.2 0.2 0.1 0.3 1.4 0.6 3.4 4.1 0.9 0.3 1.0 1.9 0.9 0.9 0.2 6.4 0.1 2.6 1.8 19.4 1.5 2.9 1.4 5.2 0.2 0.1 1.2 0.3 3.1 0.1 3.3 0.7 7.2 5.3 1.0 1.0 3.3 2.6 0.8 3.8 0.4 2.0 12.4 1.2 1.0 0.2 1.5 3.9 4.6 0.1 0.9 1.2 1.1 1.6 6.3 0.4 1.0 0.9 1.0 1.4 1.3 9.9 8.4 0.6 1.2 2.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.1 7.9 7.9 6.4 8.7 8.0 9.6 8.0 7.4 8.3 6.6 8.8 8.6 0.9 3.2 1.1 5.9 0.2 0.4 0.8 0.6 1.8 16.0 0.4 0.5 4.8 1.5 0.7 1.8 10.4 0.2 0.2 0.1 0.0 0.9 120.6 0.4 1.4 1.8 0.0 0.4 19.3 0.0 0.2 2.6 0.5 0.3 0.0 5.6 3.3 2.0 4.2 13.5 25.3 0.0 0.0 0.0 0.8 23.2 4.7 0.4 0.0 4.7 0.0 2.9 1.0 12.1 7.2 0.0 0.0 10.1 0.2 0.5 0.0 0.7 0.3 3.1 0.0 4.1 4.0 1.4 5.3 0.4 0.1 0.1 1.0 9.2 0.0 0.4 CASP8AP2 "CED-4, FLASH, FLJ11208, KIAA1315, RIP25" ENSG00000118412 "Caspase 8 associated protein 2" 6 89829894-89874436 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.6" "Cell type enhanced" "Detected in many" "Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053573 Approved "Nucleoli,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoli, Nuclear bodies" "HPA053573: AB_2682194" "unprognostic (7.80e-2)" "unprognostic (1.47e-1)" "unprognostic (6.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.64e-2)" "unprognostic (1.22e-2)" "unprognostic (1.75e-4)" "unprognostic (4.58e-1)" "unprognostic (4.36e-3)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (2.35e-1)" "unprognostic (1.63e-1)" "unprognostic (4.16e-2)" "unprognostic (3.53e-1)" 0.6 0.3 0.4 0.4 1.0 0.2 0.5 2.6 1.2 0.7 0.3 0.9 0.0 0.7 0.0 0.4 0.6 0.1 0.4 0.6 0.4 0.4 0.2 0.5 0.4 0.5 0.5 0.5 0.5 0.1 0.4 0.1 0.8 0.5 0.1 0.0 0.4 0.0 0.8 0.4 0.5 0.2 0.8 0.4 0.3 0.3 0.7 0.6 0.6 0.7 0.2 0.6 0.5 1.9 0.4 1.0 1.3 1.0 0.1 0.4 0.3 2.1 0.2 0.7 0.5 0.8 0.5 2.4 0.7 1.0 0.8 0.7 2.5 0.6 0.7 3.7 3.5 4.0 3.0 0.0 0.0 2.6 1.1 0.2 0.2 1.6 0.6 0.2 0.8 1.4 4.4 1.3 0.6 0.7 1.6 0.0 0.2 0.2 1.3 3.3 3.8 0.9 0.0 3.2 1.4 0.8 1.8 0.0 0.5 0.5 0.4 1.2 1.6 0.3 0.5 1.6 1.6 0.2 2.8 1.3 0.5 1.4 1.4 14.4 1.5 5.6 6.2 2.6 5.9 5.5 7.1 6.5 1.9 6.3 5.4 5.6 3.1 12.6 2.3 4.9 6.6 2.3 0.4 1.0 2.6 1.2 0.6 0.4 0.5 0.5 0.8 0.8 0.7 1.9 27.3 32.1 14.5 26.1 26.8 0.0 9.1 0.0 13.6 19.5 13.3 16.4 47.5 7.2 11.8 7.3 6.2 20.5 21.4 12.7 3.9 15.1 5.9 9.6 22.1 21.1 2.4 35.7 32.3 12.3 15.8 21.4 11.7 13.7 15.8 31.8 9.7 6.9 12.4 35.3 33.5 11.7 0.0 11.5 0.0 4.7 23.0 16.1 0.0 33.7 26.9 18.1 34.0 23.6 38.2 9.3 10.3 25.9 14.4 13.2 11.8 7.2 13.8 25.5 19.7 30.6 25.1 47.2 74.2 15.7 0.0 10.9 24.7 16.7 14.6 9.1 CBX1 "CBX, HP1-BETA, HP1Hs-beta, M31, MOD1" ENSG00000108468 "Chromobox 1" P83916 17 48070052-48101478 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 350.8;Spermatogonia: 304.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012265 Supported Supported "Nucleoplasm,Nuclear bodies" NA NA 120000 "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "CAB012265: AB_297216" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "unprognostic (2.02e-1)" "unprognostic (2.58e-2)" "unprognostic (3.15e-1)" "unprognostic (3.04e-1)" "prognostic unfavorable (2.70e-4)" "unprognostic (2.68e-2)" "unprognostic (3.45e-2)" "unprognostic (6.55e-2)" "unprognostic (2.78e-1)" "unprognostic (2.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.48e-3)" "unprognostic (3.82e-1)" "unprognostic (3.65e-1)" "unprognostic (6.73e-2)" 30.9 31.4 60.3 35.5 59.9 16.5 37.2 61.6 73.2 53.6 54.5 40.7 19.0 66.5 47.9 36.8 40.2 27.9 32.1 59.8 63.9 37.9 21.6 26.9 35.0 63.2 59.7 77.5 22.3 43.8 34.8 34.7 64.0 38.0 33.1 59.5 29.7 47.1 68.4 28.8 24.0 55.6 64.9 33.7 26.6 69.1 60.3 73.6 39.5 46.0 46.9 36.4 37.9 67.3 217.3 121.1 392.4 185.6 78.0 69.3 217.7 197.0 95.1 188.0 200.6 319.2 84.5 148.4 204.5 155.6 144.8 85.3 146.3 124.6 329.2 273.8 118.1 119.8 121.1 119.3 47.5 115.5 71.9 49.8 68.4 140.3 178.3 144.7 157.1 176.6 152.0 67.2 153.8 135.7 325.9 79.8 150.6 118.8 156.9 241.8 322.7 95.8 110.3 121.7 138.5 345.6 135.0 44.6 75.5 281.8 211.0 82.5 110.7 260.2 238.9 112.0 201.1 94.0 227.9 140.4 71.4 50.4 119.0 5.1 12.2 16.0 12.4 12.7 10.0 16.1 11.2 10.4 9.9 15.7 11.5 9.7 33.6 9.5 9.3 10.6 12.4 5.9 60.3 59.9 61.6 73.2 59.8 63.9 63.2 59.7 64.0 64.9 60.3 67.3 32.9 67.3 27.6 7.8 31.4 43.6 30.5 46.1 36.5 46.9 48.0 54.7 70.9 18.6 33.6 42.3 20.9 66.4 27.5 19.2 35.2 68.7 26.8 40.8 78.9 40.2 40.3 34.3 13.0 29.7 86.6 61.5 10.2 39.6 39.9 65.3 30.0 15.6 69.6 50.5 15.5 27.3 42.7 33.5 24.5 59.5 80.2 26.7 40.9 7.5 47.7 106.6 42.2 12.5 13.7 34.7 12.9 91.7 20.0 51.1 9.6 30.9 32.2 36.3 39.5 33.3 71.8 350.8 304.0 26.7 36.2 27.8 25.6 35.8 28.6 20.1 CBX3 HP1Hs-gamma ENSG00000122565 "Chromobox 3" Q13185 7 26201162-26213607 "Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001973, HPA004902" Supported Supported "Nucleoplasm,Nuclear bodies" NA Yes 180000 "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "CAB001973: , HPA004902: AB_1850635" "prognostic unfavorable (7.92e-4)" "unprognostic (1.43e-1)" "unprognostic (4.84e-2)" "unprognostic (1.12e-2)" "unprognostic (4.85e-2)" "unprognostic (9.25e-3)" "prognostic unfavorable (2.20e-8)" "unprognostic (2.13e-2)" "unprognostic (3.95e-2)" "unprognostic (3.71e-3)" "prognostic unfavorable (4.00e-4)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.56e-7)" "unprognostic (7.79e-2)" "unprognostic (4.69e-2)" "unprognostic (1.17e-1)" "unprognostic (5.78e-2)" 76.2 93.0 55.5 99.2 57.8 168.8 98.5 58.8 74.1 65.0 56.6 75.3 105.8 76.7 79.7 63.9 62.9 58.5 64.2 54.2 63.2 87.6 84.9 62.1 145.7 60.2 61.0 79.5 56.3 51.5 40.5 88.8 60.7 56.6 87.2 122.7 61.3 59.8 87.2 54.7 99.0 65.9 60.2 82.0 61.7 99.6 58.2 190.4 55.3 68.6 140.4 84.1 55.7 63.6 365.4 156.3 330.0 332.2 115.0 205.8 257.8 275.9 209.1 205.2 207.2 185.8 296.8 544.1 218.7 183.9 440.6 283.0 275.7 231.2 332.1 151.8 209.1 312.8 201.0 208.5 126.1 508.3 294.7 153.9 197.5 163.2 231.2 253.9 281.7 343.2 506.1 263.9 351.7 207.5 489.4 625.9 424.4 311.3 225.1 313.6 303.9 452.3 303.8 201.4 401.1 448.2 230.5 482.6 274.9 345.3 412.4 455.1 212.0 186.0 340.5 222.1 376.8 394.6 596.5 929.3 163.2 422.3 864.3 135.7 85.9 137.7 77.3 116.3 96.9 86.8 114.4 96.1 89.1 77.7 118.4 119.6 92.6 99.2 123.2 72.4 148.3 87.2 55.5 57.8 58.8 74.1 54.2 63.2 60.2 61.0 60.7 60.2 58.2 63.6 139.1 109.0 98.4 16.3 158.5 143.6 93.3 128.0 105.3 101.8 223.8 181.0 124.1 133.0 119.7 64.4 77.2 176.3 138.7 111.2 140.8 167.6 162.2 132.4 215.4 142.6 110.2 306.6 27.4 141.4 362.1 123.6 81.1 129.0 222.0 166.2 145.3 289.2 143.1 50.5 26.8 156.6 107.8 254.9 200.0 41.9 136.4 157.6 104.9 15.0 183.3 155.9 166.9 23.1 35.8 166.3 103.8 98.2 129.1 135.1 112.6 187.4 107.3 132.1 78.9 60.0 110.1 274.5 388.6 112.5 107.8 270.8 155.2 133.1 205.9 110.9 CBX4 "hPC2, NBP16, PC2" ENSG00000141582 "Chromobox 4" O00257 17 79833156-79839440 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 130.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 110.8;SK-MEL-30: 130.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008228, HPA012021" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "HPA008228: AB_1078413, HPA012021: AB_2668603" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (3.97e-2)" "unprognostic (8.80e-2)" "unprognostic (5.39e-3)" "unprognostic (1.49e-1)" "unprognostic (2.55e-1)" "unprognostic (1.40e-2)" "unprognostic (7.62e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (8.72e-8)" "unprognostic (7.49e-2)" "unprognostic (2.87e-1)" "unprognostic (3.99e-2)" "unprognostic (1.07e-1)" 9.3 14.2 9.6 11.1 10.8 130.3 9.0 8.8 12.5 9.1 0.0 7.9 7.1 6.3 4.6 20.7 8.1 6.3 16.0 12.4 9.7 10.6 21.6 12.3 14.6 11.5 9.5 9.6 19.0 17.0 19.1 15.2 10.7 9.3 3.2 12.3 13.2 4.6 3.4 31.6 11.9 3.8 8.2 20.9 12.9 6.9 12.2 23.1 8.6 1.4 7.2 6.7 10.3 16.6 32.1 28.3 8.4 36.3 5.2 4.7 23.5 14.3 8.5 5.1 5.4 20.5 17.5 12.3 19.7 5.6 11.4 16.3 9.3 9.5 3.8 13.3 17.7 7.0 28.0 38.4 25.4 37.0 52.5 6.5 54.4 4.7 8.4 8.5 4.3 35.5 21.7 67.5 5.5 23.0 50.9 37.7 4.6 33.2 28.2 51.9 8.6 56.3 7.2 15.3 8.7 16.6 21.4 110.8 130.9 3.5 26.3 58.3 11.2 29.8 26.3 18.4 18.6 58.0 32.4 35.0 18.7 31.6 40.4 1.6 0.5 1.8 0.9 0.6 0.6 1.5 1.2 1.3 0.3 1.5 1.4 1.3 2.1 0.4 0.7 1.7 0.2 0.6 9.6 10.8 8.8 12.5 12.4 9.7 11.5 9.5 10.7 8.2 12.2 16.6 40.4 3.2 15.7 4.6 31.8 23.3 5.4 13.4 36.5 31.7 65.2 79.8 51.6 30.0 12.1 1.8 22.9 34.2 77.6 26.6 0.0 7.5 0.2 63.9 19.3 21.6 52.7 7.8 5.5 7.3 5.0 15.8 20.9 62.8 7.0 22.3 15.7 16.3 13.8 20.2 5.5 49.5 2.0 19.8 17.0 1.0 4.4 35.4 17.8 12.2 15.4 39.2 15.5 6.0 11.6 10.0 18.4 5.7 26.1 6.3 9.6 2.8 14.6 44.3 6.6 15.3 24.4 0.5 2.4 65.7 30.7 8.6 42.5 13.7 29.7 5.2 CCAR2 "DBC-1, DBC1, KIAA1967, NET35" ENSG00000158941 "Cell cycle and apoptosis regulator 2" Q8N163 8 22604632-22621514 "Predicted intracellular proteins" "Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway" "Activator, Metalloenzyme inhibitor, Repressor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019907, HPA019943, CAB072827, CAB072828" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA 19000 "Cluster 39: Non-specific - mRNA processing" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "Nucleoplasm, Nuclear bodies" "CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454" "unprognostic (3.42e-2)" "unprognostic (5.78e-3)" "unprognostic (2.46e-3)" "unprognostic (1.33e-2)" "unprognostic (6.87e-2)" "unprognostic (2.23e-2)" "unprognostic (5.13e-2)" "unprognostic (8.56e-2)" "unprognostic (2.97e-1)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (1.54e-2)" "prognostic favorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (2.46e-1)" "unprognostic (7.54e-2)" "unprognostic (1.77e-1)" 64.1 68.3 39.2 75.4 44.2 145.5 64.4 40.2 52.4 65.6 45.6 68.5 52.1 75.0 33.0 63.4 67.9 59.7 52.0 47.0 33.8 54.8 41.1 61.4 86.7 36.9 42.3 74.6 56.4 59.8 65.1 54.0 38.6 61.1 45.6 59.8 61.5 46.9 101.4 89.0 69.3 44.9 34.7 85.6 60.0 89.4 39.6 96.0 60.6 43.5 74.3 65.4 57.6 47.9 133.7 242.8 230.8 120.8 89.5 74.7 154.0 127.7 124.9 184.3 163.9 219.5 107.4 218.6 156.4 140.5 169.6 163.2 214.5 151.9 132.9 89.2 128.2 259.1 189.5 172.8 82.9 143.6 212.0 77.8 133.1 147.0 90.0 106.4 134.4 194.4 276.2 134.8 138.0 157.5 435.0 150.5 337.6 143.2 88.1 286.7 190.7 116.8 95.2 311.7 115.1 267.6 143.7 163.0 112.6 110.7 148.8 133.2 219.3 135.8 178.4 165.3 171.1 98.5 134.0 261.4 152.7 123.4 215.7 25.9 16.2 23.5 34.8 26.6 29.4 18.7 26.5 26.6 16.6 17.5 25.7 28.4 5.7 19.9 35.6 15.5 32.6 25.8 39.2 44.2 40.2 52.4 47.0 33.8 36.9 42.3 38.6 34.7 39.6 47.9 14.4 16.0 4.2 11.1 14.1 13.9 9.5 12.2 17.6 12.9 13.5 13.1 7.5 15.7 9.4 16.5 16.7 27.3 19.4 24.1 9.8 18.1 4.7 14.1 12.3 13.1 22.2 16.4 12.5 18.0 22.2 12.8 18.8 14.3 8.8 20.2 11.7 12.0 15.7 10.1 11.9 19.6 14.2 11.9 8.5 7.3 14.9 11.0 12.4 10.3 11.2 15.9 20.6 11.1 10.3 23.6 10.4 12.0 14.8 11.7 14.4 9.4 19.5 12.9 19.7 12.4 12.2 30.0 24.1 16.9 15.3 23.7 19.3 23.5 21.7 10.5 CCDC102A MGC10992 ENSG00000135736 "Coiled-coil domain containing 102A" Q96A19 16 57512181-57536571 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Peritubular cells: 34.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "EFO-21: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA040598, HPA040958" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 9: U-2 OS - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies" "HPA040598: AB_10794035, HPA040958: AB_10794156" "unprognostic (3.46e-2)" "unprognostic (3.04e-2)" "unprognostic (1.88e-2)" "unprognostic (1.51e-1)" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (2.42e-1)" "unprognostic (4.01e-3)" "unprognostic (7.71e-2)" "unprognostic (1.72e-1)" "unprognostic (1.38e-1)" "unprognostic (5.24e-3)" "unprognostic (8.40e-3)" "unprognostic (4.08e-1)" "unprognostic (2.75e-1)" "unprognostic (2.37e-1)" "unprognostic (8.42e-3)" 5.0 3.7 1.8 2.7 1.6 0.5 4.8 1.7 2.4 10.9 4.1 11.1 2.3 11.0 1.1 3.5 8.8 1.5 6.8 1.6 1.7 5.2 1.5 4.5 3.0 2.5 2.4 8.0 3.3 1.5 2.3 2.5 2.0 8.4 0.5 0.1 4.0 3.8 1.6 4.9 4.7 2.4 2.1 5.1 4.8 3.0 2.4 1.6 5.8 0.5 1.7 11.9 8.2 1.5 6.6 7.9 3.0 4.3 1.0 1.4 6.2 4.2 2.3 2.4 1.2 3.2 7.5 6.0 16.4 1.3 3.2 4.8 1.5 2.2 0.9 4.9 6.8 0.8 3.8 1.3 3.7 0.4 7.7 3.5 1.4 2.0 0.5 5.2 1.9 2.1 4.6 0.0 0.8 2.7 5.4 5.3 7.1 0.7 14.6 4.8 3.4 2.4 3.0 1.0 0.5 7.8 6.6 2.1 3.2 1.1 4.5 2.9 5.2 4.4 14.5 0.4 3.8 6.9 2.7 2.2 2.5 2.1 7.4 0.0 0.0 0.0 1.1 0.0 0.9 0.9 0.2 1.2 0.0 0.5 0.5 0.8 0.1 0.6 0.0 0.3 0.0 0.2 1.8 1.6 1.7 2.4 1.6 1.7 2.5 2.4 2.0 2.1 2.4 1.5 8.8 0.0 3.0 0.7 8.2 12.9 8.0 2.4 14.8 0.0 4.9 10.3 3.1 5.7 2.2 7.3 0.0 1.6 16.3 0.5 9.8 1.9 0.6 6.0 8.5 10.6 0.0 3.4 0.0 0.9 1.1 13.2 2.0 1.8 0.0 14.6 7.1 0.9 0.3 0.0 0.1 1.0 0.0 0.6 2.8 1.3 19.6 1.5 1.8 1.0 0.5 3.5 18.6 0.0 0.0 0.9 0.1 34.6 18.8 10.6 1.1 10.5 3.1 0.2 19.7 10.8 11.8 2.8 8.9 2.3 5.7 0.3 10.5 3.3 1.0 3.2 CCDC159 ENSG00000183401 "Coiled-coil domain containing 159" P0C7I6 19 11344684-11354944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 275.7;Late spermatids: 277.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047126, HPA054655" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" Cytosol "HPA047126: AB_10961722, HPA054655: AB_2682558" "unprognostic (1.46e-1)" "unprognostic (3.05e-3)" "unprognostic (2.35e-3)" "prognostic favorable (1.87e-7)" "unprognostic (5.02e-2)" "unprognostic (1.06e-3)" "unprognostic (9.23e-3)" "unprognostic (2.40e-2)" "unprognostic (6.68e-2)" "prognostic favorable (9.46e-4)" "prognostic favorable (1.42e-4)" "unprognostic (2.89e-1)" "unprognostic (3.97e-2)" "unprognostic (5.09e-2)" "unprognostic (2.46e-1)" "unprognostic (3.00e-2)" "prognostic favorable (8.62e-4)" 15.7 43.4 29.3 17.3 33.8 32.6 18.2 28.9 41.0 30.0 29.2 25.8 22.9 22.5 24.9 18.2 24.0 20.6 21.8 32.3 31.3 25.9 36.0 22.8 20.9 34.4 31.3 31.3 23.3 39.5 33.5 9.3 33.4 45.1 11.8 12.4 21.6 18.5 6.1 19.0 24.0 13.8 27.4 41.8 26.2 43.2 34.2 12.4 30.4 6.7 14.5 24.2 21.7 38.1 3.7 3.2 2.6 8.0 10.3 14.8 2.7 5.8 6.0 6.7 8.9 1.0 3.8 3.0 14.7 11.0 2.0 3.0 1.5 9.2 4.1 15.0 2.2 7.2 2.5 3.9 17.9 2.8 10.4 17.8 24.0 4.9 6.5 7.1 19.2 5.3 6.5 33.6 3.4 4.5 4.5 6.0 1.4 5.0 11.5 4.8 0.0 19.6 6.1 5.3 1.1 4.3 5.9 6.6 11.0 4.6 9.8 11.9 12.8 5.3 1.6 9.3 5.5 30.8 8.0 6.2 7.2 14.7 7.9 51.5 52.8 38.5 21.5 46.3 21.1 16.0 14.6 20.2 31.6 20.4 13.2 10.4 25.3 30.2 33.8 8.4 31.5 23.5 29.3 33.8 28.9 41.0 32.3 31.3 34.4 31.3 33.4 27.4 34.2 38.1 10.7 16.0 13.6 7.5 14.5 7.5 15.4 14.9 10.8 11.3 12.5 8.9 9.8 12.8 16.7 18.4 41.7 5.1 12.4 13.0 25.4 8.2 275.7 9.0 8.8 10.3 10.8 4.6 4.5 9.5 5.5 8.1 30.5 10.0 34.2 11.5 12.8 10.9 23.3 6.7 3.0 12.5 10.2 26.7 14.8 277.4 11.5 20.3 12.4 2.8 28.9 16.6 39.1 2.0 10.2 8.7 24.0 13.5 15.0 16.6 29.2 38.6 16.9 27.9 0.0 5.2 8.4 4.7 3.9 11.0 8.1 6.0 17.9 20.1 9.5 19.7 CCDC188 ENSG00000234409 "Coiled-coil domain containing 188" H7C350 22 20148416-20151055 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "testis: 40.2" "Group enriched" "Detected in some" 89 "Early spermatids: 313.0;Late spermatids: 988.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 15 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 15 "dendritic cells: 1.5" "Cell line enhanced" "Detected in some" "AF22: 4.0;SCLC-21H: 5.5;SH-SY5Y: 7.2;TIME: 3.1;U-2 OS: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA049901 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 78: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA049901: AB_2680943" "unprognostic (9.83e-2)" "unprognostic (3.09e-2)" "unprognostic (9.79e-2)" "unprognostic (6.42e-3)" "unprognostic (2.45e-1)" "unprognostic (3.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.02e-1)" "unprognostic (8.43e-2)" "unprognostic (4.08e-3)" "unprognostic (1.67e-5)" "unprognostic (1.16e-1)" "unprognostic (5.37e-5)" "unprognostic (1.55e-1)" "unprognostic (2.79e-1)" "unprognostic (3.44e-1)" "unprognostic (1.40e-2)" 1.5 0.6 0.4 0.5 0.6 0.5 1.3 0.5 0.6 0.8 0.0 0.5 0.8 0.8 0.0 0.3 1.0 0.3 0.6 1.0 1.3 0.9 0.2 1.0 0.6 0.1 0.0 0.3 0.5 0.0 9.6 0.6 0.0 0.5 0.0 0.2 0.4 0.0 0.6 1.1 0.6 0.2 0.0 1.5 0.5 40.2 1.4 0.0 0.6 0.0 0.0 0.7 0.6 0.0 0.0 0.0 4.0 0.2 0.0 0.5 0.0 1.1 0.5 0.9 0.7 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.2 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.2 2.6 0.8 0.3 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.1 5.5 7.2 0.4 0.0 0.4 0.1 0.0 0.1 3.1 1.6 3.0 2.0 0.2 0.5 0.1 0.2 2.7 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.4 0.6 0.5 0.6 1.0 1.3 0.1 0.0 0.0 0.0 1.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 313.0 7.3 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 988.5 4.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 4.1 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.3" "Group enriched" "Detected in some" 32 "Early spermatids: 305.6;Late spermatids: 241.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "MCF7: 4.4" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No NA "Cluster 83: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: AB_2684561" "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 241.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 4.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 CCDC82 FLJ23518 ENSG00000149231 "Coiled-coil domain containing 82" Q8N4S0 11 96349241-96389956 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 493.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038704, HPA070631" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Nuclear bodies, Cytosol" "HPA038704: AB_10674835, HPA070631: " "unprognostic (3.04e-1)" "unprognostic (1.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.37e-1)" "unprognostic (9.94e-3)" "unprognostic (5.94e-2)" "unprognostic (3.68e-1)" "unprognostic (3.41e-1)" "unprognostic (7.68e-3)" "unprognostic (1.42e-1)" "unprognostic (9.84e-2)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" 22.2 15.1 16.5 19.6 19.7 17.1 17.6 32.0 26.6 15.9 8.7 18.1 13.0 18.4 13.9 10.4 15.9 16.8 13.7 17.4 24.6 16.6 22.1 17.9 23.4 18.2 16.5 18.3 13.8 11.8 18.2 17.4 19.5 13.0 13.3 43.2 12.8 15.8 14.3 14.3 16.9 13.8 12.4 20.3 16.7 23.7 17.9 22.3 17.9 14.9 20.1 16.7 14.5 31.1 12.9 17.9 52.4 21.0 35.9 30.0 20.8 47.0 28.0 29.9 42.4 31.1 41.3 26.1 42.8 23.1 50.5 29.1 17.5 14.7 42.5 44.5 11.7 49.1 42.7 26.0 25.6 41.5 33.2 18.3 9.2 58.9 22.8 28.0 35.9 25.3 31.4 28.1 40.5 1.1 34.9 40.2 12.0 21.6 12.7 23.7 44.2 21.0 22.6 32.9 9.6 22.7 26.6 2.7 23.0 35.5 5.0 19.5 42.6 50.1 28.1 43.7 25.3 9.5 29.9 36.0 16.2 30.7 38.6 59.4 12.5 25.1 23.7 15.2 24.5 22.5 24.7 23.6 14.0 19.3 26.9 25.5 17.9 35.7 16.2 18.7 28.5 17.9 16.5 19.7 32.0 26.6 17.4 24.6 18.2 16.5 19.5 12.4 17.9 31.1 57.9 19.2 31.4 30.7 32.9 30.5 27.0 31.5 19.4 58.9 14.0 18.5 37.2 18.6 28.9 31.3 100.1 16.6 55.1 10.7 27.4 34.6 493.8 57.6 37.0 53.6 19.8 16.4 67.0 17.5 20.5 44.9 13.7 26.4 40.4 36.4 38.6 32.1 25.2 32.0 67.0 9.0 24.4 27.4 38.4 76.8 43.8 32.5 26.6 23.4 37.2 41.6 42.2 54.3 119.7 32.3 12.2 42.9 27.2 14.5 8.8 40.1 71.8 50.6 32.9 45.4 48.4 85.4 57.0 13.0 20.5 8.2 40.7 24.9 10.3 18.7 CCDC85C ENSG00000205476 "Coiled-coil domain containing 85C" A6NKD9 14 99500190-99604207 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 72.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058346, HPA061922" Uncertain Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions" Yes No "Cluster 20: T-cells - T-cell receptor" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" "Nucleoli rim, Cell Junctions" "Nucleoplasm, Nuclear bodies, Mitotic chromosome" "HPA058346: AB_2683686, HPA061922: " "unprognostic (7.17e-2)" "unprognostic (2.23e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (5.70e-2)" "unprognostic (2.61e-1)" "unprognostic (1.68e-3)" "unprognostic (4.80e-2)" "unprognostic (1.45e-2)" "unprognostic (8.75e-2)" "unprognostic (3.30e-1)" "unprognostic (1.68e-3)" "prognostic favorable (2.60e-5)" "unprognostic (4.14e-2)" "unprognostic (1.95e-1)" "unprognostic (8.74e-3)" "unprognostic (9.81e-3)" 5.2 22.0 26.4 4.3 32.9 9.7 7.1 72.9 27.1 5.8 20.6 31.3 18.7 15.4 14.3 28.3 11.3 5.4 19.6 24.8 20.9 14.4 18.2 8.1 2.5 30.8 24.1 5.1 18.5 16.4 17.0 8.6 27.0 15.0 11.1 34.7 26.4 16.2 20.7 19.4 17.7 13.1 24.5 3.6 19.2 8.5 28.6 5.0 9.3 5.6 7.5 16.1 8.9 21.0 48.4 43.4 52.7 31.7 0.7 0.2 48.9 16.0 16.2 31.4 18.1 52.9 49.8 0.3 61.7 18.2 8.6 63.3 39.2 38.4 19.5 79.2 23.3 2.5 43.6 36.1 4.2 0.5 4.9 0.1 19.9 9.0 25.9 18.6 9.9 27.9 11.8 7.2 3.9 80.3 21.8 6.6 19.3 55.4 44.7 32.1 22.1 10.8 22.3 18.8 26.0 32.6 40.7 21.5 9.5 19.9 46.9 9.8 22.6 6.2 51.5 22.4 16.2 11.2 15.8 0.4 1.0 4.3 4.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.4 0.1 26.4 32.9 72.9 27.1 24.8 20.9 30.8 24.1 27.0 24.5 28.6 21.0 8.5 22.4 5.6 15.7 6.7 8.8 8.7 4.0 13.6 35.2 12.1 9.3 3.0 5.7 7.3 1.8 62.6 6.3 3.9 21.2 0.0 7.6 3.1 18.8 8.1 9.2 9.6 3.4 2.8 9.4 4.5 6.2 17.3 35.6 6.3 14.1 5.3 16.7 1.8 1.7 5.4 9.6 6.1 1.6 1.2 2.1 0.6 5.0 8.8 4.7 0.4 30.6 1.0 1.5 11.7 17.4 13.2 0.7 10.4 11.0 23.3 6.5 3.0 51.7 0.0 5.7 4.1 1.4 3.5 20.4 14.1 4.9 8.3 2.3 13.0 12.0 CCNA1 CT146 ENSG00000133101 "Cyclin A1" P78396 13 36431520-36442870 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.2;testis: 81.3" "Group enriched" "Detected in some" 5 "Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7" "Group enriched" "Detected in many" 4 "endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 103 "basophil: 49.2" "Lineage enriched" "Detected in single" 301 "granulocytes: 49.2" "Cell line enhanced" "Detected in many" "HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA060646, HPA077614" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA060646: AB_2684336, HPA077614: " "unprognostic (1.92e-3)" "unprognostic (1.21e-1)" "unprognostic (4.69e-3)" "unprognostic (1.89e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (1.24e-1)" "unprognostic (4.01e-3)" "unprognostic (1.64e-1)" "unprognostic (4.04e-6)" "unprognostic (7.04e-3)" "unprognostic (2.45e-1)" "unprognostic (1.42e-1)" "unprognostic (2.63e-2)" 0.4 0.9 5.9 0.4 5.9 2.1 0.7 2.3 7.8 5.8 4.1 0.6 0.4 3.7 7.0 0.4 18.0 0.7 0.3 5.5 7.3 0.5 0.1 1.4 0.3 5.3 5.4 0.5 0.1 22.2 8.2 0.0 10.7 0.5 0.1 1.0 0.6 0.1 1.2 0.3 0.3 8.2 4.9 0.6 0.4 81.3 6.1 0.4 0.6 0.4 0.6 0.6 1.1 4.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 15.2 0.1 15.5 1.2 12.9 1.4 0.1 0.0 0.7 0.0 0.4 0.0 0.6 8.0 350.9 0.3 34.1 0.7 2.8 5.5 0.9 1.7 0.0 0.5 0.2 4.4 0.4 71.4 2.5 0.0 8.8 0.0 8.3 0.0 2.3 0.0 2.5 5.8 0.0 8.4 0.2 1.8 0.0 71.5 4.5 0.0 0.0 0.1 2.9 0.8 0.0 0.0 0.3 90.3 0.6 49.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.9 5.9 2.3 7.8 5.5 7.3 5.3 5.4 10.7 4.9 6.1 4.0 0.1 0.0 0.6 0.3 0.3 0.6 0.6 19.1 0.0 0.4 0.5 1.4 0.4 0.0 10.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 162.4 119.1 1.8 0.4 0.0 0.0 3.5 0.0 0.8 1.1 0.0 31.9 5.1 2.2 0.0 0.0 0.2 0.0 3.0 0.0 6.1 0.0 1.8 91.1 3.1 1.1 0.0 0.0 0.0 1.4 0.0 0.5 0.4 0.0 0.0 2.6 0.0 0.7 0.0 0.1 29.3 0.8 6.6 0.5 1.5 285.7 2.4 0.0 0.4 0.3 0.9 0.0 0.1 1.1 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197177 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 20.0" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "HEL: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: AB_2677282" "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 3.2 1.4 2.3 1.3 2.1 20.0 2.1 3.8 2.6 1.4 1.9 1.7 1.5 1.4 2.1 1.2 2.0 1.0 1.3 2.0 2.4 1.5 1.7 2.7 2.2 2.4 2.3 0.7 1.3 1.1 1.2 1.4 2.5 1.3 1.9 1.8 1.5 1.1 1.7 2.8 2.6 1.2 1.8 2.6 2.1 0.9 2.6 1.5 1.7 1.2 1.9 1.7 1.1 2.4 0.2 0.2 0.4 0.2 1.3 0.8 0.4 0.3 1.6 0.3 0.3 0.4 0.3 0.5 0.4 1.1 0.1 0.5 1.1 0.5 0.2 0.7 1.1 13.5 0.6 0.5 0.9 0.7 0.7 1.5 1.2 0.1 0.2 1.3 1.0 0.2 0.8 0.4 0.4 0.0 0.4 1.4 0.9 0.5 0.3 0.4 0.5 1.2 1.7 0.6 0.6 0.9 0.5 0.4 0.3 0.5 0.0 1.1 1.2 0.2 0.1 1.0 0.2 1.4 0.6 0.1 1.3 1.4 0.4 21.8 1.9 5.6 5.1 3.7 5.4 4.7 5.5 5.2 1.8 5.3 5.6 5.9 6.2 4.8 9.5 3.0 8.4 1.8 2.3 2.1 3.8 2.6 2.0 2.4 2.4 2.3 2.5 1.8 2.6 2.4 59.8 48.1 54.9 11.1 81.8 34.7 55.7 83.3 25.0 28.9 38.0 40.9 52.6 40.0 78.6 29.5 20.9 362.7 92.0 63.6 90.1 64.0 24.2 61.6 33.8 45.2 46.2 361.2 20.7 59.3 82.1 55.9 45.3 37.0 57.0 40.2 53.6 31.0 85.4 45.4 17.8 47.7 154.6 83.5 36.2 12.6 47.2 57.1 64.0 11.2 137.8 55.9 74.2 9.5 23.4 68.6 55.8 29.3 54.2 42.1 85.8 47.5 128.0 66.0 46.0 35.2 49.4 124.3 61.6 27.8 40.3 1055.9 85.9 37.8 42.2 88.5 CCNI CCNI1 ENSG00000118816 "Cyclin I" Q14094 4 77047155-77076309 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010206, HPA039853, HPA061470" Uncertain Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533" "unprognostic (3.68e-1)" "unprognostic (2.25e-1)" "unprognostic (7.59e-2)" "unprognostic (1.11e-1)" "unprognostic (4.64e-2)" "unprognostic (1.38e-1)" "unprognostic (8.57e-3)" "unprognostic (3.07e-1)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.10e-4)" "unprognostic (3.81e-2)" "unprognostic (2.04e-1)" "unprognostic (2.30e-2)" "unprognostic (2.60e-2)" 176.7 98.4 182.1 109.8 191.0 222.9 183.6 253.4 218.2 234.8 131.4 182.7 100.0 211.0 249.1 177.9 196.5 150.7 195.7 148.1 171.8 183.8 133.7 144.8 185.2 184.0 185.9 341.6 155.2 145.2 71.1 138.0 188.6 198.9 129.8 213.2 183.0 208.9 225.8 136.4 120.8 195.6 167.5 149.1 149.0 131.7 186.1 229.2 273.5 177.8 238.8 186.6 170.5 220.7 163.3 96.0 305.0 268.6 447.6 406.7 117.0 122.5 298.4 189.9 181.5 119.3 240.6 300.1 183.2 309.4 118.9 83.4 211.7 428.9 300.2 214.0 83.7 180.3 102.1 114.0 438.1 312.0 346.4 320.4 502.6 175.1 426.2 542.6 270.1 154.3 157.2 315.9 273.4 187.7 406.3 292.5 135.2 113.9 59.0 250.7 290.0 126.5 283.5 182.7 387.3 211.8 162.9 247.2 209.2 212.6 141.2 131.6 184.6 231.0 137.0 249.0 170.4 173.7 86.1 310.9 195.4 210.6 153.3 160.7 113.2 236.7 95.6 108.0 131.2 148.2 157.0 142.0 119.5 153.7 165.2 143.8 145.8 109.3 134.0 135.3 149.7 100.0 182.1 191.0 253.4 218.2 148.1 171.8 184.0 185.9 188.6 167.5 186.1 220.7 368.4 173.1 231.3 59.7 606.6 422.9 633.0 489.3 578.8 629.5 550.2 523.5 460.5 323.1 238.7 196.8 68.8 273.7 441.5 258.8 794.3 400.9 71.0 250.5 321.3 405.5 412.3 510.9 125.8 334.3 427.4 510.9 220.2 231.2 278.4 300.9 382.7 121.5 337.0 181.7 150.3 346.6 329.6 685.1 676.5 147.5 604.0 490.4 402.0 77.8 613.0 403.2 390.3 52.3 69.1 515.1 317.6 989.2 500.8 854.8 468.4 596.6 161.4 228.7 552.2 373.3 510.8 200.4 745.5 466.1 394.8 379.5 497.3 326.5 345.9 747.1 CCNL1 ania-6a ENSG00000163660 "Cyclin L1" Q9UK58 3 157146508-157160760 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057911 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "HPA057911: AB_2683553" "unprognostic (1.03e-2)" "unprognostic (3.66e-2)" "unprognostic (1.38e-1)" "unprognostic (6.90e-3)" "unprognostic (1.79e-1)" "unprognostic (6.58e-2)" "unprognostic (3.16e-3)" "unprognostic (7.50e-2)" "unprognostic (5.54e-3)" "unprognostic (3.37e-1)" "unprognostic (3.06e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.71e-1)" "unprognostic (2.24e-1)" "unprognostic (5.62e-2)" "prognostic favorable (6.96e-7)" 52.1 25.2 12.4 11.6 12.9 56.6 27.3 14.2 21.2 21.9 12.6 22.5 13.5 19.4 5.7 22.1 30.5 13.5 23.1 13.0 13.2 31.8 45.3 30.2 14.1 15.1 12.8 31.2 33.5 8.3 21.8 10.3 13.1 23.8 6.6 5.3 18.7 6.2 21.3 25.3 29.7 9.1 11.9 35.6 29.1 9.1 13.0 20.0 23.7 10.3 9.8 19.4 22.9 14.7 19.2 11.4 16.8 11.6 16.1 10.9 16.0 12.0 14.4 13.9 13.0 19.7 14.8 20.3 10.0 8.9 9.7 14.7 12.4 14.6 12.8 18.2 14.1 12.6 12.2 17.2 13.2 8.8 7.7 13.3 25.1 13.2 17.7 13.9 11.1 11.4 8.7 12.7 10.2 13.8 17.8 16.7 13.9 14.7 12.5 16.2 13.6 31.7 8.9 11.4 8.9 16.5 9.1 8.4 26.1 12.5 8.7 26.1 9.1 12.8 7.1 13.8 15.9 25.3 21.5 26.7 12.8 13.1 12.6 5.9 10.3 16.0 13.5 8.4 14.1 13.4 12.5 14.0 13.1 15.2 17.1 14.2 28.6 17.4 11.3 14.0 15.4 8.2 12.4 12.9 14.2 21.2 13.0 13.2 15.1 12.8 13.1 11.9 13.0 14.7 367.4 218.0 392.4 33.0 222.5 268.0 499.2 203.8 310.7 73.7 279.3 247.0 54.3 177.3 259.0 68.0 133.5 139.2 253.6 389.6 23.5 189.4 41.0 379.7 426.5 287.1 247.7 86.5 30.6 127.8 152.9 302.7 268.1 761.2 222.2 281.6 167.8 90.4 164.6 40.4 32.3 294.6 154.6 241.5 251.4 20.9 128.0 292.5 140.5 42.2 160.1 69.5 122.6 35.7 66.3 143.2 378.2 75.2 258.5 408.2 415.6 21.2 188.9 183.3 131.5 460.0 276.4 46.5 25.0 252.6 276.9 209.1 282.8 182.6 244.1 503.2 CDC14A "cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32" ENSG00000079335 "Cell division cycle 14A" Q9UNH5 1 100345001-100520277 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Cell division, Hearing" "Hydrolase, Protein phosphatase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.2" "Cell type enhanced" "Detected in many" "Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023783 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA023783: AB_1846352" "unprognostic (3.72e-2)" "unprognostic (2.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (1.54e-3)" "unprognostic (1.38e-1)" "unprognostic (9.27e-4)" "unprognostic (4.88e-3)" "unprognostic (6.30e-2)" "unprognostic (3.97e-3)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (6.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (6.66e-2)" 3.6 1.5 3.9 4.6 3.1 15.5 11.3 2.7 4.2 5.4 5.2 6.0 7.3 5.3 2.7 2.2 13.0 3.3 2.3 3.7 4.5 6.3 1.8 5.9 7.2 4.3 4.9 4.6 2.0 6.0 3.6 5.1 3.3 7.6 6.0 5.5 3.4 3.0 2.6 3.8 10.7 4.7 3.5 6.7 5.8 28.2 3.6 6.4 5.8 2.8 4.4 4.4 3.3 3.2 3.3 2.6 8.1 9.3 2.9 2.1 5.7 4.1 2.7 3.9 3.1 8.9 2.7 1.6 3.0 2.4 3.2 2.5 5.6 2.3 4.0 3.4 13.7 5.8 2.3 2.9 1.1 7.8 9.8 1.8 0.6 4.3 1.4 2.0 7.0 3.3 44.7 4.8 5.8 1.4 6.3 8.7 5.1 2.1 3.3 6.8 10.6 1.7 2.8 7.2 1.5 2.7 4.3 4.1 5.6 3.9 1.9 10.0 3.1 2.2 4.9 3.8 2.5 2.4 0.9 2.5 2.7 7.3 1.3 12.2 3.6 9.0 6.9 3.3 12.5 4.5 10.9 8.2 3.5 2.9 10.2 5.5 5.4 4.4 2.3 6.2 6.0 4.1 3.9 3.1 2.7 4.2 3.7 4.5 4.3 4.9 3.3 3.5 3.6 3.2 14.1 3.2 5.5 145.9 10.6 3.7 4.5 1.7 4.6 0.4 15.8 11.0 6.6 0.0 4.4 1.8 4.2 2.7 23.2 18.4 0.0 3.0 171.5 48.3 11.8 13.5 4.8 3.8 4.3 1.9 1.0 7.0 6.6 51.1 15.2 4.8 7.1 1.0 2.8 0.0 1.4 4.0 2.0 5.5 7.3 191.7 5.0 11.1 5.4 51.5 9.3 11.4 6.2 53.8 3.6 3.1 11.2 0.7 13.5 5.2 22.9 2.5 22.5 3.8 0.0 6.2 6.0 2.3 3.6 4.9 2.4 2.2 44.1 3.0 3.7 4.1 CDKN1A "CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1" ENSG00000124762 "Cyclin dependent kinase inhibitor 1A" P38936 6 36676460-36687337 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 74.5" "Group enriched" "Detected in many" 9 "B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5" "Cell line enhanced" "Detected in many" "HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2" "Region enhanced" "Detected in all" "olfactory bulb: 76.0" "Low region specificity" "Detected in all" "CAB000064, HPA005946, CAB069401" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477" "unprognostic (7.99e-3)" "unprognostic (4.01e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-5)" "unprognostic (1.57e-2)" "unprognostic (2.19e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.30e-1)" "unprognostic (7.27e-2)" "unprognostic (2.79e-2)" "unprognostic (7.55e-3)" "prognostic favorable (4.95e-5)" "unprognostic (8.32e-2)" "unprognostic (6.52e-2)" "unprognostic (1.12e-1)" "unprognostic (3.21e-2)" 322.1 98.1 47.0 62.1 48.1 72.7 144.2 47.3 60.9 123.3 85.9 119.0 115.2 74.4 41.0 203.2 213.9 132.6 170.6 47.2 49.5 149.9 173.4 182.2 17.3 63.7 54.6 184.9 130.5 70.1 104.4 44.7 53.4 91.4 108.2 29.2 79.1 29.4 241.6 224.4 130.0 114.3 55.0 34.4 121.3 47.0 50.3 59.7 77.5 26.9 21.8 212.7 142.3 53.6 27.0 108.1 80.1 2.0 273.3 490.3 149.5 435.6 344.8 52.3 203.7 9.6 25.3 18.3 15.5 267.9 48.0 60.2 3.7 477.7 82.4 36.2 22.0 3.0 85.8 137.0 798.5 0.5 127.7 586.5 775.8 476.2 147.1 309.3 275.3 1.4 5.1 120.8 604.2 57.4 3.9 11.3 10.2 112.8 15.5 54.4 67.1 31.9 91.2 201.5 36.7 35.6 101.3 8.4 21.3 185.2 32.7 111.2 155.8 91.5 86.9 6.2 36.4 202.0 42.9 54.5 118.7 9.9 261.0 0.0 22.8 0.5 0.5 52.2 0.8 20.7 1.1 0.6 20.0 16.2 0.3 0.4 4.2 0.7 74.5 21.5 2.9 34.2 47.0 48.1 47.3 60.9 47.2 49.5 63.7 54.6 53.4 55.0 50.3 53.6 571.2 83.3 45.1 1.0 126.9 440.5 340.1 293.1 512.8 0.8 203.9 187.6 151.6 41.5 214.4 68.0 0.0 42.1 56.4 505.3 46.9 217.6 0.9 227.9 57.3 327.1 175.5 5.7 0.5 264.7 52.8 302.4 150.9 199.2 104.4 20.4 71.7 68.9 72.9 0.0 0.4 197.1 156.6 62.0 556.0 3.9 34.5 277.6 218.7 5.6 280.6 58.4 2.1 0.0 0.5 429.9 466.1 16.6 376.4 201.7 383.2 17.2 215.1 3.1 26.3 303.6 471.6 1.2 1.7 620.9 672.0 155.3 106.0 10.7 75.8 478.0 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885775 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 206.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "intermediate monocyte: 155.1;non-classical monocyte: 376.4" "Lineage enriched" "Detected in many" 14 "monocytes: 376.4" "Cell line enhanced" "Detected in many" "EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nucleoplasm, Nuclear bodies" Cytosol "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 127.4 182.9 8.2 3.3 38.0 1.7 92.5 43.3 18.7 73.7 6.5 48.1 1.4 70.6 0.2 29.9 70.7 0.8 82.6 11.7 18.8 149.5 8.3 34.5 0.2 55.1 33.5 206.4 28.5 0.2 27.8 28.1 45.0 33.1 0.2 0.5 21.7 1.5 60.3 26.6 25.0 0.4 31.8 20.6 54.1 8.6 34.3 0.2 17.0 0.9 0.4 75.0 49.4 95.3 0.1 0.1 1.6 0.0 0.4 0.5 1.8 0.3 0.6 0.3 0.0 3.3 0.4 0.0 12.0 0.2 0.1 0.5 0.3 0.3 0.1 5.6 1.2 0.1 12.8 0.0 3.3 0.0 1.4 2.4 1.6 0.0 0.2 0.1 0.3 0.1 2.7 0.8 0.5 0.1 0.0 6.0 10.6 0.5 4.0 2.2 0.0 18.7 0.7 0.0 3.5 33.0 25.2 0.3 15.2 0.9 0.2 2.8 0.4 0.0 2.2 0.0 0.1 7.3 0.0 0.1 0.0 1.8 6.8 9.1 1.2 0.9 0.4 155.1 1.8 0.0 0.4 0.6 26.9 0.3 1.0 0.3 2.2 0.0 376.4 0.2 0.7 14.7 8.2 38.0 43.3 18.7 11.7 18.8 55.1 33.5 45.0 31.8 34.3 95.3 357.3 3.2 5.8 1.0 11.6 10.7 81.7 4.9 30.7 11.9 81.0 150.5 45.3 61.5 10.8 31.3 6.2 575.3 46.9 20.3 15.6 9.8 176.5 38.8 101.5 100.8 106.5 0.8 0.6 0.6 1531.7 141.0 17.9 56.2 0.0 31.2 74.6 4.0 91.0 8.4 1.2 25.0 12.2 23.5 23.2 276.4 74.3 54.9 35.6 4.7 14.1 68.3 0.0 3.5 65.7 4.3 4.2 44.4 12.9 64.6 4.0 78.5 7.5 27.4 32.9 238.3 71.4 2.1 3.5 17.3 11.8 2241.2 25.1 781.8 15.2 71.8 CDT1 "DUP, RIS2" ENSG00000167513 "Chromatin licensing and DNA replication factor 1" Q9H211 16 88803789-88809258 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Disease variant, Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 38.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 149.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA017224 Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA017224: AB_1846468" "unprognostic (1.33e-1)" "unprognostic (2.04e-2)" "unprognostic (7.32e-2)" "unprognostic (2.67e-1)" "unprognostic (4.34e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.12e-6)" "unprognostic (3.44e-3)" "unprognostic (2.81e-2)" "unprognostic (4.59e-2)" "unprognostic (1.21e-1)" "unprognostic (9.34e-2)" "prognostic unfavorable (2.69e-6)" "unprognostic (7.72e-3)" "unprognostic (5.79e-2)" "unprognostic (2.80e-2)" "unprognostic (8.54e-2)" 0.7 0.8 0.8 3.8 1.2 38.5 0.7 2.5 1.3 1.7 0.0 3.3 4.1 0.5 0.2 6.7 0.5 0.2 0.5 0.8 2.3 0.7 1.0 1.3 4.8 2.2 1.1 0.4 0.6 1.3 2.1 2.8 1.9 0.7 1.6 0.4 1.1 0.2 0.1 3.6 3.9 0.6 0.7 3.1 2.4 3.5 1.1 8.7 0.6 0.0 3.3 0.5 2.3 1.0 33.6 34.5 16.5 25.3 0.7 3.4 64.2 24.1 6.6 19.4 12.0 79.3 33.8 51.4 24.2 5.5 12.7 46.0 21.6 17.7 6.2 18.2 92.1 51.8 28.8 59.9 0.3 28.8 21.5 1.8 1.4 19.8 4.4 1.6 5.9 60.9 80.8 18.4 7.6 90.6 109.3 149.4 41.8 12.2 31.6 120.3 22.9 42.4 4.3 23.8 36.6 26.2 44.4 13.1 16.9 7.4 39.0 55.9 5.9 24.6 42.6 37.2 35.4 61.4 55.7 73.6 19.3 71.9 31.6 0.2 0.1 0.9 0.3 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.1 0.7 0.4 0.1 0.1 0.7 0.2 0.8 1.2 2.5 1.3 0.8 2.3 2.2 1.1 1.9 0.7 1.1 1.0 0.4 0.0 1.1 0.7 4.9 11.2 4.3 1.4 7.4 0.7 5.4 7.5 2.2 1.5 1.7 1.8 0.0 51.4 2.2 12.7 1.9 1.1 0.4 1.4 1.4 2.2 2.4 71.3 0.2 0.0 92.0 5.2 9.2 2.2 0.0 29.0 0.4 1.0 19.5 0.0 0.8 16.1 4.1 5.6 5.5 1.2 0.3 2.8 1.8 0.0 1.9 1.5 4.1 0.0 0.6 0.6 2.3 0.4 23.1 2.2 2.0 1.6 2.1 1.9 0.0 2.1 3.4 6.6 37.1 10.8 7.1 24.8 5.4 5.7 30.1 4.4 CENPB ENSG00000125817 "Centromere protein B" P07199 20 3783851-3786740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011626, HPA053507, HPA054405" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" Nucleoplasm "CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477" "unprognostic (2.01e-1)" "unprognostic (8.47e-3)" "unprognostic (2.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.40e-2)" "unprognostic (3.27e-2)" "unprognostic (3.57e-1)" "unprognostic (1.48e-3)" "unprognostic (7.93e-2)" "unprognostic (2.78e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" 45.2 39.8 115.4 20.4 120.8 14.9 40.3 97.8 109.8 41.1 68.0 56.9 21.4 45.5 11.0 42.2 36.2 15.3 54.8 89.6 91.8 40.4 42.3 36.0 17.5 121.9 113.7 36.6 40.7 26.1 29.6 15.3 108.2 40.0 12.6 3.9 35.0 24.1 95.0 53.7 34.9 19.4 119.6 35.9 44.3 10.8 111.8 17.7 35.0 43.2 13.7 48.2 33.9 133.5 111.9 140.4 27.1 58.1 56.2 44.4 17.4 78.2 56.4 49.1 39.5 57.5 78.1 38.7 24.0 72.9 77.0 88.3 21.7 88.9 24.6 55.5 37.1 82.3 51.5 51.4 65.2 27.0 26.7 50.5 46.9 70.5 45.0 38.5 42.5 49.2 53.9 23.8 42.4 183.2 81.1 61.8 34.0 62.7 165.4 66.8 3.6 28.3 52.2 67.6 66.2 49.4 64.7 89.7 62.4 12.2 56.7 59.1 73.2 84.9 45.8 74.1 121.3 28.5 44.1 22.5 29.8 95.2 56.9 0.0 1.7 0.6 1.9 1.7 1.3 1.0 1.3 1.2 1.3 1.4 1.1 1.4 0.2 1.7 1.1 1.7 0.4 1.1 115.4 120.8 97.8 109.8 89.6 91.8 121.9 113.7 108.2 119.6 111.8 133.5 30.2 6.4 19.5 2.3 6.8 13.9 5.7 11.2 15.9 18.3 23.8 23.1 16.5 30.0 11.6 14.7 10.4 6.2 17.2 48.0 3.9 18.9 1.2 12.7 21.5 24.7 20.4 12.0 2.6 29.8 7.9 14.6 15.8 18.1 7.6 24.0 17.9 25.6 22.7 21.9 4.5 27.1 6.1 25.7 12.3 7.5 21.8 15.3 17.8 3.7 17.3 31.1 12.3 1.5 3.8 31.0 25.4 25.9 5.7 12.5 28.4 8.7 10.8 13.0 13.1 22.4 21.9 1.1 1.5 17.4 14.1 4.5 11.8 46.5 26.9 7.4 CENPC "CENP-C, CENPC1, hcp-4, MIF2" ENSG00000145241 "Centromere protein C" Q03188 4 67468762-67545503 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049740, HPA058252" Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "HPA049740: , HPA058252: AB_2683654" "unprognostic (4.35e-1)" "unprognostic (6.41e-3)" "unprognostic (4.31e-3)" "unprognostic (7.85e-2)" "unprognostic (6.31e-2)" "unprognostic (3.85e-3)" "unprognostic (6.40e-2)" "prognostic favorable (9.67e-4)" "unprognostic (3.22e-2)" "unprognostic (7.13e-2)" "unprognostic (8.35e-2)" "unprognostic (4.32e-2)" "prognostic favorable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.15e-1)" "unprognostic (1.92e-3)" 1.5 1.6 2.5 1.0 3.2 3.6 3.3 5.6 2.6 2.8 0.2 2.0 1.1 3.1 2.3 1.5 2.9 1.1 1.5 2.2 2.0 2.0 1.4 1.5 1.8 1.3 1.8 5.6 3.8 1.5 2.5 1.3 1.7 2.9 1.2 2.7 2.0 1.6 1.1 2.3 1.8 1.5 1.3 2.0 2.1 1.7 1.7 2.0 3.1 1.1 1.5 2.0 2.3 2.8 0.4 0.5 1.6 0.9 1.9 1.1 0.9 0.6 0.5 0.7 0.5 0.7 1.3 2.7 0.8 0.8 0.2 0.8 2.2 0.9 1.2 0.8 0.4 2.1 0.9 0.9 0.6 3.9 0.8 1.4 0.3 0.5 1.3 1.2 0.4 1.8 3.0 1.6 1.1 0.7 5.3 3.5 1.8 0.8 0.3 2.4 4.0 0.9 1.0 0.8 2.8 1.3 1.2 2.5 0.7 1.6 0.7 1.3 0.4 1.0 0.5 0.7 0.5 1.3 0.5 2.7 1.1 2.2 0.6 0.5 0.2 0.5 0.7 0.4 0.3 0.8 0.8 0.9 0.2 1.1 1.2 0.9 0.2 0.5 0.2 0.4 0.4 0.2 2.5 3.2 5.6 2.6 2.2 2.0 1.3 1.8 1.7 1.3 1.7 2.8 53.1 32.1 35.5 38.8 68.4 15.2 25.3 17.7 35.9 53.7 26.0 32.3 24.3 18.6 31.6 16.5 14.6 20.2 75.0 17.7 11.7 13.5 4.1 21.0 39.0 33.7 13.1 31.7 58.5 16.7 12.9 41.3 35.7 25.1 26.6 39.8 23.2 14.1 12.8 52.2 57.0 18.4 18.3 16.7 7.9 5.5 34.8 26.7 16.0 31.9 27.4 31.6 60.8 46.3 74.6 14.6 13.0 25.6 89.1 15.3 24.2 20.4 27.2 29.0 19.7 54.1 34.2 47.2 44.4 34.7 9.2 18.3 69.8 43.3 16.4 23.9 CENPI "CENP-I, FSHPRH1, LRPR1, Mis6" ENSG00000102384 "Centromere protein I" Q92674 X 101098218-101163681 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 6.8;lymphoid tissue: 7.1" "Cell type enhanced" "Detected in some" "Erythroid cells: 4.8;Excitatory neurons: 2.9;Extravillous trophoblasts: 4.7;Granulosa cells: 3.2;Oligodendrocytes: 3.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061297 Supported "Nuclear bodies,Cytosol" NA Yes "Cluster 33: Neutrophils - Chromatin organization" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies" Cytosol "HPA061297: AB_2684471" "unprognostic (3.10e-3)" "unprognostic (9.71e-2)" "unprognostic (1.86e-2)" "unprognostic (3.51e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (5.78e-6)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (3.62e-3)" "unprognostic (1.20e-3)" "unprognostic (4.51e-2)" "unprognostic (2.50e-13)" "unprognostic (1.25e-2)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.42e-1)" 1.1 0.6 0.9 3.1 1.0 6.8 1.2 2.0 1.0 1.0 0.5 2.7 2.8 1.8 1.4 2.6 0.6 1.4 0.5 1.1 1.1 0.4 0.8 1.0 5.4 1.4 0.6 2.3 0.9 0.2 0.0 2.5 1.4 1.2 3.5 1.8 0.5 0.6 0.2 3.2 2.3 2.7 0.1 1.6 1.5 1.2 1.0 7.1 0.8 0.6 6.3 1.4 0.8 2.9 44.9 30.3 36.6 28.1 4.6 8.2 16.4 47.5 25.2 47.1 94.5 40.9 28.0 32.7 16.5 18.8 72.5 25.7 54.2 25.3 65.4 20.6 13.8 20.2 43.5 15.6 0.5 26.8 21.2 3.3 2.2 62.5 7.7 13.5 40.7 23.3 14.5 58.3 46.1 31.5 26.7 9.8 28.3 21.2 36.8 24.7 53.0 21.0 11.8 26.4 23.4 12.3 58.1 16.3 9.6 33.0 16.2 8.6 16.7 44.0 36.6 41.2 38.3 9.1 23.3 36.5 17.3 35.2 34.7 0.7 0.5 0.6 0.4 0.7 0.3 0.6 0.4 0.6 0.2 0.4 0.4 0.4 1.1 0.7 0.7 0.7 0.8 0.3 0.9 1.0 2.0 1.0 1.1 1.1 1.4 0.6 1.4 0.1 1.0 2.9 0.5 0.0 0.0 2.3 0.9 0.3 0.1 0.6 0.0 0.5 0.4 0.3 0.4 0.0 0.7 0.0 0.0 1.9 0.5 0.8 0.0 0.2 0.2 0.4 0.8 0.5 0.0 4.8 2.9 0.0 4.7 0.6 0.0 0.6 0.0 3.2 0.7 0.2 1.4 0.0 2.3 0.7 0.0 0.6 0.8 0.0 0.3 0.3 0.0 1.0 0.6 0.5 0.0 1.5 3.3 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.1 0.3 0.0 0.7 1.0 0.3 0.9 1.4 0.1 0.3 0.4 0.8 1.4 0.2 CENPO "CENP-O, MGC11266" ENSG00000138092 "Centromere protein O" Q9BU64 2 24793136-24822376 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 11.2;Extravillous trophoblasts: 11.5;Spermatocytes: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046189 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA046189: AB_2679579" "unprognostic (1.67e-2)" "unprognostic (2.42e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (1.79e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (1.73e-6)" "unprognostic (5.56e-2)" "unprognostic (4.02e-1)" "unprognostic (4.81e-2)" "unprognostic (5.93e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (5.71e-13)" "unprognostic (4.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" 5.2 4.0 3.5 3.5 3.3 9.2 4.6 2.9 4.1 4.0 2.3 3.3 3.2 3.1 0.8 4.5 3.0 1.5 2.8 3.7 3.5 2.9 2.6 3.6 4.9 3.7 3.4 4.5 1.9 1.6 3.6 3.2 3.5 3.1 3.7 1.4 2.5 1.1 3.0 3.8 3.9 2.2 3.2 4.3 2.7 8.3 3.8 11.4 3.4 2.0 5.8 2.5 3.7 3.1 31.1 36.4 40.7 21.7 4.8 7.3 22.7 36.8 21.7 51.0 38.7 46.2 15.5 21.4 4.2 22.8 29.8 16.3 40.6 14.0 34.1 28.1 21.1 34.3 23.9 31.0 2.4 28.7 24.4 3.6 2.5 51.5 11.4 9.3 24.0 25.4 40.3 23.8 31.8 21.8 39.2 20.6 29.3 21.0 22.8 31.0 53.4 11.5 12.9 18.6 27.0 29.3 22.1 16.9 7.9 18.5 16.3 11.8 15.4 46.9 42.8 15.9 41.6 14.5 20.1 42.8 14.5 27.5 36.4 0.0 0.3 0.0 1.0 0.2 0.4 0.4 0.4 0.5 0.4 0.3 0.3 0.7 0.1 0.7 0.3 1.1 0.7 0.3 3.5 3.3 2.9 4.1 3.7 3.5 3.7 3.4 3.5 3.2 3.8 3.1 0.7 3.2 2.2 4.2 1.5 1.1 0.7 1.3 2.2 0.9 1.9 1.4 6.5 0.0 1.2 3.7 0.0 3.9 1.9 3.0 1.9 1.5 3.9 1.5 2.2 2.0 0.0 11.2 5.3 1.3 11.5 2.4 6.6 1.5 1.3 6.5 1.8 0.9 4.9 1.7 4.9 1.6 0.0 1.6 1.1 9.6 0.3 1.1 1.8 3.7 1.2 1.6 1.0 2.0 2.5 1.1 0.5 1.2 8.6 0.5 1.8 1.7 0.7 0.7 0.0 1.1 3.3 11.7 9.5 3.3 1.4 2.9 1.4 2.8 2.7 0.9 CENPT "C16orf56, CENP-T, FLJ13111" ENSG00000102901 "Centromere protein T" Q96BT3 16 67828157-67847811 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Spermatocytes: 89.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041220, HPA058036" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA041220: AB_2677367, HPA058036: AB_2683585" "unprognostic (9.84e-2)" "unprognostic (2.86e-2)" "unprognostic (3.04e-2)" "unprognostic (8.77e-2)" "unprognostic (3.14e-2)" "unprognostic (6.66e-3)" "unprognostic (1.18e-2)" "unprognostic (2.81e-1)" "unprognostic (8.04e-2)" "unprognostic (3.15e-2)" "prognostic favorable (2.96e-4)" "unprognostic (6.64e-3)" "prognostic unfavorable (1.57e-7)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (9.74e-3)" 7.0 5.6 7.2 3.1 7.1 5.3 6.4 7.4 10.0 7.9 5.7 8.1 2.4 7.0 1.4 6.6 7.3 1.8 8.0 7.4 7.8 6.3 5.3 6.3 3.6 7.5 7.3 7.7 9.6 4.9 4.3 4.2 7.6 6.5 2.0 0.8 5.8 4.3 8.2 24.8 6.3 4.7 6.8 5.5 7.4 19.6 7.3 4.4 5.1 5.6 2.3 7.3 6.9 7.2 7.6 7.4 10.0 10.2 8.1 7.8 14.7 29.5 13.6 30.2 24.1 7.9 5.6 3.3 7.1 19.8 5.3 12.4 7.5 13.2 10.3 5.3 9.5 1.2 3.2 11.3 5.1 0.6 6.9 8.5 7.7 20.7 4.4 4.4 12.3 8.1 19.3 3.6 14.5 11.9 9.8 10.7 13.5 5.9 7.1 13.4 4.5 17.6 11.2 3.1 3.9 6.8 22.2 4.6 5.8 6.3 6.1 10.0 9.7 4.3 7.4 6.6 7.0 7.0 5.8 19.4 3.3 6.1 7.4 1.4 7.2 6.3 6.5 6.6 7.0 4.9 6.0 8.2 6.0 6.1 5.3 7.0 3.4 5.4 4.3 6.0 8.5 5.1 7.2 7.1 7.4 10.0 7.4 7.8 7.5 7.3 7.6 6.8 7.3 7.2 21.0 16.0 11.3 10.4 17.4 21.0 20.2 24.4 12.5 24.9 20.3 19.3 8.2 14.3 17.2 20.2 8.4 31.5 25.4 27.5 5.9 19.0 52.2 8.8 17.8 19.7 13.1 30.3 16.9 14.2 25.0 23.0 34.1 11.2 8.2 20.9 17.5 9.4 15.2 25.2 12.3 11.3 24.4 8.5 17.8 47.9 24.2 17.9 17.8 7.5 9.8 13.7 21.6 12.1 8.4 19.7 17.8 22.2 26.9 11.1 16.3 10.3 12.2 10.5 26.3 19.9 25.1 89.8 33.5 12.8 19.5 30.1 22.6 24.3 13.7 13.6 CFAP36 "BARTL1, CCDC104, MGC15407" ENSG00000163001 "Cilia and flagella associated protein 36" Q96G28 2 55519604-55545079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 1342.4;Late spermatids: 262.5;Spermatocytes: 346.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008994, HPA017061" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies" Cytosol "HPA008994: AB_2275429, HPA017061: AB_1846129" "unprognostic (8.11e-2)" "unprognostic (3.21e-3)" "unprognostic (1.24e-1)" "unprognostic (3.36e-2)" "unprognostic (7.98e-2)" "unprognostic (3.68e-1)" "unprognostic (4.65e-3)" "unprognostic (7.79e-2)" "unprognostic (1.51e-2)" "unprognostic (1.58e-2)" "unprognostic (3.66e-3)" "unprognostic (7.63e-2)" "unprognostic (8.57e-3)" "unprognostic (4.94e-2)" "unprognostic (3.35e-2)" "unprognostic (1.56e-3)" "unprognostic (2.96e-1)" 39.1 42.7 72.7 20.2 74.8 16.5 48.9 61.8 98.8 49.8 82.8 52.3 15.1 47.1 77.0 21.9 62.3 40.9 35.7 75.0 78.5 63.2 17.7 33.9 21.7 71.8 70.4 58.9 33.6 78.0 106.7 20.6 72.1 41.6 23.2 124.3 28.7 45.0 19.2 18.8 25.2 37.4 65.9 18.2 42.1 145.2 73.6 22.8 78.0 27.1 19.7 40.7 33.6 70.1 59.5 47.3 50.2 66.3 64.4 119.4 30.4 36.6 73.4 54.9 46.6 34.6 21.2 21.3 82.3 48.9 81.9 38.4 39.3 51.4 67.7 51.9 76.2 31.0 43.9 38.1 70.0 59.4 38.4 58.1 82.7 74.0 92.1 146.8 58.9 42.5 40.1 18.2 66.1 44.4 35.7 67.5 25.2 38.7 44.8 27.2 59.7 21.7 112.1 33.7 74.1 36.6 49.4 25.6 68.5 26.2 42.1 19.7 32.5 57.6 33.7 58.5 50.8 29.9 14.2 7.3 94.0 26.7 26.8 15.5 4.3 13.6 18.3 5.0 35.4 16.9 50.6 29.6 5.8 11.7 41.1 26.0 5.2 12.3 6.4 13.5 30.5 15.9 72.7 74.8 61.8 98.8 75.0 78.5 71.8 70.4 72.1 65.9 73.6 70.1 51.3 48.1 30.6 15.7 14.5 0.0 52.6 0.0 22.2 39.6 48.7 77.2 37.9 38.6 27.2 35.0 8.4 14.3 14.8 6.4 92.0 61.9 1342.4 184.4 51.8 42.9 17.0 21.0 51.6 60.7 27.0 44.7 21.9 36.3 39.1 27.1 42.1 10.7 23.6 23.5 41.1 12.2 0.0 8.7 0.0 262.5 75.2 12.8 0.0 14.0 16.9 145.0 16.5 21.6 13.3 37.0 11.5 67.7 11.4 41.3 7.6 146.9 99.1 92.4 59.2 43.0 43.4 346.0 29.8 16.1 0.0 7.8 24.7 36.0 9.9 35.6 CFLAR "c-FLIP, CASH, CASP8AP1, Casper, cFLIP, CLARP, FLAME, FLIP, I-FLICE, MRIT" ENSG00000003402 "CASP8 and FADD like apoptosis regulator" O15519 2 201116154-201176687 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 609.9;Urothelial cells: 521.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 392.6" "Lineage enriched" "Detected in all" 6 "granulocytes: 392.6" "Cell line enhanced" "Detected in all" "U-266/70: 214.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019044, CAB022157, CAB025216" Uncertain Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA Yes "Cluster 50: Neutrophils - Cellular senescence" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Plasma membrane, Cytosol" "Nuclear bodies" "CAB022157: , CAB025216: , HPA019044: AB_10696204" "unprognostic (4.61e-2)" "unprognostic (5.32e-2)" "unprognostic (2.49e-1)" "unprognostic (1.44e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.79e-4)" "unprognostic (7.46e-2)" "unprognostic (9.01e-2)" "unprognostic (1.76e-1)" "unprognostic (6.12e-2)" "unprognostic (3.08e-2)" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (7.83e-2)" "unprognostic (9.13e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-2)" 122.4 50.6 38.8 103.9 40.9 247.6 83.1 54.1 47.4 57.0 75.6 86.0 59.2 57.9 60.6 68.0 66.6 71.6 184.8 39.4 32.7 57.5 59.2 174.6 91.1 46.5 40.5 38.3 40.7 31.8 29.4 94.0 42.1 65.6 56.4 12.4 58.0 63.2 222.8 51.0 64.8 58.8 36.6 98.1 56.5 25.3 51.9 54.1 78.8 89.2 107.3 78.7 61.7 46.1 21.5 42.9 30.0 17.9 92.3 71.0 37.5 53.6 92.1 34.3 41.6 50.4 78.4 5.8 49.6 62.5 41.6 15.5 9.8 40.3 53.9 160.7 29.9 32.3 38.4 82.2 63.6 24.2 102.2 76.8 39.6 58.2 50.3 41.7 176.7 7.3 110.8 131.2 63.1 17.9 11.3 96.3 10.2 17.2 32.7 11.7 7.2 46.5 42.5 44.0 6.6 11.8 35.7 31.2 43.2 19.6 22.1 44.8 193.6 71.0 29.5 26.7 26.1 214.6 76.2 35.9 50.6 19.5 36.3 91.8 60.3 70.3 54.4 61.8 48.4 25.6 46.5 52.1 33.4 20.9 29.5 38.3 392.6 45.2 68.5 23.0 60.7 42.0 38.8 40.9 54.1 47.4 39.4 32.7 46.5 40.5 42.1 36.6 51.9 46.1 191.3 451.9 234.9 30.3 126.4 54.8 229.6 164.9 29.0 10.9 38.9 30.0 205.8 102.9 206.7 69.9 31.3 77.2 166.2 132.5 74.3 148.8 83.3 202.8 75.0 261.0 95.1 59.1 6.9 72.5 34.8 89.5 73.4 219.2 81.6 93.4 201.0 97.5 68.6 13.5 16.8 76.8 40.7 123.2 609.9 44.8 51.9 278.0 97.8 146.1 247.0 23.4 276.0 29.7 56.8 166.4 155.6 49.7 317.8 386.0 116.7 101.5 276.1 30.7 39.5 113.2 77.9 14.4 12.2 33.2 86.1 70.1 168.3 56.1 50.9 521.3 CGNL1 "FLJ14957, JACOP, KIAA1749, PCING" ENSG00000128849 "Cingulin like 1" Q0VF96 15 57375967-57550717 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 87.2;Astrocytes: 79.7;Hepatic stellate cells: 58.5;Hepatocytes: 65.5;Microglial cells: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 52.7;SuSa: 37.6;TIME: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013500, HPA056911, HPA069214" Enhanced Supported "Nuclear bodies,Cell Junctions" No No "Cluster 15: Liver - Metabolism" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Cell Junctions" "Nuclear bodies" "CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102" "unprognostic (1.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.52e-2)" "prognostic favorable (3.55e-4)" "unprognostic (3.22e-1)" "unprognostic (1.51e-3)" "prognostic favorable (5.58e-4)" "unprognostic (4.32e-2)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (4.05e-2)" "unprognostic (1.91e-2)" "prognostic favorable (1.37e-6)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (1.88e-3)" "unprognostic (1.18e-2)" 5.0 11.5 23.6 1.5 23.0 0.0 19.8 19.8 18.5 32.0 47.2 3.2 1.2 17.8 4.4 11.0 8.9 2.8 20.1 18.6 24.2 68.3 36.0 21.0 1.1 28.9 28.2 5.8 18.6 9.6 4.1 28.8 27.7 28.7 2.3 12.3 32.3 16.2 0.7 11.5 2.5 10.8 20.0 0.4 15.5 6.6 29.9 4.6 19.8 1.9 3.2 8.9 20.2 15.7 0.0 1.3 13.1 0.0 0.0 0.0 0.2 0.2 2.9 1.1 2.4 8.4 0.1 0.0 11.4 1.7 1.9 0.0 6.2 0.1 1.8 0.1 1.0 0.1 0.1 5.7 0.2 0.1 0.0 0.4 0.4 1.3 0.0 4.4 52.7 0.5 0.0 0.0 2.1 2.4 0.0 0.2 6.5 3.7 0.6 0.1 6.6 0.3 4.4 0.0 0.3 0.7 0.0 5.1 0.0 37.6 0.5 0.6 32.5 0.0 3.3 0.1 1.9 0.0 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 23.0 19.8 18.5 18.6 24.2 28.9 28.2 27.7 20.0 29.9 15.7 3.9 51.3 87.2 79.7 0.2 4.6 13.4 5.1 4.6 0.4 27.4 27.1 21.0 10.0 11.7 22.0 0.0 1.0 1.6 0.9 41.1 9.9 3.0 11.0 9.4 21.8 13.1 2.7 0.7 13.2 1.0 17.1 11.2 11.8 1.3 3.5 58.5 65.5 0.3 0.0 1.9 3.7 18.3 1.6 4.9 18.1 19.9 0.9 7.2 156.4 0.6 43.7 0.0 11.1 1.5 4.3 1.2 27.8 0.0 18.6 0.2 39.4 2.2 1.4 0.0 6.6 2.3 0.6 0.6 0.8 2.4 1.4 1.2 0.6 2.2 7.0 CHAMP1 "C13orf8, CAMP, CHAMP, ZNF828" ENSG00000198824 "Chromosome alignment maintaining phosphoprotein 1" Q96JM3 13 114314482-114337626 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006623, HPA008900" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Midbody ring" Yes No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA006623: AB_1845548, HPA008900: AB_1845547" "unprognostic (6.60e-2)" "unprognostic (1.12e-1)" "unprognostic (1.99e-2)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (1.67e-1)" "unprognostic (3.89e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-2)" "unprognostic (1.13e-1)" "unprognostic (4.38e-2)" "unprognostic (1.13e-2)" "unprognostic (4.40e-2)" "unprognostic (3.50e-2)" "unprognostic (3.67e-1)" "unprognostic (4.62e-2)" "unprognostic (2.40e-1)" 9.9 7.1 3.4 9.8 3.3 14.2 9.5 6.6 5.2 8.1 3.8 8.7 10.0 8.5 8.0 6.4 9.8 7.6 6.2 3.0 4.3 8.9 15.2 8.9 15.7 2.7 3.4 12.1 15.4 9.3 3.6 9.9 3.4 10.0 9.9 9.1 8.4 9.3 7.9 9.2 8.0 10.1 2.3 9.6 7.7 6.9 2.7 16.5 10.7 9.7 17.3 7.5 4.4 3.1 36.9 15.8 56.6 24.2 20.1 30.9 24.3 38.2 32.0 35.6 39.4 23.5 22.0 75.2 15.1 30.0 22.3 23.0 41.8 30.6 52.7 29.8 50.0 49.7 21.8 20.7 22.5 73.3 28.3 30.4 18.8 27.8 27.3 12.6 17.4 25.8 32.1 20.3 46.1 14.6 48.6 21.4 43.1 45.2 20.2 48.1 26.9 26.0 27.0 22.2 27.5 32.8 22.2 49.2 36.7 39.1 28.2 61.3 19.3 19.5 30.8 20.7 23.6 25.7 27.9 80.4 38.6 42.7 38.1 7.5 3.3 4.4 3.7 4.0 4.6 5.4 3.3 3.7 3.9 5.8 2.6 3.0 0.8 3.5 6.6 12.5 2.4 2.1 3.4 3.3 6.6 5.2 3.0 4.3 2.7 3.4 3.4 2.3 2.7 3.1 11.2 9.6 9.6 3.6 13.9 3.3 6.6 7.6 10.8 12.5 11.3 10.8 5.7 11.5 4.1 12.9 4.2 14.2 18.1 9.3 13.7 11.7 1.0 8.5 14.8 10.9 10.8 24.4 6.1 11.4 18.1 11.5 10.2 8.3 10.1 13.1 13.9 21.6 21.7 15.2 7.8 12.5 6.1 20.7 7.8 1.6 11.8 13.0 12.4 7.5 18.4 8.8 17.5 4.0 8.0 10.9 7.8 11.3 17.6 13.2 12.5 17.0 7.6 10.9 6.6 11.7 10.5 10.6 20.7 13.1 3.8 7.9 11.4 12.4 11.4 3.5 CHFR "FLJ10796, RNF196" ENSG00000072609 "Checkpoint with forkhead and ring finger domains" Q96EP1 12 132822187-132956304 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8;Late spermatids: 89.1;Rod photoreceptor cells: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045768, HPA073826" Approved Uncertain "Nuclear bodies,Microtubules" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies, Microtubules" "HPA045768: , HPA073826: AB_2732242" "unprognostic (1.46e-1)" "unprognostic (2.11e-2)" "unprognostic (1.41e-1)" "unprognostic (3.86e-2)" "unprognostic (2.08e-1)" "unprognostic (2.14e-3)" "unprognostic (6.56e-4)" "unprognostic (1.94e-2)" "unprognostic (2.36e-2)" "unprognostic (1.25e-1)" "unprognostic (1.00e-2)" "unprognostic (3.98e-3)" "prognostic unfavorable (4.21e-9)" "unprognostic (5.03e-1)" "unprognostic (8.46e-2)" "unprognostic (6.71e-2)" "unprognostic (1.11e-2)" 9.8 8.1 7.8 15.6 7.9 22.0 9.1 7.1 9.1 9.8 6.0 12.4 15.9 10.7 3.3 15.6 8.7 9.9 10.7 6.9 7.0 8.6 9.0 12.2 20.9 7.9 7.3 6.2 11.9 7.6 9.4 17.7 7.9 9.9 8.5 6.3 9.4 9.6 8.0 12.3 15.0 12.6 6.0 17.5 12.9 15.4 8.6 25.2 9.1 9.2 13.8 14.4 10.8 9.1 11.0 24.1 19.3 1.6 16.8 21.3 41.0 23.4 17.9 23.7 22.7 20.6 8.7 0.2 21.6 25.3 16.7 18.6 2.1 21.5 12.2 1.3 21.0 36.5 16.7 24.4 42.0 1.2 67.5 32.4 20.0 19.6 13.5 15.5 30.1 2.8 15.9 0.0 16.7 40.4 24.5 25.3 27.4 20.9 19.8 2.9 2.5 11.4 15.3 49.4 20.8 28.2 18.2 20.0 17.8 22.5 34.4 36.2 33.3 1.2 4.7 11.8 7.7 37.0 0.1 4.2 0.0 6.8 21.7 38.3 25.5 35.5 16.7 29.6 15.8 10.5 13.2 17.8 20.7 6.4 12.0 13.3 34.8 23.2 31.5 10.6 21.5 19.3 7.8 7.9 7.1 9.1 6.9 7.0 7.9 7.3 7.9 6.0 8.6 9.1 11.2 12.8 19.5 20.5 17.2 6.1 7.9 6.0 4.6 22.1 8.2 5.7 9.9 4.3 15.3 7.3 93.8 12.3 29.4 17.9 9.8 10.2 53.0 11.1 14.3 13.1 21.1 13.0 33.4 13.8 15.7 10.8 28.1 12.2 66.4 14.4 11.4 7.7 19.4 21.9 32.0 10.2 14.2 21.7 9.3 89.1 7.5 22.0 10.6 24.4 29.4 8.8 40.2 18.1 31.3 16.9 11.4 8.6 24.2 11.2 11.7 4.4 10.8 117.9 19.7 9.2 10.7 19.0 24.6 11.1 9.7 23.7 24.2 16.1 8.6 13.8 CHN2 "ARHGAP3, RhoGAP3" ENSG00000106069 "Chimerin 2" P52757 7 29146569-29514328 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 101.0;intestine: 70.1" "Cell type enhanced" "Detected in many" "Bipolar cells: 307.9;Early spermatids: 130.6;Excitatory neurons: 139.5;Late spermatids: 118.1;Microglial cells: 145.2;Oligodendrocytes: 496.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 37.4;HMC-1: 68.3" "HPA018989, HPA019026" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA018989: AB_1846681, HPA019026: " "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (6.87e-2)" "unprognostic (2.56e-1)" "unprognostic (1.52e-1)" "unprognostic (8.12e-2)" "unprognostic (6.87e-2)" "unprognostic (1.19e-1)" "unprognostic (6.64e-2)" "unprognostic (4.71e-2)" "unprognostic (7.54e-2)" "unprognostic (7.85e-2)" "unprognostic (1.61e-2)" "unprognostic (1.68e-1)" "unprognostic (1.18e-1)" "unprognostic (1.15e-2)" "unprognostic (1.58e-3)" 4.6 6.3 19.0 5.3 33.0 2.2 3.4 101.0 37.5 10.2 12.4 8.5 70.1 4.1 2.3 2.6 8.0 7.0 11.7 22.2 27.1 13.1 37.9 5.6 3.1 30.4 26.5 20.2 25.1 0.5 3.4 10.8 33.2 8.0 9.8 51.5 2.7 4.1 4.7 1.9 57.9 4.3 24.2 8.2 6.6 2.5 25.4 3.8 7.8 1.4 2.5 6.3 3.2 59.6 0.3 0.8 3.0 0.0 0.0 0.0 19.0 0.0 0.0 0.7 0.0 10.4 2.9 0.9 6.0 0.2 1.2 5.2 10.1 0.1 0.0 18.1 3.8 37.4 1.7 18.4 0.2 0.0 68.3 0.0 6.4 0.0 0.7 0.0 3.5 5.9 1.5 0.5 0.0 0.4 11.2 0.4 1.2 6.8 3.4 0.8 0.0 2.0 18.2 12.0 18.3 1.4 3.9 5.8 10.2 10.7 0.7 2.0 0.4 1.0 0.3 0.1 0.4 3.6 15.2 0.0 0.3 2.2 1.2 4.4 11.6 0.1 2.8 12.7 1.9 0.3 0.4 2.1 10.1 0.1 0.4 1.1 0.5 9.6 7.3 1.1 0.0 3.6 19.0 33.0 101.0 37.5 22.2 27.1 30.4 26.5 33.2 24.2 25.4 59.6 3.3 6.4 3.6 5.5 2.0 2.7 0.8 0.2 0.6 307.9 0.3 0.3 14.1 5.7 2.0 3.7 43.8 24.6 6.1 15.3 0.0 0.5 130.6 8.8 0.3 8.5 39.4 9.5 139.5 2.1 33.5 3.8 12.2 2.7 23.5 2.2 3.9 84.4 18.5 6.7 28.8 24.0 2.0 29.0 33.1 118.1 5.0 20.5 17.8 145.2 29.3 11.7 22.6 10.1 496.8 0.2 14.3 4.9 1.3 1.0 107.8 2.3 7.6 15.9 0.0 5.4 1.1 2.6 6.2 0.2 0.6 16.4 14.4 0.7 23.6 1.1 CLBA1 C14orf79 ENSG00000140104 "Clathrin binding box of aftiphilin containing 1" Q96F83 14 104985775-105010482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Endometrial ciliated cells: 29.9;Respiratory ciliated cells: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042052, HPA061117" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA042052: AB_2677822, HPA061117: AB_2684434" "unprognostic (1.49e-2)" "unprognostic (4.04e-2)" "unprognostic (4.84e-2)" "unprognostic (2.88e-2)" "unprognostic (5.51e-2)" "unprognostic (1.49e-1)" "unprognostic (5.77e-2)" "unprognostic (9.43e-3)" "unprognostic (1.78e-1)" "unprognostic (8.21e-2)" "unprognostic (3.50e-2)" "unprognostic (2.30e-1)" "unprognostic (4.39e-3)" "unprognostic (3.12e-2)" "unprognostic (1.11e-2)" "unprognostic (9.30e-2)" "unprognostic (2.95e-1)" 3.6 7.8 5.7 1.3 6.0 1.6 5.8 3.7 6.4 8.0 11.1 5.6 1.7 7.6 11.5 7.8 14.9 3.4 3.0 6.2 7.5 15.9 6.9 5.8 1.5 5.5 6.5 7.1 14.4 9.3 21.7 1.8 4.4 9.6 2.6 3.1 8.1 6.1 1.8 7.6 3.1 3.3 5.0 3.2 5.9 23.9 7.0 1.3 18.2 1.2 1.2 6.0 5.4 4.2 5.1 8.9 2.7 8.3 2.6 3.8 4.1 4.0 3.7 4.7 2.1 0.8 8.7 0.5 8.3 4.0 2.5 10.9 1.0 6.0 3.0 4.2 3.2 0.3 8.9 0.4 9.2 2.3 2.2 2.3 13.6 5.1 10.1 8.0 2.7 4.2 3.1 1.4 2.8 17.5 0.9 6.6 3.4 5.0 8.5 3.2 1.5 2.9 10.4 2.9 17.1 8.9 5.7 2.5 5.0 1.7 18.0 3.1 3.0 5.9 2.7 12.0 3.1 1.6 1.1 0.5 7.6 0.7 4.2 0.4 0.2 0.0 0.2 0.2 0.0 0.2 0.2 0.0 0.1 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.1 0.1 5.7 6.0 3.7 6.4 6.2 7.5 5.5 6.5 4.4 5.0 7.0 4.2 1.0 16.0 3.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 7.4 7.4 0.0 0.0 2.5 16.5 0.0 1.8 0.4 0.0 3.9 7.9 0.0 29.9 8.1 0.9 0.0 0.0 0.0 1.3 0.8 1.3 0.0 8.8 2.5 3.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 6.5 19.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.4 6.5 0.0 0.0 CLCF1 "BSF-3, BSF3, CISS2, CLC, NNT-1, NNT1, NR6" ENSG00000175505 "Cardiotrophin like cytokine factor 1" Q9UBD9 11 67364168-67374177 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted secreted proteins" Cytokine "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 41.8;Glandular and luminal cells: 104.9;Pancreatic endocrine cells: 56.2;Prostatic glandular cells: 56.4;Urothelial cells: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SiHa: 57.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA042444 Uncertain Approved "Nuclear bodies,Vesicles" "Secreted to blood" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" "Nuclear bodies, Vesicles" "HPA042444: AB_10794527" "unprognostic (2.68e-1)" "unprognostic (7.87e-3)" "unprognostic (6.21e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (9.91e-4)" "unprognostic (1.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.47e-2)" "unprognostic (5.08e-2)" "unprognostic (2.65e-2)" "unprognostic (1.84e-2)" "unprognostic (1.54e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" "unprognostic (1.17e-2)" "unprognostic (2.37e-1)" 16.2 6.0 1.3 8.0 0.5 13.7 5.3 0.0 1.5 13.9 0.9 13.4 1.4 16.6 1.0 4.4 17.1 17.7 8.8 1.0 0.6 19.0 4.2 9.3 5.3 1.4 0.5 6.7 6.5 0.2 6.5 4.2 0.4 7.2 1.7 1.4 9.1 1.8 1.5 2.6 9.4 8.3 0.0 8.1 11.2 1.9 2.1 0.7 9.7 1.9 4.4 18.1 7.6 0.2 15.1 31.4 2.2 9.7 4.2 5.8 0.0 20.9 11.6 14.4 7.0 5.1 40.3 9.1 17.1 26.8 17.5 10.3 0.4 10.7 6.3 0.5 0.3 0.1 23.9 4.0 13.6 1.9 2.4 7.6 2.6 15.0 6.5 27.4 3.1 0.0 3.5 0.4 15.0 12.0 0.1 6.8 8.1 18.9 28.8 0.9 4.8 0.5 22.7 0.8 0.1 1.6 57.8 2.2 1.3 4.4 1.3 2.5 12.5 27.6 11.6 35.4 31.5 2.0 0.1 1.0 35.4 1.8 11.1 0.0 0.9 15.2 10.5 3.4 6.2 10.8 4.8 8.3 1.3 13.8 0.1 3.5 0.3 0.2 10.5 0.0 1.1 3.2 1.3 0.5 0.0 1.5 1.0 0.6 1.4 0.5 0.4 0.0 2.1 0.2 4.2 16.0 4.8 1.3 10.6 3.7 25.9 6.5 1.8 0.0 14.5 2.4 0.8 25.8 9.6 7.3 0.0 0.4 10.0 3.8 1.9 24.0 1.8 41.8 19.4 6.2 1.2 0.0 0.7 11.8 0.6 14.0 5.1 104.9 3.8 2.1 2.9 1.0 1.2 0.0 0.5 2.3 6.1 0.3 10.7 4.7 3.4 6.7 8.8 1.0 6.5 1.7 3.1 0.5 0.1 56.2 14.3 0.0 9.5 56.4 0.2 5.2 1.7 0.3 0.0 32.6 10.4 0.3 0.9 1.6 4.4 0.1 9.7 0.1 1.5 65.2 CLIC3 ENSG00000169583 "Chloride intracellular channel 3" O95833 9 136994608-136996568 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 317.0;skin 1: 122.0;thyroid gland: 109.6;vagina: 132.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 130.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 9 "plasmacytoid DC: 2635.7" "Lineage enriched" "Detected in all" 9 "dendritic cells: 2635.7" "Cell line enhanced" "Detected in many" "BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005963 Enhanced Supported "Nuclear bodies" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear bodies" "HPA005963: AB_1078536" "unprognostic (4.30e-2)" "unprognostic (2.53e-1)" "unprognostic (3.54e-1)" "unprognostic (1.55e-2)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-3)" "unprognostic (1.39e-1)" "unprognostic (3.26e-3)" "unprognostic (7.73e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.74e-4)" 8.6 0.6 0.9 1.3 1.0 4.0 2.6 1.3 1.6 75.0 1.4 1.3 0.3 1.8 4.6 317.0 1.7 0.8 8.6 0.7 1.0 1.0 1.0 38.6 4.1 1.3 0.9 0.6 0.6 0.2 2.4 41.6 1.0 3.0 0.2 0.0 37.7 1.1 1.0 122.0 1.7 0.3 0.8 6.9 7.5 0.7 1.0 7.6 109.6 1.2 20.5 2.1 132.2 1.2 28.8 0.0 0.0 0.0 0.5 1.4 350.3 2.7 1.5 1.0 0.4 3.7 14.0 0.1 22.5 24.3 0.1 12.5 0.0 1.2 0.0 0.0 0.2 0.0 20.7 4.5 3.9 0.0 0.0 1.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 168.1 0.1 0.2 0.1 58.4 5.8 0.0 0.5 0.0 0.0 0.0 0.8 0.0 45.9 65.0 0.0 0.0 147.2 0.0 118.4 0.0 4.1 2.5 0.1 0.0 0.0 0.1 0.5 0.0 0.0 2.9 0.8 2.6 232.3 2.1 99.3 2.6 32.0 143.8 9.4 5.5 6.9 120.4 10.3 283.2 2.3 2635.7 11.5 168.3 0.9 1.0 1.3 1.6 0.7 1.0 1.3 0.9 1.0 0.8 1.0 1.2 11.5 214.7 42.0 0.0 11.6 3.8 3.6 86.6 8.0 0.0 7.3 20.6 3.2 2.8 95.2 1.8 0.0 811.8 456.0 25.2 9.8 1.8 1.7 16.7 2.3 13.4 4.9 5.3 0.0 6.4 1219.2 27.0 22.4 14.4 1.3 1.8 3.6 1.1 91.6 0.0 0.0 5.6 4.1 2.2 5.9 7.8 125.6 8.5 10.6 1.9 4.9 0.0 541.7 0.0 0.0 84.6 10.4 41.8 23.7 4.5 0.7 0.4 12.0 0.0 0.0 0.2 4.4 0.0 1.0 70.2 19.5 2039.4 78.4 1.0 5.2 18.1 CLK2 ENSG00000176444 "CDC like kinase 2" P49760 1 155262868-155278491 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055366, HPA059507" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Nuclear bodies" "HPA055366: AB_2682795, HPA059507: AB_2684044" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.84e-2)" "unprognostic (3.16e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.38e-1)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (7.66e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.95e-9)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (1.11e-1)" "prognostic favorable (5.43e-4)" 23.7 25.6 11.6 10.7 11.9 11.4 24.4 14.2 14.4 39.2 14.1 24.1 11.7 29.8 12.7 22.6 28.7 9.6 18.5 11.7 12.7 26.8 29.0 22.0 19.6 12.3 11.7 33.9 23.9 14.0 31.4 13.8 12.4 33.1 8.7 9.4 23.3 11.2 16.2 27.5 24.0 10.9 11.7 40.1 20.8 16.2 12.4 18.6 33.2 8.5 15.9 28.1 29.9 13.2 10.8 10.5 29.8 11.4 17.3 9.1 22.5 8.1 12.3 8.2 7.8 13.1 8.7 23.3 9.7 6.6 4.0 17.0 16.8 13.5 6.3 11.4 17.7 20.4 12.9 15.4 14.6 26.8 20.5 7.6 10.7 11.3 20.3 19.0 13.6 16.9 29.6 15.4 10.5 22.2 12.1 11.3 21.2 27.2 17.6 17.7 21.6 28.0 17.9 25.8 11.8 25.1 4.5 10.9 9.9 21.4 15.9 24.9 9.3 4.3 12.1 9.1 9.1 31.6 28.6 22.9 9.9 19.1 5.9 0.5 0.8 1.9 0.8 0.4 1.6 1.2 1.5 0.8 0.9 0.9 1.6 1.6 0.8 0.5 0.4 0.8 0.9 0.6 11.6 11.9 14.2 14.4 11.7 12.7 12.3 11.7 12.4 11.7 12.4 13.2 9.2 16.0 24.3 9.8 13.7 4.6 5.7 4.2 17.6 5.7 7.8 7.5 14.9 12.8 12.6 7.3 4.2 8.0 7.1 5.4 0.0 6.5 6.5 6.9 15.2 11.1 6.7 8.4 8.3 4.4 8.0 11.3 25.0 9.5 10.1 12.1 7.5 8.4 6.9 5.0 6.8 9.1 2.0 11.4 4.5 6.6 7.8 10.4 3.6 9.4 9.5 5.4 8.2 9.5 8.0 4.9 4.8 3.0 17.1 5.7 5.1 3.2 5.1 7.2 6.6 6.4 12.6 8.6 4.3 14.3 4.5 12.4 11.0 7.4 7.2 5.1 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319908 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.0" "Cell type enhanced" "Detected in many" "Early spermatids: 161.8;Late spermatids: 313.5;Oligodendrocytes: 418.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.8;SK-BR-3: 16.0;T-47d: 13.5;WM-115: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favorable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 11.1 1.1 16.6 4.2 38.9 1.1 10.9 11.4 28.1 7.5 6.9 11.5 3.0 4.9 7.4 2.9 9.2 5.8 5.3 15.5 12.2 13.3 14.1 4.9 1.3 21.5 25.7 2.9 17.3 1.7 2.9 2.3 23.3 6.9 12.8 9.8 9.2 5.0 3.8 3.2 6.7 2.8 7.3 3.0 7.2 32.8 42.9 1.0 5.9 5.5 1.6 4.7 6.9 67.0 6.3 8.4 1.3 0.2 4.9 2.2 0.5 0.1 0.0 0.4 0.3 0.7 10.5 0.0 0.9 0.0 13.8 5.5 0.6 3.7 0.0 4.3 1.5 0.2 0.3 5.0 0.5 0.0 0.1 2.4 3.6 1.6 5.8 1.9 4.2 2.3 0.0 1.2 3.0 5.6 0.3 0.5 0.5 7.7 2.0 4.8 4.4 2.8 3.9 10.3 1.7 1.6 2.1 16.0 8.2 1.2 13.5 0.4 1.2 0.1 3.6 0.0 0.3 1.6 0.1 5.8 2.9 2.5 15.5 7.3 6.9 0.6 0.0 2.4 0.0 3.0 0.0 0.0 1.4 1.5 0.0 0.1 5.7 0.0 1.5 2.4 0.0 2.1 16.6 38.9 11.4 28.1 15.5 12.2 21.5 25.7 23.3 7.3 42.9 67.0 12.9 16.0 3.4 21.9 18.0 6.2 39.2 11.7 37.0 61.8 39.0 22.2 58.6 42.9 17.3 58.8 14.6 2.5 3.5 93.1 27.4 53.1 161.8 76.7 16.9 11.4 23.4 0.4 9.3 47.5 1.8 12.2 33.6 37.3 4.5 0.4 2.2 81.9 7.3 38.7 11.5 72.5 8.2 11.9 7.2 313.5 22.4 15.6 3.6 1.0 17.1 3.5 0.0 5.0 418.6 40.1 44.1 10.9 21.9 62.3 15.9 21.0 115.6 28.2 105.2 4.8 100.6 4.2 15.3 7.1 2.6 2.9 2.8 0.2 50.2 51.5 CLUH "CLU1, KIAA0664" ENSG00000132361 "Clustered mitochondria homolog" O75153 17 2689386-2712663 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CACO-2: 266.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031505, HPA044346" Uncertain Supported "Nuclear bodies,Vesicles" NA NA 5500 "Cluster 7: Monocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "Nuclear bodies" "HPA031505: AB_2673912, HPA044346: AB_10962153" "unprognostic (3.48e-2)" "unprognostic (3.97e-2)" "unprognostic (9.02e-2)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.15e-2)" "unprognostic (2.85e-2)" "unprognostic (2.84e-2)" "unprognostic (1.84e-1)" "unprognostic (2.69e-2)" "unprognostic (5.64e-2)" "unprognostic (5.11e-2)" "prognostic favorable (1.92e-5)" "unprognostic (4.99e-2)" "unprognostic (1.25e-1)" "unprognostic (1.92e-2)" "unprognostic (6.26e-2)" 30.8 56.7 13.8 18.1 12.7 14.3 28.5 16.3 18.3 19.8 19.7 45.9 46.6 21.3 1.9 67.7 19.2 15.4 80.8 14.5 11.2 50.6 135.0 19.6 14.6 14.6 13.2 17.0 50.4 15.6 20.3 9.0 15.3 24.7 13.2 7.2 32.1 11.8 127.8 47.5 34.2 8.5 9.3 25.2 35.1 25.2 17.3 6.4 25.2 52.9 11.1 29.6 29.2 11.2 69.5 131.9 8.9 33.3 20.2 14.1 99.9 34.9 13.0 41.9 31.0 266.2 30.0 122.6 41.5 19.4 26.9 127.6 45.3 52.9 14.7 43.6 86.4 68.0 112.2 93.9 17.1 53.7 44.1 22.6 29.7 48.9 24.7 9.4 20.5 43.3 81.8 42.2 11.7 79.8 69.6 58.0 28.2 35.8 67.8 104.7 37.0 70.8 26.0 117.3 43.9 32.6 40.0 129.4 44.4 6.6 72.7 31.3 33.7 33.7 44.9 92.2 80.5 18.2 22.9 49.7 35.4 73.2 41.6 0.0 2.2 0.0 1.7 3.1 1.3 2.2 1.0 0.9 2.4 2.2 2.3 2.1 0.2 0.6 2.0 2.7 1.5 0.9 13.8 12.7 16.3 18.3 14.5 11.2 14.6 13.2 15.3 9.3 17.3 11.2 5.8 6.4 20.9 20.9 6.5 30.5 12.0 11.7 16.5 18.5 23.5 22.7 42.1 41.5 16.7 18.4 22.9 9.7 7.6 47.8 11.7 18.4 1.8 12.7 10.8 8.5 25.8 22.1 9.9 18.3 8.2 6.8 22.4 24.6 1.3 18.1 6.8 122.1 13.1 8.4 11.4 38.8 14.2 10.3 6.3 4.0 5.0 7.9 21.4 4.7 7.4 6.5 2.1 7.5 6.2 19.6 21.2 6.0 11.7 22.9 39.2 35.1 14.1 17.1 6.6 12.3 11.3 8.6 17.5 42.4 35.5 8.2 7.2 43.3 68.3 22.5 CNOT7 CAF1 ENSG00000198791 "CCR4-NOT transcription complex subunit 7" Q9UIV1 8 17224966-17246878 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069543 Supported "Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Nuclear bodies" "HPA069543: AB_2686148" "unprognostic (1.55e-1)" "unprognostic (4.49e-2)" "prognostic favorable (4.99e-4)" "unprognostic (4.61e-2)" "unprognostic (8.45e-2)" "unprognostic (3.10e-2)" "unprognostic (1.44e-3)" "unprognostic (4.54e-2)" "unprognostic (6.83e-2)" "unprognostic (4.09e-3)" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (3.49e-2)" "unprognostic (1.72e-1)" "unprognostic (4.51e-1)" "unprognostic (2.24e-1)" "unprognostic (2.52e-1)" 31.9 32.7 21.6 39.8 25.4 51.0 42.1 35.0 30.7 28.0 20.5 43.0 38.3 39.5 45.1 43.7 36.3 35.7 38.2 24.2 26.8 50.8 48.8 33.0 52.2 19.7 23.3 42.1 36.0 62.6 26.2 43.1 20.3 32.7 43.8 78.0 38.5 29.5 78.9 27.8 38.4 36.6 21.5 39.0 32.0 52.0 24.4 80.2 60.0 72.2 64.9 45.0 20.4 24.0 77.3 93.6 138.1 103.1 57.0 59.6 95.3 97.6 82.5 110.4 97.5 110.2 60.4 106.1 103.9 85.9 177.5 60.3 147.0 122.9 160.2 44.1 71.0 139.9 68.6 119.9 73.2 95.3 82.8 57.3 99.7 94.3 100.3 102.0 133.7 138.2 119.1 114.9 112.9 60.2 234.7 88.2 152.6 144.4 72.0 126.1 102.7 79.9 95.6 167.6 173.6 115.9 68.6 60.3 114.4 112.9 72.5 79.2 90.8 82.0 116.5 92.4 110.8 59.3 208.2 189.5 76.9 88.7 82.8 138.0 93.9 109.5 80.2 116.6 95.3 133.3 109.7 95.7 113.5 135.3 136.6 110.0 84.5 106.5 105.1 101.3 134.8 130.1 21.6 25.4 35.0 30.7 24.2 26.8 19.7 23.3 20.3 21.5 24.4 24.0 46.9 32.1 40.3 15.0 100.4 90.9 65.2 82.5 100.7 114.9 77.1 64.0 58.2 61.5 48.2 62.5 93.8 88.4 74.5 31.0 97.8 79.0 86.5 50.7 37.1 56.8 94.1 60.5 39.1 72.5 115.1 45.9 40.2 53.5 44.9 72.2 69.3 67.2 69.7 25.2 32.1 69.6 81.4 73.5 58.7 33.9 40.7 59.4 26.6 28.1 83.7 68.5 76.2 23.1 34.8 79.3 58.1 40.6 84.0 93.8 52.6 113.9 56.6 219.2 78.9 51.6 56.2 95.9 100.7 90.7 86.0 85.5 77.6 55.3 70.5 84.3 COIL "CLN80, p80-coilin" ENSG00000121058 Coilin P38432 17 56938199-56961050 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 98.5" "Cell type enhanced" "Detected in all" "Early spermatids: 249.2;Late spermatids: 591.1;Spermatocytes: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017524, HPA027885, HPA057480, CAB069400" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Nucleoli "CAB017524: AB_1121780, CAB069400: , HPA027885: AB_2672421, HPA057480: " "unprognostic (1.01e-2)" "unprognostic (3.05e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (3.19e-2)" "unprognostic (4.13e-3)" "prognostic unfavorable (1.28e-4)" "unprognostic (1.64e-1)" "unprognostic (4.07e-3)" "unprognostic (3.00e-3)" "unprognostic (2.50e-2)" "unprognostic (2.25e-2)" "unprognostic (1.28e-3)" "unprognostic (2.50e-1)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (7.71e-2)" 7.7 7.2 6.6 8.8 6.8 19.9 12.2 9.7 8.9 9.2 7.3 9.2 10.2 10.4 11.6 9.7 9.8 7.1 8.0 6.6 7.0 8.7 13.0 7.6 12.8 6.7 6.7 11.9 8.7 12.3 6.2 13.0 7.4 9.3 10.6 12.6 9.8 7.7 11.5 9.8 10.0 8.5 6.8 10.3 9.2 98.5 6.6 13.2 12.1 9.1 13.5 9.3 8.7 8.1 25.0 18.6 37.4 14.5 12.5 14.9 25.8 17.5 16.4 26.1 27.7 25.6 21.0 29.9 34.6 14.0 19.5 14.1 25.6 20.2 37.1 36.1 32.3 48.7 17.4 29.2 13.5 41.5 28.5 13.9 24.7 19.7 21.1 15.5 22.6 17.4 42.9 24.3 24.8 31.6 32.9 26.3 22.0 27.4 18.4 15.5 45.9 23.9 18.1 24.7 31.6 31.2 11.7 11.5 30.1 21.5 41.8 40.0 16.0 30.2 22.7 14.8 23.0 35.6 47.7 34.5 15.8 22.7 18.8 22.3 13.3 17.5 15.5 12.6 17.5 27.6 17.0 16.6 13.5 25.0 19.5 18.9 8.1 16.0 17.2 16.4 18.6 10.1 6.6 6.8 9.7 8.9 6.6 7.0 6.7 6.7 7.4 6.8 6.6 8.1 21.3 12.8 21.0 6.8 26.5 18.7 39.5 34.0 21.1 35.9 21.6 22.5 14.1 22.8 28.3 14.7 37.5 42.2 26.2 12.5 13.7 30.1 249.2 22.7 23.1 26.6 23.9 17.5 8.8 27.7 32.3 23.5 18.3 19.9 22.2 20.3 22.5 23.9 22.7 25.2 10.9 16.5 16.2 16.5 10.4 591.1 42.3 12.3 3.6 10.3 19.6 28.5 34.0 9.5 13.3 23.5 17.3 30.5 15.1 32.2 16.6 23.0 22.0 52.4 13.1 24.9 21.9 142.2 46.8 20.3 22.7 29.1 23.3 17.1 20.8 29.0 COMMD3-BMI1 ENSG00000269897 "COMMD3-BMI1 readthrough" 10 22316388-22329542 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 10.1;testis: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.3;MOLT-4: 12.7;U-937: 23.8" "HPA030471, HPA030472, HPA036584" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 77: Retina - Visual perception" "Cluster 44: HDLM-2 - Immune response" "Nuclear bodies" "Nucleoplasm, Nucleoli, Cytosol" "HPA030471: AB_2673491, HPA030472: AB_10601090, HPA036584: AB_10670803" "unprognostic (8.63e-2)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" 0.9 2.2 0.4 1.0 1.4 0.3 0.8 1.0 1.9 1.5 0.8 0.8 0.6 0.4 0.0 1.8 1.3 0.2 3.0 0.3 1.6 0.4 0.5 0.9 1.0 1.3 0.7 0.6 0.8 0.4 0.1 0.7 0.9 0.5 0.2 10.1 1.8 2.7 6.4 0.7 0.8 0.3 0.4 0.9 1.1 6.7 1.3 2.0 0.4 2.3 1.5 1.0 0.8 2.0 2.1 6.4 3.9 0.2 2.5 2.3 0.4 0.9 1.3 1.4 5.8 7.8 1.2 1.9 0.8 3.0 5.1 1.1 2.8 2.2 1.3 23.3 2.4 5.4 1.5 0.0 1.7 0.6 3.0 2.9 3.2 3.3 0.1 4.3 1.6 8.3 1.4 2.8 0.8 0.0 12.7 0.9 0.4 3.9 2.1 1.7 3.1 1.7 0.5 1.9 0.4 2.7 5.5 1.1 0.2 1.4 0.0 4.7 6.8 2.3 3.9 1.3 0.7 4.9 0.9 3.5 1.2 23.8 0.0 7.4 2.1 3.0 3.4 2.4 3.7 7.5 3.2 4.1 2.2 7.3 2.4 1.8 0.7 4.9 1.3 0.3 6.5 4.9 0.4 1.4 1.0 1.9 0.3 1.6 1.3 0.7 0.9 0.4 1.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CORIN "ATC2, CRN, Lrp4, PRSC, TMPRSS10" ENSG00000145244 "Corin, serine peptidase" Q9Y5Q5 4 47593999-47838106 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "heart muscle: 56.9" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 69.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC TERT1: 44.0" "Region enhanced" "Detected in some" "basal ganglia: 2.6" "Low region specificity" "Detected in some" HPA070941 Approved "Nuclear bodies,Plasma membrane,Actin filaments" "Intracellular and membrane" Yes No "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" "Nuclear bodies, Actin filaments" "HPA070941: AB_2686324" "unprognostic (1.05e-1)" "unprognostic (2.52e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-1)" "unprognostic (3.58e-4)" "unprognostic (3.19e-1)" "unprognostic (3.67e-2)" "unprognostic (8.22e-2)" "unprognostic (9.78e-2)" "unprognostic (6.53e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (5.18e-2)" "unprognostic (7.22e-2)" "unprognostic (1.33e-2)" 0.4 0.1 0.1 0.1 0.1 0.0 1.0 0.1 0.2 2.1 0.6 0.3 0.1 4.5 0.6 0.9 1.4 4.5 56.9 0.0 0.3 1.0 0.1 1.9 0.0 0.7 0.6 0.5 0.2 1.1 1.9 0.4 0.1 2.3 0.0 0.3 0.4 6.1 0.1 7.5 0.3 0.7 0.1 1.1 0.5 2.5 0.3 0.1 0.1 0.1 0.1 1.2 3.9 0.1 0.0 0.0 0.1 0.3 10.3 44.0 0.0 2.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 2.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.4 0.0 0.3 0.2 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.3 0.7 0.6 0.1 0.1 0.3 0.1 0.3 0.0 7.5 1.0 0.0 3.8 0.3 0.0 0.0 1.0 8.3 0.3 69.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.1 1.3 1.0 0.0 0.0 6.5 0.0 0.0 9.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 10.8 0.0 0.0 0.6 5.5 2.0 4.7 0.1 5.4 1.0 0.0 0.7 0.0 2.0 3.9 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.0 0.3 0.0 0.3 2.3 4.6 4.4 0.1 2.7 0.0 0.6 0.1 0.0 0.3 CREBBP "CBP, KAT3A, RSTS, RTS" ENSG00000005339 "CREB binding protein" Q92793 16 3725054-3880713 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004212, HPA055861" Supported Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "Nuclear bodies" "CAB004212: AB_626817, HPA055861: AB_2682948" "unprognostic (1.17e-1)" "unprognostic (8.51e-2)" "unprognostic (1.60e-1)" "unprognostic (1.63e-1)" "unprognostic (1.49e-1)" "unprognostic (5.09e-2)" "unprognostic (9.59e-3)" "unprognostic (6.98e-2)" "unprognostic (8.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (2.84e-1)" "prognostic favorable (6.24e-5)" "unprognostic (1.47e-1)" "unprognostic (1.74e-1)" "unprognostic (3.97e-2)" "unprognostic (8.23e-2)" 17.4 10.6 5.8 17.1 5.2 52.9 16.8 25.4 11.5 20.9 3.7 18.8 12.5 26.5 12.4 16.5 22.4 16.6 14.4 5.9 3.1 12.0 14.3 15.9 17.6 8.9 6.8 37.3 29.7 18.5 11.3 16.9 2.9 16.1 14.1 13.8 17.2 16.2 29.6 21.0 16.4 19.6 0.4 21.0 16.3 33.2 7.9 29.1 23.3 28.9 20.7 16.6 16.5 6.4 12.3 31.0 39.3 17.4 23.5 23.1 20.4 17.4 28.9 29.2 28.2 28.2 22.4 33.7 20.1 33.3 18.7 23.2 45.7 14.2 32.9 57.5 18.5 26.6 29.2 17.9 26.0 26.9 36.5 20.7 14.2 32.5 38.9 18.0 22.3 17.0 30.9 44.8 16.0 42.0 17.9 13.0 32.3 11.7 12.7 83.4 31.1 26.1 11.2 16.2 32.6 21.5 29.5 28.7 16.8 25.3 25.6 25.9 34.7 35.5 35.2 18.4 16.0 20.8 24.3 63.7 7.2 15.8 25.6 1.9 1.1 0.9 1.7 1.5 0.8 3.7 0.8 1.3 0.7 2.1 0.8 1.1 6.7 1.4 2.9 1.5 0.8 0.9 5.8 5.2 25.4 11.5 5.9 3.1 8.9 6.8 2.9 0.4 7.9 6.4 48.1 44.8 51.6 91.1 38.3 56.2 31.0 16.0 27.3 34.2 34.4 25.7 41.2 40.0 28.0 11.0 25.0 17.4 50.1 31.2 5.9 20.9 43.0 37.2 56.4 35.7 15.0 33.4 88.7 20.3 11.3 39.5 32.1 63.5 30.4 53.1 32.5 29.5 20.9 28.6 89.8 25.3 18.3 44.0 42.8 80.2 56.5 49.0 17.8 87.1 52.5 34.5 43.3 111.6 101.2 27.5 19.5 51.1 35.6 39.8 25.2 10.9 28.2 17.6 46.0 75.8 44.9 35.1 42.2 34.6 58.8 30.8 44.2 36.2 24.6 44.2 CRTC1 "FLJ14027, KIAA0616, MECT1, TORC1" ENSG00000105662 "CREB regulated transcription coactivator 1" Q6UUV9 19 18683678-18782333 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 37.4;Horizontal cells: 43.7" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 203 "amygdala: 14.2;basal ganglia: 11.4;cerebellum: 27.1;cerebral cortex: 24.3;hippocampal formation: 24.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022035, HPA063619" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Nuclear bodies" "Plasma membrane, Cytosol" "HPA022035: AB_1847255, HPA063619: " "unprognostic (5.95e-3)" "unprognostic (2.57e-1)" "unprognostic (9.94e-2)" "unprognostic (8.62e-3)" "unprognostic (9.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.04e-1)" "unprognostic (5.57e-2)" "unprognostic (2.27e-1)" "unprognostic (6.68e-2)" "prognostic favorable (1.80e-5)" "unprognostic (3.37e-2)" "prognostic favorable (3.83e-5)" "unprognostic (6.83e-3)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (2.03e-2)" 8.8 11.3 14.2 5.2 11.4 2.1 8.2 27.1 24.3 11.3 0.0 8.9 4.0 9.3 3.4 5.2 10.3 3.2 10.5 24.5 0.0 12.8 10.4 7.9 4.1 0.0 0.0 9.4 9.8 4.7 23.7 3.9 0.0 11.6 1.5 4.4 7.3 5.1 14.4 7.4 8.5 2.5 0.0 9.6 9.9 11.3 0.0 3.6 14.4 3.6 2.2 9.7 7.4 0.0 5.2 7.9 6.7 10.7 6.3 4.5 18.6 5.4 3.6 5.3 4.8 5.1 6.6 7.1 11.6 5.2 3.9 5.5 2.1 3.5 1.3 3.1 15.1 6.0 7.8 9.3 5.5 8.3 16.3 7.8 2.9 4.4 1.3 6.8 3.1 7.2 4.8 6.3 3.0 15.2 5.7 10.0 8.8 2.7 13.1 8.7 2.9 8.1 3.2 8.0 12.1 10.7 6.0 5.8 7.0 2.2 6.6 5.2 5.4 6.0 9.1 10.8 6.4 4.4 3.6 4.6 6.9 8.6 4.6 0.3 0.6 0.4 0.4 0.2 0.3 0.5 0.5 0.6 0.7 0.7 0.5 0.3 0.2 0.3 0.4 0.8 0.4 0.4 14.2 11.4 27.1 24.3 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 5.3 31.0 6.9 2.7 8.9 7.8 5.7 29.1 5.8 6.1 17.7 10.0 3.5 18.4 27.1 9.7 7.9 6.8 11.7 4.6 1.1 9.6 14.0 5.6 19.2 3.6 37.4 6.0 2.7 7.5 8.6 9.8 2.5 14.7 3.9 4.7 8.8 43.7 26.7 7.1 12.2 6.0 4.0 3.2 9.3 6.3 3.6 10.3 5.5 9.1 8.2 12.1 20.2 3.5 9.6 4.9 2.0 3.0 6.1 5.0 4.8 14.7 0.0 14.2 6.6 2.9 8.8 2.4 2.0 10.4 5.1 8.3 5.2 3.6 CSF1 "M-CSF, MCSF, MGC31930" ENSG00000184371 "Colony stimulating factor 1" P09603 1 109910242-109930992 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 58.9;granulocytes: 113.5;Hepatic stellate cells: 53.2;Sertoli cells: 59.2;Skeletal myocytes: 94.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "basophil: 13.2;eosinophil: 22.3" "Lineage enriched" "Detected in many" 16 "granulocytes: 22.3" "Cell line enhanced" "Detected in many" "ASC diff: 220.0;BJ hTERT+: 149.5;GAMG: 142.1;HHSteC: 338.7;HSkMC: 216.4;hTERT-RPE1: 153.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076624 Supported "Nuclear bodies,Plasma membrane" "Secreted to blood" NA NA 270000 22000000 "Cluster 52: Eosinophils - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Nuclear bodies" "HPA076624: AB_2686810" "unprognostic (2.35e-3)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-1)" "unprognostic (3.60e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.04e-1)" "unprognostic (1.75e-2)" "unprognostic (2.18e-1)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (1.00e-11)" "unprognostic (2.03e-1)" "unprognostic (1.88e-2)" "unprognostic (4.01e-1)" "unprognostic (3.16e-2)" 67.4 37.5 27.5 24.5 32.9 18.4 46.4 36.9 25.8 25.0 32.9 26.8 13.3 21.1 5.2 15.6 28.5 31.9 29.0 24.5 30.9 17.3 16.4 47.6 28.2 42.3 32.6 22.1 17.5 10.5 8.7 41.2 36.1 21.4 16.2 1.5 18.9 16.6 11.4 19.4 26.7 17.6 36.0 48.0 22.0 3.7 32.2 13.5 22.2 11.3 12.2 42.0 29.6 46.5 9.3 29.3 14.7 5.7 220.0 138.3 5.7 36.0 149.5 25.9 23.9 1.3 4.5 0.2 47.0 80.1 142.1 6.8 5.7 11.0 9.4 99.5 5.3 10.9 17.3 10.3 338.7 0.0 13.7 216.4 3.2 57.5 33.0 153.1 5.4 2.8 2.9 5.5 31.2 0.5 0.3 1.8 5.3 2.4 3.1 1.0 8.4 0.9 10.9 7.9 0.5 1.6 9.7 2.6 12.6 16.7 2.3 1.0 19.2 27.8 10.5 123.7 22.1 2.8 1.1 0.3 70.7 0.1 106.6 13.2 0.0 22.3 0.3 0.0 0.6 0.0 0.9 0.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.2 27.5 32.9 36.9 25.8 24.5 30.9 42.3 32.6 36.1 36.0 32.2 46.5 30.6 9.6 35.5 11.8 2.3 7.4 5.1 7.9 13.1 0.3 10.0 9.3 3.2 14.3 5.3 3.7 0.0 0.8 2.0 0.6 0.0 40.4 0.4 20.6 9.3 21.6 7.8 11.1 0.3 2.3 0.5 58.9 4.6 24.8 113.5 0.3 53.2 3.0 9.2 0.0 1.0 0.8 0.0 3.5 13.1 0.3 25.1 8.2 10.6 28.1 1.6 1.8 0.0 3.0 17.5 9.3 1.6 8.6 1.9 8.0 1.2 0.9 1.1 0.2 59.2 94.4 37.1 0.6 0.7 5.6 5.5 0.8 20.9 0.7 1.0 2.6 CSTF2 CstF-64 ENSG00000101811 "Cleavage stimulation factor subunit 2" P33240 X 100820359-100841520 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000427, CAB004680" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "Nuclear bodies" "CAB004680: AB_425385, HPA000427: AB_1078580" "unprognostic (2.02e-2)" "unprognostic (8.70e-3)" "unprognostic (3.50e-1)" "unprognostic (3.43e-1)" "unprognostic (7.00e-2)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.23e-6)" "unprognostic (2.02e-1)" "unprognostic (4.82e-2)" "unprognostic (2.08e-3)" "unprognostic (5.98e-3)" "unprognostic (2.75e-1)" "prognostic favorable (1.12e-4)" "unprognostic (1.75e-2)" "unprognostic (2.90e-2)" "unprognostic (8.75e-2)" "unprognostic (2.89e-1)" 6.3 7.2 5.7 9.9 6.0 10.5 7.7 6.7 6.3 7.0 5.0 12.0 8.6 7.5 8.2 19.2 8.1 6.4 6.1 5.9 6.4 8.0 5.3 6.3 12.5 5.4 5.4 7.1 4.7 8.9 5.3 7.2 5.3 7.5 13.1 8.5 7.9 8.4 4.5 8.4 8.2 7.6 5.3 7.0 6.6 12.7 6.6 12.0 6.7 5.1 19.9 10.0 8.4 6.3 36.0 41.7 27.5 24.9 14.7 11.4 37.2 29.6 24.0 47.6 68.0 45.4 32.1 35.6 35.2 19.1 61.2 35.1 64.2 35.3 57.2 36.5 39.9 32.8 38.8 29.8 19.4 46.9 33.8 11.3 16.5 49.8 32.6 12.7 29.0 31.3 56.2 33.7 29.2 41.9 38.4 31.8 76.8 55.7 39.9 35.8 46.3 42.3 17.5 34.4 24.1 30.4 49.1 20.5 20.4 27.6 20.5 20.3 25.8 26.2 42.3 38.1 37.8 22.8 52.3 45.9 22.5 48.6 32.4 20.0 16.1 11.1 23.4 18.9 17.9 17.4 21.1 21.8 23.3 16.9 19.0 17.8 2.6 23.9 25.8 16.7 24.2 15.3 5.7 6.0 6.7 6.3 5.9 6.4 5.4 5.4 5.3 5.3 6.6 6.3 4.1 3.2 1.1 3.9 8.2 4.2 4.6 20.7 9.6 2.2 3.1 3.0 4.9 2.8 12.9 0.0 2.1 16.7 3.6 5.9 5.9 12.5 13.3 6.3 4.9 4.6 4.2 12.8 10.4 8.3 18.4 4.3 6.1 4.3 3.8 5.5 2.5 1.5 10.8 3.3 10.8 3.7 14.2 2.5 3.7 2.4 4.7 4.3 1.8 1.0 5.9 4.5 4.1 7.1 5.7 15.4 6.7 4.1 6.2 2.0 5.4 4.0 9.9 2.9 6.6 2.7 5.7 18.8 25.5 14.4 4.1 7.7 7.1 5.0 6.4 5.0 CTAG2 "CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803" ENSG00000126890 "Cancer/testis antigen 2" O75638 X 154651972-154653579 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 5.4;testis: 10.4" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 77.3" "Cancer enhanced" "Detected in many" "melanoma: 12.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 104.1;K-562: 140.6;OE19: 203.6;RPMI-8226: 311.3;SK-BR-3: 195.4;U-266/84: 356.9" "HPA071467, HPA076586" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA071467: AB_2686402, HPA076586: " "prognostic unfavorable (2.35e-4)" "unprognostic (3.87e-1)" "unprognostic (1.00e-1)" "unprognostic (1.25e-2)" 0.3 0.8 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.8 1.5 0.0 5.4 0.0 0.0 3.4 0.7 0.3 0.0 0.1 0.0 0.5 2.0 0.0 0.3 2.6 0.1 0.3 0.0 0.0 0.1 0.0 3.3 0.4 0.2 0.0 0.0 0.4 0.5 10.4 0.0 3.0 0.1 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 104.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 140.6 2.9 0.0 0.0 0.2 0.0 0.0 203.6 0.0 0.0 0.0 311.3 0.0 0.0 0.4 0.0 0.0 195.4 0.3 0.0 0.2 0.6 0.3 6.3 0.2 0.7 0.2 2.6 356.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.2 0.0 2.1 0.0 0.0 1.2 0.9 0.0 3.9 0.0 0.2 0.0 1.8 0.2 0.0 0.0 0.5 0.0 11.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.7 1.2 0.5 0.0 0.0 0.6 18.5 77.3 0.0 0.0 1.1 0.1 0.0 0.0 0.0 CTCFL "BORIS, CT27, dJ579F20.2" ENSG00000124092 "CCCTC-binding factor like" Q8NI51 20 57495966-57525652 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 11.0" "Group enriched" "Detected in some" 15 "Spermatocytes: 61.3;Spermatogonia: 143.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 4.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "HMC-1: 79.6;K-562: 116.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA001472 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 78: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA001472: AB_1078583" "unprognostic (2.50e-1)" "unprognostic (4.01e-2)" "unprognostic (7.70e-2)" "unprognostic (1.85e-5)" "unprognostic (9.58e-2)" "unprognostic (2.89e-1)" "unprognostic (6.44e-2)" "unprognostic (5.26e-3)" "unprognostic (3.60e-1)" "unprognostic (2.20e-1)" "unprognostic (9.00e-2)" "unprognostic (4.16e-2)" "unprognostic (4.75e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-1)" "unprognostic (4.84e-2)" 0.1 0.2 0.4 0.2 0.5 1.0 0.2 1.2 0.6 0.0 0.1 0.1 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.4 0.5 0.2 0.4 0.2 0.4 0.1 0.0 0.2 0.5 0.1 0.2 0.3 0.1 0.2 0.2 0.9 0.1 0.1 0.2 0.5 0.3 0.1 0.0 0.3 0.2 11.0 0.3 0.1 0.4 0.1 0.1 0.1 0.0 2.0 0.1 0.1 0.1 0.5 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.3 0.4 0.2 0.1 0.3 0.4 0.2 0.1 0.0 0.4 0.2 0.3 0.7 0.1 0.2 0.2 79.6 0.0 0.0 0.1 0.0 0.1 0.0 0.2 116.1 0.6 0.0 0.1 0.3 0.4 0.3 0.1 0.1 0.3 0.2 0.2 0.1 0.3 0.3 0.3 0.1 0.2 0.3 0.4 0.2 0.1 0.5 0.3 0.2 0.3 0.1 0.3 0.1 2.9 0.3 0.3 0.4 0.5 0.1 0.3 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.4 0.1 0.1 0.9 0.2 0.2 0.2 0.1 0.0 0.4 0.5 1.2 0.6 0.4 0.5 0.1 0.0 0.1 0.0 0.3 2.0 0.2 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 3.2 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.2 0.2 0.2 0.0 0.0 6.6 0.1 0.2 61.3 143.8 0.0 0.0 0.0 0.1 0.0 0.1 0.2 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 158.9;Late spermatids: 306.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favorable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 11.8 18.5 11.2 6.0 10.9 5.4 14.2 10.6 12.4 14.1 14.5 10.1 7.8 9.8 13.1 18.3 36.9 10.5 10.0 10.8 10.8 21.4 9.0 9.9 9.1 11.5 12.6 15.2 38.7 13.9 14.4 9.6 10.9 10.2 7.9 6.5 11.6 9.5 11.0 18.8 9.6 6.9 12.0 10.8 14.7 51.0 11.2 9.4 19.2 6.9 12.3 10.7 11.5 10.8 12.0 16.6 10.2 20.0 28.5 37.8 12.4 9.9 27.5 16.5 15.8 11.7 14.9 4.9 13.7 27.3 14.3 7.8 13.4 26.1 11.5 7.0 9.1 5.3 13.9 22.0 18.7 15.0 10.5 25.7 26.6 20.9 46.1 42.0 26.0 11.2 4.3 12.0 16.4 20.8 6.6 10.1 16.8 25.3 15.5 3.5 1.5 35.7 44.4 19.0 6.5 21.1 10.9 30.1 23.7 16.8 21.3 16.2 15.9 6.4 9.7 22.6 9.2 37.8 21.9 3.0 24.2 8.3 12.9 12.0 11.1 5.5 13.9 13.7 25.0 23.9 22.4 17.1 11.7 21.1 18.7 12.5 10.9 22.6 12.8 8.1 29.5 12.8 11.2 10.9 10.6 12.4 10.8 10.8 11.5 12.6 10.9 12.0 11.2 10.8 26.8 16.0 12.2 8.5 27.3 25.6 21.6 28.5 22.8 30.2 35.5 40.5 1.2 27.1 20.8 27.6 18.8 28.2 30.0 25.0 37.2 40.7 158.9 61.2 21.5 16.3 19.1 11.1 10.7 39.4 40.0 19.8 28.5 24.6 24.7 32.4 15.0 5.9 19.2 40.4 9.5 22.3 20.3 12.9 24.5 306.6 24.2 16.8 21.4 2.8 23.5 25.8 13.4 6.6 5.5 21.5 21.3 18.4 18.2 10.0 50.4 49.9 75.3 58.4 46.0 19.1 19.0 110.7 33.4 26.5 34.1 18.3 27.1 29.7 30.0 17.3 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 196.9;esophagus: 242.0;skin 1: 301.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 212.9;Muller glia cells: 913.0;Squamous epithelial cells: 736.5" "Cancer enhanced" "Detected in all" "ovarian cancer: 62.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.0;hTCEpi: 23.2;SCLC-21H: 5.9;U-87 MG: 8.4" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 1.9 56.0 1.6 0.1 1.8 0.8 28.7 1.6 6.6 47.6 1.2 2.9 0.5 0.6 196.9 242.0 80.5 0.6 0.5 1.3 9.3 3.6 0.2 1.6 0.6 1.5 5.3 1.0 22.8 0.0 24.4 0.1 2.4 9.2 0.7 115.6 30.2 1.1 1.0 301.0 1.0 0.5 1.3 0.3 1.5 1.5 4.3 4.8 34.3 0.0 25.0 8.6 108.1 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.1 0.2 23.2 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.4 5.9 0.0 0.0 0.0 0.6 0.0 0.7 1.2 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 8.4 0.0 0.0 1.2 0.8 0.5 0.1 0.6 0.2 0.4 0.2 0.1 0.3 0.4 0.1 0.1 0.5 0.7 0.1 1.2 0.4 0.1 1.6 1.8 1.6 6.6 1.3 9.3 1.5 5.3 2.4 1.3 4.3 1.2 0.6 0.0 0.0 0.0 4.1 106.9 51.8 74.8 212.9 7.2 15.0 19.6 0.1 2.8 29.8 9.2 6.2 6.0 4.9 2.0 3.9 7.6 13.8 5.6 2.2 2.0 3.0 0.0 0.2 6.0 12.8 2.4 0.0 5.4 4.5 148.1 0.7 14.3 14.7 3.3 0.4 2.0 14.2 9.1 9.3 56.1 4.1 5.0 12.4 0.0 5.4 913.0 2.1 1.0 0.1 5.8 7.1 2.2 3.4 11.8 5.9 13.3 4.8 23.8 0.0 1.9 10.9 10.8 4.2 736.5 126.6 4.5 3.1 1.7 2.3 67.4 DAW1 "FLJ25955, ODA16, WDR69" ENSG00000123977 "Dynein assembly factor with WD repeats 1" Q8N136 2 227871054-227924344 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "choroid plexus: 25.7;fallopian tube: 32.6;testis: 51.3" "Group enriched" "Detected in some" 13 "Early spermatids: 106.7;Late spermatids: 215.3;Respiratory ciliated cells: 113.9;Spermatocytes: 177.1" "Cancer enhanced" "Detected in some" "lung cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.8;HUVEC TERT2: 21.8;U-2197: 40.7" "Low region specificity" "Detected in many" HPA046118 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nuclear bodies, Plasma membrane" "HPA046118: AB_10961428" "unprognostic (1.23e-1)" "unprognostic (1.42e-1)" "unprognostic (1.95e-1)" "unprognostic (1.66e-1)" "unprognostic (4.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.63e-3)" "unprognostic (2.90e-2)" "unprognostic (9.92e-3)" "unprognostic (1.54e-5)" "unprognostic (1.52e-1)" "unprognostic (6.83e-3)" "unprognostic (1.70e-1)" "unprognostic (3.08e-1)" 0.6 0.0 4.3 0.1 5.3 0.3 0.4 2.9 4.7 0.7 25.7 0.2 0.0 0.1 0.3 0.5 32.6 0.3 0.5 4.5 4.5 0.2 0.4 3.0 0.2 7.3 8.8 0.1 0.0 0.2 0.2 0.8 5.5 0.0 0.0 0.7 0.1 0.0 3.6 0.2 0.0 0.1 6.8 0.2 0.1 51.3 5.4 0.4 0.1 0.0 0.2 0.1 0.0 5.4 0.8 0.0 0.1 0.0 0.3 1.2 0.6 0.8 0.4 0.9 0.6 5.4 0.5 0.2 0.0 0.2 8.8 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.7 0.0 1.0 0.7 5.8 21.8 0.0 0.0 0.3 0.4 0.0 0.0 0.5 0.5 0.0 0.2 0.0 0.1 0.3 0.1 0.2 0.4 0.1 0.8 0.0 0.0 0.2 0.0 0.5 2.2 0.2 2.0 40.7 0.0 0.0 0.1 0.3 3.9 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.3 2.9 4.7 4.5 4.5 7.3 8.8 5.5 6.8 5.4 5.4 0.0 0.0 1.1 0.3 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.7 0.0 11.5 0.0 4.2 0.2 0.0 0.0 0.0 0.2 106.7 11.2 0.0 0.2 0.0 0.0 6.2 0.0 2.8 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 8.2 0.0 0.0 215.3 3.4 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.1 3.0 0.2 2.6 0.0 0.1 0.0 0.1 113.9 0.3 0.0 0.7 2.1 177.1 4.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 DAXX DAP6 ENSG00000204209 "Death domain associated protein" Q9UER7 6 33318558-33323016 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation" "Chaperone, Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002224, HPA008736, HPA008797, CAB025546, HPA065779" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear bodies" "CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558" "prognostic favorable (6.05e-4)" "unprognostic (2.90e-1)" "unprognostic (9.66e-2)" "unprognostic (4.04e-2)" "unprognostic (8.55e-2)" "unprognostic (1.36e-1)" "unprognostic (1.46e-3)" "unprognostic (3.48e-1)" "unprognostic (1.92e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (6.32e-7)" "unprognostic (2.43e-1)" "unprognostic (5.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 27.5 33.6 6.4 4.0 6.2 8.1 25.3 5.0 12.0 28.4 2.9 27.9 8.1 27.8 18.9 30.8 28.6 7.2 22.3 6.8 5.8 23.2 25.0 24.0 8.7 6.9 5.9 23.8 23.1 19.3 22.1 7.9 5.5 25.1 10.8 5.2 24.2 9.3 35.4 28.8 30.4 10.6 4.8 44.3 25.0 36.7 6.7 23.5 24.2 12.5 27.3 27.2 25.9 9.0 20.8 0.1 38.0 15.6 16.0 16.0 30.1 27.4 76.7 61.5 43.6 1.6 11.8 58.5 14.8 33.3 65.5 11.8 0.3 46.1 62.5 29.9 39.6 52.0 29.9 39.9 26.5 37.0 17.0 27.0 32.5 25.8 31.0 22.7 15.5 16.2 39.1 21.2 32.1 23.2 29.7 54.1 1.2 0.2 9.1 35.2 5.6 41.8 11.7 1.6 49.7 20.2 0.0 0.9 22.7 14.8 17.5 0.5 22.9 26.3 29.1 0.5 0.3 35.4 58.3 66.4 23.3 23.0 27.7 24.1 22.5 47.3 55.6 28.9 54.9 58.8 48.3 61.3 28.2 56.8 44.5 49.6 22.9 62.9 35.1 27.0 59.0 70.5 6.4 6.2 5.0 12.0 6.8 5.8 6.9 5.9 5.5 4.8 6.7 9.0 18.4 6.4 22.8 5.2 45.3 58.5 23.5 36.2 48.3 19.2 25.8 19.4 7.9 18.6 27.6 12.9 18.8 25.2 41.3 23.3 23.5 38.5 15.7 14.5 54.8 23.9 21.0 27.1 3.7 38.3 35.9 25.2 16.8 23.6 37.9 12.9 16.4 14.5 24.3 15.2 3.8 21.2 12.2 17.2 42.5 7.6 17.7 19.7 24.9 6.5 48.8 29.9 52.5 5.0 4.6 45.4 21.8 23.3 38.7 31.8 20.3 14.4 15.6 111.1 13.1 18.7 19.9 63.8 41.5 45.9 60.9 24.8 42.8 24.1 22.0 35.7 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909553 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 15.1" "Group enriched" "Detected in all" 4 "Early spermatids: 468.6;Spermatocytes: 569.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042923 Supported "Nucleoplasm,Nuclear bodies" Yes Yes "Cluster 10: Basophils - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA042923: AB_2678222" "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavorable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 0.1 0.2 0.2 0.2 0.4 0.6 0.2 0.7 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.1 0.2 0.1 0.2 0.2 0.1 0.5 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.3 0.2 15.1 0.2 0.6 0.3 0.0 0.5 0.1 0.1 0.3 0.9 0.8 2.0 2.5 0.4 0.4 0.5 1.0 0.2 1.0 2.1 1.4 0.6 2.1 0.6 0.6 1.7 0.9 2.2 0.5 1.0 1.6 1.3 1.3 1.0 0.4 0.1 1.7 1.0 0.4 0.6 1.2 1.0 0.3 0.9 1.9 1.2 4.2 1.4 1.7 2.8 2.0 2.0 2.1 1.9 0.7 3.1 2.5 0.8 0.1 3.0 1.8 1.2 2.2 1.0 1.6 0.9 1.6 0.1 1.2 1.4 3.1 2.0 2.3 5.2 2.1 0.8 3.1 2.5 1.0 0.1 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.4 0.1 0.2 0.4 0.7 0.4 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.3 13.3 3.2 12.6 5.5 38.4 15.6 16.4 10.7 12.0 6.6 13.0 16.8 3.7 2.8 7.7 9.2 12.5 19.6 59.2 9.7 3.9 8.3 468.6 12.1 23.6 11.1 14.9 40.8 14.7 14.7 36.4 12.4 14.3 17.7 31.0 19.4 6.4 6.5 16.1 3.3 9.1 20.6 16.2 9.1 15.5 116.0 15.5 20.8 12.4 2.8 11.0 2.1 24.7 6.0 6.7 14.1 8.5 9.4 48.9 18.4 4.2 5.8 10.2 16.6 13.1 9.7 11.4 569.4 74.6 20.5 12.6 9.6 44.4 13.5 22.3 11.7 DCANP1 "C5orf20, DCNP1" ENSG00000251380 "Dendritic cell associated nuclear protein" Q8TF63 5 135444214-135447348 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "Microglial cells: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "THP-1: 1.8" HPA048308 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Nucleoplasm "Nuclear bodies" "HPA048308: AB_2680349" 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DCLRE1B "APOLLO, FLJ12810, FLJ13998, SNM1B" ENSG00000118655 "DNA cross-link repair 1B" Q9H816 1 113905213-113914086 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.6;Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064934 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Nuclear bodies" "HPA064934: AB_2685387" "unprognostic (1.21e-1)" "unprognostic (3.38e-2)" "unprognostic (4.47e-3)" "unprognostic (4.92e-3)" "unprognostic (1.89e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.31e-2)" "unprognostic (9.67e-3)" "unprognostic (2.73e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.03e-7)" "unprognostic (1.24e-2)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (5.08e-2)" 3.5 1.2 2.5 3.7 2.7 6.0 2.9 4.5 2.8 2.5 2.1 2.8 1.7 2.4 1.6 3.0 2.7 2.2 1.3 2.4 2.7 1.6 1.7 3.2 4.1 2.5 2.7 3.0 0.9 1.1 0.7 3.5 2.5 1.7 3.0 1.2 1.2 1.9 0.8 2.6 1.9 3.3 2.5 4.0 1.6 2.4 2.8 4.8 2.0 1.0 3.9 2.2 1.6 3.3 14.1 5.5 9.9 10.5 7.9 5.4 5.7 11.1 7.4 14.2 15.3 6.0 3.9 14.3 6.8 7.8 6.4 6.4 13.7 11.2 19.6 12.0 10.1 12.4 7.8 5.9 1.5 14.1 12.1 6.2 4.4 18.5 10.6 3.9 7.9 16.5 17.5 11.8 16.7 57.8 21.7 11.5 7.7 5.5 12.6 17.2 30.4 6.5 5.6 6.1 8.7 8.0 12.0 9.2 7.7 7.8 6.1 14.9 4.8 18.6 19.6 31.3 15.8 5.2 5.6 16.0 15.7 13.8 32.9 1.9 4.5 1.3 2.3 3.7 2.5 0.9 2.6 2.2 2.6 1.4 1.7 2.2 0.2 5.8 2.1 1.0 1.8 2.5 2.5 2.7 4.5 2.8 2.4 2.7 2.5 2.7 2.5 2.5 2.8 3.3 3.0 3.2 2.0 0.3 2.8 3.6 1.2 1.7 8.0 3.0 2.6 2.0 1.2 1.5 0.8 0.0 2.1 4.6 4.0 1.0 1.9 4.4 1.3 4.1 2.3 3.4 3.0 23.6 0.8 2.7 9.8 3.4 0.5 2.4 1.3 5.6 2.2 1.6 9.7 1.7 0.9 3.1 2.0 8.5 12.8 0.6 1.8 10.5 0.0 1.0 13.5 0.9 2.1 0.0 1.1 3.7 0.5 2.2 5.0 1.5 0.3 1.7 3.1 1.4 26.3 2.1 5.5 7.9 11.4 6.2 2.7 1.4 4.4 3.0 4.2 1.0 DDX20 "DP103, GEMIN3" ENSG00000064703 "DEAD-box helicase 20" Q9UHI6 1 111754832-111775602 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 52.8" "Group enriched" "Detected in all" 5 "Early spermatids: 738.2;Late spermatids: 718.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005516, CAB015427" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" Cytosol "CAB015427: AB_629518, HPA005516: AB_1849612" "unprognostic (3.71e-2)" "unprognostic (5.25e-2)" "prognostic favorable (9.85e-5)" "unprognostic (8.73e-2)" "unprognostic (2.51e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (6.35e-6)" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (7.46e-3)" "unprognostic (4.21e-1)" "unprognostic (5.22e-2)" "unprognostic (1.05e-3)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" "unprognostic (4.23e-1)" "unprognostic (1.30e-2)" 4.6 3.6 0.8 1.3 0.7 2.3 4.3 0.4 0.9 4.2 0.3 3.9 0.5 4.8 0.9 3.3 4.5 1.6 3.6 0.8 0.7 3.0 2.6 3.2 3.0 0.7 0.8 4.3 3.6 2.5 1.9 2.4 0.5 3.0 1.9 0.8 3.3 2.5 8.8 3.6 4.3 2.8 0.5 4.8 3.8 52.8 0.6 3.7 3.2 1.8 4.2 4.0 3.3 1.3 7.0 3.8 7.1 7.3 4.7 5.0 7.0 3.3 9.1 16.3 18.6 5.8 4.5 17.7 5.2 6.4 3.9 5.8 13.5 9.4 18.2 7.3 9.2 7.4 3.2 3.0 4.6 8.4 6.1 3.0 10.4 9.2 12.2 2.4 12.8 7.2 10.8 5.9 12.0 6.5 11.8 0.9 14.1 5.2 8.5 11.3 12.7 5.3 4.8 5.2 11.7 9.5 6.7 7.0 12.7 5.7 7.0 8.5 3.5 7.9 8.2 13.2 8.6 1.2 5.3 12.3 7.5 8.1 18.5 14.9 6.2 6.0 8.2 5.6 10.7 9.3 9.1 8.4 6.8 9.1 10.6 8.6 3.4 9.1 6.6 3.5 10.0 6.9 0.8 0.7 0.4 0.9 0.8 0.7 0.7 0.8 0.5 0.5 0.6 1.3 8.5 12.8 9.4 6.8 13.0 10.8 9.7 6.0 9.6 14.3 6.5 6.6 7.7 5.7 10.0 5.5 2.1 10.2 9.4 2.9 3.9 9.5 738.2 8.1 12.0 9.3 4.2 5.9 7.4 6.9 7.5 6.9 5.1 5.4 7.6 12.3 5.7 5.9 9.3 6.7 7.7 5.8 8.2 7.2 7.0 718.9 16.4 7.3 1.8 3.7 7.5 6.9 6.2 3.0 3.6 6.3 2.3 13.2 9.0 5.2 3.0 7.6 11.8 10.4 6.6 9.7 11.7 121.7 26.3 7.0 7.2 5.1 11.1 14.0 6.6 5.5 DEPTOR "DEP.6, DEPDC6, FLJ12428" ENSG00000155792 "DEP domain containing MTOR interacting protein" Q8TB45 8 119873717-120050918 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 158.2;tongue: 122.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 86.1;Glandular and luminal cells: 66.1;Oligodendrocytes: 123.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "myeloid DC: 20.3" "Lineage enriched" "Detected in many" 11 "dendritic cells: 20.3" "Cell line enhanced" "Detected in many" "Daudi: 105.1;RPMI-8226: 193.2;RPTEC TERT1: 149.3;U-698: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020841, HPA023938, HPA023945, HPA024011" Enhanced Approved "Nucleoplasm,Nuclear bodies,Mitochondria" No No "Cluster 28: Myeloid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 44: Endometrium - Transcription" Mitochondria "Nucleoplasm, Nuclear bodies" "CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608" "unprognostic (3.41e-1)" "unprognostic (1.95e-1)" "unprognostic (1.53e-2)" "unprognostic (1.15e-2)" "unprognostic (3.19e-1)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-1)" "unprognostic (2.49e-2)" "unprognostic (3.24e-2)" "unprognostic (6.02e-2)" "unprognostic (7.29e-2)" "unprognostic (5.66e-2)" "unprognostic (1.02e-1)" "unprognostic (4.16e-2)" "unprognostic (2.84e-2)" 14.4 52.8 12.0 3.0 16.7 2.0 20.7 12.6 11.9 39.2 3.8 23.3 16.9 16.5 11.1 15.2 27.1 10.8 5.1 9.7 23.2 40.0 16.3 5.3 10.1 15.8 12.5 24.7 11.9 16.9 11.4 4.9 15.3 12.1 9.9 2.0 106.3 15.6 158.2 6.6 14.5 15.5 14.8 9.5 40.0 2.9 16.3 5.1 98.0 122.3 2.9 5.6 7.0 24.2 0.1 3.5 0.3 1.1 21.0 6.2 0.3 0.1 0.3 0.6 0.5 2.4 0.4 105.1 2.3 1.2 0.3 0.3 5.4 0.2 0.4 2.3 2.7 14.2 0.9 0.6 12.8 3.0 23.7 5.5 9.5 0.8 0.6 0.1 0.0 1.8 0.1 16.9 0.3 7.1 0.1 2.5 1.3 45.5 3.7 0.4 4.9 193.2 149.3 4.1 3.2 0.7 1.7 11.0 3.2 2.8 9.6 0.5 0.0 0.4 0.9 21.4 0.5 45.4 11.4 55.2 6.5 3.9 0.6 0.0 0.9 0.0 0.2 1.7 0.8 0.1 0.4 0.7 20.3 0.1 0.8 0.6 0.3 0.4 0.2 1.0 0.4 1.0 12.0 16.7 12.6 11.9 9.7 23.2 15.8 12.5 15.3 14.8 16.3 24.2 23.1 6.4 9.3 4.9 2.9 5.2 15.4 3.8 27.3 2.1 16.5 10.4 2.4 15.7 8.4 25.8 0.0 0.6 0.8 2.7 86.1 5.7 2.2 19.0 9.7 7.5 16.7 12.4 14.5 11.8 4.1 10.0 29.6 66.1 12.0 5.4 2.5 12.7 3.3 0.0 31.0 7.7 0.0 16.0 39.5 2.2 11.8 14.9 14.2 46.9 1.5 1.2 2.1 9.5 123.9 1.1 36.5 3.4 6.4 7.1 21.0 33.6 1.1 0.7 0.0 8.1 5.7 3.6 3.8 16.5 5.5 0.4 1.3 6.0 16.5 21.9 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8 microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.3;Rod photoreceptor cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 5.2 4.4 5.3 6.1 5.2 7.7 4.8 9.4 5.6 6.8 5.0 7.0 5.0 8.5 3.6 7.1 6.9 4.7 5.2 5.3 4.6 4.7 4.5 5.3 6.3 5.1 5.1 8.4 6.2 6.4 5.2 11.6 5.6 5.5 5.0 6.5 7.2 5.6 14.8 7.5 6.7 6.0 4.7 5.9 6.1 15.2 5.3 9.5 6.0 9.3 5.9 6.8 5.7 6.2 22.7 15.7 20.1 11.9 7.7 12.4 25.5 21.3 12.6 14.1 9.9 17.0 11.3 20.1 11.6 20.0 9.4 21.4 18.4 17.8 12.2 19.7 27.4 21.7 17.4 14.0 20.3 40.7 17.5 10.0 21.6 14.8 10.7 12.9 12.6 12.1 78.7 14.1 16.5 14.6 24.7 12.1 19.4 16.5 11.8 29.0 21.2 6.8 8.5 20.9 22.3 14.3 19.4 11.3 13.0 12.0 10.9 17.2 18.8 20.5 17.1 13.0 21.9 7.8 11.5 19.9 15.3 18.2 20.3 0.0 1.1 0.6 2.0 0.9 1.5 0.7 0.9 2.1 1.3 0.6 0.9 1.2 0.2 1.6 3.6 1.5 1.2 1.5 5.3 5.2 9.4 5.6 5.3 4.6 5.1 5.1 5.6 4.7 5.3 6.2 8.1 6.4 7.9 11.8 6.0 9.6 5.2 6.8 10.2 37.1 9.1 8.0 4.2 11.5 7.3 5.5 39.6 13.6 6.9 9.6 0.0 6.1 61.3 5.5 8.3 10.2 7.3 10.3 12.4 10.2 11.2 7.3 12.8 7.3 3.8 19.2 9.7 14.4 5.3 43.7 12.7 10.3 4.1 8.4 6.5 39.2 18.3 5.0 5.4 6.5 7.2 10.9 11.3 9.5 14.0 10.9 5.8 10.5 9.3 8.6 6.2 3.4 8.1 60.7 6.6 9.7 8.1 25.2 17.5 10.4 9.2 13.5 9.3 15.1 9.7 5.6 DHX35 "C20orf15, DDX35, FLJ22759, KAIA0875" ENSG00000101452 "DEAH-box helicase 35" Q9H5Z1 20 38962299-39039723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054451, HPA062700" Uncertain Approved "Nucleoplasm,Nuclear bodies,Centrosome" No No "Cluster 39: Non-specific - mRNA processing" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 39: CACO-2 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" "Nucleoplasm, Centrosome" "HPA054451: AB_2682491, HPA062700: AB_2684838" "unprognostic (8.31e-2)" "unprognostic (2.34e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.29e-2)" "unprognostic (8.38e-2)" "prognostic unfavorable (5.63e-6)" "unprognostic (9.83e-2)" "unprognostic (2.21e-1)" "unprognostic (6.22e-2)" "unprognostic (4.47e-2)" "unprognostic (5.67e-2)" "unprognostic (8.57e-2)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (3.31e-1)" 6.6 4.2 4.2 4.5 4.9 9.8 6.0 4.4 5.2 10.1 3.1 16.7 6.2 11.2 8.0 8.1 8.5 5.6 10.2 4.5 3.9 6.0 4.8 5.3 6.7 4.1 4.3 7.9 3.7 7.0 3.8 5.2 4.1 8.1 8.6 6.0 5.1 7.2 8.2 6.9 7.9 8.1 3.8 4.8 8.0 6.6 4.2 6.4 5.1 6.3 5.4 11.9 7.0 5.1 10.3 8.4 15.9 6.6 6.0 7.8 11.3 6.0 10.3 13.5 9.9 29.1 9.0 11.4 10.4 11.4 10.4 16.0 11.0 17.5 13.2 2.9 5.2 15.4 14.3 16.7 7.2 18.4 7.7 9.0 11.3 11.7 10.9 8.3 6.1 19.4 16.0 6.5 7.2 8.2 30.0 14.0 9.1 18.5 13.5 14.5 23.2 9.5 5.0 11.8 13.9 11.1 16.4 9.6 15.4 9.9 13.3 14.7 6.0 19.1 10.6 7.8 12.6 6.5 9.2 12.3 10.9 8.2 10.4 0.0 3.0 1.2 2.9 2.7 2.9 2.5 2.4 3.1 4.0 2.9 4.5 2.4 0.6 3.9 2.4 1.4 1.7 2.9 4.2 4.9 4.4 5.2 4.5 3.9 4.1 4.3 4.1 3.8 4.2 5.1 5.4 0.0 3.7 16.0 3.8 0.5 1.4 2.2 7.4 5.1 2.3 3.0 6.7 4.3 4.8 1.8 4.2 3.7 4.1 4.2 1.9 2.4 3.7 2.5 6.6 3.8 5.4 5.5 23.5 1.1 2.4 3.8 7.7 3.2 8.2 6.1 5.7 7.0 5.0 5.0 21.5 6.3 4.1 4.7 4.0 0.8 6.2 3.3 3.6 14.0 3.6 3.3 6.2 22.6 24.8 2.0 5.8 6.4 4.9 2.7 4.6 2.2 4.3 4.7 0.0 4.7 3.9 1.9 9.4 4.5 2.0 3.0 4.5 4.9 5.4 1.1 DHX8 "DDX8, Dhr2, HRH1, PRP22, PRPF22" ENSG00000067596 "DEAH-box helicase 8" Q14562 17 43483865-43610338 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049285 Approved Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA049285: AB_2680698" "unprognostic (2.99e-1)" "unprognostic (4.42e-2)" "unprognostic (5.64e-2)" "unprognostic (9.02e-2)" "unprognostic (1.25e-1)" "unprognostic (3.09e-1)" "unprognostic (1.28e-3)" "unprognostic (9.43e-2)" "unprognostic (2.58e-1)" "unprognostic (3.40e-2)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (4.04e-1)" "unprognostic (5.08e-3)" "unprognostic (2.60e-1)" "unprognostic (6.28e-2)" 20.4 18.5 25.9 18.0 25.8 55.0 20.5 24.7 36.7 22.4 22.8 21.4 17.3 19.9 26.1 26.9 16.7 16.4 21.8 25.4 24.8 20.3 18.6 20.0 23.7 25.6 25.2 17.0 17.0 27.5 20.8 20.9 25.5 21.6 23.9 16.8 20.8 20.4 22.6 33.7 20.6 23.6 23.4 25.8 19.5 24.3 25.8 35.1 19.0 19.4 29.6 23.0 21.7 25.5 29.2 81.7 43.3 52.4 42.3 42.5 24.0 30.2 62.0 64.9 61.7 37.4 28.1 40.3 27.0 59.4 46.6 38.0 65.9 53.1 74.8 40.8 51.9 33.8 61.2 56.7 35.8 59.8 49.5 21.1 44.1 53.0 58.4 31.4 57.4 52.1 38.8 35.2 51.2 32.0 75.9 52.7 35.5 35.4 31.0 46.2 82.4 40.2 44.3 60.6 37.3 56.0 33.9 18.6 27.3 50.9 44.1 58.3 40.0 50.3 26.9 36.3 45.8 27.5 36.6 44.7 41.2 36.8 41.2 30.2 17.4 20.4 16.0 25.2 14.7 12.2 12.7 15.5 17.0 11.0 10.6 11.5 21.8 11.0 26.1 10.3 12.8 11.4 25.9 25.8 24.7 36.7 25.4 24.8 25.6 25.2 25.5 23.4 25.8 25.5 17.1 6.4 15.0 6.5 18.6 11.9 7.1 12.4 12.0 16.9 16.3 13.0 13.2 7.2 19.2 22.0 18.8 9.1 23.6 13.4 13.7 16.2 19.4 18.3 26.2 17.6 26.7 13.7 10.7 17.7 8.8 14.5 14.8 23.9 14.5 15.3 16.1 14.7 11.1 6.7 10.5 15.3 10.2 14.8 11.5 10.6 12.5 18.4 17.8 14.0 24.8 10.6 21.6 9.5 15.8 21.2 16.0 10.9 20.0 9.4 10.1 12.4 13.7 19.8 19.7 20.3 14.4 27.9 16.8 17.2 13.4 21.2 20.9 11.1 10.8 14.3 DIPK1B "C9orf136, FAM69B, MGC20262" ENSG00000165716 "Divergent protein kinase domain 1B" Q5VUD6 9 136712572-136724742 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 15 "Adipocytes: 23.1;Cardiomyocytes: 7.3;Endothelial cells: 6.9;Extravillous trophoblasts: 6.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.8" "Group enriched" "Detected in many" 9 "B-cells: 2.8;dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "EFO-21: 56.4;HEK 293: 58.2;HUVEC TERT2: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054443 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA054443: AB_2682489" "unprognostic (2.78e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (1.77e-5)" "unprognostic (3.82e-1)" "unprognostic (1.37e-1)" "unprognostic (5.59e-2)" "unprognostic (1.71e-1)" "unprognostic (6.74e-2)" "unprognostic (6.80e-2)" "unprognostic (2.10e-2)" "prognostic favorable (9.48e-5)" "unprognostic (2.77e-1)" "unprognostic (6.67e-3)" "unprognostic (4.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.84e-1)" "unprognostic (2.78e-1)" 17.4 4.8 21.7 3.7 20.3 9.1 14.0 25.7 26.8 14.9 18.7 12.3 5.4 16.8 2.1 4.9 16.7 5.5 35.9 20.1 20.0 17.8 11.4 16.4 5.8 23.5 21.1 11.5 14.3 12.8 25.1 18.7 24.2 13.6 0.8 5.9 9.8 3.1 8.9 11.5 7.7 3.0 17.3 8.6 6.8 15.0 24.2 1.7 16.8 3.8 1.3 8.0 7.7 19.4 3.2 11.3 25.3 21.0 0.0 0.0 19.5 2.9 0.0 0.8 0.9 27.7 6.6 9.2 56.4 0.0 7.9 13.5 11.7 0.3 0.2 8.1 58.2 13.5 4.7 5.9 0.2 7.0 9.0 0.2 0.0 0.3 0.1 10.1 65.2 19.7 14.8 4.2 0.0 14.8 10.8 28.3 36.9 12.6 9.7 49.9 1.9 26.2 1.4 3.7 38.5 38.3 1.8 8.2 27.4 8.7 18.3 21.9 33.3 5.6 18.7 5.3 6.8 12.9 3.3 8.9 3.2 6.7 10.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.0 2.8 0.2 0.1 0.0 0.0 0.0 1.0 0.1 0.3 21.7 20.3 25.7 26.8 20.1 20.0 23.5 21.1 24.2 17.3 24.2 19.4 23.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 6.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 DISP1 "DISPA, DKFZP434I0428, MGC13130, MGC16796" ENSG00000154309 "Dispatched RND transporter family member 1" Q96F81 1 222815022-223005995 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 47.7;Gastric mucus-secreting cells: 48.4;Inhibitory neurons: 54.4;Microglial cells: 204.2;Oligodendrocyte precursor cells: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RH-30: 15.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051411 Uncertain Approved "Nuclear bodies" No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 68: Oligodendrocytes - Mixed function" "Nuclear bodies" "HPA051411: AB_2681475" "unprognostic (2.10e-2)" "unprognostic (3.31e-1)" "unprognostic (7.00e-2)" "unprognostic (7.81e-2)" "unprognostic (7.82e-2)" "unprognostic (2.88e-1)" "unprognostic (2.71e-1)" "unprognostic (1.27e-1)" "unprognostic (2.28e-1)" "unprognostic (3.28e-1)" "prognostic favorable (5.00e-4)" "unprognostic (4.13e-1)" "prognostic favorable (3.86e-5)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "prognostic favorable (4.16e-4)" "unprognostic (9.69e-3)" 6.8 5.7 1.7 1.5 2.0 0.2 3.0 4.0 2.5 3.2 3.7 9.0 2.6 4.3 2.0 1.9 2.4 4.6 3.9 1.6 1.9 5.2 2.7 9.2 1.1 1.2 0.9 4.5 2.4 5.1 2.5 4.6 1.1 2.4 2.1 1.3 1.9 2.0 4.1 3.3 3.7 4.2 0.7 2.5 5.3 6.5 1.5 1.4 5.2 3.1 1.4 5.4 2.5 2.6 0.9 2.2 5.6 3.8 10.1 6.1 2.4 3.2 2.7 1.1 1.1 2.6 1.6 0.1 4.2 1.5 2.2 0.6 1.6 1.3 1.6 8.1 2.4 1.1 6.3 1.2 4.4 0.2 1.1 4.8 1.9 2.3 0.9 5.8 2.3 1.2 0.0 0.1 3.9 1.5 1.4 0.3 4.0 6.1 1.3 1.7 15.1 0.2 6.8 0.8 1.6 2.5 1.8 0.7 2.3 2.7 2.7 1.4 4.2 2.3 1.5 3.9 3.6 1.2 0.5 0.3 3.2 0.8 5.1 0.3 0.2 0.0 0.7 0.4 1.6 0.5 0.6 0.7 0.6 0.9 0.6 0.5 0.1 1.0 0.2 0.3 0.5 0.4 1.7 2.0 4.0 2.5 1.6 1.9 1.2 0.9 1.1 0.7 1.5 2.6 4.6 6.4 1.7 42.7 3.6 0.5 0.6 1.2 5.7 2.7 3.4 1.5 7.8 7.2 3.3 11.0 0.0 1.4 2.1 1.0 0.0 1.9 2.1 1.9 3.4 4.9 0.0 0.0 47.7 2.8 1.8 5.6 48.4 4.1 0.0 15.8 6.8 3.3 5.9 0.0 54.4 2.6 4.1 1.6 0.9 3.7 1.5 4.1 0.0 204.2 1.4 0.9 5.2 199.6 15.4 1.3 3.1 3.4 0.7 0.7 6.4 5.8 2.7 2.3 0.0 4.0 3.7 2.1 2.3 5.4 1.1 0.8 1.7 2.8 1.6 0.3 DKK3 "REIC, RIG" ENSG00000050165 "Dickkopf WNT signaling pathway inhibitor 3" Q9UBP4 11 11956207-12009769 "Plasma proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 1224.0" "Group enriched" "Detected in many" 7 "Cardiomyocytes: 884.3;Muller glia cells: 1960.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "MAIT T-cell: 6.2;memory CD8 T-cell: 3.8" "Lineage enriched" "Detected in single" 62 "T-cells: 6.2" "Cell line enhanced" "Detected in many" "BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011868, CAB024949" Approved Supported "Nuclear bodies,Vesicles,Cytosol" "Secreted in other tissues" No No 18000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 5: Muller glia cells - Visual perception" Vesicles "Nuclear bodies, Cytosol" "CAB024949: , HPA011868: AB_1847716" "unprognostic (4.24e-2)" "unprognostic (6.40e-2)" "unprognostic (1.96e-1)" "unprognostic (7.84e-2)" "unprognostic (3.06e-3)" "unprognostic (6.58e-3)" "unprognostic (1.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.31e-3)" "unprognostic (5.28e-2)" "unprognostic (4.51e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (7.41e-3)" "unprognostic (1.09e-1)" "unprognostic (2.97e-2)" "unprognostic (1.02e-3)" 31.2 79.1 110.7 10.0 183.6 0.2 26.0 12.6 135.2 89.7 104.8 53.2 14.6 47.0 16.7 29.7 23.0 67.0 1224.0 147.7 80.2 17.0 5.6 123.7 8.5 95.1 54.3 38.1 18.2 34.2 38.2 25.0 46.8 59.4 13.0 204.1 30.9 78.1 7.8 29.7 24.6 43.1 83.9 33.2 31.7 30.9 99.9 4.7 16.4 18.8 5.4 40.9 48.3 121.6 1.5 13.1 18.1 0.1 15.3 29.7 0.6 418.9 643.0 182.4 205.5 9.6 3.2 0.0 44.8 614.4 96.8 64.4 1.5 181.9 69.5 0.1 0.5 0.0 1.7 0.0 113.6 0.0 0.3 45.3 60.0 61.9 151.3 370.2 195.3 0.0 0.2 0.4 256.4 0.0 0.1 0.4 8.6 0.0 0.5 0.1 1.2 0.1 62.5 0.6 0.5 53.2 2.0 0.0 0.2 47.9 0.2 0.5 349.7 107.5 82.8 11.2 110.3 0.1 0.0 0.3 18.1 0.0 103.5 0.0 0.0 0.0 0.5 0.0 6.2 0.0 0.6 3.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 110.7 183.6 12.6 135.2 147.7 80.2 95.1 54.3 46.8 83.9 99.9 121.6 5.8 3.2 3.0 94.3 0.1 45.6 59.5 70.3 93.4 31.6 3.2 103.2 884.3 0.0 12.8 0.0 12.5 0.5 0.4 0.0 0.0 0.8 104.3 0.7 8.4 32.9 1.8 0.0 90.4 0.2 0.8 106.1 7.1 0.6 1.3 17.0 66.8 0.4 20.4 13.5 83.7 0.1 0.0 1.3 12.5 88.5 20.5 1.4 64.0 38.4 0.0 1960.4 0.0 27.6 14.7 1.1 0.1 57.6 1.7 32.8 0.0 0.2 2.9 67.5 190.7 12.7 83.4 1.2 3.2 5.8 14.8 0.8 4.1 0.5 0.3 3.0 DLX6 ENSG00000006377 "Distal-less homeobox 6" P56179 7 97005553-97011040 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.3;testis: 5.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 32.9;Early spermatids: 22.6;Endometrial ciliated cells: 37.3;Extravillous trophoblasts: 70.4;Glandular and luminal cells: 27.5;Syncytiotrophoblasts: 17.4" "Cancer enriched" "Detected in many" 8 "endometrial cancer: 12.5" "Region enhanced" "Detected in many" "basal ganglia: 7.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 10.1;BEWO: 33.4;HAP1: 15.3;SH-SY5Y: 11.0;SuSa: 19.3" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory bulb: 27.0" "HPA030608, HPA061460" Uncertain Approved "Nuclear bodies" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nuclear bodies" "HPA030608: AB_10600867, HPA061460: AB_2684529" "unprognostic (7.50e-2)" "unprognostic (1.91e-1)" "unprognostic (5.19e-2)" "unprognostic (8.06e-2)" "unprognostic (8.16e-2)" "unprognostic (3.05e-1)" "unprognostic (4.32e-2)" "unprognostic (2.51e-1)" "unprognostic (2.86e-1)" "unprognostic (6.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.12e-7)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (5.58e-2)" "unprognostic (8.12e-2)" 0.4 0.0 2.1 0.0 7.3 0.3 0.1 0.0 4.3 2.0 0.0 0.2 0.0 2.5 0.8 0.0 0.4 0.0 0.1 0.8 4.7 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.1 3.0 0.0 0.3 0.0 0.0 1.1 0.9 0.1 1.5 0.0 0.2 0.0 0.1 0.0 5.5 1.2 0.3 0.4 0.1 0.2 0.3 0.2 0.4 0.0 0.0 0.0 10.1 0.0 0.0 33.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 1.9 15.3 0.0 0.0 0.0 3.9 0.0 5.9 7.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 2.6 1.6 0.0 0.0 0.0 0.0 2.2 7.3 11.0 1.0 0.0 0.3 19.3 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.9 1.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 7.3 0.0 4.3 0.8 4.7 0.0 0.0 0.0 0.0 1.2 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 32.9 0.1 0.0 0.0 0.0 22.6 37.3 2.2 0.2 0.0 0.0 0.0 0.0 70.4 0.2 0.0 27.5 0.0 0.0 0.0 0.0 3.3 0.0 8.0 0.0 0.0 0.0 0.0 3.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.8 6.8 10.2 0.0 0.0 17.4 0.3 0.0 0.0 0.1 DNAAF3 "C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22" ENSG00000167646 "Dynein axonemal assembly factor 3" Q8N9W5 19 55158661-55166722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 40.8;testis: 65.4" "Group enriched" "Detected in many" 5 "Early spermatids: 395.2;Late spermatids: 722.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 4.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 26.2;HEL: 31.6;K-562: 25.3;U-937: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA056220 Approved "Nuclear bodies,Mitochondria" No No "Cluster 49: Ciliated cells - Cilium organization" "Cluster 36: HEL - Hemostasis" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria "Nuclear bodies" "HPA056220: AB_2683071" "unprognostic (1.71e-2)" "unprognostic (2.67e-2)" "unprognostic (6.10e-2)" "unprognostic (9.93e-3)" "unprognostic (1.77e-1)" "unprognostic (1.87e-1)" "unprognostic (2.22e-2)" "unprognostic (1.82e-1)" "unprognostic (5.36e-2)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (1.83e-5)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (2.35e-2)" "unprognostic (8.03e-2)" 0.4 1.8 1.5 0.0 1.2 0.0 0.6 0.9 0.7 2.5 6.1 0.3 0.1 0.9 3.4 0.6 40.8 0.6 5.0 1.5 2.3 2.7 0.6 4.3 0.1 4.0 8.2 0.2 1.6 3.5 0.7 0.1 4.7 0.3 0.1 0.4 0.4 0.9 0.1 0.9 0.3 0.2 3.1 0.3 0.3 65.4 1.5 0.5 2.3 0.0 0.1 0.1 0.4 2.1 8.8 6.6 0.6 6.7 0.1 0.0 0.6 0.1 0.2 1.0 0.7 0.3 4.0 10.5 2.5 0.3 1.9 10.1 1.5 3.0 0.4 0.0 26.2 31.6 0.5 0.5 0.2 13.6 3.1 0.2 4.0 1.7 2.2 0.9 0.5 4.7 25.3 13.9 0.4 5.9 0.4 0.3 0.5 9.5 15.0 16.5 1.0 3.2 5.4 0.2 0.8 2.6 1.1 1.1 1.6 0.2 8.3 0.4 1.0 0.8 3.9 4.0 0.2 0.4 2.5 0.6 4.9 18.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 1.2 0.9 0.7 1.5 2.3 4.0 8.2 4.7 3.1 1.5 2.1 0.2 0.0 0.5 0.0 0.0 3.2 0.0 4.7 4.6 0.0 1.1 0.6 3.0 1.5 7.5 7.3 0.0 0.0 0.0 0.3 7.9 2.7 395.2 55.8 0.5 0.6 0.0 0.0 0.5 1.0 0.1 1.2 0.0 1.3 0.0 1.9 0.7 0.4 0.2 0.0 0.5 0.5 12.2 0.0 0.4 722.0 4.4 4.2 0.0 0.0 0.0 2.1 0.0 0.5 0.1 0.2 0.1 3.0 0.0 0.1 0.0 5.1 75.2 0.0 0.0 0.0 2.3 104.8 18.6 0.3 1.3 0.0 0.1 1.1 0.4 0.2 DNMBP "ARHGEF36, KIAA1010, Tuba" ENSG00000107554 "Dynamin binding protein" Q6XZF7 10 99875577-100009947 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 75.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037878, HPA058216" Uncertain Approved "Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 41: Macrophages - Immune response" "Nucleoli, Golgi apparatus, Cytosol" "Nuclear bodies" "HPA037878: AB_10675622, HPA058216: AB_2683640" "unprognostic (3.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.95e-6)" "unprognostic (3.92e-2)" "unprognostic (4.13e-1)" "unprognostic (9.79e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (8.67e-3)" "unprognostic (4.03e-2)" "unprognostic (5.07e-3)" "unprognostic (6.52e-2)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "prognostic favorable (6.15e-4)" 13.6 6.0 3.6 5.5 3.7 10.3 10.2 6.2 5.3 15.8 8.6 17.7 22.5 9.6 12.5 10.2 11.3 11.0 7.5 4.7 4.2 20.6 13.1 8.4 4.6 3.7 3.6 11.5 17.6 31.7 3.9 10.5 3.8 8.9 20.7 15.8 8.4 12.8 13.4 27.4 27.2 8.8 3.0 7.7 23.8 6.9 5.2 20.1 8.1 11.1 5.2 19.8 17.7 3.1 25.7 20.7 18.4 29.2 32.9 27.4 4.4 45.2 43.6 21.5 20.7 14.2 38.0 26.6 18.9 34.9 11.8 19.9 21.6 26.1 29.9 1.4 6.7 3.8 23.7 10.0 17.1 2.6 1.8 13.0 5.7 26.6 23.4 75.5 52.1 8.5 3.6 0.0 44.1 3.2 4.5 5.1 17.7 18.0 12.3 5.5 18.7 1.4 36.6 21.9 3.1 4.2 7.4 1.9 5.7 25.3 1.5 2.4 63.4 16.0 15.3 13.1 29.8 2.1 1.7 36.3 15.2 8.4 12.2 0.0 0.8 0.2 0.7 1.2 0.7 1.2 0.1 0.4 0.3 1.9 0.1 0.3 0.7 2.1 1.2 0.3 0.0 0.6 3.6 3.7 6.2 5.3 4.7 4.2 3.7 3.6 3.8 3.0 5.2 3.1 6.8 9.6 11.0 11.1 14.8 35.1 7.2 5.0 5.2 6.3 9.3 6.3 6.1 12.8 11.2 12.9 35.5 7.7 4.4 36.7 3.9 7.5 1.0 27.0 11.0 12.6 3.6 0.0 15.9 14.3 1.4 17.6 26.0 43.9 2.5 4.1 11.4 12.8 4.7 13.5 24.8 25.0 6.1 10.7 9.6 3.2 13.7 20.5 3.6 23.4 3.3 4.3 0.0 10.6 2.6 19.3 23.6 9.1 6.1 4.0 36.5 3.7 19.9 26.6 0.0 4.3 6.9 4.2 9.3 9.0 45.6 3.7 4.3 15.0 28.4 21.8 DOK2 "Dok-2, p56dok-2" ENSG00000147443 "Docking protein 2" O60496 8 21908873-21913690 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 25.6;lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" "dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 1565.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004379, HPA005507, HPA066571" Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 220000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Nucleoplasm, Nuclear bodies, Golgi apparatus" "CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749" "unprognostic (5.39e-2)" "unprognostic (8.84e-3)" "unprognostic (8.72e-3)" "unprognostic (1.74e-3)" "unprognostic (2.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.34e-1)" "unprognostic (7.22e-2)" "prognostic favorable (4.31e-4)" "unprognostic (2.22e-1)" "unprognostic (4.19e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.88e-1)" "unprognostic (1.24e-2)" "unprognostic (3.19e-1)" "unprognostic (2.80e-1)" 9.5 5.0 1.1 26.5 1.2 19.5 5.0 1.2 2.3 1.9 2.5 5.5 7.0 2.2 0.5 2.3 3.5 6.5 3.5 1.3 1.3 3.0 6.1 25.6 26.3 1.4 1.5 1.4 1.9 0.5 1.1 7.9 1.5 2.3 3.6 0.0 3.4 1.5 2.0 2.3 9.5 6.9 1.2 40.9 6.8 1.6 4.5 16.4 2.4 1.6 7.8 8.4 2.3 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 54.3 0.0 0.1 0.0 0.4 119.8 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.8 5.0 0.0 0.0 0.9 8.7 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.1 0.3 0.0 0.1 0.2 0.1 0.2 0.1 0.3 1.4 42.0 0.2 577.6 484.3 1565.6 398.3 624.0 184.5 14.5 274.3 304.8 421.9 6.6 151.0 185.9 37.2 307.6 580.7 7.6 597.2 810.3 1.1 1.2 1.2 2.3 1.3 1.3 1.4 1.5 1.5 1.2 4.5 1.5 2.0 3.2 18.1 0.0 13.2 11.5 0.6 0.0 0.0 0.0 1.2 1.8 2.1 0.0 1.3 3.7 0.0 0.7 130.6 0.3 0.0 0.1 0.2 0.2 0.5 2.8 0.0 10.5 0.1 0.0 1.0 2.6 3.1 0.4 36.3 0.1 5.7 1.1 131.8 0.0 0.0 0.2 0.0 171.8 288.4 0.6 0.3 181.5 19.6 0.0 74.8 0.0 344.0 0.0 0.0 0.0 0.0 0.0 15.4 0.2 0.0 0.7 1.5 0.0 0.0 0.6 2.5 0.2 4.3 0.7 8.5 1.0 147.4 0.0 0.2 0.8 DPH7 "C9orf112, FLJ90634, RRT2, WDR85" ENSG00000148399 "Diphthamide biosynthesis 7" Q9BTV6 9 137554444-137578925 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 189.9;Spermatogonia: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022911 Uncertain Approved "Nuclear bodies" Yes No "Cluster 46: Basophils - DNA binding" "Cluster 50: Non-specific - Ribosome" "Cluster 21: OE19 - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" "HPA022911: AB_1858823" "unprognostic (1.43e-1)" "unprognostic (4.81e-2)" "unprognostic (3.41e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (6.60e-3)" "unprognostic (1.48e-2)" "unprognostic (1.78e-1)" "unprognostic (2.14e-2)" "unprognostic (9.48e-2)" "prognostic favorable (6.52e-4)" "unprognostic (2.10e-2)" "prognostic unfavorable (1.52e-5)" "unprognostic (2.30e-3)" "unprognostic (3.06e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.23e-4)" 8.2 12.3 3.4 2.6 3.6 4.2 9.5 4.5 4.1 15.7 3.9 13.8 2.2 12.6 7.0 9.0 14.6 2.6 9.4 3.6 3.3 10.2 10.9 9.4 4.7 3.7 3.3 12.8 20.3 6.3 13.5 3.4 4.0 15.0 4.1 2.8 9.9 5.4 8.3 11.0 12.2 4.8 3.3 15.2 12.3 9.3 3.8 5.6 12.8 2.4 5.3 11.2 11.1 5.7 4.5 5.2 8.2 7.6 6.2 5.1 10.2 5.1 5.2 9.1 7.7 11.0 5.4 10.6 9.3 5.9 4.8 9.8 10.6 10.1 8.3 9.2 13.2 4.9 6.6 3.7 7.0 10.6 9.5 5.4 7.6 5.1 9.2 6.5 14.4 7.1 9.2 5.7 7.2 15.3 8.2 9.9 10.4 19.9 13.3 13.7 3.7 7.6 6.9 4.5 10.8 7.3 8.7 7.0 5.4 5.7 7.9 9.1 6.5 6.2 5.4 7.7 9.5 3.7 9.1 12.5 3.9 6.1 6.3 9.5 5.1 6.2 4.5 4.8 6.3 5.6 7.2 6.4 5.9 4.7 5.1 4.9 1.6 4.5 4.0 8.0 5.4 4.6 3.4 3.6 4.5 4.1 3.6 3.3 3.7 3.3 4.0 3.3 3.8 5.7 21.0 6.4 11.9 21.2 17.7 16.7 9.8 18.9 8.0 18.7 14.7 20.6 15.5 2.8 11.5 1.8 50.1 22.1 22.5 7.7 3.9 10.6 3.0 11.1 17.1 13.8 6.7 5.5 17.2 9.2 14.9 14.5 13.3 10.2 10.8 26.5 8.2 6.5 11.9 16.8 21.5 11.7 6.1 6.6 7.2 7.5 16.4 8.8 8.8 15.0 9.9 15.4 23.7 16.1 28.2 11.5 10.3 15.8 24.7 18.6 7.2 5.2 14.2 58.8 19.7 13.1 16.0 189.9 100.0 11.4 18.9 12.2 18.0 19.9 15.0 11.1 DPY19L4 ENSG00000156162 "Dpy-19 like 4" Q7Z388 8 94719703-94793836 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 65.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024339, HPA024780" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA024339: , HPA024780: AB_10600869" "unprognostic (1.45e-1)" "unprognostic (2.89e-3)" "unprognostic (3.41e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.28e-1)" "unprognostic (5.54e-2)" "unprognostic (4.94e-2)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.04e-1)" "unprognostic (4.72e-2)" "unprognostic (9.38e-2)" "unprognostic (2.25e-1)" "unprognostic (1.48e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" 11.5 12.3 7.3 6.6 10.5 5.1 12.5 9.7 9.4 13.6 8.0 8.6 6.7 12.3 10.5 7.6 11.2 10.0 15.4 6.5 10.1 14.5 15.8 9.1 6.9 9.9 9.0 16.7 9.4 26.4 6.4 12.6 10.3 11.6 9.0 13.0 10.2 9.0 7.2 9.4 7.9 9.5 9.6 11.1 13.1 9.6 8.9 7.0 16.1 9.3 5.8 8.6 8.5 14.4 24.4 15.5 26.1 16.4 25.9 33.3 14.4 21.5 20.3 19.8 19.4 7.3 35.0 5.4 25.8 20.8 13.3 25.0 16.0 16.9 32.7 12.2 12.8 25.3 15.1 12.2 30.1 10.9 5.1 22.2 14.0 16.8 16.2 23.2 24.3 16.0 18.0 9.0 23.3 15.3 20.9 20.5 10.2 27.9 17.2 14.8 17.9 10.9 19.1 18.9 12.8 28.7 17.2 3.6 16.8 15.9 22.8 13.6 24.0 20.5 12.6 23.1 18.1 9.9 13.1 14.8 15.4 18.7 29.6 0.7 0.5 0.0 1.0 0.6 1.4 1.2 1.0 1.6 1.0 0.3 1.1 1.4 0.4 1.4 0.6 1.2 0.4 0.7 7.3 10.5 9.7 9.4 6.5 10.1 9.9 9.0 10.3 9.6 8.9 14.4 21.1 16.0 16.3 20.5 6.3 9.8 14.1 11.6 15.9 19.6 16.2 12.1 26.0 11.5 13.0 40.5 4.2 16.7 3.7 8.5 1.9 8.9 2.1 13.7 20.3 19.0 7.3 9.7 13.2 10.0 11.9 20.4 12.2 13.7 3.8 23.1 65.0 27.5 9.6 13.5 18.3 11.5 10.2 14.8 11.9 5.0 17.4 8.3 10.6 25.3 5.5 11.9 9.2 23.6 39.7 13.0 6.4 18.4 7.9 15.6 10.7 10.7 18.8 17.6 6.6 13.4 14.9 11.9 9.8 16.6 12.1 9.2 7.8 32.6 12.0 14.1 DRG1 NEDD3 ENSG00000185721 "Developmentally regulated GTP binding protein 1" Q9Y295 22 31399604-31530634 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 160.2" "Group enriched" "Detected in all" 5 "Early spermatids: 798.4;Late spermatids: 651.5;Spermatocytes: 469.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001218 Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No 22000 "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA001218: AB_1078704" "unprognostic (4.94e-1)" "unprognostic (3.33e-2)" "unprognostic (1.17e-3)" "unprognostic (5.26e-2)" "unprognostic (4.66e-2)" "unprognostic (3.49e-3)" "prognostic unfavorable (7.71e-4)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" "unprognostic (2.32e-3)" "unprognostic (8.69e-3)" "unprognostic (1.55e-3)" "unprognostic (4.80e-2)" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (3.89e-1)" "unprognostic (2.25e-1)" 31.4 32.6 22.6 21.4 23.9 32.3 35.1 27.0 31.6 27.3 22.8 24.7 22.6 27.8 38.7 27.4 32.7 19.5 44.6 23.7 24.6 35.9 37.9 20.9 29.2 23.9 23.7 35.0 34.1 38.4 18.6 35.7 25.0 25.0 30.0 30.1 30.5 28.8 100.5 23.7 21.3 34.1 24.5 20.1 24.2 160.2 22.7 40.4 34.5 85.1 38.3 30.8 20.6 26.4 80.3 61.3 73.9 63.3 64.4 75.2 61.5 70.2 81.7 125.7 104.4 100.3 38.3 111.2 38.6 86.9 60.3 64.5 128.5 82.8 134.4 52.0 152.0 71.9 64.9 99.6 91.4 174.2 65.1 65.6 60.9 103.7 152.9 64.6 87.5 61.6 93.9 48.1 97.2 88.0 75.7 88.4 62.1 114.0 65.9 98.7 118.9 97.3 82.1 68.6 80.8 50.4 78.5 79.8 107.2 70.8 59.7 77.2 50.6 57.7 79.3 59.1 81.3 67.2 78.5 108.6 57.0 77.7 77.4 25.0 43.3 46.0 34.3 49.7 39.6 53.6 36.6 43.0 45.2 39.4 40.5 39.8 9.8 46.7 37.5 39.6 50.9 47.0 22.6 23.9 27.0 31.6 23.7 24.6 23.9 23.7 25.0 24.5 22.7 26.4 22.0 19.2 15.4 3.9 29.4 38.6 40.8 77.2 29.6 18.7 27.2 27.2 52.4 35.8 37.6 27.6 25.0 126.4 20.6 22.5 64.6 56.4 798.4 23.7 24.4 34.4 11.4 37.8 10.3 45.4 104.5 33.2 21.4 21.1 33.7 27.1 35.7 36.9 60.4 15.2 11.2 31.0 48.8 31.1 24.0 651.5 35.8 22.9 17.8 7.5 39.2 27.6 33.0 9.5 11.1 42.7 27.0 37.2 27.1 48.7 42.9 60.3 28.7 18.4 59.2 35.4 36.1 469.3 92.1 33.1 32.1 117.1 25.5 26.2 41.0 45.3 DSN1 "C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13" ENSG00000149636 "DSN1 component of MIS12 kinetochore complex" Q9H410 20 36751791-36773818 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 49.8;Spermatocytes: 115.5;Spermatogonia: 75.1;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002813, HPA030627" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Kinetochore,Cytosol" Yes Yes "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies, Kinetochore, Cytosol" "HPA002813: AB_1078343, HPA030627: AB_2732460" "unprognostic (3.60e-2)" "prognostic favorable (4.49e-4)" "unprognostic (5.22e-3)" "unprognostic (1.13e-3)" "unprognostic (2.00e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (4.16e-5)" "unprognostic (3.93e-1)" "unprognostic (9.35e-2)" "unprognostic (5.51e-2)" "unprognostic (2.98e-2)" "unprognostic (7.66e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (6.92e-2)" "unprognostic (2.53e-1)" "unprognostic (2.58e-2)" "unprognostic (2.84e-1)" 5.9 9.9 4.2 7.5 4.2 14.3 8.6 3.9 4.5 5.0 5.2 9.2 6.8 4.4 9.3 7.9 4.1 4.4 5.1 4.3 4.4 4.8 9.1 6.3 12.8 4.0 3.9 4.3 4.3 5.5 3.5 8.8 4.1 6.5 10.8 10.7 5.9 6.3 4.0 8.0 7.8 6.3 3.9 9.6 7.3 23.3 4.1 16.4 5.1 4.8 14.3 4.4 4.7 4.7 36.7 29.1 35.7 29.5 14.0 18.0 24.7 42.9 35.1 63.9 70.2 52.5 44.4 39.3 27.4 23.0 69.1 45.8 33.3 32.7 60.3 18.2 22.7 78.3 26.2 36.1 3.0 46.2 34.0 7.0 9.4 43.7 13.8 10.4 31.5 42.4 30.9 33.7 41.7 25.3 59.2 34.5 16.8 63.3 55.1 46.1 109.4 28.4 16.2 20.5 37.8 16.9 52.9 53.7 25.8 26.3 55.9 30.5 16.4 60.1 35.0 56.9 46.1 27.3 39.1 46.4 49.8 40.8 42.6 53.4 6.4 14.5 7.4 11.0 8.4 14.6 8.1 10.3 7.1 18.4 10.1 9.0 11.9 11.1 10.1 46.9 12.2 6.7 4.2 4.2 3.9 4.5 4.3 4.4 4.0 3.9 4.1 3.9 4.1 4.7 6.5 6.4 4.4 1.6 10.3 5.0 11.4 7.6 3.4 8.0 8.7 7.6 5.4 2.8 8.6 5.5 29.2 49.8 9.8 9.2 7.9 6.8 10.6 5.5 5.9 8.1 2.4 22.1 6.3 6.4 30.4 8.4 20.9 9.4 3.8 21.8 7.9 6.2 14.7 6.7 4.4 13.6 4.1 6.3 4.6 8.0 8.7 6.7 1.8 5.6 7.4 6.0 7.2 3.0 3.6 5.1 5.4 7.5 22.9 7.1 7.7 3.6 8.2 17.5 0.0 5.3 8.2 115.5 75.1 12.3 7.2 47.5 7.7 6.9 13.6 11.0 DTWD2 FLJ33977 ENSG00000169570 "DTW domain containing 2" Q8NBA8 5 118836074-118988547 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 70.4;Inhibitory neurons: 61.8;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 43.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053173, HPA054864" Approved Approved "Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear bodies" "HPA053173: AB_2682068, HPA054864: AB_2682629" "unprognostic (1.66e-1)" "unprognostic (1.60e-1)" "prognostic favorable (3.16e-4)" "unprognostic (4.80e-2)" "unprognostic (2.45e-2)" "unprognostic (1.42e-1)" "unprognostic (2.93e-1)" "unprognostic (1.15e-1)" "unprognostic (1.11e-1)" "unprognostic (2.77e-3)" "unprognostic (5.15e-2)" "unprognostic (2.90e-1)" "prognostic favorable (6.09e-5)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (5.93e-3)" "unprognostic (1.59e-1)" 3.1 3.3 1.3 2.3 1.3 1.2 3.6 2.3 1.8 5.1 2.2 3.3 3.2 2.6 2.3 4.2 2.3 3.2 6.5 1.2 0.8 6.5 4.5 2.4 2.3 1.1 1.4 1.7 3.0 4.7 0.8 1.8 1.2 3.4 3.3 3.4 3.2 2.7 10.5 3.3 2.7 3.2 1.0 3.0 2.7 2.4 1.3 2.0 9.1 6.3 2.3 2.9 1.3 1.4 4.3 2.6 3.6 5.3 2.0 1.0 3.6 3.9 2.7 5.5 6.3 1.8 3.2 3.6 6.9 3.4 2.6 4.8 6.0 4.4 6.9 1.2 4.2 4.9 4.3 2.9 1.7 5.9 6.1 1.5 7.4 2.4 2.4 3.2 1.8 6.4 3.8 5.5 3.7 4.2 4.9 3.6 3.8 3.1 1.4 2.0 3.3 1.9 7.0 6.2 1.8 3.3 3.9 4.2 5.4 2.9 9.7 3.9 2.2 6.9 5.1 2.3 5.7 3.8 6.6 2.8 4.0 3.5 3.4 0.9 0.3 0.1 0.2 0.3 0.3 0.4 0.3 0.3 0.3 0.6 0.4 0.4 0.6 0.5 0.3 0.5 0.1 0.4 1.3 1.3 2.3 1.8 1.2 0.8 1.1 1.4 1.2 1.0 1.3 1.4 2.7 9.6 3.6 33.6 5.7 2.8 2.7 3.9 8.6 12.0 5.4 2.8 11.7 8.6 4.7 7.3 16.7 2.7 3.7 4.0 9.8 2.9 12.8 4.2 1.9 2.0 4.2 12.6 70.4 8.3 1.1 3.0 9.7 3.6 0.0 4.5 1.8 5.6 3.9 20.2 61.8 2.0 4.1 2.6 2.5 20.3 2.5 4.5 7.2 21.5 4.6 7.3 4.1 49.3 43.9 1.9 5.2 2.2 8.0 2.1 3.7 12.1 3.1 9.1 0.0 4.5 2.8 12.7 17.4 10.0 3.7 0.7 2.8 7.3 3.4 3.4 DTX1 "hDx-1, RNF140" ENSG00000135144 "Deltex E3 ubiquitin ligase 1" Q86Y01 12 113056709-113098028 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.1;lymphoid tissue: 11.8" "Group enriched" "Detected in many" 6 "Astrocytes: 48.3;Horizontal cells: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "Daudi: 109.1;REH: 45.1;U-698: 110.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051249, HPA055275" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA051249: , HPA055275: AB_2682769" "unprognostic (2.13e-3)" "unprognostic (3.20e-3)" "unprognostic (4.24e-4)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.59e-3)" "unprognostic (2.49e-3)" "unprognostic (1.81e-1)" "unprognostic (9.55e-2)" "unprognostic (6.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.58e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.41e-2)" "unprognostic (4.70e-1)" "unprognostic (1.63e-1)" "unprognostic (4.78e-3)" 9.0 1.7 6.5 5.7 6.8 2.7 6.4 3.2 5.9 2.4 0.2 0.8 1.3 1.5 0.3 0.9 1.8 0.8 1.2 5.2 11.1 3.5 8.9 0.8 11.1 5.2 8.8 0.4 1.6 0.0 3.3 0.3 5.1 0.8 0.1 2.9 2.6 0.3 0.5 1.0 3.5 0.3 3.7 11.8 0.9 1.9 10.5 0.5 2.2 0.1 6.0 0.5 0.6 2.4 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 109.1 0.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.3 4.6 0.0 2.0 0.2 0.0 45.1 0.2 2.6 0.0 0.0 2.7 7.1 0.4 0.4 2.5 0.0 0.1 0.2 1.2 0.0 4.0 0.0 0.1 0.5 0.2 110.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 6.8 3.2 5.9 5.2 11.1 5.2 8.8 5.1 3.7 10.5 2.4 0.7 0.0 0.0 48.3 8.8 1.0 0.0 0.0 0.0 4.7 0.2 0.6 0.7 0.0 0.0 1.8 8.4 0.0 0.3 0.1 7.9 2.5 0.7 0.7 17.5 1.7 0.0 0.0 10.6 0.0 0.0 4.5 0.5 0.4 7.0 0.0 0.4 12.4 0.8 171.6 13.8 0.1 0.0 0.3 0.6 1.7 7.8 0.2 3.6 2.8 0.0 11.4 2.1 13.0 1.0 0.2 0.1 7.5 2.5 0.0 0.0 0.2 0.0 2.8 0.0 0.4 1.3 0.8 2.4 0.0 0.4 0.0 2.2 0.8 0.0 0.0 DVL2 ENSG00000004975 "Dishevelled segment polarity protein 2" O14641 17 7225342-7234517 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009312, HPA021611, HPA022914, HPA064732" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Nuclear bodies" "CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338" "unprognostic (7.63e-3)" "unprognostic (6.84e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.44e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (4.34e-6)" "unprognostic (5.66e-2)" "unprognostic (8.01e-2)" "unprognostic (8.97e-2)" "prognostic favorable (3.85e-4)" "unprognostic (8.90e-2)" "unprognostic (1.28e-1)" "unprognostic (3.23e-1)" "unprognostic (2.30e-1)" "unprognostic (2.80e-1)" "unprognostic (5.45e-2)" 18.2 20.7 15.1 11.4 17.2 14.8 18.1 15.6 17.9 31.7 15.2 22.6 12.9 29.6 10.5 23.0 22.3 14.1 13.8 14.7 14.9 16.3 10.6 15.0 16.7 17.1 16.3 33.9 12.8 17.6 26.0 14.7 16.2 24.7 8.6 14.4 17.8 18.0 16.5 28.8 16.7 18.1 15.0 16.1 14.4 16.4 16.1 22.2 20.1 11.5 13.0 22.1 25.9 19.0 31.0 43.9 52.2 52.0 39.0 35.0 22.5 21.1 38.1 50.0 63.7 37.5 25.6 43.8 31.3 23.5 39.0 43.5 43.5 28.6 19.0 43.6 50.3 28.5 46.0 40.0 68.0 16.0 23.7 52.5 48.2 47.2 25.7 35.0 20.9 50.5 24.6 20.0 30.6 28.9 61.6 16.1 17.8 20.7 17.1 89.5 33.8 26.8 27.8 26.9 22.9 46.4 38.3 18.9 46.7 23.5 27.4 22.1 17.6 28.0 25.1 52.8 39.6 31.1 28.0 20.4 32.6 23.8 44.4 13.5 4.2 10.2 10.0 4.9 8.3 8.5 7.0 9.0 5.0 9.3 8.0 8.5 1.9 7.2 4.9 7.0 4.5 6.2 15.1 17.2 15.6 17.9 14.7 14.9 17.1 16.3 16.2 15.0 16.1 19.0 11.7 9.6 12.1 12.4 13.1 17.5 22.6 20.9 21.6 15.7 13.2 14.4 7.7 5.7 15.0 18.4 25.0 21.3 11.8 11.2 5.9 11.3 0.9 8.8 12.9 10.5 13.2 6.5 11.2 10.4 15.9 15.7 7.7 13.5 14.7 18.4 9.7 4.9 14.6 10.1 9.4 14.3 24.4 6.0 9.4 1.9 26.1 7.6 10.6 2.8 9.3 13.1 14.4 10.6 10.4 7.2 9.9 22.2 5.9 17.1 10.8 5.5 9.3 30.0 13.1 16.0 14.9 18.4 34.2 21.7 19.2 36.5 11.5 18.4 19.6 15.0 DYNLL1 "DLC1, DLC8, DNCL1, hdlc1, LC8, PIN" ENSG00000088986 "Dynein light chain LC8-type 1" P63167 12 120469850-120498493 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport" "Activator, Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 4098.6;Respiratory ciliated cells: 2679.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA Yes 890000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (3.43e-2)" "unprognostic (2.88e-2)" "unprognostic (5.63e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (4.41e-3)" "unprognostic (4.64e-2)" "unprognostic (6.17e-3)" "unprognostic (1.61e-2)" "unprognostic (9.10e-2)" "prognostic unfavorable (7.97e-7)" "unprognostic (4.91e-2)" "unprognostic (2.80e-2)" "unprognostic (7.91e-2)" "unprognostic (1.62e-1)" 268.6 261.9 912.5 186.7 967.7 126.8 268.0 895.2 1292.9 354.2 894.7 325.8 162.8 319.4 322.3 719.9 544.2 242.7 257.5 975.4 944.7 352.6 238.4 222.6 241.6 896.1 898.5 247.0 225.1 228.2 309.7 259.2 914.2 225.9 327.4 181.3 245.4 264.6 85.6 626.7 206.3 390.1 935.1 185.2 244.5 360.3 909.7 306.5 176.1 163.9 357.8 389.8 474.4 1001.2 721.6 811.4 779.2 600.8 677.1 713.6 250.8 968.0 451.6 785.6 466.7 770.8 472.3 400.6 510.3 945.1 753.0 629.6 949.3 818.3 781.0 528.3 617.9 390.4 532.9 1062.5 676.2 412.8 620.5 436.2 863.0 584.6 477.5 855.7 831.8 421.5 502.0 446.1 1056.8 960.1 541.4 894.8 642.2 917.7 935.7 543.0 403.0 499.2 1143.1 659.8 535.2 392.0 789.3 677.7 926.6 812.6 673.6 595.3 635.2 592.3 502.1 525.6 852.2 264.0 562.8 404.6 656.8 645.1 776.6 516.6 291.9 384.2 200.6 303.3 155.3 310.4 207.2 211.7 281.8 219.0 132.0 165.7 50.1 282.9 334.8 461.6 373.5 353.0 912.5 967.7 895.2 1292.9 975.4 944.7 896.1 898.5 914.2 935.1 909.7 1001.2 810.1 195.5 101.9 79.3 341.4 922.2 359.1 1275.0 356.8 138.4 800.0 949.4 170.8 303.1 764.6 399.1 83.4 524.6 484.1 689.9 1113.2 691.2 1407.2 1842.5 528.5 541.9 480.8 332.9 111.2 538.9 897.4 538.5 240.5 488.1 316.7 611.9 521.9 499.0 732.1 85.8 62.8 801.6 1121.0 329.4 706.1 4098.6 516.6 466.3 595.9 42.2 701.6 164.0 248.2 47.3 156.4 754.9 798.6 701.8 234.9 304.7 533.4 1125.0 2679.6 193.5 368.1 440.7 1016.3 961.5 721.4 1005.4 1610.1 1006.6 396.6 586.3 498.2 389.6 DYNLL2 "Dlc2, DNCL1B, MGC17810, RSPH22" ENSG00000264364 "Dynein light chain LC8-type 2" Q96FJ2 17 58083419-58095542 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 455.4;Late spermatids: 892.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039954 Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 1000000 "Cluster 18: Basophils - Vesicular transport" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039954: AB_2676771" "unprognostic (7.22e-2)" "unprognostic (7.76e-2)" "unprognostic (3.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.93e-1)" "unprognostic (3.72e-2)" "unprognostic (6.78e-2)" "unprognostic (2.91e-2)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "prognostic favorable (5.26e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.12e-12)" "unprognostic (2.87e-2)" "unprognostic (1.28e-1)" "unprognostic (1.31e-1)" "unprognostic (7.02e-2)" 24.5 41.8 76.8 17.7 84.5 17.7 16.9 78.1 77.7 18.2 45.6 26.1 25.0 19.6 22.4 20.3 19.4 13.4 62.8 63.4 80.4 42.1 35.2 17.9 15.5 83.6 90.1 20.4 17.8 47.2 28.7 30.4 83.6 30.3 20.1 41.2 30.8 26.3 113.7 19.1 24.3 18.9 83.4 18.0 21.3 26.2 87.9 22.5 33.0 58.7 18.4 20.7 17.6 72.0 54.1 36.0 72.3 33.1 44.0 24.0 114.6 53.2 21.1 25.2 19.7 80.4 25.4 48.0 58.8 33.1 30.1 28.4 33.8 42.2 43.2 47.8 24.5 52.1 21.9 47.7 34.8 56.2 31.1 24.3 28.2 29.4 23.2 26.4 17.1 39.8 52.7 28.4 24.7 81.5 64.1 23.2 49.9 35.3 36.5 58.3 42.5 19.9 22.0 57.9 49.3 39.4 47.7 19.0 42.0 37.2 56.2 26.1 31.0 49.3 62.2 33.2 39.8 52.6 68.5 57.0 25.5 44.2 35.2 1.0 0.2 0.5 0.6 0.1 0.7 0.4 0.5 0.6 0.1 0.4 0.5 0.8 0.4 0.4 0.9 0.2 0.4 0.2 76.8 84.5 78.1 77.7 63.4 80.4 83.6 90.1 83.6 83.4 87.9 72.0 33.9 12.8 43.8 1.0 28.1 49.1 40.7 13.7 45.5 63.7 55.7 39.8 186.2 44.3 23.8 60.7 39.6 102.1 59.7 56.7 31.3 37.6 455.4 51.5 57.3 32.5 67.2 40.6 1.2 31.2 73.4 30.6 20.9 55.2 22.8 19.1 23.9 104.7 43.0 70.7 2.0 55.7 26.4 28.4 37.4 892.8 29.5 32.8 65.8 1.9 31.9 74.7 19.6 0.5 2.8 38.0 38.6 26.7 19.4 35.3 50.0 78.2 18.4 41.1 26.3 40.1 86.1 46.5 44.8 45.1 46.0 60.1 46.9 29.0 49.7 36.5 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427598-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.1" "Group enriched" "Detected in all" 6 "Early spermatids: 268.7;Late spermatids: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 137.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA No "Cluster 16: MAIT-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 12.9 9.0 9.2 10.5 8.9 57.1 9.1 7.2 9.4 7.2 7.7 9.0 10.6 7.9 7.6 9.8 7.0 10.4 5.1 10.3 11.1 11.2 19.0 8.3 10.7 9.6 10.3 5.6 9.8 11.8 8.6 10.2 12.3 10.0 9.9 7.7 6.9 6.8 5.3 10.7 10.0 8.3 7.8 9.8 11.4 7.3 10.6 10.6 10.5 5.8 11.1 11.5 5.8 7.9 10.3 16.6 17.1 17.6 9.8 8.3 137.4 14.7 10.5 16.7 16.3 22.7 11.4 28.7 9.3 10.9 10.9 8.6 22.5 13.2 19.2 23.6 16.2 24.8 14.5 20.8 22.1 23.6 19.2 11.0 22.8 24.3 16.2 12.8 16.8 23.1 26.9 20.6 14.1 21.2 23.6 13.2 30.7 19.3 16.9 21.3 14.2 16.0 14.5 17.8 17.6 30.6 18.2 16.7 17.6 21.9 25.2 18.5 16.6 17.5 12.8 15.6 21.8 27.1 58.3 29.7 17.0 27.7 21.1 8.0 7.1 4.6 11.1 5.4 14.3 4.9 9.1 8.7 4.2 3.6 5.4 8.7 6.5 8.1 6.9 9.8 10.9 4.4 9.2 8.9 7.2 9.4 10.3 11.1 9.6 10.3 12.3 7.8 10.6 7.9 11.5 9.6 17.3 6.8 14.2 46.9 9.1 6.0 14.2 8.1 15.8 7.7 4.8 15.7 9.0 12.9 6.2 8.0 29.1 15.5 9.8 8.6 268.7 10.8 16.0 11.8 34.3 7.8 16.4 8.2 14.6 13.9 16.3 14.1 10.2 9.9 12.1 30.4 15.8 21.9 14.0 12.5 12.2 30.7 31.6 389.5 11.5 37.6 23.2 3.7 19.4 5.5 22.6 5.5 10.7 15.6 10.3 12.0 12.2 16.1 16.0 29.7 8.6 6.4 26.3 13.6 11.0 21.5 11.6 17.7 54.3 35.8 22.0 4.3 12.8 19.9 EBF2 "COE2, FLJ11500" ENSG00000221818 "EBF transcription factor 2" Q9HAK2 8 25841725-26045413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 17.8" "Cell type enhanced" "Detected in some" "Adipocytes: 11.9;Fibroblasts: 23.2;Microglial cells: 13.1;Sertoli cells: 39.5;Smooth muscle cells: 53.4" "Cancer enhanced" "Detected in many" "renal cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 22.7;ASC TERT1: 45.7;HSkMC: 46.9;hTEC/SVTERT24-B: 26.7;U-138 MG: 17.1;U-2197: 22.7;U-87 MG: 19.1" "Group enriched" "Detected in many" 4 "basal ganglia: 5.7;cerebellum: 3.1;hypothalamus: 2.0;midbrain: 4.4;pons and medulla: 2.8" "Region enriched" "Detected in many" 5 "spinal cord: 8.7" "HPA003954, HPA055101" Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear bodies" "HPA003954: , HPA055101: " "unprognostic (3.70e-1)" "unprognostic (3.88e-3)" "unprognostic (2.69e-2)" "unprognostic (2.47e-3)" "unprognostic (1.03e-1)" "unprognostic (6.10e-2)" "unprognostic (5.92e-2)" "unprognostic (6.75e-2)" "unprognostic (1.11e-2)" "unprognostic (6.13e-3)" "unprognostic (1.58e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (7.41e-4)" "unprognostic (2.28e-1)" "unprognostic (3.80e-2)" "unprognostic (1.82e-2)" 17.8 0.7 0.2 0.9 0.5 0.0 8.0 0.2 0.1 0.7 0.1 1.4 0.0 0.8 1.9 0.8 4.0 2.6 9.8 0.0 0.7 0.5 0.0 0.6 0.6 1.3 3.1 1.0 0.8 2.2 0.4 0.5 2.7 0.5 0.4 0.2 1.4 0.4 4.7 1.5 0.7 1.7 3.8 0.0 0.8 1.1 0.9 1.4 6.2 9.6 0.2 1.9 1.2 0.3 0.0 0.0 0.8 0.0 22.7 45.7 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 46.9 0.0 26.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 17.1 0.2 22.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.7 1.3 3.1 2.7 3.8 0.9 0.3 11.9 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.2 0.3 5.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.1 5.6 0.0 0.0 0.5 0.0 0.0 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.4 3.2 5.9 0.6 0.0 13.1 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 39.5 2.6 53.4 1.0 0.2 0.4 0.3 0.0 0.2 0.1 0.0 0.1 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" Nucleoplasm "HPA062510: AB_2684787, HPA068795: AB_2686038" "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.3 1.2 0.5 2.3 1.7 15.4 2.3 1.0 1.1 2.5 1.9 1.8 1.3 2.6 2.4 1.6 2.6 1.3 1.9 0.6 1.2 0.9 1.7 2.7 2.0 1.7 0.9 3.7 2.2 0.7 1.2 2.0 1.9 1.5 2.4 2.7 2.7 0.8 1.4 2.2 2.1 1.5 0.8 2.4 1.9 1.1 1.3 1.5 2.1 0.3 1.7 1.8 2.5 4.4 0.6 0.4 2.6 2.3 0.6 1.4 1.9 1.0 0.2 0.6 0.5 1.3 2.1 1.7 0.4 1.4 0.6 0.9 1.0 1.1 1.3 0.6 0.6 1.1 3.0 1.1 0.3 2.2 2.4 1.4 0.8 1.3 1.3 1.2 0.9 1.4 0.8 2.5 0.7 1.4 1.0 3.0 1.6 0.5 0.7 2.7 0.6 1.0 0.7 2.8 0.6 1.2 0.6 1.1 0.3 1.8 1.7 0.8 1.7 0.7 1.4 2.0 1.6 2.5 1.3 1.3 0.7 2.3 1.3 0.1 0.7 3.3 1.6 0.2 1.3 0.7 1.4 1.4 0.2 1.2 1.2 1.7 1.5 0.5 0.3 1.0 1.9 0.1 0.5 1.7 1.0 1.1 0.6 1.2 1.7 0.9 1.9 0.8 1.3 4.4 4.3 0.0 2.2 0.0 5.8 5.7 12.6 6.7 1.8 5.3 3.2 3.0 1.1 12.8 6.2 3.7 8.4 9.7 5.9 6.8 0.0 3.2 1.8 4.0 4.4 4.6 4.2 6.1 0.0 1.6 6.2 3.9 4.1 7.4 1.3 9.2 10.8 5.1 2.8 3.3 0.0 4.0 4.1 5.1 11.5 0.8 8.4 5.4 1.8 0.0 5.2 2.0 5.2 0.0 0.0 3.9 4.1 3.8 5.2 9.3 6.2 0.5 6.3 6.0 6.6 8.0 4.8 3.5 5.0 1.1 6.3 14.6 6.8 6.7 5.1 13.2 EEF1AKMT2 "C10orf138, Efm4, METTL10" ENSG00000203791 "EEF1A lysine methyltransferase 2" Q5JPI9 10 124748149-124791887 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 29.1;Distal tubular cells: 66.5;Extravillous trophoblasts: 29.8;Proximal tubular cells: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA050138 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Vesicles, Cytosol" "HPA050138: AB_2681030" "unprognostic (1.64e-3)" "unprognostic (3.42e-2)" "unprognostic (1.34e-1)" "unprognostic (9.75e-2)" "unprognostic (7.19e-2)" "unprognostic (1.17e-1)" "unprognostic (2.33e-2)" "unprognostic (2.29e-3)" "unprognostic (9.04e-3)" "unprognostic (9.76e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.90e-2)" "unprognostic (4.44e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.53e-4)" "unprognostic (9.09e-2)" 4.8 3.8 3.0 2.1 3.3 3.6 5.3 4.8 4.2 4.6 3.0 3.7 1.8 4.0 4.6 4.0 3.8 2.1 4.1 3.1 3.0 4.9 5.2 3.3 2.5 2.8 3.1 5.5 4.4 4.5 4.3 2.7 2.8 4.3 3.8 2.5 5.1 2.8 4.0 5.0 3.5 2.6 2.7 3.5 3.7 5.6 2.8 3.3 5.1 3.3 3.1 3.4 4.2 3.6 12.6 3.3 4.8 8.0 3.1 8.0 3.1 5.8 7.6 7.4 6.5 4.3 7.1 8.4 3.0 4.7 2.5 3.8 6.8 4.2 11.5 7.0 2.5 6.8 4.2 3.9 6.0 10.9 4.1 3.9 3.9 4.1 9.9 6.2 4.7 7.0 7.6 9.3 9.3 3.7 5.2 8.5 5.9 4.6 4.8 2.3 5.7 2.6 4.6 2.7 1.5 3.8 3.7 6.2 8.7 3.3 5.4 8.5 5.8 2.7 2.9 4.5 8.8 4.3 3.7 6.8 4.9 5.7 3.9 0.8 1.0 1.6 1.6 1.1 2.5 1.9 1.6 2.0 1.2 1.3 2.2 1.6 0.1 4.4 0.8 1.5 1.9 1.1 3.0 3.3 4.8 4.2 3.1 3.0 2.8 3.1 2.8 2.7 2.8 3.6 23.2 3.2 11.3 0.0 8.9 0.0 0.0 0.0 0.0 0.0 20.5 22.4 0.0 0.0 2.5 11.0 0.0 29.1 13.4 0.0 66.5 20.0 0.0 11.4 11.8 7.5 0.0 0.0 0.0 20.4 29.8 10.4 0.0 10.5 2.5 17.8 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 11.4 0.0 0.0 0.0 0.0 19.8 0.0 0.0 2.8 0.0 0.0 30.5 3.6 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 17.1 7.1 14.7 0.0 0.0 EEFSEC "EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153481-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 71.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 13.5 8.2 0.2 0.2 0.2 0.1 12.5 0.2 0.6 14.2 0.1 11.3 0.0 15.6 0.0 12.3 13.9 0.1 25.5 0.2 0.3 14.3 21.8 9.6 2.2 0.4 0.2 12.3 11.7 3.0 8.8 1.6 0.3 12.1 0.6 0.5 9.7 1.9 24.0 16.5 10.7 0.0 0.2 13.4 11.0 19.3 0.4 0.1 9.9 0.0 1.2 12.7 12.3 0.2 0.5 0.1 4.1 1.7 0.1 0.2 0.5 0.0 0.3 0.2 0.2 0.3 6.9 15.2 0.1 3.8 12.3 1.1 0.4 0.1 0.1 0.3 0.3 0.0 0.1 0.1 5.7 0.3 0.3 0.1 0.1 4.0 0.1 0.2 0.3 0.0 0.1 0.2 3.5 0.2 7.9 0.4 0.4 0.1 0.1 0.3 0.2 1.0 0.0 0.0 0.3 10.4 0.0 17.7 15.4 0.3 9.6 0.7 0.0 0.1 0.0 0.2 0.2 0.4 0.7 0.4 0.1 0.4 0.2 0.4 6.3 6.1 5.0 6.0 3.9 5.4 4.4 4.4 8.7 3.9 4.0 5.0 0.0 7.5 4.8 3.7 5.7 4.3 0.2 0.2 0.2 0.6 0.2 0.3 0.4 0.2 0.3 0.2 0.4 0.2 9.4 0.0 6.0 15.0 17.2 6.4 9.3 9.1 7.4 7.8 6.9 8.6 10.1 8.6 4.4 16.5 2.1 22.3 15.7 6.4 15.6 7.9 27.7 3.1 12.5 8.2 11.4 5.9 25.3 7.1 18.3 10.0 10.2 4.5 28.5 10.0 8.9 14.8 14.6 13.5 36.6 11.7 18.3 7.9 8.2 71.6 13.1 11.4 12.4 28.1 9.8 9.3 17.5 45.8 27.1 5.6 2.7 8.6 17.1 9.4 8.6 25.7 2.7 8.2 26.3 9.0 9.1 27.9 16.9 10.8 9.9 29.7 13.7 11.9 10.6 6.0 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.6;fallopian tube: 19.7" "Group enriched" "Detected in some" 4 "Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPTEC TERT1: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 8.9" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.3 0.4 0.8 0.1 1.0 0.8 0.3 1.7 1.1 1.1 12.6 0.1 0.0 0.3 0.8 0.0 19.7 0.2 0.3 1.4 1.5 0.8 1.2 1.7 0.1 4.9 7.0 1.0 0.6 1.7 3.6 0.1 3.2 3.0 0.0 1.6 0.2 0.2 0.0 0.1 0.3 0.0 3.6 0.4 0.7 6.9 2.4 0.2 1.2 0.0 0.2 0.0 0.1 1.0 0.1 0.7 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 1.5 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.3 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.7 1.1 1.4 1.5 4.9 7.0 3.2 3.6 2.4 1.0 0.2 3.2 1.7 0.3 0.5 0.5 0.1 0.8 0.0 0.4 0.7 0.4 1.3 1.5 1.8 0.0 2.1 0.0 0.3 0.1 0.0 0.2 29.6 31.9 0.7 0.5 0.0 0.0 2.7 0.2 0.1 0.5 3.1 1.9 0.0 0.1 0.0 1.1 0.1 5.0 0.8 0.3 2.0 0.0 0.0 20.1 0.3 0.3 0.0 0.0 0.1 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.9 46.0 5.6 0.0 0.5 0.6 6.8 2.7 0.7 0.3 0.0 0.3 0.3 0.0 0.2 EHMT1 "bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D" ENSG00000181090 "Euchromatic histone lysine methyltransferase 1" Q9H9B1 9 137618992-137870016 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, Methyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 167.0;Plasma cells: 170.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060022, HPA074729" Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Nuclear bodies" "HPA060022: AB_2684190, HPA074729: " "unprognostic (1.18e-1)" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "prognostic favorable (6.56e-4)" "unprognostic (1.03e-1)" "prognostic favorable (8.91e-4)" "unprognostic (5.87e-2)" "unprognostic (1.74e-2)" "unprognostic (4.18e-3)" "unprognostic (2.34e-1)" "unprognostic (2.26e-2)" "unprognostic (7.55e-3)" "unprognostic (2.01e-2)" "unprognostic (6.58e-3)" "unprognostic (4.24e-1)" "unprognostic (7.12e-3)" "unprognostic (7.75e-2)" 17.7 18.3 11.0 22.3 12.0 30.5 18.2 16.0 12.3 17.0 13.8 19.3 18.8 21.5 9.7 19.1 18.1 14.0 13.5 8.6 8.3 11.0 14.4 15.8 29.6 10.7 10.2 19.9 14.9 13.8 12.9 15.0 11.1 16.2 13.1 13.7 18.4 13.9 31.4 19.3 19.6 15.1 4.4 25.9 18.2 40.5 12.7 22.9 19.6 15.0 21.2 18.3 16.2 19.9 26.7 52.3 57.4 53.2 23.9 24.6 48.1 34.5 21.4 24.7 20.2 34.7 32.5 81.6 32.7 26.0 29.9 56.2 34.8 37.8 19.2 45.3 24.7 34.4 54.2 22.4 20.9 52.9 39.5 22.6 25.9 29.9 28.9 18.1 41.3 30.1 52.6 27.5 17.9 61.9 62.5 26.3 56.0 42.1 34.8 79.3 49.5 47.2 20.7 47.7 50.6 41.1 65.4 45.4 15.3 40.6 51.1 42.0 39.0 28.9 29.5 44.8 33.2 17.2 52.0 67.0 21.3 27.6 32.0 19.5 16.2 21.2 18.0 14.3 11.3 16.4 15.6 15.6 12.9 23.0 14.9 13.5 28.8 17.3 15.6 23.3 14.2 9.7 11.0 12.0 16.0 12.3 8.6 8.3 10.7 10.2 11.1 4.4 12.7 19.9 34.3 19.2 19.2 130.6 64.9 17.5 23.4 26.9 32.5 39.7 30.5 26.7 31.5 25.8 24.7 22.0 52.1 23.8 36.9 24.4 3.9 24.1 86.8 29.3 44.8 29.9 28.1 31.7 74.4 21.0 21.8 27.6 45.3 40.6 18.9 55.8 18.9 41.7 19.7 50.5 76.4 22.2 10.2 25.8 18.1 167.0 35.8 26.9 12.4 71.2 31.2 19.7 51.5 64.3 104.0 25.4 30.3 37.6 170.6 34.9 20.7 14.3 22.6 46.8 13.1 34.7 28.5 80.4 51.9 35.3 20.2 26.5 38.9 81.3 23.8 28.8 EIF2D LGTN ENSG00000143486 "Eukaryotic translation initiation factor 2D" P41214 1 206571292-206612465 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028220 Approved Supported "Nuclear bodies,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Cytosol "Nuclear bodies" "HPA028220: AB_10602022" "unprognostic (1.67e-2)" "unprognostic (2.44e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (4.09e-3)" "unprognostic (2.39e-1)" "unprognostic (2.20e-3)" "unprognostic (6.60e-2)" "unprognostic (1.45e-1)" "unprognostic (3.93e-1)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (3.54e-1)" "unprognostic (1.97e-1)" "unprognostic (8.32e-2)" "unprognostic (2.13e-2)" 32.7 32.5 18.1 18.8 20.4 33.0 43.3 19.0 21.0 37.8 22.0 37.9 21.9 35.5 31.9 32.4 42.7 23.9 25.6 17.5 19.1 31.0 31.3 24.4 32.7 19.9 19.7 60.3 41.3 43.6 23.5 27.4 20.1 30.0 32.6 9.8 47.1 30.1 54.1 34.0 24.3 38.1 19.3 23.4 35.7 18.3 19.6 37.0 35.6 51.7 38.6 31.7 31.8 22.1 63.4 38.3 30.6 26.7 88.2 115.1 37.2 34.9 71.7 61.8 60.4 31.3 53.6 106.7 26.5 71.5 19.7 43.6 50.3 78.8 54.4 35.2 66.2 37.5 44.4 59.5 97.2 68.6 36.9 105.9 103.2 49.1 96.9 78.4 79.4 77.0 88.8 48.5 54.5 49.6 61.8 31.7 25.1 46.9 57.9 49.4 65.5 118.4 63.0 23.2 28.6 26.3 30.7 80.9 76.4 45.5 62.0 52.9 56.1 33.9 34.0 15.9 47.2 44.1 26.3 74.4 45.7 45.7 25.9 15.1 17.6 2.8 19.2 16.7 25.9 32.7 26.4 23.6 28.9 26.9 33.7 24.7 0.4 30.0 25.1 15.3 26.3 17.7 18.1 20.4 19.0 21.0 17.5 19.1 19.9 19.7 20.1 19.3 19.6 22.1 18.1 16.0 17.5 15.0 24.1 14.4 37.6 24.3 23.3 10.6 24.6 22.9 10.1 20.0 19.1 11.0 4.2 40.7 15.2 9.4 25.4 19.9 41.3 18.8 17.5 20.9 4.9 26.9 11.4 20.0 26.6 21.6 17.3 12.6 17.7 24.8 23.6 11.4 22.1 3.3 10.7 14.8 24.4 17.2 11.7 16.1 28.9 12.7 17.8 6.5 23.3 12.0 14.4 14.1 17.6 14.4 15.0 27.4 22.9 23.7 15.2 28.8 17.1 14.3 19.7 23.3 23.3 26.4 10.4 31.5 23.2 25.6 20.6 32.7 27.6 30.5 EIF4H "KIAA0038, WBSCR1, WSCR1" ENSG00000106682 "Eukaryotic translation initiation factor 4H" Q15056 7 74174231-74197122 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 990.0;Late spermatids: 2765.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030542 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 750000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Nucleoplasm, Nuclear bodies" "HPA030542: AB_10601368" "unprognostic (2.83e-1)" "unprognostic (9.50e-2)" "unprognostic (2.36e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.15e-4)" "unprognostic (1.61e-2)" "unprognostic (2.72e-3)" "unprognostic (1.79e-1)" "unprognostic (2.99e-2)" "unprognostic (1.72e-2)" "unprognostic (2.52e-1)" "unprognostic (1.07e-2)" "unprognostic (3.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.68e-2)" "unprognostic (1.27e-2)" 186.9 174.9 151.0 117.8 159.3 283.3 168.3 163.8 157.3 179.8 129.6 208.4 130.2 186.4 76.6 249.3 163.6 100.0 171.0 149.9 151.9 156.6 197.0 158.4 130.3 161.9 156.9 181.2 226.4 160.7 119.9 162.8 162.2 150.3 100.2 149.8 170.1 125.1 399.8 230.9 148.9 119.2 165.2 137.4 192.9 79.9 164.6 150.2 141.2 173.4 137.2 175.3 179.7 187.1 526.3 341.4 251.3 303.1 220.8 231.8 283.4 359.8 276.3 300.3 289.5 423.3 388.6 444.3 96.6 338.8 424.2 266.6 280.5 481.5 286.3 298.0 329.2 247.5 305.2 345.9 253.1 429.0 236.9 273.2 300.8 326.2 460.7 341.5 326.8 260.1 445.8 186.4 305.2 448.2 342.0 516.8 337.6 430.3 328.9 386.9 342.7 401.5 250.9 324.7 252.7 325.4 340.9 420.3 296.0 331.3 476.8 272.4 340.2 411.6 284.6 345.1 474.4 218.8 299.8 771.4 326.3 435.1 441.4 213.7 229.7 245.6 156.9 255.6 164.5 146.4 161.4 158.3 224.2 132.9 183.9 151.7 150.1 193.5 270.2 95.1 194.7 388.0 151.0 159.3 163.8 157.3 149.9 151.9 161.9 156.9 162.2 165.2 164.6 187.1 105.8 83.3 81.2 15.7 97.1 119.2 153.8 101.5 78.0 93.1 103.0 95.5 43.3 68.6 68.7 44.1 25.0 198.8 91.9 98.7 107.6 148.1 990.0 104.8 98.3 103.0 90.4 79.5 25.3 157.7 381.4 101.6 61.2 112.5 122.4 112.1 79.6 95.7 124.2 97.6 24.6 87.2 91.6 101.2 102.7 2765.8 103.8 86.8 72.9 15.9 157.4 134.7 119.4 16.6 44.2 147.0 82.8 110.6 82.7 140.7 84.6 69.0 57.8 72.3 85.5 107.3 117.7 61.2 64.6 90.1 116.1 395.3 92.4 116.9 109.5 140.4 ELF2 "EU32, NERF, NERF-1A, NERF-1B, NERF-2" ENSG00000109381 "E74 like ETS transcription factor 2" Q15723 4 139028112-139177218 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006057, HPA071166" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nuclear bodies" "HPA006057: AB_1078733, HPA071166: AB_2686351" "unprognostic (7.21e-2)" "unprognostic (3.84e-2)" "unprognostic (7.41e-2)" "unprognostic (3.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-2)" "unprognostic (7.05e-3)" "unprognostic (1.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.21e-2)" "unprognostic (2.48e-2)" "unprognostic (3.65e-1)" "unprognostic (3.47e-1)" "unprognostic (1.31e-1)" "unprognostic (4.97e-3)" 23.7 14.2 12.1 15.2 17.3 47.3 24.5 19.2 16.1 21.8 9.6 24.6 15.0 24.7 18.5 17.3 20.7 17.8 20.1 11.1 15.6 15.5 20.4 19.0 19.9 15.6 14.9 28.2 16.7 20.0 22.6 26.8 15.9 21.5 19.2 30.7 21.4 21.7 36.0 23.2 17.6 23.0 13.2 19.6 17.4 37.4 14.5 32.8 23.0 33.6 21.4 19.2 18.4 20.2 15.9 11.3 27.9 21.4 28.2 31.7 26.9 18.4 31.8 19.6 21.8 22.2 31.2 32.3 18.5 25.7 10.4 16.8 41.2 26.3 20.5 20.2 18.6 28.5 26.4 20.0 20.7 32.1 22.1 31.1 24.8 19.3 23.3 25.7 29.5 18.0 46.8 18.4 17.7 27.8 37.8 28.6 17.0 36.4 13.1 36.0 36.8 30.1 25.1 27.2 28.4 32.6 23.1 28.5 17.6 32.4 19.7 38.5 25.0 18.3 15.9 16.7 12.4 40.8 48.6 28.3 13.5 32.4 17.2 13.3 8.3 14.1 12.0 7.2 13.2 17.5 11.8 10.8 9.9 19.3 14.6 13.5 9.1 12.9 7.9 18.0 9.4 5.3 12.1 17.3 19.2 16.1 11.1 15.6 15.6 14.9 15.9 13.2 14.5 20.2 103.0 48.1 22.5 64.0 57.6 53.2 41.1 36.1 120.1 42.0 50.3 40.4 37.0 40.0 39.1 40.5 75.0 32.6 71.9 31.0 43.0 26.4 26.0 60.0 54.3 67.1 47.3 43.5 73.6 24.2 32.3 63.7 35.7 56.3 34.8 44.0 53.2 46.9 22.2 67.3 75.3 38.1 42.7 52.2 40.1 24.6 52.5 59.5 30.2 98.4 49.2 37.3 77.2 83.9 279.4 24.1 33.5 38.0 51.0 52.6 35.9 23.1 48.2 57.7 39.5 81.4 59.2 59.7 42.0 79.0 47.6 23.7 50.7 33.6 27.7 39.6 ELF4 "ELFR, MEF" ENSG00000102034 "E74 like ETS transcription factor 4" Q99607 X 130063955-130110716 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 53.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 34.3;Granulosa cells: 27.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA058595, HPA060277" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 15: RT4 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" Nucleoplasm "HPA058595: AB_2683768, HPA060277: AB_2684239" "unprognostic (1.33e-1)" "unprognostic (8.51e-2)" "unprognostic (3.83e-1)" "unprognostic (2.13e-2)" "unprognostic (1.14e-1)" "unprognostic (1.80e-1)" "unprognostic (4.43e-3)" "unprognostic (7.86e-3)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.29e-2)" "unprognostic (3.95e-1)" "prognostic unfavorable (6.49e-6)" "unprognostic (1.43e-1)" "unprognostic (5.46e-2)" "unprognostic (2.51e-1)" "prognostic favorable (1.42e-4)" 12.2 3.7 1.8 14.6 1.6 53.1 9.6 2.8 2.0 9.4 2.6 18.1 14.2 10.6 2.0 11.7 12.1 9.3 5.6 1.8 2.4 6.0 2.8 15.9 18.3 2.8 2.4 17.5 2.6 4.8 4.2 23.7 2.4 6.1 17.7 0.6 5.5 4.1 2.0 10.9 17.0 10.6 1.5 18.1 20.3 2.6 2.9 19.6 3.9 3.6 18.0 18.8 9.1 3.1 56.0 20.7 3.7 0.4 9.1 19.3 52.6 25.3 32.1 30.4 33.4 28.7 38.9 28.6 49.5 34.8 42.3 35.2 20.5 30.0 29.9 31.0 16.8 56.7 27.3 13.6 20.2 49.7 69.3 20.4 32.6 49.1 48.0 19.0 30.0 6.5 22.0 7.7 16.5 32.8 8.2 28.2 2.4 28.4 19.4 17.6 6.5 12.2 18.3 63.9 13.6 6.0 22.8 21.9 6.9 19.1 11.0 46.9 27.6 21.2 16.6 39.5 47.7 4.2 1.8 22.6 24.6 44.8 5.0 1.6 4.0 5.8 7.1 7.6 5.6 2.6 4.2 6.1 4.5 2.7 4.2 4.8 6.9 6.5 5.5 2.7 4.8 4.2 1.8 1.6 2.8 2.0 1.8 2.4 2.8 2.4 2.4 1.5 2.9 3.1 10.7 9.6 4.4 0.0 8.0 13.6 8.2 2.9 9.1 0.0 2.1 1.5 0.8 0.0 4.4 0.0 0.0 10.6 12.2 24.1 0.0 2.3 0.1 8.9 3.8 8.4 9.0 7.4 0.2 4.0 34.3 6.4 17.9 17.1 1.3 27.5 6.4 1.0 9.7 0.0 0.3 8.3 2.0 12.2 9.2 0.6 1.8 14.8 3.6 5.6 13.1 0.0 16.5 0.0 1.2 9.1 17.4 1.2 2.0 7.5 11.6 0.3 5.4 0.0 6.6 2.6 2.5 0.0 4.0 6.5 10.4 11.2 9.5 5.2 7.1 18.9 ELL "C19orf17, ELL1, Men, PPP1R68" ENSG00000105656 "Elongation factor for RNA polymerase II" P55199 19 18442663-18522116 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 297.2;Late spermatids: 235.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004202, HPA046076" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA004202: , HPA046076: AB_2679526" "unprognostic (9.49e-2)" "unprognostic (1.38e-1)" "unprognostic (3.26e-3)" "unprognostic (2.07e-1)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (8.26e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-1)" "unprognostic (3.00e-2)" "unprognostic (6.28e-3)" "unprognostic (2.38e-2)" "unprognostic (1.57e-1)" "unprognostic (2.07e-1)" "unprognostic (5.12e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.1 7.7 4.0 9.0 6.2 29.8 11.8 8.4 7.0 11.2 5.0 10.6 6.5 11.0 2.0 10.3 10.6 5.7 10.5 3.6 4.2 12.6 14.1 16.6 7.6 4.7 4.2 13.0 10.0 4.1 11.3 10.0 3.8 9.9 2.3 1.2 8.3 3.6 20.1 15.3 12.8 3.6 4.0 17.3 10.1 38.5 6.1 6.8 8.2 9.9 4.3 10.5 11.0 3.9 12.7 5.7 3.2 6.8 3.4 4.2 22.7 10.0 8.8 7.5 7.1 7.1 9.8 15.6 11.8 6.7 5.2 8.6 4.7 11.1 3.8 13.3 10.9 9.4 5.9 6.3 5.2 10.3 11.8 8.6 9.3 9.8 7.7 5.6 5.4 8.5 13.5 21.8 4.0 10.3 12.5 11.9 10.6 7.8 16.8 10.9 4.8 17.4 5.3 8.8 5.7 6.4 7.4 12.3 11.0 4.1 6.4 12.4 9.0 8.6 6.6 11.6 9.3 34.8 23.4 11.7 11.4 17.6 12.5 0.3 5.9 4.5 4.5 4.1 7.3 2.9 2.6 3.9 5.0 2.1 1.7 2.7 18.1 2.3 2.1 8.6 3.1 4.1 4.0 6.2 8.4 7.0 3.6 4.2 4.7 4.2 3.8 4.0 6.1 3.9 12.3 6.4 6.1 9.1 16.3 28.0 26.4 11.9 23.3 4.5 19.7 10.7 5.1 11.5 7.2 3.7 4.2 47.5 29.5 15.2 11.7 8.7 297.2 22.9 16.0 11.4 19.7 10.3 9.1 8.0 17.6 17.2 12.8 37.7 11.4 5.1 7.5 15.5 19.3 1.7 11.2 10.1 6.1 12.8 21.7 235.9 6.5 20.4 7.2 9.4 13.8 5.3 4.1 7.1 8.0 10.8 3.7 3.0 53.6 14.2 11.8 7.0 8.4 3.4 19.7 13.0 16.7 18.2 24.7 19.4 30.4 68.7 19.2 5.9 7.1 19.9 EME1 "FLJ31364, MMS4L, SLX2A" ENSG00000154920 "Essential meiotic structure-specific endonuclease 1" Q96AY2 17 50373220-50381483 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.4;epididymis: 6.3;testis: 5.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 33 "basophil: 18.6" "Lineage enriched" "Detected in single" 33 "granulocytes: 18.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB016127, HPA052188" Supported Approved "Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Cytosol" "CAB016127: AB_2278026, HPA052188: " "unprognostic (3.81e-1)" "unprognostic (7.72e-2)" "unprognostic (6.49e-2)" "unprognostic (2.45e-3)" "unprognostic (2.74e-1)" "unprognostic (1.94e-2)" "unprognostic (9.94e-5)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.02e-2)" "unprognostic (4.37e-3)" "unprognostic (2.83e-3)" "unprognostic (0.00e+0)" "unprognostic (9.82e-2)" "unprognostic (1.26e-1)" "unprognostic (3.71e-1)" "unprognostic (3.41e-1)" 0.5 0.3 0.2 1.7 0.3 4.4 0.6 0.1 0.4 0.5 0.0 0.9 0.8 0.4 6.3 1.1 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.4 2.3 0.3 0.2 0.5 0.2 0.1 0.1 1.4 0.3 0.2 1.3 0.4 0.5 0.1 0.2 1.1 0.7 0.6 0.1 0.9 0.5 5.7 0.3 3.3 0.2 0.0 2.6 0.4 0.5 0.4 13.9 20.0 26.2 13.7 1.2 2.6 18.8 14.2 5.4 19.3 17.7 31.7 11.0 11.0 18.3 5.7 12.0 10.7 24.5 11.3 27.3 21.7 19.3 26.3 23.3 14.8 0.1 10.9 8.4 0.5 0.8 22.3 9.2 2.6 4.5 31.2 16.3 25.6 11.6 15.2 25.0 13.9 15.1 14.2 13.6 25.5 50.7 15.4 4.3 5.6 10.1 20.2 8.7 4.8 8.1 20.9 16.8 12.3 3.1 24.8 14.9 16.6 19.7 16.0 17.4 10.5 7.8 12.2 15.6 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.3 0.1 0.4 0.1 0.1 0.3 0.2 0.3 0.1 0.3 0.4 0.1 0.0 1.1 0.3 0.8 0.1 0.3 0.5 0.6 1.5 0.5 0.3 0.4 0.0 0.7 0.0 0.0 4.6 0.5 0.6 0.0 0.3 0.5 0.8 0.7 0.4 0.0 3.8 0.1 0.0 4.8 0.8 2.0 0.5 0.0 4.5 0.0 0.3 2.2 0.0 0.1 0.9 0.0 0.0 1.4 0.6 0.6 0.8 0.0 0.0 1.0 0.5 1.0 0.0 0.3 0.1 0.0 0.0 2.5 0.1 0.1 0.0 0.9 0.3 0.0 0.6 1.0 13.2 9.1 1.5 0.1 1.1 0.5 0.6 1.3 0.2 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815013-127854658 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 528.7" "Cell type enhanced" "Detected in many" "Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1" "Group enriched" "Detected in many" 4 "dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" NA NA 280000000 "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favorable (6.61e-4)" "prognostic favorable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 234.5 92.6 44.4 80.2 41.5 18.8 164.8 45.2 44.5 129.7 50.4 62.4 33.2 111.1 35.1 43.1 122.4 58.7 528.7 36.7 43.1 211.6 60.7 260.7 43.4 50.0 47.1 220.9 47.1 29.7 56.1 93.6 52.8 93.9 17.5 2.1 46.2 73.5 72.3 51.3 76.8 65.7 43.1 226.5 57.6 98.9 59.4 17.3 169.2 54.8 17.7 93.0 95.8 43.6 1.3 1.0 7.1 0.4 117.8 81.0 217.8 147.1 102.0 74.4 43.4 0.5 1.3 1.0 70.2 263.8 56.8 2.4 0.0 23.2 24.5 0.7 0.3 42.3 76.7 4.6 91.7 20.2 0.5 137.6 5.4 97.7 34.9 1.0 487.4 1.4 0.7 1.4 88.1 0.9 0.6 1.8 1.7 0.3 4.2 66.9 12.5 1.4 0.0 0.4 0.8 1.8 78.0 65.3 20.1 4.7 13.8 29.8 1027.5 248.1 13.7 164.7 0.7 5.2 1.2 0.9 67.1 52.0 83.2 0.0 19.9 0.5 1.8 28.2 0.6 0.6 3.0 3.4 10.3 1.4 1.9 3.0 0.5 7.6 22.1 3.8 1.2 8.4 44.4 41.5 45.2 44.5 36.7 43.1 50.0 47.1 52.8 43.1 59.4 43.6 407.5 3.2 16.0 2.0 9.2 12.0 2.3 2.1 2.8 2.8 9.5 9.8 28.4 18.6 2.3 3.7 4.2 30.0 8.6 0.4 0.0 10.2 8.6 7.7 67.9 514.4 2.4 49.2 0.6 1.1 294.4 85.7 3.1 8.1 15.2 0.8 579.0 9.8 132.0 0.0 0.7 1.6 0.0 65.4 29.7 51.4 487.1 56.6 24.9 78.7 36.2 2.0 4.1 1.5 1.1 1.4 0.0 1421.8 2.1 2.0 0.0 0.3 5.1 4.6 72.3 44.0 57.5 4.4 5.2 1.3 8.4 376.4 9.6 308.1 0.5 1.4 ENOPH1 "E1, MASA, mtnC" ENSG00000145293 "Enolase-phosphatase 1" Q9UHY7 4 82430590-82461177 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Methionine biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004985, HPA044607" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA 240000 "Cluster 39: Non-specific - mRNA processing" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Nuclear bodies" "CAB004985: AB_426046, HPA044607: AB_2679019" "unprognostic (6.64e-3)" "unprognostic (3.05e-1)" "unprognostic (6.77e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.68e-3)" "prognostic unfavorable (1.74e-5)" "unprognostic (9.99e-3)" "unprognostic (1.18e-1)" "unprognostic (2.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (9.30e-3)" "unprognostic (3.68e-2)" "unprognostic (2.22e-1)" "unprognostic (6.52e-3)" "unprognostic (3.52e-2)" 17.0 24.2 61.3 21.2 70.0 26.6 26.2 69.8 102.7 20.7 52.3 21.1 20.3 16.7 35.9 23.5 16.5 14.7 18.7 60.0 66.6 33.5 22.1 18.3 29.0 70.5 67.4 19.8 23.5 34.1 20.6 29.1 69.1 26.6 23.9 42.0 19.2 18.0 18.1 21.8 18.5 17.9 68.1 22.2 22.3 10.6 65.9 30.8 28.6 18.7 31.6 21.9 17.8 80.1 56.6 36.6 64.3 40.4 38.3 37.6 69.7 63.7 42.6 57.2 50.6 67.3 61.3 110.8 64.8 49.0 62.6 29.8 86.1 81.3 103.3 67.2 39.2 67.1 33.7 91.0 62.0 113.3 56.0 36.5 84.9 59.7 70.6 41.4 58.8 69.2 88.3 60.1 76.1 73.2 125.8 67.6 59.2 141.8 28.8 88.1 98.2 61.0 94.7 55.5 90.5 55.2 36.2 109.7 86.3 57.3 49.4 54.5 43.3 70.9 52.8 71.2 85.7 67.5 62.4 138.5 45.9 69.5 97.5 5.8 13.9 7.2 21.8 17.1 27.1 20.2 25.9 25.0 20.5 16.9 29.4 24.2 1.2 24.7 14.9 22.4 30.4 20.6 61.3 70.0 69.8 102.7 60.0 66.6 70.5 67.4 69.1 68.1 65.9 80.1 24.6 16.0 10.5 9.4 31.8 68.6 40.8 47.3 30.7 36.6 22.9 19.8 13.5 18.6 27.5 12.9 16.7 86.7 24.7 10.7 88.0 48.1 7.7 15.2 14.2 25.6 29.3 24.6 18.5 25.7 61.3 22.4 15.3 19.5 38.1 15.3 17.9 10.8 57.7 28.6 21.4 24.8 61.1 23.2 27.9 5.1 26.4 23.1 39.2 6.5 35.6 62.8 29.9 15.1 37.9 41.1 11.1 24.0 28.0 52.6 17.7 56.2 18.8 37.7 13.1 16.4 23.8 9.0 24.9 37.8 64.1 46.7 34.3 27.5 26.7 39.9 EPB41 "4.1R, EL1" ENSG00000159023 "Erythrocyte membrane protein band 4.1" P11171 1 28887091-29120046 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Actin-binding, Calmodulin-binding" "Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 80.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 42.2" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 136.3;K-562: 136.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 8 "cerebellum: 105.6" "HPA028076, HPA028096, HPA028412, HPA028414" Supported Supported "Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes No 1100000 "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Plasma membrane, Cell Junctions" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366" "unprognostic (2.16e-1)" "unprognostic (1.96e-1)" "unprognostic (8.92e-3)" "prognostic unfavorable (4.58e-4)" "unprognostic (5.00e-2)" "prognostic favorable (5.87e-4)" "unprognostic (5.01e-3)" "unprognostic (5.40e-3)" "unprognostic (2.52e-2)" "unprognostic (6.65e-2)" "unprognostic (7.81e-2)" "unprognostic (1.42e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (2.66e-2)" "unprognostic (2.42e-1)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 11.0 10.2 1.8 21.9 18.3 63.3 14.1 42.2 6.0 14.5 4.9 23.6 17.7 10.2 5.3 16.6 6.3 15.0 9.7 1.2 4.7 12.7 21.7 15.1 37.4 8.2 5.6 16.3 18.8 15.5 4.7 7.2 8.5 15.0 23.1 80.0 19.1 9.1 15.9 15.3 23.3 9.9 3.5 22.9 27.0 10.4 4.7 69.0 15.2 13.8 37.0 15.5 1.9 3.0 27.0 6.9 62.3 29.4 5.2 0.8 19.5 6.9 10.1 8.4 10.5 16.8 31.2 49.1 17.2 9.2 13.5 11.9 78.7 6.6 8.6 86.4 23.8 136.3 19.7 28.6 10.1 45.8 88.2 1.7 18.4 8.2 13.8 19.9 14.1 73.5 136.5 36.2 0.1 8.8 72.3 30.4 62.0 44.1 10.0 110.9 28.2 68.3 7.7 33.3 78.0 60.5 19.7 19.2 43.3 21.7 14.7 18.2 1.2 0.3 13.3 12.9 13.4 52.5 72.4 85.2 12.1 47.8 6.8 33.3 3.2 21.4 12.9 1.1 15.4 17.2 18.3 14.1 4.4 13.6 22.1 12.7 44.2 10.9 1.5 4.4 28.9 15.3 1.8 18.3 42.2 6.0 1.2 4.7 8.2 5.6 8.5 3.5 4.7 3.0 25.3 19.2 71.7 20.2 58.2 10.5 8.6 7.8 15.4 151.6 20.0 12.2 21.5 20.0 16.8 16.5 137.6 2.4 75.3 26.5 17.6 17.1 16.4 11.3 4.1 15.1 41.6 187.1 76.3 18.7 4.2 7.9 29.6 29.1 24.1 24.9 17.5 30.0 7.1 21.9 61.7 29.0 16.2 23.7 9.0 22.7 2.1 32.4 0.0 78.7 29.3 15.7 85.5 7.5 4.8 28.6 20.3 2.2 46.7 12.2 32.8 13.4 15.2 171.4 13.1 2.8 8.5 39.3 55.7 14.9 16.8 4.1 71.6 4.2 33.0 12.6 ERCC4 "FANCQ, RAD1, XPF" ENSG00000175595 "ERCC excision repair 4, endonuclease catalytic subunit" Q92889 16 13920154-13952348 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.5" "Cell type enhanced" "Detected in many" "Early spermatids: 140.7;Late spermatids: 117.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000156, HPA045828" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "CAB000156: , HPA045828: AB_2679463" "unprognostic (2.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.12e-3)" "unprognostic (9.41e-2)" "unprognostic (3.35e-1)" "unprognostic (1.40e-2)" "unprognostic (1.64e-2)" "unprognostic (2.26e-1)" "unprognostic (3.59e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (5.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (6.30e-2)" "unprognostic (5.88e-4)" 2.7 3.9 4.7 3.3 5.2 2.5 2.8 6.7 5.4 3.3 4.3 1.9 1.7 3.3 2.8 2.9 3.5 3.0 3.6 4.3 4.9 2.9 3.2 2.7 3.3 5.1 4.8 4.3 2.7 3.9 1.6 2.6 4.9 3.6 2.2 4.1 2.8 2.9 18.5 3.0 1.9 3.6 4.4 3.7 2.6 5.5 5.4 4.2 4.4 3.3 2.9 2.6 1.5 6.8 4.7 5.5 5.3 7.5 8.7 8.1 4.0 6.1 6.4 5.4 6.8 2.1 4.5 7.8 8.6 5.4 4.8 5.8 8.0 4.1 8.3 10.7 4.7 3.8 6.7 5.2 7.9 5.2 4.2 6.1 5.7 7.1 6.0 5.3 7.2 4.6 6.1 8.8 7.6 3.9 7.0 3.4 3.9 2.4 3.1 7.8 10.8 9.7 3.3 3.2 4.3 5.1 7.5 6.0 5.8 4.2 7.5 3.9 7.9 7.8 5.7 7.0 5.4 7.9 9.9 5.2 7.6 6.2 8.1 4.9 2.3 2.3 2.6 2.7 2.9 2.5 2.4 2.0 2.3 3.1 2.4 2.6 2.7 3.6 2.4 3.2 2.5 1.1 4.7 5.2 6.7 5.4 4.3 4.9 5.1 4.8 4.9 4.4 5.4 6.8 14.0 19.2 13.5 16.6 11.3 4.8 6.1 18.3 10.2 0.0 10.0 9.5 8.6 14.3 12.7 5.5 0.0 17.3 9.7 3.3 9.8 11.6 140.7 18.6 19.0 13.5 9.6 12.0 20.4 8.4 6.2 13.0 5.1 7.4 1.3 17.8 17.2 17.7 11.7 0.0 21.2 4.8 10.2 13.6 6.5 117.9 14.9 11.4 10.6 8.4 14.4 0.0 17.5 12.1 20.1 9.9 1.7 21.1 14.4 10.2 4.4 13.3 26.1 0.0 26.3 17.3 12.2 49.4 28.9 9.2 5.5 12.3 11.8 18.0 6.0 4.7 ERCC6 "ARMD5, CKN2, CSB, RAD26" ENSG00000225830 "ERCC excision repair 6, chromatin remodeling factor" "P0DP91, Q03468" 10 49454168-49539538 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 53.8;hTERT-RPE1: 123.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071297 Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "HPA071297: AB_2732177" "unprognostic (1.92e-2)" "unprognostic (1.85e-1)" "unprognostic (9.79e-3)" "unprognostic (7.26e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-2)" "unprognostic (3.03e-2)" "unprognostic (2.99e-2)" "unprognostic (1.71e-2)" "unprognostic (1.13e-1)" "unprognostic (1.80e-1)" "unprognostic (4.57e-2)" "unprognostic (1.04e-1)" "unprognostic (8.61e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" 2.7 2.1 1.6 1.9 1.5 4.6 3.8 3.0 2.3 3.1 7.7 2.4 2.0 3.0 1.5 3.8 2.9 2.7 3.4 1.2 1.1 3.2 3.3 2.7 2.9 2.4 1.9 4.5 3.1 5.9 2.8 3.4 2.1 3.3 2.7 3.1 3.2 2.2 3.5 4.6 2.5 2.3 2.2 2.9 2.4 3.1 2.1 3.3 5.1 3.6 3.4 2.6 3.3 1.9 11.2 5.5 4.1 2.1 6.6 10.5 3.4 21.2 27.1 14.1 9.9 6.2 5.6 4.9 3.7 18.7 6.7 9.5 6.3 16.6 13.5 8.4 4.1 3.9 21.7 3.4 3.9 5.0 3.7 4.3 17.2 12.9 53.8 123.4 19.8 2.9 6.8 0.8 16.8 8.3 3.4 2.0 4.0 3.5 10.2 2.3 5.8 2.6 4.1 7.1 5.9 4.7 15.4 3.6 8.2 9.4 7.1 2.7 38.9 7.0 5.5 8.6 5.2 3.3 4.5 4.1 7.3 5.0 5.1 13.1 3.0 7.5 4.1 2.6 3.0 6.8 2.3 2.2 3.9 5.2 2.8 1.4 7.2 1.2 5.3 2.2 3.1 1.8 1.6 1.5 3.0 2.3 1.2 1.1 2.4 1.9 2.1 2.2 2.1 1.9 6.9 16.0 13.2 14.7 6.0 3.6 1.4 1.5 5.2 0.0 7.1 7.1 7.1 5.7 8.2 9.2 0.0 2.5 10.9 4.8 5.9 5.2 11.3 8.1 8.7 5.1 1.2 1.3 24.3 6.0 2.1 4.9 2.0 10.1 7.6 8.9 5.3 4.3 2.6 0.0 21.7 5.3 0.0 4.4 2.6 15.3 2.8 8.0 1.8 23.4 11.2 0.0 4.1 17.6 16.6 5.2 2.6 2.2 3.6 2.5 5.0 3.6 9.0 0.0 6.6 4.4 4.2 5.3 5.0 3.5 4.1 1.8 7.4 11.4 2.8 1.9 ESRP1 "FLJ20171, RBM35A" ENSG00000104413 "Epithelial splicing regulatory protein 1" Q6NXG1 8 94641074-94707466 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA023719, HPA023720, HPA067104" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" Nucleoplasm "HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779" "prognostic unfavorable (9.28e-4)" "unprognostic (7.12e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (4.12e-1)" "unprognostic (6.99e-3)" "unprognostic (2.70e-1)" "unprognostic (2.61e-2)" "unprognostic (5.19e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (4.48e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.96e-2)" "unprognostic (1.29e-1)" 0.2 0.0 0.0 5.2 0.0 0.0 24.2 0.0 0.0 15.5 0.0 57.1 25.2 3.4 29.6 64.2 21.3 8.5 0.1 0.0 0.0 8.5 0.4 15.8 0.0 0.0 0.1 0.1 42.6 28.4 7.2 12.2 0.0 19.9 62.8 0.0 25.9 10.0 0.1 60.6 22.0 2.5 0.0 0.0 38.6 0.6 0.4 5.2 36.6 0.0 15.3 22.5 28.8 0.0 138.3 0.0 0.0 0.2 0.0 0.0 101.1 0.0 0.0 0.0 0.0 44.6 140.8 0.0 3.8 0.0 0.1 81.6 3.8 70.9 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 226.5 0.0 1.4 0.0 0.0 10.7 0.0 0.0 0.0 67.3 1.9 0.4 12.4 142.6 3.4 0.0 0.0 18.3 17.4 99.1 35.1 0.3 0.0 21.0 14.0 21.4 108.0 0.9 0.0 0.1 0.2 0.1 0.3 12.0 13.8 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.2 38.5 36.7 0.0 0.6 44.6 18.9 30.4 35.9 0.0 29.4 18.0 1.0 21.5 32.4 27.6 0.0 55.1 0.5 76.2 13.7 19.6 12.9 47.1 3.7 0.9 33.1 0.0 2.6 27.5 69.1 0.9 58.1 46.5 1.3 0.0 0.4 0.1 6.0 0.0 0.4 107.2 16.2 0.0 3.2 10.3 0.0 0.5 24.9 0.0 0.6 0.0 0.0 0.5 0.4 21.7 48.1 0.7 1.8 25.1 25.5 0.3 35.0 0.0 0.0 0.0 1.2 0.6 0.9 71.3 79.1 62.1 0.8 0.0 73.9 40.1 EVI2A "EVDA, EVI2" ENSG00000126860 "Ecotropic viral integration site 2A" P22794 17 31316410-31321749 "Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 155.7;lymphoid tissue: 105.1" "Cell type enhanced" "Detected in many" "granulocytes: 81.4;Hofbauer cells: 114.2;Kupffer cells: 240.6;Langerhans cells: 112.5;Macrophages: 112.0;monocytes: 195.8;NK-cells: 87.6;Oligodendrocytes: 218.9;T-cells: 116.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 57.1;Karpas-707: 99.1;RPMI-8226: 160.7" "Low region specificity" "Detected in all" "HPA045033, HPA057051" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Nuclear bodies" "HPA045033: AB_2679191, HPA057051: AB_2683321" "unprognostic (7.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.48e-2)" "unprognostic (1.39e-2)" "unprognostic (8.49e-2)" "unprognostic (4.89e-2)" "unprognostic (1.88e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.55e-4)" "unprognostic (1.90e-1)" "unprognostic (3.54e-2)" "unprognostic (3.15e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (7.64e-2)" "unprognostic (4.95e-2)" "unprognostic (5.87e-2)" "unprognostic (2.90e-2)" 10.9 7.9 72.3 47.9 106.9 31.2 8.1 98.9 126.4 8.1 53.3 11.3 11.0 3.6 1.4 6.0 2.8 17.9 4.2 73.2 82.1 2.9 9.6 20.1 53.6 105.0 89.1 2.4 2.8 2.3 1.4 21.0 109.1 3.8 13.6 0.9 4.0 3.2 0.9 1.9 12.2 7.1 88.3 38.2 12.8 1.8 83.3 105.1 2.5 3.7 40.8 20.3 2.8 155.7 0.1 0.1 0.0 0.0 4.9 30.0 0.1 4.1 6.6 5.0 17.3 0.0 1.5 26.2 0.0 5.3 29.0 0.1 0.0 0.3 14.3 0.0 0.2 0.1 0.1 0.1 57.1 31.5 33.4 37.6 0.0 7.2 20.0 7.7 1.8 24.7 1.1 99.1 39.4 0.6 22.9 35.3 0.0 0.0 0.0 23.8 3.9 160.7 0.5 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 34.5 11.6 21.5 0.6 0.9 14.8 44.2 0.0 30.1 17.1 23.0 18.1 6.0 91.0 3.6 36.0 44.6 44.0 28.5 51.0 42.6 62.4 14.7 60.4 53.8 177.1 32.4 35.8 20.4 60.9 95.1 72.3 106.9 98.9 126.4 73.2 82.1 105.0 89.1 109.1 88.3 83.3 155.7 1.2 0.0 5.6 1.3 48.3 4.0 0.4 0.4 0.0 0.3 0.7 0.9 0.7 0.0 1.3 0.0 0.0 0.7 68.7 0.1 0.0 0.2 2.8 0.3 0.5 2.7 0.0 8.8 0.8 0.0 0.8 2.2 4.1 0.9 81.4 0.0 6.1 1.6 114.2 0.0 0.8 0.1 2.0 240.6 112.5 1.6 0.3 112.0 14.2 9.4 195.8 0.5 87.6 1.0 218.9 0.0 0.0 0.0 53.6 0.3 0.0 0.6 1.6 1.0 0.0 0.7 1.2 0.2 0.3 0.4 3.1 1.4 116.0 0.1 0.6 0.4 EVI5L ENSG00000142459 "Ecotropic viral integration site 5 like" Q96CN4 19 7830233-7864976 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 30.5;Horizontal cells: 33.7;Late spermatids: 32.6;Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "U-2197: 53.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043099, HPA043563" Approved Approved "Nuclear bodies" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Nuclear bodies" "HPA043099: AB_10796685, HPA043563: AB_2678556" "unprognostic (3.90e-2)" "unprognostic (4.69e-2)" "unprognostic (9.29e-3)" "unprognostic (2.18e-2)" "unprognostic (1.74e-1)" "unprognostic (1.34e-2)" "unprognostic (2.06e-3)" "unprognostic (1.90e-2)" "unprognostic (7.66e-2)" "unprognostic (3.00e-1)" "unprognostic (7.48e-3)" "unprognostic (1.97e-2)" "prognostic favorable (2.18e-6)" "unprognostic (1.07e-1)" "unprognostic (1.70e-1)" "unprognostic (1.37e-2)" "unprognostic (2.04e-2)" 6.8 10.4 29.5 5.0 30.2 3.1 6.6 23.0 35.2 9.4 2.5 13.4 4.9 11.2 4.6 10.6 8.4 5.1 17.1 30.5 27.6 11.6 6.3 7.2 4.2 34.1 28.5 7.3 6.3 8.8 16.4 7.9 29.8 12.1 4.1 11.1 7.5 9.1 20.5 13.7 6.9 8.7 21.3 8.1 9.3 36.1 32.1 6.4 8.6 14.9 4.4 11.1 9.0 41.1 13.5 2.7 10.5 15.4 18.8 15.7 29.5 19.7 20.5 13.8 14.7 1.1 5.0 3.4 23.1 26.9 7.3 9.1 3.8 13.4 12.7 19.6 12.7 2.6 6.3 2.2 23.7 3.1 6.7 14.7 15.9 6.8 31.9 11.4 16.9 17.5 3.1 17.8 14.4 13.8 10.8 6.8 3.9 10.0 28.4 13.0 8.7 10.0 8.3 11.3 4.3 10.3 18.3 8.1 5.8 7.0 6.8 9.9 16.7 9.4 4.4 53.6 7.4 25.7 6.2 4.6 15.9 7.5 8.3 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.1 0.1 1.1 0.1 0.2 0.0 29.5 30.2 23.0 35.2 30.5 27.6 34.1 28.5 29.8 21.3 32.1 41.1 3.6 0.0 5.1 13.1 1.6 3.8 2.2 2.4 2.2 30.5 3.6 3.3 4.0 2.8 1.8 9.2 18.8 3.7 1.6 7.4 0.0 2.4 14.8 2.2 4.3 3.8 5.4 1.3 16.3 2.6 16.9 3.1 6.1 4.2 0.0 5.7 3.6 2.0 3.8 33.7 19.7 4.2 6.1 2.5 1.1 32.6 4.1 2.8 3.6 9.4 1.1 7.1 1.0 50.3 69.8 3.0 3.5 4.5 2.0 2.5 1.7 4.1 1.8 18.8 6.6 2.0 4.0 18.3 7.3 3.6 4.1 3.4 2.2 8.2 3.4 5.1 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377778-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 16.9;skin 1: 6.0;vagina: 8.6" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.1;Basal squamous epithelial cells: 8.0;Spermatogonia: 5.8;Squamous epithelial cells: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.2;HaCaT: 1.1;HeLa: 2.4;hTCEpi: 7.1;RT4: 2.5;SiHa: 1.3;T-47d: 2.1" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.1 0.1 0.0 0.2 16.9 0.1 0.0 0.0 0.0 0.0 1.2 2.5 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.2 0.0 0.0 1.9 0.2 0.0 6.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.4 1.1 0.0 0.1 2.2 8.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.5 0.3 0.0 1.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.5 1.6 1.3 8.0 0.0 0.1 0.6 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 5.8 10.9 1.3 0.0 0.0 0.0 0.2 1.0 EXO1 "HEX1, hExoI" ENSG00000174371 "Exonuclease 1" Q9UQ84 1 241847967-241895148 "Predicted intracellular proteins" "DNA damage, DNA excision, DNA repair, Immunity, Meiosis" "DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.3;lymphoid tissue: 11.1" "Cell type enhanced" "Detected in some" "Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053079, HPA069738" Enhanced "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA053079: AB_2682037, HPA069738: AB_2732140" "unprognostic (6.33e-3)" "unprognostic (8.54e-3)" "unprognostic (9.47e-3)" "prognostic unfavorable (8.21e-4)" "unprognostic (2.43e-1)" "unprognostic (6.34e-2)" "prognostic unfavorable (6.94e-7)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.40e-2)" "unprognostic (4.81e-3)" "unprognostic (9.40e-2)" "unprognostic (0.00e+0)" "unprognostic (6.72e-2)" "unprognostic (2.29e-1)" "unprognostic (1.75e-1)" "unprognostic (3.57e-1)" 0.5 0.3 0.2 3.3 0.2 17.3 1.2 0.1 0.7 0.5 0.1 3.2 2.9 0.8 0.0 2.5 0.3 0.4 0.2 0.3 0.1 0.3 0.5 0.6 5.8 0.1 0.2 0.2 0.3 0.7 0.1 3.3 0.2 0.2 3.7 0.0 0.5 0.2 0.1 1.8 2.5 1.2 0.2 1.5 1.6 5.7 0.3 11.1 0.4 0.0 6.4 1.2 0.8 0.4 41.3 26.8 43.4 28.6 2.7 6.7 36.5 53.4 17.7 46.7 50.5 33.9 22.5 44.3 25.3 12.6 25.1 40.0 55.5 22.5 54.8 69.5 48.4 41.5 28.8 17.3 1.0 59.8 29.4 1.7 1.1 46.8 12.5 5.7 14.7 43.4 84.6 57.0 37.8 19.0 65.9 33.6 60.4 49.7 26.0 46.2 40.5 47.5 9.6 25.6 48.1 60.9 34.8 27.9 19.5 20.2 25.8 36.6 5.5 44.9 39.5 42.7 72.9 41.5 59.0 71.3 15.6 48.1 54.9 0.8 0.2 0.0 0.2 0.0 0.0 0.3 0.2 0.2 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.3 0.2 0.2 0.1 0.7 0.3 0.1 0.1 0.2 0.2 0.2 0.3 0.4 0.2 0.0 0.0 0.3 0.7 0.8 0.1 0.7 0.0 0.0 0.3 0.5 2.3 0.0 0.1 0.0 0.0 5.3 0.2 1.2 0.0 0.1 9.3 0.3 0.4 0.7 0.0 7.4 1.0 0.0 16.7 0.9 1.1 0.5 0.0 4.6 0.4 0.0 3.3 0.0 2.9 0.5 0.0 0.3 0.8 2.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.0 0.0 11.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 9.3 9.8 2.7 0.1 4.0 0.8 0.8 1.9 0.3 EXOC6B "KIAA0919, SEC15B, SEC15L2" ENSG00000144036 "Exocyst complex component 6B" Q9Y2D4 2 72175984-72826041 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 50.7" "Cell type enhanced" "Detected in many" "Astrocytes: 210.3;Excitatory neurons: 351.1;Inhibitory neurons: 393.6;Microglial cells: 286.7;Oligodendrocyte precursor cells: 288.5;Oligodendrocytes: 863.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034546, HPA063991" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034546: AB_2674218, HPA063991: AB_2685168" "unprognostic (5.29e-2)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (1.18e-3)" "unprognostic (1.81e-1)" "unprognostic (7.56e-2)" "unprognostic (1.06e-2)" "unprognostic (9.34e-2)" "unprognostic (1.32e-1)" "unprognostic (2.16e-3)" "unprognostic (3.38e-2)" "unprognostic (2.61e-1)" "unprognostic (4.35e-3)" "unprognostic (4.38e-3)" "unprognostic (1.55e-1)" "unprognostic (1.18e-1)" "unprognostic (5.29e-2)" 11.3 13.4 22.3 4.2 32.7 1.2 8.6 18.8 23.9 12.6 3.2 8.6 7.3 10.1 6.0 15.1 7.8 6.5 50.7 20.7 25.7 7.2 3.8 7.2 3.1 23.9 25.7 15.0 5.0 13.2 6.1 13.0 23.3 8.0 5.7 14.1 7.7 8.9 11.1 26.5 9.1 10.0 16.4 5.2 6.9 6.9 22.2 4.4 10.2 11.5 6.4 9.7 13.0 40.9 21.7 16.3 14.7 17.8 41.2 16.9 25.3 15.6 21.9 13.2 8.6 22.3 3.3 5.6 9.5 26.2 19.6 35.4 12.4 25.7 18.9 4.2 10.1 16.7 11.0 12.8 22.2 2.4 5.5 14.6 36.6 14.9 23.1 20.6 21.8 8.7 1.8 0.0 17.6 7.5 6.4 2.9 15.3 14.9 9.0 3.4 26.4 2.3 12.7 50.1 7.3 6.3 26.7 8.2 10.9 16.1 5.7 2.3 24.3 15.2 12.8 13.1 9.6 5.5 5.9 0.0 17.7 1.2 12.4 1.3 0.5 0.0 0.7 0.4 0.5 0.7 0.5 0.4 0.4 0.7 0.6 0.9 0.0 0.5 0.6 0.1 0.8 0.4 22.3 32.7 18.8 23.9 20.7 25.7 23.9 25.7 23.3 16.4 22.2 40.9 17.8 0.0 4.1 210.3 4.1 26.1 10.2 9.8 14.8 17.4 5.2 5.2 87.1 12.8 5.1 9.2 25.0 15.1 5.0 10.2 5.9 9.3 62.9 5.6 14.5 14.1 3.0 2.1 351.1 11.5 13.2 12.4 30.5 9.2 8.2 11.6 11.4 5.6 4.6 16.8 393.6 6.0 4.1 12.0 7.1 8.2 8.4 5.0 5.4 286.7 2.0 9.9 1.0 288.5 863.3 11.0 8.6 7.5 3.7 8.1 28.2 5.5 8.4 11.1 0.0 13.5 14.7 12.0 4.9 13.1 37.4 24.6 4.7 5.5 4.5 10.7 EXOSC1 "CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p" ENSG00000171311 "Exosome component 1" Q9Y3B2 10 97435909-97446017 "Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038370 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" Nucleoplasm "HPA038370: AB_10672515" "unprognostic (1.77e-2)" "unprognostic (1.08e-2)" "unprognostic (1.32e-2)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (1.10e-2)" "unprognostic (3.27e-3)" "unprognostic (2.33e-2)" "unprognostic (1.62e-2)" "unprognostic (7.44e-2)" "unprognostic (1.90e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.88e-9)" "unprognostic (9.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "unprognostic (4.41e-2)" 21.9 25.4 31.4 23.5 34.3 28.7 22.4 50.4 39.9 25.5 27.7 25.6 24.3 24.0 42.6 28.4 22.2 17.0 23.5 29.7 33.6 25.3 26.9 20.5 32.3 33.3 32.2 23.6 38.8 21.1 24.2 17.6 32.6 24.5 23.5 21.2 26.6 17.3 29.0 23.5 22.3 22.1 32.6 30.3 31.2 15.2 32.8 32.5 21.6 14.8 31.9 25.3 22.9 36.3 62.9 49.6 34.8 61.7 42.1 44.3 47.0 52.2 73.9 57.2 64.4 86.5 62.1 60.4 59.0 50.2 44.1 64.0 52.5 58.9 56.6 77.3 61.3 39.5 48.0 68.9 74.5 94.2 46.1 45.8 77.9 69.6 101.3 70.2 66.3 90.5 45.6 108.0 43.2 70.3 88.0 153.3 58.1 64.7 43.2 65.8 43.4 106.4 39.4 32.8 20.4 38.3 38.6 30.0 87.6 44.1 71.2 113.2 43.6 31.9 40.1 50.4 117.6 72.5 103.1 119.5 54.3 113.2 26.3 79.0 91.0 93.5 75.5 132.8 96.5 109.6 93.1 87.9 96.4 94.7 89.4 78.1 35.7 57.9 121.7 82.9 144.0 86.4 31.4 34.3 50.4 39.9 29.7 33.6 33.3 32.2 32.6 32.6 32.8 36.3 22.5 25.6 24.6 15.0 42.4 19.1 35.7 59.3 18.2 31.0 22.5 27.3 20.5 27.1 35.8 44.1 27.1 48.6 41.2 15.4 39.2 36.0 17.4 22.6 24.1 27.7 14.3 23.8 24.7 41.8 58.1 27.0 21.9 16.7 25.3 31.0 34.6 25.3 50.9 30.3 22.2 28.1 36.7 31.4 20.7 17.0 32.6 28.7 30.2 17.8 61.0 29.1 61.8 12.1 25.5 35.9 20.0 24.0 43.6 24.9 30.1 53.8 47.1 48.1 26.3 20.7 35.2 35.8 39.1 27.6 24.4 41.2 44.3 26.4 25.7 31.7 EYA1 BOR ENSG00000104313 "EYA transcriptional coactivator and phosphatase 1" Q99502 8 71197433-71592025 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase" "Deafness, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 18.7;parathyroid gland: 23.7" "Cell type enriched" "Detected in some" 11 "Astrocytes: 214.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 20.7" HPA028917 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear bodies" "HPA028917: AB_2672826" "unprognostic (3.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.72e-3)" "unprognostic (5.95e-2)" "unprognostic (9.17e-2)" "unprognostic (2.91e-4)" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (1.81e-1)" "unprognostic (9.72e-2)" "unprognostic (1.13e-1)" "unprognostic (4.22e-12)" "unprognostic (1.06e-2)" "unprognostic (1.84e-1)" "unprognostic (3.81e-4)" "unprognostic (1.25e-2)" 0.6 0.6 2.8 0.1 7.8 0.0 0.2 0.5 2.1 5.1 18.7 0.1 0.1 0.1 0.1 0.4 2.0 0.3 4.5 1.3 2.5 0.1 0.0 0.4 0.0 2.1 4.9 0.2 0.0 23.7 10.8 0.0 2.3 12.0 0.2 0.4 0.8 4.0 2.8 0.0 0.2 0.2 0.0 0.1 0.8 0.8 4.6 11.7 0.6 2.5 0.1 2.6 4.3 0.6 0.2 0.0 6.4 27.6 0.0 0.0 0.0 0.2 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 1.6 0.0 0.0 4.7 0.0 2.2 0.0 0.0 0.5 0.0 6.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.0 2.0 0.0 1.5 0.0 21.3 9.5 0.0 0.0 2.2 51.4 0.0 0.0 1.6 5.9 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 6.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 7.8 0.5 2.1 1.3 2.5 2.1 4.9 2.3 0.0 4.6 0.6 0.2 0.0 0.0 214.5 0.0 0.1 0.0 6.4 0.6 0.1 0.0 0.1 8.8 0.0 7.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 3.1 0.1 0.2 0.0 0.0 1.3 0.0 0.5 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 13.5 0.0 2.0 0.0 0.0 6.4 0.3 0.0 0.0 11.2 0.0 0.1 0.0 18.6 0.6 0.0 0.0 0.4 0.0 0.1 0.0 0.3 10.5 0.2 0.0 0.2 0.5 0.8 1.0 1.1 0.1 0.5 0.0 1.4 0.0 0.1 FAAP20 "C1orf86, FLJ31031" ENSG00000162585 "FA core complex associated protein 20" Q6NZ36 1 2184461-2212720 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 337.5;Proximal tubular cells: 290.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038829 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cell Junctions" "HPA038829: AB_10673476" "unprognostic (1.36e-2)" "unprognostic (2.86e-2)" "unprognostic (2.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.64e-1)" "unprognostic (6.11e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (2.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.88e-4)" "unprognostic (1.59e-1)" "unprognostic (1.96e-3)" "unprognostic (1.36e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (8.55e-2)" 39.3 57.5 18.1 3.2 18.9 5.6 41.2 20.8 28.0 52.5 20.5 48.5 4.6 50.0 1.3 38.8 37.8 1.5 50.0 14.5 19.6 64.8 52.1 37.9 3.6 24.6 18.9 45.3 38.7 5.1 75.5 3.2 19.6 61.1 1.8 3.7 30.7 7.1 26.4 42.7 31.8 1.8 20.2 45.0 47.3 54.8 26.9 2.9 52.9 4.0 3.1 43.7 40.7 18.9 27.7 4.4 5.8 7.3 3.6 4.7 34.8 30.4 11.0 9.6 12.9 6.7 18.0 31.7 43.7 4.8 9.0 13.5 4.2 4.6 4.9 68.3 61.0 26.5 6.8 14.4 13.5 18.7 24.8 8.1 9.8 5.8 6.3 5.9 11.9 24.6 37.1 7.6 6.7 11.6 27.0 57.6 20.8 5.4 55.6 36.0 18.1 30.7 4.6 4.5 47.4 63.5 19.8 8.6 58.5 5.3 8.5 7.5 25.6 15.1 35.8 18.7 17.4 68.9 39.9 48.2 28.0 11.4 6.4 9.8 16.4 63.4 18.4 16.9 18.1 28.3 16.5 19.8 17.0 25.7 22.2 18.6 20.6 10.8 15.6 42.4 16.2 10.6 18.1 18.9 20.8 28.0 14.5 19.6 24.6 18.9 19.6 20.2 26.9 18.9 71.7 6.4 11.9 0.0 82.3 0.0 97.7 0.0 79.6 29.1 120.9 138.2 22.1 62.9 6.8 97.5 4.2 119.7 83.6 14.5 170.2 128.5 102.7 44.3 77.2 62.1 43.7 36.8 0.0 110.8 144.1 65.3 64.7 49.9 7.6 74.8 84.6 94.5 134.0 15.2 0.0 56.0 0.0 110.8 0.0 337.5 86.0 82.3 0.0 0.0 178.9 84.7 91.6 0.0 0.0 141.1 40.8 82.8 60.9 152.8 56.2 290.1 8.0 29.5 65.7 63.3 68.8 101.5 38.3 88.4 0.0 89.8 62.4 102.5 42.2 113.2 FAM122A "C9orf42, MGC17347" ENSG00000187866 "Family with sequence similarity 122A" Q96E09 9 68780065-68785566 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056646 Approved Approved "Nucleoplasm,Nuclear bodies" No No "Cluster 26: Non-specific - Mitochondria" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" Nucleoplasm "HPA056646: AB_2683202" "unprognostic (1.88e-2)" "unprognostic (7.62e-2)" "unprognostic (9.17e-2)" "unprognostic (1.48e-2)" "unprognostic (2.55e-2)" "unprognostic (1.16e-1)" "unprognostic (9.79e-2)" "unprognostic (1.45e-2)" "unprognostic (4.18e-1)" "unprognostic (8.49e-3)" "unprognostic (1.45e-2)" "unprognostic (4.58e-3)" "prognostic favorable (1.34e-5)" "unprognostic (9.35e-2)" "unprognostic (3.02e-2)" "unprognostic (2.72e-1)" "unprognostic (6.89e-2)" 9.9 9.3 4.6 5.8 4.9 5.3 9.7 8.2 6.3 9.7 15.0 7.9 4.4 9.3 6.7 8.3 8.5 5.6 9.0 5.4 5.4 9.7 9.9 6.8 7.4 5.1 5.4 10.5 8.9 11.0 6.8 10.2 5.1 7.7 6.5 6.8 8.2 8.4 8.9 7.6 7.4 7.8 4.4 8.3 7.4 4.9 5.0 6.5 8.5 8.6 7.2 7.2 8.0 5.0 5.2 3.4 4.8 4.1 15.9 10.3 6.4 7.3 6.9 6.3 5.0 1.2 2.5 11.0 3.5 7.7 4.5 9.6 5.3 4.9 7.8 11.9 5.6 6.1 6.0 4.4 9.7 11.2 4.1 8.4 11.0 5.8 4.5 7.1 6.3 7.8 6.5 12.1 6.8 2.9 6.3 2.9 6.0 12.4 6.2 7.6 6.6 3.4 5.7 4.3 7.6 3.4 5.4 4.5 3.8 6.6 2.7 4.8 8.0 5.8 4.2 11.0 5.5 14.2 6.1 4.4 6.3 6.9 6.7 1.9 2.0 1.5 1.7 1.9 1.4 1.5 1.7 1.8 2.2 2.5 3.5 2.0 1.1 1.8 1.9 2.6 2.0 1.0 4.6 4.9 8.2 6.3 5.4 5.4 5.1 5.4 5.1 4.4 5.0 5.0 10.0 3.2 9.8 0.0 19.6 23.6 18.7 13.3 20.5 18.8 18.2 17.0 15.9 10.0 13.1 5.5 16.7 28.2 11.8 11.3 66.5 18.3 32.0 10.4 20.2 17.2 18.0 27.0 0.0 13.8 17.0 13.9 14.3 8.1 17.7 12.7 17.2 18.6 21.6 8.4 0.0 17.0 10.2 22.3 17.0 15.4 15.2 15.0 14.2 0.0 16.8 38.3 24.7 0.0 0.0 12.9 15.8 17.0 18.3 11.9 11.1 27.2 23.0 19.8 46.0 18.8 43.9 52.4 21.3 19.5 23.7 30.6 16.8 23.1 15.3 17.8 FAM163B C9orf166 ENSG00000196990 "Family with sequence similarity 163 member B" P0C2L3 9 133577081-133609389 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 60.1" "Group enriched" "Detected in some" 6 "Excitatory neurons: 24.8;Inhibitory neurons: 17.8;Late spermatids: 17.3" "Cancer enriched" "Detected in some" 6 "glioma: 3.2" "Group enriched" "Detected in many" 6 "amygdala: 26.5;basal ganglia: 44.4;cerebral cortex: 60.1;hippocampal formation: 38.2;white matter: 32.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "SH-SY5Y: 50.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067336 Enhanced Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies, Plasma membrane, Cytosol" "HPA067336: AB_2685825" "unprognostic (2.94e-2)" "unprognostic (6.87e-3)" "unprognostic (2.65e-2)" "unprognostic (2.70e-1)" "unprognostic (1.23e-2)" "unprognostic (9.05e-2)" "unprognostic (1.02e-2)" "unprognostic (3.48e-2)" "unprognostic (1.43e-1)" "unprognostic (1.16e-1)" "unprognostic (3.31e-3)" "unprognostic (7.61e-2)" "unprognostic (5.75e-4)" "unprognostic (1.07e-1)" "unprognostic (9.54e-2)" "unprognostic (1.65e-1)" "unprognostic (4.73e-4)" 0.1 10.0 26.5 0.0 44.4 0.0 0.0 0.0 60.1 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.1 0.4 5.2 38.2 0.0 0.8 8.7 0.3 1.7 0.0 0.0 0.4 0.1 0.0 0.5 0.8 7.3 0.2 0.5 0.2 0.3 0.8 0.0 0.0 0.0 0.0 6.0 0.2 0.4 2.4 0.0 0.2 0.2 0.0 0.0 1.1 0.1 32.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.7 0.2 0.1 0.0 0.0 2.4 50.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 44.4 0.0 60.1 38.2 0.0 0.0 0.0 7.3 6.0 0.0 32.5 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "FA complementation group D2" Q9BXW9 3 10026414-10101932 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 120.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 1.1 0.7 2.7 7.7 2.1 17.8 3.4 1.6 5.3 1.5 1.1 4.0 3.2 2.0 0.7 2.5 2.6 2.0 0.5 3.4 1.6 0.9 1.1 1.9 12.2 3.9 1.4 3.6 0.8 0.8 0.5 4.7 3.0 1.9 6.4 3.1 4.9 1.0 4.8 4.5 4.0 2.0 2.4 6.4 3.5 11.8 2.3 9.8 1.9 0.4 13.0 2.3 1.3 5.1 24.1 25.4 46.5 13.2 2.4 3.5 120.7 22.0 9.8 31.3 25.4 18.8 23.0 46.7 9.8 7.0 25.1 20.2 48.8 16.7 31.0 22.6 33.0 63.6 39.6 17.9 0.4 48.1 37.9 1.2 2.6 34.1 18.4 4.2 18.4 39.3 39.6 51.6 23.1 27.2 40.6 17.9 56.1 18.1 17.6 43.4 37.7 32.5 10.3 26.7 13.0 25.3 26.4 20.1 8.3 33.5 31.0 29.4 10.6 24.6 28.4 15.1 31.5 21.7 46.4 77.2 14.1 47.7 43.2 2.7 0.6 1.9 0.6 0.5 0.6 2.4 0.9 0.5 0.4 3.2 1.1 0.9 1.5 1.0 1.4 1.8 1.5 0.5 2.7 2.1 1.6 5.3 3.4 1.6 3.9 1.4 3.0 2.4 2.3 5.1 0.7 0.0 0.5 0.7 12.5 4.6 3.5 2.9 2.8 3.1 4.5 2.7 2.0 1.5 1.9 1.8 10.4 12.7 5.6 3.1 0.0 1.9 5.9 2.6 1.5 2.1 1.2 25.2 3.0 3.5 15.2 2.6 2.0 3.4 1.3 11.8 3.3 1.5 5.7 0.0 2.6 3.2 6.1 3.8 7.0 8.0 2.1 3.7 3.6 1.9 4.9 0.6 1.0 1.5 2.4 1.8 3.6 1.5 8.1 2.2 0.5 0.7 2.0 5.6 19.7 2.6 2.1 62.5 30.2 4.1 2.7 7.0 5.2 1.6 7.6 3.1 FANCL "FAAP43, FLJ10335, PHF9, Pog" ENSG00000115392 "FA complementation group L" Q9NW38 2 58159243-58241372 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 188.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033842, HPA036685, HPA036686" Supported Approved "Nuclear bodies,Vesicles" NA Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Vesicles "CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844" "unprognostic (3.02e-1)" "unprognostic (5.52e-2)" "unprognostic (2.19e-1)" "unprognostic (2.02e-3)" "unprognostic (6.24e-2)" "unprognostic (2.92e-2)" "prognostic unfavorable (2.81e-7)" "unprognostic (4.71e-2)" "unprognostic (2.63e-2)" "unprognostic (1.31e-2)" "unprognostic (3.50e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.50e-1)" "unprognostic (1.39e-1)" "unprognostic (9.08e-3)" "prognostic favorable (7.80e-5)" 8.5 35.3 39.4 11.0 49.5 15.1 19.5 35.3 39.4 18.6 27.2 12.1 11.5 19.9 18.4 11.5 13.9 12.0 13.0 34.1 45.1 12.2 21.7 9.6 14.8 51.6 40.3 24.8 14.5 14.0 44.3 12.5 55.4 14.7 14.8 24.6 18.7 10.7 9.1 17.9 12.8 13.5 40.9 16.8 13.1 19.1 41.2 13.2 17.1 9.1 12.6 11.7 14.6 68.6 48.6 35.0 69.4 34.0 11.9 15.1 36.9 34.8 21.5 33.8 43.5 30.9 59.4 33.4 43.8 11.4 46.3 27.5 39.0 26.4 56.0 78.8 61.7 54.8 49.5 42.1 13.0 53.3 29.0 11.8 12.4 24.8 9.7 29.9 27.0 23.5 51.9 29.6 23.2 24.6 18.9 65.8 75.2 77.4 7.2 35.2 52.5 26.1 29.9 47.2 78.1 39.3 49.5 20.2 33.8 37.0 18.7 35.4 15.9 30.0 45.0 22.3 39.0 30.4 20.6 19.7 63.7 35.7 46.6 3.2 3.0 4.9 3.7 5.6 3.0 9.1 3.2 4.2 5.9 9.3 1.0 2.3 0.8 7.6 4.3 5.3 4.8 2.2 39.4 49.5 35.3 39.4 34.1 45.1 51.6 40.3 55.4 40.9 41.2 68.6 16.7 19.2 20.0 18.6 9.4 10.3 13.9 26.1 11.4 16.6 12.5 15.4 16.4 8.6 16.1 9.2 4.2 29.1 4.8 7.2 11.7 9.7 2.5 11.1 15.8 14.8 9.0 14.5 45.0 4.2 14.0 12.2 15.3 6.2 10.8 25.8 13.2 12.5 10.9 8.4 38.4 15.0 30.5 6.3 4.6 3.6 10.8 7.0 26.6 34.7 6.8 22.8 3.1 81.4 188.9 4.6 13.3 14.3 9.7 6.2 21.7 5.7 23.2 18.7 13.1 10.8 12.4 52.6 37.9 9.5 6.8 7.4 5.6 13.2 16.0 9.3 FAS "APO-1, APT1, CD95, FAS1, TNFRSF6" ENSG00000026103 "Fas cell surface death receptor" P25445 10 88990531-89017059 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis "Calmodulin-binding, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 114.7" "Group enriched" "Detected in all" 5 "granulocytes: 114.7;T-cells: 96.2" "Cell line enhanced" "Detected in many" "HDLM-2: 83.4;Karpas-707: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027444 Uncertain Supported "Nuclear bodies,Plasma membrane,Cytosol" "Secreted to blood" NA NA 11900000 420000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Nuclear bodies, Cytosol" "HPA027444: AB_10601378" "unprognostic (6.84e-2)" "unprognostic (2.88e-3)" "unprognostic (8.38e-3)" "unprognostic (1.94e-1)" "unprognostic (2.35e-2)" "unprognostic (9.56e-2)" "unprognostic (7.00e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (7.70e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.52e-3)" "unprognostic (2.10e-1)" "unprognostic (2.32e-2)" "unprognostic (4.95e-3)" "unprognostic (1.65e-1)" 14.1 26.3 3.6 17.0 3.6 20.8 10.9 2.9 4.7 12.7 2.8 16.4 7.0 12.8 10.3 10.8 14.8 15.7 7.5 3.6 3.7 7.2 23.3 21.7 18.9 4.6 3.1 20.1 3.7 2.7 3.7 10.4 4.0 8.9 23.3 3.3 6.5 9.3 2.3 9.4 9.2 15.0 3.5 11.2 4.4 2.6 3.9 14.4 7.3 2.6 15.6 12.9 10.2 4.3 22.7 8.2 5.4 13.9 37.0 51.3 0.0 51.8 50.2 1.7 9.1 0.1 23.4 4.7 19.0 52.1 9.6 4.0 1.0 44.8 3.2 83.4 8.7 0.4 5.2 14.7 31.6 3.4 1.6 69.2 38.7 31.4 66.0 24.5 4.7 17.8 0.0 109.0 44.0 1.4 6.4 3.4 0.6 0.2 1.8 1.4 0.5 5.0 60.7 7.3 0.4 0.2 7.7 0.0 0.8 7.0 13.9 1.0 9.5 15.8 9.0 15.2 12.3 45.3 5.3 0.4 11.8 10.2 4.5 43.1 9.4 30.9 9.9 12.3 13.8 7.5 27.6 19.6 11.5 4.0 3.1 10.0 114.7 3.1 22.1 0.2 96.2 12.8 3.6 3.6 2.9 4.7 3.6 3.7 4.6 3.1 4.0 3.5 3.9 4.3 10.3 57.7 13.8 40.1 12.8 45.9 109.7 53.1 39.9 0.0 5.5 9.5 3.5 12.8 27.5 9.2 0.0 0.4 16.3 24.9 0.0 6.3 11.3 9.2 22.3 8.9 8.4 9.5 8.8 4.3 0.2 35.4 8.6 15.5 3.8 4.9 2.2 19.3 5.5 1.7 2.8 14.4 8.2 7.0 31.7 4.9 19.0 17.7 12.4 17.8 20.9 14.5 10.3 8.0 0.7 6.5 8.7 13.9 32.2 46.0 15.6 14.4 26.3 0.7 6.6 26.8 29.1 11.3 1.1 28.5 43.9 0.4 48.4 11.8 24.4 30.0 FBXL3 "FBL3, FBL3A, FBXL3A" ENSG00000005812 "F-box and leucine rich repeat protein 3" Q9UKT7 13 76992598-77027195 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053283, HPA065626" Enhanced "Nuclear bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 6: Erythroid cells - Oxygen transport" "Nuclear bodies" "HPA053283: AB_2682100, HPA065626: AB_2685523" "unprognostic (3.98e-1)" "unprognostic (3.00e-2)" "unprognostic (1.55e-2)" "unprognostic (7.24e-2)" "unprognostic (9.92e-2)" "unprognostic (1.01e-1)" "unprognostic (2.75e-1)" "unprognostic (2.23e-1)" "unprognostic (5.12e-2)" "unprognostic (8.70e-2)" "unprognostic (2.81e-1)" "unprognostic (4.24e-2)" "unprognostic (1.10e-3)" "unprognostic (8.52e-2)" "unprognostic (1.43e-1)" "unprognostic (1.97e-1)" "unprognostic (2.78e-1)" 45.7 25.0 17.9 24.0 20.4 69.1 42.6 23.5 26.1 31.7 12.4 27.4 24.0 31.4 23.1 27.9 27.4 24.2 25.1 17.1 17.5 37.8 31.4 29.8 32.7 17.6 17.4 44.6 20.8 29.7 9.7 32.5 18.3 29.9 25.1 21.1 22.9 26.2 30.0 30.5 25.0 27.8 18.5 31.3 22.2 30.0 17.0 36.2 48.0 37.9 31.4 25.4 23.1 28.1 43.4 11.1 21.4 14.8 50.7 50.1 17.0 48.6 39.6 28.3 36.0 16.0 30.1 27.9 31.6 43.1 17.1 31.9 21.4 26.1 40.4 55.7 56.8 36.2 32.9 14.3 33.6 46.7 26.9 42.5 34.2 22.6 31.0 33.1 37.7 15.3 14.0 20.8 34.0 15.8 33.7 25.0 8.2 37.0 20.1 27.3 24.3 17.0 30.2 22.7 25.2 20.5 31.0 30.0 28.4 14.5 16.6 51.1 46.7 27.1 17.8 18.6 23.9 26.5 32.9 25.6 46.9 33.1 30.0 8.0 1.9 4.6 2.1 2.9 2.9 2.6 3.8 2.2 1.9 2.8 4.5 3.1 5.2 2.1 3.1 2.0 5.1 1.4 17.9 20.4 23.5 26.1 17.1 17.5 17.6 17.4 18.3 18.5 17.0 28.1 35.9 44.8 22.2 31.6 48.9 67.3 38.0 17.0 50.1 25.1 36.5 21.6 21.6 12.8 15.4 22.0 10.4 33.0 42.4 54.8 41.1 17.9 41.2 26.8 29.0 38.3 23.9 50.7 30.4 18.8 41.7 42.8 17.3 34.7 28.5 20.4 32.2 28.5 23.3 37.0 29.8 23.9 22.4 36.1 41.5 24.6 74.6 33.3 42.7 37.5 36.5 45.4 20.6 33.7 58.1 19.1 25.7 74.9 33.6 40.2 38.3 29.2 19.9 24.3 59.2 46.1 52.7 52.5 58.9 40.9 56.1 28.5 44.9 22.7 23.1 38.5 FBXO48 ENSG00000204923 "F-box protein 48" Q5FWF7 2 68459422-68467294 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 32.1;Alveolar cells type 2: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA049775, HPA054782" Uncertain Approved "Nuclear bodies" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 54: Non-specific - Microtubule organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "Nuclear bodies" "HPA049775: AB_2680874, HPA054782: AB_2682599" "unprognostic (2.90e-1)" "unprognostic (2.62e-2)" "unprognostic (2.25e-1)" "unprognostic (2.75e-3)" "unprognostic (6.56e-3)" "unprognostic (2.90e-3)" "unprognostic (2.30e-1)" "unprognostic (4.74e-2)" "unprognostic (6.01e-3)" "unprognostic (3.92e-2)" "unprognostic (3.81e-2)" "unprognostic (2.33e-1)" "unprognostic (2.09e-2)" "unprognostic (6.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-3)" "unprognostic (1.89e-2)" 1.1 1.2 1.3 1.4 1.8 0.7 1.3 1.5 1.5 1.1 1.2 1.1 1.8 0.8 1.1 1.1 0.7 0.8 0.7 1.3 1.2 1.4 2.0 1.0 1.7 1.5 1.4 1.7 0.8 1.3 0.5 1.2 1.7 0.8 1.2 3.0 1.3 0.7 3.1 2.5 1.5 0.6 1.2 1.8 1.3 1.0 1.7 1.2 1.1 1.8 1.8 0.7 0.9 2.7 2.1 0.7 1.3 0.9 1.6 1.8 0.9 1.5 1.8 1.4 1.6 1.0 0.9 2.6 1.0 0.7 1.9 1.1 1.2 1.2 2.7 3.5 1.3 1.3 0.7 0.5 0.7 0.6 1.5 0.8 2.1 2.0 1.7 0.7 0.6 4.3 0.6 4.9 1.1 0.4 1.5 1.9 0.7 1.4 1.0 1.3 2.3 1.7 1.1 0.6 1.3 0.9 0.7 0.3 1.7 1.1 0.4 0.6 0.6 1.6 1.5 2.0 1.6 3.9 2.5 1.1 1.0 1.1 1.2 2.6 0.7 0.9 1.0 0.7 1.0 0.9 1.7 1.0 0.4 1.0 1.2 1.2 1.4 1.0 1.3 0.9 2.1 0.6 1.3 1.8 1.5 1.5 1.3 1.2 1.5 1.4 1.7 1.2 1.7 2.7 9.1 32.1 52.0 1.3 6.4 7.1 5.0 3.1 9.1 3.9 7.7 10.4 11.7 7.2 16.3 5.5 2.1 4.2 4.5 7.1 11.7 3.2 1.7 4.0 3.1 8.2 3.0 4.0 0.8 3.3 3.5 6.8 3.1 4.1 12.6 2.1 5.3 7.1 4.1 3.3 0.8 6.2 0.0 5.1 6.6 1.0 4.1 8.7 1.8 0.0 2.5 2.2 2.1 1.5 1.7 3.1 2.7 1.5 5.8 3.4 7.4 9.2 12.9 5.7 0.0 5.5 3.9 18.0 11.1 6.7 8.0 1.6 8.1 2.8 3.5 3.9 FGF2 FGFB ENSG00000138685 "Fibroblast growth factor 2" P09038 4 122826708-122898236 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 33.7;Astrocytes: 111.0;Endometrial stromal cells: 40.6;Fibroblasts: 77.1;Oligodendrocyte precursor cells: 42.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 243.8;BJ hTERT+: 148.4;fHDF/TERT166: 278.2;hTERT-HME1: 147.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000125, HPA065502" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Secreted in other tissues" NA NA 92500 "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Nuclear bodies" "CAB000125: , HPA065502: " "unprognostic (1.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.08e-1)" "unprognostic (7.42e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-1)" "unprognostic (6.98e-2)" "unprognostic (1.25e-1)" "unprognostic (2.82e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (9.85e-4)" "unprognostic (3.37e-1)" "unprognostic (4.61e-3)" "unprognostic (2.36e-1)" "unprognostic (1.81e-1)" "unprognostic (4.45e-2)" "unprognostic (3.45e-3)" 24.3 2.6 14.8 5.3 16.1 0.1 9.5 12.2 14.7 8.7 14.2 14.1 1.7 14.2 4.5 4.7 8.0 7.1 5.0 12.2 18.8 4.0 2.0 8.3 1.8 18.6 20.5 12.6 1.5 4.7 3.2 6.4 15.6 7.6 4.0 3.4 3.5 8.7 1.4 1.9 3.7 12.6 16.8 1.1 6.2 1.9 18.3 1.6 2.4 4.8 1.8 14.8 6.1 13.3 4.7 14.1 7.8 30.5 18.8 31.1 0.0 243.8 148.4 104.3 60.2 0.2 0.4 0.0 20.5 278.2 81.8 0.7 8.1 0.5 104.3 12.3 3.3 0.0 28.7 0.2 55.3 1.4 0.1 16.8 1.7 103.6 147.6 52.0 11.8 0.0 6.9 8.4 27.4 0.1 0.1 0.2 21.6 0.1 5.4 0.0 3.9 0.1 33.0 0.0 4.4 4.0 48.4 0.1 2.0 44.7 0.1 0.5 10.6 85.7 12.2 32.0 20.0 8.6 10.3 0.0 24.7 0.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 16.1 12.2 14.7 12.2 18.8 18.6 20.5 15.6 16.8 18.3 13.3 33.7 6.4 0.0 111.0 0.3 1.7 1.6 0.8 2.8 4.6 4.5 8.9 4.7 0.0 1.3 7.3 0.0 2.7 0.4 0.0 3.9 8.2 10.9 1.5 40.6 11.5 1.8 0.4 1.8 1.0 0.1 77.1 0.0 1.6 0.0 5.7 17.2 1.3 0.5 0.0 6.6 0.0 0.0 0.0 2.4 3.8 9.9 1.7 5.4 15.9 0.6 9.3 0.0 42.3 5.8 11.0 0.0 8.2 1.6 16.0 0.0 0.6 0.0 2.0 0.0 15.2 14.2 4.7 1.1 0.3 1.3 4.8 0.5 0.1 0.0 2.0 FGGY FLJ10986 ENSG00000172456 "FGGY carbohydrate kinase domain containing" Q96C11 1 59296638-59810647 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 77.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 191.7;Cholangiocytes: 343.1;Hepatocytes: 142.3" "Cancer enhanced" "Detected in all" "liver cancer: 13.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;RH-30: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054971, HPA075137" Approved "Nucleoplasm,Nuclear bodies" NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "Nuclear bodies" "HPA054971: , HPA075137: " "unprognostic (4.15e-1)" "unprognostic (1.87e-1)" "unprognostic (2.31e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.47e-3)" "unprognostic (1.80e-2)" "unprognostic (4.09e-1)" "unprognostic (2.78e-1)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (4.36e-3)" "unprognostic (7.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.70e-1)" "unprognostic (1.78e-1)" 4.2 14.6 10.5 2.0 12.8 2.3 6.6 21.8 10.2 6.3 4.5 7.1 7.1 4.7 36.5 5.5 9.9 5.4 11.3 7.4 12.1 19.1 77.1 4.7 3.3 12.9 13.4 4.8 12.0 10.5 9.7 3.0 12.9 7.8 6.7 9.6 7.5 10.3 41.8 5.7 8.1 4.2 9.3 2.8 6.1 4.2 16.5 4.1 7.7 17.1 3.6 7.0 5.2 12.7 4.8 1.4 9.2 3.9 4.7 16.6 0.8 4.1 6.8 2.3 3.4 0.0 3.8 5.4 13.0 11.0 4.1 2.0 1.6 11.9 4.9 42.9 1.1 3.8 2.9 8.6 12.3 2.3 2.4 23.2 10.2 5.0 7.9 10.0 4.6 6.0 2.7 3.4 15.3 5.2 3.0 3.2 5.8 13.0 5.3 6.5 28.3 2.1 12.9 8.8 7.2 3.2 5.6 3.3 12.0 8.0 2.8 2.3 4.7 4.0 2.6 4.7 2.8 7.5 2.9 4.6 12.9 9.2 3.8 1.5 1.3 1.4 3.0 1.3 2.7 5.1 1.4 3.8 2.2 3.6 2.7 4.3 2.2 2.9 3.4 1.1 2.8 1.8 10.5 12.8 21.8 10.2 7.4 12.1 12.9 13.4 12.9 9.3 16.5 12.7 3.7 54.5 191.7 83.2 7.9 20.9 23.8 45.2 14.2 10.1 33.1 66.9 29.9 343.1 40.4 12.9 12.5 9.3 3.7 4.2 17.6 62.6 14.0 33.2 7.5 6.9 2.4 12.2 20.4 42.5 4.5 7.6 7.1 20.4 10.1 5.3 5.3 142.3 11.4 8.4 33.7 11.3 22.4 8.8 7.6 11.4 1.8 6.7 35.6 17.8 11.2 12.2 3.1 39.2 36.0 17.7 7.7 3.0 3.4 19.1 14.9 47.9 91.2 16.4 0.0 31.4 8.9 4.6 11.5 13.5 31.5 4.5 5.1 5.9 17.1 35.5 FLI1 "EWSR2, SIC-1" ENSG00000151702 "Fli-1 proto-oncogene, ETS transcription factor" Q01543 11 128686535-128813267 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.8" "Cell type enhanced" "Detected in many" "B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065030, HPA073099" Approved Supported "Nucleoplasm,Nuclear bodies" Yes NA "Cluster 10: Basophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA065030: , HPA073099: AB_2686572" "unprognostic (1.38e-2)" "unprognostic (7.46e-2)" "unprognostic (6.16e-2)" "unprognostic (3.74e-2)" "unprognostic (6.22e-2)" "unprognostic (4.26e-3)" "unprognostic (1.33e-1)" "unprognostic (8.32e-3)" "unprognostic (2.97e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (4.60e-4)" "unprognostic (4.79e-2)" "unprognostic (2.07e-2)" "unprognostic (2.62e-1)" "unprognostic (4.79e-2)" 10.2 1.9 3.7 10.9 2.3 12.2 6.0 2.1 2.8 5.7 1.2 3.7 3.2 4.6 1.1 2.8 2.7 6.1 6.2 1.8 2.9 2.1 2.8 10.8 12.3 4.7 2.7 1.2 1.7 3.5 0.7 12.5 4.3 1.9 2.9 0.5 2.2 2.2 2.8 1.7 4.0 5.9 3.5 35.8 4.3 0.9 3.9 17.2 2.9 6.6 10.4 6.7 1.9 2.8 0.2 0.0 5.6 0.0 0.8 1.0 0.1 3.3 9.2 3.8 3.1 0.0 0.0 18.5 31.7 11.1 1.1 0.1 0.8 13.5 4.1 9.0 0.2 113.9 0.5 0.0 6.0 13.7 14.6 0.8 1.1 7.7 17.3 11.1 60.5 25.6 0.0 23.3 0.8 0.0 13.3 8.1 1.8 0.0 3.1 49.8 0.1 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.0 0.0 20.4 63.0 0.7 0.0 0.2 3.5 7.3 16.4 16.6 0.1 31.8 5.2 34.5 15.5 24.5 10.1 15.3 11.9 6.8 8.9 8.2 19.1 6.0 3.7 8.2 11.8 12.3 19.1 3.3 11.1 20.1 3.7 2.3 2.1 2.8 1.8 2.9 4.7 2.7 4.3 3.5 3.9 2.8 53.4 6.4 5.3 0.3 65.7 5.1 0.3 1.7 2.2 0.0 0.7 1.3 5.5 5.7 0.1 1.8 0.0 0.4 43.1 0.0 0.0 0.0 0.5 0.4 0.6 84.2 0.0 23.4 0.3 0.0 0.4 5.9 2.0 0.3 22.8 0.0 64.6 1.3 43.2 0.0 1.5 0.1 0.0 86.4 24.7 0.5 1.8 60.3 7.2 231.4 68.4 0.1 93.7 4.0 0.7 0.0 0.0 0.7 56.9 0.3 0.0 0.4 0.8 0.4 6.6 2.1 3.1 0.2 0.1 0.6 4.1 0.3 52.8 0.9 0.2 0.4 FLYWCH1 DKFZp761A132 ENSG00000059122 "FLYWCH-type zinc finger 1" Q4VC44 16 2911931-2951208 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040753, HPA041001" Approved Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA040753: AB_10794880, HPA041001: AB_10794259" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" "unprognostic (2.93e-1)" "unprognostic (2.06e-3)" "unprognostic (1.71e-1)" "unprognostic (2.68e-2)" "unprognostic (3.51e-2)" "unprognostic (1.92e-1)" "unprognostic (7.44e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-3)" "unprognostic (6.61e-2)" "unprognostic (1.61e-1)" "unprognostic (3.84e-2)" "unprognostic (7.33e-2)" "unprognostic (2.19e-3)" "unprognostic (7.91e-2)" 16.0 14.6 22.6 11.7 22.4 12.5 14.2 22.6 28.7 18.6 15.9 19.3 12.9 17.7 4.8 12.8 17.0 13.0 19.0 18.9 20.8 12.8 8.3 14.0 11.3 33.2 23.3 20.6 10.7 14.7 16.4 8.2 30.0 17.2 3.7 13.3 13.7 12.5 32.8 20.4 14.4 7.6 19.2 18.7 13.4 4.0 27.3 9.1 15.5 10.7 6.2 21.8 16.2 23.7 10.0 34.8 7.8 23.2 12.4 12.5 23.6 18.2 14.1 9.0 9.2 5.8 31.8 24.4 47.3 14.0 14.7 20.5 6.5 12.2 1.8 40.8 19.6 8.2 30.9 19.5 27.7 10.9 27.3 11.2 37.9 19.1 13.8 16.7 12.9 16.0 18.6 25.0 7.0 23.8 25.1 13.3 12.7 7.5 23.6 43.5 11.6 44.0 10.6 6.7 16.7 15.5 19.1 20.6 24.1 4.3 16.1 19.6 24.4 15.0 13.6 29.4 12.4 37.1 34.5 22.7 16.4 17.8 17.9 1.2 0.8 0.3 1.3 0.4 2.3 0.9 2.1 2.7 0.8 2.6 1.7 1.5 0.1 0.5 0.4 0.5 1.1 1.1 22.6 22.4 22.6 28.7 18.9 20.8 33.2 23.3 30.0 19.2 27.3 23.7 16.7 0.0 4.2 34.3 10.4 12.4 9.3 9.2 23.3 42.1 8.6 11.3 12.3 8.6 5.1 22.0 35.5 21.2 14.3 6.5 1.9 6.1 0.4 6.0 7.7 13.4 2.4 6.5 26.9 6.5 8.5 13.9 12.2 8.9 0.0 48.3 11.0 6.8 8.5 33.7 29.0 4.9 4.1 9.9 5.1 1.2 11.1 8.9 8.8 13.1 7.9 18.8 9.2 18.6 25.6 7.1 2.9 14.3 10.4 5.3 8.9 6.3 8.3 39.3 0.0 16.6 20.9 0.9 3.2 13.1 13.9 8.8 11.9 5.3 7.4 5.6 FOXC2 "FKHL14, MFH-1" ENSG00000176692 "Forkhead box C2" Q99958 16 86566829-86569728 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 5.6" "Group enriched" "Detected in some" 4 "Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 6 "spinal cord: 42.7" HPA056302 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nuclear bodies" "HPA056302: AB_2683093" "unprognostic (3.17e-2)" "unprognostic (1.76e-3)" "unprognostic (4.87e-2)" "unprognostic (4.32e-1)" "unprognostic (1.15e-1)" "unprognostic (1.60e-2)" "unprognostic (4.49e-2)" "unprognostic (1.15e-2)" "unprognostic (4.71e-2)" "unprognostic (8.88e-2)" "unprognostic (1.47e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (1.12e-2)" "unprognostic (3.47e-2)" "unprognostic (2.43e-1)" "unprognostic (1.84e-4)" 2.4 1.5 0.5 0.3 1.1 0.0 1.8 0.9 1.6 2.2 3.2 0.5 0.1 0.8 0.6 0.5 2.0 1.3 5.6 0.4 0.4 5.4 0.1 2.1 0.4 0.5 0.5 1.1 0.2 0.1 2.4 0.1 0.5 1.0 0.1 0.1 2.4 0.6 0.7 0.8 0.4 0.4 0.7 0.0 0.4 1.9 0.7 0.1 2.0 0.5 0.1 0.8 1.5 0.3 0.0 0.0 0.0 0.0 5.8 7.8 0.0 11.3 14.3 8.0 1.5 0.0 0.0 0.0 1.5 1.4 11.2 0.0 0.2 3.3 7.0 0.0 0.6 0.0 7.9 0.0 2.7 0.0 0.0 1.3 3.4 25.2 7.9 14.5 19.5 0.0 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 1.7 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.0 5.9 0.0 0.0 36.0 18.4 0.0 31.5 0.0 0.0 0.0 0.0 24.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.9 1.6 0.4 0.4 0.5 0.5 0.5 0.7 0.7 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.8 2.1 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 5.7 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.6 1.5 0.1 1.8 1.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 30.9 1.2 0.8 0.0 0.0 0.0 0.1 19.7 0.6 33.2 0.2 5.0 0.5 0.0 0.0 0.0 0.0 0.1 1.4 FZD2 ENSG00000180340 "Frizzled class receptor 2" Q14332 17 44557484-44561262 "Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 10.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.1;myeloid DC: 1.8" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;monocytes: 1.1" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 53.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA057667 Uncertain Approved "Nucleoplasm,Nuclear bodies,Cell Junctions" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear bodies" "Cell Junctions" "HPA057667: AB_2683497" "unprognostic (6.94e-2)" "unprognostic (1.12e-2)" "unprognostic (3.04e-2)" "unprognostic (8.83e-3)" "unprognostic (2.04e-1)" "unprognostic (5.29e-3)" "unprognostic (1.44e-2)" "unprognostic (2.29e-1)" "unprognostic (9.45e-2)" "unprognostic (5.61e-2)" "unprognostic (1.15e-2)" "unprognostic (1.86e-1)" "unprognostic (5.10e-3)" "unprognostic (1.19e-2)" "unprognostic (6.35e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-3)" 1.5 1.6 1.0 1.4 1.5 0.2 1.3 0.9 1.2 5.9 10.5 1.8 0.9 5.3 1.3 0.9 3.8 1.8 2.8 1.1 1.3 2.8 0.2 2.9 0.8 1.3 1.9 3.3 1.5 2.1 1.1 3.6 2.0 1.7 0.4 0.7 1.0 1.9 0.4 0.6 1.6 1.5 1.3 2.1 1.2 1.5 1.4 0.3 2.4 0.7 0.7 2.0 2.5 1.6 12.9 37.7 38.3 13.8 8.7 6.4 0.4 39.5 30.4 53.4 38.2 28.4 6.2 0.0 8.9 13.9 13.1 5.5 3.6 2.8 30.2 2.9 7.2 1.7 6.6 0.1 7.7 0.2 7.5 10.7 2.8 9.6 8.8 40.8 1.8 4.9 2.5 0.3 20.9 5.9 6.7 3.6 26.8 0.1 6.7 18.1 8.6 1.9 7.7 0.6 3.8 10.9 5.2 1.1 2.3 32.4 14.6 8.4 0.7 24.1 17.5 4.4 22.6 0.8 0.7 3.0 4.0 2.4 11.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.2 1.0 1.5 0.9 1.2 1.1 1.3 1.3 1.9 2.0 1.3 1.4 1.6 0.5 19.2 0.0 1.6 0.6 0.6 0.3 0.9 0.0 0.0 0.9 2.9 1.9 0.0 0.2 1.8 0.0 1.6 1.8 0.0 0.0 0.3 0.6 1.1 8.4 0.7 1.2 1.3 0.0 1.8 0.5 5.9 0.0 1.5 0.0 1.4 0.7 0.0 4.8 0.0 0.0 0.3 0.0 9.8 6.0 0.4 23.3 5.6 0.0 6.5 6.2 6.0 0.0 0.0 0.2 0.7 0.0 18.0 0.3 0.1 0.0 0.3 0.2 0.4 0.0 0.4 5.3 0.3 1.2 0.3 0.4 2.3 0.2 2.4 0.0 0.0 GABARAPL2 "ATG8, ATG8C, GATE-16, GATE16, GEF2" ENSG00000034713 "GABA type A receptor associated protein like 2" P60520 16 75566375-75577881 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036726 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA036726: AB_10672476" "unprognostic (3.29e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-2)" "unprognostic (7.00e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.58e-1)" "unprognostic (6.85e-2)" "unprognostic (2.13e-1)" "unprognostic (4.95e-2)" "unprognostic (9.86e-3)" "unprognostic (1.33e-2)" "prognostic favorable (5.95e-8)" "unprognostic (3.11e-3)" "unprognostic (3.84e-3)" "unprognostic (1.37e-2)" "unprognostic (3.85e-1)" 129.2 166.9 269.1 68.0 278.1 101.6 122.3 297.7 310.8 105.9 237.2 118.5 67.1 101.3 158.1 91.9 106.0 84.1 279.9 259.7 294.9 153.8 113.6 111.3 94.7 280.8 278.4 108.7 81.4 209.5 169.0 113.8 289.2 113.7 81.4 201.4 100.8 102.2 262.9 135.0 90.1 98.6 306.0 112.0 99.7 78.3 282.4 102.1 124.5 186.7 98.9 95.3 104.8 320.2 103.4 85.9 142.7 67.7 217.1 189.9 72.6 118.2 169.9 158.0 176.4 79.8 129.1 148.1 143.0 135.3 95.2 86.6 107.6 110.6 193.9 64.8 208.7 86.9 72.2 119.1 118.2 84.1 151.3 132.0 153.5 133.3 98.6 143.0 130.5 130.5 130.3 58.4 160.2 145.7 125.4 161.0 85.8 114.5 95.8 139.4 69.0 179.6 166.2 66.4 167.7 175.5 184.7 43.7 177.4 113.3 140.1 130.4 119.5 67.9 104.7 100.0 64.5 166.2 172.8 310.6 163.6 80.6 102.6 345.1 148.8 370.8 128.4 140.3 163.0 215.0 135.2 146.8 176.8 199.0 121.4 114.6 502.5 115.3 157.0 274.1 208.1 241.5 269.1 278.1 297.7 310.8 259.7 294.9 280.8 278.4 289.2 306.0 282.4 320.2 341.0 86.6 136.2 30.7 163.9 274.9 278.8 311.4 141.7 247.9 196.5 236.2 361.4 145.8 212.5 174.7 45.9 251.3 188.5 201.5 686.7 183.9 48.2 209.6 112.8 270.1 277.8 457.6 37.0 175.4 120.6 203.5 80.5 162.4 110.1 85.9 239.8 128.5 223.9 307.9 39.6 156.4 297.0 169.6 428.8 59.7 243.5 197.2 257.9 21.5 404.6 491.0 145.2 27.6 63.6 223.6 237.0 261.1 137.5 306.1 195.7 552.4 263.0 208.1 157.8 182.1 187.9 288.1 219.9 136.6 273.9 390.1 159.3 182.5 121.2 328.6 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132144-71713600 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.0;choroid plexus: 46.0;heart muscle: 43.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3" "Cancer enhanced" "Detected in many" "prostate cancer: 8.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 3.2 8.7 30.5 1.9 37.9 0.0 2.0 35.9 51.2 4.0 46.0 16.6 0.3 16.6 3.1 9.3 8.7 2.5 43.5 55.0 3.2 5.7 0.4 9.3 0.0 2.1 3.8 31.6 10.1 1.2 13.3 0.2 3.0 14.7 1.0 3.3 3.3 8.2 4.7 2.2 3.9 8.3 0.0 3.4 2.4 5.0 11.2 2.6 10.1 2.9 1.5 21.2 3.3 24.8 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.7 0.0 0.0 45.7 0.0 14.1 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 37.9 35.9 51.2 55.0 3.2 2.1 3.8 3.0 0.0 11.2 24.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 GATA4 ENSG00000136574 "GATA binding protein 4" P43694 8 11676959-11760002 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 88.6;ovary: 95.4;pancreas: 53.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1" "Cancer enhanced" "Detected in many" "stomach cancer: 21.8;testis cancer: 12.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013125, HPA073899" Uncertain Supported "Nuclear bodies" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "CAB013125: AB_2533804, HPA073899: AB_2686641" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (8.68e-4)" "unprognostic (2.66e-3)" "unprognostic (1.71e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-2)" "unprognostic (5.47e-2)" "unprognostic (2.55e-1)" "unprognostic (2.78e-2)" "unprognostic (2.49e-1)" "unprognostic (1.67e-8)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.29e-2)" 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.2 0.2 0.0 0.0 2.3 4.0 88.6 0.0 0.0 0.0 36.6 0.2 0.0 0.0 0.0 95.4 53.5 0.0 0.1 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.1 35.2 32.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.7 20.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.2 1.3 0.0 0.0 1.5 20.5 0.0 0.0 0.1 3.9 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 16.1 0.0 0.1 6.1 0.0 0.0 0.1 33.7 0.2 12.0 61.2 0.0 0.0 158.4 57.8 12.1 0.6 0.0 0.1 0.8 0.0 2.8 0.0 37.0 41.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 41.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 5.3 2.4 2.2 0.0 0.0 0.8 0.1 80.1 0.9 0.0 GCNT7 "C20orf105, dJ1153D9.2" ENSG00000124091 "Glucosaminyl (N-acetyl) transferase family member 7" Q6ZNI0 20 56491492-56525925 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "bone marrow: 4.4" "Cell type enhanced" "Detected in some" "Early spermatids: 2.2;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.0;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA052617, HPA059403" Uncertain Approved "Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies, Vesicles" Cytosol "HPA052617: AB_2681886, HPA059403: " "unprognostic (3.57e-2)" "unprognostic (1.39e-1)" "unprognostic (7.74e-2)" "unprognostic (1.89e-1)" "unprognostic (3.96e-2)" "unprognostic (9.08e-2)" "unprognostic (3.10e-1)" "unprognostic (1.13e-2)" "unprognostic (4.38e-2)" "unprognostic (2.38e-1)" "unprognostic (9.69e-2)" "unprognostic (2.84e-2)" "unprognostic (2.16e-3)" "unprognostic (1.84e-1)" "unprognostic (1.74e-1)" "unprognostic (1.96e-1)" "unprognostic (8.69e-2)" 0.0 0.1 0.1 0.3 0.2 4.4 0.0 0.6 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.4 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.9 0.0 0.1 0.2 0.2 0.0 0.1 0.2 0.6 0.2 0.1 0.2 0.3 0.2 0.3 0.1 0.4 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GEMIN2 SIP1 ENSG00000092208 "Gem nuclear organelle associated protein 2" O14893 14 39114223-39136973 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 45.8;Late spermatids: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015426, HPA046570, HPA057114" Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" Nucleoli "CAB015426: AB_629517, HPA046570: AB_2679703, HPA057114: AB_2683340" "unprognostic (4.53e-1)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (3.52e-2)" "prognostic unfavorable (3.88e-6)" "unprognostic (8.62e-3)" "unprognostic (3.05e-2)" "unprognostic (1.99e-3)" "unprognostic (3.08e-1)" "unprognostic (3.03e-1)" "unprognostic (4.53e-3)" "unprognostic (1.52e-1)" "unprognostic (1.58e-1)" "unprognostic (3.95e-1)" "unprognostic (6.78e-2)" 6.1 4.3 6.1 4.5 6.3 10.3 7.9 10.2 7.9 5.9 4.6 6.0 6.7 5.4 7.2 5.7 5.9 4.2 7.7 5.7 3.9 6.1 5.6 4.8 8.8 3.6 2.6 5.9 4.7 3.7 4.6 5.6 3.6 4.8 6.1 4.7 4.3 4.5 12.1 6.3 4.7 7.7 1.1 5.2 5.1 8.3 3.4 9.1 5.5 7.9 7.8 6.2 5.5 6.2 23.6 34.5 33.3 23.7 11.3 12.6 17.0 11.5 9.0 30.3 30.0 30.7 27.9 36.0 23.4 9.8 11.0 17.5 45.6 18.7 31.5 17.6 26.7 21.5 18.1 76.8 23.9 32.6 12.8 7.3 17.6 18.8 27.5 8.7 26.6 31.4 25.2 25.6 17.3 48.9 36.3 31.2 23.6 29.7 38.3 32.8 36.4 22.6 17.5 15.6 32.2 6.2 24.5 17.7 12.4 18.4 41.5 14.0 11.2 12.7 20.0 13.3 18.6 26.8 44.2 54.1 6.6 34.0 19.6 10.8 12.0 9.9 13.5 13.1 9.8 15.3 12.3 13.5 16.2 15.8 13.5 14.4 3.1 11.9 11.5 16.1 11.8 9.2 6.1 6.3 10.2 7.9 5.7 3.9 3.6 2.6 3.6 1.1 3.4 6.2 11.6 6.4 3.7 4.9 10.3 8.5 8.1 20.9 8.0 5.9 7.3 12.1 6.0 5.7 11.4 5.5 10.4 12.9 7.0 2.2 11.7 10.8 45.8 11.2 11.3 10.6 3.6 17.2 7.4 6.4 18.9 12.5 2.6 7.5 5.7 11.7 9.7 6.6 11.4 5.0 6.2 7.1 14.2 10.6 7.3 41.1 9.0 6.3 7.2 4.7 9.4 8.1 9.2 4.0 7.4 6.9 2.5 9.8 9.4 8.0 3.1 14.7 15.5 6.9 6.6 8.3 8.1 25.9 15.4 11.3 8.0 3.8 9.1 11.6 9.3 4.8 GEMIN4 "DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97" ENSG00000179409 "Gem nuclear organelle associated protein 4" P57678 17 744421-753999 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065699, HPA067891" Uncertain Supported "Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA065699: AB_2685534, HPA067891: AB_2685918" "unprognostic (1.85e-1)" "unprognostic (3.36e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-2)" "unprognostic (1.60e-1)" "unprognostic (7.41e-3)" "unprognostic (2.00e-2)" "unprognostic (7.95e-2)" "unprognostic (1.98e-2)" "unprognostic (1.63e-1)" "unprognostic (1.89e-2)" "unprognostic (8.67e-3)" "unprognostic (4.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (4.74e-2)" "unprognostic (8.56e-3)" 12.4 7.7 3.0 8.2 3.0 15.5 12.3 10.5 6.2 13.4 5.9 9.5 8.0 12.1 5.7 14.8 12.3 13.0 11.2 2.9 3.3 4.9 8.6 9.8 13.6 2.3 2.4 15.6 9.7 6.3 5.7 6.6 2.6 14.4 6.3 3.4 11.7 8.2 13.9 38.9 9.8 8.5 2.1 10.0 14.5 48.9 3.1 13.2 15.6 10.1 12.3 11.8 12.4 2.6 44.8 77.8 25.5 38.3 15.8 19.9 31.7 25.0 17.4 44.4 39.1 44.5 23.6 77.9 32.5 21.6 23.6 55.4 48.3 47.0 35.3 29.6 72.3 28.0 40.9 25.1 11.3 30.1 36.8 19.3 23.3 36.5 25.6 15.4 25.3 44.9 39.6 31.7 24.0 31.7 49.8 17.0 24.7 37.4 33.0 53.1 12.1 36.6 18.9 32.5 26.4 21.4 25.7 26.1 11.7 18.2 27.8 21.7 20.2 27.3 24.6 35.6 61.4 5.3 12.4 44.8 23.5 41.9 31.8 1.6 7.0 0.3 7.9 9.6 13.6 11.8 8.6 8.4 9.3 12.3 10.1 10.2 0.9 8.7 11.6 5.2 6.0 10.0 3.0 3.0 10.5 6.2 2.9 3.3 2.3 2.4 2.6 2.1 3.1 2.6 2.9 16.0 6.7 1.3 8.5 20.4 14.3 6.6 9.1 2.9 4.6 4.7 38.4 4.3 8.5 0.0 0.0 8.4 4.4 3.1 3.9 7.5 148.3 2.6 3.9 5.8 1.2 3.0 1.2 6.4 8.3 6.4 7.7 2.9 1.3 11.1 4.6 5.2 5.4 5.0 1.5 7.0 8.2 3.9 5.7 157.2 11.5 2.6 5.4 1.0 4.8 2.4 2.1 0.0 0.5 8.4 1.8 6.8 4.3 7.4 2.3 2.2 4.4 1.4 0.0 6.2 6.4 57.0 11.2 8.7 16.1 4.0 3.2 7.4 8.7 9.8 GEMIN5 ENSG00000082516 "Gem nuclear organelle associated protein 5" Q8TEQ6 5 154887411-154938211 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037392, HPA037393" Uncertain Enhanced "Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Cytosol "Nuclear bodies" "HPA037392: AB_2675453, HPA037393: AB_10672489" "unprognostic (1.14e-2)" "unprognostic (2.81e-3)" "unprognostic (5.41e-3)" "prognostic unfavorable (6.23e-5)" "unprognostic (5.44e-2)" "unprognostic (1.69e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (9.91e-2)" "unprognostic (8.70e-2)" "unprognostic (3.61e-2)" "unprognostic (9.38e-2)" "unprognostic (5.11e-2)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (9.40e-3)" "unprognostic (5.01e-2)" 8.3 4.4 5.0 5.0 5.9 3.3 8.2 5.4 5.6 5.9 5.0 5.4 3.3 6.2 4.6 5.3 6.1 3.4 6.7 5.1 5.4 4.7 6.0 4.3 6.5 5.2 5.2 8.4 5.5 6.4 4.4 4.8 5.4 5.8 4.6 4.1 4.6 5.9 12.3 7.3 4.0 6.9 5.2 5.6 4.3 6.0 5.4 7.5 5.3 10.2 7.3 6.8 5.0 6.9 17.2 25.0 15.9 37.0 16.8 14.2 20.4 16.4 9.9 28.0 20.6 41.6 15.0 45.0 20.2 15.7 28.8 17.8 47.7 29.8 38.0 9.0 22.3 27.3 15.6 25.2 9.3 48.0 15.2 10.7 13.6 38.9 23.2 10.1 23.2 10.7 43.9 10.7 21.2 23.6 26.0 19.2 22.3 13.4 19.4 33.3 31.2 37.4 11.6 11.6 20.9 14.4 18.9 20.7 13.3 15.7 24.6 11.0 14.2 25.1 18.0 19.1 37.2 10.7 17.5 34.5 10.7 38.8 22.6 0.0 1.9 1.7 2.4 2.3 3.9 3.4 2.2 2.2 2.6 2.7 3.2 3.5 0.1 2.8 2.2 1.9 2.2 2.1 5.0 5.9 5.4 5.6 5.1 5.4 5.2 5.2 5.4 5.2 5.4 6.9 6.7 0.0 6.4 6.8 8.4 10.3 6.7 5.3 10.2 6.3 5.2 5.0 15.0 1.5 12.3 3.7 0.0 4.4 5.0 1.9 0.0 5.7 3.4 4.3 9.5 8.4 1.2 8.8 19.1 4.2 4.4 11.1 5.1 4.8 1.3 15.6 4.6 9.2 4.5 16.8 20.5 3.9 0.0 14.4 2.6 4.1 10.8 4.5 7.2 11.2 6.0 7.0 5.2 15.1 19.3 3.4 1.1 13.2 4.5 7.0 2.6 4.5 2.5 4.3 0.0 11.5 8.6 11.7 16.1 8.2 15.9 2.1 5.6 15.6 4.7 4.9 GEMIN6 FLJ23459 ENSG00000152147 "Gem nuclear organelle associated protein 6" Q8WXD5 2 38751534-38785002 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 164.5;Spermatocytes: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035726, HPA035727" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" "HPA035726: AB_10669528, HPA035727: AB_2674753" "unprognostic (1.97e-2)" "unprognostic (3.83e-1)" "unprognostic (2.32e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (2.10e-2)" "unprognostic (3.82e-3)" "unprognostic (3.10e-2)" "unprognostic (8.13e-2)" "unprognostic (3.53e-3)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.47e-1)" "unprognostic (2.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-2)" 6.5 10.1 7.7 7.7 8.2 3.6 8.3 8.2 10.9 6.7 8.2 6.9 9.0 6.5 10.3 7.1 9.0 5.5 6.0 7.7 7.6 12.5 13.8 5.3 10.8 7.7 7.8 9.8 6.8 7.5 6.2 7.4 8.1 5.6 8.5 6.1 6.1 5.2 13.1 5.4 7.8 8.7 7.4 7.9 7.2 19.6 8.0 8.1 6.7 7.0 12.4 7.7 5.8 10.5 38.8 31.2 21.3 24.9 27.3 23.8 36.4 32.4 16.1 28.1 23.3 33.1 18.1 52.8 36.3 16.8 39.4 18.1 33.5 31.6 40.7 45.5 42.3 34.4 17.9 54.4 18.7 29.0 17.2 16.3 22.9 37.6 18.5 19.2 29.9 14.1 35.9 17.9 28.4 27.4 35.1 37.0 36.6 45.4 37.0 24.1 37.6 28.9 25.8 13.4 26.6 41.9 8.3 31.1 25.3 24.7 16.0 9.8 16.4 27.1 34.6 21.4 49.1 36.7 77.4 50.6 21.8 43.0 27.7 3.1 24.3 7.8 19.6 28.6 21.7 32.4 20.3 20.3 24.0 29.5 24.4 25.5 3.6 26.3 26.6 17.7 31.3 22.4 7.7 8.2 8.2 10.9 7.7 7.6 7.7 7.8 8.1 7.4 8.0 10.5 11.8 12.8 24.0 1.0 18.7 8.3 10.3 31.5 7.4 6.9 13.9 21.1 9.1 14.3 22.3 11.0 4.2 29.7 7.5 7.5 29.4 22.2 164.5 28.6 21.3 14.9 1.2 18.5 1.7 17.8 37.8 16.1 16.8 8.3 12.6 19.0 16.8 33.5 26.4 11.8 1.8 10.7 6.1 19.5 15.5 29.0 20.5 15.0 10.6 1.9 23.4 9.2 15.5 1.5 1.2 19.1 11.4 11.3 13.3 10.7 21.2 68.5 32.6 7.9 19.7 10.7 15.7 87.8 18.3 16.1 11.5 7.3 12.5 30.5 17.7 7.7 GIPC3 "C19orf64, DFNB15, DFNB72, DFNB95" ENSG00000179855 "GIPC PDZ domain containing family member 3" Q8TF64 19 3585478-3593541 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 16.7" "Group enriched" "Detected in some" 4 "Adipocytes: 10.4;Endothelial cells: 6.2;Hepatic stellate cells: 12.8;Rod photoreceptor cells: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 19.0;HMC-1: 11.8;THP-1: 23.1;WM-115: 44.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA067765 Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 77: Retina - Visual perception" "Cluster 17: WM-115 - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA067765: " "unprognostic (1.77e-1)" "unprognostic (1.73e-1)" "unprognostic (5.13e-2)" "unprognostic (6.99e-2)" "unprognostic (1.22e-1)" "unprognostic (1.76e-2)" "unprognostic (1.41e-1)" "unprognostic (3.67e-3)" "unprognostic (4.76e-2)" "unprognostic (2.97e-1)" "unprognostic (5.06e-3)" "unprognostic (2.26e-2)" "unprognostic (1.51e-3)" "unprognostic (1.96e-2)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" 4.6 2.2 1.4 1.0 1.0 0.3 2.8 1.0 1.1 3.0 0.8 1.9 1.2 2.8 2.9 5.2 2.1 2.1 3.9 1.2 1.2 3.6 1.4 3.8 2.4 1.6 1.2 0.7 0.7 2.7 1.0 1.1 1.6 3.5 1.4 16.7 0.7 2.3 1.7 1.1 4.4 8.3 1.4 3.9 2.0 0.3 1.6 3.1 3.0 1.9 1.6 1.1 1.8 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.3 0.1 0.9 1.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 1.5 0.0 0.2 6.9 19.0 0.0 0.7 0.0 11.8 0.2 0.0 1.1 0.0 0.0 2.1 0.2 3.2 0.0 0.3 0.0 0.0 1.1 0.7 0.0 1.2 0.5 0.0 0.8 0.0 0.0 0.0 0.1 0.5 0.0 4.7 1.1 0.0 23.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 1.0 1.1 1.2 1.2 1.6 1.2 1.6 1.4 1.6 1.1 10.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.4 0.1 0.3 2.4 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 12.8 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 2.8 0.0 0.8 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.2 1.1 0.0 0.4 0.1 0.3 0.1 0.3 0.1 0.0 0.1 GMFB GMF ENSG00000197045 "Glia maturation factor beta" P60983 14 54474484-54489026 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Approved Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 240000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (7.93e-2)" "unprognostic (7.69e-3)" "unprognostic (4.81e-3)" "unprognostic (2.99e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (1.48e-2)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "prognostic favorable (9.48e-5)" "unprognostic (1.80e-1)" "unprognostic (2.82e-1)" "unprognostic (1.23e-1)" "unprognostic (9.09e-2)" 25.2 21.8 62.8 23.5 68.8 28.8 26.0 61.6 90.4 18.6 39.8 35.0 33.5 19.3 14.0 15.8 14.2 16.5 17.2 61.4 75.6 33.6 25.8 24.2 25.3 73.0 64.5 16.1 12.8 20.1 12.3 26.5 71.4 14.8 35.2 18.4 10.7 12.9 7.0 13.7 29.5 18.2 84.0 18.4 19.0 11.1 71.9 16.2 21.9 10.2 24.4 22.3 11.4 85.3 92.7 36.9 71.8 53.2 75.8 94.5 53.9 93.2 67.9 66.2 82.1 42.6 79.4 85.2 42.4 92.0 39.5 33.4 73.7 64.0 104.4 30.9 25.4 42.5 37.4 39.9 64.7 59.9 35.5 72.0 58.8 57.1 56.0 67.9 60.8 38.4 31.4 28.8 106.1 45.7 36.8 22.9 46.4 52.1 38.9 36.9 84.7 24.4 84.4 86.3 42.4 65.5 64.6 54.4 71.4 59.0 59.8 46.4 48.1 94.9 71.9 48.7 58.4 10.4 19.4 52.0 80.0 36.3 61.5 6.8 10.2 9.1 5.0 13.3 7.0 6.6 5.9 5.1 12.6 7.8 6.2 6.6 16.1 8.0 14.0 4.4 8.5 6.2 62.8 68.8 61.6 90.4 61.4 75.6 73.0 64.5 71.4 84.0 71.9 85.3 23.3 25.6 16.2 8.1 39.3 59.9 50.2 33.6 48.9 18.4 28.0 18.0 17.3 20.0 22.6 25.8 4.2 39.3 33.7 61.8 21.5 38.7 27.3 21.5 29.5 22.2 29.9 14.5 16.8 23.3 84.5 35.1 23.9 36.1 21.6 25.4 16.8 24.5 45.4 21.9 13.6 33.6 26.4 34.6 36.4 7.5 20.2 43.0 46.2 8.4 37.8 25.7 25.7 14.1 16.5 37.3 32.1 15.8 16.9 56.0 26.0 60.5 16.4 15.4 13.1 77.0 54.5 16.0 11.4 33.5 43.8 58.3 26.2 18.8 36.2 56.2 GMFG ENSG00000130755 "Glia maturation factor gamma" O60234 19 39328353-39342372 "Plasma proteins, Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 577.4;lymphoid tissue: 460.7" "Cell type enhanced" "Detected in many" "Adipocytes: 304.3;Hofbauer cells: 467.5;Kupffer cells: 523.4;Langerhans cells: 343.2;Macrophages: 409.6;monocytes: 409.4;NK-cells: 423.3;T-cells: 370.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 356.7;HMC-1: 602.6;JURKAT: 464.5;Karpas-707: 494.4;NB-4: 361.6;REH: 409.8;THP-1: 641.5;U-937: 482.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002954 Uncertain Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 810000 "Cluster 5: Granulocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA002954: AB_1078997" "unprognostic (1.22e-2)" "prognostic favorable (7.35e-4)" "unprognostic (2.37e-2)" "unprognostic (1.21e-3)" "unprognostic (9.93e-2)" "unprognostic (2.14e-2)" "unprognostic (1.19e-1)" "unprognostic (4.84e-2)" "unprognostic (1.00e-1)" "unprognostic (2.09e-1)" "unprognostic (3.09e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (9.11e-6)" "unprognostic (3.01e-1)" "unprognostic (8.76e-3)" "unprognostic (1.06e-1)" "unprognostic (5.27e-3)" 111.6 26.3 27.1 188.6 27.4 577.4 71.3 26.9 41.6 26.0 29.3 45.6 33.8 20.7 19.6 19.7 29.0 60.8 25.1 27.9 29.1 36.8 65.9 117.7 299.5 30.7 30.1 9.2 14.4 15.6 10.8 102.4 30.5 18.5 53.2 2.0 18.9 15.0 11.4 16.2 75.0 47.8 29.1 325.3 41.5 7.4 28.6 460.7 37.6 23.6 262.7 93.5 18.3 32.6 1.4 0.0 2.0 0.4 0.0 0.0 0.7 1.1 0.3 0.3 0.2 0.3 33.1 309.6 2.4 0.3 0.1 1.5 0.0 0.7 1.2 99.7 0.5 329.7 0.4 3.5 5.1 356.7 602.6 0.7 0.6 0.5 0.8 0.8 19.2 464.5 12.3 494.4 2.4 0.0 316.6 361.6 0.6 0.1 0.2 409.8 3.2 196.8 0.5 40.9 0.8 0.5 1.3 1.9 2.1 0.6 0.8 641.5 175.7 0.2 3.2 0.8 1.1 26.9 107.3 340.0 1.7 482.4 2.7 4389.0 1574.5 3622.3 720.9 1447.6 773.8 812.5 1058.2 894.4 1139.9 742.7 1044.5 858.2 5262.9 908.0 1686.2 459.6 1840.4 2617.7 27.1 27.4 26.9 41.6 27.9 29.1 30.7 30.1 30.5 29.1 28.6 32.6 304.3 28.9 97.6 0.0 211.7 18.6 4.4 0.3 2.8 0.0 4.2 9.4 3.2 11.5 17.3 0.0 0.0 3.6 273.5 0.9 0.0 1.1 11.8 0.6 2.2 176.4 0.0 119.4 0.5 0.7 4.0 18.2 9.7 0.8 238.0 0.3 272.4 11.8 467.5 0.0 0.4 0.3 2.0 523.4 343.2 30.4 1.8 409.6 74.7 1.9 409.4 0.7 423.3 0.5 0.3 0.3 0.0 0.4 216.8 1.1 0.3 4.6 8.9 0.3 46.0 4.2 26.4 8.6 3.3 1.4 14.8 5.5 370.6 2.3 1.1 4.1 GNL3 "C77032, E2IG3, MGC800, NS" ENSG00000163938 "G protein nucleolar 3" Q9BVP2 3 52681156-52694497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020770, HPA036742, HPA036743" Enhanced Enhanced "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No 13000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli rim" "Nuclear bodies, Mitotic chromosome" "CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283" "unprognostic (4.40e-1)" "unprognostic (9.30e-2)" "unprognostic (4.10e-3)" "unprognostic (2.21e-1)" "unprognostic (5.11e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.46e-1)" "unprognostic (3.29e-3)" "unprognostic (1.14e-2)" "unprognostic (1.67e-3)" "prognostic unfavorable (6.11e-4)" "prognostic unfavorable (5.69e-5)" "unprognostic (1.33e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-3)" "unprognostic (1.06e-2)" 47.2 47.1 17.1 42.1 17.0 27.4 68.8 18.4 24.4 38.8 18.7 40.0 38.8 33.8 25.6 65.0 28.2 28.0 29.6 17.9 19.4 33.4 50.3 29.7 51.5 17.9 17.7 35.8 60.7 27.1 35.9 36.4 17.8 46.7 46.0 16.0 46.4 26.3 78.2 39.1 29.6 32.2 16.9 34.0 41.0 26.8 17.9 35.9 28.6 42.9 64.9 92.3 41.3 19.1 110.4 79.1 114.4 125.3 105.6 105.1 178.1 133.0 101.5 135.4 100.6 121.3 80.8 255.4 42.2 100.1 104.6 78.2 189.1 125.1 180.5 156.3 134.6 196.8 139.0 189.3 218.1 283.7 138.0 96.1 216.5 147.8 224.1 90.3 107.8 99.7 214.8 136.2 93.8 77.7 170.6 162.1 195.6 153.4 151.2 99.3 93.0 315.0 108.9 153.9 81.4 105.6 82.1 190.5 193.6 101.7 74.7 155.8 86.6 92.8 100.0 139.2 281.7 147.6 252.0 387.0 96.9 203.5 148.4 1.2 15.2 3.3 19.9 16.7 34.1 28.7 26.8 24.1 26.1 23.9 30.4 29.4 1.8 26.1 12.9 40.7 18.8 20.2 17.1 17.0 18.4 24.4 17.9 19.4 17.9 17.7 17.8 16.9 17.9 19.1 34.6 22.4 48.2 5.2 84.3 163.7 146.0 111.9 77.4 19.0 72.6 46.4 51.3 25.8 144.9 12.9 10.4 73.2 78.5 42.8 41.1 105.1 54.4 44.7 76.5 53.4 47.8 51.5 11.6 104.6 117.5 92.9 47.9 53.0 63.1 47.5 23.2 41.9 40.9 21.9 11.1 71.7 67.1 24.2 77.6 28.2 51.9 43.0 78.2 5.6 59.5 17.7 38.1 7.1 9.4 99.9 34.4 34.3 122.3 126.1 19.1 47.2 56.5 14.8 6.6 106.2 79.1 37.9 74.4 59.4 153.7 90.3 63.0 74.5 85.8 135.7 GON4L "FLJ20203, GON-4, GON4, YARP" ENSG00000116580 "Gon-4 like" Q3T8J9 1 155749659-155859400 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 160.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006986, HPA057305, HPA074504" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear bodies" "HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696" "unprognostic (3.16e-2)" "unprognostic (9.26e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (9.85e-3)" "unprognostic (5.21e-2)" "unprognostic (1.83e-2)" "unprognostic (1.15e-1)" "unprognostic (7.49e-2)" "unprognostic (7.50e-2)" "unprognostic (1.69e-1)" "unprognostic (1.94e-1)" "unprognostic (5.12e-3)" "unprognostic (3.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.26e-2)" "unprognostic (5.83e-2)" 11.3 7.6 4.7 10.7 4.9 9.5 11.4 7.6 5.9 10.1 6.3 10.9 7.4 10.7 10.4 8.3 9.7 7.4 8.4 4.4 4.5 8.9 7.9 10.5 12.3 4.4 6.1 10.1 10.1 10.8 9.5 10.0 4.3 9.9 9.2 14.0 9.5 9.1 12.4 11.4 11.2 10.5 3.5 12.6 9.4 9.0 5.2 14.3 11.3 8.1 12.1 10.0 9.4 5.9 13.7 11.1 21.2 13.0 13.0 16.2 13.2 12.0 14.7 15.4 14.9 13.2 12.2 15.7 13.0 15.8 7.7 15.3 15.9 14.1 17.6 14.7 11.1 15.3 14.0 7.3 12.2 18.6 14.0 14.4 12.2 17.0 15.9 15.7 18.5 17.0 20.3 5.8 13.2 13.5 16.2 11.1 23.4 16.7 12.6 14.8 13.2 17.7 11.2 16.1 11.8 19.8 14.3 14.4 11.6 21.0 16.2 22.2 20.5 12.4 10.1 12.7 15.4 23.9 16.9 25.6 10.8 11.0 14.0 3.5 2.6 2.4 3.6 2.0 2.4 2.1 2.4 2.5 2.7 4.0 2.4 2.2 5.7 4.5 1.8 2.9 2.5 1.8 4.7 4.9 7.6 5.9 4.4 4.5 4.4 6.1 4.3 3.5 5.2 5.9 52.3 16.0 36.1 52.5 41.8 12.1 20.6 18.6 17.6 67.2 25.0 26.2 22.1 17.2 27.7 20.2 131.3 27.1 41.6 25.5 9.8 23.5 18.8 29.5 40.0 42.2 32.4 36.4 45.0 18.1 23.8 28.8 37.8 37.5 38.1 40.8 29.3 13.8 19.7 77.4 40.3 23.5 16.2 23.8 19.1 11.7 35.1 27.0 16.0 28.1 40.2 39.2 80.3 26.2 27.6 24.0 20.6 27.4 38.5 26.9 23.2 14.0 19.8 160.7 39.5 38.8 30.6 54.7 40.5 18.3 17.5 45.0 47.9 50.1 22.6 24.0 GPR155 "DEP.7, DEPDC3, FLJ31819, PGR22" ENSG00000163328 "G protein-coupled receptor 155" Q7Z3F1 2 174431571-174487094 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 83.4;stomach 1: 52.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 14.6;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036159, HPA057384" Approved Approved "Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies, Cytosol" "HPA036159: AB_10671835, HPA057384: AB_2683424" "unprognostic (3.91e-2)" "unprognostic (7.93e-2)" "unprognostic (3.14e-2)" "unprognostic (4.11e-4)" "unprognostic (5.03e-2)" "unprognostic (2.48e-1)" "unprognostic (8.49e-2)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.91e-2)" "unprognostic (2.48e-2)" "unprognostic (4.82e-2)" "unprognostic (2.59e-2)" "unprognostic (9.90e-2)" "unprognostic (1.82e-2)" "unprognostic (4.54e-2)" 4.3 9.7 8.7 5.9 16.3 2.3 2.4 6.5 12.1 2.4 83.4 10.2 3.8 1.9 12.3 5.9 1.6 5.7 7.0 12.2 5.3 20.1 7.3 3.0 6.3 5.5 5.3 2.5 18.2 8.9 2.3 4.4 5.2 7.5 3.7 10.0 3.6 8.4 4.7 13.2 4.0 6.1 3.5 5.4 52.6 2.2 7.1 3.0 8.3 4.4 3.6 4.1 2.7 6.1 0.7 0.3 0.8 2.0 4.9 2.7 0.5 3.8 1.3 0.6 2.1 0.3 0.2 2.2 1.2 2.8 1.3 0.2 1.3 1.1 2.1 0.8 1.5 2.3 1.1 0.2 0.9 0.7 1.1 3.9 3.1 1.9 0.6 4.0 1.0 3.0 0.3 5.5 4.2 0.6 1.6 0.8 0.4 2.3 1.5 1.9 5.6 1.0 2.0 1.3 5.9 5.0 1.2 0.8 2.0 2.5 0.3 0.3 2.6 2.7 1.0 3.9 0.5 14.6 2.2 0.3 3.0 0.6 9.9 1.3 2.2 0.1 1.8 4.0 1.6 1.1 3.1 2.9 0.6 1.0 2.5 3.9 7.3 3.6 5.7 0.3 5.5 1.4 8.7 16.3 6.5 12.1 12.2 5.3 5.5 5.3 5.2 3.5 7.1 6.1 18.5 12.8 3.6 31.3 9.8 42.7 4.0 4.0 29.0 34.9 5.8 6.1 26.0 2.8 6.8 11.0 125.1 1.5 12.2 0.6 1.9 1.9 0.7 1.4 24.1 9.8 12.7 15.2 99.4 6.0 1.2 9.7 9.7 0.6 1.3 4.0 16.1 16.1 6.1 50.5 131.1 0.8 2.0 50.4 23.0 1.8 14.9 27.0 152.9 8.4 34.3 16.7 11.3 130.2 21.2 3.5 0.1 32.0 14.3 3.1 0.4 41.7 0.5 25.8 0.0 16.9 9.5 3.3 3.2 7.5 28.6 0.8 25.7 52.4 1.0 1.8 GSDMA "FLJ39120, GSDM, GSDM1" ENSG00000167914 "Gasdermin A" Q96QA5 17 39953263-39977768 "Predicted intracellular proteins, Transporters" Necrosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 58.9" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.7;Hofbauer cells: 5.0;Kupffer cells: 5.6;Macrophages: 2.6;Suprabasal keratinocytes: 2.7;Theca cells: 2.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.6" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HBEC3-KT: 4.1;hTCEpi: 2.7;hTERT-HME1: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023313, HPA064826" Enhanced Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 44000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 30: Epithelial cell lines - Translation" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA023313: AB_1850378, HPA064826: AB_2685361" "unprognostic (1.32e-2)" "unprognostic (2.01e-1)" "unprognostic (2.95e-2)" "unprognostic (1.06e-1)" "unprognostic (3.62e-1)" "unprognostic (1.97e-1)" "unprognostic (7.77e-2)" "unprognostic (1.39e-1)" "unprognostic (3.24e-1)" "unprognostic (3.52e-2)" "unprognostic (2.71e-1)" "unprognostic (2.90e-2)" "unprognostic (1.06e-2)" "unprognostic (9.86e-2)" "unprognostic (7.45e-2)" "unprognostic (3.63e-2)" "unprognostic (3.79e-2)" 3.4 0.7 0.2 0.9 0.2 0.4 3.5 0.4 0.4 0.8 0.2 0.7 0.6 0.4 6.6 3.2 0.3 0.8 0.3 0.3 0.2 0.3 0.3 0.4 0.7 0.4 0.0 0.1 0.3 1.3 0.1 1.6 0.4 0.1 1.2 0.0 0.8 0.0 0.4 58.9 0.5 0.6 0.0 0.2 0.3 0.3 0.4 0.5 0.1 0.1 3.4 1.1 1.5 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.1 0.2 0.5 0.4 0.2 0.0 0.1 0.8 0.0 2.7 0.5 5.4 0.0 0.0 0.0 0.1 1.3 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.9 0.1 0.1 2.2 0.0 2.6 0.0 1.3 0.8 0.1 0.1 0.6 0.9 0.7 0.1 0.1 0.2 0.5 0.5 0.2 0.2 0.4 0.4 0.3 0.2 0.4 0.0 0.4 0.0 0.4 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 3.7 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.7 0.0 5.0 0.0 0.1 0.7 0.0 5.6 0.6 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.7 0.0 0.2 2.8 0.0 0.0 GTF2B TFIIB ENSG00000137947 "General transcription factor IIB" Q00403 1 88852633-88891944 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061626 Supported Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "HPA061626: AB_2684570" "prognostic favorable (4.81e-4)" "unprognostic (5.21e-2)" "unprognostic (3.94e-3)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "unprognostic (2.43e-1)" "unprognostic (1.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.37e-3)" "unprognostic (3.37e-1)" "unprognostic (1.37e-2)" "unprognostic (3.13e-1)" "unprognostic (1.42e-2)" "unprognostic (1.10e-2)" "unprognostic (1.40e-1)" "unprognostic (4.06e-3)" "unprognostic (3.74e-2)" 25.3 26.4 14.8 18.8 15.7 62.2 28.3 16.4 24.0 22.9 17.7 22.6 17.9 21.8 30.3 26.3 22.7 23.8 15.7 15.5 16.5 22.9 32.6 22.0 28.9 15.5 15.9 26.3 23.3 22.7 20.3 25.2 15.7 18.1 23.1 17.9 22.9 16.3 23.1 28.3 23.9 20.7 16.2 28.7 23.0 16.3 15.1 40.2 21.2 18.5 31.3 31.5 23.7 17.0 40.0 13.6 34.6 18.8 49.8 34.4 42.9 32.1 39.4 44.1 46.4 17.9 24.3 45.5 37.8 28.0 53.3 22.0 36.8 32.1 38.3 42.8 34.3 48.6 21.2 32.1 31.9 56.8 28.7 30.0 32.1 38.2 21.7 33.4 25.1 41.1 43.1 33.6 47.0 12.6 54.9 46.7 28.8 35.4 29.3 34.4 46.8 34.2 47.0 47.2 26.7 22.4 28.5 35.4 57.8 30.7 15.9 51.1 22.3 19.2 24.0 35.0 38.8 35.1 29.9 62.6 12.8 48.8 16.7 91.2 49.3 82.1 45.9 57.1 53.2 57.8 52.1 50.5 62.5 48.2 62.9 53.9 99.7 54.9 60.4 40.5 70.1 50.9 14.8 15.7 16.4 24.0 15.5 16.5 15.5 15.9 15.7 16.2 15.1 17.0 106.6 6.4 29.7 13.7 114.9 46.3 75.4 63.3 58.6 14.6 39.7 104.9 12.3 21.5 45.6 11.0 2.1 74.0 122.3 39.1 39.2 49.2 22.9 53.9 28.4 30.3 20.3 51.1 22.7 38.6 60.0 53.0 41.8 29.8 48.9 30.2 16.8 17.6 40.5 18.5 21.4 30.5 52.9 32.3 42.5 7.9 36.4 93.4 28.4 22.5 40.3 30.7 33.0 18.1 25.2 49.9 70.5 29.3 74.3 27.8 26.9 47.4 55.2 18.5 13.1 86.6 65.0 24.2 29.0 40.1 50.0 150.1 122.8 34.5 22.7 79.4 GTF3C6 "bA397G5.3, C6orf51, TFIIIC35" ENSG00000155115 "General transcription factor IIIC subunit 6" Q969F1 6 110958706-110967890 "Predicted intracellular proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056179, HPA061345" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Nuclear bodies" "HPA056179: AB_2683058, HPA061345: AB_2684485" "unprognostic (6.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.66e-1)" "unprognostic (3.04e-1)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (2.08e-2)" "unprognostic (9.79e-3)" "unprognostic (2.89e-1)" "unprognostic (5.42e-2)" "unprognostic (7.75e-2)" "unprognostic (1.42e-3)" "unprognostic (9.31e-2)" "unprognostic (1.69e-1)" "unprognostic (2.39e-2)" "unprognostic (1.14e-2)" 53.2 55.0 71.5 53.5 73.6 53.5 47.1 73.7 114.9 42.0 73.4 66.9 52.3 30.8 45.8 44.8 45.2 57.8 86.6 70.8 76.3 76.2 51.3 33.9 55.8 72.4 72.6 28.2 30.8 65.3 37.1 32.5 72.7 94.6 65.4 39.0 38.3 41.6 231.2 31.1 46.7 48.7 72.9 33.6 49.8 61.9 72.3 49.7 40.2 168.0 58.1 61.1 27.5 74.9 85.8 154.0 166.5 155.7 59.9 121.9 145.4 143.8 105.1 131.9 109.2 229.0 74.7 121.1 137.8 132.9 30.4 38.6 141.1 120.0 145.5 175.9 205.3 234.2 145.9 347.5 113.4 360.9 190.8 121.4 103.3 115.2 112.8 89.7 155.2 154.3 281.7 79.4 246.8 166.5 198.6 371.4 169.9 109.6 121.0 183.2 95.6 109.7 221.5 214.7 105.4 148.5 107.0 16.8 133.0 98.6 58.7 244.2 163.0 38.2 112.0 260.5 232.3 51.7 127.2 235.9 39.7 208.1 191.3 112.6 116.9 71.0 104.2 170.7 117.9 164.1 130.0 131.0 158.3 133.7 100.9 118.9 18.5 116.2 141.1 173.4 292.4 167.5 71.5 73.6 73.7 114.9 70.8 76.3 72.4 72.6 72.7 72.9 72.3 74.9 58.0 70.5 47.1 12.7 67.1 30.3 70.9 169.2 34.1 37.6 85.3 90.4 279.1 203.0 99.5 104.8 16.7 94.6 75.0 138.8 305.2 190.4 169.1 119.1 82.0 66.0 109.8 86.9 4.9 293.0 251.1 66.4 47.9 167.8 54.4 71.2 55.6 94.5 284.6 26.9 6.7 98.6 144.5 79.8 50.1 223.9 65.0 104.5 55.2 6.5 172.4 133.2 81.4 7.1 13.4 210.8 125.2 68.4 78.3 126.9 118.9 404.7 74.9 37.0 65.7 63.5 88.1 153.1 105.8 72.5 29.7 90.4 72.3 120.2 121.4 117.8 GTPBP1 "GP-1, HSPC018" ENSG00000100226 "GTP binding protein 1" O00178 22 38705742-38738299 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003166, HPA064702" Approved Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 64000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus, Cytosol" "Nuclear bodies" "HPA003166: AB_10601476, HPA064702: AB_2685329" "unprognostic (1.42e-3)" "unprognostic (5.82e-3)" "unprognostic (1.08e-1)" "unprognostic (1.18e-2)" "unprognostic (1.94e-2)" "unprognostic (4.95e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (3.17e-1)" "unprognostic (3.67e-2)" "unprognostic (1.56e-2)" "unprognostic (2.95e-2)" "unprognostic (2.88e-1)" "unprognostic (5.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.76e-2)" "unprognostic (3.40e-1)" "unprognostic (1.98e-3)" 18.4 19.0 16.5 23.4 19.1 105.4 18.4 20.0 44.3 20.3 20.8 20.5 20.5 20.0 12.1 22.4 22.1 17.7 20.0 18.4 19.3 18.4 17.1 28.9 23.0 19.3 17.0 27.4 22.0 19.2 25.5 16.0 17.0 23.8 17.6 34.7 21.2 15.5 31.7 27.5 22.9 16.6 15.5 28.0 20.4 20.3 16.7 20.0 24.9 19.9 23.0 18.7 19.4 23.9 29.2 10.5 37.4 30.2 12.6 19.7 18.3 27.4 28.7 39.0 33.9 22.0 16.3 27.9 9.8 26.9 17.5 26.6 45.5 28.8 21.6 49.2 32.8 48.7 36.9 16.3 23.9 57.7 24.3 20.3 22.0 31.2 48.7 21.3 24.3 20.2 29.4 56.5 21.8 12.1 32.1 26.1 27.0 16.7 20.8 61.8 38.2 36.7 13.8 23.3 51.0 17.7 33.3 21.0 19.6 16.2 19.0 24.2 26.1 22.3 22.0 16.4 21.2 51.8 18.7 38.5 20.1 29.0 16.9 3.5 3.1 3.9 4.7 4.6 4.2 4.6 3.5 4.9 3.4 3.8 2.5 3.7 7.8 2.3 5.1 1.7 3.3 3.4 16.5 19.1 20.0 44.3 18.4 19.3 19.3 17.0 17.0 15.5 16.7 23.9 17.8 9.6 8.4 7.8 31.8 27.8 36.0 12.7 15.4 32.6 17.5 15.5 11.2 5.7 12.4 12.9 22.9 7.2 35.9 40.3 5.9 13.2 4.5 22.2 14.3 13.1 16.2 35.3 5.5 19.3 7.9 14.5 23.4 26.4 14.0 17.5 13.6 12.4 8.6 20.2 7.9 24.3 16.2 18.4 43.9 5.4 16.1 19.3 10.6 4.7 26.6 13.2 20.6 5.5 15.2 19.9 21.1 19.2 52.8 47.4 29.8 6.1 16.6 41.0 26.3 19.9 14.5 17.2 7.7 19.2 34.2 19.0 31.9 15.5 13.0 51.0 H1-0 "H1.0, H1F0, H1FV" ENSG00000189060 "H1.0 linker histone" P07305 22 37805093-37807436 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 660.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 51.4;Cytotrophoblasts: 42.9;Extravillous trophoblasts: 125.7;Hofbauer cells: 73.2;Syncytiotrophoblasts: 219.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 8.1;granulocytes: 17.1;monocytes: 11.7" "Cell line enhanced" "Detected in many" "OE19: 662.8;U-2 OS: 823.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000843 Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments" Yes No 120000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" "Golgi apparatus, Actin filaments" "HPA000843: AB_1079062" "unprognostic (1.29e-2)" "unprognostic (1.68e-1)" "unprognostic (1.69e-2)" "unprognostic (1.27e-1)" "unprognostic (3.31e-3)" "unprognostic (1.19e-1)" "unprognostic (2.18e-1)" "unprognostic (3.85e-1)" "unprognostic (7.68e-2)" "unprognostic (1.86e-1)" "unprognostic (5.95e-3)" "unprognostic (4.86e-3)" "prognostic favorable (7.68e-7)" "unprognostic (3.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 89.8 53.5 56.6 36.7 55.4 660.5 121.4 72.5 64.1 218.3 42.5 146.2 129.9 168.2 43.5 230.6 119.7 56.3 86.5 55.4 67.1 292.8 179.3 72.4 24.4 58.4 54.2 120.7 125.9 93.2 58.2 80.0 57.7 151.7 120.0 39.9 155.3 40.2 216.2 228.6 137.1 97.7 52.6 36.7 131.2 42.4 58.3 136.2 93.9 93.5 46.6 85.6 194.9 55.8 159.6 67.9 206.0 91.8 53.4 48.4 291.6 126.9 262.3 362.6 512.6 278.1 247.3 0.2 31.1 106.3 84.1 303.8 0.0 87.2 256.0 0.9 15.3 268.2 25.3 187.4 185.8 0.1 0.7 45.4 152.4 182.3 203.2 4.0 97.8 60.4 0.1 0.5 28.5 263.3 45.4 26.5 80.2 662.8 329.9 74.6 122.6 56.1 58.0 42.7 47.3 263.9 349.9 235.4 473.9 91.8 184.2 167.1 65.4 27.4 823.3 122.7 25.9 0.7 18.5 1.2 33.5 95.9 80.3 17.1 9.9 15.7 0.1 11.7 0.1 0.0 1.0 0.2 8.1 0.1 2.8 0.4 5.4 0.1 10.3 7.4 0.2 6.9 56.6 55.4 72.5 64.1 55.4 67.1 58.4 54.2 57.7 52.6 58.3 55.8 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.0 0.0 42.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 125.7 25.2 0.0 0.0 0.0 0.0 0.0 0.0 73.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 219.7 0.0 0.0 0.0 0.0 HACE1 KIAA1320 ENSG00000085382 "HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1" Q8IYU2 6 104728094-104859919 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Excitatory neurons: 118.8;Inhibitory neurons: 84.2;Microglial cells: 45.9;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046071 Supported "Nuclear bodies,Endoplasmic reticulum" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Endoplasmic reticulum" "Nuclear bodies" "HPA046071: AB_2679524" "unprognostic (6.32e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (1.12e-2)" "unprognostic (3.75e-2)" "unprognostic (3.75e-3)" "unprognostic (1.22e-3)" "unprognostic (4.63e-2)" "unprognostic (7.41e-2)" "unprognostic (1.24e-1)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.12e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (1.75e-1)" 3.7 3.2 2.7 2.2 4.4 2.9 3.1 5.0 4.8 3.9 0.4 2.6 2.1 3.9 1.1 5.3 3.3 3.1 3.3 3.1 2.5 6.2 1.6 3.6 2.2 1.9 2.6 3.8 1.9 7.2 1.5 30.6 2.3 3.7 1.8 11.5 2.9 4.1 2.2 2.5 2.1 4.0 1.4 2.5 2.4 10.4 3.1 3.9 4.5 4.1 2.4 3.3 2.9 5.8 3.9 2.7 11.3 14.3 6.6 8.8 13.3 7.7 11.9 4.8 7.2 2.5 2.3 2.2 3.4 5.9 8.1 2.6 2.8 5.3 10.0 9.1 7.2 7.7 2.5 3.4 6.6 6.8 2.5 5.9 4.7 6.2 5.2 6.3 8.0 9.2 7.6 2.4 9.6 2.8 5.1 4.1 5.0 2.9 2.6 8.0 12.8 0.9 3.8 6.6 6.1 9.1 4.2 4.3 2.3 7.3 2.7 9.2 8.5 3.9 3.2 10.5 7.4 3.5 4.1 7.6 4.0 6.4 7.1 0.0 0.6 0.7 1.2 1.0 1.3 0.9 1.1 1.1 0.6 0.8 1.2 0.9 0.1 0.8 0.5 0.8 0.4 0.5 2.7 4.4 5.0 4.8 3.1 2.5 1.9 2.6 2.3 1.4 3.1 5.8 11.6 3.2 1.1 42.4 5.1 4.7 2.3 2.3 5.2 11.6 5.3 3.7 6.7 1.5 3.9 5.5 45.9 10.6 4.1 1.5 1.9 1.6 6.2 2.7 6.2 12.9 1.8 3.0 118.8 1.5 5.4 7.1 5.6 3.4 1.3 7.1 4.2 2.6 5.7 16.8 84.2 2.0 0.0 4.1 2.4 4.6 6.2 3.5 1.8 45.9 4.3 6.1 8.2 64.3 74.6 1.4 2.9 3.8 3.7 1.6 3.8 5.7 2.6 31.7 6.6 6.4 6.6 13.2 3.5 5.3 4.7 6.3 6.2 2.9 1.9 1.9 HAND1 "bHLHa27, eHand, Hxt, Thing1" ENSG00000113196 "Heart and neural crest derivatives expressed 1" O96004 5 154474972-154478227 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 24.3;intestine: 66.1" "Cell type enriched" "Detected in some" 8 "Cardiomyocytes: 15.2" "Cancer enriched" "Detected in some" 5 "testis cancer: 2.8" "Region enriched" "Detected in single" 4 "thalamus: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "SH-SY5Y: 119.5;SuSa: 212.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040925, HPA075313" Uncertain Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA040925: AB_10796563, HPA075313: " "unprognostic (2.37e-2)" "unprognostic (8.29e-2)" "unprognostic (2.46e-3)" "unprognostic (7.23e-2)" "unprognostic (5.21e-2)" "unprognostic (6.38e-3)" 0.2 4.7 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 3.7 0.0 0.0 0.0 0.0 0.5 24.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 14.3 12.3 0.0 0.0 0.0 0.3 1.5 0.1 0.0 0.0 0.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 119.5 0.0 0.0 0.0 212.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 15.2 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.6 1.7 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.1 1.1 0.0 0.0 0.2 0.0 HBS1L "DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038" ENSG00000112339 "HBS1 like translational GTPase" Q9Y450 6 134960378-135103056 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis, Translation regulation" "Elongation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 198.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029728, HPA029729" Approved Approved "Nuclear bodies,Cytosol" NA NA 9200 "Cluster 44: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 36: HEL - Hemostasis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies, Cytosol" "HPA029728: AB_10611112, HPA029729: AB_10601228" "unprognostic (3.68e-3)" "unprognostic (6.39e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.26e-1)" "unprognostic (2.51e-2)" "unprognostic (1.14e-1)" "unprognostic (2.89e-2)" "unprognostic (8.66e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (1.23e-1)" "unprognostic (7.73e-2)" "unprognostic (3.84e-1)" "unprognostic (4.98e-2)" "unprognostic (1.47e-1)" "unprognostic (4.20e-2)" 35.3 32.5 29.7 31.2 51.8 82.5 39.7 37.9 48.1 31.8 23.6 29.9 23.0 31.8 23.0 43.9 29.9 26.6 50.9 28.3 44.6 36.9 63.1 24.5 40.3 41.2 34.7 32.6 39.5 47.1 17.1 35.4 43.0 28.7 29.5 44.8 42.3 29.4 167.2 26.9 26.9 38.5 33.2 23.5 29.6 32.8 39.4 65.5 38.6 123.4 43.4 34.0 20.0 87.1 63.9 41.9 85.7 124.8 76.7 67.9 65.4 125.5 107.7 116.7 143.6 70.7 46.8 109.5 55.3 111.9 84.3 46.6 121.1 92.4 181.2 111.8 82.9 335.3 113.6 95.5 91.9 209.5 87.9 67.8 68.7 111.0 135.0 87.2 98.5 128.2 182.7 89.4 125.1 60.0 129.6 53.0 55.4 75.6 45.3 120.0 95.3 74.9 72.3 59.7 84.2 57.4 85.6 88.7 88.4 67.4 74.1 124.6 93.6 82.4 85.5 103.3 134.8 202.5 158.3 184.8 125.5 106.8 104.9 108.7 47.8 52.0 44.0 44.9 48.9 49.3 51.2 44.2 55.9 42.7 68.9 57.0 22.0 66.4 44.9 44.6 67.5 57.7 29.7 51.8 37.9 48.1 28.3 44.6 41.2 34.7 43.0 33.2 39.4 87.1 25.9 25.6 25.7 27.1 32.0 27.3 26.9 23.2 31.3 42.7 22.1 17.8 56.0 17.2 30.4 11.0 14.6 32.2 36.8 11.1 25.4 25.2 36.3 27.1 28.9 24.4 16.3 58.0 61.4 20.4 33.7 26.2 20.4 27.1 60.0 23.9 18.2 39.3 13.5 21.9 56.2 11.1 16.2 18.0 18.9 12.6 18.6 17.6 30.2 29.0 28.0 26.5 19.6 47.3 198.7 18.7 12.3 22.2 53.7 21.6 13.9 23.5 24.0 26.6 39.5 36.6 25.9 28.3 25.8 24.9 18.6 40.5 34.5 27.5 14.6 25.7 HDC ENSG00000140287 "Histidine decarboxylase" P19113 15 50241947-50265965 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 102.9;epididymis: 46.1" "Cell type enriched" "Detected in some" 12 "granulocytes: 596.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.9;testis cancer: 2.7" "Region enriched" "Detected in many" 6 "hypothalamus: 102.9" "Immune cell enriched" "Detected in single" 2140 "basophil: 686.2" "Lineage enriched" "Detected in single" 2140 "granulocytes: 686.2" "Group enriched" "Detected in some" 4 "HEL: 460.8;HMC-1: 1051.3" "Region enriched" "Detected in many" 5 "hypothalamus: 43.9" "Group enriched" "Detected in some" 10 "hypothalamus: 16.5;midbrain: 4.2" HPA038891 Enhanced Approved "Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear bodies" "HPA038891: AB_10673231" "unprognostic (4.97e-2)" "unprognostic (7.42e-2)" "unprognostic (1.43e-4)" "unprognostic (1.08e-1)" "unprognostic (6.16e-2)" "unprognostic (3.93e-7)" "unprognostic (4.18e-5)" "unprognostic (8.79e-3)" "unprognostic (1.48e-1)" "unprognostic (8.46e-2)" "unprognostic (4.60e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-1)" "unprognostic (7.20e-2)" "unprognostic (9.78e-2)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" 2.3 0.4 0.0 3.5 5.6 4.7 1.4 0.0 0.2 2.3 0.7 3.8 4.1 2.5 46.1 4.8 0.8 11.2 0.7 0.2 102.9 0.4 0.5 6.9 0.9 0.0 13.7 0.1 1.2 0.5 0.4 0.4 0.0 1.7 3.6 0.8 1.3 0.9 0.3 2.3 4.6 2.5 0.0 0.5 12.9 1.3 17.8 0.9 0.1 0.8 1.0 3.8 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 460.8 0.2 0.0 0.0 1.2 1051.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 181.8 0.3 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.4 686.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 5.6 0.0 0.2 0.2 102.9 0.0 13.7 0.0 0.0 17.8 0.1 0.0 12.8 47.5 0.3 0.0 0.8 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 10.9 0.3 0.0 0.0 2.3 9.2 0.0 596.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.8 0.4 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.1 0.1 HES6 bHLHb41 ENSG00000144485 "Hes family bHLH transcription factor 6" Q96HZ4 2 238238267-238240662 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.2;pituitary gland: 62.6" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 86.0;Enteroendocrine cells: 109.9;Erythroid cells: 120.0;Intestinal goblet cells: 176.0;Ionocytes: 93.6" "Cancer enhanced" "Detected in all" "glioma: 62.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "eosinophil: 5.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.1" "Cell line enhanced" "Detected in many" "NB-4: 196.8;SCLC-21H: 123.5;SK-MEL-30: 192.4;THP-1: 85.1;U-937: 100.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073997 Approved "Nuclear bodies,Cytosol" NA No "Cluster 52: Eosinophils - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 24: NB-4 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" Cytosol "HPA073997: " "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.56e-1)" "unprognostic (2.40e-3)" "unprognostic (7.46e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.79e-4)" "prognostic favorable (9.18e-5)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-2)" "unprognostic (4.35e-1)" "unprognostic (6.30e-2)" "unprognostic (5.13e-2)" "unprognostic (8.50e-2)" "unprognostic (6.66e-2)" "unprognostic (3.49e-2)" 3.4 10.2 44.8 2.8 53.1 12.5 2.6 55.1 57.6 13.8 32.4 22.3 18.4 16.9 0.5 3.0 14.0 1.6 4.7 43.8 37.8 10.0 8.3 5.5 3.1 49.6 43.3 2.6 23.5 4.1 62.6 1.1 44.8 3.9 9.0 1.0 5.1 1.0 25.8 2.6 19.8 2.7 56.2 9.1 11.1 25.5 43.9 3.6 5.1 1.6 2.2 4.6 2.8 58.2 4.9 5.6 23.5 26.9 1.6 0.8 15.1 1.7 1.8 2.3 3.5 4.8 3.0 0.3 3.9 0.4 9.8 3.1 24.1 1.8 0.7 11.5 30.4 5.9 4.5 50.7 3.8 42.7 33.0 2.3 14.6 3.4 4.7 1.3 1.5 25.1 53.4 0.5 1.5 12.3 6.3 196.8 38.5 4.8 4.3 28.1 62.5 11.7 3.1 2.3 123.5 54.6 7.7 10.7 192.4 2.8 9.4 85.1 1.9 2.3 4.9 13.2 14.7 11.6 2.1 8.9 8.2 100.2 4.2 0.1 0.1 5.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.1 44.8 53.1 55.1 57.6 43.8 37.8 49.6 43.3 44.8 56.2 43.9 58.2 3.3 0.0 1.1 63.0 5.7 3.3 6.4 3.0 1.8 9.2 8.8 5.2 6.5 1.5 4.7 3.7 22.9 2.2 30.5 37.1 7.9 9.2 32.2 86.0 7.8 3.8 109.9 120.0 9.6 31.8 3.9 3.5 13.7 6.7 0.0 39.0 2.2 5.2 5.5 3.3 10.3 176.0 93.6 4.8 5.8 9.3 1.5 7.4 35.6 8.4 8.3 6.2 23.7 17.6 19.6 14.9 22.2 1.5 7.1 5.2 13.1 4.9 9.5 4.9 0.0 26.9 12.5 35.3 36.5 2.9 2.0 0.3 9.4 30.0 41.8 2.2 HEY2 "bHLHb32, HERP1, HESR2" ENSG00000135547 "Hes related family bHLH transcription factor with YRPW motif 2" Q9UBP5 6 125747664-125761269 "Predicted intracellular proteins, Transcription factors, Transporters" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.7" "Cell type enhanced" "Detected in many" "Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030205, HPA074851" Approved Approved "Nuclear bodies,Aggresome" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" Aggresome "HPA030205: AB_10600712, HPA074851: AB_2686718" "unprognostic (5.10e-2)" "unprognostic (4.34e-2)" "unprognostic (1.41e-3)" "unprognostic (2.43e-3)" "unprognostic (1.99e-1)" "unprognostic (2.52e-3)" "unprognostic (2.56e-1)" "unprognostic (1.38e-2)" "unprognostic (2.01e-1)" "unprognostic (9.10e-3)" "unprognostic (7.34e-2)" "unprognostic (6.20e-2)" "unprognostic (1.79e-1)" "unprognostic (2.28e-1)" "unprognostic (6.74e-2)" "unprognostic (1.51e-3)" "unprognostic (1.19e-1)" 6.5 0.9 8.8 1.0 12.0 0.1 5.7 9.4 7.6 8.0 3.0 2.5 1.3 7.5 16.4 1.8 13.5 1.7 30.7 7.2 10.4 3.1 5.3 3.2 0.5 12.7 10.0 7.1 3.3 2.6 5.5 3.7 10.6 2.1 1.3 5.7 2.0 2.7 16.2 2.4 2.1 1.7 14.1 1.9 2.0 6.6 11.8 0.7 3.1 4.9 0.6 2.7 4.7 12.2 0.0 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.5 7.1 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.0 0.6 0.0 0.4 0.0 0.0 3.2 0.0 0.3 0.5 0.6 0.9 0.0 0.1 2.3 0.0 0.0 0.0 6.6 3.2 1.9 0.0 14.8 0.3 0.0 0.1 0.8 17.6 0.3 0.1 0.6 0.0 2.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 8.8 12.0 9.4 7.6 7.2 10.4 12.7 10.0 10.6 14.1 11.8 12.2 2.8 3.2 1.1 12.4 0.7 3.8 0.5 8.7 3.4 0.4 9.8 5.7 21.5 0.0 2.7 0.0 8.4 0.0 1.4 0.1 9.8 0.1 49.9 46.1 4.2 6.0 0.0 2.7 0.1 1.8 0.1 3.3 1.1 36.8 0.0 73.9 1.8 8.0 0.1 1.7 0.4 0.0 2.0 0.8 3.0 80.6 6.5 0.6 3.6 5.6 0.0 34.8 3.1 2.5 23.4 1.1 0.1 23.3 3.1 0.3 0.0 6.4 5.4 5.2 52.6 17.5 41.8 16.2 15.1 7.7 2.0 0.0 2.0 2.8 0.1 0.3 HGH1 "Brp16, C8orf30A, C8orf30B, FAM203A, FAM203B, FLJ40907, LOC51236" ENSG00000235173 "HGH1 homolog" Q9BTY7 8 144137774-144140851 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "K-562: 26.4;PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042470 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear bodies, Cytosol" Nucleoplasm "HPA042470: AB_2678013" "unprognostic (2.13e-2)" "prognostic unfavorable (3.12e-4)" "unprognostic (9.72e-2)" "unprognostic (2.63e-1)" "unprognostic (9.82e-2)" "unprognostic (2.17e-1)" "unprognostic (7.89e-3)" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.30e-2)" "unprognostic (4.39e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (4.62e-3)" "unprognostic (3.10e-1)" "unprognostic (2.27e-1)" "unprognostic (1.48e-1)" 2.3 3.2 1.8 1.0 1.3 0.6 1.5 1.4 1.8 2.0 1.2 1.9 0.6 2.3 0.1 3.1 1.7 0.5 2.1 1.7 1.1 1.9 3.2 1.3 0.6 2.1 1.2 1.7 3.1 0.8 1.4 0.4 1.4 1.9 0.5 0.1 1.8 0.8 2.7 2.2 1.6 0.7 1.3 2.2 2.9 2.4 1.5 0.6 2.0 1.2 0.6 2.6 1.9 1.6 8.3 2.7 1.9 3.5 2.7 1.7 4.9 13.8 1.1 2.9 1.9 3.6 2.1 23.9 18.7 2.6 1.1 8.6 3.8 1.9 0.9 11.7 14.5 9.1 2.4 1.8 2.6 5.1 5.9 1.2 5.9 3.2 2.0 1.0 1.3 4.9 26.4 0.9 1.8 6.9 17.5 4.7 5.4 3.1 46.6 21.8 1.6 3.7 1.7 1.9 4.1 4.4 6.4 3.4 5.1 0.6 2.9 1.8 4.9 1.7 14.2 5.1 16.5 13.9 9.7 6.1 1.7 8.5 2.8 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.4 0.7 0.2 0.8 0.4 0.3 0.0 0.6 0.2 0.1 0.1 0.1 1.8 1.3 1.4 1.8 1.7 1.1 2.1 1.2 1.4 1.3 1.5 1.6 5.2 0.0 2.4 2.6 5.8 0.0 2.6 0.0 5.2 4.2 6.7 5.7 2.2 2.8 0.6 5.5 0.0 11.1 7.2 1.3 11.7 3.5 11.2 2.8 7.0 3.1 4.9 5.9 1.2 1.8 13.4 4.3 7.1 4.0 0.0 7.9 1.4 9.9 12.2 6.7 1.2 4.0 0.0 4.8 0.0 22.1 7.5 5.6 0.0 1.0 3.5 8.3 14.4 0.0 1.0 2.9 5.6 3.4 4.9 3.2 5.4 10.2 1.5 3.7 6.6 2.6 3.8 15.1 14.8 6.9 0.0 3.1 5.9 11.0 6.5 1.6 HHEX "HEX, HOX11L-PEN, PRHX" ENSG00000152804 "Hematopoietically expressed homeobox" Q03014 10 92689955-92695647 "Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1" "Cell type enhanced" "Detected in many" "B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5" "Group enriched" "Detected in all" 5 "liver cancer: 20.1;thyroid cancer: 56.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 43 "basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7" "Low region specificity" "Detected in many" "HPA003257, HPA051894" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Nuclear bodies" "HPA003257: , HPA051894: AB_2681653" "prognostic favorable (8.83e-4)" "prognostic favorable (3.91e-5)" "unprognostic (2.98e-2)" "unprognostic (7.92e-2)" "unprognostic (6.46e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (1.56e-2)" "unprognostic (1.13e-1)" "unprognostic (1.96e-2)" "unprognostic (5.27e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.25e-5)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.50e-2)" 16.2 18.5 5.0 22.2 5.4 84.7 11.2 5.6 8.8 7.1 5.1 7.8 6.4 6.4 3.5 4.1 6.1 27.4 6.1 4.8 5.2 7.0 91.2 16.9 39.1 6.3 5.4 3.0 38.1 1.9 2.2 14.6 6.4 4.7 6.5 0.3 3.5 4.0 2.9 4.6 19.0 5.8 6.2 39.9 5.2 2.4 6.0 4.4 102.1 6.3 30.4 12.7 5.0 6.7 11.2 20.6 10.5 0.1 0.9 0.7 0.2 5.6 46.4 7.4 6.6 4.0 2.6 10.7 87.7 0.7 0.0 2.1 9.5 0.3 9.1 0.1 11.1 99.9 8.8 67.4 21.0 58.6 105.6 0.3 0.2 6.5 0.0 3.7 106.1 0.3 154.8 0.1 0.5 3.2 0.4 101.8 0.2 30.2 11.8 34.0 3.0 0.1 0.9 4.3 4.9 1.0 6.2 0.0 0.1 0.5 3.3 30.6 37.2 0.0 0.6 0.1 0.1 2.6 1.8 21.2 0.0 79.7 51.4 28.0 41.5 61.8 0.8 45.7 0.3 59.3 0.0 0.1 30.8 65.8 0.1 0.1 31.4 1.0 50.7 36.3 0.4 15.5 5.0 5.4 5.6 8.8 4.8 5.2 6.3 5.4 6.4 6.2 6.0 6.7 31.9 0.0 3.0 0.0 77.2 6.4 2.1 0.9 2.2 0.0 3.0 3.2 3.6 125.8 1.6 0.0 0.0 0.7 57.6 0.4 0.0 107.9 0.3 0.8 0.5 80.0 5.3 28.2 0.0 12.0 0.7 2.2 0.5 1.0 7.0 0.0 88.9 58.3 72.6 0.0 0.0 1.6 0.0 63.5 29.1 1.1 0.3 51.7 7.2 5.6 50.4 0.0 9.2 0.5 0.0 10.5 0.0 1.2 1.6 3.2 0.0 0.2 0.9 0.2 0.0 1.9 2.1 0.3 6.3 1.0 3.7 1.1 8.3 3.4 0.7 1.3 HIF1A "bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8" ENSG00000100644 "Hypoxia inducible factor 1 subunit alpha" Q16665 14 61695513-61748259 "Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 448.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 155.0" "Lineage enriched" "Detected in all" 7 "granulocytes: 155.0" "Cell line enhanced" "Detected in many" "LHCN-M2: 941.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000907, HPA001275, CAB017442" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies" "CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057" "unprognostic (1.07e-2)" "unprognostic (1.13e-3)" "unprognostic (9.41e-2)" "unprognostic (1.07e-1)" "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (2.94e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.77e-2)" "unprognostic (8.39e-2)" "unprognostic (1.24e-1)" "unprognostic (3.23e-2)" "unprognostic (3.58e-1)" "unprognostic (7.35e-2)" "unprognostic (3.88e-2)" 64.9 133.7 22.1 146.6 24.0 448.3 36.2 28.2 26.1 132.9 24.7 42.8 33.6 52.4 74.8 62.1 41.1 145.4 36.5 21.1 28.4 104.2 51.6 75.7 71.4 29.7 29.7 35.3 36.0 91.7 30.7 77.6 33.3 46.9 41.7 35.5 45.3 67.2 12.1 34.2 37.3 59.1 27.2 72.4 37.6 32.4 38.5 55.8 49.5 17.6 88.2 169.9 43.1 26.5 313.6 123.6 112.7 344.7 185.2 297.1 161.5 253.8 270.1 288.7 258.9 54.1 100.3 75.8 186.2 293.0 73.6 71.8 71.0 416.1 352.5 33.7 41.0 46.5 105.3 93.1 414.8 20.1 49.3 523.4 129.2 216.5 225.6 408.6 198.1 44.4 32.3 0.4 941.4 65.6 59.2 24.3 108.9 49.6 159.7 4.3 269.1 22.8 400.2 204.3 100.3 111.9 472.5 67.0 170.7 148.9 70.6 36.3 119.2 700.2 157.3 235.9 215.2 39.1 61.2 84.1 369.9 38.5 194.7 43.8 22.3 155.0 11.5 18.0 14.4 19.5 15.0 13.3 19.6 19.0 22.6 15.6 56.3 19.7 19.4 9.2 11.0 18.4 22.1 24.0 28.2 26.1 21.1 28.4 29.7 29.7 33.3 27.2 38.5 26.5 93.3 70.5 116.0 69.2 157.3 106.4 101.8 102.6 97.9 54.1 38.5 30.1 43.5 87.2 69.0 261.1 50.1 24.8 65.1 44.1 103.7 278.5 3.6 95.6 131.3 152.3 66.4 35.3 45.6 251.6 67.1 81.4 49.5 272.3 223.6 339.7 176.0 30.7 136.4 156.5 39.3 39.0 57.0 145.9 111.7 6.2 24.2 240.2 103.2 53.4 87.1 134.0 26.8 78.9 35.8 236.9 21.9 48.5 60.0 59.3 20.2 192.1 37.7 54.8 52.6 75.8 136.9 80.5 44.2 128.7 87.9 25.4 91.6 92.2 51.8 116.0 HIKESHI "C11orf73, HSPC138, HSPC179, OPI10" ENSG00000149196 "Heat shock protein nuclear import factor hikeshi" Q53FT3 11 86302211-86345943 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 129.6;Extravillous trophoblasts: 146.2;Hofbauer cells: 94.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012708, HPA035063, HPA035064" Approved Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA012708: , HPA035063: AB_10601143, HPA035064: AB_2674441" "unprognostic (1.10e-3)" "unprognostic (5.09e-2)" "unprognostic (1.92e-1)" "unprognostic (2.40e-2)" "unprognostic (1.50e-1)" "unprognostic (2.18e-1)" "prognostic unfavorable (8.81e-4)" "unprognostic (9.92e-2)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (8.24e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (4.01e-12)" "unprognostic (1.76e-1)" "unprognostic (2.58e-1)" "unprognostic (1.33e-3)" "unprognostic (1.71e-1)" 34.7 27.0 46.1 17.8 46.7 19.0 31.4 47.8 71.5 33.9 44.5 40.8 10.4 32.3 24.7 33.4 31.0 15.0 57.1 46.1 47.2 17.0 24.7 23.9 26.0 46.6 46.0 37.5 22.8 22.9 31.5 28.3 47.1 24.5 19.1 32.5 19.8 28.6 59.9 29.5 20.8 31.1 49.1 28.5 23.5 19.0 47.1 32.9 17.7 57.8 30.8 32.8 31.8 50.9 28.6 30.5 72.7 40.5 59.9 74.2 38.2 43.2 52.0 44.2 52.6 90.8 77.8 29.0 96.9 57.4 83.9 59.9 54.2 95.1 47.0 62.0 47.6 47.0 47.5 68.2 80.8 58.0 36.8 52.7 94.9 52.8 62.5 56.9 85.9 54.7 51.1 64.6 91.5 78.0 69.6 136.7 59.5 186.3 20.1 53.0 35.7 65.4 77.2 53.2 44.8 38.7 53.8 39.8 31.1 72.7 64.1 38.5 44.2 52.1 36.4 105.8 32.7 27.7 68.3 57.6 26.6 54.4 52.6 47.8 53.4 44.4 48.6 52.5 54.3 61.8 59.1 53.6 68.9 52.9 51.1 52.3 11.2 57.9 53.9 53.7 84.5 43.2 46.1 46.7 47.8 71.5 46.1 47.2 46.6 46.0 47.1 49.1 47.1 50.9 59.9 38.5 32.1 0.0 16.1 0.0 0.0 0.0 0.0 0.0 53.4 81.3 0.0 0.0 14.9 27.6 0.0 129.6 28.7 0.0 41.1 76.1 0.0 41.4 60.4 28.7 0.0 0.0 0.0 66.3 146.2 30.2 0.0 36.8 22.7 52.1 0.0 0.0 94.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.6 0.0 0.0 50.1 0.0 0.0 0.0 0.0 49.8 0.0 0.0 4.1 0.0 0.0 43.2 27.7 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.0 77.6 18.1 59.3 0.0 0.0 HIPK3 "DYRK6, FIST3, PKY, YAK1" ENSG00000110422 "Homeodomain interacting protein kinase 3" Q9H422 11 33256672-33357023 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028069 Approved Supported "Nuclear bodies,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "Nuclear bodies" "HPA028069: AB_10601815" "unprognostic (2.41e-3)" "unprognostic (1.02e-1)" "unprognostic (4.61e-1)" "unprognostic (5.74e-2)" "unprognostic (2.09e-1)" "unprognostic (1.78e-2)" "unprognostic (1.63e-1)" "unprognostic (7.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.78e-1)" "unprognostic (2.18e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-3)" "unprognostic (7.89e-3)" "unprognostic (1.80e-1)" "unprognostic (1.87e-1)" "unprognostic (2.48e-2)" 57.8 21.5 29.5 25.3 31.5 23.3 35.1 32.9 23.4 27.6 75.9 30.7 16.7 33.1 24.2 30.9 31.7 30.6 53.7 19.9 42.1 38.2 29.8 26.9 22.8 35.5 36.2 27.2 25.8 46.7 12.8 34.7 27.8 23.3 20.6 22.4 22.9 26.1 69.0 22.3 20.2 39.3 34.2 30.6 22.1 18.9 43.1 25.5 33.7 85.3 24.7 32.3 22.4 33.0 19.3 18.0 13.4 15.1 60.5 37.9 12.9 20.0 23.1 15.9 13.3 19.9 13.8 20.7 16.3 24.4 8.0 24.3 10.2 22.2 22.1 30.8 15.8 21.0 20.3 15.2 25.0 22.9 12.8 35.8 42.8 6.1 17.7 16.5 19.4 14.8 6.4 40.4 26.0 10.1 19.2 15.8 3.4 17.3 11.1 25.4 47.3 19.9 26.4 29.4 2.0 11.3 27.1 30.7 18.7 14.2 34.6 41.2 25.8 24.8 16.9 28.9 14.6 21.7 37.2 21.4 11.9 23.5 23.7 10.6 12.7 6.1 4.0 9.4 5.0 2.8 3.6 4.3 14.0 3.3 3.2 4.0 21.1 4.4 11.1 1.7 4.0 5.0 29.5 31.5 32.9 23.4 19.9 42.1 35.5 36.2 27.8 34.2 43.1 33.0 122.2 12.8 44.7 46.0 29.6 66.5 42.8 21.3 39.3 16.2 35.8 25.8 159.9 37.1 32.9 33.1 18.8 18.6 31.2 32.7 5.9 13.0 21.8 76.5 80.5 96.5 37.1 20.6 44.9 24.9 13.4 59.2 23.0 49.0 14.5 24.3 57.5 53.2 30.7 32.0 48.0 28.4 12.2 102.0 76.0 26.1 42.9 68.1 58.7 73.1 69.1 16.2 25.7 45.8 69.1 21.5 21.1 37.6 24.9 52.6 40.7 35.0 65.4 24.9 52.6 83.4 56.4 10.7 8.1 33.4 75.0 15.5 29.8 12.5 25.2 51.2 HIVEP1 "CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A" ENSG00000095951 "HIVEP zinc finger 1" P15822 6 12008762-12164999 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050724, HPA067457" Approved Supported "Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies, Mitochondria, Cytosol" "HPA050724: AB_2616457, HPA067457: " "unprognostic (2.55e-1)" "unprognostic (5.85e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.75e-2)" "unprognostic (5.65e-3)" "unprognostic (4.83e-2)" "unprognostic (1.38e-1)" "unprognostic (2.20e-1)" "unprognostic (1.85e-1)" "unprognostic (5.69e-2)" "unprognostic (1.98e-1)" "unprognostic (4.40e-2)" "unprognostic (3.01e-2)" "unprognostic (2.21e-1)" "unprognostic (4.49e-2)" "unprognostic (2.38e-1)" 7.2 2.3 0.8 8.0 3.0 16.7 5.5 0.7 3.0 7.4 6.5 6.4 5.0 5.9 4.5 7.4 6.1 7.3 3.8 2.2 0.8 4.5 11.7 6.3 8.0 1.3 2.8 6.5 6.7 10.5 3.3 4.9 0.5 6.9 6.6 5.8 4.8 5.8 2.8 5.7 5.2 6.2 0.0 6.0 4.9 4.8 1.2 9.1 4.9 6.2 8.3 9.3 3.3 1.6 8.1 5.9 7.5 4.2 5.8 7.3 7.2 6.4 5.5 5.2 5.7 3.8 4.2 6.7 13.6 7.8 12.4 7.6 7.4 9.2 7.1 14.6 4.3 3.1 5.6 3.7 4.7 3.7 2.5 5.1 9.0 10.6 16.3 11.0 15.5 4.6 32.9 7.5 11.5 6.0 5.9 3.3 6.4 2.8 2.7 3.2 9.8 10.7 3.1 8.7 7.1 5.2 15.9 12.8 4.3 16.6 7.6 4.7 25.2 13.0 5.8 12.3 7.4 30.0 27.3 12.0 4.0 4.8 5.5 2.4 1.8 2.1 1.2 2.0 0.9 3.1 2.0 0.8 1.2 4.8 3.4 2.1 11.7 3.3 5.2 9.0 4.4 0.7 0.8 3.0 0.7 3.0 2.2 0.8 1.3 2.8 0.5 0.0 1.2 1.6 40.2 28.9 16.9 74.7 35.6 32.2 25.4 7.4 30.7 20.4 12.3 10.9 10.4 17.2 17.6 7.3 12.5 3.4 18.7 17.5 3.9 5.6 2.5 37.7 16.4 20.3 10.8 6.5 94.6 7.2 1.8 25.2 22.4 51.0 7.6 7.0 6.4 12.3 5.9 21.9 68.3 14.4 4.1 9.6 47.9 1.8 3.7 23.1 19.6 44.0 29.6 13.1 5.2 59.3 25.0 11.5 10.3 4.5 33.6 25.2 6.7 2.5 16.7 9.7 0.0 21.0 17.1 3.9 3.5 18.7 33.4 5.2 18.8 6.6 8.6 23.7 HMBOX1 "FLJ21616, HNF1LA, HOT1, PBHNF" ENSG00000147421 "Homeobox containing 1" Q6NT76 8 28890395-29064764 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.0" "Cell type enhanced" "Detected in all" "Astrocytes: 125.7;Oligodendrocyte precursor cells: 118.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055855, HPA058586, CAB070418" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Nuclear bodies, Cytosol" "CAB070418: AB_11154826, HPA055855: AB_2682945, HPA058586: AB_2683764" "unprognostic (2.68e-3)" "unprognostic (2.30e-3)" "unprognostic (4.52e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.03e-3)" "unprognostic (1.20e-1)" "unprognostic (2.75e-3)" "unprognostic (1.49e-1)" "unprognostic (4.25e-2)" "unprognostic (1.89e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (3.84e-2)" "unprognostic (2.81e-1)" "unprognostic (1.02e-1)" "unprognostic (1.47e-1)" 4.6 6.7 7.6 5.1 11.9 10.8 4.2 10.6 5.7 3.7 1.7 3.8 3.1 4.4 3.0 3.2 3.7 4.2 4.5 5.3 17.9 4.3 4.2 4.6 5.3 15.0 20.0 6.1 3.3 5.0 1.8 6.8 15.6 2.9 3.9 6.2 3.1 2.5 2.8 4.4 4.3 5.2 10.4 5.7 4.3 7.6 11.6 4.9 6.2 3.7 5.9 3.8 2.4 12.9 6.2 6.8 7.1 8.2 6.5 6.7 6.0 2.6 3.5 4.0 4.3 3.1 3.9 15.1 6.3 4.5 6.0 5.3 14.4 5.3 5.6 5.5 2.4 15.6 13.8 4.2 5.3 5.4 10.2 3.3 7.5 5.3 10.1 4.9 9.1 9.0 22.7 14.4 5.7 3.8 9.9 2.7 5.0 6.6 1.6 8.1 7.1 3.4 2.8 11.5 3.0 9.2 5.1 3.9 5.4 5.9 3.9 4.8 13.0 3.6 16.8 3.9 3.8 4.4 4.8 5.9 4.6 6.5 5.4 3.2 2.4 1.1 1.9 2.6 2.7 3.4 1.9 1.8 2.5 2.6 2.4 2.4 1.4 1.2 4.7 1.9 0.8 1.4 7.6 11.9 10.6 5.7 5.3 17.9 15.0 20.0 15.6 10.4 11.6 12.9 25.5 16.0 18.1 125.7 30.3 16.7 15.8 18.1 15.9 24.4 15.3 10.5 23.6 20.0 14.0 29.5 39.6 12.9 18.7 16.2 15.6 8.3 93.0 15.0 21.2 34.2 17.4 19.6 90.1 14.4 14.1 19.2 11.2 29.4 17.1 36.7 68.6 13.7 10.3 30.3 109.8 12.9 22.4 19.8 36.4 31.5 35.8 20.1 16.0 91.8 21.4 28.3 26.8 118.1 111.8 14.1 11.3 31.6 14.4 21.0 20.4 8.8 14.3 31.6 19.7 34.6 17.3 43.6 15.2 10.1 19.7 19.2 22.8 19.5 14.7 22.6 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 716.7;skin 1: 1439.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8" "Cancer enhanced" "Detected in many" "glioma: 43.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 518.2;NK-cell: 781.6" "Group enriched" "Detected in all" 15 "NK-cells: 781.6;T-cells: 518.2" "Cell line enhanced" "Detected in many" "HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 9.5 33.7 212.8 27.7 235.6 12.1 112.2 215.4 322.0 250.1 239.2 30.5 17.2 19.1 541.4 716.7 10.5 35.1 48.8 237.4 212.0 24.0 2.9 372.8 18.4 237.6 211.6 9.4 5.3 13.3 11.7 59.6 218.5 26.9 7.0 22.1 172.0 64.7 19.2 1439.9 11.3 115.6 238.8 11.9 33.9 45.3 215.0 15.8 224.5 31.8 190.4 34.1 368.6 234.2 0.0 0.0 0.0 0.0 5.0 15.7 5.9 0.0 0.0 1.4 1.0 0.0 0.0 12.6 0.7 0.3 2.3 2.2 1.4 0.0 1.9 31.2 0.2 0.1 0.0 0.0 2.0 0.0 0.1 2.6 11.9 3.6 0.0 3.4 66.9 0.0 0.0 0.5 3.2 0.5 0.1 1.0 0.1 3.6 0.0 0.0 0.0 0.3 0.0 50.5 1.0 0.6 0.0 0.0 0.0 4.6 0.0 0.0 76.2 0.0 0.2 0.5 0.1 26.0 0.1 0.1 3.2 0.0 0.0 5.7 1.1 2.0 518.2 3.5 282.0 43.4 123.6 227.6 2.6 36.5 20.9 150.8 11.2 781.6 4.5 3.6 9.1 365.6 212.8 235.6 215.4 322.0 237.4 212.0 237.6 211.6 218.5 238.8 215.0 234.2 14.5 750.0 569.2 38.2 23.3 414.6 42.2 8.7 59.7 3.5 3.4 3.0 14.8 2.8 125.6 1.8 0.0 2.3 345.3 0.8 1.9 0.4 33.3 2.8 4.0 28.7 8.4 30.5 62.2 0.2 5.5 16.7 5.6 5.2 10.1 99.5 5.3 1.2 4.0 0.0 7.9 11.1 4.1 11.4 30.9 45.9 3.1 7.9 35.6 14.0 41.4 166.4 1150.4 7.1 6.7 1.7 0.0 3.0 9.6 31.3 1.2 0.6 12.5 5.6 32.9 3.7 104.8 3.3 15.3 31.6 377.2 321.8 219.9 0.1 1.4 28.8 HOXA10 "HOX1, HOX1H" ENSG00000253293 "Homeobox A10" P31260 7 27170592-27180261 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 76.8;skeletal muscle: 76.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 10.7;NK-cell: 13.1" "Group enriched" "Detected in many" 5 "granulocytes: 10.7;NK-cells: 13.1" "Cell line enhanced" "Detected in many" "HEK 293: 179.0;THP-1: 96.7;U-937: 100.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 190 "spinal cord: 18.9" "CAB019384, HPA071918" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm "Nuclear bodies" "CAB019384: , HPA071918: " "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (1.93e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.73e-3)" "unprognostic (2.61e-2)" "unprognostic (1.41e-2)" "unprognostic (8.05e-2)" "unprognostic (2.71e-2)" "unprognostic (3.83e-3)" "unprognostic (1.57e-1)" "unprognostic (7.13e-2)" "unprognostic (8.46e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-2)" 13.4 6.8 0.0 6.1 0.0 4.3 6.8 0.0 0.0 40.8 0.0 32.6 0.1 76.8 9.1 0.2 8.3 0.1 0.0 0.0 0.0 13.7 0.1 0.1 2.3 0.0 0.0 0.8 0.0 0.0 0.0 13.4 0.0 26.3 13.2 0.0 0.0 15.4 76.4 6.0 7.9 44.9 0.1 0.2 0.1 0.3 0.0 5.2 0.1 0.0 0.2 20.4 17.2 0.1 20.6 4.3 0.0 59.9 29.3 28.0 0.2 40.1 27.2 18.0 16.8 6.1 17.8 0.0 10.9 31.6 0.0 22.6 15.5 0.0 13.2 9.5 179.0 21.6 15.0 0.5 0.8 9.6 31.4 17.8 0.9 1.5 0.0 0.0 27.5 6.3 0.9 0.0 13.3 0.0 0.0 63.1 0.0 16.6 18.8 1.9 4.0 0.1 34.7 9.6 46.7 0.1 13.8 0.0 0.1 6.4 0.1 96.7 0.0 0.0 16.1 21.1 0.2 0.4 0.1 0.0 0.0 100.4 0.5 10.7 0.1 0.3 2.2 0.0 0.0 0.1 0.0 0.2 1.2 0.3 0.0 0.0 0.0 13.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 5.5 0.0 0.0 0.0 0.2 3.7 10.0 0.0 0.6 0.0 4.4 4.6 1.6 0.0 0.0 7.3 0.0 0.5 4.5 28.8 19.6 0.0 0.0 3.1 174.0 5.4 68.1 15.5 0.0 0.0 0.4 13.3 0.0 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 25.0 0.0 2.5 4.7 0.0 0.0 2.0 5.4 0.0 0.5 0.0 7.2 0.0 0.0 0.0 32.1 0.4 1.3 18.1 18.8 27.1 0.0 0.0 0.0 13.3 15.7 2.3 4.6 0.5 4.1 0.5 3.1 0.0 25.5 10.1 HOXA4 "HOX1, HOX1D" ENSG00000197576 "Homeobox A4" Q00056 7 27128507-27130780 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 10 "medulla oblongata: 19.3;pons: 16.1;spinal cord: 15.6;white matter: 14.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1" "Region enriched" "Detected in single" 46 "pons and medulla: 11.3" HPA060088 Approved Supported "Nuclear bodies" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Nuclear bodies" "HPA060088: AB_2684200" "unprognostic (3.37e-2)" "unprognostic (6.27e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (3.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.64e-1)" "unprognostic (1.32e-1)" "unprognostic (4.22e-1)" "unprognostic (1.31e-1)" "unprognostic (7.39e-2)" "unprognostic (4.23e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (3.38e-1)" "unprognostic (3.59e-4)" "unprognostic (3.93e-2)" 16.2 10.0 0.0 2.1 0.0 0.7 10.5 0.1 0.1 5.5 0.0 13.2 4.9 5.9 13.0 15.3 22.1 3.6 1.9 0.0 0.0 16.3 1.5 14.7 1.3 19.3 1.6 6.8 1.9 25.8 0.0 0.1 16.1 5.9 2.4 0.0 0.6 5.8 18.8 4.9 8.2 4.6 15.6 6.9 13.4 1.6 0.0 1.9 3.7 8.2 0.4 7.7 4.6 14.1 9.5 3.1 0.0 29.0 0.0 0.0 1.9 0.9 0.9 3.0 3.0 5.9 1.9 2.5 0.1 2.8 2.7 4.0 1.1 0.4 2.3 0.1 22.2 0.0 0.9 13.7 3.3 3.3 5.4 3.2 2.4 10.2 0.8 0.0 10.3 0.8 0.0 0.0 10.0 2.5 0.0 11.2 0.0 3.3 7.2 21.0 4.4 0.2 14.6 2.2 1.4 0.0 2.9 0.0 11.2 1.0 0.7 1.7 13.5 0.0 4.6 7.6 0.2 0.0 0.0 1.0 6.1 5.1 29.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 19.3 1.6 16.1 15.6 0.0 14.1 11.6 0.0 0.0 0.0 0.1 0.9 3.1 0.0 31.9 0.0 3.6 7.7 0.4 0.0 0.0 0.0 0.0 0.0 0.4 1.7 15.6 0.0 0.4 0.2 2.6 5.2 3.0 0.8 0.0 0.0 0.9 5.4 0.5 0.1 0.0 0.4 16.8 0.0 0.2 0.0 0.0 0.9 0.0 0.6 0.3 0.4 0.0 0.9 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.5 0.7 1.4 0.7 1.0 13.1 0.0 0.0 0.0 8.3 5.8 0.4 3.2 12.5 1.3 0.1 0.8 1.4 2.0 2.5 HOXB7 "HOX2, HOX2C" ENSG00000260027 "Homeobox B7" P09629 17 48607232-48633572 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "epididymis: 135.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3" "Region enriched" "Detected in single" 58 "pons and medulla: 5.7" "Region enriched" "Detected in some" 7 "spinal cord: 22.2" HPA049940 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nuclear bodies" Cytosol "HPA049940: AB_2616461" "unprognostic (6.76e-2)" "unprognostic (6.76e-2)" "unprognostic (1.03e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-3)" "unprognostic (1.42e-2)" "unprognostic (1.69e-2)" "unprognostic (8.05e-3)" "unprognostic (9.16e-2)" "unprognostic (9.91e-2)" "unprognostic (7.01e-3)" "unprognostic (7.81e-3)" "unprognostic (1.17e-2)" "unprognostic (1.56e-2)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" "prognostic favorable (2.39e-4)" 13.2 11.0 0.1 3.9 0.1 0.2 12.4 0.0 0.3 21.8 0.1 16.9 1.1 5.2 135.1 0.4 8.7 0.7 0.3 0.1 0.1 30.4 0.4 2.2 2.7 5.6 0.1 0.5 0.8 5.5 0.1 5.8 1.1 2.4 15.9 0.0 0.2 16.9 1.7 3.3 18.1 6.7 13.3 3.0 5.9 1.9 0.3 0.2 0.4 0.2 0.9 7.7 5.5 7.5 48.1 20.6 0.0 0.5 14.2 21.1 0.0 0.0 0.0 0.2 0.8 31.9 0.9 0.9 81.9 19.9 23.9 6.9 0.1 0.0 0.0 22.3 15.1 7.4 15.4 0.0 11.7 0.0 14.8 13.8 6.3 14.2 0.0 3.5 43.8 14.7 8.0 0.3 46.0 12.5 1.0 0.4 0.0 74.7 0.1 0.0 39.2 5.5 66.5 15.8 0.0 0.1 16.0 0.0 84.3 1.1 3.8 4.7 38.1 0.0 24.8 20.5 36.9 2.6 6.3 0.1 0.4 0.0 58.6 0.0 0.0 0.0 1.5 0.0 0.8 0.7 0.2 0.8 0.0 1.4 0.0 0.5 0.0 1.0 0.0 0.7 2.1 0.2 0.1 0.1 0.0 0.3 0.1 0.1 5.6 0.1 1.1 13.3 0.3 7.5 55.4 0.0 0.0 0.0 2.0 5.5 0.9 0.0 0.6 0.0 0.9 1.0 0.3 0.0 0.0 86.5 0.0 6.8 1.6 131.3 148.7 0.1 0.3 82.9 6.3 20.3 36.5 1.3 0.0 1.3 19.3 6.4 0.0 73.1 5.1 0.0 1.4 0.2 11.5 0.0 0.0 77.6 0.0 10.6 5.4 0.2 0.6 2.8 24.9 0.0 1.7 0.0 2.1 0.0 0.0 0.3 67.8 0.0 5.1 0.6 140.3 31.6 0.0 0.0 0.0 3.5 8.9 1.7 20.9 0.2 2.0 1.8 2.6 0.1 63.1 3.5 HOXC10 HOX3I ENSG00000180818 "Homeobox C10" Q9NYD6 12 53985065-53990279 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 113.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 21.2;Collecting duct cells: 16.5;Distal tubular cells: 62.6;Proximal tubular cells: 100.4;Skeletal myocytes: 22.4;Suprabasal keratinocytes: 19.2" "Cancer enhanced" "Detected in many" "renal cancer: 20.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 291.5;ASC diff: 82.5;ASC TERT1: 75.6;fHDF/TERT166: 67.6;T-47d: 99.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 319 "spinal cord: 31.8" HPA053919 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear bodies" Nucleoplasm "HPA053919: AB_2682308" "unprognostic (1.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.56e-4)" "unprognostic (1.57e-1)" "unprognostic (1.59e-3)" "unprognostic (1.98e-1)" "unprognostic (1.73e-2)" "unprognostic (1.23e-1)" "unprognostic (9.60e-3)" "unprognostic (3.96e-2)" "unprognostic (7.37e-3)" "unprognostic (2.25e-2)" "unprognostic (3.56e-2)" "unprognostic (5.07e-2)" "unprognostic (5.24e-3)" "unprognostic (1.91e-1)" 13.1 1.1 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.7 0.0 0.2 0.0 1.5 0.0 0.1 8.8 0.0 0.0 0.0 0.0 22.5 0.0 0.0 1.6 0.0 0.0 1.8 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.5 113.5 16.4 2.1 0.8 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 1.2 0.1 0.7 3.3 0.0 291.5 82.5 75.6 0.5 10.1 24.4 13.6 12.6 0.6 0.9 0.5 2.7 67.6 1.9 31.4 4.1 0.0 6.5 15.2 5.6 3.0 36.2 0.0 0.4 0.0 3.7 36.0 0.5 1.0 0.0 0.0 0.1 8.5 2.3 0.0 9.4 1.8 0.1 7.5 0.1 36.4 1.1 0.0 0.4 0.0 30.6 0.0 0.0 3.9 6.9 10.0 15.7 0.4 99.4 2.2 0.0 8.0 10.2 0.2 13.3 1.3 0.2 0.1 0.1 1.7 22.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 1.0 21.2 0.0 0.0 0.0 0.0 4.8 7.9 0.3 0.0 0.0 16.5 0.0 0.0 0.1 0.0 62.6 0.0 0.2 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.4 0.6 0.9 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 100.4 0.0 0.0 0.0 22.4 5.2 3.6 4.4 0.0 19.2 0.1 0.4 0.0 0.0 0.0 HOXD3 "HOX1D, HOX4, HOX4A" ENSG00000128652 "Homeobox D3" P31249 2 176136612-176173102 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 42.1" "Cell type enhanced" "Detected in some" "Adipocytes: 6.6;Collecting duct cells: 9.2;Distal tubular cells: 15.6;Early spermatids: 14.4;Endothelial cells: 6.5;Theca cells: 4.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.2" "Group enriched" "Detected in many" 8 "medulla oblongata: 8.9;pons: 5.7;spinal cord: 5.7;white matter: 4.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 9.7;HSkMC: 11.2;RPTEC TERT1: 12.0;SCLC-21H: 14.5;SH-SY5Y: 10.1" "Region enriched" "Detected in single" 35 "pons and medulla: 3.5" "Group enriched" "Detected in some" 6 "medulla oblongata: 4.1;pons: 1.1;spinal cord: 3.0" "HPA051831, HPA063671" Supported "Nucleoplasm,Nuclear bodies" No NA "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA051831: , HPA063671: AB_2685083" "unprognostic (1.13e-1)" "unprognostic (3.28e-1)" "unprognostic (1.52e-2)" "unprognostic (6.50e-2)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.97e-2)" "unprognostic (1.54e-2)" "unprognostic (9.56e-2)" "unprognostic (5.57e-2)" "unprognostic (1.08e-1)" "unprognostic (1.56e-1)" "unprognostic (2.57e-4)" "unprognostic (1.47e-3)" "unprognostic (1.55e-1)" "unprognostic (3.44e-1)" "unprognostic (7.44e-2)" 3.2 2.3 0.2 0.8 0.4 0.0 2.8 0.4 0.3 3.2 0.1 1.0 0.3 6.9 42.1 0.7 6.8 0.6 0.2 0.2 0.4 7.9 0.0 0.2 0.8 8.9 0.8 5.5 0.2 0.1 0.0 0.1 5.7 1.7 0.6 0.0 0.5 7.1 0.7 0.9 0.8 4.1 5.7 0.7 0.3 1.7 0.4 0.2 0.4 0.0 0.2 1.0 2.0 4.9 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 1.7 0.2 0.0 0.4 0.0 0.0 0.1 3.6 0.0 0.0 0.1 0.0 0.0 0.0 11.2 0.9 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 12.0 0.9 14.5 10.1 0.2 0.1 4.6 0.2 0.0 0.0 1.0 0.2 0.2 1.5 0.8 0.0 0.2 0.0 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.4 0.3 0.2 0.4 8.9 0.8 5.7 5.7 0.4 4.9 6.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.3 15.6 0.0 14.4 0.1 2.1 6.5 1.2 0.0 0.2 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.8 3.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.3 4.5 0.0 0.1 0.3 2.9 0.0 0.0 0.0 1.3 1.1 0.8 0.5 0.0 1.3 0.0 0.1 4.7 0.6 0.1 ICE1 KIAA0947 ENSG00000164151 "Interactor of little elongation complex ELL subunit 1" Q9Y2F5 5 5420664-5490220 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054452, HPA061934" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA054452: AB_2682492, HPA061934: AB_2684641" "unprognostic (1.45e-2)" "unprognostic (9.73e-2)" "unprognostic (6.92e-2)" "unprognostic (2.39e-3)" "unprognostic (4.42e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (1.16e-1)" "unprognostic (4.29e-1)" "unprognostic (1.78e-1)" "unprognostic (3.51e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (4.59e-2)" "unprognostic (2.72e-1)" "unprognostic (3.02e-2)" "unprognostic (2.33e-1)" 8.7 6.9 8.1 9.1 8.8 13.7 10.2 11.3 8.4 8.7 4.4 9.0 7.2 11.6 9.0 7.6 8.2 7.1 8.1 10.2 7.0 10.0 7.1 8.1 11.5 6.2 5.7 13.9 9.2 14.1 7.5 12.7 6.4 7.8 7.8 12.8 7.5 8.8 16.5 8.7 7.5 10.3 4.5 10.0 7.7 7.5 7.1 14.5 10.2 15.5 11.3 9.5 6.6 8.1 17.9 22.1 24.8 23.9 23.6 23.1 32.0 15.1 18.0 17.8 19.5 17.1 12.9 24.1 20.6 21.8 35.1 16.5 34.4 17.7 29.8 33.4 17.5 19.5 68.9 12.5 14.3 44.5 15.4 18.5 18.6 21.3 32.8 17.7 22.3 18.0 28.1 19.5 18.8 15.6 32.6 15.9 21.0 11.4 18.6 37.7 22.6 16.3 15.0 19.9 16.0 16.6 52.5 16.9 20.2 23.8 14.7 13.9 25.4 23.0 29.4 29.9 23.9 21.1 26.9 39.6 19.3 32.9 19.9 0.4 0.5 1.1 0.9 0.7 1.1 0.9 0.8 0.9 0.5 0.8 0.7 0.9 0.1 1.1 0.4 1.1 1.1 0.3 8.1 8.8 11.3 8.4 10.2 7.0 6.2 5.7 6.4 4.5 7.1 8.1 29.8 22.4 29.5 42.1 30.3 0.0 17.7 0.0 26.2 40.2 20.1 26.3 33.0 14.3 14.2 16.5 31.3 35.6 35.1 10.8 25.4 22.6 5.8 19.5 37.4 27.5 9.0 23.5 68.2 22.7 22.4 25.0 19.9 25.7 11.4 28.6 15.4 13.8 15.7 45.4 57.3 11.6 0.0 13.8 0.0 5.2 22.4 19.9 0.0 36.5 26.1 24.6 17.5 39.7 62.1 23.0 6.4 22.2 37.5 24.1 11.1 14.8 6.6 34.7 6.6 50.5 27.8 51.6 47.0 25.9 0.0 10.9 33.9 36.4 11.4 16.9 ICE2 "BRCC1, FLJ11896, NARG2" ENSG00000128915 "Interactor of little elongation complex ELL subunit 2" Q659A1 15 60419609-60479160 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040058 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA040058: AB_10795686" "unprognostic (3.80e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (5.59e-3)" "unprognostic (8.78e-3)" "unprognostic (2.71e-1)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (8.39e-3)" "unprognostic (1.68e-1)" "unprognostic (3.45e-1)" "unprognostic (3.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (5.74e-2)" 5.5 5.5 3.0 6.2 4.0 5.5 8.4 4.5 3.2 5.0 5.8 4.8 4.4 8.0 5.5 6.6 6.4 6.5 5.3 2.6 3.2 6.5 7.0 4.9 9.1 3.9 3.3 9.9 6.3 34.6 4.2 7.9 4.2 6.6 7.1 4.8 6.0 5.4 4.4 5.0 5.4 6.4 3.4 7.7 5.3 6.8 3.2 12.7 9.3 5.1 9.8 6.1 3.6 6.7 14.7 25.5 21.1 20.3 15.6 16.9 11.0 8.5 13.1 13.3 14.4 20.0 10.6 25.5 18.3 9.2 25.2 27.2 28.3 11.4 18.3 30.9 12.6 25.8 17.4 11.8 8.4 28.8 17.6 8.5 13.6 11.0 19.7 17.7 22.2 24.9 39.9 23.3 16.7 6.3 22.9 7.6 26.3 26.8 17.1 27.1 16.7 22.4 10.7 18.0 23.8 22.8 12.0 12.2 15.1 24.8 19.7 14.6 10.5 18.4 16.0 15.8 26.5 11.0 31.6 37.7 12.1 32.4 17.4 4.0 4.5 5.3 5.7 6.3 9.7 7.6 7.0 7.6 5.9 10.5 9.3 9.1 0.7 4.2 5.8 4.9 8.1 6.0 3.0 4.0 4.5 3.2 2.6 3.2 3.9 3.3 4.2 3.4 3.2 6.7 32.5 19.2 19.6 34.6 30.6 0.0 20.4 0.0 16.5 31.3 24.4 27.7 20.2 15.7 17.3 20.2 39.6 22.7 32.4 8.8 21.5 12.2 15.5 25.6 27.5 25.1 19.2 28.0 39.9 10.4 14.9 21.1 25.0 21.8 29.8 70.6 29.6 20.6 14.0 30.3 42.6 16.1 0.0 16.8 0.0 17.4 25.4 21.1 0.0 49.6 25.3 19.6 25.7 49.3 83.6 14.6 13.7 17.7 15.9 23.0 11.6 18.1 19.7 33.3 0.0 31.4 17.5 22.1 34.8 21.3 0.0 14.6 31.3 39.3 19.4 19.2 ID2 "bHLHb26, GIG8" ENSG00000115738 "Inhibitor of DNA binding 2" Q02363 2 8678845-8684461 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Developmental protein, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 1209.7" "Cell type enhanced" "Detected in all" "Langerhans cells: 2393.2;monocytes: 1987.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 1038.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 731.4;HEK 293: 459.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027612 Approved "Nucleoplasm,Nuclear bodies,Centrosome" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Nuclear bodies" Centrosome "HPA027612: AB_10599729" "unprognostic (2.53e-1)" "unprognostic (8.16e-3)" "unprognostic (8.51e-2)" "unprognostic (6.66e-2)" "unprognostic (2.24e-1)" "prognostic favorable (9.95e-4)" "unprognostic (4.39e-2)" "unprognostic (6.31e-2)" "unprognostic (1.95e-1)" "unprognostic (2.07e-1)" "unprognostic (1.11e-1)" "unprognostic (2.81e-1)" "unprognostic (5.98e-2)" "unprognostic (2.42e-2)" "unprognostic (1.74e-1)" "unprognostic (1.38e-3)" "unprognostic (1.92e-3)" 160.8 175.9 86.6 73.9 88.5 390.3 82.6 83.8 118.2 97.4 68.5 149.9 99.1 69.7 21.0 35.3 108.3 150.8 177.4 89.6 86.8 128.2 562.5 108.1 92.6 80.2 82.9 213.1 60.1 1209.7 65.7 70.3 85.2 125.1 124.7 69.7 114.3 142.4 18.9 69.6 99.4 85.3 81.4 107.4 66.7 13.8 90.1 73.8 223.5 41.2 47.4 110.2 76.2 95.8 2.0 132.4 56.0 68.6 86.8 13.9 208.5 156.6 18.3 68.4 29.1 266.0 7.3 4.1 175.1 262.5 16.9 115.9 36.0 1.0 20.7 731.4 459.5 101.3 81.7 333.9 24.8 76.5 266.3 23.4 3.1 30.5 1.9 19.2 1.4 6.7 6.2 113.9 109.1 45.3 7.8 9.0 102.4 338.5 102.9 9.7 38.4 75.6 71.3 60.5 103.5 146.6 8.4 117.8 12.1 142.0 19.3 44.9 27.5 83.9 14.5 126.5 9.4 8.9 7.9 88.7 106.6 230.2 46.5 110.3 76.0 1038.0 356.7 221.7 214.2 3.6 108.1 251.9 223.8 1.6 133.7 262.1 96.6 880.8 248.9 10.3 9.2 200.1 86.6 88.5 83.8 118.2 89.6 86.8 80.2 82.9 85.2 81.4 90.1 95.8 429.9 141.1 237.9 316.7 41.4 131.3 143.0 494.8 138.9 9.8 231.2 218.4 179.5 316.0 211.2 101.2 16.7 260.3 604.5 337.7 555.7 471.0 12.0 601.1 344.6 281.1 425.9 59.8 23.5 160.3 142.4 276.0 189.1 647.2 973.6 17.1 487.6 554.7 700.3 6.7 13.8 548.0 494.4 415.8 2393.2 21.7 124.2 528.4 282.8 15.9 1987.9 519.9 1070.1 26.7 3.2 69.6 301.9 32.7 86.0 130.1 231.3 264.1 66.7 27.4 19.7 166.6 185.6 2.1 39.9 97.6 104.6 666.0 690.0 16.7 323.1 51.3 IDH1 ENSG00000138413 "Isocitrate dehydrogenase (NADP(+)) 1" O75874 2 208236229-208266074 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 536.3" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 320.2;Granulosa cells: 257.5;Hepatocytes: 328.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 768.1;RT4: 524.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033218, HPA035248, HPA057936, CAB062556" Enhanced Approved "Nuclear bodies,Cytosol" NA NA 16000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies, Cytosol" "CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559" "unprognostic (2.79e-1)" "unprognostic (1.00e-1)" "unprognostic (1.02e-1)" "unprognostic (2.47e-3)" "unprognostic (1.93e-1)" "unprognostic (2.39e-2)" "prognostic unfavorable (6.93e-5)" "unprognostic (3.32e-1)" "unprognostic (2.20e-3)" "unprognostic (8.03e-2)" "unprognostic (5.54e-2)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.45e-5)" "unprognostic (2.09e-1)" "unprognostic (1.77e-1)" "unprognostic (1.13e-1)" "unprognostic (2.69e-2)" 150.8 230.8 24.0 37.5 23.9 10.7 63.0 24.6 30.9 67.9 40.8 124.9 179.4 22.9 164.9 92.2 36.6 69.5 25.3 23.5 26.1 122.0 536.3 49.8 33.3 26.4 25.7 84.4 39.9 42.0 16.7 82.5 25.9 214.6 131.2 35.0 59.3 79.1 25.7 23.6 117.4 43.8 25.5 40.1 113.6 57.0 30.0 21.8 45.5 28.1 29.8 153.1 39.9 30.6 66.5 109.6 152.5 63.3 275.1 191.4 86.7 26.3 122.3 44.2 107.3 176.1 159.1 13.1 168.8 84.4 181.6 101.4 112.4 130.7 43.0 8.8 41.7 56.7 87.3 768.1 367.3 37.0 54.7 169.5 278.0 102.7 74.2 69.8 126.1 37.2 58.1 44.5 68.9 42.8 26.3 66.2 284.5 479.7 43.9 25.2 54.8 37.8 206.3 524.0 25.9 45.2 100.5 99.7 351.7 161.2 37.9 111.0 81.1 45.2 44.1 65.3 29.6 20.8 34.5 16.9 148.2 226.7 37.0 12.4 70.1 11.0 9.1 32.3 10.6 10.6 8.2 10.9 50.9 10.1 6.7 7.8 13.8 17.2 15.5 18.8 15.1 29.9 24.0 23.9 24.6 30.9 23.5 26.1 26.4 25.7 25.9 25.5 30.0 30.6 13.9 12.8 49.5 39.2 20.2 12.4 18.8 60.5 52.3 19.5 61.8 31.5 21.8 45.8 69.1 29.5 25.0 320.2 23.7 106.8 21.5 31.1 13.8 31.0 23.4 22.0 58.4 30.3 16.6 86.5 178.8 29.6 76.0 108.8 14.0 257.5 39.7 328.2 175.3 11.8 16.2 98.4 57.0 130.2 23.8 11.2 24.5 71.7 26.6 19.7 47.8 25.4 18.6 66.4 20.0 44.8 55.5 29.3 13.7 53.2 181.2 108.5 21.9 56.6 13.1 7.8 23.6 8.0 26.2 82.4 14.9 95.6 19.8 127.1 129.3 46.7 IGFBP5 ENSG00000115461 "Insulin like growth factor binding protein 5" P24593 2 216672105-216695549 "Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 1492.5;ovary: 1323.4" "Cell type enhanced" "Detected in many" "Fibroblasts: 1104.1;Ionocytes: 980.6;Leydig cells: 1828.2;Peritubular cells: 981.7;Sertoli cells: 1275.3;Skeletal myocytes: 2750.9;Smooth muscle cells: 1376.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 831.3;BJ hTERT+: 2192.6;T-47d: 531.7;U-138 MG: 710.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059827, HPA070407" Supported Approved "Nuclear bodies,Golgi apparatus,Vesicles" "Secreted to blood" NA NA 110000000 380000000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus, Vesicles" "Nuclear bodies" "HPA059827: AB_2732640, HPA070407: " "unprognostic (7.69e-2)" "unprognostic (2.56e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (4.58e-2)" "unprognostic (3.47e-1)" "unprognostic (2.04e-1)" "unprognostic (1.76e-1)" "unprognostic (1.32e-1)" "unprognostic (9.58e-2)" "unprognostic (1.12e-1)" "unprognostic (2.41e-2)" "unprognostic (4.04e-2)" "unprognostic (9.62e-3)" "unprognostic (1.55e-1)" "unprognostic (3.28e-2)" "unprognostic (1.91e-3)" 375.1 221.8 35.6 178.2 35.1 0.7 354.6 21.9 30.9 1492.5 46.9 232.3 35.0 837.7 121.3 166.4 953.0 129.3 155.0 50.4 41.8 479.1 34.2 78.2 71.3 36.3 37.9 1323.4 30.7 30.7 272.8 290.7 31.5 241.4 66.2 105.4 111.0 121.8 470.9 129.0 139.3 621.2 28.1 38.7 323.5 28.8 43.8 95.0 326.2 292.9 45.9 259.2 382.9 62.4 0.0 0.0 210.6 0.9 237.1 7.5 0.8 831.3 2192.6 108.8 10.4 0.0 1.0 0.1 3.3 2.3 0.0 0.1 26.2 0.0 5.6 0.1 8.2 218.1 4.4 0.2 103.1 0.1 1.8 33.1 0.0 14.7 0.1 24.8 0.1 0.2 0.7 0.1 0.5 70.9 0.9 1.2 2.3 0.0 3.4 0.3 0.8 1.2 70.3 249.1 14.5 8.5 14.6 100.4 0.0 12.8 531.7 0.1 80.3 710.2 42.2 109.3 41.0 0.7 0.1 0.1 1.4 0.1 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.6 35.1 21.9 30.9 50.4 41.8 36.3 37.9 31.5 28.1 43.8 62.4 237.3 3.2 4.4 40.1 20.6 102.5 13.5 211.0 25.0 8.7 73.9 199.9 92.0 5.7 251.6 112.2 6.2 3.9 1.7 0.0 5.9 10.3 8.4 140.2 250.7 120.8 0.0 0.0 6.0 0.0 4.5 1104.1 30.5 128.5 2.5 11.4 49.6 1.4 8.7 3.3 13.7 0.0 980.6 0.6 189.7 39.9 1828.2 18.4 101.4 29.0 0.6 674.4 0.0 5.5 0.4 2.2 0.0 981.7 5.5 17.0 0.0 1.1 120.9 18.7 1275.3 2750.9 1376.0 2.2 3.0 17.7 67.9 5.6 18.4 124.7 0.1 16.8 IGHMBP2 "CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7" ENSG00000132740 "Immunoglobulin mu DNA binding protein 2" P38935 11 68903863-68940602 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004092, HPA060994" Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA004092: , HPA060994: AB_2684406" "unprognostic (1.17e-1)" "unprognostic (1.04e-1)" "unprognostic (7.17e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (1.69e-1)" "unprognostic (3.59e-3)" "unprognostic (4.31e-2)" "unprognostic (3.81e-1)" "unprognostic (1.19e-1)" "prognostic favorable (5.89e-4)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.29e-8)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (4.06e-2)" "unprognostic (2.18e-2)" 5.2 4.0 1.2 2.5 1.3 6.0 5.4 0.7 1.7 7.0 0.1 11.8 1.5 7.8 0.6 5.5 6.7 1.7 5.2 1.6 1.2 4.4 6.3 5.1 3.3 0.8 0.4 6.1 5.2 2.8 4.0 2.0 0.7 6.3 1.5 1.4 6.4 3.1 8.5 7.7 6.3 2.6 0.5 5.7 6.2 15.4 0.6 4.3 4.9 3.8 1.7 6.3 5.8 1.1 5.1 7.3 4.0 7.4 3.6 3.1 5.2 5.8 3.9 7.8 4.6 14.5 7.0 7.3 9.7 3.3 6.9 8.0 5.8 4.9 1.8 8.3 6.2 6.6 9.6 5.6 5.5 6.5 7.4 1.8 4.9 9.2 4.6 4.5 4.6 11.1 10.6 4.6 2.3 5.1 11.1 8.9 2.3 7.9 10.3 9.4 5.7 7.6 3.3 5.9 8.6 5.4 7.4 6.1 16.6 3.0 9.3 6.0 6.6 5.3 3.8 7.7 6.6 6.0 6.3 6.9 5.3 6.1 5.1 0.0 2.0 0.8 1.5 1.8 1.3 1.0 0.9 1.0 1.8 0.6 0.5 0.7 0.6 0.1 1.1 0.3 0.6 1.3 1.2 1.3 0.7 1.7 1.6 1.2 0.8 0.4 0.7 0.5 0.6 1.1 6.6 6.4 7.7 7.5 5.7 5.7 3.8 3.5 6.2 9.1 5.6 3.8 6.3 8.6 6.1 1.8 20.9 4.9 10.2 6.0 1.9 5.1 94.6 7.0 8.1 6.4 3.0 9.3 7.4 5.1 4.4 5.5 6.1 14.0 7.0 10.7 3.3 6.1 5.8 11.8 6.4 4.1 2.0 3.5 4.3 46.9 7.8 7.2 1.8 5.6 7.3 6.6 9.2 6.0 5.2 6.5 8.4 7.2 5.8 7.5 3.9 2.9 3.8 10.1 0.0 5.1 10.1 51.6 7.1 5.3 6.7 6.7 8.0 4.6 7.1 6.3 IKZF2 "Helios, ZNFN1A2" ENSG00000030419 "IKAROS family zinc finger 2" Q9UKS7 2 212999691-213152427 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 40.3" "Cell type enhanced" "Detected in many" "Astrocytes: 77.4;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 78.3;Squamous epithelial cells: 47.8;Urothelial cells: 51.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 4.8;NK-cells: 5.5;T-cells: 5.8" "Cell line enhanced" "Detected in many" "JURKAT: 70.5;MOLT-4: 31.1;RT4: 28.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059142 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" Cytosol "HPA059142: AB_2683923" "unprognostic (2.29e-1)" "unprognostic (1.04e-1)" "unprognostic (7.81e-2)" "unprognostic (1.42e-1)" "unprognostic (2.87e-2)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (3.03e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.21e-1)" "unprognostic (3.56e-3)" "unprognostic (4.05e-1)" "unprognostic (2.09e-1)" "unprognostic (5.93e-3)" "unprognostic (7.09e-2)" 2.1 2.0 2.6 3.8 5.5 5.5 2.3 3.2 3.2 3.4 0.7 1.8 0.8 1.9 3.2 19.4 2.8 3.1 1.9 2.9 3.8 1.5 1.4 2.9 7.0 5.2 3.5 2.0 2.0 5.2 1.9 2.0 5.3 3.3 1.7 5.5 8.4 4.3 4.1 9.1 1.2 0.8 3.2 5.5 4.4 2.5 3.9 40.3 7.8 1.6 6.8 9.6 8.3 7.4 2.8 1.0 5.3 0.3 17.1 17.2 3.3 3.4 3.9 0.8 1.7 1.4 4.6 3.7 4.4 2.0 0.4 6.5 0.1 1.8 2.7 0.0 0.9 1.9 3.6 0.5 0.1 8.9 0.6 16.9 1.6 0.1 0.5 4.3 0.0 70.5 1.2 3.1 1.6 5.2 31.1 8.9 1.1 2.2 0.8 18.1 3.5 0.0 1.5 28.6 1.6 1.0 0.0 3.6 0.0 4.4 4.8 0.9 9.2 4.9 3.8 2.3 0.7 6.0 2.0 20.6 2.4 0.0 1.1 3.9 0.0 4.8 1.8 0.0 4.9 0.2 0.6 1.4 0.0 1.0 0.3 1.5 0.0 5.5 0.0 0.5 5.8 0.3 2.6 5.5 3.2 3.2 2.9 3.8 5.2 3.5 5.3 3.2 3.9 7.4 2.1 9.6 12.6 77.4 5.2 5.9 23.2 7.9 11.4 4.8 5.1 2.2 7.6 1.5 19.5 7.3 4.2 4.3 27.4 2.8 0.0 2.3 1.3 16.1 1.8 2.4 3.0 9.0 17.7 3.1 1.2 2.7 8.6 18.1 3.8 2.5 2.5 2.2 2.1 0.0 19.9 2.3 4.1 2.4 2.1 0.7 1.8 2.8 1.8 31.9 1.3 3.0 39.1 100.5 78.3 3.6 1.0 2.2 13.9 15.9 1.1 1.0 31.7 7.3 0.0 10.2 4.5 0.8 0.7 47.8 8.7 4.0 22.1 2.0 1.4 51.8 IKZF4 "Eos, ZNFN1A4" ENSG00000123411 "IKAROS family zinc finger 4" Q9H2S9 12 56007659-56038435 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "T-reg: 1.9" "Lineage enriched" "Detected in single" 12 "T-cells: 1.9" "Cell line enhanced" "Detected in many" "HDLM-2: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046270, HPA049016" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 35: Glandular cells - Unknown function" "Nucleoplasm, Nuclear bodies" "HPA046270: AB_2679607, HPA049016: AB_2680600" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (1.34e-1)" "unprognostic (8.95e-3)" "unprognostic (5.67e-2)" "unprognostic (2.08e-2)" "unprognostic (3.63e-3)" "prognostic favorable (3.46e-4)" "unprognostic (2.42e-1)" "unprognostic (5.43e-2)" "prognostic favorable (4.37e-4)" "unprognostic (6.52e-2)" "unprognostic (7.97e-2)" "unprognostic (3.64e-1)" "unprognostic (1.26e-1)" "unprognostic (9.98e-3)" "unprognostic (7.74e-3)" 4.9 9.2 5.6 2.1 5.7 3.8 3.7 7.1 6.5 4.8 5.7 5.5 1.6 4.5 4.0 2.6 5.8 2.7 4.1 5.3 5.8 3.7 3.2 3.7 2.1 6.4 6.2 7.6 2.9 8.1 7.5 3.0 5.8 3.9 2.0 8.5 2.7 4.2 9.9 2.5 3.5 2.9 5.5 2.9 4.1 5.0 6.2 4.0 5.1 5.4 2.3 4.3 3.2 6.0 1.7 1.6 11.6 3.9 2.3 2.4 2.7 1.8 3.1 2.1 3.0 6.5 2.5 1.1 2.0 2.9 2.3 1.3 1.5 1.8 4.6 36.2 1.7 7.3 1.7 3.0 2.6 3.3 2.6 4.0 2.1 2.2 1.7 3.9 2.2 0.2 10.7 5.5 3.4 2.0 4.1 1.6 5.1 1.8 1.4 3.6 3.1 1.3 3.1 1.4 4.4 3.8 2.6 0.8 4.3 2.9 3.0 3.3 1.3 1.8 3.1 1.8 1.5 3.5 2.2 1.5 3.7 3.2 2.4 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.9 0.1 5.6 5.7 7.1 6.5 5.3 5.8 6.4 6.2 5.8 5.5 6.2 6.0 5.5 3.2 9.4 10.7 2.5 3.6 1.9 3.4 10.2 20.3 16.6 15.4 7.5 10.0 4.2 3.7 8.4 3.0 0.8 3.9 1.9 2.9 13.8 7.7 10.4 5.3 6.0 4.2 13.3 4.2 2.8 8.8 2.0 8.0 1.3 4.0 8.2 6.7 2.7 8.4 17.7 3.0 4.1 9.8 3.1 2.7 8.7 4.1 5.4 7.5 6.0 18.3 0.0 14.6 15.5 4.3 2.1 10.9 1.6 2.4 1.7 4.9 4.3 12.3 0.0 10.3 9.9 21.2 5.9 10.4 3.3 4.0 3.8 16.0 2.3 2.1 INAVA "C1orf106, FLJ10901" ENSG00000163362 "Innate immunity activator" Q3KP66 1 200891048-200915742 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Immunity, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.2;intestine: 55.4;skin 1: 47.0" "Cell type enhanced" "Detected in some" "Ductal cells: 33.3;Endometrial ciliated cells: 26.8;Exocrine glandular cells: 45.5;Glandular and luminal cells: 25.1;Pancreatic endocrine cells: 118.6;Proximal tubular cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 60.3;CAPAN-2: 49.6;HaCaT: 66.0;OE19: 57.8;RPMI-8226: 54.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027499, HPA027511, HPA079622" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Nuclear bodies" "HPA027499: AB_10599708, HPA027511: AB_10600334, HPA079622: " "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.78e-5)" "unprognostic (4.56e-2)" "unprognostic (2.18e-1)" "unprognostic (2.74e-2)" "unprognostic (6.62e-3)" "unprognostic (2.84e-2)" "unprognostic (9.38e-2)" "unprognostic (2.52e-2)" "unprognostic (2.81e-1)" "unprognostic (3.23e-3)" "unprognostic (1.67e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-1)" "unprognostic (7.73e-2)" 0.1 0.0 1.4 4.0 1.4 4.5 1.7 0.8 1.3 8.8 1.8 33.8 47.3 1.1 0.5 44.2 4.2 16.3 0.2 1.4 1.4 15.3 0.4 3.5 0.4 1.1 1.4 0.1 13.2 0.1 0.3 1.9 1.0 7.0 30.1 0.4 12.3 2.6 0.2 47.0 55.4 1.1 1.0 0.3 27.3 1.1 1.5 0.9 0.1 0.0 5.7 17.1 20.3 1.0 27.5 40.8 23.3 0.0 0.0 0.0 60.3 0.0 0.0 0.7 0.5 43.4 49.6 0.0 13.3 0.0 1.1 66.0 0.0 17.4 0.5 0.0 5.0 3.8 1.8 17.2 0.1 8.5 0.8 0.0 26.1 0.4 1.1 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.1 1.4 45.2 57.8 9.2 0.2 9.7 54.0 24.4 34.9 0.1 2.8 2.6 41.5 0.0 27.3 17.1 7.9 0.0 0.1 10.1 0.1 2.9 46.2 20.6 0.0 0.1 8.6 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.4 1.4 0.8 1.3 1.4 1.4 1.1 1.4 1.0 1.0 1.5 1.0 0.6 12.8 7.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.5 3.3 0.0 0.0 5.0 14.7 0.0 7.6 0.1 0.0 5.9 33.3 0.0 26.8 2.2 0.7 0.0 0.0 0.0 45.5 13.2 0.4 0.0 25.1 1.3 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 118.6 0.0 0.0 0.0 0.0 0.0 26.0 4.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.1 0.5 0.3 0.0 0.0 INCA1 ENSG00000196388 "Inhibitor of CDK, cyclin A1 interacting protein 1" Q0VD86 17 4988130-4997610 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 47.8" "Group enriched" "Detected in many" 19 "Early spermatids: 130.0;Late spermatids: 306.6;Spermatocytes: 211.3;Spermatogonia: 87.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044359, HPA052401" Uncertain Approved "Nucleoplasm,Nuclear bodies" No No "Cluster 7: Monocytes - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA044359: AB_10794289, HPA052401: AB_2681816" "unprognostic (1.78e-2)" "unprognostic (9.38e-2)" "unprognostic (4.08e-2)" "unprognostic (9.81e-2)" "unprognostic (1.22e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-3)" "unprognostic (7.88e-2)" "unprognostic (2.68e-1)" "unprognostic (2.66e-2)" "prognostic favorable (3.61e-5)" "unprognostic (3.14e-2)" "unprognostic (1.68e-1)" "unprognostic (9.54e-2)" "unprognostic (2.04e-1)" "unprognostic (1.17e-1)" "unprognostic (1.05e-1)" 2.9 3.7 3.2 6.3 3.4 1.6 2.1 4.3 4.2 3.6 2.0 3.3 10.8 5.2 0.8 5.1 3.2 7.1 6.6 3.0 3.8 4.0 3.8 4.6 8.5 4.3 3.4 8.1 3.9 1.6 2.2 3.0 4.5 4.5 1.2 4.4 5.7 1.7 10.6 8.0 7.9 2.2 3.6 7.3 5.0 47.8 4.3 0.4 8.0 4.8 0.4 2.7 2.4 3.9 5.0 5.6 3.9 3.7 2.6 1.0 4.7 5.3 0.5 1.4 1.5 4.0 5.9 23.9 3.5 1.4 4.6 14.0 0.7 0.3 0.8 10.0 5.9 5.2 7.6 2.7 1.8 0.8 12.2 1.5 0.0 0.8 0.4 8.5 0.5 8.4 6.6 10.9 1.0 2.6 7.4 1.7 1.7 2.3 1.5 9.0 2.0 2.2 0.9 1.6 11.7 3.5 2.6 3.4 3.1 4.1 7.0 1.1 10.8 4.9 1.8 4.7 4.1 1.8 1.0 1.1 4.8 12.6 2.5 0.2 0.8 0.0 0.2 1.5 0.6 0.4 0.4 0.5 0.3 0.2 0.7 0.6 0.2 0.0 1.2 0.4 0.2 0.2 3.2 3.4 4.3 4.2 3.0 3.8 4.3 3.4 4.5 3.6 4.3 3.9 1.0 0.0 1.1 1.0 0.6 1.1 1.5 1.2 0.6 0.5 0.9 0.8 1.0 1.5 1.2 3.7 2.1 0.6 0.1 9.3 0.0 0.7 130.0 0.6 0.8 1.3 0.0 2.7 0.8 1.6 0.7 1.3 1.5 0.6 4.5 2.5 0.7 1.4 1.2 0.0 0.9 2.0 2.0 0.0 1.5 306.6 7.2 1.1 1.8 1.0 0.7 6.1 0.0 1.0 1.1 1.2 9.3 1.2 0.1 0.4 5.2 2.2 1.5 0.8 6.6 2.0 1.9 211.3 87.1 0.3 0.9 0.8 0.2 0.7 2.9 0.8 INCENP FLJ31633 ENSG00000149503 "Inner centromere protein" Q9NQS7 11 62123998-62153169 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 20.9" "Cell type enhanced" "Detected in many" "Squamous epithelial cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "basophil: 1.2;NK-cell: 1.1" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;NK-cells: 1.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013292, HPA051339, HPA070550" Enhanced Supported "Nucleoplasm,Nuclear bodies,Kinetochore,Midbody" Yes Yes "Cluster 15: NK-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Kinetochore" "Nucleoplasm, Midbody" "CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279" "unprognostic (6.31e-2)" "unprognostic (7.29e-2)" "unprognostic (1.65e-3)" "unprognostic (7.35e-2)" "unprognostic (3.18e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (8.58e-4)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (1.74e-2)" "unprognostic (1.08e-3)" "unprognostic (1.17e-3)" "unprognostic (1.22e-1)" "unprognostic (1.36e-1)" "unprognostic (2.78e-3)" 3.1 2.5 2.7 7.5 1.1 20.9 2.8 6.2 3.0 4.6 0.0 4.8 6.8 3.0 8.1 14.0 3.5 2.2 2.8 2.9 0.5 2.4 1.9 3.0 11.6 1.6 0.8 3.8 3.1 3.1 1.5 4.1 1.3 2.5 3.6 3.4 6.1 2.9 4.2 7.9 5.7 3.4 0.1 5.5 4.5 6.4 0.5 17.8 5.1 3.4 8.2 2.8 5.5 1.2 74.3 69.4 51.6 45.5 6.8 8.4 28.1 47.6 21.2 44.4 28.3 37.0 50.7 70.0 36.2 16.0 46.2 72.6 52.2 28.4 31.8 60.5 36.6 45.7 68.0 29.6 2.7 53.5 62.1 4.3 6.5 41.3 23.6 6.8 25.8 50.2 48.8 57.6 25.3 59.7 85.0 43.3 56.2 28.0 34.4 79.3 66.4 53.4 12.0 35.8 40.1 42.2 46.8 30.8 27.9 19.8 48.2 19.4 28.5 41.8 51.9 59.8 50.0 29.7 48.3 75.8 23.5 34.7 50.6 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.7 1.1 6.2 3.0 2.9 0.5 1.6 0.8 1.3 0.1 0.5 1.2 1.2 3.2 2.3 1.3 3.4 5.6 0.8 1.0 2.8 2.4 1.1 0.6 1.3 0.0 3.7 0.0 0.0 4.2 4.2 5.4 0.0 1.9 1.0 2.0 2.1 1.5 0.0 10.9 3.3 2.5 7.1 1.9 9.2 2.7 3.8 5.7 0.0 0.7 4.2 0.0 2.5 3.4 0.0 0.9 1.6 0.5 2.8 3.3 3.6 1.0 5.0 1.5 3.1 2.0 1.5 2.2 1.6 1.5 10.9 1.2 1.3 0.3 2.6 2.3 0.0 1.9 4.3 6.5 7.8 15.1 3.3 2.2 3.7 1.9 4.8 1.1 INF2 "C14orf151, C14orf173, MGC13251" ENSG00000203485 "Inverted formin 2" Q27J81 14 104681146-104722535 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 229.3;Gastric mucus-secreting cells: 183.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 100.8" "Region enhanced" "Detected in all" "basal ganglia: 224.1" "Low region specificity" "Detected in all" HPA000724 Approved Approved "Nuclear bodies,Endoplasmic reticulum" NA NA 3000000 "Cluster 35: T-regs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "Nuclear bodies" "HPA000724: AB_1078325" "unprognostic (1.42e-1)" "unprognostic (9.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.00e-2)" "unprognostic (1.49e-2)" "unprognostic (5.90e-3)" "prognostic unfavorable (8.18e-4)" "unprognostic (1.13e-2)" "unprognostic (9.55e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-2)" "unprognostic (1.36e-3)" "unprognostic (7.24e-2)" "unprognostic (4.01e-1)" "unprognostic (2.36e-1)" "unprognostic (5.80e-2)" "unprognostic (7.70e-2)" 42.8 21.4 14.0 8.4 29.6 7.5 35.2 18.3 29.5 28.7 1.4 40.4 21.2 24.3 2.3 20.4 20.9 8.9 24.1 14.7 14.7 27.3 30.2 34.3 6.9 30.7 25.5 13.6 15.7 2.0 8.3 11.7 27.5 23.2 4.7 3.3 17.9 7.5 13.7 26.9 31.7 4.4 12.2 31.4 34.7 32.2 26.3 2.1 20.8 1.5 3.4 30.2 28.5 71.2 26.3 92.1 9.9 16.0 7.6 12.2 84.2 49.0 14.5 21.9 14.0 35.5 40.2 3.7 46.6 17.9 17.0 43.3 9.4 22.7 9.5 18.5 26.6 22.0 59.9 23.9 16.5 6.8 21.0 11.4 14.5 15.8 6.8 15.0 24.1 9.1 10.7 10.5 18.0 30.0 10.2 17.9 17.1 18.3 100.8 29.8 19.2 9.4 12.6 38.0 20.5 12.8 26.4 36.7 11.7 8.0 8.0 4.9 49.9 29.4 22.1 45.7 22.5 6.9 3.7 3.7 41.2 12.1 25.1 0.5 2.1 0.1 0.9 0.7 0.7 1.6 3.2 0.6 2.4 1.5 2.5 1.6 1.6 1.2 0.1 5.1 4.0 3.2 14.0 29.6 18.3 29.5 14.7 14.7 30.7 25.5 27.5 12.2 26.3 71.2 48.8 64.1 13.4 10.1 22.5 22.7 17.5 19.0 17.1 0.3 16.5 14.6 14.3 28.6 15.0 3.7 0.0 54.8 5.2 229.3 5.9 24.1 1.2 7.8 8.6 29.8 17.4 17.2 16.7 25.5 87.8 17.9 183.0 18.2 14.7 8.4 25.4 29.8 32.6 0.0 1.9 86.2 12.2 21.8 35.6 2.1 5.6 25.5 8.8 20.6 14.0 55.3 1.0 11.1 89.6 58.1 110.7 4.5 7.8 26.6 90.4 7.3 9.4 2.0 32.9 5.7 36.1 1.1 4.5 8.5 18.8 31.6 9.3 12.9 66.9 38.2 INO80 "hINO80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex ATPase subunit" Q9ULG1 15 40978880-41116280 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041484, HPA048601" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" Cytosol "HPA041484: AB_2677506, HPA048601: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favorable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 9.3 6.5 5.4 7.3 5.7 15.7 8.8 10.1 5.9 8.3 5.3 9.3 7.3 8.9 4.7 9.6 7.7 5.7 6.9 5.3 5.2 7.9 7.8 9.4 9.7 5.9 5.2 9.1 6.9 10.0 5.5 6.8 5.6 7.9 8.6 5.7 7.3 6.6 15.7 10.9 8.7 8.2 5.0 8.9 7.9 7.0 5.8 10.8 8.5 9.6 10.4 9.1 8.5 7.5 13.1 12.9 10.6 10.7 16.5 13.8 11.4 12.2 18.8 17.3 15.0 14.8 10.4 14.0 8.8 17.6 21.6 24.3 19.5 20.7 19.0 17.5 10.0 18.9 17.7 11.8 15.2 17.9 16.2 13.5 18.4 13.8 36.9 11.1 16.8 14.5 20.5 11.6 12.3 10.6 13.2 11.2 11.3 20.6 13.5 19.1 11.2 11.0 12.7 26.1 14.5 9.6 9.6 18.5 7.3 10.4 10.5 19.9 19.2 14.3 11.1 17.3 19.0 12.4 9.6 22.2 16.1 24.7 11.7 0.3 1.0 0.2 0.8 0.5 0.9 1.3 0.8 0.8 0.7 1.1 1.0 1.1 0.3 2.1 0.2 0.6 0.7 0.4 5.4 5.7 10.1 5.9 5.3 5.2 5.9 5.2 5.6 5.0 5.8 7.5 23.7 9.6 25.7 27.4 27.6 8.5 16.2 7.5 23.3 30.4 18.1 15.9 25.1 14.3 16.4 16.5 22.9 13.5 25.4 17.3 7.9 17.6 2.2 17.2 21.5 17.6 13.1 23.8 54.1 13.3 12.0 16.0 32.6 28.9 15.8 18.4 13.2 10.0 9.8 26.9 47.5 11.8 2.0 14.4 6.8 3.3 14.6 18.6 7.2 25.3 20.8 12.9 19.6 43.2 53.3 15.2 16.1 15.8 19.8 21.7 9.5 11.3 16.3 33.0 6.6 28.1 21.3 19.2 24.7 28.2 12.8 19.2 25.8 25.1 13.9 15.1 INO80B "hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4" ENSG00000115274 "INO80 complex subunit B" Q9C086 2 74455087-74457944 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 28.0;Suprabasal keratinocytes: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA070644, HPA078274" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "Nucleoli, Nuclear bodies" "HPA070644: AB_2732159, HPA078274: " "prognostic favorable (2.89e-4)" "unprognostic (2.24e-2)" "unprognostic (5.62e-2)" "unprognostic (6.59e-3)" "unprognostic (9.45e-2)" "unprognostic (3.82e-2)" "unprognostic (2.20e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-1)" "unprognostic (1.54e-2)" "unprognostic (7.52e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (1.56e-5)" "prognostic favorable (8.44e-4)" "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (1.18e-3)" 26.3 30.5 18.9 18.0 20.7 20.6 29.1 17.2 27.6 38.1 15.7 24.1 19.4 30.4 17.1 31.1 31.5 15.1 20.1 19.6 17.5 27.4 32.1 25.9 18.9 18.4 17.1 48.1 41.9 19.6 42.0 11.6 19.2 34.7 12.3 18.7 29.9 17.9 30.1 40.8 23.9 14.8 14.2 24.5 32.7 31.0 16.7 12.8 39.3 9.1 20.1 27.1 32.2 20.9 27.8 29.0 11.0 14.2 21.0 29.6 28.2 25.7 23.0 19.4 16.3 19.9 34.4 46.7 32.2 18.8 18.2 29.1 9.1 20.4 15.8 42.5 28.8 35.9 14.5 20.5 22.4 33.9 17.2 29.5 35.0 27.8 31.2 48.4 26.2 27.4 20.7 18.5 16.5 32.7 44.3 47.7 7.7 20.2 39.7 26.3 34.9 47.4 23.5 18.9 16.7 31.8 13.5 37.3 15.4 12.1 16.1 11.6 22.1 17.7 27.9 29.7 20.0 65.8 48.4 16.9 33.3 21.3 18.9 3.2 2.5 1.0 1.2 1.9 1.6 2.6 1.4 0.7 1.6 2.1 1.2 1.1 3.2 2.1 1.7 3.2 2.2 0.9 18.9 20.7 17.2 27.6 19.6 17.5 18.4 17.1 19.2 14.2 16.7 20.9 4.4 0.0 2.2 0.0 5.4 28.0 2.8 8.5 2.2 14.0 11.3 6.0 0.9 4.3 6.8 3.7 12.5 4.3 7.1 5.8 0.0 15.9 3.0 6.5 5.7 5.4 4.8 9.3 0.0 27.0 4.7 3.4 2.6 3.8 5.7 2.4 6.8 10.8 5.6 13.5 0.0 7.9 12.2 9.7 21.0 6.5 3.1 4.3 5.4 0.0 12.5 4.7 9.2 0.0 0.0 17.4 3.3 3.0 5.1 2.2 11.6 6.5 12.3 15.0 0.0 2.1 4.9 5.6 1.9 3.3 31.7 5.3 7.5 2.2 6.7 2.0 INTS12 "INT12, PHF22, SBBI22" ENSG00000138785 "Integrator complex subunit 12" Q96CB8 4 105682627-105895986 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035772, HPA041814" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies, Plasma membrane" "HPA035772: AB_10671109, HPA041814: AB_2677687" "unprognostic (5.30e-2)" "unprognostic (4.54e-2)" "unprognostic (1.84e-3)" "unprognostic (1.78e-1)" "unprognostic (3.68e-2)" "unprognostic (2.58e-3)" "prognostic unfavorable (2.67e-4)" "unprognostic (3.95e-2)" "unprognostic (1.13e-1)" "unprognostic (1.53e-3)" "unprognostic (3.00e-2)" "unprognostic (3.48e-2)" "unprognostic (5.93e-3)" "unprognostic (3.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-1)" 15.2 11.1 12.8 10.9 13.3 30.4 20.2 14.9 18.0 14.1 12.0 14.7 18.1 14.6 17.8 13.5 13.2 12.7 18.9 12.4 14.9 18.7 22.6 16.4 14.0 12.3 14.0 11.6 12.6 17.2 10.3 11.9 12.5 18.1 15.6 17.2 14.4 13.4 26.5 14.0 15.5 17.1 12.7 12.6 15.0 13.9 14.3 19.9 19.9 26.0 17.0 15.6 11.2 13.7 24.4 12.8 28.5 29.8 27.5 32.6 20.8 28.2 29.1 34.7 35.9 18.1 26.9 34.9 15.4 31.9 26.9 13.8 31.7 40.7 42.8 36.9 19.0 26.3 19.6 25.7 44.3 46.7 23.0 31.0 51.7 34.5 51.4 22.5 32.3 29.1 39.8 26.7 37.8 25.6 55.3 28.9 12.4 35.3 19.5 28.0 31.0 26.8 32.5 16.3 30.7 24.6 19.8 32.6 31.0 22.4 26.4 27.2 21.3 22.7 23.3 24.8 30.5 40.8 40.9 52.2 25.3 31.5 46.0 64.0 23.7 38.5 25.7 26.6 28.9 33.0 29.4 29.4 27.7 32.1 30.6 28.3 17.9 42.9 28.3 42.6 34.8 21.9 12.8 13.3 14.9 18.0 12.4 14.9 12.3 14.0 12.5 12.7 14.3 13.7 19.0 12.8 11.8 14.0 15.1 11.0 11.8 25.8 15.4 10.5 12.1 11.7 18.7 11.5 12.9 3.7 10.4 16.1 13.6 8.3 43.0 25.2 35.8 8.1 11.2 16.8 6.0 15.6 13.8 20.3 18.6 10.8 8.6 8.7 24.7 9.9 11.7 9.3 17.8 10.1 15.7 5.2 30.5 9.0 9.5 28.4 12.2 9.8 7.2 9.4 15.5 14.0 21.6 27.2 19.1 20.5 6.8 8.2 18.9 14.2 16.5 17.1 6.2 9.3 0.0 12.9 20.1 13.4 16.2 14.1 10.4 18.3 13.0 14.9 10.2 11.0 INTS13 "ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30" ENSG00000064102 "Integrator complex subunit 13" Q9NVM9 12 26905181-26938326 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039543, HPA040109, HPA073020" Uncertain Enhanced "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Vesicles" "HPA039543: AB_10795150, HPA040109: , HPA073020: " "unprognostic (2.09e-1)" "unprognostic (8.48e-3)" "unprognostic (2.75e-2)" "unprognostic (1.40e-3)" "unprognostic (3.94e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (1.17e-10)" "unprognostic (5.22e-3)" "unprognostic (5.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.78e-3)" "unprognostic (3.75e-3)" "prognostic unfavorable (3.16e-6)" "unprognostic (1.02e-1)" "unprognostic (8.51e-2)" "unprognostic (4.37e-2)" "unprognostic (4.78e-2)" 9.9 21.4 9.3 11.3 13.4 17.2 11.7 13.2 14.3 10.4 8.1 9.7 9.9 10.0 10.3 14.6 8.5 8.2 12.2 9.5 11.6 13.2 15.1 7.9 16.7 15.4 12.0 8.0 11.5 8.0 8.1 10.0 14.8 8.5 10.7 21.8 9.0 7.0 19.0 11.8 8.5 11.9 13.9 12.9 15.4 12.1 12.2 18.6 9.9 18.1 16.8 12.8 10.6 20.0 33.4 38.1 21.5 46.4 30.5 48.9 30.9 44.9 27.4 43.3 48.1 58.4 43.1 82.7 45.0 25.1 40.6 46.2 56.1 43.6 72.8 39.5 37.4 66.7 44.5 44.9 53.9 110.6 38.4 26.3 32.2 69.5 147.0 53.5 56.8 35.6 71.5 31.9 46.7 40.9 57.9 197.8 94.6 45.6 68.9 40.8 62.3 114.0 36.4 31.0 17.8 16.7 39.1 30.6 47.4 72.8 42.6 23.4 36.5 50.1 36.2 85.6 55.1 15.6 19.6 119.4 33.1 75.8 36.2 7.8 8.1 7.8 14.6 5.7 22.1 9.7 18.2 18.2 9.9 11.3 12.7 15.7 2.5 25.9 5.2 6.7 28.1 10.5 9.3 13.4 13.2 14.3 9.5 11.6 15.4 12.0 14.8 13.9 12.2 20.0 7.2 22.4 7.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 7.9 8.3 0.0 0.0 2.5 5.5 0.0 11.8 8.8 0.0 3.9 13.7 0.0 8.7 16.7 3.9 0.0 0.0 0.0 11.9 16.1 8.3 0.0 8.2 7.6 13.9 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 5.7 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.6 0.0 0.0 11.6 2.9 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 13.1 6.5 18.5 0.0 0.0 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 12.5 15.8 13.2 14.2 15.8 18.0 22.3 14.7 16.6 20.9 18.2 21.8 14.1 18.1 27.4 16.1 24.2 19.6 13.4 13.5 14.8 21.3 21.1 15.6 22.7 14.5 14.9 18.4 17.7 22.9 16.3 19.2 14.6 19.1 23.6 13.1 16.2 19.8 9.9 18.0 17.2 18.8 14.8 18.9 18.1 18.9 15.8 25.4 23.2 13.6 24.3 23.6 13.6 17.7 26.4 46.7 46.1 36.8 25.2 31.4 29.5 28.4 36.5 46.4 42.5 42.2 61.2 42.9 38.9 35.6 38.5 52.0 99.4 47.6 40.5 37.8 60.2 37.5 32.2 46.4 50.0 38.7 46.2 30.6 46.9 35.1 53.7 34.1 50.8 64.8 52.2 24.3 33.4 41.7 44.3 41.2 33.8 66.2 25.6 37.5 38.8 49.0 36.7 48.6 33.1 26.3 34.2 34.5 49.5 39.2 32.3 44.0 25.2 31.8 33.2 28.8 45.6 23.9 48.4 58.1 32.1 70.0 38.1 25.7 11.0 6.2 19.8 12.7 22.3 19.3 20.3 22.6 19.8 14.8 21.1 19.2 1.2 23.8 9.5 17.9 30.8 16.6 13.2 15.8 14.7 16.6 13.5 14.8 14.5 14.9 14.6 14.8 15.8 17.7 12.2 22.4 10.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 13.0 11.0 0.0 0.0 5.6 12.9 0.0 40.5 7.7 0.0 21.5 18.2 0.0 12.8 11.8 6.8 0.0 0.0 0.0 15.4 30.5 6.7 0.0 12.6 7.6 22.5 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 9.3 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.5 0.0 0.0 15.1 10.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 49.8 4.8 24.0 0.0 0.0 INTS6L "DDX26B, FLJ41215" ENSG00000165359 "Integrator complex subunit 6 like" Q5JSJ4 X 135520659-135582510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 20.7;U-937: 19.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001552, HPA013200, HPA013335, HPA030747" Uncertain Approved "Nuclear bodies,Centrosome,Mitochondria" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" Centrosome "Nuclear bodies, Mitochondria" "HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589" "unprognostic (2.03e-1)" "prognostic favorable (5.39e-4)" "unprognostic (1.96e-1)" "unprognostic (7.42e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.33e-3)" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (2.87e-1)" "unprognostic (1.81e-1)" "unprognostic (5.37e-2)" "prognostic favorable (2.94e-4)" 3.4 7.5 3.3 6.3 2.9 13.1 3.8 8.7 3.7 6.7 2.6 7.7 2.6 4.6 2.8 4.7 6.5 3.8 4.4 3.0 3.0 3.8 1.1 4.4 12.6 3.5 3.6 8.2 2.1 1.8 6.7 3.3 3.4 5.0 7.1 5.1 12.0 3.6 1.1 6.1 7.3 3.7 3.3 10.2 3.4 6.3 3.4 8.4 3.3 0.8 11.3 5.7 5.1 3.7 0.1 0.0 7.5 8.9 2.2 2.5 0.0 1.9 4.0 2.2 6.6 0.7 3.2 7.5 6.3 1.6 5.4 5.6 8.4 2.5 1.5 5.8 3.0 6.5 0.7 0.0 1.9 6.8 0.5 3.3 2.4 2.5 2.5 3.8 2.8 4.9 4.3 11.8 1.6 5.5 6.5 20.7 3.5 8.0 3.1 5.3 2.4 6.4 1.8 3.0 1.2 2.7 2.6 2.6 0.2 3.2 2.8 12.5 1.6 5.6 3.2 0.0 2.2 13.5 11.2 11.3 1.9 19.0 1.1 0.0 1.6 1.4 2.9 1.4 3.8 3.3 3.4 3.5 2.3 3.5 5.2 3.4 0.8 1.9 1.8 2.2 2.0 2.5 3.3 2.9 8.7 3.7 3.0 3.0 3.5 3.6 3.4 3.3 3.4 3.7 6.8 12.8 5.8 0.0 7.3 0.0 0.0 0.0 0.0 0.0 7.2 14.0 0.0 0.0 3.7 3.7 0.0 2.1 15.9 0.0 0.0 1.3 0.0 16.0 5.3 3.3 0.0 0.0 0.0 1.6 0.3 3.3 0.0 11.1 25.2 7.3 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 6.3 0.0 0.0 1.0 6.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.8 6.9 11.1 0.0 0.0 INTS7 "C1orf73, DKFZP434B168, INT7" ENSG00000143493 "Integrator complex subunit 7" Q9NVH2 1 211940399-212035557 "Predicted intracellular proteins" "DNA damage" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 35.6;Oligodendrocytes: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072611 Supported "Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" "HPA072611: AB_2732204" "unprognostic (1.25e-1)" "unprognostic (2.92e-1)" "unprognostic (1.81e-1)" "unprognostic (2.63e-2)" "unprognostic (4.26e-2)" "unprognostic (5.74e-2)" "unprognostic (1.65e-2)" "unprognostic (4.66e-3)" "unprognostic (2.80e-3)" "unprognostic (1.37e-2)" "unprognostic (9.80e-2)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.42e-5)" "unprognostic (2.48e-1)" "unprognostic (4.17e-2)" "unprognostic (2.11e-1)" "unprognostic (7.44e-2)" 5.5 5.1 5.4 6.3 7.1 7.9 6.7 5.8 8.5 5.1 5.3 6.3 5.8 4.6 6.6 8.2 4.5 4.5 4.7 5.3 5.7 4.4 11.1 5.1 9.1 6.0 6.1 4.3 4.7 2.7 5.6 5.8 6.8 5.5 7.6 7.8 4.2 3.1 5.4 7.6 5.4 7.1 5.5 6.0 5.3 21.4 5.7 13.6 6.6 8.5 10.2 6.4 5.5 9.0 31.1 27.2 21.4 17.1 15.3 16.7 25.7 24.9 15.8 29.2 36.8 25.8 26.4 36.0 13.1 18.1 22.7 27.9 32.2 20.0 24.2 34.8 27.5 31.3 27.9 19.0 16.6 56.3 27.9 14.9 24.1 46.8 35.4 13.8 17.7 19.5 46.8 31.2 24.3 18.1 45.6 16.1 39.2 21.3 26.8 27.9 39.7 53.0 16.9 23.2 36.1 28.2 32.4 34.7 20.6 24.7 28.9 26.7 12.6 23.7 25.5 22.0 37.5 13.5 24.3 42.8 21.0 22.8 27.2 12.6 7.3 6.1 8.7 7.5 7.3 9.4 8.7 10.4 10.9 10.9 5.2 6.4 0.8 22.2 10.0 7.6 15.0 7.6 5.4 7.1 5.8 8.5 5.3 5.7 6.0 6.1 6.8 5.5 5.7 9.0 2.4 0.0 12.0 9.1 7.3 9.9 8.2 4.6 10.8 8.5 5.9 3.7 4.9 5.7 4.6 3.7 4.2 10.5 6.9 6.7 1.9 5.1 35.0 5.1 4.9 4.6 1.2 11.6 20.4 7.0 7.9 5.7 6.6 4.5 4.5 8.1 4.6 10.8 5.5 5.0 24.5 5.6 6.1 4.7 5.1 35.6 5.0 3.8 1.8 19.7 6.2 4.2 10.3 34.7 46.6 5.5 1.9 6.8 9.1 4.2 4.4 3.3 6.2 5.6 0.0 5.4 4.5 31.5 18.8 9.9 11.9 6.8 6.7 17.7 8.3 3.9 IRAG1 "IRAG, JAW1L, MRVI1" ENSG00000072952 "Inositol 1,4,5-triphosphate receptor associated 1" Q9Y6F6 11 10573091-10693988 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 24.0" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.0" "Cell line enhanced" "Detected in some" "ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8" "Region enriched" "Detected in many" 5 "thalamus: 7.6" "Low region specificity" "Detected in all" HPA008704 Uncertain Approved "Nuclear bodies,Cytosol" NA NA 220000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "Nuclear bodies" "HPA008704: AB_1079413" "unprognostic (2.18e-1)" "unprognostic (3.40e-2)" "unprognostic (2.86e-3)" "prognostic favorable (5.78e-4)" "unprognostic (5.30e-1)" "unprognostic (3.37e-3)" "unprognostic (1.04e-2)" "unprognostic (1.87e-1)" "unprognostic (5.63e-3)" "unprognostic (1.04e-2)" "unprognostic (1.48e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (3.72e-2)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-3)" 29.7 8.0 64.6 18.2 85.8 1.5 16.1 50.4 53.4 55.4 17.7 67.6 8.5 60.8 16.1 37.5 45.6 33.2 10.1 54.5 54.3 9.3 2.1 13.3 3.7 65.8 71.4 20.2 2.9 2.7 3.8 11.8 54.4 37.9 17.3 1.7 4.1 39.5 6.7 9.3 22.0 69.1 55.2 7.1 33.7 8.2 89.8 2.3 10.2 8.1 1.8 43.8 21.9 48.8 0.1 0.0 4.2 0.0 20.8 4.1 0.2 15.3 17.6 0.0 0.0 0.4 1.7 0.0 0.1 6.9 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.0 0.2 4.8 0.4 0.0 0.1 0.0 1.2 0.0 0.6 0.1 0.3 0.0 0.1 0.3 0.5 0.0 0.1 6.8 0.0 0.3 0.0 0.0 0.0 3.1 0.0 2.6 0.0 4.4 0.0 0.5 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.3 6.0 0.0 0.7 2.2 1.7 0.0 3.9 0.0 0.8 0.0 0.0 0.6 0.9 0.0 0.0 24.0 0.0 5.7 0.1 0.0 0.7 64.6 85.8 50.4 53.4 54.5 54.3 65.8 71.4 54.4 55.2 89.8 48.8 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 ISX RAXLX ENSG00000175329 "Intestine specific homeobox" Q2M1V0 22 35066136-35087387 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 69 "intestine: 37.5" "Group enriched" "Detected in some" 32 "Distal enterocytes: 24.2;Enteroendocrine cells: 19.4;Intestinal goblet cells: 16.0;Paneth cells: 19.4;Proximal enterocytes: 32.7;Undifferentiated cells: 23.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 6.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "CACO-2: 1.6;Hep G2: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA060328 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies" "HPA060328: AB_2684254" "unprognostic (5.02e-2)" "unprognostic (2.68e-1)" "unprognostic (2.23e-1)" "unprognostic (3.33e-1)" "unprognostic (3.86e-1)" "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.6 37.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 26.0 0.0 0.0 0.0 0.0 0.0 27.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.2 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.1 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.8 0.0 ITGB1BP1 "ICAP-1A, ICAP-1alpha, ICAP-1B, ICAP1, ICAP1A, ICAP1B" ENSG00000119185 "Integrin subunit beta 1 binding protein 1" O14713 2 9403475-9423528 "Predicted intracellular proteins" "Angiogenesis, Biomineralization, Cell adhesion, Differentiation, Notch signaling pathway, Transcription, Transcription regulation" Mitogen "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 391.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067348, HPA071538" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 57: Non-specific - Angiogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear bodies, Cytosol" "HPA067348: AB_2732765, HPA071538: AB_2686413" "unprognostic (2.21e-1)" "unprognostic (8.31e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.03e-5)" "unprognostic (4.39e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (4.67e-5)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (6.46e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (7.10e-5)" "unprognostic (3.75e-2)" "unprognostic (2.01e-1)" "unprognostic (1.14e-3)" "unprognostic (4.08e-3)" 113.7 23.2 45.5 19.3 63.1 31.3 60.4 50.3 58.0 43.7 49.3 37.3 13.6 31.0 26.6 20.9 24.3 22.6 37.3 46.4 48.3 50.2 13.3 22.8 22.1 48.2 47.0 22.3 11.8 26.2 19.1 24.2 49.9 18.5 24.2 27.5 15.5 23.7 29.8 29.7 19.1 35.9 41.8 15.2 22.9 9.4 54.3 27.0 22.4 33.5 25.7 30.4 32.5 52.7 53.5 35.4 43.4 51.5 148.9 131.2 23.3 94.9 66.2 83.8 66.1 49.5 33.1 55.6 43.1 135.9 56.1 50.1 66.3 62.7 92.8 158.6 30.2 53.2 43.2 61.1 54.1 42.2 57.4 70.5 49.5 78.4 56.5 75.2 76.6 43.0 29.9 46.1 109.0 44.6 74.7 25.5 35.9 90.3 53.9 39.4 59.1 51.4 88.5 40.6 44.1 45.0 54.8 40.3 71.3 38.9 30.5 32.1 48.6 73.8 54.5 103.3 105.7 46.8 111.0 89.0 106.1 54.8 54.5 86.1 43.1 56.0 54.9 54.0 52.5 40.1 46.6 53.2 56.8 33.0 35.2 45.7 9.3 50.4 41.1 52.8 61.7 53.1 45.5 63.1 50.3 58.0 46.4 48.3 48.2 47.0 49.9 41.8 54.3 52.7 90.0 28.9 18.1 18.3 47.1 61.2 40.6 70.4 40.9 25.2 30.4 41.8 104.3 22.8 35.1 38.6 2.1 45.0 70.7 16.1 391.3 72.0 26.3 31.3 51.9 85.5 33.1 49.4 61.6 72.7 73.9 98.6 25.5 30.9 41.7 44.4 53.6 21.6 91.4 35.3 47.3 30.4 32.6 45.0 88.5 25.7 54.3 51.7 97.8 15.9 95.6 64.2 121.5 25.6 40.1 108.9 27.0 57.2 42.7 35.2 24.7 88.4 35.6 30.6 92.1 49.0 102.4 27.8 19.0 47.5 63.1 31.5 63.0 70.7 35.2 60.4 IVL ENSG00000163207 Involucrin P07476 1 152908546-152911886 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "cervix: 162.3;esophagus: 298.3;salivary gland: 94.5;skin 1: 160.9;vagina: 235.2" "Cell type enhanced" "Detected in some" "Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3" "Group enriched" "Detected in many" 5 "cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3" "Not detected" "Not detected" "CAB002243, HPA055211" Enhanced Supported "Nuclear bodies,Centrosome,Cytosol" NA NA 4700000 "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Cytosol "Nuclear bodies, Centrosome" "CAB002243: AB_563785, HPA055211: AB_2682739" "unprognostic (3.29e-4)" "unprognostic (1.91e-1)" "unprognostic (2.92e-2)" "unprognostic (2.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (4.82e-2)" "unprognostic (3.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-1)" 0.3 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 162.3 0.0 0.0 0.0 0.0 18.2 298.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.6 0.0 0.0 94.5 0.1 0.4 160.9 0.1 0.0 0.0 0.1 0.2 0.1 0.0 3.5 0.1 0.0 36.9 17.4 235.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 6.0 0.0 0.0 0.2 0.0 292.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 76.9 0.0 0.0 0.0 86.3 0.0 0.2 3.6 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 3.1 3.5 0.0 0.0 0.0 0.0 0.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.6 0.0 0.0 30.8 71.0 0.0 0.1 0.0 0.0 13.3 JRK "jerky, JH8" ENSG00000234616 "Jrk helix-turn-helix protein" O75564 8 142657460-142681968 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052675 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" No No "Cluster 46: Basophils - DNA binding" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA052675: AB_2681910" "unprognostic (3.65e-2)" "unprognostic (5.30e-2)" "unprognostic (9.67e-2)" "unprognostic (3.90e-3)" "unprognostic (1.27e-1)" "unprognostic (1.84e-2)" "unprognostic (6.58e-6)" "unprognostic (1.05e-1)" "unprognostic (3.87e-1)" "unprognostic (6.90e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (7.50e-2)" "unprognostic (2.07e-1)" "unprognostic (2.53e-1)" "unprognostic (1.22e-2)" "unprognostic (1.69e-2)" 3.7 4.5 5.9 4.1 6.1 2.1 4.0 7.9 7.4 7.4 4.0 5.9 3.0 6.7 3.4 4.9 5.5 2.5 5.9 5.8 4.7 7.9 4.0 3.9 5.4 6.2 5.2 8.5 5.4 4.6 6.4 3.0 5.5 6.2 2.8 3.8 4.7 4.0 7.5 6.0 5.3 3.7 4.3 7.2 5.7 6.6 6.2 5.1 6.9 4.7 5.9 5.7 4.7 6.8 6.5 6.9 8.0 6.4 7.6 10.8 4.8 10.4 4.2 11.9 6.8 6.3 13.1 11.0 4.1 8.2 8.2 8.7 7.0 6.2 6.0 8.5 12.0 11.2 25.3 7.2 3.1 8.6 7.5 7.2 5.4 7.6 4.3 6.0 6.8 13.1 12.0 4.8 10.1 11.1 10.1 4.8 6.8 4.6 9.6 13.1 5.0 6.2 4.1 11.1 14.5 9.6 18.1 7.3 4.3 5.0 7.3 5.2 8.1 9.1 19.5 9.1 5.5 6.3 7.6 6.3 6.9 10.7 9.0 1.0 0.7 0.9 0.9 0.5 0.5 0.4 1.0 0.9 0.7 1.2 1.3 1.0 0.8 0.6 0.2 0.6 0.6 0.4 5.9 6.1 7.9 7.4 5.8 4.7 6.2 5.2 5.5 4.3 6.2 6.8 3.5 6.4 1.1 8.5 4.8 0.0 2.5 0.0 2.2 14.7 4.5 3.3 11.5 4.3 0.6 7.3 20.9 4.4 8.6 3.2 3.9 2.8 1.9 1.4 4.9 6.5 9.1 12.0 11.3 2.5 2.7 3.7 6.6 2.1 1.3 15.5 8.2 2.6 3.0 10.1 11.0 3.1 0.0 6.6 0.0 2.2 11.5 3.4 0.0 8.4 4.5 4.4 12.3 9.5 9.5 5.6 1.4 11.7 4.3 3.7 2.7 2.7 0.7 10.0 0.0 5.8 4.8 9.1 19.4 3.2 0.0 2.2 2.5 6.8 4.2 4.5 KAT6B "Morf, MOZ2, MYST4, qkf, querkopf, ZC2HC6B" ENSG00000156650 "Lysine acetyltransferase 6B" Q8WYB5 10 74824927-75032624 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006104 Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" "HPA006104: AB_1079445" "unprognostic (4.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.82e-1)" "unprognostic (2.32e-2)" "unprognostic (7.83e-2)" "unprognostic (2.85e-2)" "unprognostic (3.56e-1)" "unprognostic (2.62e-1)" "unprognostic (2.54e-1)" "unprognostic (1.09e-1)" "unprognostic (9.47e-2)" "unprognostic (8.78e-2)" "prognostic favorable (4.82e-4)" "unprognostic (2.52e-1)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (3.15e-1)" 7.6 6.3 5.0 3.1 5.6 8.8 7.3 5.6 5.3 10.5 2.0 9.6 3.2 9.2 5.2 6.9 8.3 3.8 7.5 5.7 4.0 4.3 4.6 6.5 4.4 3.1 3.5 12.2 8.6 10.5 7.4 4.4 3.0 6.5 4.1 6.4 7.3 4.3 11.8 8.0 8.1 6.0 3.0 5.4 9.3 7.8 5.6 9.8 7.3 6.0 4.1 9.1 8.9 4.9 4.7 4.4 8.0 6.9 6.2 9.2 4.1 4.1 7.5 3.4 3.6 3.4 5.3 9.8 2.1 7.1 3.5 3.8 4.2 3.3 5.6 4.2 6.8 3.6 3.9 4.5 4.5 8.6 2.4 5.9 5.3 4.5 6.9 10.5 3.8 7.7 3.9 9.0 4.2 4.7 8.2 4.3 5.0 4.9 25.7 12.7 4.3 2.4 2.3 2.3 4.2 6.9 4.1 7.4 3.7 2.8 4.5 3.2 4.7 4.6 5.5 3.1 3.8 6.4 8.1 6.4 5.0 8.9 1.3 1.7 1.3 1.6 2.3 1.0 2.6 2.2 1.9 2.1 1.1 2.8 2.9 2.6 1.8 4.4 1.1 1.7 1.7 1.0 5.0 5.6 5.6 5.3 5.7 4.0 3.1 3.5 3.0 3.0 5.6 4.9 34.5 44.8 53.7 90.1 48.1 19.9 20.8 16.3 74.6 52.8 36.7 27.3 53.9 12.8 29.3 9.2 68.8 10.4 51.8 22.5 9.8 12.7 6.2 41.1 72.7 24.9 23.8 32.0 130.2 18.0 10.6 44.4 57.6 50.8 41.7 68.0 18.9 16.0 11.0 43.7 131.2 21.7 12.2 12.3 15.0 8.3 42.3 24.1 14.2 41.2 13.6 45.5 42.2 101.0 92.1 10.5 19.4 40.3 62.5 21.0 17.8 10.2 28.6 52.5 26.3 55.3 44.1 33.1 32.2 46.6 17.5 22.7 59.7 27.1 17.5 23.5 KCNE4 MiRP3 ENSG00000152049 "Potassium voltage-gated channel subfamily E regulatory subunit 4" Q8WWG9 2 223051814-223198399 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 37.5" "Cell type enhanced" "Detected in many" "Fibroblasts: 32.3;Melanocytes: 32.0;Sertoli cells: 118.3;Smooth muscle cells: 128.3" "Cancer enhanced" "Detected in all" "breast cancer: 20.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "AN3-CA: 164.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA011420 Approved Approved "Nuclear bodies,Microtubules" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 48: Smooth muscle cells - ECM organization" Microtubules "Nuclear bodies" "HPA011420: AB_1079170" "unprognostic (1.23e-1)" "unprognostic (2.02e-3)" "prognostic unfavorable (9.42e-5)" "unprognostic (2.17e-2)" "unprognostic (7.56e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (9.06e-2)" "unprognostic (3.32e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.02e-7)" "unprognostic (4.70e-3)" "unprognostic (1.20e-1)" "unprognostic (6.24e-3)" "unprognostic (9.08e-3)" 13.3 3.4 7.7 11.0 6.9 0.5 6.9 6.0 11.2 5.0 5.8 8.0 1.3 30.7 2.3 5.1 7.9 20.3 13.5 8.0 6.9 7.5 5.1 3.1 5.7 9.5 8.1 12.3 10.3 1.8 10.3 6.7 9.3 4.4 2.0 3.3 2.7 5.5 5.4 3.2 3.6 37.5 6.9 4.5 12.5 1.1 7.5 0.7 9.4 3.2 1.1 10.7 3.8 8.0 0.0 0.8 0.0 164.3 36.6 3.7 0.2 4.0 3.8 0.8 1.8 0.0 0.2 0.0 0.0 2.5 5.8 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.3 0.0 4.5 0.0 0.1 6.3 0.0 5.5 0.0 0.0 0.0 0.1 0.0 0.2 6.7 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.1 0.1 0.4 6.4 0.1 12.1 0.7 0.1 0.0 0.0 3.8 0.1 3.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.7 6.9 6.0 11.2 8.0 6.9 9.5 8.1 9.3 6.9 7.5 8.0 8.2 0.0 2.2 4.2 0.0 3.8 0.4 0.2 0.0 0.1 1.8 0.4 4.9 0.0 1.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.8 16.3 19.8 4.8 0.0 0.0 0.0 0.2 32.3 9.2 0.6 3.8 0.4 3.9 0.2 0.1 3.3 0.3 0.0 2.0 0.0 5.8 0.3 21.1 1.0 32.0 5.6 0.0 6.1 0.0 1.0 0.0 0.4 0.1 17.0 0.4 1.4 0.0 0.0 3.7 0.7 118.3 1.7 128.3 0.1 0.2 0.4 3.1 0.3 0.6 0.1 0.2 1.8 KCTD13 "FKSG86, PDIP1, POLDIP1" ENSG00000174943 "Potassium channel tetramerization domain containing 13" Q8WZ19 16 29905012-29926236 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Autism, Autism spectrum disorder, Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.5;testis: 36.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043524 Enhanced Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA043524: AB_2678528" "unprognostic (6.97e-2)" "unprognostic (9.06e-3)" "prognostic unfavorable (8.54e-4)" "unprognostic (4.00e-2)" "unprognostic (2.39e-1)" "unprognostic (3.13e-2)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (3.59e-2)" "unprognostic (1.97e-2)" "prognostic favorable (9.05e-4)" "unprognostic (3.92e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "unprognostic (5.49e-3)" 6.0 7.5 27.3 7.8 28.7 8.5 5.4 17.6 37.5 5.0 17.4 6.3 7.3 5.1 9.9 5.9 8.3 7.8 4.4 36.9 24.5 3.9 3.5 4.5 9.8 19.5 21.3 7.5 7.5 7.9 3.6 4.5 19.6 6.7 6.5 9.4 6.5 8.0 2.7 12.2 7.0 5.2 20.5 7.6 5.8 36.3 23.0 9.6 5.7 2.4 7.1 6.0 2.7 28.8 9.7 12.4 6.2 15.5 10.0 8.1 12.5 5.8 7.2 5.7 8.9 3.5 12.6 17.4 11.3 8.5 9.6 14.4 6.8 5.5 4.4 26.5 17.0 3.7 7.1 6.0 13.7 9.2 15.9 10.2 15.3 11.6 8.7 6.1 4.7 19.9 9.1 14.8 7.9 28.1 18.7 14.2 3.6 5.0 6.0 13.9 4.5 9.0 7.8 9.1 15.5 15.4 2.4 7.0 31.7 5.8 10.1 7.2 10.0 5.0 5.1 15.3 10.6 12.4 5.3 3.9 12.0 10.4 14.4 7.2 3.3 8.0 2.9 2.6 3.0 3.0 5.4 5.0 3.5 2.4 5.0 4.7 11.1 3.1 4.4 3.8 4.4 1.9 27.3 28.7 17.6 37.5 36.9 24.5 19.5 21.3 19.6 20.5 23.0 28.8 7.1 0.0 9.7 20.9 10.6 6.0 5.7 10.4 12.5 9.9 8.5 8.0 3.4 5.7 5.8 0.0 8.4 5.3 7.9 5.2 3.9 6.9 17.9 9.1 6.8 4.7 7.7 3.0 15.4 4.2 5.1 6.5 4.6 8.7 2.5 10.9 6.4 2.4 7.6 5.0 20.5 7.2 10.2 4.4 5.6 9.0 6.2 6.3 8.8 12.2 5.7 5.0 11.3 17.6 28.9 11.0 7.4 6.4 3.6 8.7 6.5 2.9 6.3 6.5 0.0 5.0 7.8 20.6 26.5 12.4 9.1 6.7 10.6 5.8 6.1 7.0 KDM5A "JARID1A, RBBP2" ENSG00000073614 "Lysine demethylase 5A" P29375 12 280057-389320 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 45.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006201 Supported "Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear bodies" Cytosol "HPA006201: AB_1079160" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.12e-1)" "unprognostic (4.46e-2)" "unprognostic (1.60e-1)" "unprognostic (3.53e-3)" "unprognostic (1.81e-2)" "unprognostic (5.81e-2)" "unprognostic (3.19e-1)" "unprognostic (1.77e-3)" "unprognostic (6.11e-2)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (2.60e-2)" "unprognostic (7.69e-2)" 8.1 8.7 5.8 11.4 8.3 45.5 11.1 11.6 8.5 8.6 10.0 8.2 7.2 9.7 7.1 8.9 7.6 8.0 5.2 6.2 6.5 7.8 9.9 8.8 15.3 6.8 5.7 11.0 9.4 10.1 4.2 11.8 6.5 8.6 9.9 9.6 6.7 7.3 5.5 12.5 7.3 9.4 6.0 13.5 8.8 21.1 6.7 21.6 9.1 7.6 14.4 8.7 7.2 15.0 14.4 25.3 18.3 14.2 16.1 15.2 20.3 12.5 16.5 18.4 19.8 15.2 17.0 24.0 3.9 21.0 16.0 13.3 19.2 14.2 21.9 37.9 15.9 29.3 26.5 9.0 13.0 38.6 22.1 16.6 13.1 22.6 29.9 18.8 18.8 21.0 17.9 32.7 15.7 9.7 27.9 11.0 28.4 12.3 7.9 25.7 47.5 11.4 8.8 32.6 7.0 20.5 24.5 11.0 13.0 25.0 11.9 24.0 26.0 12.0 17.0 13.6 21.1 11.5 13.6 53.7 15.5 16.5 18.0 64.5 21.8 44.4 31.4 25.0 32.3 27.1 24.6 25.9 22.8 32.0 26.3 22.8 63.0 35.8 28.9 32.0 20.9 22.5 5.8 8.3 11.6 8.5 6.2 6.5 6.8 5.7 6.5 6.0 6.7 15.0 53.1 64.1 61.6 61.7 80.6 33.0 22.2 30.1 48.9 69.0 35.3 27.9 38.2 31.5 39.0 35.0 116.7 48.8 103.3 51.3 3.9 37.4 96.8 60.2 72.8 51.6 69.7 51.3 71.7 31.6 34.7 47.2 39.8 99.8 54.4 106.9 42.8 30.9 30.2 87.5 59.1 40.0 40.7 52.5 37.5 32.5 48.4 63.9 26.6 57.1 82.9 48.3 105.0 68.3 85.9 38.7 37.0 55.7 73.1 32.4 33.6 11.8 40.2 71.9 59.2 64.0 59.9 137.1 104.8 50.1 47.6 71.1 80.1 67.5 40.1 42.0 KIF18B ENSG00000186185 "Kinesin family member 18B" Q86Y91 17 44924709-44947773 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 12.7;lymphoid tissue: 14.4" "Cell type enhanced" "Detected in some" "Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.4" "Low region specificity" "Detected in many" HPA024205 Enhanced Supported "Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol" Yes Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Microtubule ends" "Nuclear bodies, Cytosol" "HPA024205: AB_1852472" "unprognostic (1.88e-1)" "unprognostic (9.92e-2)" "unprognostic (4.61e-2)" "unprognostic (1.13e-2)" "unprognostic (4.17e-1)" "unprognostic (7.27e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (3.34e-3)" "prognostic unfavorable (6.90e-4)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (8.18e-2)" "unprognostic (0.00e+0)" "unprognostic (4.69e-3)" "unprognostic (1.93e-1)" "unprognostic (3.08e-1)" "unprognostic (1.68e-2)" 0.4 0.4 0.3 3.8 0.4 12.7 0.2 0.7 0.3 0.9 0.3 2.0 2.7 0.4 0.0 5.1 0.2 0.4 0.3 0.3 0.4 0.2 0.4 0.8 5.7 0.5 1.1 0.1 0.1 0.0 0.1 1.9 0.6 0.2 1.7 0.1 0.7 0.0 0.4 3.0 2.5 1.1 0.3 2.9 1.5 2.9 0.6 14.4 0.2 0.0 4.7 0.6 1.6 0.5 31.5 41.7 35.3 32.8 0.8 3.0 28.1 25.8 10.3 34.6 26.9 34.0 27.4 28.3 10.9 10.8 21.5 34.0 25.1 11.3 17.9 56.6 36.4 35.4 51.7 22.1 0.0 30.0 30.2 0.7 0.6 29.7 12.2 4.7 17.9 29.2 28.1 48.0 18.2 25.9 60.0 31.1 25.4 30.4 28.9 43.5 51.8 19.2 5.8 16.7 26.2 24.7 18.0 16.1 9.8 17.0 30.2 21.6 11.2 49.9 48.0 28.8 56.8 15.1 15.7 34.4 16.3 22.9 33.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.3 0.4 0.7 0.3 0.3 0.4 0.5 1.1 0.6 0.3 0.6 0.5 0.1 0.0 0.0 0.0 0.9 0.4 0.1 0.2 0.0 0.5 0.5 0.4 2.6 0.0 0.0 0.0 0.0 2.4 0.4 1.9 0.0 0.0 0.0 0.3 0.8 0.6 0.0 9.0 0.3 0.0 3.8 1.4 1.5 0.5 0.0 5.9 0.4 0.3 2.3 0.0 0.3 1.6 0.0 2.2 1.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 7.1 0.1 0.1 0.0 0.0 2.1 0.2 0.3 0.0 0.0 0.3 0.0 0.2 0.8 1.1 2.9 2.5 0.4 0.8 1.3 0.3 3.2 0.3 KIF3C ENSG00000084731 "Kinesin family member 3C" O14782 2 25926598-25982749 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 75.5;retina: 19.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 53.5;Horizontal cells: 42.1;Inhibitory neurons: 45.9;Oligodendrocyte precursor cells: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035755 Approved "Nuclear membrane,Nuclear bodies,Intermediate filaments" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Nuclear bodies, Intermediate filaments" "Nuclear membrane" "HPA035755: AB_10602242" "unprognostic (3.95e-1)" "unprognostic (1.40e-2)" "unprognostic (7.85e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.75e-1)" "unprognostic (4.69e-2)" "unprognostic (3.96e-4)" "unprognostic (1.53e-2)" "prognostic favorable (1.22e-4)" "unprognostic (2.03e-1)" "unprognostic (2.20e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (3.90e-2)" "unprognostic (3.54e-1)" "unprognostic (1.76e-1)" "unprognostic (1.22e-1)" 3.1 6.8 28.4 2.3 40.2 1.5 2.9 6.9 75.5 4.0 0.0 5.4 1.3 3.6 1.7 2.2 2.7 3.6 2.9 46.1 18.6 1.6 0.7 2.0 1.2 37.5 10.9 6.8 1.4 3.7 11.7 2.1 32.7 2.9 1.7 19.6 2.2 3.8 1.8 2.5 2.5 4.2 0.0 1.6 2.3 2.3 13.8 2.6 3.0 2.5 1.1 2.7 3.7 37.8 25.7 38.1 19.9 15.4 11.4 13.1 15.9 13.1 6.4 7.7 8.7 6.8 3.8 0.0 10.6 11.9 24.1 2.7 15.2 7.8 5.2 4.5 7.3 9.3 2.6 14.0 6.7 2.3 7.7 9.6 2.3 24.2 4.8 29.6 25.8 7.3 3.3 3.2 8.3 1.8 6.7 3.2 20.5 0.7 11.1 10.4 9.9 1.7 17.7 6.2 24.2 54.4 5.2 2.2 27.3 16.4 0.8 3.1 20.6 13.4 13.7 6.1 12.9 0.8 4.6 3.1 30.4 12.5 11.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.5 0.2 0.0 0.0 0.4 0.3 28.4 40.2 6.9 75.5 46.1 18.6 37.5 10.9 32.7 0.0 13.8 37.8 1.9 0.0 0.0 9.4 0.2 0.5 1.6 1.5 1.2 16.7 2.0 2.4 3.5 2.8 1.1 0.0 6.2 0.6 2.1 0.1 0.0 8.4 3.4 1.0 2.1 5.6 3.0 0.0 53.5 1.4 4.2 2.6 0.5 1.4 7.0 8.8 7.9 0.1 3.5 42.1 45.9 0.3 2.0 4.6 1.1 4.8 1.8 2.6 3.6 12.2 2.0 7.0 0.0 27.6 13.7 10.1 0.0 4.5 1.5 1.0 0.0 1.2 1.3 9.6 6.6 2.8 3.1 0.3 1.6 1.0 0.3 1.2 1.7 5.1 0.2 1.0 KLF11 "MODY7, TIEG2, Tieg3" ENSG00000172059 "Kruppel like factor 11" O14901 2 10042849-10054836 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 135.0;Suprabasal keratinocytes: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058276 Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies, Focal adhesion sites, Cytosol" "HPA058276: AB_2683664" "unprognostic (9.66e-3)" "unprognostic (1.87e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-3)" "unprognostic (2.63e-3)" "unprognostic (6.34e-2)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.17e-3)" "unprognostic (3.08e-2)" "unprognostic (2.48e-3)" "unprognostic (8.96e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-2)" "unprognostic (9.24e-2)" 27.7 15.6 4.0 7.6 3.2 27.8 22.3 8.3 3.9 13.5 4.1 17.9 7.5 20.0 9.7 13.2 13.7 18.1 19.1 2.9 3.9 15.7 35.2 22.4 9.3 3.7 3.3 23.9 54.2 18.3 2.5 19.5 3.4 10.1 9.3 3.0 15.9 14.8 12.1 26.9 8.7 16.8 3.2 18.8 12.4 30.0 3.5 4.0 16.5 27.3 5.5 12.6 13.1 5.1 6.9 3.3 7.8 0.7 5.3 9.4 18.8 7.9 7.9 4.4 4.6 7.8 15.8 0.0 13.9 9.6 17.9 1.6 6.8 6.1 2.9 47.6 5.2 3.5 9.7 1.6 5.2 14.6 22.1 14.7 22.3 8.4 2.3 11.4 3.9 1.3 9.7 30.8 4.6 8.2 0.0 2.7 12.5 5.6 6.7 7.8 0.2 13.6 10.8 8.5 10.0 6.2 12.0 24.5 23.4 12.2 5.7 19.6 11.2 19.3 15.9 14.7 2.6 27.9 36.0 18.7 5.0 3.8 10.4 0.0 8.2 2.0 2.6 12.3 0.8 3.2 1.8 1.9 7.3 2.9 0.5 1.1 0.2 6.6 14.8 0.3 3.0 5.4 4.0 3.2 8.3 3.9 2.9 3.9 3.7 3.3 3.4 3.2 3.5 5.1 58.8 6.4 4.6 0.3 12.5 60.5 17.7 5.5 25.6 6.2 14.3 13.2 3.5 10.0 6.1 7.3 6.2 3.2 10.1 2.5 29.4 8.2 135.0 9.1 21.5 33.3 7.1 4.6 1.7 8.5 4.2 17.5 9.7 26.6 8.2 15.5 37.5 38.1 12.5 3.3 1.4 7.0 16.2 32.4 42.4 25.9 14.6 22.0 30.2 1.0 16.6 2.2 3.1 0.5 0.3 8.9 1.5 16.6 5.3 15.0 6.1 8.4 4.3 5.8 32.9 10.4 35.7 13.8 39.0 13.1 86.2 8.2 10.8 11.2 7.8 11.7 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49768130-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: AB_2666051" "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favorable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 21.5 22.3 12.8 8.6 13.3 10.1 19.6 13.7 16.1 18.8 15.0 23.8 18.4 20.7 14.8 15.0 17.0 13.8 38.0 14.4 14.0 34.1 49.1 14.5 10.9 12.4 12.3 25.1 30.3 16.8 17.7 12.7 13.9 18.5 18.0 23.9 20.1 20.1 53.0 18.8 21.6 14.1 13.3 12.3 24.4 23.3 12.6 15.2 28.2 38.2 10.5 22.3 16.2 14.9 14.7 12.2 22.5 11.0 31.7 27.5 23.7 15.0 28.8 18.8 19.0 7.1 19.6 29.1 20.4 27.4 10.8 12.8 13.9 13.9 15.9 20.1 14.7 9.1 8.6 17.0 23.1 19.6 7.8 28.6 23.5 8.6 16.9 23.1 17.4 24.6 11.8 21.5 15.1 17.3 20.1 8.6 16.6 17.0 34.8 15.3 24.0 18.1 8.6 31.2 27.4 22.0 25.1 46.4 17.1 17.2 17.8 7.4 14.9 17.2 13.3 13.7 7.8 29.0 19.7 17.1 9.7 10.0 9.2 12.3 9.1 19.9 11.1 6.1 13.8 18.2 16.8 17.4 9.0 19.0 23.5 15.8 8.4 16.8 5.8 6.8 18.0 12.3 12.8 13.3 13.7 16.1 14.4 14.0 12.4 12.3 13.9 13.3 12.6 14.9 40.6 41.7 52.4 30.3 42.1 48.9 53.5 64.8 53.5 65.1 48.6 40.9 9.3 77.2 53.9 47.8 50.1 102.5 40.7 68.9 107.6 59.8 96.8 44.8 41.9 36.4 57.2 47.8 30.6 85.8 68.6 51.2 67.2 38.7 30.4 62.8 45.3 91.8 33.2 65.6 35.4 75.3 63.1 28.7 33.6 27.1 81.4 26.5 39.2 18.7 36.3 73.9 54.6 28.1 33.1 54.8 78.9 77.5 74.5 53.9 143.9 170.1 27.8 98.1 65.7 46.3 90.5 238.7 93.2 42.7 66.3 82.4 44.9 54.7 78.9 55.5 KLHL17 ENSG00000187961 "Kelch like family member 17" Q6TDP4 1 960584-965719 "Predicted intracellular proteins" "Ubl conjugation pathway" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031251 Approved Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" Nucleoplasm "HPA031251: AB_10601539" "unprognostic (1.28e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.18e-1)" "unprognostic (8.55e-2)" "unprognostic (1.41e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (3.09e-2)" "unprognostic (1.51e-1)" "unprognostic (8.53e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.70e-6)" "unprognostic (1.61e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-1)" "unprognostic (7.73e-2)" 5.3 5.8 5.2 3.8 5.4 3.8 6.0 6.1 8.3 9.7 5.3 6.9 3.5 7.3 0.6 12.3 6.7 2.3 4.8 5.4 4.7 9.0 7.9 7.1 3.7 5.7 5.0 1.9 7.1 2.3 10.4 2.2 5.6 8.2 0.7 1.7 7.5 1.9 2.8 9.5 7.6 1.2 4.6 12.0 7.5 12.4 5.8 3.0 6.5 0.8 1.6 8.2 8.6 5.5 6.8 7.5 9.2 22.1 3.2 3.3 10.1 13.1 3.5 7.2 7.0 9.9 10.1 2.4 9.0 5.8 6.9 14.4 8.5 5.4 1.1 13.9 20.7 4.4 32.2 14.3 2.1 5.1 13.4 2.8 2.6 7.1 2.0 9.0 4.5 14.0 14.9 4.3 3.2 8.0 8.4 17.8 10.0 2.7 11.0 13.5 3.7 4.8 4.0 2.7 22.3 21.0 3.8 11.8 12.4 2.8 6.4 8.9 7.8 13.7 18.5 12.1 11.1 8.5 3.2 5.9 7.9 11.4 6.5 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 5.4 6.1 8.3 5.4 4.7 5.7 5.0 5.6 4.6 5.8 5.5 2.2 0.0 3.1 6.2 1.7 2.5 1.0 1.2 3.4 5.7 2.6 2.8 3.7 0.0 0.7 3.7 2.1 1.2 4.0 1.1 0.0 1.0 1.3 1.8 4.1 1.2 3.0 0.0 5.9 0.8 1.9 1.8 7.7 2.0 0.0 1.4 3.3 0.7 1.2 6.7 4.6 1.6 0.0 1.0 1.8 2.0 0.3 2.1 3.6 2.8 1.4 1.2 1.0 1.5 2.1 2.0 0.3 1.5 2.2 0.9 1.2 1.2 1.1 6.2 0.0 0.8 2.0 4.7 5.3 1.9 3.0 0.8 2.2 0.2 1.4 1.4 KLHL18 "FLJ13703, KIAA0795" ENSG00000114648 "Kelch like family member 18" O94889 3 47282917-47346816 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035027, HPA035028" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Nuclear bodies" "HPA035027: AB_10602340, HPA035028: AB_10669899" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.22e-1)" "unprognostic (9.01e-2)" "unprognostic (3.05e-1)" "unprognostic (9.60e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-3)" "unprognostic (3.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.07e-1)" "unprognostic (4.67e-1)" 5.9 6.2 6.5 6.2 6.9 15.9 4.6 5.9 7.7 5.7 3.9 5.8 4.4 5.3 5.1 8.7 4.6 5.4 6.2 6.8 6.3 6.1 3.7 6.2 6.9 4.9 6.0 3.9 5.5 7.2 6.0 5.5 5.1 5.1 4.6 20.2 4.4 6.2 6.7 13.8 5.6 6.6 5.5 8.8 4.9 6.3 6.7 5.1 7.0 5.6 7.5 6.7 6.7 6.3 11.6 14.6 11.1 16.5 12.0 8.6 7.9 15.6 8.1 15.5 12.6 15.6 7.0 22.6 8.6 13.1 14.2 7.0 33.7 16.5 15.9 18.0 11.3 33.3 20.9 14.3 12.3 17.9 14.7 10.0 12.5 22.4 20.8 8.7 17.5 12.1 41.0 9.2 12.6 9.6 13.7 10.3 20.4 9.4 29.2 9.4 7.3 13.2 14.6 21.6 7.6 10.1 10.9 13.2 7.9 11.3 7.8 9.7 18.4 14.3 14.8 16.6 19.9 10.3 21.9 19.5 9.2 20.5 15.4 6.1 12.1 3.7 2.0 10.7 2.9 3.8 1.6 3.9 7.8 2.4 1.3 2.0 4.9 1.3 18.6 2.0 1.7 5.7 6.5 6.9 5.9 7.7 6.8 6.3 4.9 6.0 5.1 5.5 6.7 6.3 19.6 12.8 13.7 13.1 24.4 11.3 10.6 8.1 12.0 65.2 17.4 13.0 62.1 4.3 7.5 3.7 20.9 10.6 26.1 15.2 21.5 15.5 3.0 15.5 24.8 16.1 9.5 21.7 24.2 14.8 11.9 9.3 12.2 27.5 36.1 11.0 14.3 19.7 29.6 13.5 23.0 11.1 4.1 28.8 14.9 3.5 5.9 26.7 0.0 18.7 22.4 13.9 8.2 15.1 17.4 17.7 10.6 8.2 12.0 9.3 9.8 28.2 6.3 54.2 6.6 19.5 13.5 13.9 14.8 14.8 21.0 14.1 20.8 15.4 10.3 13.0 KMT2E "HDCMC04P, MLL5" ENSG00000005483 "Lysine methyltransferase 2E (inactive)" Q8IZD2 7 105014190-105115019 "Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Growth arrest, Transcription, Transcription regulation" "Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042866, HPA056125" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear bodies" "HPA042866: , HPA056125: AB_2683044" "unprognostic (1.05e-1)" "unprognostic (6.33e-2)" "unprognostic (6.49e-2)" "unprognostic (4.34e-1)" "unprognostic (1.94e-1)" "unprognostic (4.77e-2)" "unprognostic (2.20e-1)" "unprognostic (3.98e-3)" "unprognostic (2.03e-2)" "unprognostic (3.16e-2)" "unprognostic (3.53e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.80e-5)" "unprognostic (1.68e-1)" "unprognostic (1.53e-1)" "unprognostic (3.57e-2)" "unprognostic (1.06e-1)" 23.0 16.4 17.6 28.8 23.6 69.9 22.5 53.6 26.1 28.9 11.6 29.0 22.7 33.4 22.1 22.7 24.8 24.5 21.1 16.9 25.9 18.7 16.4 27.9 31.4 19.0 19.2 43.8 22.8 23.1 11.5 26.8 17.7 24.9 28.5 40.5 25.5 23.0 15.0 30.3 22.3 26.8 14.4 33.4 26.7 18.6 17.1 35.6 27.4 22.9 33.0 27.9 14.3 34.4 35.7 24.8 49.3 43.5 29.3 34.5 12.3 24.3 38.2 21.0 25.5 19.0 30.1 28.8 24.7 30.0 27.7 26.2 27.1 25.7 35.0 45.8 17.4 27.0 31.6 19.2 28.1 39.7 34.8 24.2 23.3 28.6 30.6 38.6 40.2 32.3 39.9 76.9 28.7 26.5 62.1 35.0 17.9 19.1 19.1 53.4 30.3 33.5 23.0 34.5 28.8 36.1 35.7 32.3 20.2 32.8 13.6 23.5 47.2 50.0 33.1 57.5 26.4 61.6 50.8 63.5 34.3 29.5 36.3 246.8 73.2 173.1 118.3 56.2 114.6 153.9 109.7 103.0 53.8 152.0 106.0 100.0 290.3 89.9 94.4 103.2 101.5 71.7 17.6 23.6 53.6 26.1 16.9 25.9 19.0 19.2 17.7 14.4 17.1 34.4 169.3 141.1 158.4 108.4 283.5 146.6 115.5 119.2 118.4 236.4 93.4 81.5 102.9 85.8 124.6 115.8 252.3 40.5 278.0 138.0 35.2 82.2 27.0 77.8 89.3 205.6 100.0 90.5 160.2 68.1 50.4 128.8 91.7 112.4 247.9 78.2 119.2 33.6 60.4 185.1 148.9 96.4 89.5 91.8 348.4 27.3 141.1 152.2 140.5 148.9 147.5 104.1 255.4 189.0 236.2 80.7 102.9 131.7 223.1 149.7 82.6 32.4 78.3 297.5 124.9 136.7 168.3 100.0 76.4 86.1 134.7 65.3 278.3 58.2 115.4 159.9 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes "Cluster 21: B-cells - Adaptive immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.2 0.1 0.1 1.9 0.0 5.3 0.3 0.2 0.2 0.2 0.2 1.3 1.6 0.3 0.2 1.0 0.1 0.3 0.1 0.1 0.1 0.5 0.7 0.4 3.6 0.1 0.3 0.0 0.0 0.3 0.0 1.3 0.1 0.1 1.4 0.2 0.2 0.0 0.0 0.8 1.7 0.7 0.0 0.6 0.9 16.9 0.3 7.4 0.3 0.1 3.4 0.5 0.2 0.1 19.1 9.3 18.0 13.8 0.5 2.6 8.6 20.5 8.1 16.0 13.1 11.6 7.2 11.9 6.1 9.3 12.0 21.9 17.6 9.7 16.3 21.4 5.0 35.5 15.5 3.9 0.0 26.2 17.8 0.5 0.4 10.8 6.4 2.1 13.8 20.9 22.9 19.2 18.3 6.1 23.5 6.1 9.4 11.3 9.5 21.2 25.8 5.9 2.6 15.6 15.9 7.7 17.7 10.6 2.1 5.9 11.1 9.0 13.1 18.7 16.3 21.9 11.7 7.5 27.9 22.3 7.6 18.5 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.3 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 1.8 1.8 0.0 8.5 2.6 0.0 1.9 0.2 0.0 3.5 3.5 1.9 0.0 0.0 0.0 0.6 11.3 4.2 0.0 2.9 0.0 22.8 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 11.5 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.7 1.9 1.7 0.0 0.0 KREMEN1 "KREMEN, KRM1" ENSG00000183762 "Kringle containing transmembrane protein 1" Q96MU8 22 29073035-29168333 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Wnt signaling pathway" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 59.1;Skeletal myocytes: 82.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 1.3;neutrophil: 4.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "RH-30: 34.7;U-2197: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058513 Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No 1100000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear bodies, Cytosol" "HPA058513: AB_2683739" 7.3 13.5 10.3 9.5 22.3 4.1 7.6 7.4 10.8 9.1 5.6 13.1 6.6 6.7 8.7 37.2 10.9 4.0 22.7 12.7 7.6 9.0 2.4 11.9 2.9 8.2 9.8 22.2 4.6 48.2 6.5 6.1 8.0 9.1 11.3 4.0 28.3 9.8 28.7 36.3 11.1 6.2 5.6 9.1 9.4 12.5 12.9 22.4 9.5 42.6 16.4 9.2 13.7 8.3 5.2 3.6 11.8 6.2 3.9 11.9 9.9 1.4 12.0 3.8 5.7 16.5 2.4 0.1 4.5 5.6 9.6 24.7 24.6 9.9 4.1 6.2 15.5 1.4 1.7 15.6 4.1 0.1 1.3 11.4 19.7 4.3 2.4 1.6 0.6 10.1 5.4 0.3 4.8 4.4 0.1 1.7 0.5 34.0 2.5 0.8 34.7 0.3 4.1 9.7 23.6 13.1 14.2 5.0 18.3 3.9 18.5 0.9 0.4 15.7 4.8 59.3 1.7 1.2 0.4 0.2 10.0 2.2 18.5 1.3 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 4.6 0.3 0.2 0.6 0.1 0.1 10.3 22.3 7.4 10.8 12.7 7.6 8.2 9.8 8.0 5.6 12.9 8.3 2.0 16.0 18.4 59.1 0.3 15.3 14.0 14.1 7.4 4.4 5.7 6.1 23.9 14.3 18.3 7.3 0.0 15.5 0.3 3.9 1.9 5.4 3.2 6.2 19.7 3.9 0.0 17.2 10.3 4.2 1.8 24.4 8.6 8.0 19.0 5.9 5.3 2.6 2.6 0.0 2.7 19.4 4.1 24.1 6.8 10.8 17.7 2.5 0.0 15.9 2.7 22.2 2.1 10.6 6.3 3.0 9.5 10.5 0.1 10.9 2.2 4.7 18.4 3.4 13.1 82.2 7.9 8.1 6.0 26.3 19.5 5.3 2.3 33.5 10.2 10.5 L3MBTL1 "dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3" ENSG00000185513 "L3MBTL histone methyl-lysine binding protein 1" Q9Y468 20 43489442-43550954 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 31.2;Oligodendrocytes: 25.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SuSa: 5.1" HPA059648 Supported "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA "Cluster 48: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA059648: " "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (5.66e-2)" "unprognostic (7.19e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-2)" "unprognostic (7.65e-4)" "unprognostic (6.02e-2)" "unprognostic (6.00e-2)" "unprognostic (2.23e-2)" "unprognostic (1.15e-3)" "unprognostic (1.20e-2)" "unprognostic (1.44e-3)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (2.89e-1)" "unprognostic (1.56e-4)" 2.7 4.8 8.6 0.8 8.5 0.8 3.9 6.4 10.2 6.4 6.1 6.1 1.1 5.0 2.0 4.2 6.9 0.6 3.9 8.0 9.4 5.9 2.0 3.0 0.8 8.0 8.8 7.5 3.3 1.1 16.7 0.6 8.7 6.4 0.7 3.4 4.6 1.7 5.1 3.9 4.8 0.8 6.1 5.5 3.9 10.1 10.8 0.8 6.9 1.1 0.5 4.8 6.4 7.6 0.1 0.1 1.6 0.9 0.1 0.0 2.6 0.2 0.3 0.5 0.4 0.2 1.7 0.9 0.4 0.9 0.5 1.1 0.0 0.4 0.3 0.0 1.1 0.3 1.4 2.1 0.3 0.0 0.3 0.3 0.6 0.1 0.0 2.9 0.3 0.9 0.6 0.2 0.1 0.3 0.4 1.2 1.0 0.7 1.4 0.6 0.2 0.5 1.2 0.4 0.4 1.3 0.5 0.5 0.1 5.1 0.6 1.7 0.6 0.2 1.1 0.0 0.4 1.0 0.4 0.3 1.5 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.2 8.6 8.5 6.4 10.2 8.0 9.4 8.0 8.8 8.7 6.1 10.8 7.6 1.2 3.2 3.2 16.0 3.3 0.9 2.0 1.9 8.0 17.2 2.7 2.8 1.9 1.5 4.2 5.5 14.6 2.1 5.2 0.9 1.9 1.3 2.0 2.4 2.6 2.2 1.2 1.7 12.4 0.2 3.3 1.9 2.0 1.8 5.1 8.3 1.8 0.6 1.4 6.7 24.4 2.1 4.1 1.6 1.8 2.8 5.0 2.0 3.6 4.7 1.0 4.7 4.1 31.2 25.4 0.8 1.9 6.0 1.7 2.5 3.1 0.7 6.6 10.8 0.0 4.2 2.8 13.9 12.3 1.5 1.1 1.9 2.3 4.6 1.8 1.4 LACTBL1 ENSG00000215906 "Lactamase beta like 1" A8MY62 1 22953043-22965338 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "retina: 3.0" "Cell type enriched" "Detected in single" 10 "Bipolar cells: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA066810 Approved "Nuclear bodies" NA NA "Cluster 77: Retina - Visual perception" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "HPA066810: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LAGE3 "CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1" ENSG00000196976 "L antigen family member 3" Q14657 X 154477769-154479257 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036122, HPA036123" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Nuclear bodies" "HPA036122: AB_2674951, HPA036123: AB_10601926" "unprognostic (1.70e-1)" "prognostic favorable (5.29e-6)" "unprognostic (1.09e-2)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" "unprognostic (3.04e-2)" "unprognostic (4.88e-3)" "unprognostic (6.73e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (7.37e-2)" "unprognostic (3.57e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" 11.9 29.1 41.2 7.7 43.0 19.4 12.1 41.2 52.4 16.9 36.9 14.2 6.8 12.3 8.4 15.0 11.1 5.9 21.9 44.3 40.6 14.2 20.9 10.8 10.2 38.9 38.3 18.5 25.1 8.9 34.0 5.4 40.4 16.7 4.7 4.6 16.5 6.5 24.4 19.8 12.2 4.0 39.9 16.2 15.2 9.6 41.1 13.4 9.7 10.2 8.9 17.2 13.6 43.4 44.7 41.6 15.1 32.1 16.0 13.3 44.7 13.3 9.4 19.7 22.0 27.0 23.4 94.2 118.6 17.5 34.9 19.1 37.5 13.2 6.8 53.9 59.9 34.4 38.3 15.6 27.2 46.1 49.1 20.5 8.6 29.6 7.7 15.0 14.1 44.9 34.2 44.4 27.3 104.6 61.9 134.3 28.5 59.5 99.7 54.0 26.0 106.4 11.6 12.0 41.8 38.8 31.0 73.8 57.1 10.4 32.0 33.5 15.8 14.1 41.9 59.6 51.3 104.2 117.5 145.0 24.8 81.8 33.3 27.1 25.8 10.9 26.4 25.5 33.9 40.4 36.5 38.6 35.6 33.7 82.0 41.7 2.8 47.0 20.8 66.5 31.7 40.0 41.2 43.0 41.2 52.4 44.3 40.6 38.9 38.3 40.4 39.9 41.1 43.4 41.7 9.6 14.7 8.5 57.1 58.0 50.1 68.4 70.6 54.9 84.5 107.8 30.8 58.6 34.2 35.0 8.4 62.4 58.5 40.0 127.2 50.7 2.0 15.3 22.4 46.5 56.4 79.7 10.9 93.4 119.9 40.0 27.5 14.8 46.9 75.7 33.5 49.6 126.3 23.5 8.3 50.8 67.1 37.4 93.1 6.3 41.7 55.6 92.5 3.7 63.4 87.2 74.2 4.5 9.3 40.9 28.4 36.9 65.0 46.1 38.5 72.6 33.0 18.4 6.6 35.3 31.0 43.5 100.9 61.4 56.0 56.8 51.8 56.8 54.3 45.2 LARS1 "FLJ10595, FLJ21788, HSPC192, LARS, LEUS, RNTLS" ENSG00000133706 "Leucyl-tRNA synthetase 1" Q9P2J5 5 146110566-146182696 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 26.8;Cardiomyocytes: 135.7;Cytotrophoblasts: 39.2;Extravillous trophoblasts: 40.3;Hofbauer cells: 36.7;Smooth muscle cells: 22.7;Syncytiotrophoblasts: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036424, HPA040881" Supported Approved "Nuclear bodies,Cytosol" NA NA 110000 "Cluster 7: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" "Nuclear bodies, Cytosol" "HPA036424: AB_10670102, HPA040881: AB_2677185" "unprognostic (2.20e-2)" "unprognostic (1.87e-1)" "unprognostic (2.38e-3)" "unprognostic (1.92e-1)" "unprognostic (2.69e-1)" "unprognostic (3.39e-1)" "prognostic unfavorable (3.78e-5)" "unprognostic (8.17e-2)" "unprognostic (2.72e-1)" "unprognostic (6.80e-2)" "unprognostic (1.32e-1)" "unprognostic (1.60e-1)" "unprognostic (1.06e-1)" "unprognostic (3.13e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.96e-2)" 35.4 37.0 40.0 26.6 42.0 20.2 46.3 42.8 48.9 33.9 44.0 34.4 18.4 33.9 35.4 35.0 34.8 18.7 38.5 40.4 44.3 34.6 25.6 26.4 29.7 42.3 42.9 37.2 49.7 34.7 37.0 22.2 41.8 35.6 34.8 34.7 40.0 28.3 70.6 31.7 28.1 33.4 43.1 35.7 29.8 23.9 43.2 32.7 34.7 58.8 34.8 35.6 30.9 46.2 56.1 59.5 65.9 125.9 88.0 95.7 102.5 45.5 57.8 71.4 92.4 66.1 59.8 67.8 32.7 91.2 72.6 52.9 107.2 116.5 106.4 45.2 88.2 65.5 76.0 58.5 122.7 101.4 51.9 83.7 153.6 92.0 173.3 73.2 87.7 108.0 67.4 121.3 83.4 56.9 102.8 116.1 126.8 63.8 86.8 75.0 62.0 101.9 73.6 44.1 77.7 97.3 50.2 111.6 221.2 76.6 103.1 159.3 63.4 61.2 44.3 56.7 89.4 79.3 82.3 86.3 89.8 164.1 79.1 1.1 11.8 5.4 14.5 19.2 19.6 18.9 16.6 14.9 21.2 15.5 21.2 21.9 0.7 19.2 16.7 16.6 19.6 14.9 40.0 42.0 42.8 48.9 40.4 44.3 42.3 42.9 41.8 43.1 43.2 46.2 26.8 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.7 0.0 0.0 0.0 0.0 39.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 40.3 16.6 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 33.0 2.8 0.0 0.0 0.0 LBX1 "HPX6, LBX1H" ENSG00000138136 "Ladybird homeobox 1" P52954 10 101226195-101229794 "Predicted intracellular proteins, Transcription factors" "Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 26.5" "Cell type enriched" "Detected in single" 5 "Skeletal myocytes: 3.2" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "cerebellum: 1.9;medulla oblongata: 3.5;pons: 2.5;spinal cord: 4.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 3.4;RH-30: 4.3;SCLC-21H: 9.1" "Group enriched" "Detected in some" 24 "cerebellum: 1.6;pons and medulla: 3.0" "Group enriched" "Detected in some" 18 "cerebellum: 1.2;medulla oblongata: 2.0;spinal cord: 2.0" "HPA002016, HPA002086, CAB079927" Uncertain Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242" "unprognostic (4.13e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" "unprognostic (2.29e-1)" "unprognostic (7.28e-3)" "unprognostic (3.31e-1)" "unprognostic (9.76e-2)" "unprognostic (1.45e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.4 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 0.0 0.0 0.0 9.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 3.5 0.4 2.5 4.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LETM2 "FLJ25409, SLC55A2" ENSG00000165046 "Leucine zipper and EF-hand containing transmembrane protein 2" Q2VYF4 8 38386207-38409527 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 23.8" "Cell type enhanced" "Detected in many" "Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "neutrophil: 21.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 21.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.2;hTERT-HME1: 26.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebellum: 24.0" HPA025032 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Cluster 50: Neutrophils - Cellular senescence" "Cluster 78: Testis - Spermatogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies, Cytosol" "HPA025032: AB_1852808" "unprognostic (3.37e-2)" "unprognostic (2.73e-1)" "unprognostic (3.14e-1)" "unprognostic (2.05e-2)" "unprognostic (2.27e-4)" "unprognostic (3.20e-2)" "unprognostic (3.96e-2)" "unprognostic (1.43e-1)" "unprognostic (8.27e-2)" "unprognostic (3.80e-2)" "unprognostic (1.39e-1)" "unprognostic (1.35e-1)" "unprognostic (3.40e-2)" "unprognostic (4.09e-3)" "unprognostic (2.49e-1)" "unprognostic (1.16e-1)" "unprognostic (9.25e-2)" 1.2 1.0 3.4 1.1 3.6 5.3 0.7 5.7 4.9 1.6 2.9 0.7 0.8 1.4 1.1 1.1 1.4 1.2 0.8 3.2 2.8 2.3 0.7 2.0 1.3 2.3 2.9 2.1 0.7 1.6 1.3 1.8 3.1 1.1 0.8 4.2 0.4 0.8 0.2 1.1 0.5 0.6 2.0 1.6 2.7 23.8 2.6 2.4 1.0 0.3 1.4 1.9 0.6 4.2 21.2 4.5 3.0 2.9 2.3 7.0 2.5 7.5 9.2 10.6 6.2 1.5 8.3 2.8 16.5 1.5 3.1 2.2 5.9 25.2 11.7 1.2 2.9 3.2 2.3 4.2 2.7 0.7 2.8 1.7 7.2 11.7 26.9 5.9 10.7 3.4 2.6 3.9 9.3 4.2 7.5 1.8 0.8 1.6 18.2 2.9 4.8 1.6 16.8 1.1 2.4 2.3 2.5 0.4 0.9 1.8 2.4 1.2 20.0 3.3 22.5 7.4 1.7 2.6 1.6 2.0 5.6 3.3 2.5 1.3 4.1 0.7 0.9 1.6 2.0 1.5 0.9 1.5 1.7 1.8 1.7 1.7 21.5 1.4 5.0 0.7 5.2 1.3 3.4 3.6 5.7 4.9 3.2 2.8 2.3 2.9 3.1 2.0 2.6 4.2 3.0 3.2 6.4 2.3 10.3 0.5 13.9 7.6 6.8 6.6 2.1 3.3 1.8 4.3 3.2 5.5 6.2 2.6 10.1 1.4 1.9 4.0 76.9 21.8 7.1 4.2 0.0 0.8 3.6 20.5 7.9 5.0 16.8 20.5 9.5 1.1 1.4 0.0 1.4 6.7 7.3 1.9 2.0 2.2 2.3 57.6 2.1 3.6 1.8 1.0 2.0 3.6 1.0 1.5 1.6 48.6 0.1 1.5 4.5 2.9 0.3 3.0 4.9 8.4 0.0 4.5 3.3 54.8 3.3 2.5 0.9 8.1 9.1 1.5 1.3 4.5 LHFPL2 KIAA0206 ENSG00000145685 "LHFPL tetraspan subfamily member 2" Q6ZUX7 5 78485215-78770021 "Predicted membrane proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 121.9;Microglial cells: 209.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.9;plasmacytoid DC: 6.3" "Group enriched" "Detected in many" 9 "dendritic cells: 6.3;granulocytes: 7.9;monocytes: 3.9" "Cell line enhanced" "Detected in many" "GAMG: 116.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042402, HPA076743" Uncertain Approved "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane" "Nuclear bodies, Vesicles" "HPA042402: AB_10794276, HPA076743: " "unprognostic (2.19e-2)" "unprognostic (3.86e-2)" "unprognostic (2.00e-2)" "unprognostic (1.09e-1)" "unprognostic (2.40e-1)" "unprognostic (4.45e-2)" "prognostic unfavorable (2.73e-4)" "unprognostic (3.44e-3)" "unprognostic (2.32e-1)" "unprognostic (8.43e-2)" "unprognostic (3.62e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.45e-7)" "unprognostic (3.40e-2)" "unprognostic (3.88e-2)" "unprognostic (1.34e-2)" "unprognostic (7.85e-2)" 18.2 18.8 10.9 19.6 11.5 18.4 20.5 12.0 13.4 14.0 15.3 17.7 23.8 18.0 18.9 6.3 9.1 22.6 12.2 10.1 11.1 3.1 6.4 19.7 15.2 17.2 13.7 18.5 11.4 10.4 5.7 14.8 14.9 11.4 17.5 5.5 19.3 24.7 2.7 5.7 21.2 22.0 14.6 4.3 14.8 9.1 18.5 14.8 9.1 4.1 14.4 36.3 10.3 18.7 9.8 36.1 10.6 14.1 63.0 18.0 32.7 11.0 28.0 18.7 32.5 12.8 28.4 24.4 4.8 21.7 116.4 16.6 10.2 11.8 30.6 0.2 9.1 24.3 7.2 21.6 46.5 0.1 0.2 20.7 46.6 57.3 88.4 29.6 44.8 0.9 0.2 17.8 42.9 5.2 0.1 1.4 11.8 7.9 10.3 4.7 15.0 6.8 7.1 42.6 2.0 14.4 17.9 6.6 62.5 22.3 3.9 3.0 29.8 21.7 11.8 60.1 33.2 0.7 0.1 34.1 57.5 0.2 39.7 7.9 3.9 4.0 0.0 1.4 0.1 0.6 0.0 0.0 0.9 0.6 0.0 0.0 0.7 0.0 0.5 6.3 0.1 1.3 10.9 11.5 12.0 13.4 10.1 11.1 17.2 13.7 14.9 14.6 18.5 18.7 13.5 3.2 3.4 20.2 5.7 8.7 7.3 5.2 0.6 6.6 18.2 15.6 3.7 1.5 7.6 7.3 0.0 4.0 20.3 34.8 0.0 9.1 1.5 7.5 26.3 21.4 2.4 10.7 15.8 12.9 2.6 38.1 10.7 14.6 0.0 121.9 35.3 1.4 60.1 3.3 7.9 16.3 6.1 40.4 14.7 1.7 19.3 36.3 10.6 209.9 5.5 5.4 0.0 55.3 4.6 17.0 16.1 33.4 3.3 10.4 29.8 0.7 3.9 2.2 6.6 19.1 13.1 0.7 1.7 1.4 4.8 7.3 1.3 22.1 10.0 12.4 LHX5 ENSG00000089116 "LIM homeobox 5" Q9H2C1 12 113462033-113472280 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 5.0" "Cell type enhanced" "Detected in single" "Basal respiratory cells: 1.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA053908 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "Nucleoplasm, Nuclear bodies" "HPA053908: AB_2682304" "unprognostic (5.20e-2)" "unprognostic (4.04e-3)" "unprognostic (1.73e-1)" "unprognostic (1.21e-1)" "unprognostic (2.19e-2)" "unprognostic (1.06e-2)" "unprognostic (1.95e-1)" "unprognostic (4.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (5.10e-2)" "unprognostic (7.54e-3)" 0.0 0.0 0.4 0.0 0.3 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 5.0 1.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 1.7 0.1 0.0 1.9 5.0 1.5 1.7 1.1 2.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 LPAR4 "GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9" ENSG00000147145 "Lysophosphatidic acid receptor 4" Q99677 X 78747709-78757094 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;ovary: 3.6" "Cell type enhanced" "Detected in some" "Astrocytes: 10.1;Fibroblasts: 4.2;Leydig cells: 20.2;Oligodendrocyte precursor cells: 3.5;Skeletal myocytes: 3.6" "Cancer enhanced" "Detected in single" "glioma: 0.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "basophil: 6.3" "Lineage enriched" "Detected in single" 19 "granulocytes: 6.3" "Cell line enhanced" "Detected in some" "AF22: 9.3;NTERA-2: 15.2;RH-30: 6.4;U-937: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA046563, HPA054951, HPA055571" Uncertain Supported "Nuclear bodies,Vesicles,Plasma membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Nuclear bodies, Vesicles" "HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853" "unprognostic (1.62e-1)" "unprognostic (3.53e-1)" "unprognostic (1.58e-1)" "unprognostic (5.81e-4)" "unprognostic (3.12e-2)" "unprognostic (4.85e-3)" "unprognostic (2.81e-1)" "unprognostic (2.57e-1)" "unprognostic (6.75e-2)" "unprognostic (6.73e-2)" "unprognostic (8.91e-2)" "unprognostic (4.86e-4)" "unprognostic (2.99e-5)" "unprognostic (9.27e-3)" "unprognostic (1.00e-1)" "unprognostic (3.58e-2)" "unprognostic (6.03e-3)" 0.5 0.0 1.8 0.4 1.3 0.3 0.8 1.1 1.7 0.6 1.1 0.3 0.0 1.1 0.3 0.6 0.3 0.8 0.7 3.0 1.2 0.1 0.1 0.1 0.0 1.8 1.7 3.6 0.4 0.0 0.1 0.0 1.3 0.2 0.4 0.1 0.3 0.1 0.0 0.5 0.3 0.5 2.6 0.1 0.4 0.3 1.1 0.7 0.1 0.3 0.4 0.3 0.2 3.8 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.6 1.0 1.2 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.6 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.1 2.1 0.0 0.4 1.7 15.2 0.0 0.2 0.8 6.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.0 2.6 0.0 0.0 0.2 0.0 0.6 1.2 0.0 0.7 0.7 3.7 1.5 6.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.8 1.3 1.1 1.7 3.0 1.2 1.8 1.7 1.3 2.6 1.1 3.8 1.2 0.0 0.0 10.1 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.1 0.8 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.4 0.5 20.2 0.1 1.8 1.0 0.6 1.0 0.0 3.5 0.1 0.0 0.0 2.6 0.1 0.2 0.0 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.3 1.5 0.4 0.0 0.4 0.2 0.0 0.2 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515385-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 45.3;skeletal muscle: 165.0;tongue: 94.1" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 198.4" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 2.4 0.7 1.5 0.7 3.6 0.8 1.9 1.1 2.8 3.5 0.2 1.9 0.7 4.8 2.4 1.4 2.4 3.0 45.3 2.7 0.1 4.5 5.6 1.2 0.5 0.4 0.4 5.2 1.1 0.9 1.2 0.9 0.3 2.1 1.6 0.3 2.2 0.3 165.0 1.9 0.8 4.0 0.2 2.8 1.8 0.8 0.1 3.2 22.1 94.1 0.7 2.3 2.0 1.4 0.1 0.0 0.1 0.1 0.6 1.4 0.1 0.5 1.0 0.3 0.5 0.0 0.1 0.2 0.1 7.2 0.0 0.1 2.5 0.0 0.9 0.3 0.0 4.2 0.3 0.0 0.1 0.1 0.0 0.1 0.0 2.8 0.0 2.3 0.1 0.5 0.0 0.2 4.1 0.0 0.5 0.1 1.0 0.3 0.1 0.1 0.0 0.2 0.0 0.2 0.3 0.8 0.5 0.1 1.0 0.7 0.1 0.5 3.2 0.1 0.3 1.6 1.1 0.2 0.2 1.9 0.1 0.1 0.9 0.6 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.1 0.1 0.5 0.1 1.5 3.6 1.1 2.8 2.7 0.1 0.4 0.4 0.3 0.2 0.1 1.4 1.6 9.6 1.1 2.0 0.2 1.9 1.1 0.6 0.6 0.1 0.8 1.3 198.4 7.2 0.0 1.8 0.0 0.1 0.0 0.2 9.8 0.6 2.3 0.3 1.6 4.0 3.0 0.0 12.5 1.0 0.0 11.9 3.1 0.4 10.2 2.5 5.0 10.2 2.0 0.0 11.2 1.8 0.0 0.8 5.7 2.9 0.6 0.6 10.6 3.7 0.0 0.4 0.0 3.5 0.7 1.0 0.4 0.0 3.0 0.6 0.0 0.8 0.7 0.2 0.0 32.7 2.6 0.6 0.7 0.0 2.4 0.1 2.1 7.9 1.9 0.4 LRRC41 MUF1 ENSG00000132128 "Leucine rich repeat containing 41" Q15345 1 46261196-46303616 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 133.1;Syncytiotrophoblasts: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051941 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Nuclear bodies" Nucleoplasm "HPA051941: AB_2681669" "unprognostic (1.57e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.80e-3)" "unprognostic (2.23e-2)" "unprognostic (2.11e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.66e-9)" "unprognostic (6.09e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (5.34e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (8.11e-2)" "unprognostic (1.80e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-2)" 37.7 43.5 30.4 19.1 31.1 20.0 36.7 29.1 32.7 45.0 28.0 41.4 22.7 50.7 29.0 44.3 45.9 30.9 36.7 31.7 31.4 33.4 36.0 33.7 20.7 31.9 30.2 48.5 41.6 44.1 44.3 34.0 29.8 43.3 19.8 19.4 37.6 41.4 55.3 43.3 29.4 35.4 30.4 28.5 35.1 32.7 30.9 29.9 38.7 33.2 22.7 44.8 39.5 32.6 42.2 30.2 51.1 55.8 67.7 84.0 48.1 42.7 78.6 60.8 40.6 25.7 13.7 26.7 55.5 102.0 81.4 32.0 50.5 60.5 30.7 32.5 54.7 43.5 34.3 37.7 94.6 27.1 22.1 103.8 80.1 56.9 68.2 87.0 78.6 49.3 43.7 26.7 67.5 26.8 36.2 36.0 76.9 27.4 29.3 29.6 26.4 43.4 68.4 50.9 47.4 54.0 57.8 56.6 69.5 78.3 33.5 80.9 52.4 53.0 23.9 44.8 41.5 43.5 21.8 11.8 49.7 20.6 37.6 30.6 32.7 15.5 21.1 30.8 22.6 18.7 22.9 24.0 46.4 22.0 24.9 19.3 3.3 32.7 21.7 26.4 24.4 30.2 30.4 31.1 29.1 32.7 31.7 31.4 31.9 30.2 29.8 30.4 30.9 32.6 19.0 19.2 22.7 17.0 17.9 28.4 36.6 40.4 17.1 23.7 28.6 24.8 11.3 28.6 32.0 35.0 25.0 83.1 20.2 27.4 39.2 42.0 28.2 57.5 36.2 22.0 36.6 24.0 19.8 30.0 48.7 34.8 23.9 133.1 7.0 42.4 25.7 28.0 36.5 47.1 21.1 30.4 30.5 20.6 22.8 19.3 34.8 20.7 10.6 11.2 23.5 25.4 20.6 18.6 22.3 30.1 24.2 33.1 26.5 36.7 38.0 32.7 23.4 27.4 39.5 40.4 32.1 46.6 45.8 21.2 29.0 142.6 18.8 37.7 30.0 34.7 LRRC9 FLJ46156 ENSG00000131951 "Leucine rich repeat containing 9" Q6ZRR7 14 59919713-60063559 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.4;choroid plexus: 12.4;testis: 8.1" "Cell type enhanced" "Detected in some" "Early spermatids: 112.6;Excitatory neurons: 28.0;Inhibitory neurons: 18.0;Late spermatids: 75.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040965, HPA041381, HPA077675" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Cell Junctions" "Nucleoplasm, Nuclear bodies" "HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: " "unprognostic (1.01e-2)" "unprognostic (2.00e-1)" "unprognostic (4.45e-2)" "unprognostic (2.12e-3)" "unprognostic (2.80e-1)" "unprognostic (2.95e-3)" "unprognostic (1.93e-1)" "unprognostic (3.11e-2)" "unprognostic (1.91e-2)" "unprognostic (4.82e-2)" "unprognostic (3.45e-3)" "unprognostic (6.06e-2)" "unprognostic (2.62e-3)" "unprognostic (8.54e-3)" "unprognostic (8.30e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-2)" 0.3 0.1 0.9 0.0 1.6 0.1 0.0 1.0 0.6 0.0 12.4 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 5.2 5.4 0.0 0.0 0.7 0.5 0.0 3.7 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 4.3 0.0 0.0 8.1 1.9 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.6 1.0 0.6 1.0 1.7 5.2 5.4 3.7 4.3 1.9 5.0 0.0 0.0 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.6 1.5 0.1 0.1 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 18.0 0.0 0.0 0.0 0.0 75.8 0.9 0.1 0.0 1.9 0.0 0.8 0.0 5.5 2.0 0.0 0.0 0.7 0.0 0.7 0.4 0.0 2.9 0.2 0.0 0.0 0.0 10.3 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 LRRN4CL ENSG00000177363 "LRRN4 C-terminal like" Q8ND94 11 62686406-62689530 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 62.1;Leydig cells: 27.1;Melanocytes: 33.8;Peritubular cells: 17.3;Skeletal myocytes: 33.0" "Cancer enriched" "Detected in many" 5 "melanoma: 26.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.7;ASC TERT1: 25.3;HHSteC: 19.8;HSkMC: 10.6;LHCN-M2: 13.4" "Low region specificity" "Detected in many" HPA050317 Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear bodies" "HPA050317: AB_2681084" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (2.84e-1)" "unprognostic (9.95e-3)" "unprognostic (2.61e-2)" "unprognostic (4.03e-3)" "unprognostic (1.18e-1)" "unprognostic (1.41e-1)" "unprognostic (3.04e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-7)" "unprognostic (2.73e-2)" "unprognostic (6.12e-2)" "unprognostic (4.53e-3)" "unprognostic (1.86e-2)" 23.3 6.6 0.4 2.5 0.4 0.5 16.0 1.5 1.3 22.4 2.6 15.1 1.8 29.7 3.7 4.5 18.2 3.6 7.2 0.6 0.6 1.0 0.1 3.5 0.5 0.5 0.3 21.0 1.1 0.3 1.7 0.7 0.4 6.1 2.1 0.4 5.5 5.8 4.8 10.6 7.2 9.1 0.2 0.2 8.2 1.5 0.5 0.4 4.2 5.6 0.3 9.7 16.1 0.7 0.0 0.1 0.2 0.3 7.7 25.3 0.3 2.8 4.0 0.3 1.4 0.2 0.1 0.2 0.3 4.6 0.1 0.3 0.1 0.0 0.4 0.2 0.2 0.5 0.2 0.2 19.8 0.2 0.2 10.6 0.1 0.6 0.0 0.2 0.1 0.4 0.3 0.1 13.4 0.1 0.3 0.6 0.6 0.1 0.1 0.1 1.7 0.3 0.0 0.2 0.8 0.3 0.4 0.3 0.8 0.1 0.2 0.3 0.3 2.4 0.2 2.7 0.1 0.2 0.2 0.3 1.5 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.0 0.1 0.0 0.0 0.4 0.4 1.5 1.3 0.6 0.6 0.5 0.3 0.4 0.2 0.5 0.7 4.0 0.0 1.8 0.0 0.1 6.6 2.1 0.0 0.0 2.1 0.5 0.8 1.5 0.0 0.6 0.0 2.1 0.1 0.2 0.0 0.0 0.0 1.0 0.5 11.0 3.7 1.2 0.0 0.1 0.0 0.2 62.1 0.5 0.4 1.3 0.2 1.4 0.1 0.4 1.7 0.3 0.3 0.0 0.6 8.3 0.5 27.1 1.1 33.8 1.9 0.1 0.2 1.0 0.0 0.1 0.0 0.1 17.3 0.4 1.4 0.1 0.3 0.0 1.0 0.0 33.0 2.8 0.4 0.3 0.5 7.0 0.1 1.1 1.2 0.1 1.3 LRRTM3 ENSG00000198739 "Leucine rich repeat transmembrane neuronal 3" Q86VH5 10 66926036-67101551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;brain: 4.8;ovary: 2.7;pituitary gland: 3.4" "Group enriched" "Detected in some" 22 "Early spermatids: 164.0;Excitatory neurons: 485.6;Inhibitory neurons: 577.7;Late spermatids: 178.7;Oligodendrocyte precursor cells: 601.7;Oligodendrocytes: 253.5" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.4;HAP1: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA070444, HPA078598" Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies" "HPA070444: , HPA078598: " "unprognostic (1.21e-2)" "unprognostic (4.85e-2)" "unprognostic (1.12e-1)" "unprognostic (4.02e-2)" "unprognostic (1.15e-4)" "unprognostic (8.11e-2)" "unprognostic (4.77e-1)" 0.1 2.6 2.7 0.0 3.1 0.0 0.0 1.0 4.8 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.9 0.7 0.0 0.0 0.2 0.0 0.0 0.6 2.7 1.0 0.0 3.4 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.1 1.0 4.8 3.9 0.7 0.0 0.6 0.0 0.1 1.0 3.4 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.0 0.0 0.2 0.2 0.0 0.0 485.6 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 577.7 0.0 0.0 0.0 0.0 178.7 8.7 0.1 0.0 8.4 0.0 0.4 0.0 601.7 253.5 0.1 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.3 2.5 1.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640791-194672463 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 14.9 12.8 13.2 15.8 13.8 28.1 15.8 13.9 15.9 12.8 14.0 15.1 17.2 15.2 19.8 15.9 14.5 12.6 14.0 13.1 14.5 16.6 21.7 12.8 18.7 14.7 16.4 14.2 15.5 16.8 11.1 17.2 15.8 14.6 18.1 14.0 13.8 13.9 23.0 19.3 14.9 14.5 14.0 15.4 13.6 14.4 14.4 17.2 15.5 18.9 21.3 18.2 14.3 15.4 55.6 36.0 21.2 35.3 32.3 17.8 43.1 31.0 30.1 42.9 37.6 47.9 25.1 43.1 93.5 29.4 75.5 39.5 68.2 35.0 52.1 56.3 32.5 46.8 38.4 27.6 22.9 51.1 42.4 17.3 31.5 44.4 41.7 16.0 47.1 29.4 39.5 46.2 36.0 76.6 46.3 30.8 57.7 73.5 65.6 56.2 35.0 49.3 23.7 46.9 40.5 27.9 39.9 38.2 40.0 39.7 90.3 32.9 36.5 32.4 37.3 46.2 66.6 50.6 71.1 97.7 26.2 64.7 52.4 3.5 10.1 13.6 15.3 13.2 17.1 16.6 12.5 13.9 17.2 14.3 14.4 12.9 1.3 21.0 8.9 9.0 15.4 10.6 13.2 13.8 13.9 15.9 13.1 14.5 14.7 16.4 15.8 14.0 14.4 15.4 25.0 19.2 29.6 10.4 22.5 16.2 13.4 8.9 25.0 18.3 12.1 11.9 17.2 18.6 27.9 9.2 12.5 25.1 21.2 14.0 5.9 23.3 12.0 22.1 24.5 23.7 7.8 16.2 10.5 22.4 19.4 17.7 21.9 24.0 53.7 21.9 11.7 14.0 13.0 15.2 8.3 14.2 12.2 4.4 10.2 8.9 15.5 15.5 12.4 8.4 14.0 18.2 12.3 12.5 12.2 19.7 8.0 14.7 23.8 11.5 10.8 9.7 34.3 18.6 19.7 22.1 14.6 26.4 35.7 30.5 16.1 28.5 24.0 23.2 17.6 9.0 LSM10 MGC15749 ENSG00000181817 "LSM10, U7 small nuclear RNA associated" Q969L4 1 36391238-36397908 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048469 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" Nucleoplasm "Nuclear bodies" "HPA048469: AB_2756307" "unprognostic (2.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (6.21e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.84e-1)" "unprognostic (2.80e-1)" "unprognostic (3.59e-2)" "unprognostic (8.54e-2)" 39.2 32.7 53.1 32.0 54.2 23.9 32.8 54.5 67.5 31.9 55.0 62.3 20.1 36.3 30.4 26.8 31.6 22.7 72.9 53.4 58.7 42.3 51.7 30.6 52.3 54.4 55.2 31.7 30.5 36.9 41.8 18.0 55.3 40.8 17.7 9.7 29.1 30.5 165.0 30.1 36.7 27.9 55.2 55.3 38.7 28.9 57.8 27.2 31.0 110.3 47.6 42.8 28.2 54.3 54.6 81.2 29.9 80.7 68.9 67.2 31.0 47.9 69.4 75.1 57.1 36.4 50.6 127.4 64.5 65.0 55.6 29.3 51.2 62.1 49.5 87.1 61.2 64.1 47.1 87.1 83.8 49.0 90.3 56.8 54.4 67.6 47.6 40.7 77.8 71.7 60.2 60.5 53.4 96.3 54.8 55.5 77.5 67.0 83.3 40.9 28.8 86.3 73.6 32.6 38.1 28.7 38.7 49.4 120.6 47.9 25.5 41.3 52.2 34.0 47.3 90.0 76.0 79.5 115.7 102.4 68.4 73.9 78.7 240.2 264.1 340.1 125.3 266.4 139.0 386.4 125.1 132.0 189.4 388.0 112.1 120.7 346.4 111.6 256.4 243.9 172.3 301.8 53.1 54.2 54.5 67.5 53.4 58.7 54.4 55.2 55.3 55.2 57.8 54.3 27.8 12.8 14.4 3.9 82.2 32.2 37.2 53.3 13.1 17.4 40.9 44.4 55.9 21.5 30.4 46.0 6.2 56.1 58.5 23.4 140.8 40.7 9.7 18.6 32.7 31.7 28.2 40.2 8.6 47.1 58.8 36.8 19.4 23.3 41.2 25.7 32.2 66.8 105.7 18.5 9.1 23.4 63.1 77.0 89.3 32.9 38.8 67.6 51.6 7.5 72.0 41.0 66.9 3.5 6.7 47.4 35.3 47.0 67.0 40.3 47.7 106.4 12.4 14.3 13.1 28.4 38.8 7.8 23.4 27.7 40.1 40.0 51.0 43.3 28.5 27.3 LSM11 FLJ38273 ENSG00000155858 "LSM11, U7 small nuclear RNA associated" P83369 5 157743712-157760709 "Predicted intracellular proteins" "mRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039587 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nuclear bodies" "HPA039587: AB_10796330" "unprognostic (3.99e-2)" "unprognostic (2.05e-1)" "unprognostic (2.38e-2)" "unprognostic (6.90e-2)" "unprognostic (2.32e-2)" "unprognostic (1.90e-1)" "unprognostic (6.61e-3)" "unprognostic (9.68e-3)" "unprognostic (1.70e-1)" "unprognostic (2.89e-2)" "unprognostic (3.77e-2)" "unprognostic (3.57e-1)" "unprognostic (1.62e-3)" "unprognostic (1.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.11e-2)" "unprognostic (3.01e-2)" 2.0 2.1 3.6 1.9 3.8 1.7 2.2 3.8 4.8 4.3 0.2 6.4 2.3 5.3 1.5 2.2 3.1 2.3 1.2 4.0 2.3 1.3 1.3 1.8 2.1 2.7 3.0 3.4 1.9 1.8 2.2 2.1 3.0 4.3 2.6 7.1 1.8 4.7 1.4 2.2 2.3 3.3 3.0 1.6 2.3 4.1 2.7 1.8 1.2 1.4 2.1 9.8 3.5 3.0 3.2 2.3 6.2 6.6 2.7 3.5 5.4 4.3 1.9 3.6 4.7 6.9 3.1 7.0 4.9 2.5 2.5 3.7 8.1 4.7 3.9 5.0 7.6 2.9 8.6 4.4 1.0 8.7 3.5 1.6 3.1 4.3 4.4 4.0 5.9 5.7 5.5 3.7 3.9 3.0 4.9 5.1 1.8 2.6 6.9 7.7 7.7 2.9 1.8 2.9 3.6 5.7 2.8 3.8 3.8 4.5 3.2 5.3 4.2 6.9 2.7 4.1 6.9 3.0 2.0 6.9 2.8 8.9 3.1 0.4 0.1 0.0 0.2 0.1 0.3 0.1 0.3 0.2 0.1 0.1 0.2 0.2 0.1 0.4 0.0 0.0 0.2 0.1 3.6 3.8 3.8 4.8 4.0 2.3 2.7 3.0 3.0 3.0 2.7 3.0 3.6 6.4 4.1 2.3 2.7 3.6 3.5 1.3 2.2 26.1 3.3 2.5 2.2 1.5 3.1 3.7 6.2 2.1 4.7 3.1 0.0 1.7 10.6 0.8 3.7 3.2 3.0 1.3 11.7 0.9 4.8 3.6 2.0 1.6 1.3 5.5 3.9 2.2 2.2 8.4 11.8 2.0 0.0 4.2 5.7 15.7 1.5 2.6 0.0 1.0 3.5 2.2 4.1 1.5 2.4 1.8 6.2 4.1 2.4 3.7 2.1 1.5 1.9 7.8 0.0 4.3 9.1 10.5 10.9 1.9 4.3 1.2 2.8 2.1 5.5 4.0 LYRM4 "C6orf149, CGI-203, ISD11" ENSG00000214113 "LYR motif containing 4" Q9HD34 6 5103629-5260950 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA030362 Approved Supported "Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" "Nuclear bodies" "HPA030362: AB_10601546" "unprognostic (2.41e-2)" "unprognostic (3.72e-2)" "unprognostic (7.68e-2)" "unprognostic (8.58e-2)" "unprognostic (1.30e-1)" "unprognostic (8.73e-2)" "unprognostic (1.85e-3)" "unprognostic (4.58e-2)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.03e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-3)" "unprognostic (1.43e-1)" "unprognostic (2.76e-1)" "unprognostic (9.80e-2)" "unprognostic (5.23e-1)" 16.9 18.8 22.8 14.6 22.5 19.0 19.0 21.4 31.0 16.2 24.0 14.7 7.7 18.1 18.1 13.4 19.1 11.2 20.5 22.3 22.1 14.5 13.6 12.1 22.9 22.7 21.7 27.1 19.4 15.9 20.4 14.2 22.3 12.3 16.2 15.9 13.0 10.2 14.4 17.1 10.4 16.6 22.3 15.9 14.1 16.0 21.8 20.8 19.5 11.0 21.8 16.9 14.2 24.1 28.9 27.4 41.1 32.0 41.3 60.1 37.1 27.1 44.0 36.9 38.0 57.8 19.2 44.7 51.7 35.8 51.6 25.4 58.9 34.2 41.0 79.4 45.9 19.7 20.9 77.4 25.9 52.2 19.2 47.9 53.1 33.1 43.3 34.9 35.8 42.4 64.3 15.2 32.1 15.6 49.6 70.5 39.6 45.9 42.1 49.2 30.8 82.2 38.6 23.4 55.2 35.6 23.8 14.6 65.5 58.6 39.8 44.7 29.5 39.2 26.3 32.9 44.8 22.4 82.4 42.7 19.0 36.6 54.2 1.9 18.8 2.1 11.7 19.8 15.6 31.3 17.5 13.3 34.4 26.2 26.6 24.6 4.3 23.6 17.5 23.0 19.1 17.6 22.8 22.5 21.4 31.0 22.3 22.1 22.7 21.7 22.3 22.3 21.8 24.1 75.6 25.6 16.2 28.4 45.0 73.5 55.6 80.9 25.0 16.4 51.9 48.4 29.1 28.6 33.9 18.4 8.4 49.5 23.0 12.3 31.3 44.1 38.8 26.0 29.3 40.3 32.3 32.0 103.4 43.8 72.2 37.6 11.2 19.0 41.3 39.6 41.7 35.9 65.2 11.8 57.4 26.5 32.6 46.8 93.0 91.7 46.3 31.7 69.4 32.8 74.2 45.1 23.7 80.4 50.8 34.1 15.3 35.3 32.6 108.9 7.2 90.0 26.6 16.8 32.9 32.2 34.8 79.4 78.7 32.1 82.8 47.2 29.5 43.9 38.6 63.5 LYSMD2 MGC35274 ENSG00000140280 "LysM domain containing 2" Q8IV50 15 51723011-51751585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 164.4;monocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040460 Approved Approved "Nuclear bodies,Mitochondria" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" Mitochondria "Nuclear bodies" "HPA040460: AB_10794874" "unprognostic (7.71e-3)" "unprognostic (2.69e-1)" "unprognostic (3.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.11e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.60e-1)" "unprognostic (1.85e-1)" "unprognostic (3.98e-1)" "unprognostic (4.17e-3)" "unprognostic (6.86e-2)" "unprognostic (1.58e-2)" "unprognostic (5.03e-1)" "unprognostic (4.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" 11.6 19.7 33.0 22.2 34.0 15.1 8.7 30.9 42.0 10.4 22.3 12.7 15.8 10.7 11.1 8.7 10.9 11.4 7.1 33.8 39.6 11.5 21.1 14.4 29.0 34.1 33.2 8.5 12.9 10.7 22.8 9.5 39.3 9.4 9.7 7.6 7.3 13.8 18.3 5.6 13.6 11.7 32.4 21.3 12.0 11.0 35.0 17.9 8.1 13.1 25.7 12.8 8.8 29.4 14.6 10.6 1.7 13.2 4.4 8.4 0.1 16.8 9.2 20.0 25.8 1.3 13.0 56.9 2.4 9.0 23.1 21.0 11.0 11.1 14.0 55.1 5.4 15.9 8.9 0.2 9.3 38.2 6.9 8.4 22.0 8.2 8.6 9.0 12.1 20.5 0.7 0.0 6.5 21.0 14.8 47.6 4.6 0.6 14.5 23.1 0.2 20.6 19.9 11.5 45.3 11.5 16.2 0.4 29.8 2.5 11.7 28.5 7.8 19.8 11.1 20.9 23.7 0.0 0.0 0.2 10.1 77.4 15.1 0.3 39.5 76.6 29.8 48.8 42.3 47.0 29.1 36.3 33.4 49.7 35.6 29.4 112.5 34.9 62.0 54.4 19.4 40.4 33.0 34.0 30.9 42.0 33.8 39.6 34.1 33.2 39.3 32.4 35.0 29.4 45.7 3.2 4.8 18.3 70.8 19.4 31.2 8.0 20.5 16.7 17.5 23.4 3.3 22.8 6.4 14.7 0.0 1.2 89.1 4.1 25.4 16.7 164.4 2.6 2.8 32.3 79.8 17.2 25.4 18.3 0.8 15.6 15.3 0.9 12.7 4.3 27.8 14.6 38.0 32.0 28.7 16.2 8.2 46.4 24.7 71.2 16.1 49.0 7.2 23.4 97.4 7.0 45.3 15.1 7.3 10.8 17.1 15.8 5.1 38.5 32.6 29.0 9.9 4.1 26.3 14.1 24.0 5.0 8.3 31.7 16.2 0.8 51.3 12.4 21.2 24.6 MAGEA11 "CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511" ENSG00000185247 "MAGE family member A11" P43364 X 149688228-149717268 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 21.0" "Group enriched" "Detected in some" 5 "Spermatocytes: 29.4;Spermatogonia: 30.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 23.8" HPA052687 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 9: U-2 OS - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA052687: AB_2681915" "unprognostic (4.06e-3)" "unprognostic (2.05e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-2)" "unprognostic (9.64e-2)" "unprognostic (1.32e-1)" "unprognostic (6.13e-2)" "unprognostic (1.16e-1)" "unprognostic (6.67e-4)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 23.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.4 30.9 0.0 0.0 5.9 0.0 0.0 0.0 0.0 MAML2 "KIAA1819, MAM3" ENSG00000184384 "Mastermind like transcriptional coactivator 2" Q8IZL2 11 95976598-96343195 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Notch signaling pathway, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 690.5;Microglial cells: 579.9;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 311.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035223 Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 40: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA035223: AB_10671101" "unprognostic (8.11e-2)" "unprognostic (2.51e-1)" "unprognostic (7.08e-2)" "unprognostic (9.07e-2)" "unprognostic (3.57e-3)" "unprognostic (3.32e-2)" "unprognostic (3.66e-2)" "unprognostic (2.33e-1)" "unprognostic (3.99e-2)" "unprognostic (8.05e-2)" "prognostic unfavorable (3.89e-4)" "unprognostic (9.11e-2)" "prognostic favorable (1.90e-4)" "unprognostic (9.76e-2)" "unprognostic (1.73e-2)" "unprognostic (1.99e-1)" "unprognostic (7.19e-2)" 10.9 2.7 5.8 6.3 5.5 3.1 14.2 17.2 3.9 10.6 6.9 6.1 3.0 5.4 1.8 5.5 8.0 7.7 4.4 7.1 10.6 9.9 2.4 9.8 8.7 9.0 9.0 7.9 5.9 5.9 4.0 12.2 7.4 7.4 6.2 6.8 11.0 5.7 2.0 7.9 4.8 6.5 7.0 10.3 4.8 2.3 7.5 13.7 6.5 4.8 7.0 8.8 6.5 6.6 10.7 2.0 17.8 4.7 18.1 20.7 3.8 12.1 17.9 7.8 8.1 1.3 22.1 2.3 27.7 28.1 4.1 9.6 3.6 11.7 10.7 52.8 1.3 1.4 3.7 4.1 10.5 0.1 0.0 30.4 1.1 13.9 8.2 14.3 4.5 0.3 6.1 3.2 14.0 0.9 0.2 2.9 1.9 5.5 3.3 3.7 3.4 12.3 11.6 14.8 0.1 1.6 4.5 1.9 5.0 5.7 1.7 0.5 19.7 13.6 3.2 4.7 7.7 2.2 0.4 3.3 6.5 2.0 25.6 0.1 0.6 0.0 0.8 0.3 1.3 0.9 1.6 2.1 0.6 1.2 3.2 2.2 2.6 2.4 0.4 0.5 0.6 1.2 5.8 5.5 17.2 3.9 7.1 10.6 9.0 9.0 7.4 7.0 7.5 6.6 43.5 16.0 8.6 690.5 35.4 19.5 21.5 12.6 19.9 44.1 28.6 43.1 5.3 18.6 16.6 12.9 91.8 15.4 21.8 31.0 11.7 19.3 1.4 61.6 49.4 24.0 6.7 2.7 81.6 0.4 26.0 41.6 20.9 52.3 1.3 44.0 9.3 0.4 18.6 0.0 36.8 7.6 4.1 19.2 21.2 3.0 8.7 29.3 12.4 579.9 26.0 21.9 16.5 1300.8 311.4 15.0 16.8 8.6 18.1 19.1 9.4 17.1 24.2 25.9 32.9 3.6 51.5 0.6 0.8 19.4 13.5 13.0 38.1 9.0 14.3 19.2 MAU2 "KIAA0892, mau-2, MAU2L, MGC75361, SCC4" ENSG00000129933 "MAU2 sister chromatid cohesion factor" Q9Y6X3 19 19320829-19358754 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059897 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA059897: AB_2684154" "unprognostic (3.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.18e-1)" "unprognostic (9.57e-3)" "unprognostic (1.87e-1)" "prognostic favorable (3.90e-5)" "unprognostic (1.68e-2)" "unprognostic (3.49e-3)" "unprognostic (5.56e-3)" "unprognostic (3.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.28e-1)" "unprognostic (4.27e-3)" "unprognostic (2.42e-2)" "unprognostic (1.10e-1)" "unprognostic (6.67e-3)" "unprognostic (2.96e-2)" 16.2 15.9 15.9 12.6 19.1 21.2 15.8 16.4 19.4 18.8 15.1 17.9 13.1 18.4 11.8 20.2 18.4 10.6 19.6 15.1 15.2 15.1 14.3 14.2 14.6 20.1 17.4 23.4 16.5 13.4 21.1 12.2 18.7 17.6 7.6 10.9 15.5 12.1 36.0 21.7 16.5 11.2 15.7 22.2 15.0 19.7 17.6 17.4 17.0 17.6 12.0 16.5 17.2 26.1 13.6 10.4 18.0 16.1 14.5 15.1 24.9 12.7 12.9 16.8 15.1 14.8 18.9 16.9 26.7 13.7 8.5 15.9 15.5 12.8 7.8 9.0 39.3 13.0 16.5 13.2 16.8 23.7 19.5 16.7 14.4 12.1 13.8 17.4 16.3 15.0 18.0 20.3 11.3 15.5 24.3 32.5 15.8 18.7 29.1 27.1 11.6 18.2 11.8 17.6 26.0 23.8 15.7 16.2 16.1 9.1 14.0 32.9 14.8 25.9 6.0 25.7 19.3 26.1 23.5 16.9 12.8 24.8 19.9 3.1 5.8 4.3 6.0 5.0 6.8 4.6 5.3 5.7 5.1 4.5 5.6 5.4 10.4 6.5 11.1 4.9 5.4 6.1 15.9 19.1 16.4 19.4 15.1 15.2 20.1 17.4 18.7 15.7 17.6 26.1 16.4 19.2 18.3 33.6 17.3 6.2 5.5 8.5 18.8 30.4 13.1 15.2 19.1 11.5 10.5 11.0 54.2 10.4 16.4 15.8 3.9 8.2 9.7 16.5 17.0 13.4 14.4 17.4 26.1 9.4 7.1 13.0 15.8 14.5 10.1 26.0 14.6 8.6 8.8 50.5 31.8 11.9 4.1 13.8 6.4 12.3 15.2 13.9 10.6 14.0 15.4 12.0 20.6 26.7 55.3 11.8 10.7 13.9 12.8 10.5 13.7 6.2 21.0 29.3 6.6 17.2 14.8 31.9 12.6 11.8 9.7 15.2 13.6 21.1 13.1 8.6 MCIDAS "IDAS, MCI, MCIN" ENSG00000234602 "Multiciliate differentiation and DNA synthesis associated cell cycle protein" D6RGH6 5 55219564-55227315 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation, Transcription, Transcription regulation" Activator "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "parathyroid gland: 2.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Collecting duct cells: 1.8;Endometrial ciliated cells: 1.2;Respiratory ciliated cells: 3.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 4.9;HeLa: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049981, HPA058073" Uncertain Supported "Nuclear bodies" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear bodies" "HPA049981: , HPA058073: AB_2683596" "unprognostic (3.11e-2)" "unprognostic (7.50e-4)" "unprognostic (2.48e-1)" "unprognostic (2.89e-2)" "unprognostic (1.76e-1)" "unprognostic (3.57e-2)" "unprognostic (2.41e-3)" "unprognostic (1.50e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (3.17e-2)" "unprognostic (4.67e-1)" "unprognostic (2.90e-3)" "unprognostic (4.17e-2)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "unprognostic (2.70e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 2.9 0.4 0.0 0.6 0.0 0.0 4.9 0.0 0.0 0.4 0.7 4.0 4.4 0.0 0.4 0.0 1.2 0.7 2.9 0.2 0.0 0.2 4.0 0.0 6.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 1.9 1.4 0.0 0.0 1.6 0.0 0.1 0.2 0.7 2.2 0.8 1.5 0.0 1.7 2.6 1.3 0.0 2.1 0.5 2.2 0.0 4.0 0.4 0.0 0.0 3.4 0.2 0.1 3.3 4.2 0.0 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.7 0.0 0.9 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 MCPH1 "BRIT1, FLJ12847" ENSG00000147316 "Microcephalin 1" Q8NEM0 8 6406596-6648508 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 107.5;Inhibitory neurons: 94.3;Oligodendrocyte precursor cells: 78.4;Oligodendrocytes: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008238, HPA012064, CAB012177" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nuclear bodies" "CAB012177: AB_303207, HPA008238: AB_1853655, HPA012064: " "unprognostic (1.00e-1)" "unprognostic (2.17e-2)" "prognostic favorable (8.52e-4)" "unprognostic (6.45e-2)" "unprognostic (1.16e-2)" "unprognostic (1.19e-2)" "unprognostic (1.14e-2)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" "unprognostic (4.79e-2)" "unprognostic (5.55e-3)" "unprognostic (4.24e-2)" "unprognostic (2.48e-1)" "unprognostic (4.79e-2)" "unprognostic (2.94e-1)" 5.7 3.7 1.9 2.9 2.1 12.3 5.7 2.9 2.4 5.7 2.2 5.0 2.4 5.7 2.5 4.7 5.2 2.5 4.3 1.9 1.9 4.3 3.8 4.4 4.7 1.9 1.9 5.4 5.1 3.3 3.8 4.0 1.9 4.6 2.8 3.3 5.9 2.7 9.8 5.2 4.6 3.4 1.7 4.7 4.7 6.1 2.1 5.5 4.6 3.9 4.2 5.4 5.1 2.7 4.5 3.9 7.0 4.9 3.4 6.1 5.9 6.7 5.8 8.3 6.2 5.0 3.3 8.7 1.8 5.5 7.6 5.1 8.9 6.3 9.8 3.6 4.9 11.1 3.9 6.7 5.6 5.6 8.4 5.8 6.4 5.7 8.1 5.8 6.2 9.2 13.7 8.5 6.4 2.9 15.1 6.1 12.0 8.2 3.9 8.9 6.6 5.3 4.8 8.2 4.8 6.4 4.9 5.2 7.4 7.7 4.5 7.8 5.2 6.4 3.5 2.1 6.4 3.9 5.7 12.7 5.9 6.4 9.0 1.6 2.1 8.7 3.1 2.5 4.1 4.0 2.7 3.7 2.1 4.4 3.4 3.7 0.3 4.3 3.2 2.8 3.0 2.1 1.9 2.1 2.9 2.4 1.9 1.9 1.9 1.9 1.9 1.7 2.1 2.7 21.3 3.2 16.1 50.6 28.3 4.6 14.5 7.1 10.8 13.4 9.7 9.0 13.7 10.0 17.7 14.7 16.7 10.9 28.2 4.6 3.9 10.9 46.6 20.0 21.2 15.6 0.0 17.9 107.5 10.5 10.6 14.2 14.8 25.9 19.7 15.5 11.4 6.9 7.0 30.3 94.3 6.1 2.0 12.2 2.7 30.6 12.2 12.1 0.0 69.3 14.2 13.1 19.6 78.4 79.5 10.4 7.8 13.2 27.0 9.7 6.3 8.7 25.6 10.6 6.6 20.2 13.8 29.5 12.6 10.9 6.0 12.3 23.5 12.8 7.2 10.1 MDC1 "Em:AB023051.5, KIAA0170, NFBD1" ENSG00000137337 "Mediator of DNA damage checkpoint 1" Q14676 6 30699807-30717447 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Spermatocytes: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 3.2" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006915 Enhanced Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites" No No "Cluster 48: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "Focal adhesion sites" "HPA006915: AB_1853669" "unprognostic (8.52e-2)" "unprognostic (4.32e-1)" "unprognostic (4.11e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-2)" "unprognostic (9.44e-2)" "unprognostic (2.74e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.99e-1)" "unprognostic (4.39e-3)" "unprognostic (3.23e-1)" 11.3 7.0 2.7 8.6 3.2 13.0 10.9 4.1 5.2 12.4 3.3 11.0 4.9 13.7 8.5 6.2 12.3 4.6 9.5 2.4 4.1 8.2 9.7 9.5 10.2 4.5 3.3 16.8 10.8 8.6 12.8 7.4 3.5 10.1 6.9 14.1 9.1 8.2 11.0 9.4 10.9 8.9 2.0 11.3 8.4 28.2 3.4 14.5 16.4 5.8 11.3 10.7 9.3 3.6 36.7 11.1 47.4 34.8 6.3 10.0 23.0 14.8 10.0 25.2 21.3 22.7 8.5 37.7 17.5 17.0 23.5 20.2 63.0 28.6 34.9 29.9 65.6 43.4 28.7 12.5 4.1 27.1 16.9 7.9 9.2 48.6 27.3 9.0 11.5 25.7 61.0 36.7 19.1 14.7 14.6 20.0 20.6 8.4 7.8 33.2 24.7 37.4 11.0 10.7 39.9 23.2 11.5 26.2 13.5 29.1 21.8 16.8 13.8 24.8 26.4 19.2 26.3 19.3 21.6 34.5 7.8 63.9 34.3 0.1 0.1 0.1 0.6 0.1 0.3 0.4 0.4 0.5 0.1 0.7 0.5 0.5 0.0 3.2 0.1 0.7 0.0 0.3 2.7 3.2 4.1 5.2 2.4 4.1 4.5 3.3 3.5 2.0 3.4 3.6 9.7 16.0 13.0 10.1 13.4 4.5 5.5 5.6 15.9 11.5 6.8 8.6 7.6 7.2 5.7 5.5 8.4 7.9 11.0 2.5 3.9 5.3 4.7 8.0 8.7 9.7 6.7 14.5 8.3 6.2 11.4 11.2 4.1 13.7 17.1 12.8 6.1 12.0 6.7 5.0 8.1 3.3 12.2 6.0 5.7 3.9 7.8 7.3 1.8 11.2 5.9 10.6 14.4 12.5 9.9 5.2 1.1 6.0 16.9 2.9 1.2 3.0 8.0 17.1 13.1 16.2 8.3 74.5 18.0 8.7 3.7 1.9 12.1 7.7 6.0 1.9 MEAF6 "C1orf149, CENP-28, Eaf6, FLJ11730, NY-SAR-91" ENSG00000163875 "MYST/Esa1 associated factor 6" Q9HAF1 1 37489993-37514766 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029599 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 35: Glandular cells - Unknown function" "Nuclear bodies" Nucleoplasm "HPA029599: AB_10599996" "unprognostic (4.95e-2)" "unprognostic (5.06e-2)" "unprognostic (1.16e-1)" "unprognostic (7.41e-3)" "unprognostic (4.36e-2)" "unprognostic (3.16e-2)" "unprognostic (9.75e-3)" "unprognostic (2.87e-3)" "unprognostic (4.91e-2)" "unprognostic (2.68e-3)" "unprognostic (3.57e-2)" "unprognostic (4.77e-2)" "unprognostic (1.32e-2)" "unprognostic (2.57e-1)" "unprognostic (3.93e-2)" "unprognostic (5.12e-3)" "unprognostic (2.19e-1)" 37.9 31.4 28.8 18.7 30.5 28.4 39.0 23.9 38.5 42.3 23.5 45.2 19.7 36.7 32.0 37.3 35.6 26.9 25.8 30.5 38.4 32.9 29.5 32.9 29.0 25.9 29.6 41.7 38.9 52.4 67.6 20.9 29.8 66.5 20.3 18.8 43.1 45.1 43.3 46.5 31.8 26.4 23.8 26.7 35.5 38.8 34.2 50.5 31.0 25.1 28.0 41.6 38.7 28.1 56.3 11.2 36.0 37.5 42.3 57.9 32.8 49.0 51.8 57.4 47.4 24.0 48.2 45.9 52.4 41.8 39.0 30.4 47.6 43.0 44.5 75.8 55.6 67.4 17.6 44.5 46.1 59.4 46.2 37.6 72.0 53.7 78.5 31.2 49.5 58.7 89.1 36.4 46.2 23.4 61.9 39.5 69.7 36.4 49.3 60.4 53.4 65.0 42.7 26.6 68.2 38.9 61.8 35.2 73.3 23.0 41.1 41.3 39.4 47.3 36.1 58.5 39.4 58.1 88.0 83.7 43.4 77.8 33.4 108.4 71.1 123.0 97.7 61.3 100.3 102.2 87.6 95.8 73.4 101.8 86.0 79.7 33.3 80.3 70.3 62.3 109.9 114.4 28.8 30.5 23.9 38.5 30.5 38.4 25.9 29.6 29.8 23.8 34.2 28.1 71.4 64.1 47.2 30.0 102.9 211.8 179.3 158.5 84.2 44.0 115.7 81.8 28.1 107.2 98.1 108.5 22.9 88.6 94.0 23.0 223.0 96.0 47.0 127.2 53.3 59.4 70.2 83.5 34.1 63.0 58.3 74.2 47.9 89.7 54.3 67.5 75.3 59.9 88.9 20.2 28.9 60.3 146.5 66.3 125.5 103.2 75.8 61.5 131.6 9.4 81.4 71.2 115.4 28.6 36.9 64.2 35.8 81.6 59.4 251.4 52.8 184.2 174.7 42.5 46.0 52.4 79.2 143.7 197.5 91.8 246.6 53.8 111.6 56.5 52.3 120.4 MED11 "HSPC296, MGC88387" ENSG00000161920 "Mediator complex subunit 11" Q9P086 17 4731428-4733608 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056669 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nuclear bodies" "HPA056669: AB_2683204" "unprognostic (4.01e-2)" "unprognostic (2.34e-2)" "unprognostic (7.91e-2)" "prognostic favorable (1.86e-5)" "unprognostic (8.24e-2)" "unprognostic (5.47e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.82e-2)" "unprognostic (3.86e-2)" "unprognostic (2.10e-3)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (4.84e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" 20.5 41.3 28.6 22.5 32.0 11.2 20.3 32.3 33.8 21.1 28.2 25.4 27.2 18.9 25.3 29.2 24.4 19.0 29.5 28.2 30.5 32.7 38.6 22.9 28.5 31.9 31.2 16.8 29.0 35.6 19.1 16.4 31.6 23.3 23.4 17.2 26.6 19.5 39.0 27.2 26.5 16.9 30.4 34.5 30.6 16.2 31.3 25.3 22.4 32.9 26.5 22.3 21.3 35.3 26.2 73.5 26.9 27.8 28.6 34.6 20.7 18.4 30.8 26.4 33.0 25.6 19.7 35.7 18.9 22.3 17.2 38.8 27.1 51.9 20.5 42.5 63.1 17.8 42.6 40.6 17.7 12.9 20.7 30.1 35.6 28.3 17.3 28.2 30.3 36.4 18.1 26.5 23.4 37.6 24.8 16.8 16.0 39.3 23.6 24.5 19.7 23.3 54.3 27.5 10.9 18.1 23.7 31.5 18.5 22.0 28.4 15.1 18.1 14.1 14.1 27.4 29.3 12.5 11.8 14.2 24.4 22.0 18.8 49.1 31.0 79.3 41.6 45.6 45.4 62.8 40.8 41.8 31.0 61.9 48.3 53.1 136.3 40.9 68.0 49.8 33.7 38.5 28.6 32.0 32.3 33.8 28.2 30.5 31.9 31.2 31.6 30.4 31.3 35.3 12.5 6.4 23.5 7.8 31.5 12.2 28.8 42.6 19.4 22.1 20.0 17.8 15.1 32.9 32.3 14.7 10.4 45.4 34.3 32.8 64.6 37.0 1.2 35.1 24.8 15.8 10.8 13.5 5.5 35.3 34.2 17.3 28.5 25.0 29.1 9.3 22.5 29.4 33.8 30.3 7.2 30.9 48.8 31.5 21.1 3.8 17.4 25.5 10.6 5.6 44.6 20.9 50.4 5.0 14.6 22.4 51.1 13.9 18.8 22.9 66.4 99.5 36.9 26.6 19.7 16.5 18.2 56.6 49.9 31.3 18.8 25.0 27.3 33.8 29.7 28.6 MED19 LCMR1 ENSG00000156603 "Mediator complex subunit 19" A0JLT2 11 57703714-57712323 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039912, HPA040860" Uncertain Enhanced "Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" "HPA039912: AB_10795262, HPA040860: AB_10794153" "unprognostic (2.61e-1)" "unprognostic (1.62e-1)" "unprognostic (5.01e-2)" "unprognostic (2.23e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.40e-1)" "unprognostic (4.87e-3)" "prognostic favorable (1.76e-6)" "unprognostic (3.08e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-2)" "unprognostic (6.71e-2)" "unprognostic (6.97e-2)" "unprognostic (4.91e-2)" "unprognostic (1.38e-2)" 11.3 18.1 22.7 6.2 23.7 6.8 11.6 20.7 41.5 11.0 21.0 10.0 9.6 11.6 13.4 15.5 9.2 6.1 11.3 23.4 22.6 14.7 13.2 8.9 7.5 21.4 22.9 9.6 11.6 9.8 16.0 10.2 22.2 12.5 7.8 12.0 12.1 8.9 10.6 15.5 9.7 8.1 22.2 10.8 11.1 22.8 26.0 8.2 13.6 9.2 9.4 10.1 11.9 23.7 30.3 19.1 22.7 21.0 23.6 21.4 27.0 25.4 19.7 23.9 24.0 13.6 23.0 16.6 38.5 24.4 21.0 22.6 17.1 16.1 21.0 21.8 18.6 14.3 11.3 12.7 35.5 15.7 16.4 17.5 28.9 23.8 46.6 16.7 31.1 13.3 15.9 16.1 29.1 14.5 22.3 29.2 19.8 21.4 37.7 21.1 32.2 20.2 15.9 12.6 17.6 24.7 20.5 20.7 47.2 19.1 43.8 16.0 25.7 20.7 24.8 49.2 22.6 19.9 20.5 15.7 28.3 11.5 22.1 27.9 25.8 31.3 29.2 37.2 31.6 45.0 32.8 31.4 25.6 39.4 34.0 32.0 16.4 24.6 39.2 36.9 33.9 26.0 22.7 23.7 20.7 41.5 23.4 22.6 21.4 22.9 22.2 22.2 26.0 23.7 40.7 9.6 27.1 4.6 32.5 87.6 60.9 72.0 62.0 38.6 37.4 39.8 14.7 30.0 40.2 51.5 35.5 58.2 32.2 36.2 39.2 44.1 12.2 33.3 37.8 39.3 23.3 21.4 9.2 45.4 48.6 38.1 20.9 34.0 22.2 39.2 36.0 26.3 29.3 37.0 8.3 38.3 54.9 17.6 31.4 15.4 28.3 18.6 37.4 2.8 26.3 37.4 24.7 5.5 7.2 40.6 33.2 29.7 22.9 53.6 32.9 47.2 42.1 59.7 19.7 31.3 50.5 111.7 97.9 42.7 82.3 73.1 35.8 37.5 31.8 52.8 MED7 "CRSP33, CRSP9" ENSG00000155868 "Mediator complex subunit 7" O43513 5 157137424-157159019 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 314.5;Late spermatids: 289.0;Spermatocytes: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067181 Supported "Nuclear bodies" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 6: T47d - Mammary gland" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" "HPA067181: AB_2685798" "unprognostic (1.63e-1)" "unprognostic (1.29e-1)" "unprognostic (7.81e-3)" "unprognostic (8.12e-2)" "unprognostic (1.45e-3)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.37e-5)" "unprognostic (7.32e-2)" "unprognostic (1.11e-1)" "unprognostic (5.01e-2)" "unprognostic (2.46e-2)" "unprognostic (2.12e-1)" "prognostic favorable (8.69e-5)" "unprognostic (9.68e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (2.39e-3)" 10.1 11.4 7.9 9.2 8.3 10.5 12.6 9.9 11.1 8.4 10.3 10.5 6.3 9.2 13.5 8.5 7.9 7.6 10.2 8.3 8.4 15.5 10.1 8.0 12.9 8.7 8.2 10.8 6.9 10.9 8.0 8.2 8.5 10.3 11.0 12.0 7.6 7.1 14.3 6.0 8.8 9.0 7.6 12.3 10.0 26.5 8.4 9.7 11.8 10.9 11.6 9.3 6.4 9.0 13.2 15.3 20.6 14.5 17.2 12.2 15.3 20.5 11.8 15.2 19.2 20.7 24.8 23.4 17.8 15.4 29.1 16.3 11.5 23.0 22.2 10.1 11.1 8.7 15.3 11.1 15.4 12.6 11.9 14.5 16.5 13.5 14.8 13.3 19.5 15.2 8.1 17.4 24.5 12.9 12.5 11.0 6.1 18.3 18.9 11.2 17.9 12.9 32.6 18.2 15.9 11.9 13.8 14.1 19.7 16.1 36.0 12.8 14.7 22.3 18.3 11.6 18.6 16.7 19.4 11.3 14.0 17.7 18.1 40.9 22.3 30.8 19.3 24.6 23.0 35.4 23.2 24.4 16.1 34.5 34.4 24.8 19.3 26.1 35.7 15.0 28.3 22.2 7.9 8.3 9.9 11.1 8.3 8.4 8.7 8.2 8.5 7.6 8.4 9.0 12.3 9.6 10.1 6.2 17.1 7.1 14.8 52.4 7.4 22.7 9.6 11.3 20.8 10.0 26.6 23.9 22.9 38.0 10.7 15.3 52.8 28.0 314.5 10.7 12.9 12.3 11.4 17.7 9.1 18.7 22.9 14.4 13.3 9.4 20.3 15.7 16.4 9.4 22.8 18.5 9.5 12.0 32.6 19.9 12.0 289.0 18.6 13.8 3.6 5.6 20.4 22.0 35.0 4.5 10.7 18.9 14.1 16.6 11.8 11.3 16.1 40.2 21.7 14.3 6.6 10.5 18.1 112.9 43.0 7.5 6.0 30.5 16.1 22.4 11.5 14.2 MESD "BOCA, KIAA0081, MESDC2" ENSG00000117899 "Mesoderm development LRP chaperone" Q14696 15 80946289-80989828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" Chaperone "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039414, HPA041721" Approved Supported "Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 1600000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "Nuclear bodies, Cytosol" "HPA039414: AB_10674981, HPA041721: AB_2756310" "unprognostic (9.21e-2)" "unprognostic (4.50e-2)" "unprognostic (8.02e-2)" "prognostic favorable (2.31e-4)" "unprognostic (4.93e-3)" "unprognostic (2.32e-3)" "unprognostic (3.47e-2)" "unprognostic (3.09e-3)" "unprognostic (4.04e-1)" "prognostic favorable (1.12e-4)" "unprognostic (7.93e-2)" "unprognostic (3.05e-2)" "unprognostic (3.42e-2)" "unprognostic (1.68e-1)" "unprognostic (4.32e-2)" "unprognostic (3.83e-1)" "unprognostic (1.88e-1)" 14.4 17.4 11.9 13.7 13.6 5.4 13.9 13.7 13.0 17.8 14.6 14.6 12.8 11.3 42.7 14.6 12.4 11.5 12.8 11.7 14.2 14.4 20.6 14.1 14.0 13.4 13.1 17.4 19.2 14.0 17.8 26.9 13.8 18.2 14.5 10.4 18.4 14.3 7.7 10.9 12.7 11.1 13.4 13.8 15.3 9.8 13.8 14.2 33.7 10.6 13.2 15.4 14.4 15.0 26.8 40.2 34.6 22.3 57.1 32.4 54.0 40.0 47.4 42.7 51.6 36.0 72.9 22.4 45.4 32.3 45.1 43.8 54.1 41.1 40.3 50.2 35.5 28.3 33.0 61.9 43.7 33.8 30.0 33.9 46.6 36.1 42.4 35.7 41.1 27.0 34.7 55.5 36.7 34.0 20.9 28.3 41.9 39.3 16.4 31.7 21.3 59.7 35.6 36.3 29.9 17.6 43.9 29.3 70.0 62.4 34.0 26.8 32.4 40.9 39.1 22.1 52.2 35.0 48.0 30.2 38.5 59.7 43.8 39.4 26.1 19.1 35.6 24.9 41.8 34.5 37.2 35.4 27.2 35.4 34.6 34.7 8.1 44.8 22.5 45.2 42.5 31.1 11.9 13.6 13.7 13.0 11.7 14.2 13.4 13.1 13.8 13.4 13.8 15.0 59.7 80.1 59.6 0.0 20.6 0.0 0.0 0.0 0.0 0.0 51.0 44.2 0.0 0.0 27.9 58.8 0.0 341.4 41.6 0.0 13.7 100.9 0.0 41.4 79.4 36.9 0.0 0.0 0.0 111.9 279.3 48.4 0.0 69.8 36.6 56.4 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 86.3 0.0 0.0 0.0 0.0 82.5 0.0 0.0 18.8 0.0 0.0 48.8 43.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 436.0 25.8 63.6 0.0 0.0 MKNK2 "GPRK7, MNK2" ENSG00000099875 "MAPK interacting serine/threonine kinase 2" Q9HBH9 19 2037465-2051244 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 475.7;tongue: 551.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 367.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021875, CAB037253, HPA070499" Supported Supported "Nuclear bodies" No No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" "CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: AB_2732157" "unprognostic (8.76e-2)" "unprognostic (1.71e-1)" "unprognostic (1.64e-1)" "prognostic favorable (4.86e-5)" "unprognostic (3.08e-1)" "unprognostic (1.59e-2)" "unprognostic (6.42e-3)" "unprognostic (1.35e-1)" "unprognostic (4.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.08e-1)" "unprognostic (6.56e-2)" "unprognostic (4.07e-2)" "prognostic favorable (4.01e-4)" "unprognostic (1.63e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-1)" 87.2 50.2 70.5 51.3 78.0 133.6 39.5 109.2 131.2 41.9 80.6 55.2 47.4 24.7 47.8 114.5 38.1 26.7 54.8 67.2 65.4 27.6 71.2 51.8 66.8 80.3 70.7 34.5 191.9 34.5 39.6 35.3 74.6 38.6 30.0 35.7 133.8 39.7 475.7 63.8 57.3 21.8 68.2 80.2 55.1 21.6 75.7 34.5 54.6 551.1 58.6 39.9 60.9 91.0 64.9 71.8 30.1 66.3 219.5 79.0 65.1 37.3 27.1 26.5 26.8 45.5 111.8 88.2 50.7 77.4 27.9 78.4 38.4 110.9 12.0 122.1 34.4 36.8 62.1 49.2 367.4 72.3 61.6 84.1 262.0 50.8 107.2 61.9 63.5 59.2 62.0 155.4 18.6 37.7 42.8 59.3 78.6 49.6 78.1 81.8 8.6 113.1 48.1 41.2 39.9 48.2 89.0 125.1 166.4 33.5 52.7 89.5 96.5 9.5 37.5 38.5 46.0 238.9 97.0 85.7 78.2 53.5 17.9 4.4 9.2 9.8 8.1 10.2 7.5 16.9 8.4 9.4 7.7 15.0 5.4 6.6 41.7 9.5 13.6 9.2 12.5 3.6 70.5 78.0 109.2 131.2 67.2 65.4 80.3 70.7 74.6 68.2 75.7 91.0 102.2 38.5 56.5 9.8 91.4 82.5 105.6 84.5 50.1 55.7 99.0 103.5 54.5 38.6 65.5 36.8 25.0 23.5 106.5 155.3 9.8 27.3 8.7 60.2 28.0 51.9 150.2 80.2 5.6 56.6 47.2 45.0 57.6 76.2 29.2 14.5 82.5 60.3 36.9 42.1 5.9 104.1 46.8 52.5 134.6 13.0 20.2 68.0 56.9 8.4 41.8 63.6 30.9 6.0 5.2 47.2 86.6 20.3 55.4 94.2 98.8 18.6 55.2 47.5 19.7 132.6 48.7 18.1 19.5 97.8 117.2 56.5 69.3 18.1 79.7 114.0 MRPL36 "BRIP1, L36mt, MRP-L36, PRPL36, RPMJ" ENSG00000171421 "Mitochondrial ribosomal protein L36" Q9P0J6 5 1798385-1801366 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 472.3;Late spermatids: 471.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047238 Approved Supported "Nuclear bodies,Mitochondria" No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear bodies, Mitochondria" "HPA047238: AB_10965331" "unprognostic (2.23e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-2)" "unprognostic (7.83e-3)" "unprognostic (2.03e-2)" "unprognostic (2.01e-2)" "unprognostic (1.09e-3)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (5.39e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (8.53e-2)" "unprognostic (9.83e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" 46.2 60.4 35.6 24.7 36.9 19.2 42.1 40.9 44.2 31.5 36.3 49.6 27.9 38.6 26.3 51.1 32.3 22.0 77.3 36.6 38.4 70.4 76.1 28.6 30.1 37.8 36.9 35.1 44.4 34.6 29.1 21.8 38.4 44.0 20.0 22.6 36.5 21.6 140.2 39.3 33.7 26.9 38.3 34.3 44.9 97.4 38.3 29.1 27.4 86.1 25.9 38.8 34.2 38.3 93.3 134.9 61.7 116.9 111.3 91.2 80.9 79.4 69.4 92.7 88.2 98.4 73.4 124.2 140.2 85.7 136.1 99.1 139.9 130.9 66.8 136.1 155.8 60.2 285.1 158.4 142.0 78.9 45.5 80.9 98.9 103.6 133.4 80.8 91.1 72.3 93.4 77.9 133.6 169.4 93.2 177.5 60.1 102.2 164.0 73.8 46.0 149.6 84.6 74.9 68.5 46.8 172.6 133.1 89.8 56.3 78.2 84.5 55.5 79.9 87.1 54.7 89.4 74.0 100.3 167.4 100.4 144.5 111.3 88.4 103.2 68.6 90.6 104.8 109.6 132.6 101.5 111.1 127.3 103.3 89.1 106.3 29.7 101.7 92.9 476.0 143.0 142.0 35.6 36.9 40.9 44.2 36.6 38.4 37.8 36.9 38.4 38.3 38.3 38.3 52.6 32.1 29.0 6.8 37.6 106.0 108.8 150.2 89.4 23.0 61.5 93.2 163.1 50.1 83.6 58.8 6.2 93.4 66.0 47.3 307.2 84.1 472.3 45.4 63.9 63.7 26.4 50.9 7.9 75.0 74.0 62.7 35.2 33.1 27.9 46.2 35.7 118.2 88.2 15.2 7.9 53.8 107.8 43.0 52.4 471.3 74.9 32.0 60.5 2.8 62.5 76.0 70.0 7.1 9.6 92.1 58.7 59.8 45.6 148.8 79.2 199.6 63.2 31.2 65.7 51.1 68.6 188.6 76.2 92.4 124.9 87.4 37.3 79.8 65.7 112.6 MRPL44 "FLJ12701, FLJ13990" ENSG00000135900 "Mitochondrial ribosomal protein L44" Q9H9J2 2 223957463-223967714 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038147, HPA038148" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Mitochondria" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Mitochondria "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA038147: AB_10671521, HPA038148: AB_2675863" "unprognostic (5.21e-2)" "unprognostic (3.48e-1)" "unprognostic (3.38e-2)" "unprognostic (3.00e-1)" "unprognostic (7.05e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (2.16e-2)" "unprognostic (3.32e-1)" "unprognostic (7.65e-2)" "unprognostic (8.33e-2)" "unprognostic (6.65e-2)" "prognostic favorable (2.02e-4)" "unprognostic (2.47e-2)" "unprognostic (1.14e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-1)" 16.2 26.9 16.2 14.9 17.4 45.4 17.6 17.1 20.3 12.9 19.0 21.8 19.3 12.7 13.2 18.0 16.3 17.5 33.8 17.1 18.8 37.4 39.3 12.5 32.5 16.2 16.1 15.2 17.4 19.7 11.6 20.0 16.8 15.3 22.9 10.0 16.1 13.2 42.6 15.7 17.9 14.4 17.5 17.8 16.2 18.2 17.8 21.4 16.2 40.6 26.5 17.1 11.5 17.9 27.3 22.6 33.1 38.3 30.6 36.1 52.4 30.0 33.6 48.0 50.4 81.0 33.4 41.1 31.9 26.0 43.9 35.3 54.5 41.5 44.1 39.0 38.7 45.0 24.0 64.4 44.9 50.0 33.1 42.5 50.9 29.1 38.7 40.4 47.8 41.4 43.7 31.6 38.9 31.9 37.8 62.9 49.4 54.8 23.6 43.8 40.6 25.5 64.3 22.8 45.0 25.7 22.0 49.0 74.8 48.6 41.4 71.2 31.5 31.8 24.7 27.3 24.5 34.5 25.9 58.7 32.2 47.4 35.6 55.7 44.5 35.3 28.5 44.8 36.5 45.9 30.4 34.4 42.2 42.3 36.5 32.3 58.1 33.8 41.2 33.9 33.7 36.3 16.2 17.4 17.1 20.3 17.1 18.8 16.2 16.1 16.8 17.5 17.8 17.9 11.7 6.4 13.1 3.9 31.3 17.8 27.4 52.6 23.9 17.3 15.6 17.4 10.4 27.1 30.0 27.6 0.0 95.3 29.5 25.0 82.2 45.3 8.1 17.1 22.3 20.7 13.1 26.5 6.5 35.1 64.8 24.9 14.3 26.6 18.4 22.0 20.7 51.5 46.6 11.8 6.9 22.0 48.8 33.3 14.5 7.9 18.0 25.4 33.8 4.7 35.3 16.5 20.6 7.5 9.7 37.2 18.1 18.0 24.8 21.7 23.6 106.1 25.6 12.7 19.7 14.2 18.8 41.1 56.3 22.8 16.6 48.7 20.9 40.9 28.3 37.6 MSANTD2 "C11orf61, FLJ23342" ENSG00000120458 "Myb/SANT DNA binding domain containing 2" Q6P1R3 11 124766498-124800706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 33.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038694, HPA038695" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 17: WM-115 - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Nucleoplasm "HPA038694: AB_2676155, HPA038695: AB_10674693" "unprognostic (2.20e-1)" "unprognostic (1.86e-1)" "unprognostic (7.06e-2)" "unprognostic (2.31e-1)" "unprognostic (2.06e-1)" "unprognostic (6.19e-2)" "unprognostic (7.77e-4)" "unprognostic (4.77e-3)" "unprognostic (3.32e-2)" "unprognostic (3.91e-1)" "unprognostic (1.14e-1)" "unprognostic (2.60e-3)" "prognostic unfavorable (2.50e-4)" "unprognostic (5.67e-2)" "unprognostic (1.64e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.65e-4)" 9.8 6.3 8.0 3.8 9.0 0.7 9.9 8.2 10.8 16.2 8.5 10.2 4.0 11.5 7.5 7.5 12.8 2.8 7.2 7.4 8.6 19.1 8.3 9.3 4.5 8.4 8.6 14.1 14.2 3.2 15.3 5.1 8.6 13.5 3.8 5.9 9.3 4.0 4.7 8.4 10.1 2.8 7.8 13.7 10.5 4.7 8.4 3.4 25.3 1.9 3.9 9.4 11.4 10.9 3.0 0.9 10.5 9.9 5.2 6.7 6.1 6.4 3.6 2.3 3.0 4.3 6.2 3.5 5.9 3.3 3.4 5.5 4.5 2.1 3.6 5.8 4.0 3.3 3.9 4.5 2.6 1.9 2.7 3.4 3.8 4.0 3.3 9.1 5.3 3.0 3.9 4.7 5.8 2.6 1.4 9.4 8.0 5.5 14.4 4.2 2.6 3.3 4.4 2.6 3.3 13.0 2.9 3.7 1.9 7.7 8.6 2.1 6.8 15.4 4.3 4.5 6.4 3.0 2.2 2.1 3.2 3.4 8.0 0.0 0.2 0.6 0.6 0.4 0.3 0.3 0.5 0.9 0.3 0.8 0.5 0.4 0.0 0.2 0.5 0.2 1.1 0.2 8.0 9.0 8.2 10.8 7.4 8.6 8.4 8.6 8.6 7.8 8.4 10.9 10.9 3.2 10.3 28.7 7.7 8.8 4.4 2.5 9.6 8.7 6.7 6.7 3.3 5.7 1.8 7.3 2.1 2.9 7.7 3.4 3.9 4.6 5.2 3.2 11.1 9.4 1.2 1.3 33.5 1.0 4.4 10.1 6.6 5.6 1.3 9.0 10.4 3.0 3.0 13.5 30.6 3.1 4.1 3.8 7.3 1.5 9.6 4.1 1.8 31.9 4.4 5.6 8.2 33.7 48.4 4.6 4.0 7.2 4.3 5.0 2.2 3.6 2.9 6.2 13.1 11.3 14.0 2.4 1.6 4.4 4.1 1.9 5.8 7.3 5.0 3.2 MSH3 "DUP, MRP1" ENSG00000113318 "MutS homolog 3" P20585 5 80654652-80876815 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 95.1;Inhibitory neurons: 98.9;Oligodendrocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036081 Approved "Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear bodies" "HPA036081: AB_10673229" "unprognostic (1.91e-1)" "unprognostic (7.61e-2)" "prognostic favorable (5.90e-5)" "unprognostic (2.95e-2)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (1.81e-1)" "unprognostic (8.70e-2)" "unprognostic (3.17e-2)" "unprognostic (2.62e-2)" "unprognostic (2.63e-1)" "unprognostic (3.91e-1)" "prognostic favorable (1.77e-4)" "unprognostic (5.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 9.4 4.6 1.8 4.3 2.4 5.0 5.5 1.6 2.0 6.6 1.5 6.0 6.0 5.2 5.3 5.0 7.0 5.7 4.9 1.7 2.0 12.5 11.4 4.2 4.9 1.7 2.0 5.3 5.2 8.8 3.3 4.3 1.7 5.2 6.2 3.7 4.5 5.2 5.1 5.1 5.6 5.1 2.2 4.1 5.0 3.9 2.5 7.1 10.8 4.7 6.1 6.3 3.9 2.0 12.4 15.0 11.7 13.1 6.6 12.3 16.6 12.2 11.8 13.6 16.7 10.0 15.6 22.2 14.0 15.3 12.8 10.4 15.6 20.5 17.3 14.2 13.9 8.4 13.4 9.9 6.8 9.9 8.5 10.9 9.5 15.8 16.6 13.8 12.9 7.9 12.1 12.9 16.1 11.9 19.0 4.7 9.0 4.8 7.7 13.2 24.2 16.4 15.2 13.0 11.6 13.9 10.4 11.5 13.0 14.4 15.2 9.4 12.4 7.8 9.5 6.2 23.0 8.7 15.6 21.6 12.2 16.8 10.2 0.7 2.9 1.9 3.3 3.4 3.8 3.4 3.5 3.6 3.3 2.2 2.6 2.6 1.7 3.1 4.6 2.8 4.8 2.4 1.8 2.4 1.6 2.0 1.7 2.0 1.7 2.0 1.7 2.2 2.5 2.0 16.7 35.3 9.3 66.9 18.1 10.5 12.3 12.4 12.5 25.8 19.4 12.8 17.6 8.6 14.3 14.7 14.6 18.9 18.7 18.2 15.6 12.4 14.6 28.4 20.2 12.0 14.5 17.0 95.1 10.3 12.9 15.9 31.6 18.9 8.2 19.9 10.0 20.1 11.5 21.9 98.9 13.2 8.2 13.0 7.0 17.2 13.7 16.3 3.6 72.1 19.9 22.5 19.6 71.9 92.3 10.6 9.6 25.9 22.0 6.5 16.8 43.6 65.4 28.3 19.7 20.2 14.7 24.7 25.5 22.3 10.1 13.1 25.4 14.7 17.4 10.7 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 22: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: AB_2681185" "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 1.3 1.1 1.0 2.5 1.2 4.0 2.6 3.6 1.7 1.6 0.7 1.7 1.5 2.1 2.4 1.4 1.7 1.2 0.6 1.0 0.9 1.0 0.8 1.3 4.3 1.0 1.0 2.4 0.9 1.0 0.8 2.1 1.2 1.5 2.6 4.3 1.1 1.0 0.7 3.0 1.3 2.0 0.9 1.8 1.1 5.0 1.1 4.6 0.8 0.8 4.0 1.0 1.3 1.4 15.3 4.5 14.6 6.0 2.1 3.5 7.1 11.4 6.5 16.4 21.0 4.9 8.3 13.8 11.2 3.8 4.9 13.0 13.9 6.8 20.3 11.5 10.6 11.6 6.7 5.6 1.1 12.4 8.6 1.3 2.9 12.7 8.1 2.5 7.3 12.6 7.6 10.2 9.7 6.9 19.8 7.6 6.5 12.0 9.0 11.3 15.0 9.8 3.9 5.3 7.4 8.6 7.7 44.8 7.0 7.9 8.5 8.9 4.5 7.0 12.7 9.0 18.6 3.9 8.9 8.0 6.6 15.1 8.3 0.0 0.1 0.1 0.3 0.6 0.5 0.7 0.5 0.7 0.2 0.5 0.8 0.7 0.0 0.5 0.3 0.0 0.7 0.3 1.0 1.2 3.6 1.7 1.0 0.9 1.0 1.0 1.2 0.9 1.1 1.4 1.6 0.0 1.5 7.5 2.9 0.8 1.7 1.5 1.8 0.0 1.4 1.3 1.1 0.0 1.1 1.8 0.0 2.3 2.5 0.5 0.0 0.9 0.8 1.3 2.6 1.1 0.0 12.8 14.7 1.8 3.0 2.5 2.6 1.5 2.5 5.0 1.8 0.9 1.6 0.0 9.1 0.9 0.0 0.3 1.8 0.4 1.5 1.7 1.8 3.7 1.0 0.0 2.1 9.0 16.1 0.6 0.1 1.2 2.3 1.2 0.3 0.3 2.4 0.0 0.0 5.6 2.6 16.2 10.2 1.4 0.6 0.7 3.3 1.5 0.8 0.8 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 86.2;Oligodendrocytes: 149.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: AB_2667508" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favorable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 18.6 9.5 29.3 10.7 46.9 18.7 10.3 49.4 33.3 11.2 24.8 9.9 12.8 9.4 9.4 20.9 7.5 9.6 12.7 28.0 36.3 30.6 24.2 13.6 12.0 57.6 48.5 11.5 12.4 21.3 1.9 25.9 56.5 11.0 10.3 12.1 14.9 11.4 29.4 11.2 11.6 10.0 45.3 15.1 13.0 8.5 40.8 16.7 14.2 24.0 10.6 10.1 5.4 63.3 8.1 9.0 8.2 5.2 17.7 9.6 7.2 11.9 23.9 9.4 9.4 5.9 3.5 3.9 15.5 15.5 9.1 11.5 6.5 7.0 8.9 12.5 2.1 5.5 6.2 10.4 10.3 8.9 12.2 13.2 5.4 6.1 6.7 10.8 23.7 10.9 4.9 9.2 8.9 2.3 9.3 5.6 4.7 9.7 4.3 6.7 6.7 19.5 35.6 12.7 3.0 7.8 5.4 6.3 2.4 10.4 4.2 16.4 10.9 10.6 8.0 5.6 6.8 9.4 7.8 9.0 6.7 4.7 13.4 3.7 3.2 3.1 0.7 4.0 0.8 1.9 0.8 0.6 3.1 2.8 1.2 1.2 13.5 1.4 7.4 3.7 1.2 1.7 29.3 46.9 49.4 33.3 28.0 36.3 57.6 48.5 56.5 45.3 40.8 63.3 15.8 25.6 15.2 86.2 11.3 8.9 4.3 3.3 8.0 0.0 6.7 4.6 24.1 10.0 7.0 33.1 0.0 19.3 12.9 12.7 1.9 3.4 13.6 10.1 9.6 16.8 6.0 5.2 15.4 3.8 3.1 8.6 13.3 19.7 17.1 9.4 11.4 33.9 11.8 0.0 13.6 7.7 2.0 24.9 16.2 24.9 10.5 19.0 8.8 55.3 13.8 0.0 3.1 25.6 149.3 5.6 9.2 7.5 8.0 6.7 14.4 18.6 4.7 0.0 0.0 10.6 8.9 11.1 8.9 33.6 11.1 38.4 6.8 6.7 8.2 8.7 MYH9 "DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA" ENSG00000100345 "Myosin heavy chain 9" P35579 22 36281280-36387967 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 1343.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001644, CAB015386, HPA064783" Enhanced Supported "Nuclear bodies,Plasma membrane,Actin filaments,Cytosol" No No 410000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 82: Adipose tissue - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane, Actin filaments" "Nuclear bodies, Cytosol" "CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721" "unprognostic (1.38e-1)" "unprognostic (9.12e-2)" "unprognostic (4.21e-2)" "unprognostic (6.34e-2)" "unprognostic (1.49e-1)" "unprognostic (3.90e-2)" "unprognostic (9.56e-2)" "unprognostic (8.28e-2)" "unprognostic (5.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-1)" "unprognostic (7.98e-2)" "unprognostic (9.48e-2)" "unprognostic (1.64e-1)" "unprognostic (1.62e-1)" "unprognostic (2.59e-2)" 295.9 95.5 42.3 181.1 42.1 245.9 231.5 40.6 54.7 181.2 65.5 192.6 107.0 356.4 39.3 153.8 182.2 134.5 161.1 50.8 39.4 140.7 101.6 286.2 161.7 52.7 51.7 121.1 160.3 55.0 52.6 166.5 48.1 131.8 89.8 9.7 177.2 98.4 84.0 160.6 163.5 174.1 48.8 232.5 135.8 38.2 52.1 125.1 141.2 46.3 104.1 168.8 166.8 48.2 612.2 277.0 86.2 74.2 156.8 195.1 437.3 398.4 507.5 554.6 413.2 302.1 170.3 156.9 230.1 666.1 265.0 412.7 125.2 779.4 559.6 356.1 120.9 302.6 294.3 259.9 481.1 346.9 463.8 233.0 234.7 751.9 626.4 540.3 461.8 113.2 67.3 205.8 448.9 161.9 124.4 204.0 51.7 171.1 169.2 233.3 267.3 146.7 314.5 581.5 129.6 53.0 559.7 217.0 251.6 218.5 162.4 177.1 1343.7 1222.6 370.3 237.5 731.5 135.2 114.7 129.0 463.2 172.3 363.1 72.6 25.2 64.7 32.4 19.8 28.4 13.4 23.5 26.4 17.2 11.9 18.3 20.4 41.2 9.0 26.5 8.0 26.3 54.5 42.3 42.1 40.6 54.7 50.8 39.4 52.7 51.7 48.1 48.8 52.1 48.2 303.9 118.6 87.1 12.7 108.4 144.0 182.4 123.1 72.8 2.6 90.5 89.4 62.6 80.1 89.7 92.0 2.1 87.0 151.7 359.8 7.9 309.4 35.8 89.7 121.6 258.7 73.8 51.9 42.5 245.8 193.1 82.9 123.8 194.7 93.1 117.1 132.8 102.8 100.4 82.4 6.7 131.0 59.0 119.6 124.2 37.4 68.0 168.8 85.4 61.8 196.6 11.9 137.0 7.5 33.3 344.6 186.8 211.4 125.9 184.4 159.8 27.5 51.5 5.3 203.8 39.9 275.2 6.9 10.4 133.6 135.1 46.4 213.2 141.3 139.5 134.3 MYO1C myr2 ENSG00000197879 "Myosin IC" O00159 17 1464186-1492686 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001768, HPA005924, CAB037023" Enhanced Enhanced "Nuclear bodies,Plasma membrane" NA NA 3800000 "Cluster 43: B-cells - Humoral immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies, Plasma membrane" "CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469" "unprognostic (3.60e-1)" "unprognostic (4.71e-3)" "unprognostic (2.89e-1)" "unprognostic (2.96e-3)" "unprognostic (1.38e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-2)" "unprognostic (1.99e-2)" "unprognostic (5.02e-2)" "unprognostic (4.66e-2)" "unprognostic (4.93e-2)" "unprognostic (3.47e-2)" 169.3 27.0 12.4 34.4 11.8 4.9 115.9 13.3 12.7 77.4 17.1 104.9 47.4 97.1 21.5 64.7 66.4 46.1 97.5 10.2 14.7 56.8 39.5 87.2 24.1 14.8 11.2 43.6 69.3 34.3 22.9 56.9 14.6 69.9 41.7 2.1 91.7 58.2 49.5 57.7 65.6 65.7 11.9 30.8 76.3 17.1 13.7 21.3 60.6 35.8 25.1 86.3 67.8 10.8 169.8 182.1 19.3 79.5 88.8 87.6 74.2 168.6 138.9 108.7 91.0 122.3 90.7 16.9 118.7 261.1 72.7 139.9 29.2 117.2 56.3 75.2 74.5 16.2 96.4 46.2 131.7 1.6 81.5 68.7 57.3 100.2 57.3 99.5 141.7 10.5 13.1 13.7 93.5 129.5 1.9 1.4 12.4 105.8 34.0 6.9 26.4 30.7 100.5 86.9 7.8 43.0 105.9 152.6 67.4 47.5 125.3 8.7 187.9 156.6 119.1 77.7 147.8 10.7 9.1 7.2 124.7 4.1 138.8 0.1 0.9 0.0 0.9 2.0 0.4 4.8 2.1 0.9 1.1 3.8 0.7 0.4 0.5 0.0 1.7 1.0 1.9 1.5 12.4 11.8 13.3 12.7 10.2 14.7 14.8 11.2 14.6 11.9 13.7 10.8 133.7 125.0 35.9 5.5 20.8 39.8 38.2 27.8 31.9 4.1 44.0 33.0 75.4 48.6 36.3 86.5 0.0 57.8 2.5 159.0 21.5 62.3 17.4 26.3 44.4 78.0 39.5 13.5 2.5 52.0 28.4 51.8 66.3 75.5 12.0 25.4 83.6 38.5 20.0 5.0 3.8 111.8 14.2 14.5 43.4 11.4 42.3 16.7 64.0 15.0 20.3 5.6 0.0 2.5 1.0 92.8 88.7 48.5 12.8 64.7 92.8 15.4 12.9 2.1 118.3 37.7 90.6 9.4 7.5 39.5 42.6 47.6 10.0 10.6 88.1 39.2 NAA15 "FLJ13340, NARG1, NATH, TBDN100" ENSG00000164134 "N-alpha-acetyltransferase 15, NatA auxiliary subunit" Q9BXJ9 4 139301505-139420033 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023589, HPA050661" Approved Supported "Nuclear bodies,Cytosol" NA NA 140000 "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "Nuclear bodies" "HPA023589: AB_1854311, HPA050661: AB_2681208" "unprognostic (6.25e-3)" "unprognostic (5.95e-2)" "unprognostic (7.80e-3)" "unprognostic (8.45e-2)" "unprognostic (2.88e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (2.16e-2)" "unprognostic (9.20e-3)" "unprognostic (1.07e-2)" "unprognostic (5.21e-3)" "unprognostic (1.99e-2)" "unprognostic (8.65e-2)" "unprognostic (7.37e-3)" "unprognostic (2.12e-1)" "unprognostic (8.28e-3)" "unprognostic (1.58e-1)" 9.1 8.9 6.5 11.4 7.3 16.4 9.9 12.4 8.3 7.3 7.3 8.4 7.6 8.9 6.0 12.5 7.1 7.0 10.0 6.5 6.7 7.5 10.9 6.4 14.5 7.3 6.8 7.9 7.8 9.7 5.8 10.6 7.7 8.3 9.1 9.2 6.2 7.2 17.0 9.3 7.0 8.7 6.9 8.5 7.9 13.1 6.9 13.4 9.0 16.3 15.5 14.5 7.7 10.5 44.7 32.1 30.4 49.2 21.7 26.4 37.3 42.2 27.6 39.9 30.6 45.3 38.2 91.1 25.3 35.0 34.6 28.1 80.5 51.7 57.2 42.8 29.6 49.0 29.6 29.8 23.0 90.5 30.5 18.7 31.0 50.4 39.1 21.1 40.5 35.2 92.1 38.7 42.9 35.6 86.8 26.8 50.7 83.4 25.0 53.4 40.9 47.0 31.8 37.2 39.3 30.8 28.2 45.7 28.8 30.6 27.8 35.2 35.0 38.3 27.0 36.7 48.7 46.5 89.0 88.7 32.9 64.6 37.4 4.2 3.4 1.1 5.0 3.9 5.9 4.8 5.3 5.9 4.7 5.3 5.1 5.8 2.6 4.5 3.9 4.0 5.5 2.1 6.5 7.3 12.4 8.3 6.5 6.7 7.3 6.8 7.7 6.9 6.9 10.5 28.4 48.1 33.8 28.4 39.7 93.4 69.6 20.7 29.0 34.0 28.1 15.7 46.9 22.8 32.3 20.2 20.9 39.9 22.8 14.4 15.6 28.1 9.0 40.3 38.9 31.5 15.6 34.5 44.0 19.5 50.8 32.9 21.4 40.5 34.8 35.7 16.8 28.1 32.5 40.4 45.9 20.8 18.3 24.1 35.0 11.3 25.4 27.8 28.4 29.0 26.6 27.7 32.0 42.3 57.6 26.5 16.2 29.0 23.4 53.8 10.2 16.4 34.0 36.3 32.9 69.0 47.4 90.0 59.7 44.0 99.3 41.7 31.7 32.1 32.5 70.2 NBR1 "1A1-3B, CA125, KIAA0049, M17S2" ENSG00000188554 "NBR1 autophagy cargo receptor" Q14596 17 43170481-43211689 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 276.9;Late spermatids: 909.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022944, HPA022999, HPA023999" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" Vesicles "Nucleoplasm, Nuclear bodies" "HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533" "unprognostic (1.85e-1)" "unprognostic (1.78e-1)" "unprognostic (3.26e-2)" "unprognostic (3.28e-2)" "unprognostic (3.27e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (2.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.02e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "prognostic favorable (2.00e-5)" "unprognostic (1.65e-1)" "unprognostic (4.88e-2)" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" 45.7 52.3 48.4 39.4 54.5 20.1 55.9 52.1 48.2 52.0 51.2 66.2 70.1 48.9 39.9 40.3 53.4 44.5 67.3 43.7 49.9 84.7 91.3 47.3 41.0 52.2 50.4 69.7 43.9 97.1 28.8 60.1 52.9 64.7 70.4 80.1 49.4 52.0 112.2 42.9 73.8 49.3 52.1 53.0 52.6 141.0 51.6 59.0 68.2 116.0 45.4 47.3 34.5 65.2 42.3 49.8 42.6 44.6 93.5 95.2 41.0 77.1 147.2 60.5 50.4 26.6 65.1 22.7 77.8 105.1 62.6 46.1 48.5 97.4 90.3 70.0 51.2 27.1 62.0 60.0 89.4 23.2 40.1 108.4 111.6 67.2 133.7 127.3 96.0 50.8 58.1 58.7 83.7 23.9 48.9 17.7 13.6 50.0 32.8 16.5 65.6 73.3 81.6 48.0 25.9 45.8 53.1 26.1 79.8 70.7 70.7 38.0 82.2 89.9 34.1 42.7 31.5 69.9 61.8 29.1 61.8 31.5 63.6 41.6 25.7 40.1 20.3 23.3 20.7 13.7 18.1 19.6 19.3 9.4 17.0 16.6 34.4 24.3 36.4 12.0 26.4 25.0 48.4 54.5 52.1 48.2 43.7 49.9 52.2 50.4 52.9 52.1 51.6 65.2 36.9 41.7 44.1 24.5 21.9 23.8 29.2 28.1 54.1 37.3 33.8 27.4 86.4 35.8 40.4 36.8 39.6 28.0 34.6 94.2 19.6 25.4 276.9 40.5 30.4 39.0 40.2 53.2 24.7 21.9 19.4 37.6 31.1 33.0 25.9 53.1 45.3 67.8 22.0 20.2 28.2 56.4 20.3 62.9 19.9 909.9 58.7 35.7 26.6 29.0 35.6 49.3 44.3 33.2 41.4 25.8 64.5 44.4 26.1 41.1 100.3 57.4 63.4 56.9 39.5 33.9 36.2 49.6 30.9 26.7 27.3 15.7 31.9 68.6 52.4 38.7 NCAM2 "MGC51008, NCAM21" ENSG00000154654 "Neural cell adhesion molecule 2" O15394 21 20998409-21543329 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 12.0;brain: 26.0" "Group enriched" "Detected in some" 19 "Astrocytes: 713.0;Excitatory neurons: 866.5;Inhibitory neurons: 909.2;Oligodendrocyte precursor cells: 1729.1;Oligodendrocytes: 1526.6" "Group enriched" "Detected in some" 4 "breast cancer: 2.6;glioma: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030900, HPA030901" Enhanced Supported Supported "Nuclear bodies,Plasma membrane" No No 120000000 "Cluster 65: Brain - Ion transport" "Cluster 6: T47d - Mammary gland" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies, Plasma membrane" "HPA030900: AB_10602037, HPA030901: AB_2673650" "unprognostic (9.70e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (1.37e-2)" "unprognostic (3.01e-2)" "unprognostic (5.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-1)" "unprognostic (5.61e-1)" "unprognostic (3.07e-4)" "unprognostic (2.47e-4)" "unprognostic (1.62e-1)" "unprognostic (8.05e-2)" "unprognostic (1.35e-3)" 0.7 12.0 14.1 0.9 19.0 0.0 1.6 8.4 17.5 1.6 0.0 2.0 0.2 1.0 0.5 0.5 0.6 1.2 2.0 21.3 22.7 0.2 6.7 2.8 0.1 8.6 14.4 0.3 0.2 0.6 0.8 0.5 8.8 0.9 1.0 1.2 0.7 1.0 0.4 0.8 0.7 1.4 8.8 0.8 0.6 6.3 26.0 0.1 0.3 0.8 0.2 0.6 1.2 21.6 0.0 0.0 0.5 0.0 4.6 4.7 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.5 1.3 0.0 0.5 1.3 0.0 2.2 0.0 0.1 11.3 0.0 3.5 0.0 0.4 0.0 0.0 11.4 2.4 0.2 15.4 0.2 0.0 0.4 0.0 0.0 1.0 0.0 4.7 0.0 0.0 0.0 5.3 0.0 0.8 0.6 0.1 92.1 7.2 0.0 1.3 0.9 0.1 0.0 0.6 0.0 0.0 2.5 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.1 19.0 8.4 17.5 21.3 22.7 8.6 14.4 8.8 8.8 26.0 21.6 0.4 3.2 1.3 713.0 0.1 0.5 0.3 0.0 0.0 1.0 2.0 1.4 1.8 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 57.6 0.3 6.1 0.4 0.0 0.0 866.5 0.0 0.4 4.8 0.0 0.2 0.0 0.2 2.2 0.0 0.3 0.0 909.2 0.0 0.0 0.0 0.3 24.7 0.9 0.1 1.8 30.9 0.0 1.0 0.0 1729.1 1526.6 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.1 0.0 2.4 1.6 3.7 9.6 0.1 0.1 0.3 0.2 1.9 0.0 0.2 NCOA2 "bHLHe75, GRIP1, KAT13C, NCoA-2, TIF2" ENSG00000140396 "Nuclear receptor coactivator 2" Q15596 8 70109782-70403808 "Cancer-related genes, Disease related genes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 161.6;Excitatory neurons: 158.9;Inhibitory neurons: 314.8;Microglial cells: 233.3;Oligodendrocyte precursor cells: 249.8;Oligodendrocytes: 186.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060243 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nuclear bodies" "HPA060243: AB_2684229" "unprognostic (9.79e-3)" "unprognostic (1.40e-1)" "unprognostic (2.72e-1)" "unprognostic (4.94e-3)" "unprognostic (1.91e-2)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (2.06e-1)" "unprognostic (7.00e-2)" "unprognostic (2.20e-2)" "unprognostic (2.63e-2)" "prognostic favorable (5.08e-4)" "unprognostic (2.52e-1)" "unprognostic (3.35e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-1)" 8.4 8.9 8.9 9.9 10.5 23.3 13.4 8.9 10.0 10.0 1.5 10.6 11.6 10.1 29.6 15.3 10.9 8.9 15.0 13.6 13.2 14.4 23.8 10.0 11.6 8.0 6.8 16.2 7.3 15.2 7.3 12.1 7.7 12.9 10.6 26.1 11.3 12.1 8.3 10.5 12.1 9.0 4.6 12.4 10.9 14.7 9.9 15.3 12.1 15.9 12.5 10.0 9.9 6.1 13.7 16.9 18.2 10.3 16.2 16.5 18.6 7.8 7.8 5.9 5.5 8.6 15.6 16.3 3.1 14.3 9.7 8.0 22.5 10.7 6.5 38.7 17.9 28.5 8.5 13.8 8.5 5.8 7.2 14.5 11.7 7.9 11.3 9.2 4.0 11.7 9.2 24.0 6.9 13.7 14.5 5.8 9.6 15.7 7.9 14.1 7.6 10.3 9.3 22.5 13.8 10.2 13.4 7.1 11.0 12.7 16.7 10.5 5.3 8.4 10.6 10.8 4.2 31.5 17.3 15.4 8.6 7.6 12.5 3.1 1.6 2.2 2.2 2.3 1.5 1.3 1.3 1.9 1.5 2.1 1.5 1.6 5.7 1.4 5.2 0.6 2.0 1.2 8.9 10.5 8.9 10.0 13.6 13.2 8.0 6.8 7.7 4.6 9.9 6.1 20.9 12.8 25.1 161.6 27.3 16.2 8.6 10.8 17.6 25.8 29.5 17.5 34.1 28.6 25.8 25.8 52.1 22.1 26.9 30.8 11.7 9.3 6.4 23.6 26.4 17.7 25.2 28.8 158.9 12.4 12.5 21.6 21.4 38.0 22.2 23.2 22.1 65.9 17.4 74.0 314.8 17.4 10.2 46.8 17.8 7.6 19.9 28.1 21.4 233.3 23.1 14.3 19.6 249.8 186.0 12.8 14.8 22.2 49.9 15.5 22.7 17.6 19.0 33.4 26.3 22.5 20.2 13.3 16.5 18.8 21.5 31.7 36.6 10.9 17.0 15.8 NCOA7 "dJ187J11.3, ERAP140, TLDC4" ENSG00000111912 "Nuclear receptor coactivator 7" Q8NI08 6 125781161-125932034 "Predicted intracellular proteins, Transporters" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030289, HPA030290, HPA030291, HPA030292" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834" "unprognostic (1.01e-2)" "unprognostic (3.21e-2)" "unprognostic (7.32e-3)" "unprognostic (7.27e-3)" "unprognostic (1.54e-1)" "unprognostic (4.67e-2)" "unprognostic (1.26e-1)" "unprognostic (6.27e-2)" "unprognostic (2.73e-1)" "unprognostic (2.14e-1)" "unprognostic (6.08e-2)" "unprognostic (4.37e-2)" "prognostic favorable (1.78e-6)" "unprognostic (2.10e-1)" "unprognostic (2.58e-1)" "unprognostic (1.14e-1)" "unprognostic (8.10e-2)" 53.9 60.4 19.5 45.8 30.6 42.7 27.4 21.4 50.2 29.0 0.0 30.1 33.0 22.3 5.2 30.4 15.9 46.6 16.0 28.2 23.9 56.6 32.9 52.1 30.1 47.5 12.3 14.8 19.9 8.8 29.7 12.9 45.0 18.6 29.2 18.2 38.2 12.9 6.9 11.1 39.2 28.3 10.6 24.4 30.8 7.8 19.0 21.7 25.1 9.2 28.5 101.8 19.7 48.3 13.7 36.6 2.2 16.0 78.2 46.3 23.7 18.2 71.9 22.1 30.1 34.3 12.7 55.2 96.5 10.0 108.0 78.7 12.6 12.4 13.3 120.2 16.5 28.0 43.7 12.3 44.5 16.4 25.4 33.3 29.4 21.1 16.3 39.1 46.7 18.0 38.7 30.6 13.9 13.7 16.1 16.2 2.7 33.8 7.6 12.3 5.7 10.3 39.1 90.4 36.9 33.5 93.7 22.6 42.1 6.5 3.8 19.3 27.7 5.1 10.9 26.3 14.1 39.9 34.1 28.8 11.5 21.2 18.7 17.0 11.4 4.0 19.2 9.1 24.1 17.7 18.1 15.6 10.0 11.1 9.6 9.4 6.4 13.6 14.2 34.1 8.1 5.1 19.5 30.6 21.4 50.2 28.2 23.9 47.5 12.3 45.0 10.6 19.0 48.3 144.6 314.1 371.9 27.7 33.7 98.1 270.8 311.2 709.7 50.2 94.2 47.9 11.4 98.7 324.1 62.5 43.8 9.3 84.6 113.2 80.3 241.7 0.9 160.1 90.2 130.2 35.8 29.8 144.9 139.2 8.9 94.8 142.8 298.2 37.3 18.5 106.7 23.2 13.6 37.0 89.5 119.3 288.9 33.8 57.4 6.8 42.3 41.9 51.6 75.9 33.4 76.8 59.8 34.2 303.9 108.7 160.1 29.3 44.1 129.5 24.3 103.2 335.8 53.3 13.1 33.8 49.3 11.2 33.9 515.9 59.2 3.8 63.5 36.5 130.6 294.4 NDUFS3 CI-30 ENSG00000213619 "NADH:ubiquinone oxidoreductase core subunit S3" O75489 11 47565336-47584562 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 292.3" "Cell type enhanced" "Detected in all" "Distal tubular cells: 405.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004484, CAB034894" Enhanced Supported "Nuclear bodies,Mitochondria" NA NA 14000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nuclear bodies" "CAB034894: AB_2151118, HPA004484: AB_1079464" "unprognostic (2.18e-1)" "unprognostic (7.42e-3)" "unprognostic (1.75e-1)" "unprognostic (5.01e-2)" "unprognostic (7.51e-2)" "unprognostic (3.13e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "unprognostic (1.93e-1)" "unprognostic (1.41e-2)" "unprognostic (6.75e-3)" "unprognostic (7.73e-2)" "prognostic favorable (2.61e-6)" "unprognostic (2.77e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (3.17e-3)" 52.4 91.3 47.4 16.5 52.6 44.1 50.7 55.6 50.2 43.5 59.4 97.5 53.8 49.7 26.2 78.7 42.6 18.1 210.3 49.3 51.9 94.2 96.2 40.5 25.5 48.8 49.3 37.3 56.7 53.6 67.5 17.6 49.4 44.0 52.7 23.5 60.9 27.5 292.3 66.2 69.4 26.6 50.3 55.5 81.4 48.2 54.7 33.8 49.7 194.2 33.3 51.4 52.0 47.7 37.7 68.7 59.8 62.9 48.8 52.3 48.2 35.0 60.3 84.6 80.4 103.6 65.1 81.8 34.8 49.7 63.0 64.9 81.7 61.8 69.4 44.2 137.2 49.5 90.6 106.5 49.7 121.5 62.1 50.1 46.6 32.0 52.2 37.5 55.3 69.2 73.7 57.1 57.7 118.6 87.0 164.9 83.6 109.6 97.7 100.7 81.8 68.7 76.4 60.2 63.9 47.1 43.4 76.9 83.5 35.2 84.4 118.2 37.0 49.3 56.4 57.0 80.4 61.2 93.5 91.8 50.1 94.9 51.3 38.3 69.3 48.9 43.2 79.8 46.4 60.6 45.2 47.5 83.3 59.2 42.4 46.0 18.4 45.6 66.7 89.3 61.3 90.3 47.4 52.6 55.6 50.2 49.3 51.9 48.8 49.3 49.4 50.3 54.7 47.7 54.7 54.5 42.6 23.5 54.6 65.6 67.4 217.5 62.6 45.6 60.2 72.5 176.9 81.5 108.5 69.9 41.7 122.0 70.8 183.1 405.0 113.0 132.3 56.8 58.6 60.0 84.7 73.8 12.7 111.3 116.5 60.8 81.1 40.5 57.7 67.1 58.5 126.3 195.9 60.6 14.5 162.8 173.0 66.9 59.3 63.2 67.4 62.8 119.2 7.5 83.9 117.9 58.7 12.5 13.1 91.7 109.3 69.2 69.8 53.0 257.8 297.0 109.7 59.5 105.2 55.5 154.8 85.5 74.7 115.3 75.9 89.1 55.5 128.3 210.7 85.3 NELFA "NELF-A, WHSC2" ENSG00000185049 "Negative elongation factor complex member A" Q9H3P2 4 1982717-2041903 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009960, HPA039858, HPA043931" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Nuclear bodies" "CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737" "unprognostic (1.66e-1)" "unprognostic (2.23e-1)" "unprognostic (3.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.32e-1)" "unprognostic (1.73e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (2.40e-1)" "unprognostic (1.12e-1)" "unprognostic (9.38e-2)" "unprognostic (2.74e-2)" "unprognostic (1.88e-3)" "unprognostic (1.58e-1)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (2.43e-1)" "unprognostic (3.05e-2)" 9.3 7.8 7.5 10.8 8.6 14.2 6.0 8.0 11.5 7.1 6.1 9.4 13.4 11.3 6.3 9.5 12.4 5.7 6.3 8.0 6.9 6.8 5.8 6.6 10.8 8.7 8.9 15.5 16.7 10.1 3.0 10.3 6.8 8.9 4.7 7.0 18.2 8.4 12.0 12.8 13.4 5.7 8.1 12.1 12.7 16.5 7.4 9.4 7.4 4.6 7.4 6.8 1.8 9.5 27.2 24.6 21.0 38.8 8.5 8.9 41.6 14.3 10.1 16.9 13.4 41.1 45.7 47.8 20.1 9.3 21.0 25.2 21.3 17.9 8.2 24.5 33.2 31.5 18.0 39.4 12.4 33.1 30.9 7.6 15.6 11.3 12.0 12.5 13.0 26.6 60.5 22.3 7.4 31.7 63.8 94.4 60.8 23.2 36.5 57.6 18.3 30.2 12.1 22.5 57.1 35.7 16.4 19.3 24.4 13.0 37.1 24.5 14.7 17.0 19.2 19.8 31.9 47.2 52.7 53.6 19.4 34.5 21.4 7.0 14.4 14.9 15.4 16.9 18.5 16.3 17.9 13.9 13.9 24.0 15.0 12.0 5.3 15.4 14.0 17.3 22.1 13.1 7.5 8.6 8.0 11.5 8.0 6.9 8.7 8.9 6.8 8.1 7.4 9.5 11.1 12.8 17.9 30.7 18.5 32.6 18.6 20.3 17.6 19.2 17.6 19.3 4.6 14.3 19.1 12.9 39.6 27.9 16.2 14.6 9.8 18.7 24.0 25.2 17.7 13.2 16.2 17.2 55.9 13.6 28.1 14.7 13.3 28.5 9.5 23.3 11.4 8.3 16.4 37.0 40.9 17.8 14.2 10.1 12.1 7.4 15.5 11.3 14.2 13.1 19.6 18.1 19.6 31.7 30.2 16.2 18.7 13.2 14.0 23.6 17.5 8.9 17.3 21.9 0.0 15.4 15.2 32.9 39.4 29.8 38.2 28.5 18.8 15.8 20.1 27.0 NELFCD "HSPC130, NELF-C, NELF-D, TH1, TH1L" ENSG00000101158 "Negative elongation factor complex member C/D" Q8IXH7 20 58981208-58995133 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050641, HPA066262, HPA074936" Enhanced Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Nuclear bodies" "Vesicles, Cytosol" "HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: " "unprognostic (1.70e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.98e-5)" "unprognostic (6.20e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.47e-1)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.07e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (9.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" 18.9 29.5 20.5 17.7 22.8 23.8 24.5 21.7 23.4 20.7 21.2 18.2 19.3 18.2 16.3 32.9 24.4 16.2 16.9 19.6 21.0 31.7 31.2 14.7 26.4 21.2 20.9 25.2 21.2 30.7 31.8 25.6 21.8 20.4 17.9 31.9 30.0 17.1 29.4 25.9 19.6 14.1 20.8 20.7 19.3 27.9 21.5 31.5 28.5 20.5 27.9 22.6 22.7 24.3 54.7 57.6 68.5 71.9 22.5 38.9 49.6 42.4 38.8 117.1 66.8 189.6 70.7 68.3 64.0 39.8 60.8 89.1 90.1 98.0 94.8 22.4 64.1 90.5 72.4 150.5 26.7 64.2 60.1 40.9 34.3 44.2 32.8 32.8 68.3 54.0 118.1 51.8 53.3 198.2 135.6 95.4 40.3 151.5 122.9 78.4 56.6 121.1 49.0 76.5 75.9 112.6 126.0 148.3 85.9 38.2 157.5 75.0 30.2 91.6 88.8 36.3 67.7 44.4 80.0 71.1 53.7 57.3 80.6 20.0 44.6 22.9 42.0 51.5 50.0 48.6 39.7 51.2 64.9 44.5 37.7 40.1 5.6 47.1 68.8 33.0 39.7 49.0 20.5 22.8 21.7 23.4 19.6 21.0 21.2 20.9 21.8 20.8 21.5 24.3 23.0 9.6 27.6 18.3 50.5 30.2 62.6 43.8 40.9 67.3 32.7 34.2 10.9 47.1 24.3 22.0 41.7 133.1 35.5 14.5 50.9 57.0 18.8 26.2 33.3 26.7 23.4 60.0 23.0 31.4 69.2 26.2 26.5 27.4 16.5 50.9 23.2 24.1 36.9 55.5 22.8 21.9 26.4 15.3 24.0 32.1 37.0 24.0 26.6 10.3 48.1 52.9 49.4 21.1 23.6 34.9 14.4 26.4 37.4 37.8 27.8 49.9 15.0 61.5 39.5 31.6 34.2 63.1 94.9 40.5 31.4 103.0 48.5 43.9 36.2 52.8 NELFE "D6S45, NELF-E, RD, RDBP, RDP" ENSG00000204356 "Negative elongation factor complex member E" P18615 6 31952087-31959038 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 635.4;Late spermatids: 1699.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007187, HPA007594, HPA046502" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677" "unprognostic (1.09e-1)" "unprognostic (3.28e-1)" "unprognostic (1.45e-1)" "unprognostic (6.33e-3)" "unprognostic (4.43e-2)" "unprognostic (4.25e-2)" "unprognostic (7.71e-3)" "unprognostic (1.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-2)" "unprognostic (1.97e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (5.21e-2)" "unprognostic (1.07e-1)" "unprognostic (2.21e-1)" "unprognostic (3.68e-2)" 51.9 48.5 37.4 15.2 38.2 23.5 49.4 38.6 40.3 47.9 36.6 45.9 12.7 50.1 26.9 51.7 46.9 11.9 57.1 35.8 39.2 50.0 24.5 43.6 16.9 39.1 38.3 47.4 52.4 41.1 42.5 20.5 37.4 35.4 24.2 6.3 40.5 26.7 58.2 51.3 37.2 27.7 38.7 38.7 46.6 166.2 39.2 36.8 39.6 30.8 25.4 44.1 43.5 39.6 51.8 59.9 55.5 48.4 54.7 59.9 50.9 40.3 73.8 90.1 74.6 69.5 35.7 49.0 41.3 79.0 117.1 44.0 47.4 85.7 64.5 39.4 63.2 35.9 41.9 80.5 110.6 43.4 29.0 63.2 119.2 96.2 113.5 75.6 84.2 87.6 51.6 56.6 90.2 89.6 77.1 44.6 22.9 79.6 68.1 63.0 49.1 95.2 61.0 49.8 42.3 52.8 30.4 44.4 80.1 48.4 66.0 89.6 37.1 39.7 63.5 34.5 67.8 65.9 77.8 47.6 26.0 36.4 69.8 44.9 60.4 58.7 49.4 68.8 46.2 50.9 45.4 47.2 56.9 49.9 41.9 41.0 31.4 48.8 67.8 45.4 49.0 55.4 37.4 38.2 38.6 40.3 35.8 39.2 39.1 38.3 37.4 38.7 39.2 39.6 49.0 16.0 27.9 4.6 42.8 47.2 69.0 61.5 40.5 15.5 55.1 62.5 47.2 72.9 43.1 33.1 12.5 98.4 37.7 84.6 133.1 93.3 635.4 68.4 40.8 49.8 34.2 52.2 6.2 136.5 112.1 47.7 31.1 45.6 45.6 46.7 45.3 34.8 82.8 11.8 6.2 71.1 46.8 55.3 42.6 1699.6 71.1 45.0 49.8 3.7 73.2 65.5 51.5 6.6 9.9 113.1 99.1 45.1 68.6 79.6 124.8 107.7 112.5 25.6 32.9 48.7 84.9 224.7 91.0 54.2 41.8 114.4 41.7 41.0 72.4 64.6 NEMF "FLJ10051, NY-CO-1, SDCCAG1" ENSG00000165525 "Nuclear export mediator factor" O60524 14 49782083-49852821 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004160 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 830000 "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA004160: AB_1079884" "unprognostic (9.92e-2)" "unprognostic (6.03e-2)" "unprognostic (4.44e-2)" "unprognostic (3.37e-2)" "unprognostic (1.54e-1)" "unprognostic (1.65e-1)" "unprognostic (9.15e-3)" "unprognostic (7.62e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.50e-1)" "unprognostic (1.12e-1)" "prognostic favorable (2.85e-4)" "unprognostic (3.61e-1)" "unprognostic (2.36e-1)" "unprognostic (8.98e-2)" "unprognostic (1.81e-2)" 16.5 13.8 9.5 18.0 13.0 42.1 14.7 18.1 14.7 16.2 5.9 13.6 10.0 16.2 13.5 22.5 12.2 13.2 17.7 7.9 10.6 14.9 11.9 13.8 17.9 11.8 11.6 15.2 15.2 24.8 10.3 18.2 11.9 16.0 14.5 14.7 14.6 15.8 23.0 14.3 13.6 15.7 10.9 15.5 14.1 10.7 10.7 16.3 18.5 21.5 17.9 18.0 11.6 18.4 34.3 39.2 35.9 24.1 37.3 31.0 32.1 42.0 28.3 27.6 27.3 23.2 35.3 13.3 32.0 35.7 21.2 47.5 34.1 26.7 42.2 38.9 22.7 38.7 40.3 29.1 23.8 50.7 33.4 26.8 19.6 29.9 27.2 36.3 39.8 23.8 47.3 36.2 37.7 30.6 31.2 17.9 21.9 28.6 36.8 32.6 35.5 20.8 33.7 44.8 23.6 22.2 41.6 40.4 39.2 37.2 37.6 31.1 47.2 39.2 34.4 26.6 28.9 24.5 47.6 40.9 14.7 23.9 35.5 76.4 38.9 45.8 45.7 36.9 44.8 83.7 47.1 44.4 33.9 86.7 55.6 59.1 61.3 47.8 54.4 79.7 46.1 20.3 9.5 13.0 18.1 14.7 7.9 10.6 11.8 11.6 11.9 10.9 10.7 18.4 66.2 41.7 76.7 65.3 81.1 34.4 67.4 81.6 29.6 92.1 31.7 43.1 97.2 34.3 74.4 44.1 100.1 85.8 78.4 51.8 37.2 57.0 13.9 52.2 60.1 65.2 54.0 57.0 75.7 39.1 58.1 53.0 41.8 60.7 89.3 68.0 49.6 28.1 58.9 131.2 80.7 48.9 71.2 48.7 57.0 13.1 65.9 57.9 24.9 62.8 79.4 54.8 82.4 56.8 99.5 46.4 68.5 67.4 50.0 66.1 59.4 29.9 82.4 90.0 72.3 65.7 70.7 83.0 58.3 32.5 34.1 108.4 66.9 64.1 54.6 88.6 NEUROG1 "AKA, bHLHa6, Math4C, NEUROD3, ngn1" ENSG00000181965 "Neurogenin 1" Q92886 5 135534282-135535964 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Bipolar cells: 9.1" "Cancer enriched" "Detected in single" 12 "testis cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA072232 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Nuclear bodies" "HPA072232: " "unprognostic (3.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NFATC1 "NF-ATC, NFAT2, NFATc" ENSG00000131196 "Nuclear factor of activated T cells 1" O95644 18 79395856-79529325 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "B-cells: 50.4;Skeletal myocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004513, HPA071732" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Nuclear bodies" Nucleoplasm "CAB004513: AB_628011, HPA071732: AB_2686439" "unprognostic (3.53e-2)" "unprognostic (2.16e-3)" "unprognostic (3.08e-3)" "unprognostic (3.40e-2)" "unprognostic (4.54e-2)" "unprognostic (2.79e-2)" "unprognostic (1.92e-1)" "unprognostic (4.85e-3)" "unprognostic (7.02e-2)" "unprognostic (8.37e-2)" "unprognostic (1.90e-2)" "unprognostic (1.38e-1)" "unprognostic (5.87e-2)" "unprognostic (1.38e-1)" "unprognostic (4.54e-2)" "unprognostic (5.04e-2)" "unprognostic (3.11e-3)" 12.8 4.6 4.8 11.7 6.0 3.9 10.6 5.6 4.1 6.0 27.9 10.1 3.0 7.7 0.9 3.0 8.0 10.0 15.5 4.3 5.4 4.8 2.7 13.6 21.2 8.3 7.2 7.2 7.0 4.1 3.4 4.1 6.4 6.4 1.5 0.5 6.4 2.9 32.7 10.6 13.2 3.2 7.5 18.7 5.4 8.5 7.2 8.3 7.7 9.3 13.5 7.1 6.1 6.4 0.0 4.0 1.9 3.6 3.3 3.6 6.9 2.4 0.3 0.6 0.3 0.3 3.6 22.0 1.5 3.2 5.6 0.4 9.9 0.0 0.8 15.3 8.0 15.4 0.9 0.1 7.3 4.9 8.2 4.3 0.0 1.2 0.1 0.0 12.2 9.0 12.5 4.5 2.4 8.4 12.8 1.7 3.5 2.9 2.6 4.0 2.5 5.0 1.8 1.6 0.0 0.0 3.2 2.6 5.6 4.2 3.2 19.7 11.4 5.0 20.9 0.0 0.3 0.1 0.1 60.2 0.0 6.6 9.3 1.8 3.4 7.5 4.0 9.1 4.2 7.6 6.2 5.5 3.1 10.0 5.2 3.7 2.9 2.1 13.6 3.0 5.0 4.7 4.8 6.0 5.6 4.1 4.3 5.4 8.3 7.2 6.4 7.5 7.2 6.4 19.4 0.0 6.0 13.4 50.4 37.2 30.0 7.0 6.2 0.1 19.2 13.5 8.4 5.7 8.1 0.0 0.0 0.3 11.8 0.1 0.0 5.7 12.1 10.6 5.4 25.2 0.0 5.9 0.2 4.0 7.2 24.3 8.6 16.1 31.8 1.2 39.3 0.6 12.3 0.0 0.2 0.0 2.0 12.6 35.4 20.3 8.4 21.9 10.6 9.4 6.9 2.5 13.4 4.0 1.3 4.9 0.0 9.8 8.9 12.0 0.0 0.5 4.4 0.1 0.0 52.1 14.2 11.4 13.2 1.5 29.7 0.5 29.4 2.1 0.1 7.7 NFIL3 "E4BP4, IL3BP1, NF-IL3A, NFIL3A" ENSG00000165030 "Nuclear factor, interleukin 3 regulated" Q16649 9 91409045-91423832 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 122.0;Endometrial stromal cells: 127.4;Glandular and luminal cells: 152.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 57.9;neutrophil: 26.9" "Lineage enriched" "Detected in many" 35 "granulocytes: 57.9" "Cell line enhanced" "Detected in all" "ASC diff: 152.6;HDLM-2: 179.1;hTCEpi: 141.2;hTERT-HME1: 149.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003261 Approved Approved "Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" "Nuclear bodies" "HPA003261: AB_1079477" "unprognostic (2.18e-1)" "unprognostic (7.30e-2)" "unprognostic (4.81e-2)" "unprognostic (5.17e-3)" "unprognostic (2.13e-1)" "unprognostic (4.91e-3)" "unprognostic (1.00e-1)" "unprognostic (2.34e-2)" "unprognostic (2.54e-2)" "unprognostic (6.45e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (3.23e-6)" "unprognostic (5.44e-3)" "unprognostic (2.65e-1)" "unprognostic (1.30e-2)" "unprognostic (3.37e-2)" 149.8 84.1 11.1 37.5 12.1 211.2 80.2 16.5 17.0 75.6 14.0 55.3 18.1 62.0 15.0 22.9 94.0 47.5 60.9 11.9 13.8 36.2 121.6 68.7 9.4 15.7 14.6 92.6 30.3 15.9 31.6 47.4 14.7 59.9 21.8 33.6 22.9 16.4 133.5 59.5 29.3 52.5 13.2 20.0 44.1 18.5 13.7 18.2 26.7 24.9 11.6 61.2 64.9 12.9 18.3 10.7 12.8 7.1 152.6 117.9 62.1 21.3 61.1 23.8 35.8 7.4 8.9 7.9 12.9 17.8 69.5 11.7 14.9 21.4 27.1 179.1 6.4 8.7 10.2 62.2 124.4 12.1 50.8 120.3 141.2 21.5 149.2 13.5 10.8 20.2 14.3 89.6 15.8 9.2 1.3 16.1 9.8 31.3 9.7 29.3 13.9 11.7 29.5 8.7 16.0 11.8 14.9 13.2 21.5 22.6 7.4 15.8 11.6 52.0 11.5 45.2 10.9 76.3 18.9 3.5 27.8 11.3 9.4 57.9 1.6 10.3 1.2 0.7 0.6 0.4 0.0 0.3 0.9 0.1 0.1 0.2 26.9 0.1 1.0 0.6 0.0 0.6 11.1 12.1 16.5 17.0 11.9 13.8 15.7 14.6 14.7 13.2 13.7 12.9 60.1 22.4 32.4 1.3 7.8 46.1 14.7 15.2 22.2 17.7 31.7 28.6 81.8 8.6 16.4 0.0 16.7 9.6 75.6 23.7 9.8 10.5 24.1 122.0 127.4 34.3 16.1 1.3 5.1 9.8 24.9 55.0 9.7 152.6 9.5 27.5 13.9 29.4 10.6 20.2 5.6 9.5 6.1 25.3 78.0 6.4 10.8 75.4 33.8 2.8 15.4 17.8 6.2 3.5 2.9 7.8 9.1 11.7 24.3 25.6 17.7 10.0 10.3 15.5 6.6 60.2 83.8 0.8 3.9 23.3 39.5 23.1 22.6 6.8 9.6 13.1 NFKBID "IkappaBNS, IkBNS, TA-NFKBH" ENSG00000167604 "NFKB inhibitor delta" Q8NI38 19 35887653-35902303 "Predicted intracellular proteins, Transcription factors" "Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.9" "Cell type enhanced" "Detected in many" "B-cells: 152.7;granulocytes: 90.3;Langerhans cells: 418.5;Macrophages: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054778 Uncertain "Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" Cytosol "Nuclear bodies, Plasma membrane" "HPA054778: " "prognostic favorable (6.01e-4)" "unprognostic (9.60e-2)" "unprognostic (1.00e-1)" "unprognostic (3.28e-2)" "unprognostic (1.51e-2)" "prognostic favorable (5.43e-4)" "unprognostic (4.21e-2)" "unprognostic (7.68e-2)" "unprognostic (3.83e-1)" "unprognostic (4.10e-2)" "unprognostic (1.47e-3)" "unprognostic (5.64e-2)" "unprognostic (6.83e-2)" "unprognostic (1.04e-1)" "unprognostic (5.21e-2)" "unprognostic (2.71e-2)" "prognostic favorable (8.34e-6)" 4.0 1.8 0.7 4.4 0.6 15.9 2.5 2.7 1.6 1.9 2.1 2.3 1.1 1.8 0.0 2.1 3.0 2.4 1.5 0.8 1.4 2.5 1.5 5.6 4.8 1.4 0.9 3.3 2.1 0.9 4.2 0.8 1.2 2.2 0.8 0.7 1.6 0.5 0.4 2.2 4.0 0.5 1.0 5.4 2.0 0.4 1.3 5.2 3.9 0.2 3.1 2.2 2.0 1.7 3.3 3.0 0.6 2.0 0.3 0.5 1.4 2.0 2.4 2.1 1.5 0.7 2.6 4.0 1.5 2.1 1.9 1.7 2.1 1.6 0.9 2.3 0.4 2.4 4.9 0.7 0.5 2.1 7.0 0.7 1.0 3.9 0.9 0.5 0.8 1.8 0.5 2.4 0.4 2.6 1.7 2.5 0.8 0.6 0.6 0.9 0.4 0.8 1.8 1.4 1.0 0.8 2.7 2.1 0.2 0.5 0.9 2.1 0.8 3.3 3.0 1.5 1.4 1.7 0.6 4.6 1.8 4.9 0.5 0.0 0.9 1.7 1.4 0.6 1.1 3.3 0.6 1.1 0.9 5.5 1.0 0.6 3.2 1.5 1.1 1.2 1.5 0.5 0.7 0.6 2.7 1.6 0.8 1.4 1.4 0.9 1.2 1.0 1.3 1.7 11.7 0.0 11.3 2.9 152.7 29.7 14.3 12.9 34.7 8.0 10.9 7.5 1.1 5.7 5.6 1.8 20.9 1.3 58.9 5.7 0.0 2.5 0.1 27.8 6.8 21.5 3.0 1.7 4.9 1.0 2.8 11.3 2.0 80.8 90.3 3.8 9.3 0.3 39.2 0.0 3.4 5.7 2.0 31.0 418.5 0.4 1.2 89.4 19.6 2.8 40.0 1.0 13.4 1.5 0.5 2.8 2.1 1.9 38.1 13.8 9.2 1.7 3.9 9.2 0.0 3.3 6.7 0.4 1.0 20.7 33.4 1.0 45.3 2.4 6.2 10.0 NHLH2 "bHLHa34, HEN2, NSCL2" ENSG00000177551 "Nescient helix-loop-helix 2" Q02577 1 115836377-115843917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 7.4;esophagus: 2.3;retina: 2.1;skin 1: 3.3" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 14.8;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 7.9;Spermatocytes: 5.1;Squamous epithelial cells: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 58.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055238 Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 37: Myocytes - Muscle contraction" "Nuclear bodies" Nucleoplasm "HPA055238: AB_2682752" "unprognostic (2.20e-2)" "unprognostic (2.28e-1)" "unprognostic (1.97e-1)" "unprognostic (1.82e-1)" "unprognostic (2.17e-1)" "unprognostic (1.58e-1)" "unprognostic (4.82e-2)" "unprognostic (1.11e-2)" "unprognostic (5.26e-2)" "unprognostic (9.55e-2)" "unprognostic (2.80e-3)" "unprognostic (1.53e-1)" "unprognostic (3.09e-1)" "unprognostic (2.25e-1)" 0.0 0.0 2.0 0.0 1.4 0.0 0.1 5.9 2.1 0.3 0.2 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.0 3.2 4.0 0.0 0.0 0.2 0.0 3.8 5.1 0.0 0.0 0.0 0.2 0.0 7.4 0.2 0.0 2.1 0.4 0.1 0.2 3.3 0.0 0.0 2.5 0.0 0.2 0.4 6.7 0.0 0.0 0.0 0.0 0.0 0.7 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.4 5.9 2.1 3.2 4.0 3.8 5.1 7.4 2.5 6.7 3.0 0.0 0.0 0.0 0.3 0.0 2.8 2.8 3.3 14.8 3.9 0.0 0.6 3.4 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 1.8 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 4.5 7.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.4 0.0 3.5 0.3 5.1 3.4 7.0 2.3 0.0 0.0 0.0 0.0 0.4 NKX2-4 "NKX2.4, NKX2D" ENSG00000125816 "NK2 homeobox 4" Q9H2Z4 20 21395365-21397526 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 4.3;testis: 1.2" "Group enriched" "Detected in some" 24 "Cardiomyocytes: 1.3;Early spermatids: 3.0;Late spermatids: 2.7;Spermatocytes: 3.8;Spermatogonia: 1.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "hypothalamus: 3.4;thalamus: 4.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.5;HEK 293: 5.1;SCLC-21H: 3.2;SK-MEL-30: 4.2;WM-115: 1.2" "Region enriched" "Detected in single" 23 "hypothalamus: 2.7" "Region enriched" "Detected in single" 11 "hypothalamus: 1.1" HPA074996 Approved "Nuclear bodies" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" "HPA074996: AB_2686725" "unprognostic (3.77e-1)" "unprognostic (2.15e-1)" "unprognostic (1.68e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 4.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.1 0.2 0.1 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Biological rhythms, Cell adhesion" "Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 13.8" "Group enriched" "Detected in many" 31 "Excitatory neurons: 1484.7;Inhibitory neurons: 1700.0;Oligodendrocyte precursor cells: 4004.1;Oligodendrocytes: 1261.9" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 25.9;HUVEC TERT2: 24.9;RH-30: 26.2;WM-115: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680, CAB033261" Enhanced Uncertain "Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA NA 82000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Nuclear bodies" "CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 2.0 1.0 12.6 0.5 10.8 0.0 0.7 31.0 12.1 3.1 0.0 2.0 0.2 2.1 2.5 2.5 3.0 1.6 3.2 12.5 15.2 2.9 0.0 0.4 0.2 5.3 5.4 1.3 0.8 0.7 1.8 0.5 4.0 2.2 0.9 13.8 0.3 3.0 0.2 0.3 0.6 2.7 4.4 0.0 0.8 7.0 20.5 0.2 0.9 1.0 0.1 2.9 1.3 7.2 0.1 0.0 6.1 0.0 11.8 12.4 0.0 5.2 12.8 0.6 0.8 0.0 0.5 0.0 0.2 25.9 4.7 0.0 3.7 0.0 1.3 0.0 6.0 1.7 0.1 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 10.0 24.9 0.0 0.0 1.7 0.1 0.0 0.0 0.0 7.2 0.0 1.7 0.0 26.2 6.4 4.7 0.1 2.5 1.7 0.0 0.0 12.3 1.1 0.6 0.0 3.1 13.5 1.3 9.9 11.6 11.7 0.0 0.0 4.6 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 10.8 31.0 12.1 12.5 15.2 5.3 5.4 4.0 4.4 20.5 7.2 0.3 0.0 0.5 66.6 0.0 0.8 0.4 0.0 0.6 14.3 0.1 0.0 4.4 0.0 0.0 3.7 4.2 0.3 0.0 0.0 0.0 0.3 55.9 0.6 12.4 0.8 0.0 0.0 1484.7 0.0 0.2 8.2 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 1700.0 0.0 0.0 0.0 0.3 12.5 25.7 0.4 14.2 60.9 0.0 24.9 0.0 4004.1 1261.9 0.1 0.0 14.3 0.0 2.6 0.0 8.5 0.0 10.3 6.6 2.9 2.1 0.4 1.6 0.1 0.9 0.1 0.1 1.6 0.0 0.3 NME5 "nm23-H5, RSPH23" ENSG00000112981 "NME/NM23 family member 5" P56597 5 138115175-138139443 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 37.2;testis: 53.3" "Group enriched" "Detected in many" 4 "Early spermatids: 704.9;Endometrial ciliated cells: 205.8;Late spermatids: 256.5;Respiratory ciliated cells: 431.9;Spermatocytes: 326.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RPTEC TERT1: 29.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035648, HPA044555, HPA058103" Enhanced Approved "Nucleoplasm,Nuclear bodies" Yes NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear bodies" "HPA035648: AB_2674719, HPA044555: AB_10960286, HPA058103: " "unprognostic (2.49e-2)" "unprognostic (7.63e-4)" "unprognostic (9.97e-2)" "prognostic favorable (7.24e-5)" "unprognostic (3.27e-2)" "unprognostic (2.27e-1)" "unprognostic (3.04e-3)" "unprognostic (3.06e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-2)" "unprognostic (1.83e-2)" "unprognostic (2.14e-1)" "prognostic favorable (1.76e-4)" "unprognostic (9.14e-4)" "unprognostic (1.11e-3)" "unprognostic (3.45e-1)" "unprognostic (3.16e-2)" 1.4 6.5 9.7 0.5 10.5 0.0 4.5 9.2 11.7 8.6 18.6 2.1 0.2 4.9 23.1 1.0 37.2 8.7 3.6 10.5 9.2 20.5 0.5 4.5 0.4 10.5 12.3 5.3 4.4 24.3 8.9 0.1 12.1 5.0 1.1 12.9 3.7 4.5 0.4 0.3 0.6 3.1 9.6 0.2 2.8 53.3 11.0 0.7 12.4 0.6 0.2 2.1 0.6 8.9 0.0 0.0 3.9 4.3 0.0 0.0 0.0 0.7 0.4 0.7 0.3 0.1 1.8 0.0 1.1 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 1.7 0.0 0.0 2.1 0.0 0.9 0.0 3.8 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 29.9 0.0 6.7 2.5 0.0 0.8 4.9 1.7 0.5 1.6 0.0 0.7 0.0 0.0 0.9 0.4 0.8 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 10.5 9.2 11.7 10.5 9.2 10.5 12.3 12.1 9.6 11.0 8.9 1.0 6.4 7.5 26.8 0.3 0.6 8.5 41.1 0.0 11.7 9.0 7.9 4.3 8.6 38.1 33.1 14.6 0.5 0.1 0.3 86.1 23.8 704.9 205.8 9.2 3.5 5.4 0.0 57.9 4.0 0.0 4.2 2.6 12.7 0.0 7.7 3.6 0.6 0.1 6.7 42.2 3.3 44.7 0.0 0.3 256.5 9.0 1.4 10.6 3.7 0.6 19.1 0.0 11.1 8.1 4.2 0.3 13.9 0.0 4.8 0.2 92.3 431.9 25.8 0.0 0.5 12.6 326.8 24.7 0.0 0.3 0.0 0.8 10.9 1.7 5.9 NMNAT1 "LCA9, NMNAT, PNAT1" ENSG00000173614 "Nicotinamide nucleotide adenylyltransferase 1" Q9HAN9 1 9943428-9985501 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Disease variant, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059447 Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nuclear bodies" "HPA059447: AB_2684022" "unprognostic (1.94e-1)" "unprognostic (3.81e-3)" "unprognostic (7.54e-3)" "unprognostic (1.01e-1)" "unprognostic (3.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.56e-1)" "unprognostic (2.29e-1)" "unprognostic (4.45e-3)" "unprognostic (4.55e-2)" "unprognostic (1.12e-1)" "unprognostic (3.57e-1)" "prognostic favorable (3.85e-14)" "unprognostic (3.11e-3)" "unprognostic (1.17e-1)" "unprognostic (1.47e-3)" "unprognostic (5.16e-2)" 5.2 7.4 5.4 4.4 6.0 2.5 5.7 4.8 7.7 5.4 9.2 9.0 6.0 3.8 5.8 5.2 4.8 3.4 10.7 5.1 5.2 8.2 7.8 3.2 4.3 5.6 5.4 2.9 4.9 8.2 3.8 3.7 5.5 4.5 9.0 5.3 5.2 5.4 23.3 5.7 6.1 5.0 4.7 5.0 4.4 4.3 5.9 4.2 7.3 16.9 4.6 4.0 3.6 7.2 4.6 5.4 7.5 7.1 13.4 12.2 1.8 9.1 7.2 10.3 6.7 2.4 7.7 4.8 5.7 12.9 4.5 4.6 9.4 12.4 11.0 10.4 4.8 7.6 3.0 7.6 11.4 6.7 7.7 13.3 14.2 12.1 17.4 9.5 10.2 10.4 9.7 3.1 10.9 8.0 3.8 4.4 0.9 10.2 10.2 4.2 4.7 2.7 11.9 2.5 5.4 2.8 11.8 9.7 10.4 3.8 3.5 7.2 10.2 4.1 3.3 8.7 4.2 4.5 4.3 4.5 7.1 13.8 8.6 7.5 3.7 3.2 1.6 2.6 0.8 4.9 1.6 1.9 3.3 2.3 1.4 1.8 9.1 2.5 3.9 3.2 1.5 1.8 5.4 6.0 4.8 7.7 5.1 5.2 5.6 5.4 5.5 4.7 5.9 7.2 5.6 3.2 4.4 10.1 3.7 2.3 5.6 14.3 2.2 7.7 6.1 5.1 14.4 4.3 7.3 7.3 6.2 10.1 3.7 18.8 23.5 9.1 7.8 5.5 8.1 7.9 3.0 2.1 13.0 6.9 4.7 5.7 4.1 6.1 4.5 9.2 7.5 9.0 12.9 10.1 14.3 7.6 12.2 10.3 2.7 3.7 6.5 7.2 5.4 4.7 13.5 9.6 12.3 6.0 13.2 6.0 6.2 6.4 0.9 5.9 19.0 14.3 8.6 7.1 6.6 5.9 5.1 17.3 8.3 3.6 1.8 9.0 3.6 13.1 14.5 4.8 NOCT "Ccr4c, CCR4L, CCRN4L, NOC" ENSG00000151014 Nocturnin Q9UK39 4 139015781-139045939 "Predicted intracellular proteins" "Biological rhythms" "Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012287, HPA053714" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA012287: AB_2668640, HPA053714: AB_2682238" "unprognostic (2.16e-1)" "unprognostic (2.16e-3)" "unprognostic (1.47e-1)" "unprognostic (2.29e-1)" "unprognostic (3.36e-3)" "unprognostic (2.00e-3)" "unprognostic (3.24e-1)" "prognostic unfavorable (5.28e-5)" "unprognostic (1.86e-1)" "unprognostic (5.64e-3)" "unprognostic (4.63e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (3.52e-4)" "prognostic unfavorable (6.23e-4)" 8.2 2.0 2.8 3.2 2.6 36.3 4.5 1.7 7.1 1.4 0.0 1.8 1.2 1.6 0.5 1.9 1.0 5.5 2.9 5.0 2.9 3.6 13.9 2.9 2.1 1.5 3.4 0.6 3.0 1.7 2.2 5.6 2.6 1.0 1.6 3.4 1.6 0.5 6.5 2.2 2.2 3.0 1.4 1.7 1.7 2.2 4.4 1.9 1.5 6.1 2.6 4.9 1.3 2.9 6.5 7.1 2.9 5.7 6.6 2.7 17.2 9.4 6.9 13.7 10.0 10.3 2.8 22.7 7.4 7.3 18.4 4.5 15.8 8.9 13.7 9.5 6.1 10.3 4.4 8.7 6.2 15.3 6.0 3.2 4.4 15.4 10.4 2.7 6.3 4.3 18.6 7.0 6.6 8.0 10.0 7.8 10.1 3.0 8.1 8.5 8.6 7.7 9.4 4.3 11.3 7.3 6.0 6.8 5.6 11.2 5.0 11.2 8.7 7.7 9.4 7.2 11.8 5.9 5.5 14.0 7.0 29.8 9.9 0.8 0.5 0.3 1.0 0.6 0.5 0.4 0.4 0.5 0.2 0.7 0.3 0.6 2.7 0.6 1.6 0.6 0.3 0.1 2.8 2.6 1.7 7.1 5.0 2.9 1.5 3.4 2.6 1.4 4.4 2.9 10.9 9.6 1.1 0.0 2.8 0.0 2.7 0.0 5.7 5.6 2.7 2.5 0.0 1.5 0.6 0.0 14.6 6.1 4.7 0.6 1.9 2.3 0.7 10.4 6.3 2.6 0.0 1.7 0.0 0.2 11.8 2.9 6.1 20.6 2.5 0.8 1.1 2.6 1.5 1.7 0.0 0.4 0.0 1.6 0.0 0.1 0.9 6.9 0.0 0.0 0.1 0.6 4.1 0.0 0.0 2.5 0.0 0.0 5.5 2.5 2.6 4.0 0.7 5.2 0.0 5.4 4.3 1.0 3.9 6.5 0.0 12.0 4.3 0.8 0.2 2.3 NOP10 "MGC70651, NOLA3, NOP10P" ENSG00000182117 "NOP10 ribonucleoprotein" Q9NPE3 15 34341719-34343136 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 878.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059198 Supported Supported "Nuclear bodies" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 52: Non-specific - Ribosome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" "HPA059198: AB_2683945" "unprognostic (2.65e-1)" "unprognostic (1.72e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.48e-5)" "unprognostic (3.12e-1)" "unprognostic (2.39e-3)" "unprognostic (8.11e-3)" "unprognostic (9.99e-2)" "unprognostic (2.28e-1)" "unprognostic (8.31e-3)" "unprognostic (1.77e-3)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" "unprognostic (2.61e-1)" "unprognostic (2.59e-1)" "unprognostic (1.05e-1)" "unprognostic (6.77e-3)" 154.9 145.7 119.9 104.8 122.2 208.3 151.7 124.3 149.6 118.6 120.1 164.3 109.3 91.9 285.5 175.0 120.0 90.2 179.4 120.7 129.1 167.7 241.1 148.0 146.2 125.3 123.2 63.3 90.4 142.5 90.5 126.8 125.6 98.2 202.1 48.4 93.6 102.2 184.4 114.4 110.2 163.6 125.1 167.5 119.0 41.7 132.7 213.2 112.8 227.4 218.6 213.6 121.2 132.8 212.2 471.9 325.1 205.3 520.4 443.7 172.4 281.3 471.8 555.4 703.6 358.5 200.3 146.7 328.6 457.7 627.3 292.8 599.1 502.8 526.0 216.0 341.7 461.6 396.5 523.7 724.2 303.2 228.6 513.8 471.0 508.3 588.1 305.0 795.6 399.9 417.0 206.4 695.3 295.8 234.0 486.1 319.8 628.7 453.3 252.2 223.4 241.8 754.0 475.5 210.4 279.5 202.1 211.7 221.4 442.9 235.4 619.4 331.2 295.3 219.6 418.2 242.7 198.9 427.1 406.8 377.5 495.8 214.5 1080.4 852.4 889.6 368.7 867.8 394.9 723.0 476.7 442.7 636.3 639.5 503.6 441.2 2797.7 534.1 696.7 824.6 700.1 1065.2 119.9 122.2 124.3 149.6 120.7 129.1 125.3 123.2 125.6 125.1 132.7 132.8 202.7 109.0 153.3 7.2 175.1 239.5 179.8 470.8 130.3 30.9 158.6 195.2 299.7 143.0 273.9 149.0 12.5 210.7 158.0 286.1 446.1 365.6 15.0 230.7 148.1 257.5 195.7 169.5 6.7 351.9 402.1 154.2 122.9 234.0 164.0 81.3 240.9 359.7 878.9 13.5 7.1 283.9 315.3 504.5 321.5 16.8 103.8 309.2 190.3 12.2 322.1 70.0 250.3 5.0 10.0 600.6 362.9 100.1 209.5 251.2 304.2 668.9 298.6 33.7 105.2 91.7 336.0 19.0 101.8 224.8 302.8 214.0 154.2 128.7 241.0 451.3 NOVA2 "ANOVA, NOVA-2, NOVA3" ENSG00000104967 "NOVA alternative splicing regulator 2" Q9UNW9 19 45933734-45974044 "Human disease related genes, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7" "Cell type enhanced" "Detected in some" "Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9" "Cancer enriched" "Detected in many" 4 "glioma: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045607 Enhanced Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" No No "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Nuclear bodies" "HPA045607: AB_10962628" "unprognostic (9.84e-2)" "unprognostic (2.07e-1)" "unprognostic (9.68e-2)" "unprognostic (2.01e-1)" "unprognostic (1.79e-1)" "unprognostic (3.04e-3)" "unprognostic (1.46e-1)" "unprognostic (6.21e-2)" "unprognostic (2.36e-1)" "unprognostic (3.02e-3)" "unprognostic (6.42e-5)" "unprognostic (1.16e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (5.05e-2)" "unprognostic (2.54e-1)" "unprognostic (1.41e-1)" "unprognostic (8.31e-2)" 6.7 1.9 12.4 0.7 15.1 0.0 5.7 0.5 16.7 3.2 0.0 1.8 0.6 3.4 0.6 1.4 2.9 1.4 6.7 16.0 5.8 4.7 1.0 9.3 0.5 4.6 3.0 1.2 1.1 1.0 6.2 3.9 3.6 2.3 0.5 5.6 1.1 0.8 2.3 1.1 1.7 2.0 0.6 1.5 1.5 2.0 4.6 0.4 4.5 2.5 0.2 2.5 2.0 9.8 0.0 0.1 9.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 1.3 0.0 0.0 11.0 0.4 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.0 5.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 15.1 0.5 16.7 16.0 5.8 4.6 3.0 3.6 0.6 4.6 9.8 39.4 0.0 0.0 5.9 0.1 0.6 0.2 0.0 0.6 56.7 0.1 0.5 3.4 1.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.1 32.0 0.0 0.0 21.8 0.2 0.0 1.2 0.0 0.1 0.0 0.1 42.5 0.5 0.1 21.9 20.9 0.0 0.0 1.6 1.5 3.5 0.0 0.1 0.0 9.4 0.0 1.3 0.0 11.6 9.5 0.2 0.0 0.4 1.2 0.3 0.0 0.0 0.0 3.3 0.0 0.6 0.6 2.4 2.3 0.3 0.1 0.0 0.5 0.4 0.0 0.3 NPAT "E14, p220" ENSG00000149308 "Nuclear protein, coactivator of histone transcription" Q14207 11 108157215-108222638 "Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045908, HPA066370" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA045908: AB_2679493, HPA066370: AB_2685665" "unprognostic (6.93e-2)" "unprognostic (5.81e-2)" "unprognostic (1.09e-2)" "unprognostic (3.82e-2)" "unprognostic (5.37e-2)" "unprognostic (2.60e-2)" "unprognostic (4.89e-2)" "unprognostic (7.38e-2)" "unprognostic (5.03e-3)" "unprognostic (1.26e-1)" "unprognostic (7.04e-2)" "unprognostic (4.14e-2)" "unprognostic (2.76e-3)" "unprognostic (1.97e-1)" "unprognostic (1.86e-1)" "unprognostic (5.76e-2)" "unprognostic (1.93e-1)" 4.6 4.2 1.6 8.1 2.1 4.5 6.9 7.4 2.8 6.4 3.9 5.4 4.1 6.7 5.9 4.6 4.6 4.7 4.3 1.4 2.4 5.6 5.6 5.4 14.9 2.6 3.0 7.6 3.1 6.8 3.2 6.6 2.4 5.6 6.2 6.6 4.4 4.4 3.1 5.2 4.9 5.1 2.2 9.9 5.9 7.0 2.3 12.0 8.3 5.3 13.3 7.0 3.8 3.0 7.9 6.3 9.7 12.1 11.7 8.5 7.9 11.6 14.6 10.0 14.9 13.0 16.8 13.5 15.2 7.3 11.2 14.6 13.4 11.7 17.8 12.2 5.3 22.5 6.8 6.7 5.0 17.0 14.3 8.1 6.7 17.6 11.2 7.8 14.3 15.5 21.2 6.5 14.1 3.9 21.0 9.1 8.0 12.6 8.7 14.3 13.6 18.5 6.4 11.3 10.3 9.5 14.9 8.8 11.3 10.1 10.0 8.3 11.8 17.3 9.3 10.3 10.5 4.5 6.1 51.9 4.3 12.4 13.7 6.8 1.6 2.9 4.9 2.6 5.5 4.1 5.7 6.3 1.8 4.3 8.9 7.5 1.9 5.3 2.9 1.5 4.6 3.2 1.6 2.1 7.4 2.8 1.4 2.4 2.6 3.0 2.4 2.2 2.3 3.0 23.1 19.2 13.2 24.2 40.8 16.3 16.4 10.5 27.3 16.5 12.0 7.6 15.2 4.3 13.2 12.9 29.2 10.3 32.8 5.6 1.9 8.4 4.9 11.1 15.0 21.1 10.3 29.5 25.5 6.8 8.2 15.9 12.2 14.2 19.6 16.7 22.9 9.1 7.4 10.1 32.2 7.9 8.2 13.0 12.8 3.2 15.8 13.8 8.8 19.7 14.5 11.8 27.8 19.6 24.3 6.8 6.5 17.0 37.8 14.1 7.1 5.6 10.9 16.9 6.6 19.8 13.1 26.2 32.5 14.0 13.2 14.1 35.3 14.9 8.7 15.9 NPHP4 "KIAA0673, POC10, SLSN4" ENSG00000131697 "Nephrocystin 4" O75161 1 5862811-5992473 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ciliopathy, Disease variant, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 24.2;Cone photoreceptor cells: 33.3;Excitatory neurons: 47.1;Inhibitory neurons: 30.8" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 2.7;hippocampal formation: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063852, HPA065526" Approved Approved "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "Nuclear bodies, Vesicles" "HPA063852: , HPA065526: AB_2685505" "unprognostic (1.82e-1)" "unprognostic (1.57e-2)" "unprognostic (1.76e-1)" "unprognostic (7.30e-2)" "unprognostic (5.83e-2)" "unprognostic (2.53e-2)" "unprognostic (1.08e-2)" "unprognostic (1.95e-1)" "unprognostic (2.52e-1)" "unprognostic (1.23e-2)" "unprognostic (7.49e-3)" "unprognostic (9.00e-2)" "unprognostic (1.75e-2)" "unprognostic (2.96e-2)" "unprognostic (1.34e-1)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" 2.7 2.2 1.0 2.3 0.8 3.7 2.7 0.0 2.7 2.9 2.5 2.2 2.1 2.8 2.3 2.0 7.9 2.1 1.9 3.1 0.0 2.2 1.3 3.0 2.3 0.0 0.0 2.9 2.4 2.7 7.8 1.6 0.0 2.2 1.2 2.4 2.2 2.3 2.2 4.9 2.1 2.2 0.0 2.2 2.0 5.3 0.0 2.5 6.7 1.9 1.1 2.1 2.5 0.0 7.8 4.8 5.4 4.3 4.7 6.8 4.1 3.9 3.9 5.3 4.2 4.1 6.5 4.0 9.6 4.6 3.6 7.4 2.7 6.6 2.7 5.1 7.3 3.4 8.1 4.1 3.7 6.5 5.1 5.6 3.2 6.3 3.9 3.4 3.8 9.4 6.2 4.1 2.4 5.9 8.3 7.1 1.0 4.0 5.5 7.1 3.4 6.5 2.6 1.0 17.0 5.5 6.1 4.5 6.5 2.3 6.0 7.2 3.7 7.6 3.2 13.0 4.8 5.0 7.0 4.2 3.4 8.3 2.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 1.0 0.8 0.0 2.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 1.1 24.2 1.3 4.0 1.2 1.8 3.4 7.3 3.0 3.6 3.1 4.3 3.9 3.7 33.3 0.6 2.2 2.1 1.9 1.6 2.0 10.2 3.3 2.9 3.6 3.2 47.1 1.8 0.5 3.5 4.1 3.0 0.0 4.0 1.8 1.5 2.0 5.0 30.8 2.2 2.0 3.5 3.7 1.4 4.1 2.4 10.6 14.0 1.8 6.3 2.1 10.6 17.3 2.1 2.2 2.2 2.6 1.8 1.1 1.9 10.9 18.2 6.6 1.6 2.7 11.6 6.5 1.9 5.3 1.1 1.7 4.0 1.7 1.1 NR1D1 "ear-1, hRev, Rev-ErbAalpha, REVERBA, REVERBalpha, THRA1, THRAL" ENSG00000126368 "Nuclear receptor subfamily 1 group D member 1" P20393 17 40092793-40100589 "Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 325.5" "Cell type enhanced" "Detected in all" "Squamous epithelial cells: 95.5;Suprabasal keratinocytes: 81.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.5" "Group enriched" "Detected in many" 6 "monocytes: 5.5;T-cells: 18.5" "Cell line enhanced" "Detected in all" "Karpas-707: 60.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007935 Uncertain Supported "Nuclear bodies" NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 2: Karpas-707 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Nuclear bodies" "HPA007935: AB_10601277" "unprognostic (1.38e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (1.94e-4)" "unprognostic (2.53e-1)" "unprognostic (2.24e-2)" "unprognostic (1.05e-1)" "unprognostic (4.50e-2)" "unprognostic (1.03e-1)" "prognostic favorable (1.36e-4)" "unprognostic (1.93e-3)" "unprognostic (9.93e-3)" "unprognostic (2.73e-1)" "unprognostic (9.15e-3)" "unprognostic (4.54e-3)" "unprognostic (2.49e-1)" "unprognostic (3.09e-1)" "unprognostic (1.34e-1)" 72.3 53.7 23.5 6.3 27.0 5.4 63.1 52.9 49.7 109.6 10.6 53.3 14.3 35.8 4.5 42.5 27.7 7.1 60.8 24.9 17.2 38.0 43.2 49.2 9.3 18.1 20.9 71.3 24.3 9.0 32.0 6.0 15.9 40.5 4.0 50.4 52.9 16.3 99.0 325.5 23.0 7.5 12.9 11.6 31.5 12.5 34.0 6.3 32.1 38.1 5.4 42.5 96.5 25.2 5.5 7.8 1.6 6.2 9.0 6.2 2.2 11.9 19.5 3.9 4.9 5.1 19.5 6.7 6.9 13.8 12.9 15.4 4.1 18.0 2.9 5.6 4.1 4.8 7.9 13.5 14.6 7.2 6.9 13.5 12.8 13.3 28.2 12.6 4.9 7.7 7.2 60.6 3.8 3.8 10.7 6.1 3.0 10.8 12.3 7.5 2.2 20.7 5.4 4.9 5.1 2.9 7.6 9.7 12.4 2.7 4.6 5.8 4.7 17.2 16.7 14.1 9.5 21.5 35.7 2.6 23.4 4.0 13.6 0.0 0.5 0.0 4.4 2.0 18.5 1.7 5.5 6.4 1.1 2.1 4.8 3.5 0.2 1.0 5.5 1.4 8.0 1.8 23.5 27.0 52.9 49.7 24.9 17.2 18.1 20.9 15.9 12.9 34.0 25.2 16.4 3.2 2.0 17.3 5.7 64.5 47.5 20.5 67.2 71.4 9.4 15.1 5.7 8.6 11.9 1.8 4.2 2.6 4.9 26.0 7.9 16.1 2.3 25.4 30.6 18.6 8.3 3.6 7.1 11.8 1.2 26.5 31.1 64.2 2.5 2.7 6.8 31.8 2.5 42.1 6.2 7.2 8.2 3.4 19.4 1.5 21.8 7.7 19.6 8.4 1.2 39.0 5.2 5.0 1.2 26.0 14.7 38.7 10.5 35.4 58.8 7.9 5.0 29.7 6.6 9.6 19.4 2.0 11.1 95.5 81.1 2.3 11.9 13.7 6.0 28.7 NR2E1 "TLL, TLX, XTLL" ENSG00000112333 "Nuclear receptor subfamily 2 group E member 1" Q9Y466 6 108166022-108188805 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 57 "brain: 19.7;choroid plexus: 14.3;retina: 30.6" "Cell type enhanced" "Detected in some" "Astrocytes: 22.2;Inhibitory neurons: 8.5;Muller glia cells: 44.9;Oligodendrocyte precursor cells: 4.5" "Cancer enriched" "Detected in single" 14 "glioma: 6.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;GAMG: 1.4;HEK 293: 1.0;U-251 MG: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036954, HPA055642" Uncertain Approved "Nuclear bodies" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 28: BEWO - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" "Nuclear bodies" "HPA036954: AB_10670958, HPA055642: AB_2682871" "unprognostic (3.43e-1)" "unprognostic (1.41e-1)" "unprognostic (1.77e-1)" "unprognostic (9.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.00e-1)" "unprognostic (1.78e-2)" "unprognostic (7.31e-2)" "unprognostic (8.64e-2)" "unprognostic (9.59e-8)" "unprognostic (2.87e-1)" "unprognostic (2.49e-1)" "unprognostic (3.07e-1)" 0.0 0.3 16.9 0.0 19.7 0.0 0.0 7.3 18.6 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 14.3 0.1 0.0 0.0 0.0 7.4 13.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 30.6 0.1 0.0 0.0 0.1 0.0 0.0 7.2 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 19.7 7.3 18.6 16.6 14.3 7.4 13.0 7.8 7.2 16.4 12.9 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.9 0.0 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NRIP2 DKFZP761G1913 ENSG00000053702 "Nuclear receptor interacting protein 2" Q9BQI9 12 2825348-2835544 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.4" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 6.2;Rod photoreceptor cells: 8.8;Sertoli cells: 26.3;Smooth muscle cells: 23.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "basophil: 3.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039197, HPA039860" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Cluster 34: Basophils - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA039197: AB_10673416, HPA039860: AB_10794203" "unprognostic (3.28e-3)" "unprognostic (3.83e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (2.10e-2)" "unprognostic (8.11e-2)" "unprognostic (4.26e-3)" "unprognostic (5.66e-2)" "unprognostic (4.42e-3)" "unprognostic (2.89e-1)" "unprognostic (4.39e-2)" "prognostic favorable (8.69e-5)" "unprognostic (7.15e-2)" "unprognostic (2.82e-2)" "unprognostic (7.55e-2)" "unprognostic (5.23e-2)" "unprognostic (1.00e-1)" "unprognostic (8.97e-2)" 5.4 3.9 7.7 3.6 12.4 4.0 5.1 23.4 10.2 7.0 4.8 5.3 2.4 7.4 7.2 2.4 4.8 5.9 5.2 5.8 10.6 12.0 1.6 1.8 4.1 12.4 10.0 8.4 3.0 0.6 2.8 2.6 12.9 4.1 3.0 3.9 3.6 4.9 4.9 2.6 4.7 4.9 8.1 9.1 3.6 2.1 12.0 3.0 5.5 7.5 2.6 4.3 4.7 13.3 0.4 0.9 1.5 0.8 0.0 0.0 1.8 1.1 0.0 0.0 0.0 2.3 1.1 1.2 0.3 0.0 0.3 0.8 0.0 0.0 0.0 0.9 1.3 2.0 2.9 0.2 0.0 2.4 1.4 0.0 0.0 0.0 0.0 2.2 0.0 1.3 1.1 2.7 0.0 1.0 1.5 1.2 1.5 0.9 0.4 0.9 1.6 0.7 0.0 1.5 1.1 1.7 0.8 1.2 0.3 2.7 0.8 0.4 1.2 0.6 0.7 0.9 1.6 0.4 0.1 1.8 1.5 1.1 0.8 3.7 0.3 0.1 0.5 0.2 0.3 0.7 0.4 0.5 0.2 0.6 0.8 0.3 0.1 0.4 0.1 0.3 0.1 0.1 7.7 12.4 23.4 10.2 5.8 10.6 12.4 10.0 12.9 8.1 12.0 13.3 0.6 0.0 1.1 0.0 0.2 0.1 0.5 0.0 0.0 5.0 0.1 0.9 1.3 0.0 0.0 1.8 6.2 0.3 0.3 0.0 0.0 0.0 1.6 0.2 0.9 0.6 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.3 0.0 0.2 0.4 0.0 0.1 3.3 3.3 0.0 0.0 0.6 0.3 1.8 0.3 0.5 0.0 2.8 0.0 0.6 3.1 0.5 4.9 0.0 0.0 5.3 0.0 0.3 0.0 0.2 0.0 8.8 26.3 0.5 23.1 0.1 0.3 0.1 0.1 0.0 1.1 0.4 0.0 0.1 NSMCE2 "C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7" ENSG00000156831 "NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase" Q96MF7 8 125091679-125367120 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway" Transferase "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 136.1;Excitatory neurons: 150.1;Inhibitory neurons: 156.8;Microglial cells: 157.4;Oligodendrocyte precursor cells: 139.2;Oligodendrocytes: 386.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051614, HPA065734" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 52: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA051614: AB_2681551, HPA065734: AB_2685549" "unprognostic (1.14e-3)" "unprognostic (1.29e-1)" "unprognostic (6.56e-2)" "unprognostic (1.22e-3)" "unprognostic (8.65e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (7.54e-4)" "unprognostic (3.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.09e-2)" "unprognostic (1.17e-1)" "unprognostic (7.53e-2)" "unprognostic (2.61e-2)" "unprognostic (6.85e-2)" 19.9 18.1 11.0 14.1 12.8 30.3 23.7 12.4 12.9 17.0 13.4 18.6 12.5 15.8 18.6 17.0 13.4 15.9 23.8 11.2 12.4 18.9 17.8 14.2 21.7 12.2 11.9 19.0 12.8 17.8 11.2 19.6 12.6 13.2 17.5 16.7 16.0 13.9 33.6 15.8 12.3 16.1 11.8 14.5 16.6 15.5 12.7 26.0 18.1 27.2 26.1 20.7 14.7 16.1 43.0 36.3 42.3 26.9 32.7 48.9 20.5 33.5 62.5 58.2 67.0 23.4 39.9 53.2 38.5 32.0 42.9 31.1 33.4 28.2 58.8 60.0 32.4 75.4 20.0 34.1 47.7 22.8 22.1 36.5 38.4 33.6 43.6 38.8 53.2 27.5 44.1 34.2 51.4 74.3 58.9 20.9 9.3 48.4 48.0 33.3 29.4 48.6 35.5 32.1 28.0 29.7 40.1 119.2 56.3 24.9 50.9 25.9 33.3 22.3 62.9 27.8 48.3 45.1 86.6 67.6 35.4 43.4 35.3 12.9 23.9 69.4 22.0 21.7 24.3 25.0 23.1 24.8 24.4 25.5 23.7 25.9 11.3 22.0 23.3 14.2 37.6 24.5 11.0 12.8 12.4 12.9 11.2 12.4 12.2 11.9 12.6 11.8 12.7 16.1 21.8 9.6 13.1 136.1 22.0 23.8 36.3 39.1 21.1 23.8 23.3 24.8 20.1 21.5 26.0 11.0 16.7 34.2 20.3 16.2 27.4 33.1 28.0 26.4 19.7 23.0 13.8 36.2 150.1 42.5 27.8 21.4 13.7 20.7 25.4 24.1 23.2 13.7 44.3 15.2 156.8 17.7 18.3 26.5 24.3 9.9 23.3 24.4 17.8 157.4 29.4 18.4 20.6 139.2 386.0 34.2 19.5 24.5 20.2 28.1 20.6 35.2 23.4 26.4 6.6 20.7 23.4 44.4 31.7 16.0 18.9 46.7 24.6 20.9 19.8 37.6 NT5C3A "cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1" ENSG00000122643 "5'-nucleotidase, cytosolic IIIA" Q9H0P0 7 33014114-33062797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 87.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 191.0;Paneth cells: 186.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010520, HPA010630, HPA029058" Uncertain Supported "Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 10000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 51: Myeloid cells - Hemostasis" "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380" "unprognostic (7.50e-2)" "unprognostic (3.10e-1)" "unprognostic (1.14e-1)" "unprognostic (2.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.56e-2)" "prognostic unfavorable (2.42e-4)" "unprognostic (3.25e-2)" "unprognostic (3.12e-2)" "unprognostic (2.82e-3)" "unprognostic (2.08e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (9.37e-2)" "unprognostic (2.05e-1)" "unprognostic (2.12e-3)" "unprognostic (3.43e-3)" 12.4 14.3 11.4 26.1 11.4 32.6 21.3 15.2 15.6 12.6 10.8 51.9 40.0 16.9 14.3 18.6 15.9 23.4 16.6 11.5 11.5 22.4 11.8 17.6 30.8 11.1 11.8 13.4 21.4 9.7 7.5 16.3 11.5 12.3 51.0 20.4 9.7 10.0 87.4 28.7 37.3 13.2 12.7 22.9 27.0 9.5 12.0 22.5 17.1 51.0 45.8 23.8 14.4 13.1 42.2 27.6 25.2 29.6 21.2 16.1 20.3 44.8 30.5 29.2 38.9 19.9 115.1 100.4 27.7 29.6 48.3 63.8 28.3 30.8 40.4 16.2 36.2 54.7 36.5 28.7 23.3 55.6 36.9 21.7 23.8 35.9 63.0 16.4 22.2 33.2 43.3 24.8 37.3 29.9 25.0 87.8 27.8 47.1 31.2 25.9 22.9 60.0 87.8 39.8 28.1 37.0 31.1 52.4 66.6 24.5 35.2 33.5 19.8 25.1 20.9 42.6 55.7 50.6 69.0 54.8 20.6 34.9 42.5 112.5 25.9 82.5 26.6 32.7 30.6 64.0 34.2 30.8 22.1 63.6 34.5 29.1 103.8 28.2 39.2 20.6 56.2 37.9 11.4 11.4 15.2 15.6 11.5 11.5 11.1 11.8 11.5 12.7 12.0 13.1 39.1 22.4 13.7 30.7 85.1 46.8 40.9 85.3 47.8 23.9 22.6 18.9 16.9 32.9 40.4 16.5 41.7 36.9 42.5 191.0 29.4 34.4 5.7 40.9 21.0 40.8 119.6 127.1 45.3 79.0 31.6 35.2 42.8 21.4 17.7 38.3 30.0 18.9 25.0 1.7 49.4 98.9 40.7 31.2 23.5 5.0 33.8 111.4 26.6 29.0 37.0 23.4 55.6 48.2 52.4 48.3 186.6 22.2 43.8 45.7 91.8 84.8 53.7 27.1 13.1 30.7 24.9 46.4 24.0 35.5 38.9 28.3 53.7 23.3 71.0 65.9 NUDT21 "CFIM25, CPSF5" ENSG00000167005 "Nudix hydrolase 21" O43809 16 56429133-56452199 "Predicted intracellular proteins" "Differentiation, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 445.9;Late spermatids: 230.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019863, HPA074228" Uncertain Supported "Nuclear bodies,Centriolar satellite" NA NA 12000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "Centriolar satellite" "HPA019863: AB_2670299, HPA074228: AB_2686675" "unprognostic (4.95e-2)" "unprognostic (4.42e-2)" "unprognostic (4.25e-3)" "unprognostic (1.31e-1)" "unprognostic (5.85e-3)" "unprognostic (1.29e-2)" "unprognostic (8.80e-3)" "unprognostic (6.87e-3)" "unprognostic (4.09e-2)" "unprognostic (3.19e-1)" "unprognostic (3.76e-3)" "unprognostic (4.27e-2)" "unprognostic (1.39e-2)" "unprognostic (2.85e-1)" "unprognostic (1.02e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-2)" 29.5 32.0 23.4 37.7 27.1 64.4 39.4 27.0 28.7 39.7 19.9 39.3 49.3 39.2 27.4 39.9 35.9 28.4 31.4 28.9 32.2 42.6 37.0 27.7 56.7 20.7 22.5 55.8 32.3 40.2 22.0 38.5 25.3 29.6 40.1 36.0 30.5 32.1 28.0 25.0 34.7 34.7 22.6 34.5 34.0 71.0 22.6 58.3 37.7 37.9 65.7 39.7 26.0 26.9 143.8 79.3 144.3 116.8 78.0 110.0 131.1 96.2 112.2 135.9 94.7 167.7 146.6 193.5 98.5 90.5 84.8 129.8 190.2 116.8 206.0 67.2 78.5 126.6 73.0 146.2 63.6 183.0 124.8 65.5 83.4 113.7 80.3 78.2 127.5 145.8 137.5 69.1 111.2 88.1 195.5 130.1 178.9 106.6 133.0 286.2 196.3 165.4 94.5 121.9 161.1 107.2 184.0 88.0 77.6 99.2 107.6 106.5 74.8 107.4 153.3 93.1 104.1 103.1 120.0 364.7 71.4 117.9 100.1 32.0 24.9 32.9 28.0 26.1 27.7 22.8 29.4 26.1 25.8 20.9 27.1 27.4 27.2 25.5 29.2 19.9 49.6 22.2 23.4 27.1 27.0 28.7 28.9 32.2 20.7 22.5 25.3 22.6 22.6 26.9 30.7 28.9 37.8 23.8 45.5 60.9 52.9 78.4 47.8 19.5 46.3 34.3 39.3 27.1 54.4 42.3 18.8 63.8 29.1 29.2 66.5 63.4 445.9 32.9 40.2 45.2 31.1 69.9 26.5 86.5 90.6 45.8 25.0 38.7 35.5 35.9 48.9 39.1 67.2 35.3 27.9 57.7 20.3 58.8 50.5 230.2 44.7 42.7 37.4 13.1 61.1 25.6 18.6 18.1 34.6 62.5 36.0 41.0 70.0 60.3 49.2 78.3 47.7 24.2 39.5 33.9 59.6 217.4 96.9 67.4 60.0 68.3 49.7 39.5 64.0 70.1 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422573-87459455 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 160.7" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" NA NA 9900 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885" "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favorable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favorable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 23.6 36.1 20.8 16.2 21.4 6.7 19.7 25.5 38.5 27.6 39.1 27.0 42.6 24.8 32.2 19.6 24.9 16.2 28.8 21.9 24.7 40.4 46.6 23.0 13.7 21.0 20.5 26.7 67.6 55.3 29.1 19.9 21.9 30.4 27.1 20.1 28.1 23.8 42.1 16.6 40.3 23.8 19.6 14.7 22.3 22.5 22.1 13.4 28.8 45.0 14.8 22.4 24.3 26.0 30.8 25.6 34.0 19.8 67.6 39.6 26.0 59.8 35.6 21.3 21.1 17.1 53.1 47.6 58.9 47.6 41.0 21.1 32.1 38.1 33.2 34.5 24.0 13.4 34.5 31.8 42.4 25.6 21.2 41.5 52.4 25.6 22.6 45.5 41.6 13.7 40.3 30.0 38.7 33.4 39.1 23.2 29.1 68.5 12.0 45.0 31.8 27.0 160.7 24.2 41.3 28.7 37.6 63.0 30.8 44.5 36.8 38.2 43.7 34.7 34.3 25.8 27.8 21.5 18.7 37.9 51.3 21.9 48.2 1.6 17.9 5.9 19.1 21.2 18.2 22.2 18.5 19.5 21.4 18.8 22.5 26.0 1.8 15.6 24.0 20.6 19.0 16.0 20.8 21.4 25.5 38.5 21.9 24.7 21.0 20.5 21.9 19.6 22.1 26.0 32.6 67.3 44.8 20.2 14.9 9.9 40.4 45.0 9.6 15.3 11.3 13.1 40.9 30.0 55.0 23.9 27.1 33.2 13.1 21.0 41.1 44.7 28.6 26.0 26.2 25.8 16.8 6.7 21.7 36.5 32.5 29.4 8.6 27.0 20.8 23.3 18.2 47.5 33.2 6.7 24.0 18.0 40.7 12.7 11.0 11.5 25.4 14.7 10.6 20.6 16.4 26.8 8.2 18.6 24.8 29.4 37.0 26.7 15.8 32.9 55.7 56.2 41.0 18.6 26.3 36.9 23.7 44.5 23.6 15.7 9.5 37.6 12.1 29.8 24.9 27.3 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "Nuclear FMR1 interacting protein 2" Q7Z417 17 29255839-29294148 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 79.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 15.3 14.9 4.4 22.7 3.6 79.9 12.5 10.3 20.4 12.7 11.7 14.9 16.2 11.5 11.9 17.2 10.9 14.0 13.6 5.1 19.9 13.0 24.0 21.0 19.8 12.1 14.7 12.0 14.7 18.4 11.0 29.6 11.0 12.1 13.0 23.1 15.5 9.8 15.9 12.1 13.2 10.3 2.1 20.7 18.7 14.2 10.8 18.0 13.5 17.6 17.5 16.4 14.2 14.1 42.5 67.1 38.9 27.2 32.8 38.0 65.1 41.3 24.8 31.1 28.4 75.0 22.5 68.5 60.1 28.5 27.7 58.6 31.4 28.9 39.3 74.0 55.9 51.8 64.7 19.8 30.3 66.6 53.8 33.1 34.5 34.4 36.7 35.9 23.2 24.8 86.2 49.5 32.1 34.8 70.6 30.1 40.2 32.2 24.9 57.2 66.8 29.4 26.1 68.4 37.1 23.5 73.6 136.6 44.6 51.5 47.3 44.2 38.5 59.1 59.1 35.0 71.3 68.4 68.9 79.3 39.0 34.9 51.6 13.6 6.1 8.5 5.6 5.9 4.3 8.5 5.5 6.2 5.2 7.6 7.0 5.9 25.4 5.1 9.6 12.1 3.2 2.3 4.4 3.6 10.3 20.4 5.1 19.9 12.1 14.7 11.0 2.1 10.8 14.1 139.7 80.1 67.0 58.1 76.8 99.5 78.2 40.0 118.4 55.3 105.0 124.8 81.7 38.6 69.3 31.3 95.9 69.2 124.3 72.6 15.6 33.9 35.2 108.2 139.0 85.9 48.3 55.6 47.4 27.9 31.3 86.4 82.6 154.2 46.2 41.2 55.0 54.6 44.6 57.2 47.1 62.5 20.3 74.7 108.8 24.9 35.4 122.9 40.9 41.2 50.0 35.2 37.0 44.7 85.9 37.4 43.1 35.0 65.2 91.8 26.5 27.6 88.8 60.6 19.7 171.7 78.5 36.6 29.8 120.8 97.7 182.0 93.8 51.8 57.1 111.9 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Cell type enhanced" "Detected in some" "Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "MCF7: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies" "HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.1 0.0 0.2 0.0 0.7 0.1 0.0 2.4 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.7 0.6 0.1 0.1 0.0 0.3 0.0 0.8 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 26.6 0.5 0.0 0.2 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.8 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.7 2.4 0.9 0.4 0.3 0.7 0.6 0.8 0.3 0.5 2.3 0.6 0.0 0.0 6.2 0.5 0.3 0.1 0.1 0.0 0.0 0.3 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 20.3 0.7 0.6 0.9 0.0 0.4 7.0 0.2 0.1 0.5 0.0 1.5 0.0 0.1 0.0 0.0 0.2 0.0 8.4 0.1 0.0 0.0 0.6 8.5 0.9 0.8 0.0 2.8 0.0 0.0 0.0 4.5 19.2 0.0 0.0 1.2 1.7 0.1 0.0 0.1 0.1 0.0 6.6 1.8 0.3 28.2 5.1 0.3 0.6 0.0 0.4 0.1 0.1 0.3 NUTM2A FAM22A ENSG00000184923 "NUT family member 2A" Q8IVF1 10 87225448-87236908 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 10.2" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies" "HPA064635: " "unprognostic (1.75e-2)" "unprognostic (1.33e-2)" "unprognostic (1.03e-1)" "unprognostic (8.29e-2)" "unprognostic (5.67e-2)" "unprognostic (8.08e-2)" "unprognostic (1.75e-2)" "unprognostic (6.84e-2)" "unprognostic (2.46e-3)" "unprognostic (1.75e-2)" "unprognostic (7.24e-2)" "unprognostic (1.40e-1)" "unprognostic (4.24e-3)" "unprognostic (1.35e-1)" "unprognostic (1.11e-1)" "unprognostic (1.96e-2)" "unprognostic (2.65e-1)" 1.4 1.1 1.8 0.5 2.6 0.9 1.1 0.8 2.8 0.9 0.0 1.3 0.7 1.4 0.9 0.9 1.0 0.5 2.2 1.2 1.7 1.3 1.3 1.1 0.6 3.2 2.2 1.3 1.7 1.4 1.5 0.7 2.5 1.6 0.5 0.6 2.4 0.4 1.3 1.8 1.2 0.4 1.1 1.3 1.5 2.0 2.9 1.0 1.5 1.6 0.3 1.1 1.2 4.4 1.4 0.1 0.8 0.0 1.3 0.6 0.7 0.6 1.3 0.6 0.4 0.3 0.6 1.2 0.1 0.0 0.2 1.1 0.0 0.9 0.1 0.4 1.0 2.0 0.3 0.3 0.6 0.8 10.2 0.4 3.2 1.0 1.0 1.2 0.0 1.9 1.9 0.3 0.1 1.0 1.0 2.0 2.3 0.0 0.3 1.5 0.1 0.0 0.4 0.1 1.2 2.0 0.6 0.5 0.5 0.1 0.6 0.8 1.4 0.0 0.3 0.6 0.2 0.0 0.2 0.6 0.6 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.6 0.8 2.8 1.2 1.7 3.2 2.2 2.5 1.1 2.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 NUTM2B "bA119F19.1, FAM22B" ENSG00000188199 "NUT family member 2B" A6NNL0 10 79703227-79714681 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 43: Testis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" "HPA064635: " "unprognostic (9.51e-2)" "unprognostic (6.09e-2)" "unprognostic (1.21e-2)" "unprognostic (1.10e-1)" "unprognostic (3.63e-1)" "unprognostic (6.60e-2)" "unprognostic (2.47e-2)" "unprognostic (7.66e-2)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (7.79e-3)" "unprognostic (1.15e-1)" "unprognostic (9.70e-2)" "unprognostic (9.97e-2)" "unprognostic (5.72e-2)" "unprognostic (5.37e-2)" "unprognostic (2.32e-2)" 0.6 0.7 1.6 0.7 1.3 1.4 0.6 3.1 1.9 0.6 0.0 0.8 0.2 0.8 0.5 0.6 0.9 0.2 1.5 1.7 0.9 1.6 1.1 0.8 0.7 1.6 0.9 0.9 1.4 0.7 1.8 0.3 1.5 1.1 0.2 0.8 1.0 0.3 1.0 1.1 0.9 0.1 0.3 1.3 0.9 3.4 1.8 0.7 0.9 0.1 0.7 0.5 0.8 1.8 0.7 0.8 1.7 1.0 0.4 0.4 0.7 0.3 0.5 0.4 0.4 0.1 1.5 1.7 0.2 0.4 0.6 0.7 0.1 0.8 0.3 1.1 0.6 1.3 0.2 0.5 0.7 1.2 2.9 1.1 0.4 0.2 0.3 1.5 0.0 2.4 1.9 0.8 0.3 1.4 0.3 2.3 1.6 0.0 0.8 0.4 0.2 0.2 0.5 0.2 0.7 1.8 1.0 1.3 1.7 0.8 0.4 1.4 1.0 0.2 0.3 0.2 0.6 0.3 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 3.1 1.9 1.7 0.9 1.6 0.9 1.5 0.3 1.8 1.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 NUTM2D FAM22D ENSG00000214562 "NUT family member 2D" Q5VT03 10 87357720-87370695 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.2;Cone photoreceptor cells: 4.2;Gastric mucus-secreting cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 12.4;hTCEpi: 11.7" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies" "HPA064635: " "unprognostic (2.13e-1)" "unprognostic (7.95e-2)" "unprognostic (3.94e-2)" "unprognostic (2.16e-1)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.35e-4)" "unprognostic (1.87e-1)" "unprognostic (2.62e-2)" "unprognostic (2.45e-1)" "unprognostic (2.46e-1)" "unprognostic (3.57e-1)" "unprognostic (7.76e-3)" "unprognostic (1.00e-2)" "unprognostic (1.16e-1)" "unprognostic (1.80e-1)" "unprognostic (2.32e-1)" 3.1 3.0 5.3 1.4 7.2 2.4 3.1 4.5 8.4 2.4 0.2 3.6 2.1 3.0 3.4 2.8 3.1 2.6 5.6 4.5 4.9 4.8 4.2 3.3 2.1 8.1 7.0 3.7 4.7 4.1 4.8 2.5 7.0 4.5 2.0 2.7 3.9 2.0 3.8 4.7 3.2 1.3 3.6 3.7 4.0 4.9 7.1 2.5 4.5 2.9 1.6 3.1 3.1 10.5 3.9 2.8 6.1 0.0 1.6 2.3 1.4 1.0 5.0 2.2 2.5 1.8 1.9 3.3 0.9 1.7 1.0 1.8 0.1 2.0 1.0 2.2 2.7 4.9 0.2 2.8 3.8 3.1 12.4 3.7 11.7 2.5 1.9 3.4 2.2 4.3 5.2 0.8 0.5 3.5 2.4 5.2 3.4 0.8 0.3 3.3 0.4 0.1 2.2 0.8 2.4 3.7 1.1 2.6 1.2 2.3 4.9 2.4 5.5 1.5 1.0 1.4 1.8 4.0 2.4 0.9 0.9 1.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 7.2 4.5 8.4 4.5 4.9 8.1 7.0 7.0 3.6 7.1 10.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.9 0.3 0.3 1.2 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.1 0.0 0.0 0.2 1.1 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 NUTM2E FAM22E ENSG00000228570 "NUT family member 2E" B1AL46 10 79841358-79850878 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 1.2;Exocrine glandular cells: 1.0;Pancreatic endocrine cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.0;NB-4: 1.6;U-266/84: 1.2" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 43: Testis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear bodies" "HPA064635: " "unprognostic (2.82e-1)" "unprognostic (3.95e-1)" "unprognostic (1.90e-1)" "unprognostic (1.00e-2)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (1.11e-1)" "unprognostic (4.19e-1)" "unprognostic (1.96e-2)" "unprognostic (2.51e-1)" "unprognostic (2.33e-1)" "unprognostic (1.03e-1)" "unprognostic (2.58e-1)" "unprognostic (3.66e-1)" "unprognostic (4.35e-1)" "unprognostic (4.09e-1)" 0.1 0.1 0.6 0.0 0.5 0.1 0.1 1.0 0.6 0.2 0.1 0.1 0.2 0.2 0.6 0.1 0.2 0.1 0.2 0.6 0.4 0.3 0.2 0.2 0.3 0.5 0.5 0.2 0.3 0.0 0.5 0.1 0.4 0.2 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.3 0.3 0.1 0.7 0.5 0.5 0.3 0.3 0.0 0.1 0.1 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.5 0.2 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.5 2.0 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.6 1.6 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.7 1.2 0.1 0.3 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 1.0 0.6 0.6 0.4 0.5 0.5 0.4 0.3 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 1.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 NUTM2F "DKFZp434I1117, FAM22F" ENSG00000130950 "NUT family member 2F" A1L443 9 94318196-94328644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 1.9" "Cell type enhanced" "Detected in some" "Astrocytes: 10.4;Excitatory neurons: 42.9;Inhibitory neurons: 29.0;Microglial cells: 11.2;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 31.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "NTERA-2: 1.3" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear bodies" "HPA064635: " "unprognostic (1.40e-1)" "unprognostic (4.93e-3)" "unprognostic (4.16e-2)" "unprognostic (1.47e-1)" "unprognostic (9.26e-3)" "unprognostic (1.03e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (6.72e-3)" "unprognostic (8.48e-2)" "unprognostic (1.11e-2)" "unprognostic (5.14e-1)" "unprognostic (1.83e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 27.2 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NUTM2G FAM22G ENSG00000188152 "NUT family member 2G" Q5VZR2 9 96928310-96940253 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 2.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.2;Oligodendrocyte precursor cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;HeLa: 1.7;SiHa: 1.7" HPA064635 Approved "Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies" "HPA064635: " "unprognostic (2.80e-1)" "unprognostic (2.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.78e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (2.44e-1)" "unprognostic (1.31e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.50e-2)" "unprognostic (1.92e-2)" "unprognostic (3.50e-3)" "unprognostic (2.31e-1)" "unprognostic (3.22e-2)" "unprognostic (2.13e-1)" "unprognostic (4.52e-2)" 0.1 0.2 0.7 0.1 1.0 0.6 0.1 1.3 0.9 0.3 0.2 0.2 0.1 0.2 0.0 0.4 0.1 0.2 0.2 0.8 0.5 0.3 0.1 0.3 0.3 0.8 0.4 0.4 0.3 0.0 0.2 0.1 0.5 0.3 0.0 0.2 0.4 0.0 0.7 0.8 0.2 0.0 0.1 0.3 0.2 2.9 0.8 0.0 0.3 0.0 0.0 0.2 0.3 1.3 0.6 0.5 0.4 0.8 0.0 0.0 0.6 0.2 0.0 0.0 0.0 1.8 0.2 0.6 0.1 0.0 0.5 0.8 0.0 0.0 0.0 0.4 0.7 0.6 1.7 0.8 0.0 0.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.9 0.4 0.0 1.0 0.3 0.7 0.9 0.6 0.4 0.4 0.6 0.0 0.0 0.6 0.7 0.2 1.7 0.2 0.1 0.2 0.1 0.0 0.4 0.9 0.3 0.3 0.3 0.2 0.0 0.3 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 1.0 1.3 0.9 0.8 0.5 0.8 0.4 0.5 0.1 0.8 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OBI1 "C13orf7, FLJ13449, RNF219" ENSG00000152193 "ORC ubiquitin ligase 1" Q5W0B1 13 78614289-78659155 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034785, HPA034786" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies" Cytosol "HPA034785: AB_10601496, HPA034786: AB_2674331" "unprognostic (2.99e-1)" "unprognostic (1.11e-1)" "unprognostic (1.79e-1)" "unprognostic (2.60e-1)" "unprognostic (7.88e-2)" "unprognostic (1.34e-2)" "unprognostic (2.83e-3)" "unprognostic (1.50e-1)" "unprognostic (1.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.84e-2)" "unprognostic (4.26e-3)" "prognostic unfavorable (4.99e-6)" "unprognostic (6.87e-2)" "unprognostic (2.01e-1)" "unprognostic (6.91e-2)" "unprognostic (2.53e-2)" 5.8 4.8 5.4 6.1 5.8 2.4 6.7 6.6 6.7 5.9 3.0 4.8 4.8 7.1 4.5 5.0 5.6 4.5 7.1 5.6 6.1 4.6 4.4 5.2 9.9 5.5 5.9 7.6 4.1 4.1 2.9 7.4 5.0 5.5 5.3 9.6 4.2 6.1 4.8 5.5 4.7 6.5 6.1 7.3 4.5 14.8 7.2 13.3 5.9 6.4 11.3 6.0 4.5 5.9 23.7 9.1 39.1 23.1 13.5 12.9 17.8 19.3 14.5 18.7 23.3 18.3 17.3 39.8 9.2 12.4 12.2 23.0 31.2 15.3 32.6 24.9 22.8 61.0 11.4 16.1 11.3 59.6 18.2 12.4 16.7 15.7 16.8 10.6 15.6 19.9 16.1 5.3 24.6 6.6 36.5 20.2 0.0 25.1 10.0 42.0 32.2 15.4 12.7 12.5 28.4 15.9 13.4 16.9 14.8 22.2 8.6 47.3 12.9 16.2 14.7 10.7 16.3 5.5 6.6 37.9 25.9 35.6 17.8 4.9 5.4 7.5 7.9 8.8 9.5 8.8 8.8 9.8 6.3 8.9 10.8 9.8 1.8 11.1 10.3 5.3 9.6 6.6 5.4 5.8 6.6 6.7 5.6 6.1 5.5 5.9 5.0 6.1 7.2 5.9 14.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 15.8 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 12.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 5.1 1.1 0.0 0.0 0.0 OGFOD2 "FLJ13491, FLJ37501" ENSG00000111325 "2-oxoglutarate and iron dependent oxygenase domain containing 2" Q6N063 12 122974580-122980043 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 431.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039448, HPA040306" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 22: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA039448: AB_10795035, HPA040306: AB_10794026" "unprognostic (2.14e-1)" "unprognostic (2.47e-1)" "unprognostic (6.86e-2)" "unprognostic (3.36e-1)" "unprognostic (3.09e-2)" "unprognostic (1.57e-2)" "unprognostic (6.12e-3)" "unprognostic (1.14e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.07e-3)" "unprognostic (2.48e-3)" "unprognostic (1.13e-3)" "unprognostic (1.88e-1)" "unprognostic (1.38e-1)" "unprognostic (2.60e-2)" "unprognostic (1.13e-1)" 6.5 15.0 10.8 7.7 11.1 8.4 7.5 10.9 14.0 9.1 12.4 9.9 13.8 6.8 5.9 10.7 10.2 4.8 10.3 10.6 10.9 14.1 21.2 7.7 11.0 12.3 11.4 9.4 20.9 6.5 13.2 5.6 11.5 12.0 5.5 4.9 14.7 7.8 10.9 11.9 12.7 3.3 10.8 14.4 13.0 29.1 11.6 9.3 11.8 4.5 6.6 7.8 8.3 13.5 11.7 18.6 7.6 12.4 5.2 5.5 20.4 6.9 7.1 9.5 8.6 17.6 10.2 13.0 14.1 6.0 5.6 16.5 5.5 9.5 3.6 9.1 12.0 20.6 17.8 18.3 11.1 20.7 15.5 8.1 14.0 8.8 7.8 13.7 10.1 24.7 24.4 9.3 4.8 22.4 17.6 39.0 4.6 8.0 23.5 19.2 7.3 23.2 7.2 10.4 9.7 8.8 9.4 13.4 13.8 5.0 34.0 17.6 6.5 13.0 13.2 15.5 7.3 23.4 15.1 12.4 17.9 10.7 12.8 18.7 11.7 18.9 9.1 12.9 7.8 15.9 7.5 9.0 13.1 11.3 8.1 7.7 9.6 9.7 18.2 7.8 16.0 9.0 10.8 11.1 10.9 14.0 10.6 10.9 12.3 11.4 11.5 10.8 11.6 13.5 4.1 0.0 7.0 4.6 10.0 2.9 6.5 10.3 8.0 3.6 9.2 8.6 0.4 10.0 8.6 12.9 2.1 25.9 5.6 9.2 9.8 11.8 97.3 13.0 5.2 5.9 2.4 17.2 3.2 15.0 14.0 5.4 8.6 5.3 0.0 8.6 7.9 21.1 12.5 11.8 3.6 8.0 16.2 11.9 3.4 431.0 8.7 6.4 7.2 1.0 7.7 7.8 10.3 3.0 2.6 12.7 7.8 4.5 18.4 4.6 32.4 34.1 30.5 6.4 13.1 4.1 5.7 36.8 16.2 7.3 4.5 16.4 7.2 11.5 10.1 4.3 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772485-128775794 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 84 "retina: 41.0" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 41.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "LHCN-M2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" Yes NA "Cluster 79: Retina - Phototransduction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (9.33e-4)" 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 41.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTP ENSG00000171540 "Orthopedia homeobox" Q5XKR4 5 77628712-77638713 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "brain: 28.7" "Cell type enhanced" "Detected in some" "Microglial cells: 1.0;Sertoli cells: 6.6;Spermatocytes: 2.2;Spermatogonia: 1.5" "Cancer enriched" "Detected in single" 6 "glioma: 1.2" "Region enhanced" "Detected in many" "hypothalamus: 28.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in many" 7 "hypothalamus: 20.0" "Region enhanced" "Detected in some" "hypothalamus: 15.5" HPA059342 Enhanced Supported Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Nucleoli fibrillar center, Nuclear bodies" "HPA059342: AB_2732635" "unprognostic (1.00e-1)" "unprognostic (2.40e-2)" "unprognostic (6.25e-2)" "unprognostic (8.06e-3)" "unprognostic (1.16e-1)" "unprognostic (7.77e-2)" "unprognostic (7.77e-2)" "unprognostic (2.39e-2)" "unprognostic (9.66e-2)" "unprognostic (4.64e-2)" "unprognostic (7.76e-14)" "unprognostic (3.38e-2)" "unprognostic (1.84e-1)" "unprognostic (9.49e-3)" 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.1 0.0 9.2 1.7 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.4 0.0 28.7 9.2 1.7 6.6 0.8 8.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 2.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTUD1 "DUBA7, OTDC1" ENSG00000165312 "OTU deubiquitinase 1" Q5VV17 10 23439075-23442377 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038503, HPA038504" Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA038503: AB_2676049, HPA038504: AB_10672712" "unprognostic (1.84e-1)" "unprognostic (2.80e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.56e-1)" "unprognostic (1.29e-2)" "unprognostic (3.18e-3)" "unprognostic (2.41e-1)" "unprognostic (7.77e-2)" "unprognostic (4.10e-2)" "unprognostic (1.80e-2)" "unprognostic (1.32e-1)" "prognostic favorable (6.61e-7)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-2)" 13.0 11.7 8.0 10.2 8.4 60.4 10.3 9.5 10.2 8.4 8.4 8.7 6.8 10.2 6.8 7.8 11.2 9.7 43.4 8.7 9.0 19.7 7.6 19.7 14.4 8.3 8.0 13.6 6.9 19.4 8.0 12.1 7.6 8.8 7.6 5.9 6.7 7.6 29.4 20.9 8.2 9.4 8.4 13.7 22.9 7.5 9.2 6.8 13.3 22.6 12.5 11.9 7.6 9.2 4.8 2.3 2.4 1.1 9.3 4.6 3.2 1.9 4.2 4.4 4.0 0.9 38.1 2.2 4.1 2.4 1.5 36.5 2.5 4.5 2.9 17.4 7.1 0.1 5.7 1.5 8.0 0.4 3.2 4.8 19.4 1.3 6.1 3.9 1.5 2.2 0.5 15.1 2.5 2.3 1.5 1.4 1.9 2.7 1.3 2.4 10.8 2.2 5.8 4.0 1.1 2.6 23.4 4.1 11.3 6.3 1.7 3.3 2.7 2.5 3.7 7.0 0.8 7.6 15.0 1.1 3.8 1.5 1.0 2.5 0.5 1.0 0.3 0.6 0.3 0.7 0.5 0.3 0.3 1.2 0.4 0.6 1.3 0.0 1.9 0.2 1.3 0.2 8.0 8.4 9.5 10.2 8.7 9.0 8.3 8.0 7.6 8.4 9.2 9.2 17.3 67.3 11.5 3.3 55.9 32.0 7.1 5.0 13.6 20.1 12.3 9.1 149.0 7.2 4.9 5.5 2.1 3.3 9.6 47.2 11.7 6.0 8.0 35.0 44.5 25.6 6.0 13.5 4.3 7.1 3.2 20.8 47.4 33.8 5.7 10.4 16.4 10.1 51.0 53.8 4.8 77.9 10.2 68.2 219.1 7.6 6.5 105.7 33.8 8.4 9.3 33.8 10.3 4.0 6.5 10.1 16.3 13.2 50.0 7.7 8.0 25.1 9.8 26.2 6.6 82.2 19.4 7.2 4.7 15.1 30.5 7.9 16.5 7.5 24.3 10.9 PABPC1L "C20orf119, dJ1069P2.3, ePAB, PABPC1L1" ENSG00000101104 "Poly(A) binding protein cytoplasmic 1 like" Q4VXU2 20 44910060-44959035 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 24.6;Collecting duct cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA066650 Approved "Nuclear bodies,Cytosol" NA Yes "Cluster 50: Neutrophils - Cellular senescence" "Cluster 18: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Cytosol "Nuclear bodies" "HPA066650: AB_2685698" "unprognostic (4.98e-2)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.73e-2)" "unprognostic (2.26e-1)" "unprognostic (2.24e-2)" "unprognostic (1.77e-3)" "unprognostic (4.92e-3)" "unprognostic (3.69e-2)" "unprognostic (2.44e-1)" "unprognostic (2.28e-3)" "unprognostic (7.96e-2)" "prognostic unfavorable (4.00e-15)" "unprognostic (1.01e-1)" "unprognostic (1.88e-1)" "unprognostic (8.63e-2)" "prognostic favorable (8.84e-4)" 2.1 2.3 1.7 2.0 1.8 4.1 2.9 1.1 2.1 4.0 2.5 1.7 0.8 1.5 3.4 2.1 3.4 1.4 1.3 1.7 1.8 6.1 5.9 2.9 3.3 1.4 1.8 6.6 6.1 0.5 6.1 0.6 1.4 5.2 0.6 0.4 2.5 0.9 0.5 2.1 2.9 0.6 1.3 4.4 2.8 1.9 2.5 3.0 7.9 0.1 1.9 1.9 1.9 1.7 2.0 3.4 1.9 4.1 0.4 2.6 8.9 3.7 0.3 1.4 0.4 8.4 3.4 2.2 7.3 0.2 1.2 4.7 0.5 1.3 0.9 1.9 4.0 1.9 8.1 7.2 2.1 1.6 0.5 0.5 6.4 1.2 1.5 1.1 0.0 3.1 3.0 2.2 0.3 8.0 2.8 4.9 1.2 3.0 7.6 3.7 0.6 2.2 0.7 2.6 2.0 3.0 1.6 5.7 6.7 1.8 9.7 1.8 0.2 5.2 5.7 3.4 1.6 5.4 8.8 1.8 1.7 0.8 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 1.8 1.1 2.1 1.7 1.8 1.4 1.8 1.4 1.3 2.5 1.7 1.3 6.4 24.6 11.8 7.0 1.9 3.3 3.3 6.2 0.5 7.6 9.9 1.5 7.2 15.6 20.2 0.0 6.7 4.7 2.8 0.0 3.3 0.6 9.5 6.8 1.5 4.2 1.7 5.3 0.5 4.4 4.2 12.8 11.1 3.8 10.3 0.4 5.7 3.0 0.0 2.3 3.0 2.0 0.8 1.6 0.6 1.8 3.3 0.0 1.9 2.3 1.4 3.1 11.1 3.2 1.8 2.4 1.9 5.1 3.5 1.5 1.5 10.1 1.3 0.0 2.1 2.6 0.9 2.1 4.9 1.7 3.8 7.0 2.1 4.4 2.9 PALM2AKAP2 PALM2-AKAP2 ENSG00000157654 "PALM2 and AKAP2 fusion" "Q8IXS6, Q9Y2D5" 9 109498325-110172512 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 10.6;naive B-cell: 10.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA058905, HPA074153, HPA076866" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA058905: AB_2683851, HPA074153: AB_2686669, HPA076866: " "unprognostic (7.12e-2)" "unprognostic (1.64e-6)" "unprognostic (7.90e-2)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" "unprognostic (3.19e-1)" "unprognostic (9.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.75e-1)" "unprognostic (8.37e-3)" "unprognostic (2.40e-2)" "unprognostic (2.77e-1)" "unprognostic (1.19e-1)" "unprognostic (2.05e-3)" "unprognostic (7.77e-2)" "unprognostic (1.98e-4)" "unprognostic (3.36e-5)" 97.0 13.5 21.8 37.3 21.1 9.9 17.5 6.9 22.7 28.5 0.0 17.4 14.8 28.8 8.5 26.5 14.7 37.4 93.8 15.7 18.5 30.8 38.2 69.1 32.2 18.1 26.6 9.3 13.1 14.0 0.1 97.9 20.3 14.9 18.1 3.3 38.0 25.1 17.0 10.1 13.3 48.5 10.5 38.4 18.5 4.6 38.8 45.4 25.6 24.3 31.7 43.0 0.4 26.3 20.6 7.7 112.5 0.1 110.8 93.0 33.4 116.0 141.3 101.6 93.4 134.6 17.9 92.1 30.6 129.6 146.2 28.9 9.5 98.8 185.4 68.9 12.5 9.2 30.4 11.0 75.9 12.4 256.2 109.8 24.7 183.3 280.4 62.5 150.9 14.5 0.3 76.2 204.7 1.2 61.9 31.1 47.2 9.1 62.6 5.5 98.2 25.3 72.4 2.8 25.2 1.5 10.3 9.5 26.4 87.8 4.1 22.2 240.0 94.0 77.9 137.5 108.8 52.5 89.1 52.5 81.4 51.3 73.9 2.9 0.1 1.3 1.0 0.2 0.2 10.6 1.2 1.4 1.2 10.3 0.7 0.8 0.5 2.2 0.0 2.4 3.9 1.4 21.8 21.1 6.9 22.7 15.7 18.5 18.1 26.6 20.3 10.5 38.8 26.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PALM3 ENSG00000187867 "Paralemmin 3" A6NDB9 19 14053363-14062076 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 46.9;liver: 55.7;stomach 1: 30.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Alveolar cells type 2: 40.9;Cholangiocytes: 22.8;Collecting duct cells: 38.6;Exocrine glandular cells: 27.9;Hepatocytes: 40.5;Spermatogonia: 18.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AN3-CA: 17.6;CACO-2: 20.2;GAMG: 5.5;HAP1: 15.8;NTERA-2: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052794, HPA056119" Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 81: Kidney & Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA052794: AB_2681952, HPA056119: AB_2683042" "unprognostic (3.67e-2)" "unprognostic (9.08e-2)" "unprognostic (4.72e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.14e-2)" "unprognostic (1.47e-1)" "unprognostic (4.66e-2)" "unprognostic (7.62e-2)" "unprognostic (1.97e-1)" "unprognostic (3.91e-1)" "unprognostic (3.93e-2)" "unprognostic (3.88e-2)" "unprognostic (2.09e-2)" "unprognostic (1.06e-1)" "unprognostic (5.68e-2)" "unprognostic (1.10e-2)" "unprognostic (1.72e-3)" 0.1 0.2 1.3 0.1 1.4 0.0 0.6 1.3 1.5 2.0 1.0 0.8 1.6 1.0 6.7 0.3 1.8 1.0 0.4 1.3 1.8 46.9 55.7 4.3 0.0 2.9 1.7 0.2 24.5 6.5 0.4 0.4 2.6 4.0 0.2 0.5 3.7 4.5 0.1 0.5 1.1 0.0 1.7 0.1 30.5 15.2 1.8 0.0 12.7 0.0 0.0 4.7 1.6 1.7 1.4 1.3 2.9 17.6 0.3 0.0 3.3 0.3 0.0 0.7 0.5 20.2 0.3 0.0 0.2 0.4 5.5 0.0 15.8 0.0 0.3 0.0 0.9 0.1 0.5 2.3 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.5 0.0 0.0 3.4 0.0 0.0 3.2 0.2 0.0 10.3 1.6 0.8 0.0 0.0 0.0 0.0 1.7 1.9 2.3 0.1 0.0 0.0 3.2 1.3 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.4 1.3 1.5 1.3 1.8 2.9 1.7 2.6 1.7 1.8 1.7 0.1 57.7 40.9 0.3 0.5 0.0 0.6 0.1 0.0 0.7 1.0 1.4 0.3 22.8 10.1 38.6 0.0 0.3 0.0 0.7 1.9 9.4 0.0 3.2 1.0 0.2 1.2 0.0 0.3 27.9 3.1 1.7 7.1 6.3 1.3 0.1 1.8 40.5 0.1 0.0 0.5 3.0 0.0 1.3 0.3 0.5 0.9 0.2 1.8 0.0 1.0 0.8 0.0 0.0 0.1 5.5 1.3 2.6 0.0 1.0 3.2 9.5 2.1 0.6 0.0 0.1 0.2 0.0 18.8 0.0 0.0 2.2 0.3 0.0 1.0 1.0 PARP11 "ARTD11, C12orf6" ENSG00000111224 "Poly(ADP-ribose) polymerase family member 11" Q9NR21 12 3791047-3873448 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, mRNA transport, Protein transport, Spermatogenesis, Translocation, Transport" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.5;Granulosa cells: 72.0;Late spermatids: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026895 Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA026895: AB_1854980" "unprognostic (9.58e-2)" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (4.12e-2)" "unprognostic (6.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.53e-1)" "unprognostic (2.61e-1)" "unprognostic (3.58e-2)" "unprognostic (2.32e-2)" "unprognostic (2.50e-1)" "unprognostic (2.11e-1)" "unprognostic (7.52e-2)" "unprognostic (3.81e-2)" "unprognostic (2.87e-2)" 3.4 5.0 2.7 5.0 2.9 3.2 5.3 2.0 2.9 4.2 2.0 3.6 3.7 6.5 5.4 3.1 4.1 4.0 2.3 2.5 3.4 3.9 4.5 3.8 10.2 3.4 3.2 8.2 2.5 7.8 1.8 3.2 3.3 8.6 4.1 3.3 4.0 4.2 1.8 2.2 3.7 5.2 2.8 6.2 3.3 9.4 3.5 10.4 9.1 2.9 9.4 5.0 1.9 3.5 2.7 2.3 14.0 2.3 4.4 7.2 4.1 3.3 5.5 5.6 5.7 8.7 2.2 8.0 2.0 6.4 6.6 2.2 4.8 4.8 9.0 16.1 4.9 12.0 0.0 6.5 5.1 8.1 4.4 5.9 3.8 4.4 12.4 0.0 4.4 15.3 3.1 6.5 8.1 4.0 4.2 3.1 5.2 2.9 0.3 8.3 9.8 1.8 2.6 6.3 0.9 2.9 3.1 2.8 4.2 15.1 0.5 7.1 8.5 4.9 4.8 7.3 4.4 3.1 7.3 11.7 4.6 4.4 1.2 20.3 8.9 9.2 7.4 7.4 10.0 10.0 8.3 5.5 8.9 8.8 9.2 7.5 8.5 7.7 6.1 7.8 3.7 6.2 2.7 2.9 2.0 2.9 2.5 3.4 3.4 3.2 3.3 2.8 3.5 3.5 8.6 9.6 9.5 16.0 18.3 1.9 4.4 6.7 7.4 10.6 5.7 4.1 3.8 2.8 4.5 1.8 2.1 4.2 17.7 2.6 0.0 3.4 61.5 2.1 9.6 5.3 3.6 12.0 30.8 3.1 1.6 8.4 1.1 1.9 14.7 72.0 6.8 4.1 7.1 3.3 30.8 4.7 2.0 9.8 5.8 45.1 10.5 9.7 1.8 18.7 10.3 5.4 17.5 32.6 18.8 3.3 7.6 8.6 3.7 6.6 2.6 4.1 6.0 6.4 6.6 7.0 9.8 9.9 10.9 3.6 1.8 2.6 15.0 8.9 5.0 3.4 PARP3 "ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3" ENSG00000041880 "Poly(ADP-ribose) polymerase family member 3" Q9Y6F1 3 51942345-51948867 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020984, HPA067657" Supported Supported "Nucleoplasm,Nuclear bodies" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nuclear bodies" "HPA020984: , HPA067657: AB_2685881" "prognostic favorable (6.39e-5)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (2.85e-2)" "unprognostic (7.31e-2)" "unprognostic (1.56e-1)" "unprognostic (4.13e-1)" "unprognostic (3.53e-2)" "unprognostic (2.26e-1)" "unprognostic (2.01e-1)" "unprognostic (7.44e-3)" "unprognostic (4.30e-1)" "prognostic favorable (1.25e-8)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-3)" 16.0 33.4 12.7 9.9 13.5 3.1 15.3 12.9 14.6 9.6 14.4 17.1 28.1 11.4 5.9 10.4 11.2 11.3 13.6 11.6 14.2 21.2 29.2 13.4 10.9 13.8 14.9 8.9 4.4 35.8 10.9 5.9 13.7 14.6 10.2 4.7 14.5 15.5 15.8 7.5 25.2 9.3 12.9 14.8 16.4 5.4 14.9 8.2 19.6 17.6 8.0 15.4 10.8 12.4 10.0 6.6 2.0 17.3 17.8 30.0 4.8 15.4 29.0 23.1 24.9 3.9 28.1 14.1 4.5 29.4 12.6 1.6 5.0 14.5 9.1 34.8 1.2 7.8 15.1 13.2 18.8 5.3 10.9 24.4 12.4 16.2 9.1 35.7 10.8 10.2 3.5 14.7 19.9 3.4 4.6 12.5 2.4 4.2 16.4 7.3 2.8 13.9 14.0 13.5 2.0 6.4 16.3 4.8 10.7 1.4 6.5 5.9 24.0 42.5 9.9 7.4 10.4 22.5 26.0 6.0 27.2 14.4 13.6 0.0 1.6 1.2 2.4 3.0 2.2 6.3 2.6 1.8 2.6 2.5 3.6 3.5 0.1 5.7 1.6 0.9 3.2 1.8 12.7 13.5 12.9 14.6 11.6 14.2 13.8 14.9 13.7 12.9 14.9 12.4 5.3 6.4 10.0 6.2 8.1 2.7 10.6 15.9 21.1 2.0 8.6 8.9 7.4 8.6 8.6 0.0 0.0 0.6 2.1 13.1 7.9 9.7 7.8 2.4 3.8 5.3 3.0 1.7 2.6 6.3 0.4 4.7 17.3 2.7 4.5 0.8 2.5 9.5 3.7 0.0 3.0 11.3 6.1 3.2 2.2 15.3 4.7 3.7 7.2 3.7 5.0 3.8 0.0 1.0 1.8 11.5 6.5 1.5 4.9 4.3 33.4 20.6 9.5 2.1 6.6 4.1 5.7 3.4 3.3 7.8 1.4 0.5 5.9 1.6 13.8 9.3 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 24.3 32.1 16.5 11.8 22.3 3.1 36.1 10.7 18.0 88.3 1.9 52.3 22.4 136.8 21.6 30.1 74.6 37.6 24.0 15.3 14.1 29.4 7.7 20.7 4.5 8.8 32.7 52.1 48.1 29.5 14.3 19.5 6.7 38.0 19.8 17.1 43.8 53.8 36.3 10.2 19.9 125.2 13.7 10.2 21.9 6.8 12.6 10.9 35.1 26.5 8.1 40.2 41.5 12.1 2.9 74.4 82.4 19.1 50.8 23.3 3.4 25.2 20.9 8.4 6.1 14.2 11.8 0.0 5.5 47.8 4.3 22.8 31.7 8.1 3.6 3.1 31.3 93.0 56.5 0.3 34.7 0.0 22.2 24.4 0.0 5.4 2.1 19.2 0.3 0.0 0.2 0.0 2.2 47.1 0.2 0.6 111.5 3.8 4.5 0.0 21.6 27.0 6.3 44.1 2.5 39.6 27.8 186.1 0.1 71.4 73.2 0.0 0.5 3.7 8.6 24.2 8.1 8.5 61.2 0.1 0.4 0.2 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 16.5 22.3 10.7 18.0 15.3 14.1 8.8 32.7 6.7 13.7 12.6 12.1 28.6 22.4 18.6 382.3 2.8 22.8 115.0 39.8 70.6 39.9 129.9 87.8 50.0 98.7 25.3 33.1 110.5 101.3 1.5 29.2 33.2 47.9 91.3 47.7 144.3 47.0 90.9 30.3 475.9 68.7 7.3 126.7 32.1 38.5 71.7 57.6 68.9 18.7 9.7 5.0 405.0 38.2 50.8 1.9 17.5 124.4 63.6 12.1 16.0 125.5 1.6 33.5 1.0 327.2 227.4 31.7 72.5 103.8 2.8 41.5 40.4 57.9 37.3 30.6 39.5 142.0 70.9 2.3 17.5 83.6 28.1 104.7 7.6 168.0 43.7 75.9 PBX3 ENSG00000167081 "PBX homeobox 3" P40426 9 125747345-125967377 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 153.1" "Cell type enhanced" "Detected in many" "Microglial cells: 91.8;Oligodendrocyte precursor cells: 136.2;Oligodendrocytes: 192.2" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "plasmacytoid DC: 13.9" "Lineage enriched" "Detected in all" 4 "dendritic cells: 13.9" "Cell line enhanced" "Detected in many" "THP-1: 90.1" "Region enhanced" "Detected in all" "olfactory bulb: 167.4" "Group enriched" "Detected in all" 5 "basal ganglia: 46.3;olfactory bulb: 161.9" HPA003881 Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 43: THP-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA003881: AB_1855020" "unprognostic (1.97e-2)" "unprognostic (3.78e-2)" "unprognostic (1.15e-1)" "unprognostic (1.93e-2)" "unprognostic (1.27e-1)" "unprognostic (2.35e-1)" "unprognostic (2.20e-1)" "unprognostic (3.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.88e-1)" "unprognostic (2.42e-3)" "unprognostic (7.02e-2)" "unprognostic (1.53e-1)" "unprognostic (2.74e-2)" "unprognostic (1.63e-1)" "unprognostic (8.03e-2)" "unprognostic (6.29e-2)" 10.9 56.0 10.4 12.9 14.6 6.9 10.0 17.4 13.2 27.2 7.0 47.9 6.8 9.8 20.0 11.8 14.2 22.5 38.0 7.2 15.0 7.1 18.1 13.0 8.0 19.7 21.0 58.2 18.8 153.1 12.6 6.7 19.4 30.9 13.7 28.0 11.8 28.0 8.5 19.4 14.3 22.6 18.8 12.8 21.5 8.2 15.3 16.7 35.1 5.7 6.9 20.7 21.9 21.7 11.6 11.0 50.0 43.1 13.1 19.1 8.5 29.9 16.8 19.2 14.5 14.3 21.1 11.3 3.6 22.1 20.8 8.5 28.3 12.3 38.3 12.4 20.5 9.7 7.9 5.8 17.2 9.6 15.5 9.5 13.7 14.5 10.0 45.3 23.1 7.2 0.4 10.3 43.5 5.9 10.0 4.9 35.8 14.2 7.4 18.9 73.3 1.5 15.6 6.4 25.9 45.1 20.2 3.8 9.4 18.8 15.7 90.1 26.6 40.0 10.2 23.8 57.1 7.2 12.8 11.5 19.7 15.2 20.6 2.3 1.7 2.2 0.8 1.4 0.9 1.0 0.9 0.7 1.9 1.5 1.7 0.7 1.4 3.2 1.3 13.9 0.8 1.0 10.4 14.6 17.4 13.2 7.2 15.0 19.7 21.0 19.4 18.8 15.3 21.7 7.3 9.6 16.7 17.9 10.0 22.7 10.3 3.0 6.8 7.5 11.5 8.3 60.3 2.8 8.6 12.9 37.5 0.6 20.7 1.3 7.9 13.5 15.2 1.1 14.0 11.9 11.5 6.3 44.3 2.5 0.9 23.4 5.6 1.5 16.5 9.4 9.7 12.6 15.3 42.1 19.3 5.7 6.1 29.0 23.7 11.4 19.9 22.9 7.2 91.8 13.6 11.5 6.2 136.2 192.2 3.1 12.1 11.3 3.8 13.0 0.9 2.8 8.5 43.1 0.0 5.3 13.0 33.7 16.0 10.4 26.3 0.4 10.5 8.7 3.4 8.7 PCNP ENSG00000081154 "PEST proteolytic signal containing nuclear protein" Q8WW12 3 101574180-101594465 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035011, HPA063861" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No 38000 "Cluster 2: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "Nuclear bodies" "HPA035011: AB_10601386, HPA063861: " "unprognostic (4.34e-2)" "unprognostic (9.65e-2)" "unprognostic (6.74e-2)" "unprognostic (2.08e-3)" "unprognostic (7.67e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.91e-1)" "unprognostic (3.44e-3)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (4.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (8.32e-2)" "unprognostic (2.05e-1)" 47.0 47.6 42.6 43.5 45.3 58.7 53.5 48.6 69.1 48.2 54.5 47.8 38.8 53.8 52.6 48.1 43.8 41.0 57.7 43.1 50.6 51.9 49.6 41.0 57.3 43.7 43.9 69.7 33.3 50.0 39.3 50.5 44.0 47.6 45.2 58.3 42.5 49.1 66.5 39.0 36.1 53.4 45.8 39.8 34.8 28.4 45.8 58.0 49.8 66.4 57.5 50.7 40.0 52.9 135.0 71.1 105.2 82.9 96.1 136.8 113.4 90.0 126.3 94.1 105.1 85.8 73.1 139.4 66.5 100.0 92.8 71.4 138.0 119.6 196.9 102.6 76.6 151.1 84.9 103.4 73.6 141.1 72.1 82.4 115.5 78.0 109.6 134.8 129.6 64.1 143.7 82.6 117.2 55.8 123.8 120.2 162.4 110.8 113.9 71.8 93.2 110.0 123.7 76.7 136.1 108.0 83.4 82.0 132.6 119.3 76.7 105.4 81.5 86.5 113.8 44.1 97.1 62.1 100.2 174.0 84.1 150.9 107.4 58.3 22.4 38.6 22.1 27.0 29.1 29.8 28.9 26.9 23.9 24.1 29.1 27.3 20.2 36.4 36.0 18.9 35.9 40.9 42.6 45.3 48.6 69.1 43.1 50.6 43.7 43.9 44.0 45.8 45.8 52.9 94.9 60.9 101.4 25.5 124.2 232.6 235.2 171.7 126.9 89.5 90.3 65.8 111.5 75.8 106.2 64.4 39.6 120.3 75.0 46.6 266.1 130.3 30.1 89.1 80.4 111.0 81.9 195.9 50.4 95.0 205.7 126.9 55.5 114.6 102.6 53.8 90.3 51.7 90.3 97.6 51.3 70.8 187.2 87.3 242.1 15.0 130.8 105.0 250.8 39.4 131.0 128.4 102.0 36.2 49.1 111.2 51.6 134.6 77.8 207.5 72.2 182.6 85.8 90.5 131.5 110.8 170.3 105.7 70.1 100.6 238.5 235.9 125.1 60.9 78.8 196.3 PEX6 "PAF-2, PXAAA1" ENSG00000124587 "Peroxisomal biogenesis factor 6" Q13608 6 42963865-42979181 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 76.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 78.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025924, HPA074179" Supported Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA025924: AB_1855230, HPA074179: " "unprognostic (7.32e-3)" "unprognostic (2.43e-1)" "unprognostic (1.38e-1)" "unprognostic (9.16e-2)" "unprognostic (9.18e-2)" "unprognostic (3.27e-1)" "unprognostic (8.88e-2)" "unprognostic (5.92e-2)" "unprognostic (3.36e-1)" "unprognostic (7.12e-2)" "unprognostic (7.24e-3)" "unprognostic (5.31e-2)" "unprognostic (3.79e-3)" "unprognostic (1.86e-1)" "unprognostic (1.13e-1)" "unprognostic (1.81e-1)" "unprognostic (1.55e-1)" 11.6 20.5 24.9 9.2 25.2 9.5 12.1 23.9 27.7 19.1 25.5 16.3 9.3 15.5 7.7 16.4 22.7 9.6 18.7 25.1 25.5 16.5 27.7 10.0 14.5 27.2 25.5 26.1 76.2 15.2 24.3 9.6 24.2 21.6 7.8 9.9 14.8 11.4 23.4 14.0 16.3 9.6 23.9 17.5 16.3 16.2 25.1 14.7 19.8 15.0 10.4 17.3 15.7 25.2 35.0 16.4 8.1 30.6 29.6 28.3 8.4 6.0 9.4 4.8 10.0 10.5 10.1 14.1 8.2 14.3 20.5 32.2 28.7 31.1 5.0 27.6 15.2 4.7 24.4 6.2 20.0 4.8 9.4 35.5 35.5 19.9 5.5 39.1 24.7 18.9 25.2 14.1 10.7 3.9 12.7 15.8 10.0 78.8 14.3 26.8 14.3 5.8 12.3 10.0 25.4 11.1 5.6 21.9 32.7 13.1 43.2 21.2 14.0 15.2 2.9 7.5 14.0 21.0 19.8 19.7 5.2 24.6 12.4 1.3 1.3 2.1 1.2 1.1 2.1 1.0 1.8 2.5 1.9 1.9 2.2 2.1 0.8 2.0 0.7 1.0 0.9 1.1 24.9 25.2 23.9 27.7 25.1 25.5 27.2 25.5 24.2 23.9 25.1 25.2 5.6 6.4 2.6 19.9 5.6 5.0 10.2 6.2 10.8 15.2 11.8 12.7 4.1 10.0 5.6 7.3 2.1 11.4 5.4 10.2 13.7 2.8 2.5 17.6 10.6 5.8 5.4 1.7 24.6 1.5 6.7 9.2 11.2 9.1 0.0 19.8 8.6 14.1 5.8 21.9 22.4 8.5 6.1 9.7 3.2 3.6 14.6 5.4 8.8 9.4 4.5 11.8 9.2 13.0 16.6 1.9 10.4 9.4 3.1 6.3 15.1 13.9 14.3 7.0 0.0 13.0 6.6 7.3 2.6 6.3 5.5 7.4 7.8 26.1 10.5 6.6 PGP ENSG00000184207 "Phosphoglycolate phosphatase" A6NDG6 16 2211593-2214840 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.2" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 404.5;Early spermatids: 480.5;Late spermatids: 1591.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043096, HPA046739" Approved Approved "Nuclear bodies" NA NA 250000 "Cluster 52: Eosinophils - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" "HPA043096: AB_2678311, HPA046739: AB_2679779" "unprognostic (8.33e-2)" "unprognostic (4.77e-3)" "unprognostic (2.36e-2)" "unprognostic (7.23e-2)" "unprognostic (2.12e-3)" "unprognostic (1.76e-1)" "unprognostic (5.75e-3)" "unprognostic (5.87e-2)" "unprognostic (7.90e-2)" "unprognostic (4.43e-3)" "unprognostic (6.50e-2)" "unprognostic (9.04e-2)" "prognostic favorable (7.05e-4)" "unprognostic (1.28e-1)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "prognostic favorable (6.42e-4)" 7.5 11.8 17.3 6.1 17.6 8.3 7.6 19.5 26.9 6.4 10.6 11.2 6.0 8.7 4.7 6.9 7.2 3.2 33.0 16.3 13.3 14.0 11.5 10.0 6.4 26.8 15.2 4.7 7.8 5.6 11.9 5.3 27.6 8.3 3.8 7.8 7.3 4.8 41.1 7.8 11.5 3.4 12.6 13.7 10.3 52.2 15.7 5.5 16.1 18.0 3.8 8.6 5.4 17.8 16.2 26.0 18.9 17.5 7.3 6.1 35.4 18.5 8.6 16.5 17.0 40.3 20.0 12.3 17.7 8.5 13.5 26.7 12.7 15.7 7.4 17.0 35.3 12.4 44.3 18.4 4.9 21.8 19.6 6.8 7.0 15.6 5.7 6.3 10.9 20.0 22.4 12.7 9.3 44.1 25.1 35.7 24.1 9.8 23.9 40.9 16.3 27.5 13.9 10.1 24.1 14.8 16.8 29.8 13.1 13.4 22.9 25.3 10.9 17.6 22.5 15.9 18.7 30.1 13.9 17.8 5.8 19.2 13.7 0.0 0.8 2.5 0.7 1.2 0.1 0.2 0.4 0.5 0.5 0.8 0.2 0.4 0.6 0.1 1.2 0.7 0.5 0.2 17.3 17.6 19.5 26.9 16.3 13.3 26.8 15.2 27.6 12.6 15.7 17.8 35.0 6.4 7.8 17.6 20.9 23.3 7.8 2.6 4.0 196.1 31.1 33.8 40.7 17.2 5.7 40.5 404.5 121.1 44.8 63.6 58.7 10.4 480.5 28.5 22.5 24.7 29.8 38.3 38.0 14.0 107.1 20.3 28.5 27.7 10.2 54.1 20.3 39.2 58.0 144.7 30.9 37.3 2.0 33.1 64.8 1591.0 25.7 37.9 35.6 7.5 20.2 63.4 42.2 11.6 21.9 14.4 32.5 28.2 36.9 21.9 34.8 39.4 3.4 220.6 39.5 19.3 94.3 162.9 64.8 12.7 31.8 54.5 30.0 70.8 50.5 15.2 PGRMC2 "DG6, PMBP" ENSG00000164040 "Progesterone receptor membrane component 2" O15173 4 128269237-128288829 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 274.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041172, HPA058652" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA 76000 "Cluster 46: Basophils - DNA binding" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "Nuclear bodies, Plasma membrane, Cytosol" "HPA041172: AB_2677345, HPA058652: AB_2683786" "unprognostic (6.16e-2)" "unprognostic (1.35e-1)" "unprognostic (1.41e-2)" "prognostic favorable (3.62e-4)" "unprognostic (6.03e-2)" "unprognostic (6.57e-3)" "unprognostic (2.53e-2)" "unprognostic (2.57e-1)" "unprognostic (1.31e-1)" "unprognostic (8.24e-2)" "unprognostic (9.04e-2)" "unprognostic (3.80e-2)" "prognostic favorable (9.60e-4)" "unprognostic (3.12e-2)" "unprognostic (1.82e-1)" "unprognostic (2.51e-2)" "unprognostic (6.03e-2)" 107.3 51.9 23.8 38.1 25.6 41.7 76.6 25.8 29.8 58.4 34.1 68.1 127.3 52.3 51.3 57.5 44.2 53.4 50.7 25.0 30.2 96.0 173.8 42.7 30.6 25.6 29.6 57.9 74.2 80.5 49.0 85.3 27.7 53.0 65.2 55.1 55.3 73.2 54.4 98.2 121.9 67.4 26.6 32.5 95.8 39.5 28.5 28.0 65.6 44.0 40.8 56.3 51.0 29.8 123.3 44.4 80.3 64.9 339.8 177.6 80.5 164.6 182.7 119.4 158.3 46.4 123.6 86.3 187.8 213.4 138.8 70.1 74.3 81.6 149.3 49.7 42.7 58.0 111.3 88.3 429.1 84.7 41.7 140.9 161.3 100.3 123.3 277.0 109.1 55.0 98.2 105.6 173.7 38.2 78.9 39.2 63.1 148.5 39.7 62.5 64.2 59.8 176.8 42.9 63.3 59.7 92.4 103.1 97.3 131.2 79.7 38.0 203.5 100.0 81.4 103.8 77.3 121.0 106.0 91.3 109.9 74.4 70.1 2.2 1.0 2.0 1.5 0.9 0.7 1.2 1.8 1.5 0.6 0.9 1.6 1.5 0.9 1.1 0.7 2.4 2.0 0.6 23.8 25.6 25.8 29.8 25.0 30.2 25.6 29.6 27.7 26.6 28.5 29.8 95.9 54.5 41.0 16.6 27.0 100.1 49.7 27.8 54.1 22.4 49.2 32.8 60.7 58.6 35.9 44.1 10.4 85.4 41.2 68.2 29.4 57.3 80.9 42.2 59.1 50.0 35.5 104.2 20.4 74.2 146.6 69.9 53.0 64.2 12.0 31.0 47.2 125.1 35.3 11.8 19.1 67.8 40.7 15.7 39.5 49.5 46.3 22.1 67.6 13.1 19.0 98.6 21.6 13.6 25.0 69.7 50.6 37.6 48.9 58.0 177.3 111.0 27.4 41.1 13.1 63.3 53.1 33.3 27.3 51.9 111.8 274.9 32.4 39.4 58.8 34.4 PHPT1 "bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14" ENSG00000054148 "Phosphohistidine phosphatase 1" Q9NRX4 9 136848724-136851027 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 953.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013584, HPA020952" Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA 590000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "Nucleoplasm, Nuclear bodies, Plasma membrane" "CAB013584: , HPA020952: AB_1855331" "unprognostic (7.34e-2)" "unprognostic (9.21e-2)" "unprognostic (7.90e-2)" "unprognostic (1.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.30e-1)" "unprognostic (4.64e-2)" "unprognostic (1.69e-2)" "unprognostic (3.23e-2)" "unprognostic (1.82e-1)" "unprognostic (1.26e-3)" "unprognostic (5.85e-2)" "unprognostic (9.66e-3)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (3.95e-2)" "unprognostic (8.49e-2)" 71.5 109.2 196.7 54.5 200.5 64.6 62.4 206.2 245.6 76.0 192.2 74.0 54.0 44.7 103.0 70.6 99.3 62.0 267.2 192.3 203.3 82.6 47.9 57.3 57.4 199.3 191.9 65.0 153.4 160.9 85.2 49.8 200.3 89.2 50.5 26.3 144.0 86.6 432.6 45.8 62.9 78.1 198.8 41.6 61.5 56.9 199.1 68.5 86.7 441.5 40.0 71.8 41.4 216.2 53.6 452.5 225.6 199.1 153.4 266.0 412.8 147.6 170.8 158.8 138.6 165.7 138.0 145.1 142.8 168.6 180.0 155.0 51.2 293.9 50.2 116.9 132.5 45.4 276.8 380.3 177.5 82.6 176.4 322.8 248.7 91.8 109.5 145.8 218.8 93.1 102.9 129.7 257.2 328.2 156.9 176.7 216.0 372.5 206.6 106.5 106.6 196.7 255.6 113.3 137.6 132.8 146.7 155.8 75.1 107.0 127.2 226.4 177.0 390.6 130.8 91.5 166.5 60.5 93.4 94.0 174.3 59.7 235.8 38.2 290.0 31.0 197.6 318.4 170.7 241.3 173.9 184.6 321.8 178.9 126.0 175.8 13.7 196.7 231.7 425.4 223.6 324.1 196.7 200.5 206.2 245.6 192.3 203.3 199.3 191.9 200.3 198.8 199.1 216.2 125.7 96.1 159.8 24.8 111.8 150.3 187.7 659.2 204.9 43.9 223.1 317.7 384.8 178.7 326.5 217.0 22.9 322.1 111.8 337.1 747.4 196.1 271.3 122.2 168.1 111.9 265.1 80.2 8.1 252.4 489.5 213.1 140.6 170.3 123.5 367.4 83.6 201.9 286.5 67.3 12.5 370.9 309.3 97.2 197.1 953.5 205.0 133.6 334.4 5.6 273.2 194.7 146.2 10.6 25.0 185.3 359.8 223.4 187.8 257.5 540.1 817.4 250.6 77.7 85.5 137.1 249.6 141.8 143.8 140.3 161.8 264.1 106.4 352.5 336.0 199.5 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 198.5;Excitatory neurons: 93.4;Inhibitory neurons: 102.6;Late spermatids: 124.5;Spermatocytes: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" No No "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 5.8 8.0 7.8 6.5 7.7 18.7 3.9 15.5 8.5 5.1 18.9 4.8 3.5 5.0 7.2 2.5 10.5 6.9 5.6 7.4 9.2 8.6 8.1 8.1 5.6 7.7 7.7 3.0 6.8 11.5 12.1 6.8 9.1 4.3 4.9 14.2 4.0 5.1 4.6 1.8 4.1 6.6 6.2 8.6 6.7 30.4 8.0 3.3 4.7 2.9 6.3 6.3 3.0 7.3 28.5 14.7 40.5 21.5 20.1 18.0 9.4 25.6 34.0 22.3 36.4 16.0 22.3 8.1 35.3 17.8 16.6 15.3 15.6 10.2 25.7 33.8 15.5 19.6 30.0 18.5 16.4 24.4 26.7 15.0 2.7 29.9 6.6 32.3 41.9 0.0 12.0 36.1 27.4 41.9 0.3 23.6 32.4 10.6 21.3 25.5 60.8 16.3 35.9 12.3 27.7 26.0 28.7 13.9 16.1 20.9 5.6 19.6 44.4 17.5 23.8 32.6 25.2 48.9 53.5 14.8 43.0 20.8 48.6 1.4 1.2 2.5 1.3 0.7 1.1 1.7 1.6 1.6 2.1 0.7 0.0 1.2 2.8 2.2 0.9 1.5 2.9 0.9 7.8 7.7 15.5 8.5 7.4 9.2 7.7 7.7 9.1 6.2 8.0 7.3 12.5 6.4 10.5 34.3 16.7 2.4 6.8 7.9 6.8 30.1 8.7 6.0 8.5 14.3 10.0 5.5 54.2 19.9 22.9 4.7 9.8 12.6 198.5 51.7 18.7 19.7 19.2 12.0 93.4 20.9 10.1 10.8 15.8 9.6 21.5 13.6 10.0 9.0 12.6 28.6 102.6 3.1 18.3 13.4 19.2 124.5 8.1 18.0 5.4 21.5 11.0 6.6 18.6 25.1 13.6 19.6 1.2 9.1 31.0 8.3 1.4 5.9 58.7 43.9 0.0 13.5 12.2 130.8 41.3 6.1 1.7 26.4 23.1 16.9 4.6 7.7 PKN2 "Pak-2, PRK2, PRKCL2, STK7" ENSG00000065243 "Protein kinase N2" Q16513 1 88684222-88836255 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 80.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 80.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034861, HPA057913" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Intermediate filaments" "Nuclear bodies, Plasma membrane, Centrosome, Cytosol" "HPA034861: AB_2674363, HPA057913: AB_2732617" "unprognostic (7.52e-2)" "unprognostic (1.46e-1)" "prognostic favorable (5.67e-4)" "unprognostic (5.95e-2)" "unprognostic (3.39e-2)" "unprognostic (2.51e-2)" "unprognostic (4.64e-3)" "unprognostic (1.38e-1)" "unprognostic (4.43e-2)" "unprognostic (1.27e-2)" "unprognostic (2.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.51e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-1)" "unprognostic (1.01e-2)" "unprognostic (1.99e-1)" 19.3 16.5 9.3 17.6 14.2 48.7 24.1 20.7 10.9 16.4 17.0 23.9 30.5 23.6 25.0 24.7 18.1 17.1 14.1 9.5 9.7 16.9 20.5 20.4 18.2 12.3 10.4 31.2 15.5 22.3 10.1 24.7 12.7 20.3 30.0 26.7 16.3 15.4 9.8 20.3 30.8 18.5 10.1 19.0 20.9 10.5 12.6 17.8 26.1 13.4 17.4 21.3 15.4 17.6 61.1 23.8 45.2 27.3 29.8 33.6 29.6 35.3 32.2 38.5 39.8 25.3 42.5 23.9 41.0 33.6 47.3 46.7 44.7 26.6 52.4 8.6 33.0 17.7 49.3 21.4 26.2 17.6 5.1 27.7 27.1 30.2 36.3 30.6 44.7 18.6 29.9 16.8 42.2 12.2 20.5 15.2 22.8 23.1 27.1 19.3 68.8 9.8 34.3 117.9 22.0 14.5 52.7 29.8 45.7 33.9 22.5 15.7 42.2 32.5 29.2 42.1 37.2 9.2 8.6 16.6 13.6 17.1 12.6 15.3 9.9 16.6 5.7 5.9 5.1 8.0 5.1 5.3 5.0 9.3 6.6 5.6 80.5 3.5 8.0 8.6 4.6 2.7 9.3 14.2 20.7 10.9 9.5 9.7 12.3 10.4 12.7 10.1 12.6 17.6 104.7 41.7 57.8 102.5 52.5 48.4 44.3 33.3 75.1 85.4 60.2 67.9 50.8 38.6 47.9 69.9 89.6 42.9 48.1 101.5 11.7 61.2 2.6 63.7 68.7 59.5 44.3 57.7 134.2 60.7 33.1 53.1 85.6 84.6 15.8 107.0 47.5 39.4 24.2 65.6 130.8 64.3 32.6 35.8 27.9 6.6 54.3 44.9 32.0 178.0 57.3 50.5 22.6 117.1 146.4 77.6 98.1 48.2 54.8 64.7 84.0 26.7 49.1 150.5 39.5 62.8 55.5 43.6 34.6 83.0 52.4 37.4 44.8 90.2 65.0 124.2 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 252.3" "Cell type enhanced" "Detected in many" "Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 99.0;RH-30: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 33: Fibroblasts - ECM organization" "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: AB_2682893" "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.94e-6)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 37.7 74.8 4.1 18.5 5.2 21.7 29.6 1.9 7.0 31.4 5.8 28.8 9.6 29.5 9.0 32.9 20.8 26.9 26.4 3.8 2.9 17.0 3.6 26.7 12.1 3.6 4.1 36.5 27.7 9.5 81.6 252.3 3.9 26.0 21.3 1.6 30.1 12.1 12.2 61.9 20.6 19.7 3.2 15.6 26.9 8.7 6.0 6.6 13.8 22.3 12.1 39.6 34.4 4.0 0.2 5.0 99.0 0.1 39.4 78.0 0.3 32.9 21.6 16.1 33.5 0.3 6.0 2.7 16.0 30.4 4.0 0.0 0.8 12.0 32.2 3.1 4.4 45.2 58.7 0.9 13.9 40.9 8.9 60.5 4.6 15.8 13.8 23.4 33.5 16.1 4.4 0.8 18.0 6.2 16.9 19.8 17.2 0.0 3.7 20.7 94.1 0.1 33.1 1.1 8.7 10.3 51.0 0.1 0.1 29.6 0.1 50.1 19.8 0.2 35.2 77.7 36.4 9.1 9.0 0.6 25.3 16.6 2.0 4.9 12.0 25.1 1.4 9.1 1.4 3.7 1.3 1.9 14.9 5.8 0.9 1.5 21.7 2.2 2.9 6.7 2.0 3.8 4.1 5.2 1.9 7.0 3.8 2.9 3.6 4.1 3.9 3.2 6.0 4.0 19.5 51.3 51.0 28.4 15.2 21.7 14.6 5.3 34.1 2.1 16.8 14.0 8.4 5.7 12.6 5.5 0.0 4.6 19.0 16.1 7.9 11.8 1.8 8.6 91.9 23.8 16.7 19.3 60.3 11.3 15.0 143.6 11.7 13.0 18.4 38.7 8.6 0.2 20.3 8.4 76.6 33.6 18.3 26.8 27.8 5.5 138.5 26.8 8.8 49.6 37.6 0.9 2.1 10.6 5.5 13.0 22.5 97.0 5.7 52.0 4.3 15.3 4.4 0.4 13.1 61.7 31.1 0.9 1.0 24.1 43.3 9.9 10.0 205.8 28.5 19.7 PLEKHA2 TAPP2 ENSG00000169499 "Pleckstrin homology domain containing A2" 8 38901235-38973912 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 78.7" "Cell type enhanced" "Detected in many" "B-cells: 94.1;dendritic cells: 132.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 164.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004706 Approved Uncertain "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA004706: AB_1079633" "unprognostic (2.78e-1)" "unprognostic (8.80e-3)" "unprognostic (4.15e-3)" "unprognostic (3.03e-1)" "unprognostic (8.61e-2)" "unprognostic (9.07e-3)" "unprognostic (6.16e-3)" "unprognostic (1.45e-1)" "unprognostic (1.76e-1)" "unprognostic (1.08e-1)" "unprognostic (1.39e-2)" "unprognostic (6.59e-2)" "prognostic unfavorable (1.95e-6)" "unprognostic (2.39e-2)" "unprognostic (1.00e-1)" "unprognostic (4.55e-2)" "unprognostic (9.60e-3)" 17.5 15.7 13.6 35.3 11.1 39.7 10.6 6.1 18.3 16.9 13.1 16.9 10.1 15.0 10.6 14.0 15.8 17.7 42.8 25.3 10.2 17.1 9.4 20.1 78.7 10.7 6.9 19.1 6.6 21.2 8.7 17.8 11.8 10.2 12.4 5.4 7.4 18.8 4.5 8.4 16.0 18.9 10.1 43.0 12.6 5.9 10.1 17.9 19.3 8.0 66.1 17.3 10.3 16.3 30.0 6.5 4.1 10.0 10.2 20.1 4.6 35.7 27.2 25.9 21.5 3.7 19.4 164.7 41.3 31.9 22.9 17.9 10.8 21.6 38.4 42.8 1.0 84.7 54.4 4.0 36.9 28.0 32.9 46.3 14.7 13.2 23.6 60.1 4.4 26.3 8.7 45.0 24.1 3.7 56.0 12.8 3.9 23.2 10.2 14.1 22.4 34.6 31.3 24.9 0.5 6.5 41.9 7.4 27.9 6.1 16.9 13.0 6.5 18.5 14.5 3.2 28.5 14.7 14.8 76.3 29.3 28.7 4.2 6.9 1.5 8.1 1.9 2.0 2.0 10.0 2.2 2.3 1.8 12.7 1.4 2.6 3.3 3.9 2.2 5.4 1.9 1.0 13.6 11.1 6.1 18.3 25.3 10.2 10.7 6.9 11.8 10.1 10.1 16.3 8.8 3.2 17.9 15.0 94.1 8.8 15.7 17.1 6.8 1.8 7.2 5.2 40.7 12.8 17.3 40.5 0.0 7.7 132.0 9.0 1.9 7.4 1.0 17.8 28.7 10.9 13.1 12.2 21.2 5.5 17.7 22.2 9.2 25.4 36.8 21.3 19.6 10.2 48.8 58.9 7.7 11.8 6.1 79.6 55.3 2.5 22.7 49.7 16.0 35.6 48.4 12.1 64.9 52.3 4.7 24.5 4.7 25.2 56.4 9.9 15.9 16.3 23.5 1.4 13.1 35.8 24.8 0.7 7.9 5.1 6.7 4.5 53.9 4.4 12.8 35.7 PLEKHH2 "KIAA2028, PLEKHH1L" ENSG00000152527 "Pleckstrin homology, MyTH4 and FERM domain containing H2" Q8IVE3 2 43637260-43767987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 66.2;Endometrial stromal cells: 150.5;Oligodendrocyte precursor cells: 191.0" "Cancer enhanced" "Detected in many" "renal cancer: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 7.4;RPTEC TERT1: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077225 Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 36: Stromal cells - Cell proliferation" "Plasma membrane, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA077225: AB_2686828" "unprognostic (1.11e-1)" "unprognostic (1.05e-1)" "unprognostic (3.49e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (4.27e-3)" "unprognostic (1.77e-1)" "unprognostic (2.32e-2)" "unprognostic (2.94e-2)" "unprognostic (6.99e-2)" "unprognostic (2.81e-1)" "unprognostic (2.53e-2)" "unprognostic (1.92e-3)" "unprognostic (3.03e-2)" "unprognostic (1.29e-1)" "unprognostic (8.57e-3)" "unprognostic (1.82e-2)" 13.1 3.0 2.8 1.7 2.7 0.1 8.9 3.6 2.8 20.9 8.8 11.8 3.7 19.8 4.4 4.6 15.9 7.3 4.8 2.3 2.8 15.9 1.7 27.6 2.9 3.0 3.4 23.0 2.9 5.4 2.0 3.8 3.1 5.1 4.3 1.7 4.8 5.0 1.8 8.4 6.5 9.8 2.7 5.4 5.0 3.9 2.7 0.4 5.5 2.5 1.8 6.2 8.5 2.5 0.5 4.0 1.6 0.0 3.1 7.4 0.3 0.5 2.0 0.8 2.0 0.0 1.3 1.0 0.2 0.6 3.3 2.6 0.5 0.6 1.5 0.0 1.1 0.1 0.6 0.1 0.5 0.0 0.5 2.2 0.6 1.9 0.1 1.1 1.7 1.6 3.9 0.1 0.7 1.1 0.8 0.1 0.9 0.6 3.9 0.0 4.6 0.0 6.3 0.2 1.2 0.6 0.4 0.0 3.9 1.1 0.5 0.1 0.2 4.5 1.3 0.2 1.4 0.9 0.2 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.8 2.7 3.6 2.8 2.3 2.8 3.0 3.4 3.1 2.7 2.7 2.5 4.6 38.5 8.7 19.2 0.9 8.7 17.5 5.8 6.8 1.0 5.3 8.3 2.9 11.5 12.9 66.2 6.2 0.3 1.3 0.1 5.9 6.2 1.6 5.9 150.5 3.8 0.0 0.0 15.6 1.4 0.3 57.4 3.1 8.8 1.3 42.6 2.2 0.0 0.8 0.0 4.3 0.3 2.0 0.3 8.6 3.3 35.8 1.2 12.4 15.9 0.2 5.8 0.0 191.0 52.7 7.2 0.0 50.4 0.4 9.2 0.3 4.1 7.3 4.1 46.0 40.7 24.6 10.8 5.9 2.6 8.4 0.5 3.6 13.1 0.6 8.7 PLSCR4 ENSG00000114698 "Phospholipid scramblase 4" Q9NRQ2 3 146192335-146251179 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 77.3;Astrocytes: 151.1;Endothelial cells: 63.4;Hepatic stellate cells: 110.3;Oligodendrocyte precursor cells: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 60.5;ASC TERT1: 48.2;hTERT-RPE1: 62.1;HUVEC TERT2: 50.8;TIME: 106.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002276 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: Liver - Metabolism" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA002276: AB_1855479" "unprognostic (3.73e-3)" "unprognostic (4.03e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.62e-1)" "unprognostic (6.77e-3)" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (7.33e-2)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-4)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" "unprognostic (8.13e-3)" "unprognostic (2.97e-3)" 60.2 43.8 30.2 9.4 28.2 2.3 41.9 30.9 32.5 28.9 11.6 27.4 6.8 30.1 15.7 23.2 41.2 45.6 28.0 28.7 38.5 25.3 69.0 37.4 10.5 39.3 44.0 36.4 20.5 4.3 11.2 56.4 32.6 13.8 25.2 13.7 23.6 25.8 7.4 16.1 13.6 33.7 36.9 30.1 14.4 21.6 41.8 6.6 31.2 18.8 6.7 19.8 25.5 32.2 0.0 9.9 1.7 0.0 60.5 48.2 0.3 11.5 15.7 5.0 10.9 1.0 12.6 0.0 12.3 21.0 5.0 1.4 2.4 1.1 2.8 0.1 0.1 5.0 7.9 1.3 28.1 0.1 1.3 29.6 1.6 10.4 3.0 62.1 50.8 0.0 0.2 0.9 7.4 0.3 0.0 0.1 2.1 5.1 3.4 0.0 0.8 0.0 0.1 0.0 0.6 0.0 20.1 0.1 3.9 2.5 0.7 0.6 106.4 10.4 2.6 23.6 2.1 0.3 0.0 0.0 2.6 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.2 28.2 30.9 32.5 28.7 38.5 39.3 44.0 32.6 36.9 41.8 32.2 77.3 3.2 10.3 151.1 1.0 10.8 5.6 0.8 12.0 0.6 10.2 8.6 4.1 25.8 6.0 3.7 0.0 0.7 0.3 27.4 0.0 8.2 1.1 3.6 11.6 63.4 10.3 15.6 1.7 11.6 0.5 57.1 2.0 1.5 1.3 7.0 110.3 44.1 0.8 0.0 0.6 11.7 0.0 7.1 11.8 3.8 42.9 1.1 3.6 40.3 0.1 51.4 0.0 61.3 0.6 4.7 13.3 32.4 2.8 2.6 6.4 28.3 6.4 1.5 0.0 18.9 23.6 1.2 0.9 4.8 8.7 0.8 1.8 20.0 8.1 2.7 PLXDC2 "FLJ14623, TEM7R" ENSG00000120594 "Plexin domain containing 2" Q6UX71 10 19816239-20289856 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Microglial cells: 1508.4;Oligodendrocytes: 470.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3" "Group enriched" "Detected in many" 13 "dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5" "Cell line enhanced" "Detected in some" "HHSteC: 19.4;U-2197: 45.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017268, HPA070793" Approved Supported "Nuclear bodies" No No 720000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nuclear bodies" "HPA017268: AB_10965928, HPA070793: AB_2686313" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.15e-1)" "unprognostic (3.05e-1)" "unprognostic (3.31e-2)" "unprognostic (2.99e-1)" "unprognostic (1.94e-2)" "unprognostic (1.57e-1)" "unprognostic (5.32e-2)" "unprognostic (7.52e-2)" "unprognostic (1.89e-1)" "unprognostic (1.35e-1)" "unprognostic (5.44e-2)" "unprognostic (3.91e-3)" "unprognostic (8.71e-2)" "unprognostic (3.35e-1)" "unprognostic (2.66e-2)" 12.4 9.4 13.3 7.3 14.1 5.2 11.5 9.6 13.3 12.7 16.8 5.3 4.2 10.7 3.5 7.5 10.1 17.4 10.2 11.3 25.6 10.7 3.1 17.1 2.4 18.0 17.3 9.4 3.6 16.2 3.3 4.7 19.2 7.6 4.6 18.2 6.2 7.7 5.0 15.5 7.1 16.2 16.2 9.4 3.8 5.9 22.3 2.5 6.8 10.0 2.8 8.5 8.9 29.1 0.0 0.0 5.8 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 7.7 2.2 1.8 0.0 0.0 0.7 2.8 8.6 0.4 19.4 0.0 0.0 7.7 0.6 0.0 2.3 8.9 0.0 0.0 0.1 1.7 0.9 1.1 0.6 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.4 0.2 2.4 0.4 0.0 1.8 0.8 0.9 0.0 7.6 3.9 45.9 0.0 0.1 0.0 0.0 3.5 0.1 0.0 10.7 57.5 11.8 1.3 33.4 2.7 0.0 0.0 0.3 36.0 0.0 0.0 0.0 81.6 4.4 37.3 1.6 0.0 17.7 13.3 14.1 9.6 13.3 11.3 25.6 18.0 17.3 19.2 16.2 22.3 29.1 101.4 16.0 8.9 131.9 2.6 36.8 23.8 12.3 41.5 44.2 14.4 45.3 10.9 15.7 10.9 5.5 8.4 0.9 2.9 7.1 0.0 6.9 2.9 16.5 7.6 45.3 3.0 10.5 190.9 0.0 8.1 97.2 1.1 19.4 31.6 80.9 82.1 4.2 94.3 1.7 59.9 27.3 8.2 91.3 46.3 2.1 19.3 147.7 7.2 1508.4 94.5 25.5 5.2 158.3 470.2 1.0 16.6 57.2 3.8 5.5 16.0 22.2 3.0 73.6 19.7 110.1 12.7 1.6 1.2 35.5 38.1 1.2 4.2 71.4 8.8 11.7 PML "MYL, RNF71, TRIM19" ENSG00000140464 "PML nuclear body scaffold" P29590 15 73994673-74047827 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Transferase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008312, CAB010194, CAB016304" Supported Enhanced "Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear bodies" "CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643" "prognostic favorable (3.24e-4)" "unprognostic (4.83e-2)" "unprognostic (5.76e-2)" "unprognostic (1.58e-3)" "unprognostic (7.53e-3)" "unprognostic (1.58e-1)" "unprognostic (2.35e-2)" "unprognostic (5.30e-3)" "unprognostic (4.54e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (2.67e-2)" "prognostic unfavorable (6.27e-8)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.99e-2)" 84.4 29.4 14.4 25.6 13.8 38.1 77.0 11.8 16.4 53.7 11.6 46.7 18.4 47.1 7.5 38.3 44.6 21.6 39.3 13.8 13.1 35.4 25.4 75.2 25.6 18.2 13.8 37.5 20.3 8.3 26.8 23.7 14.8 41.5 8.5 3.9 44.2 17.2 22.5 47.4 39.0 19.5 14.6 48.6 35.3 11.3 15.2 17.0 48.1 7.9 15.2 42.7 44.5 13.1 37.2 13.8 11.8 11.4 30.2 43.2 40.6 18.5 31.6 55.9 63.3 14.6 64.2 16.4 63.7 31.6 53.3 66.6 16.3 37.1 7.6 58.0 25.1 35.8 21.3 16.3 36.9 33.9 31.1 83.7 24.8 37.5 19.2 39.3 38.3 26.1 30.6 28.3 32.7 17.3 28.3 52.6 12.8 7.7 25.0 21.6 13.4 30.8 60.3 59.5 10.1 11.1 29.7 16.3 44.8 10.3 12.8 28.7 66.1 56.6 15.5 28.5 38.1 29.4 20.0 8.0 38.9 42.2 18.2 7.4 14.7 23.4 13.0 20.2 9.8 12.4 10.4 14.1 14.5 10.2 8.2 8.5 12.0 14.5 22.6 9.2 14.3 10.1 14.4 13.8 11.8 16.4 13.8 13.1 18.2 13.8 14.8 14.6 15.2 13.1 127.8 16.0 12.2 8.8 24.9 22.9 14.3 30.4 37.5 8.1 13.5 12.8 10.0 5.7 16.7 5.5 2.1 9.4 18.8 13.1 7.9 25.8 3.4 16.0 16.7 48.0 14.3 29.3 4.7 19.1 15.0 20.7 58.1 26.0 12.0 11.5 32.2 11.3 30.8 8.4 4.8 14.3 14.2 20.1 18.5 4.0 27.7 19.6 7.2 7.5 24.6 8.5 20.6 4.5 6.0 62.8 15.5 24.0 21.6 26.2 22.8 10.4 18.3 5.4 39.5 7.7 20.4 1.1 4.0 27.1 19.6 4.9 20.4 16.8 12.1 26.0 PMS1 "MLH2, PMSL1" ENSG00000064933 "PMS1 homolog 1, mismatch repair system component" P54277 2 189784085-189877629 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.4" "Group enriched" "Detected in many" 6 "Early spermatids: 474.4;Late spermatids: 570.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031013 Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" "HPA031013: AB_2673696" "unprognostic (1.03e-1)" "unprognostic (1.58e-2)" "unprognostic (9.31e-2)" "unprognostic (2.14e-1)" "unprognostic (3.16e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (2.38e-6)" "unprognostic (5.31e-2)" "unprognostic (1.60e-2)" "unprognostic (7.29e-3)" "unprognostic (3.55e-1)" "unprognostic (2.30e-1)" "prognostic unfavorable (1.86e-6)" "unprognostic (1.29e-1)" "unprognostic (3.77e-2)" "unprognostic (1.92e-2)" "prognostic favorable (3.73e-4)" 9.2 9.0 9.6 12.0 8.2 12.1 11.6 14.7 9.7 10.8 7.6 7.7 7.4 13.3 15.7 6.3 9.7 8.3 7.0 7.8 10.0 6.3 7.7 8.0 13.7 7.5 8.2 11.9 8.3 7.3 9.8 8.7 8.7 9.5 9.1 18.4 9.9 10.2 9.4 11.5 8.4 10.2 7.2 13.2 13.0 48.4 9.5 8.0 10.6 6.6 10.7 7.4 7.5 11.4 13.8 11.8 29.9 23.8 16.1 24.3 26.6 25.3 12.3 21.2 25.4 19.6 18.1 39.7 14.0 10.6 15.1 19.2 29.9 18.7 29.5 30.3 17.4 39.5 24.1 30.3 22.5 23.3 17.3 15.6 18.4 19.3 39.7 18.8 22.4 27.6 34.0 20.8 26.1 9.7 27.6 32.2 31.6 14.1 27.6 31.9 19.5 38.8 20.9 19.6 27.8 19.3 18.5 12.5 19.6 36.2 13.4 20.1 17.3 22.8 15.4 14.7 23.2 16.6 21.9 34.4 13.1 20.4 14.7 2.9 6.4 3.7 13.6 4.2 13.3 14.4 10.1 15.5 6.4 15.9 10.6 13.0 3.0 12.0 5.2 10.0 10.8 4.8 9.6 8.2 14.7 9.7 7.8 10.0 7.5 8.2 8.7 7.2 9.5 11.4 18.5 16.0 14.4 45.1 22.7 6.9 8.9 12.9 21.6 30.8 13.7 14.6 16.3 10.0 15.8 5.5 8.4 16.4 18.7 3.6 0.0 7.6 474.4 17.3 26.6 14.8 12.0 10.9 68.6 8.0 11.7 18.5 13.7 11.7 13.3 27.7 8.2 9.6 9.2 10.1 80.2 7.3 16.2 16.0 5.1 570.1 21.8 14.9 7.2 43.1 9.8 11.2 22.6 80.9 64.8 6.4 4.3 19.5 30.1 7.5 4.9 6.1 27.0 28.0 13.1 16.3 15.0 25.3 25.9 19.3 7.0 5.2 20.9 22.2 11.1 4.3 PNMA8A "FLJ10781, KIAA1183L, PNMAL1" ENSG00000182013 "PNMA family member 8A" Q86V59 19 46466491-46471563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 11.0;Endometrial ciliated cells: 8.4;Granulosa cells: 13.5;Respiratory ciliated cells: 10.9;Theca cells: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 32.9;K-562: 36.3;LHCN-M2: 35.9;SH-SY5Y: 31.3" "Low region specificity" "Detected in all" "HPA012956, HPA077702" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nuclear bodies" Cytosol "HPA012956: AB_1844328, HPA077702: " "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (1.12e-1)" "unprognostic (2.98e-2)" "unprognostic (9.35e-3)" "unprognostic (1.01e-1)" "unprognostic (6.90e-3)" "unprognostic (1.76e-3)" "unprognostic (9.56e-2)" "unprognostic (1.78e-2)" "unprognostic (2.85e-2)" "unprognostic (1.82e-1)" "unprognostic (6.48e-3)" 1.1 22.8 45.8 0.9 44.8 0.7 4.7 16.2 54.3 5.8 13.9 3.6 0.7 12.5 16.2 1.2 22.1 5.2 15.0 45.4 53.9 8.7 0.4 1.7 0.3 27.0 30.1 17.2 6.3 15.8 36.7 2.6 35.3 8.8 0.7 35.6 6.0 9.6 1.6 1.2 1.3 7.2 23.3 0.6 1.8 22.5 39.8 30.1 15.4 1.1 0.6 3.1 1.6 34.6 0.0 13.9 19.7 19.6 5.6 12.7 3.5 1.3 0.2 2.4 1.2 0.2 1.6 0.1 18.1 0.9 6.8 0.2 32.9 5.3 1.6 0.1 12.2 0.0 0.5 0.5 9.4 0.2 0.2 3.3 6.5 8.2 0.0 1.8 2.0 11.9 36.3 0.2 35.9 0.1 0.2 0.2 16.5 0.0 0.0 0.0 21.5 0.0 8.2 0.1 16.0 31.3 0.1 0.3 0.0 18.0 0.2 0.3 1.2 0.0 0.2 0.2 6.8 0.1 0.1 0.2 0.3 0.1 2.1 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.1 0.0 0.0 45.8 44.8 16.2 54.3 45.4 53.9 27.0 30.1 35.3 23.3 39.8 34.6 0.2 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 3.9 0.0 0.0 1.8 11.0 0.0 1.9 0.0 0.0 3.9 0.9 0.0 8.4 2.3 0.3 0.0 0.0 0.0 0.0 0.5 2.8 0.0 1.3 0.0 13.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 10.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 8.6 0.0 0.0 POLE2 DPE2 ENSG00000100479 "DNA polymerase epsilon 2, accessory subunit" P56282 14 49643555-49688422 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 21.0;Spermatogonia: 24.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" HPA027555 Uncertain Supported "Nucleoplasm,Nuclear bodies,Vesicles" No No "Cluster 48: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear bodies" Vesicles "HPA027555: AB_10610282" "unprognostic (1.42e-1)" "unprognostic (6.57e-3)" "unprognostic (3.53e-2)" "unprognostic (7.44e-2)" "unprognostic (2.04e-2)" "unprognostic (4.99e-3)" "unprognostic (7.60e-3)" "unprognostic (2.32e-3)" "unprognostic (1.10e-3)" "unprognostic (2.69e-2)" "unprognostic (1.88e-2)" "unprognostic (1.37e-3)" "unprognostic (5.13e-11)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (1.50e-3)" 0.9 0.9 0.5 5.1 0.3 18.2 3.0 0.5 0.6 2.1 0.0 3.8 2.5 2.5 0.7 3.7 1.0 0.9 0.6 0.2 0.2 0.7 3.1 1.2 5.1 0.2 0.4 1.0 0.8 0.7 0.5 3.0 0.2 1.4 4.5 3.0 1.0 0.7 0.5 3.5 3.6 2.3 0.3 1.5 2.1 4.1 0.2 5.5 0.9 0.9 6.2 1.4 1.9 0.6 37.2 18.6 34.3 16.3 1.7 9.9 18.2 20.4 10.4 31.9 36.7 19.3 27.5 23.6 11.6 11.6 17.5 22.3 35.3 12.8 36.9 27.4 19.6 35.4 20.6 23.9 0.8 41.2 14.6 2.8 0.8 18.5 2.9 4.1 19.0 30.5 30.9 14.3 31.6 32.7 43.6 28.4 20.2 30.9 42.6 35.9 31.7 21.0 11.6 20.6 24.8 14.3 20.5 11.9 6.7 16.5 24.5 15.8 6.7 5.3 38.5 21.4 16.9 10.7 22.7 52.7 9.8 30.1 20.9 0.0 0.0 0.2 0.2 0.0 0.1 0.3 0.2 0.4 0.1 0.2 0.0 0.2 0.0 0.9 0.0 0.2 0.7 0.1 0.5 0.3 0.5 0.6 0.2 0.2 0.2 0.4 0.2 0.3 0.2 0.6 2.0 3.2 0.5 4.2 2.4 4.8 2.1 1.9 2.2 0.8 1.5 1.1 1.2 1.5 1.3 0.0 0.0 9.1 1.0 2.2 0.0 1.3 1.2 0.8 2.6 1.5 1.2 21.0 9.5 1.5 10.6 2.7 1.1 1.5 0.0 4.3 5.0 5.5 5.5 0.0 11.9 2.8 0.0 1.9 1.6 0.8 1.5 1.1 1.8 7.5 1.0 2.0 4.1 12.1 11.5 0.8 0.5 3.0 5.7 1.9 1.1 1.2 0.9 3.1 0.0 2.1 7.4 5.3 24.4 6.0 3.7 3.4 1.7 1.8 4.7 1.5 POLG2 "HP55, MTPOLB" ENSG00000256525 "DNA polymerase gamma 2, accessory subunit" Q9UHN1 17 64477785-64497054 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Skeletal myocytes: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017030, HPA023202, HPA078396" Approved Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear bodies" "CAB017030: , HPA023202: AB_1855523, HPA078396: " "unprognostic (1.76e-1)" "unprognostic (2.20e-1)" "unprognostic (1.59e-1)" "unprognostic (7.02e-2)" "unprognostic (6.01e-2)" "unprognostic (2.91e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (4.38e-2)" "unprognostic (8.46e-2)" "unprognostic (3.14e-1)" "unprognostic (5.17e-3)" "prognostic unfavorable (6.59e-4)" "prognostic unfavorable (1.17e-5)" "unprognostic (5.17e-2)" "unprognostic (1.58e-1)" "unprognostic (2.88e-2)" "unprognostic (4.82e-2)" 4.5 5.8 2.7 4.4 3.0 3.6 4.5 3.9 4.5 6.8 3.0 4.7 3.5 4.7 2.0 4.0 5.6 2.4 5.0 2.8 3.6 5.7 5.3 3.9 5.4 3.2 3.0 7.9 4.7 2.4 4.0 2.9 3.1 5.1 1.9 2.6 3.9 2.9 6.8 4.2 5.6 2.0 2.9 7.5 4.0 12.8 3.1 6.3 5.8 4.2 4.0 4.8 5.3 3.9 8.1 10.4 6.7 7.6 7.2 4.7 8.4 4.6 4.6 7.0 5.9 10.1 6.2 15.7 5.4 2.8 6.5 5.3 9.3 3.9 8.8 4.6 11.0 9.9 12.2 10.5 7.0 14.2 10.6 4.5 4.7 5.3 7.2 8.4 4.7 7.6 18.3 4.7 6.5 10.0 15.3 15.4 7.3 8.6 11.2 13.3 23.8 14.2 6.4 2.4 9.3 10.0 4.4 7.1 8.0 8.7 7.4 12.0 6.1 7.0 9.9 5.8 12.3 8.4 7.2 11.3 5.9 13.4 4.8 7.2 5.2 6.0 6.5 3.2 6.6 10.7 7.5 6.2 9.7 11.9 9.7 9.7 0.9 5.8 8.4 4.4 8.1 4.0 2.7 3.0 3.9 4.5 2.8 3.6 3.2 3.0 3.1 2.9 3.1 3.9 24.6 12.8 21.2 7.8 19.6 8.2 13.7 7.8 16.5 5.0 30.1 37.5 18.4 12.8 13.3 3.7 0.0 13.0 22.7 31.7 0.0 5.4 14.7 16.5 26.7 16.0 10.9 20.4 9.1 3.8 14.4 19.2 14.8 29.2 13.3 9.9 14.6 4.7 9.2 6.7 7.4 13.9 6.1 6.9 7.1 7.3 6.5 17.7 7.2 11.2 8.0 4.5 18.6 13.0 14.1 2.9 21.8 3.0 6.3 9.8 8.9 5.2 7.1 9.2 6.6 92.0 18.4 49.7 9.2 10.8 8.7 4.0 16.2 15.2 19.8 5.2 POLR3G "C31, RPC32, RPC7" ENSG00000113356 "RNA polymerase III subunit G" O15318 5 90471748-90514557 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 84.5" "CAB010109, HPA052658, HPA074330" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies, Cytosol" "CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: " "unprognostic (4.31e-1)" "unprognostic (5.35e-2)" "unprognostic (2.62e-2)" "unprognostic (3.55e-3)" "unprognostic (1.18e-1)" "unprognostic (3.42e-2)" "unprognostic (4.19e-6)" "unprognostic (2.17e-3)" "unprognostic (1.91e-1)" "unprognostic (1.93e-2)" "unprognostic (3.52e-2)" "unprognostic (9.71e-2)" "unprognostic (1.21e-14)" "unprognostic (3.86e-2)" "unprognostic (3.19e-2)" "unprognostic (1.53e-2)" "unprognostic (8.17e-5)" 1.8 0.6 3.5 2.4 4.5 3.0 2.0 6.3 5.9 1.3 0.7 1.6 1.8 1.5 4.7 4.3 1.2 1.3 1.8 3.6 6.0 0.9 2.2 1.6 4.7 5.7 4.4 1.9 2.4 2.0 0.9 1.8 6.8 1.7 1.5 3.3 2.3 0.5 3.0 4.3 1.4 0.8 1.9 1.8 1.2 4.5 4.2 0.8 3.2 0.8 1.9 2.0 1.7 6.3 24.1 13.0 18.8 5.3 5.9 8.2 7.7 11.9 4.3 19.8 16.8 9.0 18.8 63.7 4.2 5.3 20.0 11.6 20.8 23.2 69.2 29.6 19.6 26.2 8.1 15.1 9.5 19.4 6.2 6.7 8.1 32.7 25.8 4.6 27.2 26.5 35.8 6.4 8.3 13.2 19.1 14.1 78.1 4.0 63.2 16.5 7.4 40.2 5.9 3.2 22.0 6.4 3.7 9.6 35.1 7.7 5.4 6.2 29.1 10.3 21.2 13.2 48.3 13.5 36.7 50.0 22.1 23.7 84.5 3.3 0.2 0.2 1.5 0.4 0.7 1.7 0.5 0.9 0.4 0.9 1.1 1.2 0.7 2.9 1.5 1.0 0.2 0.3 3.5 4.5 6.3 5.9 3.6 6.0 5.7 4.4 6.8 1.9 4.2 6.3 3.2 6.4 2.2 11.8 2.8 3.6 1.6 1.5 1.8 3.0 2.8 3.7 5.2 0.0 0.7 1.8 8.4 0.8 0.7 0.9 3.9 2.4 4.5 1.6 2.3 2.0 6.7 8.8 24.8 4.4 5.4 3.8 0.5 1.2 7.0 1.6 4.6 2.6 1.7 3.3 21.2 1.4 0.0 0.3 0.3 1.0 0.3 1.2 1.8 5.6 0.0 1.1 1.0 14.6 70.8 4.1 3.0 1.2 5.4 6.1 0.4 1.5 3.0 0.8 0.0 1.1 1.8 7.2 26.6 6.3 8.5 0.8 1.7 6.5 2.0 0.8 POU2F3 "Epoc-1, OCT11, PLA-1, Skn-1a" ENSG00000137709 "POU class 2 homeobox 3" Q9UKI9 11 120236640-120319945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 48.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019652, HPA073468" Enhanced Approved "Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 61: Skin - Cornification" "Cluster 6: T47d - Mammary gland" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm "Nucleoli, Nuclear bodies, Plasma membrane, Cytosol" "HPA019652: AB_1855585, HPA073468: " "unprognostic (1.75e-1)" "unprognostic (2.12e-2)" "unprognostic (6.37e-2)" "unprognostic (2.41e-4)" "unprognostic (2.60e-1)" "unprognostic (4.46e-3)" "unprognostic (8.56e-3)" "unprognostic (9.34e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.27e-2)" "unprognostic (9.69e-3)" "unprognostic (1.70e-1)" "prognostic favorable (8.14e-4)" "unprognostic (1.45e-1)" 0.1 0.1 0.2 0.1 0.1 0.2 2.0 0.3 0.4 0.8 0.0 0.6 0.9 0.0 1.7 1.3 0.5 0.7 0.1 0.1 0.1 0.3 0.1 1.0 0.2 0.1 0.1 0.1 0.2 6.3 0.4 0.3 0.1 0.6 0.2 0.1 1.1 2.0 0.2 48.0 0.7 0.3 0.0 0.2 0.7 0.1 0.1 0.2 0.7 0.0 0.5 0.4 2.1 0.3 1.4 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.3 0.0 0.0 0.0 3.6 0.1 1.3 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 2.5 0.0 0.3 3.9 0.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.0 8.2 0.3 0.0 20.9 10.6 5.0 1.8 0.0 3.0 1.5 0.8 0.0 3.9 11.0 0.0 1.5 0.1 0.9 0.0 5.3 2.2 1.3 0.7 0.3 3.0 0.0 0.4 1.3 0.4 0.6 10.2 4.8 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.2 8.2 0.0 2.2 5.5 0.0 0.1 5.4 0.0 0.0 0.4 0.0 0.0 0.5 20.8 1.1 0.0 0.0 5.0 0.4 0.1 1.8 0.0 0.0 0.0 0.4 0.0 0.1 7.0 37.6 7.9 0.5 0.2 0.6 14.2 POU6F1 "BRN5, MPOU, TCFB1" ENSG00000184271 "POU class 6 homeobox 1" 12 51186936-51217708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 20.9;Excitatory neurons: 22.2;Inhibitory neurons: 29.4;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 23.6" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 6.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Karpas-707: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047021, HPA050411" Enhanced Supported "Nuclear bodies,Actin filaments" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies" "Actin filaments" "HPA047021: AB_2679905, HPA050411: AB_2681119" "unprognostic (4.96e-2)" "unprognostic (1.08e-1)" "unprognostic (1.48e-3)" "unprognostic (1.45e-2)" "unprognostic (2.72e-1)" "unprognostic (6.58e-2)" "unprognostic (9.70e-2)" "unprognostic (7.11e-3)" "unprognostic (4.45e-1)" "unprognostic (2.05e-1)" "prognostic favorable (6.61e-4)" "unprognostic (2.48e-2)" "unprognostic (9.36e-2)" "unprognostic (2.09e-3)" "unprognostic (1.74e-1)" "unprognostic (2.02e-1)" "unprognostic (2.33e-1)" 2.0 1.5 0.3 1.2 1.3 0.4 1.7 3.6 6.0 3.1 0.0 2.4 0.6 2.5 0.1 0.7 2.2 1.2 1.1 1.4 0.0 1.2 0.5 1.8 0.8 0.0 0.0 3.2 1.3 0.8 2.6 0.6 0.0 2.1 0.2 1.3 2.1 1.4 4.0 1.4 1.5 1.5 0.0 1.5 1.3 0.3 0.3 0.2 2.3 1.3 0.5 1.7 1.7 0.0 0.3 0.8 1.0 1.4 0.3 1.2 0.5 0.5 0.6 0.6 0.7 0.1 0.5 1.8 0.2 0.4 0.3 0.0 1.2 0.0 0.0 2.8 1.8 0.5 1.1 0.0 1.0 0.4 2.4 0.6 0.5 1.0 0.1 1.4 2.0 0.7 0.7 4.9 0.3 0.0 0.2 0.7 1.8 0.0 0.0 0.5 0.6 0.0 0.3 0.0 1.3 2.2 1.2 0.0 2.3 0.5 0.5 1.7 1.5 1.1 0.9 0.3 1.3 3.2 2.8 0.2 1.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 3.6 6.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.5 6.4 2.8 20.9 2.1 3.1 1.3 0.4 0.0 10.0 2.3 1.3 3.1 1.5 1.7 7.3 4.2 0.6 1.1 0.1 1.9 0.8 5.3 0.9 1.7 4.8 0.0 2.7 22.2 2.0 0.2 3.2 0.5 1.6 5.1 2.4 3.6 1.2 0.3 1.7 29.4 0.3 4.1 2.2 3.9 3.7 5.9 1.1 1.8 8.4 1.7 3.7 0.0 21.1 23.6 1.6 0.2 6.8 0.7 1.8 0.0 0.7 2.7 7.9 0.0 3.8 4.1 0.1 0.7 0.5 2.8 0.4 1.8 0.2 0.6 0.7 PPM1M "FLJ32332, PP2Ceta" ENSG00000164088 "Protein phosphatase, Mg2+/Mn2+ dependent 1M" Q96MI6 3 52245759-52250599 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 42.2;Kupffer cells: 39.0;Macrophages: 31.1;NK-cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036905, HPA062291" Uncertain Approved "Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA036905: AB_10602818, HPA062291: AB_2684740" "unprognostic (4.26e-3)" "prognostic favorable (7.73e-4)" "unprognostic (2.55e-2)" "unprognostic (4.85e-3)" "unprognostic (5.64e-2)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "prognostic favorable (6.69e-4)" "unprognostic (4.63e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.49e-1)" "unprognostic (4.14e-2)" "unprognostic (9.27e-2)" "unprognostic (4.37e-2)" 19.5 9.4 12.7 20.3 13.7 24.6 15.5 9.9 13.6 25.9 12.2 18.7 6.0 18.3 9.9 12.3 18.1 14.1 11.4 13.6 14.2 10.9 5.6 23.5 29.6 12.8 11.4 18.6 8.0 11.2 9.1 11.6 12.2 16.7 8.7 2.2 11.6 15.2 3.7 10.7 13.1 18.0 12.0 30.1 11.4 8.8 15.5 27.6 13.8 7.8 28.2 17.5 18.2 12.9 0.9 5.4 3.2 7.6 46.1 45.7 5.2 12.2 26.2 17.0 13.1 3.2 4.2 9.0 3.6 32.0 9.5 1.5 10.9 2.3 6.9 11.0 2.7 20.5 14.6 3.3 33.6 3.1 18.7 37.8 5.2 18.9 11.9 27.3 22.2 40.5 3.6 14.5 20.2 2.2 13.7 0.9 4.1 4.0 14.7 3.0 1.6 20.0 7.3 2.6 2.3 9.3 9.0 2.2 11.1 6.8 7.6 7.9 15.5 6.5 10.7 3.8 1.6 54.3 11.2 9.9 12.7 5.4 8.0 1.8 24.1 13.3 20.6 19.3 15.9 6.8 16.1 19.2 14.4 7.4 15.2 19.0 28.9 11.7 29.6 8.5 20.5 17.5 12.7 13.7 9.9 13.6 13.6 14.2 12.8 11.4 12.2 12.0 15.5 12.9 6.8 0.0 5.4 1.3 15.4 5.1 6.5 0.7 8.0 1.6 5.9 7.2 1.8 5.7 2.0 1.8 0.0 3.3 25.9 0.7 3.9 1.8 9.7 4.7 8.9 7.0 1.2 3.0 1.5 1.1 5.8 11.9 3.1 11.0 5.7 7.3 12.5 3.7 42.2 1.7 0.6 0.4 2.0 39.0 17.0 18.0 12.8 31.1 5.4 4.7 29.1 5.1 30.9 1.5 0.7 1.3 3.2 9.8 11.4 2.3 0.9 3.0 0.9 0.7 19.7 5.2 7.3 0.7 4.2 11.9 3.8 1.9 25.1 3.1 1.0 3.5 PPME1 "ABDH19, PME-1" ENSG00000214517 "Protein phosphatase methylesterase 1" Q9Y570 11 74171267-74254703 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 432.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004541, HPA043900, HPA064396" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 45000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "Nuclear bodies" "CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254" "unprognostic (2.99e-2)" "unprognostic (1.27e-2)" "unprognostic (2.28e-1)" "unprognostic (1.98e-1)" "unprognostic (9.26e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (4.45e-6)" "unprognostic (2.31e-2)" "unprognostic (7.92e-2)" "unprognostic (9.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.84e-1)" "unprognostic (1.54e-1)" "unprognostic (4.14e-3)" "unprognostic (1.33e-3)" 14.7 25.1 16.8 10.0 18.1 16.9 14.9 8.5 21.3 17.3 7.8 15.2 11.0 16.8 29.1 20.8 24.1 14.0 21.4 18.8 19.4 18.6 10.1 13.0 9.3 12.7 14.5 18.3 15.4 62.5 14.5 14.9 17.5 23.8 15.7 23.8 20.1 24.9 29.7 28.7 11.5 21.4 9.8 8.1 13.4 31.9 13.4 18.8 23.1 24.1 14.7 22.3 13.9 14.0 50.5 62.3 42.4 45.9 45.4 36.0 41.3 71.8 48.4 134.8 103.6 139.1 32.3 26.3 47.7 55.1 73.6 79.9 63.4 50.3 123.1 36.4 23.8 38.7 66.6 64.1 96.7 28.9 33.2 34.6 41.8 69.7 32.7 54.8 39.1 37.5 93.0 22.5 236.6 34.1 38.0 36.1 34.4 71.2 50.3 39.9 432.4 39.9 56.7 33.9 57.2 49.2 85.1 38.7 108.4 46.2 72.7 29.1 23.5 52.1 67.6 51.5 55.2 41.4 54.6 46.9 39.2 26.7 43.4 1.4 8.7 11.3 10.4 10.5 13.2 7.2 13.4 12.6 11.2 8.3 13.3 10.9 4.9 13.7 9.5 11.8 10.9 9.2 16.8 18.1 8.5 21.3 18.8 19.4 12.7 14.5 17.5 9.8 13.4 14.0 16.1 28.9 12.8 28.7 10.8 20.3 24.4 30.5 23.3 31.3 18.5 17.7 18.0 7.2 28.5 35.0 37.5 14.1 11.2 15.4 17.6 16.9 51.4 44.9 32.8 15.0 25.7 96.4 65.3 13.4 38.9 19.1 23.9 24.2 8.2 21.2 10.8 9.7 13.6 33.7 59.3 13.5 34.6 6.7 14.8 13.4 13.7 11.1 3.6 20.6 10.8 15.2 16.5 35.7 40.5 16.6 12.0 25.2 8.2 19.2 10.3 11.6 40.9 18.8 6.6 19.0 33.0 61.9 45.6 21.5 24.9 15.5 12.4 18.8 13.4 17.3 PPP1R10 "CAT53, FB19, p99, PNUTS" ENSG00000204569 "Protein phosphatase 1 regulatory subunit 10" Q96QC0 6 30600413-30618612 "Predicted intracellular proteins" "DNA-binding, Protein phosphatase inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "basophil: 7.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025501, HPA047248, HPA056756" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies" "CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227" "unprognostic (1.68e-1)" "prognostic favorable (4.84e-4)" "unprognostic (1.21e-1)" "unprognostic (9.31e-3)" "unprognostic (6.31e-2)" "unprognostic (9.57e-3)" "unprognostic (2.02e-1)" "unprognostic (1.36e-1)" "unprognostic (1.62e-2)" "unprognostic (1.25e-1)" "prognostic favorable (9.74e-5)" "unprognostic (2.72e-1)" "unprognostic (8.02e-3)" "unprognostic (5.90e-2)" "unprognostic (1.76e-1)" "unprognostic (2.89e-1)" "unprognostic (3.74e-2)" 20.9 27.5 0.2 12.0 0.1 1.0 15.8 0.2 1.3 23.3 0.1 21.8 8.9 21.2 1.1 23.1 22.0 10.7 14.6 0.5 0.4 22.8 33.6 17.4 5.0 1.2 1.3 22.8 28.0 4.8 26.3 5.0 0.6 22.8 6.4 5.2 20.1 7.9 23.0 21.1 21.0 7.0 0.3 25.1 25.2 21.7 0.3 10.1 22.9 1.2 5.6 22.5 21.8 0.2 9.1 20.0 30.9 16.8 17.0 2.2 8.9 15.9 7.0 5.6 23.3 5.0 9.7 11.5 9.6 16.0 10.5 23.6 24.3 35.7 9.7 13.1 0.0 19.8 14.1 0.2 7.6 16.3 27.3 14.2 4.0 28.0 30.9 13.2 9.7 3.9 18.4 3.7 14.4 5.4 5.5 2.4 9.1 1.9 2.3 25.4 39.3 19.8 1.4 8.0 19.3 9.1 29.5 28.3 8.8 13.0 13.8 21.8 2.6 12.7 9.0 18.5 10.7 26.9 5.1 11.3 15.8 19.9 15.8 7.9 1.2 2.0 0.9 2.1 1.6 2.9 0.4 1.7 3.3 0.7 0.5 1.1 1.0 1.0 0.8 1.2 1.9 0.4 0.2 0.1 0.2 1.3 0.5 0.4 1.2 1.3 0.6 0.3 0.3 0.2 243.9 32.1 40.3 20.5 152.7 69.8 64.9 41.1 167.9 72.7 165.1 163.8 59.1 28.6 34.2 27.6 131.3 44.0 178.9 120.5 35.2 27.2 32.0 138.2 103.8 102.6 71.3 30.5 26.1 23.0 21.8 103.2 107.0 151.4 44.9 143.0 38.2 33.6 33.1 35.3 27.0 102.2 54.9 35.5 70.6 11.3 46.3 123.4 37.4 30.0 46.4 59.0 72.1 21.1 29.7 29.8 58.3 30.1 140.1 51.9 88.1 40.3 46.9 102.2 32.9 211.5 114.9 45.9 23.4 125.7 77.9 88.5 144.1 99.9 77.0 34.5 PPP1R14A "CPI-17, PPP1INL" ENSG00000167641 "Protein phosphatase 1 regulatory inhibitor subunit 14A" Q96A00 19 38251237-38256532 "Plasma proteins, Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 492.0;intestine: 450.3" "Cell type enhanced" "Detected in many" "Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9" "Group enriched" "Detected in many" 24 "B-cells: 299.4;dendritic cells: 246.9" "Group enriched" "Detected in some" 4 "A549: 164.1;EFO-21: 112.2;K-562: 64.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005044, CAB009803, HPA042097, HPA054534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 880000 "Cluster 37: B-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "Nuclear bodies" "CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518" "unprognostic (5.40e-2)" "unprognostic (4.00e-3)" "unprognostic (4.02e-2)" "unprognostic (2.53e-1)" "unprognostic (1.74e-1)" "unprognostic (8.92e-3)" "unprognostic (2.18e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (1.96e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.25e-5)" "prognostic unfavorable (7.12e-4)" "unprognostic (4.13e-1)" "unprognostic (5.81e-2)" "unprognostic (2.22e-2)" 134.0 144.2 175.2 22.1 347.5 2.9 111.9 321.5 226.5 149.7 63.2 450.3 18.6 273.5 5.2 47.6 153.7 14.8 94.6 175.2 219.6 53.3 17.9 163.1 2.6 402.3 322.9 125.1 31.1 2.8 12.6 34.1 336.3 142.0 12.6 0.3 19.0 86.1 27.5 28.6 82.1 57.2 222.0 101.2 140.3 77.6 365.3 1.7 25.8 12.3 1.4 301.6 106.1 492.0 0.0 164.1 0.4 0.0 1.0 0.0 6.1 10.8 0.0 0.1 0.0 12.8 0.2 0.0 112.2 1.0 0.0 0.5 13.6 0.2 0.0 1.4 0.0 25.5 0.0 0.0 4.6 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.0 64.5 0.3 0.0 0.8 0.0 0.3 4.9 0.0 0.0 0.2 2.4 0.4 0.4 0.0 3.5 0.2 0.0 0.0 0.1 9.2 0.0 0.4 0.4 0.0 0.8 0.4 0.0 0.4 0.0 0.5 0.2 0.0 0.1 11.3 0.6 1.2 0.1 0.7 0.2 299.4 0.2 0.4 44.3 283.9 0.6 0.1 1.7 8.7 0.2 246.9 0.2 21.6 175.2 347.5 321.5 226.5 175.2 219.6 402.3 322.9 336.3 222.0 365.3 492.0 332.5 0.0 1.1 1.3 29.9 9.6 3.0 1.2 3.4 0.4 8.8 209.8 19.6 2.8 0.7 0.0 0.0 48.3 48.7 32.7 0.0 0.7 14.1 15.4 239.5 108.5 1.8 34.7 0.5 10.9 7.4 66.8 2.0 10.8 3.8 435.0 224.5 2.3 9.5 0.0 0.6 0.4 0.0 5.6 24.6 42.1 341.1 41.4 8.8 14.0 66.1 0.5 4.1 3.5 155.6 2.2 2.6 656.0 4.8 2.4 3.8 0.3 0.0 1.6 979.5 8.7 465.2 9.9 46.2 0.6 8.0 26.4 3.7 66.0 0.4 1.2 PPWD1 KIAA0073 ENSG00000113593 "Peptidylprolyl isomerase domain and WD repeat containing 1" Q96BP3 5 65563236-65587549 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019353, HPA019360" Enhanced Supported "Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "HPA019353: AB_1855668, HPA019360: AB_1855669" "unprognostic (3.31e-2)" "unprognostic (2.07e-2)" "unprognostic (6.78e-2)" "unprognostic (2.85e-1)" "unprognostic (9.61e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.37e-1)" "unprognostic (4.97e-2)" "unprognostic (1.09e-1)" "unprognostic (7.84e-3)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.72e-4)" "unprognostic (2.40e-1)" "unprognostic (1.18e-1)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" 15.0 12.1 12.3 18.2 14.6 27.6 17.2 16.5 16.4 17.3 13.4 14.7 13.4 19.0 17.8 13.5 16.1 15.7 13.5 12.4 13.2 13.0 15.5 14.9 30.0 13.6 12.8 22.9 14.0 15.5 14.7 19.6 13.4 15.0 19.2 14.7 12.7 13.7 13.2 22.2 17.1 13.2 12.9 22.6 14.4 18.1 13.0 32.9 16.3 15.6 26.0 13.7 15.2 18.5 36.5 23.6 35.1 35.2 30.6 36.9 38.8 34.5 25.3 36.5 45.5 37.8 35.4 41.5 28.5 24.3 49.1 32.3 38.4 35.5 49.8 35.7 32.3 26.0 40.0 31.1 25.9 23.9 26.4 29.2 15.3 35.5 25.5 27.0 32.3 31.6 35.3 28.8 28.8 35.8 40.0 31.6 24.7 15.2 13.3 35.4 46.7 35.1 21.2 29.5 18.1 14.8 34.8 14.5 33.1 26.8 21.5 30.8 24.9 20.2 29.2 22.4 52.9 17.1 26.3 45.5 22.3 35.8 21.4 35.0 15.1 31.6 26.1 19.3 32.0 25.8 29.1 29.9 21.2 19.1 36.1 31.0 14.3 26.5 24.0 11.8 38.1 23.4 12.3 14.6 16.5 16.4 12.4 13.2 13.6 12.8 13.4 12.9 13.0 18.5 25.1 28.9 22.4 28.1 36.0 12.4 14.9 15.4 18.2 14.2 9.1 12.8 19.8 7.2 22.1 11.0 8.4 27.7 27.0 6.9 9.8 8.7 76.8 16.4 28.7 20.7 9.6 21.5 37.2 7.7 14.4 21.1 15.8 13.8 11.4 32.6 18.9 6.0 11.8 6.7 46.8 14.9 8.2 16.4 11.9 41.7 20.2 15.2 14.2 23.4 22.6 11.8 23.7 42.3 67.1 8.9 14.7 18.8 29.4 6.6 10.0 7.9 17.8 20.9 6.6 19.9 17.8 32.5 33.7 13.2 11.8 25.2 35.4 15.8 11.4 9.0 PRDM15 "C21orf83, ZNF298" ENSG00000141956 "PR/SET domain 15" P57071 21 41798225-41879482 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 12.5;Plasma cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "Daudi: 31.1;U-266/70: 32.2;U-698: 76.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024268, HPA029255, HPA029256" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear bodies" Nucleoplasm "HPA024268: AB_1855688, HPA029255: AB_2672970, HPA029256: AB_2672971" "unprognostic (8.73e-2)" "unprognostic (1.32e-2)" "unprognostic (2.43e-2)" "unprognostic (6.93e-2)" "unprognostic (2.44e-1)" "unprognostic (1.85e-4)" "unprognostic (4.22e-4)" "unprognostic (6.50e-2)" "unprognostic (4.88e-2)" "unprognostic (1.91e-2)" "unprognostic (5.52e-2)" "unprognostic (1.77e-1)" "unprognostic (1.30e-8)" "unprognostic (1.34e-1)" "unprognostic (2.70e-1)" "unprognostic (9.72e-2)" "unprognostic (4.86e-3)" 2.0 1.8 1.8 4.5 1.7 1.7 2.1 1.3 1.9 2.2 1.2 2.3 2.8 2.2 1.6 2.5 2.4 1.4 1.7 1.7 1.4 1.5 2.1 1.9 8.3 1.4 1.4 2.4 2.3 1.8 2.1 1.2 1.4 2.4 1.8 1.6 2.3 1.5 4.5 3.9 2.9 1.4 1.0 3.7 2.2 2.0 1.3 3.2 2.2 1.7 7.4 1.9 2.2 1.6 2.8 6.0 4.4 5.8 1.9 2.4 4.4 2.2 1.8 2.2 1.6 4.1 3.0 31.1 2.5 2.7 2.1 4.1 3.9 2.9 2.1 3.3 5.5 6.5 15.1 5.0 1.3 5.6 3.9 1.1 3.9 2.7 1.8 2.4 3.3 3.4 5.6 2.0 3.0 6.4 5.5 3.7 5.1 3.1 3.1 8.5 3.5 2.5 2.3 4.8 7.5 4.3 10.1 5.1 1.5 1.7 3.8 2.7 3.3 3.8 2.1 2.9 4.3 32.2 3.5 76.0 3.6 6.5 5.3 0.0 0.4 0.5 0.2 0.8 0.2 0.6 0.1 0.3 0.4 0.2 0.2 0.3 0.0 0.1 0.1 0.1 0.2 0.4 1.8 1.7 1.3 1.9 1.7 1.4 1.4 1.4 1.4 1.0 1.3 1.6 2.4 3.2 12.5 6.2 5.1 2.9 1.8 1.6 2.2 3.4 2.8 2.4 4.4 1.5 7.8 1.8 6.2 1.4 2.0 2.3 0.0 1.3 2.2 2.6 2.5 2.5 0.0 2.5 9.0 2.6 0.9 2.6 3.1 2.0 3.8 3.3 1.1 2.2 1.9 3.3 6.4 1.3 2.0 2.8 2.2 4.3 1.2 3.3 1.8 6.5 2.9 1.1 4.1 3.5 8.0 1.7 0.8 0.4 15.9 2.3 1.1 0.8 5.3 3.1 0.0 3.1 2.3 2.3 2.9 3.2 3.4 0.7 2.7 1.3 2.2 1.8 PRDM5 PFM2 ENSG00000138738 "PR/SET domain 5" Q9NQX1 4 120684919-120922870 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "eosinophil: 7.5;neutrophil: 5.4" "Lineage enriched" "Detected in single" 32 "granulocytes: 7.5" "Cell line enhanced" "Detected in many" "U-266/84: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051406 Enhanced Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" Nucleoli "HPA051406: AB_2681472" "unprognostic (7.74e-2)" "unprognostic (8.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.09e-1)" "unprognostic (7.20e-2)" "unprognostic (9.30e-2)" "unprognostic (3.28e-2)" "unprognostic (4.52e-2)" "unprognostic (5.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.13e-1)" "unprognostic (3.00e-2)" "unprognostic (4.91e-4)" "unprognostic (2.34e-1)" "unprognostic (1.29e-1)" "unprognostic (5.56e-3)" 3.0 4.0 1.8 1.6 2.0 3.5 3.0 3.2 2.0 5.2 4.2 3.2 1.3 6.0 2.8 2.2 4.6 2.4 3.0 1.6 3.2 1.9 0.4 4.2 0.9 4.1 4.0 10.3 4.8 8.6 3.9 3.5 4.0 4.1 2.9 4.7 1.8 4.3 1.6 1.5 1.8 4.4 4.7 2.4 2.1 3.6 2.9 1.4 5.8 3.0 0.8 2.9 3.3 4.4 2.2 3.4 7.8 0.1 4.5 9.3 9.2 4.7 9.9 4.7 4.2 4.4 1.2 0.4 1.2 6.2 4.5 0.1 0.0 1.0 6.0 0.0 1.4 2.9 3.1 0.3 4.9 10.0 0.1 6.6 2.9 3.3 4.1 4.3 3.4 1.2 0.0 14.2 5.7 0.4 1.5 0.1 5.7 0.8 2.7 0.0 9.3 6.1 1.6 0.0 1.4 6.2 0.0 0.1 0.9 4.0 6.4 4.1 1.4 0.2 2.7 4.8 4.6 13.0 19.7 0.1 3.6 0.1 3.6 0.1 0.0 7.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.4 0.0 0.0 0.0 0.0 0.0 1.8 2.0 3.2 2.0 1.6 3.2 4.1 4.0 4.0 4.7 2.9 4.4 7.1 12.8 5.6 51.2 0.5 1.7 2.7 2.4 9.1 9.1 1.1 2.4 8.2 2.8 3.8 1.8 8.4 1.0 0.2 1.5 1.9 2.3 75.6 1.4 9.4 6.3 3.6 0.0 25.0 2.5 2.6 9.6 2.6 1.4 2.5 15.5 3.6 0.0 0.8 0.0 31.9 3.6 4.1 0.3 0.7 31.0 8.7 0.6 1.8 23.4 0.2 7.6 0.0 52.8 8.0 1.5 0.8 9.4 0.7 2.6 0.1 0.2 1.8 7.5 6.6 10.1 6.6 8.2 3.5 4.6 1.7 0.5 1.2 14.9 3.0 0.7 PRDM8 KMT8D ENSG00000152784 "PR/SET domain 8" Q9NQV8 4 80183879-80204329 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 26.1;seminal vesicle: 27.2" "Cell type enriched" "Detected in many" 9 "Bipolar cells: 271.5" "Cancer enhanced" "Detected in many" "prostate cancer: 4.6" "Region enhanced" "Detected in many" "cerebral cortex: 17.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 27.3;LHCN-M2: 41.7;NB-4: 48.2;SCLC-21H: 99.3" "Region enhanced" "Detected in many" "hippocampal formation: 28.7" "Low region specificity" "Detected in all" HPA057253 Supported "Nucleoplasm,Nuclear bodies" No NA "Cluster 24: B-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" Nucleoplasm "HPA057253: AB_2683382" "unprognostic (2.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.68e-1)" "unprognostic (1.65e-1)" "unprognostic (7.95e-2)" "unprognostic (1.19e-1)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (2.80e-2)" "unprognostic (1.89e-11)" "unprognostic (4.64e-2)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-1)" 4.8 2.3 5.1 5.0 10.2 4.0 4.0 0.0 17.0 11.7 0.0 11.4 1.1 9.3 1.9 1.7 5.2 1.7 1.7 13.7 0.0 1.3 0.3 1.6 5.1 0.0 0.0 5.2 0.9 0.0 5.4 4.3 0.0 26.1 1.5 24.1 1.4 27.2 2.2 2.7 5.7 3.8 0.6 1.8 5.0 1.1 0.1 0.7 1.2 0.9 2.4 10.2 9.8 3.2 2.3 0.2 0.7 0.0 2.1 7.2 0.1 5.8 20.5 2.8 3.2 0.0 2.2 0.0 0.0 7.2 1.8 0.7 0.1 2.4 12.1 8.8 1.8 0.8 0.0 0.0 4.1 9.1 2.5 4.4 0.2 11.1 3.2 27.3 0.4 2.4 0.0 3.7 41.7 0.0 4.2 48.2 0.0 0.2 17.0 1.6 0.0 0.2 1.2 0.3 99.3 13.8 0.3 0.0 0.1 0.1 0.0 4.5 8.8 7.1 1.0 5.2 0.4 1.7 0.0 0.0 17.8 4.2 1.0 0.0 0.0 0.0 0.4 0.0 0.6 0.1 0.5 0.5 0.1 0.7 0.3 0.1 0.5 0.2 0.0 0.1 0.2 0.1 5.1 10.2 0.0 17.0 13.7 0.0 0.0 0.0 0.0 0.6 0.1 3.2 0.9 0.0 0.5 2.3 8.2 0.6 3.4 0.4 0.0 271.5 0.1 0.4 1.8 0.0 5.2 1.8 2.1 0.0 2.5 0.0 0.0 0.0 1.5 0.3 6.5 2.2 0.0 2.5 29.9 0.2 0.2 8.8 0.0 0.5 0.0 0.1 0.0 0.0 0.5 3.3 2.0 0.2 2.0 1.2 6.2 6.7 3.1 5.9 1.8 3.7 0.9 6.1 2.1 7.1 17.0 0.7 0.0 3.4 2.7 3.7 0.0 0.2 5.0 11.6 0.0 4.2 2.9 0.3 0.4 0.0 0.1 0.1 5.0 0.1 0.0 0.6 PRPF40B HYPC ENSG00000110844 "Pre-mRNA processing factor 40 homolog B" Q6NWY9 12 49568218-49644666 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Spermatocytes: 61.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038426, HPA038599" Enhanced Approved "Nucleoplasm,Nuclear bodies,Aggresome,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" "Nucleoplasm, Aggresome, Cytosol" "HPA038426: AB_10674684, HPA038599: AB_10674689" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (2.44e-3)" "unprognostic (2.36e-2)" "unprognostic (1.83e-1)" "unprognostic (2.47e-1)" "unprognostic (7.50e-6)" "unprognostic (1.02e-1)" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.06e-3)" "unprognostic (3.31e-1)" "unprognostic (3.29e-3)" "unprognostic (3.23e-2)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (2.80e-2)" 8.3 16.3 16.3 3.2 15.6 0.7 11.5 13.3 18.8 23.9 13.7 15.6 4.0 17.9 10.4 10.4 19.1 6.4 15.6 16.6 16.5 23.9 9.2 7.4 3.1 16.4 14.5 25.4 16.0 20.3 26.2 6.5 15.9 17.5 3.4 12.3 13.3 11.7 25.2 11.4 7.6 7.8 13.3 9.5 14.5 33.7 14.7 3.5 29.2 13.5 3.4 14.6 14.6 15.3 7.2 10.5 10.3 10.0 8.4 5.4 9.5 5.8 8.1 6.1 3.0 12.2 15.8 5.8 12.0 7.7 8.6 4.2 6.3 20.1 3.1 4.4 2.5 6.1 4.2 4.4 10.6 2.0 7.8 7.7 16.8 6.1 22.0 13.2 4.9 11.7 3.0 3.0 7.3 6.7 1.4 4.2 4.4 8.2 3.9 5.1 1.6 4.8 13.0 6.6 10.9 13.1 4.7 12.8 7.2 9.4 24.5 5.7 2.0 3.7 14.9 4.9 2.5 7.1 4.3 2.4 11.2 1.5 3.5 0.0 0.1 0.0 0.8 0.1 1.1 0.3 0.8 0.3 0.2 0.6 0.8 0.9 0.0 1.3 0.0 0.5 0.3 0.3 16.3 15.6 13.3 18.8 16.6 16.5 16.4 14.5 15.9 13.3 14.7 15.3 5.3 12.8 20.3 15.7 4.1 3.6 8.7 10.2 11.4 19.1 6.6 9.7 1.2 5.7 17.5 18.4 10.4 21.9 1.2 1.5 7.9 13.8 28.9 8.6 7.5 5.2 7.7 3.0 19.3 11.1 7.4 7.2 4.1 5.6 2.5 15.6 8.2 3.1 5.4 11.8 22.9 3.2 12.2 1.6 2.1 23.1 11.8 1.5 3.6 6.5 4.9 8.3 2.1 20.6 17.2 6.8 1.1 12.0 1.1 6.7 1.4 5.6 24.5 19.8 13.1 9.8 9.7 61.3 26.6 8.0 6.0 26.4 3.1 9.2 5.2 5.0 PRR19 MGC70924 ENSG00000188368 "Proline rich 19" A6NJB7 19 42302098-42310814 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 21.6" "Group enriched" "Detected in some" 9 "Early spermatids: 26.7;Late spermatids: 60.1;Spermatocytes: 37.9;Spermatogonia: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA070350 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Mitochondria" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoli, Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA070350: AB_2686259" "unprognostic (2.05e-1)" "unprognostic (8.03e-3)" "unprognostic (4.02e-2)" "unprognostic (7.55e-3)" "unprognostic (7.33e-2)" "unprognostic (1.08e-2)" "unprognostic (2.44e-5)" "unprognostic (3.57e-1)" "unprognostic (1.92e-2)" "unprognostic (8.10e-3)" "unprognostic (3.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.87e-3)" "unprognostic (4.21e-1)" "unprognostic (7.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-2)" 0.4 1.1 1.9 0.7 2.5 2.3 0.5 2.1 2.4 0.7 1.3 0.4 0.4 0.6 0.4 1.1 0.5 0.5 0.2 1.9 1.7 0.7 0.6 0.3 0.5 1.8 1.5 0.5 0.4 0.4 0.9 0.4 1.9 0.7 0.2 0.5 0.7 0.4 0.3 0.7 0.5 0.3 1.4 0.5 0.4 21.6 2.0 0.6 0.4 0.1 0.5 0.4 0.7 2.0 2.7 3.9 2.2 2.9 0.1 0.2 2.2 1.2 1.2 3.5 3.5 1.6 2.5 0.5 4.5 1.3 2.6 0.8 1.0 1.0 0.7 1.8 1.0 2.8 2.0 1.0 0.8 0.7 1.6 1.1 1.6 2.3 0.4 0.7 0.6 2.9 1.5 1.3 1.6 6.2 2.7 1.3 2.3 2.5 0.0 1.0 0.4 0.2 1.1 2.1 4.9 1.9 2.1 1.5 0.6 0.6 2.0 1.0 0.8 2.3 3.4 0.5 2.1 0.2 1.0 0.8 2.4 2.0 2.4 0.4 0.4 0.1 0.4 0.4 0.1 0.6 0.3 0.5 0.5 0.4 0.4 0.2 0.4 0.5 0.1 0.3 0.5 0.2 1.9 2.5 2.1 2.4 1.9 1.7 1.8 1.5 1.9 1.4 2.0 2.0 1.2 0.0 0.5 0.0 0.7 0.6 0.9 1.9 4.0 0.4 2.7 2.8 0.5 0.0 0.6 0.0 0.0 0.9 0.3 0.8 1.9 0.9 26.7 1.0 0.7 1.2 0.0 0.0 0.4 1.2 0.6 0.6 1.1 1.5 0.0 0.3 0.0 0.4 0.8 1.7 0.4 0.1 0.0 0.0 0.3 60.1 1.2 0.4 0.0 1.0 0.1 0.0 1.0 1.0 0.3 0.4 1.2 1.2 0.6 0.4 0.6 0.6 2.3 0.2 0.0 0.8 0.7 37.9 22.5 2.1 0.9 0.5 0.4 0.6 0.4 0.7 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139003962-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 78: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.48e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.2 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 1.3" "Group enriched" "Detected in some" 8 "Spermatocytes: 6.4;Spermatogonia: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 83: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 17: Basophils - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PRRX2 "PMX2, PRX2" ENSG00000167157 "Paired related homeobox 2" Q99811 9 129665647-129722674 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 23.3;skin 1: 25.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 27.4;Early spermatids: 78.7;Fibroblasts: 44.2;Langerhans cells: 28.0;Smooth muscle cells: 21.2;Suprabasal keratinocytes: 29.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.9;BJ: 28.7;BJ hTERT+: 20.3;fHDF/TERT166: 41.6;U-2197: 34.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "spinal cord: 1.3" "HPA006607, HPA026808" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Nuclear bodies" "HPA006607: AB_2667623, HPA026808: AB_10603228" "unprognostic (4.02e-2)" "unprognostic (5.17e-2)" "unprognostic (7.65e-3)" "unprognostic (4.47e-3)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (2.16e-2)" "unprognostic (1.03e-2)" "unprognostic (8.58e-3)" "unprognostic (9.27e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" "unprognostic (1.94e-10)" "unprognostic (6.66e-2)" "unprognostic (4.48e-1)" "unprognostic (2.65e-2)" "unprognostic (9.47e-3)" 14.2 2.4 0.5 1.2 0.5 0.0 11.7 0.4 0.7 23.3 1.0 2.2 0.2 3.9 0.2 5.4 3.4 1.3 9.5 0.6 1.2 1.2 0.1 4.6 1.1 0.5 0.5 1.3 0.9 0.5 4.5 1.4 0.6 14.1 0.3 0.0 7.5 2.7 1.6 25.5 1.6 0.6 0.4 0.1 2.8 10.7 0.5 0.3 9.5 0.6 0.8 10.7 18.3 0.5 0.0 0.7 0.0 1.1 3.3 12.9 0.1 28.7 20.3 3.6 4.0 0.0 0.0 0.0 10.2 41.6 1.5 0.3 0.8 0.0 0.3 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 1.1 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.6 0.0 0.0 4.4 2.1 6.4 0.0 0.0 0.0 0.9 0.0 0.0 2.7 1.3 0.1 0.0 1.4 2.7 0.5 0.0 0.0 8.3 34.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.7 0.6 1.2 0.5 0.5 0.6 0.4 0.5 0.5 3.9 0.0 0.0 0.7 0.1 27.4 1.1 16.0 0.6 0.0 6.0 6.0 0.3 0.0 10.1 0.0 0.0 0.2 0.1 0.0 1.9 0.1 78.7 1.0 6.3 3.0 0.0 0.0 0.4 0.0 0.4 44.2 0.5 1.8 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 2.0 0.0 28.0 10.2 2.8 0.3 8.8 0.0 0.0 0.0 0.0 5.0 0.1 0.9 0.0 3.4 0.0 4.0 0.0 0.1 7.9 0.0 0.0 0.4 21.2 3.6 6.8 0.5 29.7 0.4 0.8 0.0 0.0 6.2 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86047109-86088621 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "retina: 2.4" "Cell type enhanced" "Detected in single" "Rod photoreceptor cells: 2.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "HEL: 9.4" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 36: HEL - Hemostasis" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 PSMA1 "HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30" ENSG00000129084 "Proteasome 20S subunit alpha 1" P25786 11 14504874-14643635 "Enzymes, Predicted intracellular proteins" Immunity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 627.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033765, HPA037646, HPA043891, CAB079995" Supported Supported "Nucleoplasm,Nuclear bodies,Centrosome" NA NA 20000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "Nuclear bodies, Centrosome" "CAB033765: AB_2253026, CAB079995: , HPA037646: AB_10670386, HPA043891: AB_2678718" "unprognostic (1.72e-2)" "unprognostic (4.97e-2)" "unprognostic (7.33e-2)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (6.66e-3)" "prognostic unfavorable (3.79e-5)" "unprognostic (3.28e-3)" "unprognostic (7.44e-2)" "unprognostic (3.43e-3)" "unprognostic (8.27e-3)" "unprognostic (8.77e-2)" "prognostic unfavorable (4.03e-11)" "unprognostic (1.93e-1)" "unprognostic (1.69e-1)" "unprognostic (4.66e-2)" "unprognostic (1.23e-2)" 87.2 85.5 55.1 94.9 57.8 135.8 96.2 55.4 68.2 76.8 58.7 92.5 96.4 80.7 108.0 94.7 79.4 79.6 140.5 59.4 64.4 98.4 139.2 77.5 114.9 55.8 56.6 79.4 54.6 78.5 50.4 113.0 58.8 81.7 101.9 63.2 74.4 85.8 168.7 80.5 86.1 96.1 56.6 75.6 75.7 56.2 60.2 122.2 88.4 152.6 109.9 111.2 56.0 58.6 408.8 279.8 227.8 275.7 223.7 225.5 193.3 232.9 305.2 348.3 283.9 244.2 500.1 349.5 262.1 248.6 315.4 303.1 259.3 290.1 328.3 344.0 389.6 220.4 190.5 326.1 291.0 355.3 277.5 217.8 171.6 188.9 390.7 252.7 347.0 271.6 398.9 283.4 315.2 277.8 334.0 319.5 191.6 340.5 414.1 223.3 336.1 217.5 313.0 304.7 188.2 119.3 246.6 273.9 229.0 233.8 164.4 222.9 272.0 226.2 222.9 402.7 295.4 123.3 366.1 319.9 334.8 291.1 296.6 115.5 191.2 47.5 97.7 139.8 128.0 104.1 110.8 109.7 243.3 95.3 98.5 94.4 36.3 145.1 137.5 138.7 154.9 235.8 55.1 57.8 55.4 68.2 59.4 64.4 55.8 56.6 58.8 56.6 60.2 58.6 119.0 83.3 90.2 64.3 101.7 142.9 231.2 365.7 76.2 50.3 105.7 125.9 0.0 82.9 176.1 88.3 18.8 469.5 135.3 49.2 256.3 228.5 75.5 84.0 94.0 135.5 40.1 163.9 56.8 233.1 370.6 128.5 66.8 79.8 78.2 134.7 95.3 127.9 292.9 57.2 66.3 63.6 231.9 161.8 170.5 36.3 116.5 153.6 144.1 122.7 263.7 111.6 168.9 64.8 35.3 223.2 88.6 127.5 112.1 209.1 135.0 257.1 115.1 54.8 85.5 99.2 129.8 174.9 80.1 114.3 151.9 627.3 130.7 137.2 97.1 248.1 PSMB7 Z ENSG00000136930 "Proteasome 20S subunit beta 7" Q99436 9 124353465-124415444 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052408, HPA054902" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No No 2100000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA052408: AB_2681820, HPA054902: AB_2682635" "unprognostic (7.75e-2)" "unprognostic (1.83e-2)" "unprognostic (1.27e-1)" "unprognostic (3.64e-3)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.02e-2)" "unprognostic (2.24e-3)" "unprognostic (9.03e-2)" "unprognostic (3.60e-1)" "unprognostic (2.99e-1)" "unprognostic (1.78e-1)" "unprognostic (1.26e-2)" "unprognostic (1.67e-1)" "unprognostic (3.45e-1)" "unprognostic (1.93e-3)" "unprognostic (3.98e-2)" 115.7 180.4 129.4 103.9 136.9 189.7 122.6 132.7 144.8 99.8 119.6 103.5 98.7 102.9 147.0 139.1 94.6 87.2 212.0 135.8 137.0 150.9 222.9 91.4 112.7 138.2 139.5 101.6 142.2 143.4 74.7 120.2 138.2 94.8 107.8 81.0 114.3 75.0 277.8 166.2 98.3 92.7 131.5 91.7 115.3 155.2 137.8 147.6 91.3 205.3 124.6 110.5 104.2 135.0 344.4 411.7 275.8 336.4 190.4 224.8 396.1 325.3 447.6 461.7 315.1 546.3 327.1 389.2 256.8 307.4 457.2 480.2 346.7 345.4 420.0 375.0 299.3 245.3 673.3 460.0 428.5 491.6 234.3 270.8 299.6 483.7 478.5 355.1 394.3 345.5 507.9 269.8 362.4 600.0 355.9 329.5 409.7 519.6 581.5 309.8 411.4 457.2 331.5 221.9 323.7 263.6 310.4 394.0 498.4 268.7 454.8 212.7 315.9 297.5 240.7 384.9 499.0 289.9 873.7 394.9 498.1 297.8 429.1 162.7 201.5 154.5 128.3 211.4 138.9 177.8 145.7 142.5 221.1 159.7 138.2 135.9 87.0 185.3 206.8 187.5 226.0 264.8 129.4 136.9 132.7 144.8 135.8 137.0 138.2 139.5 138.2 131.5 137.8 135.0 73.1 76.9 77.6 26.1 88.0 194.1 184.4 309.1 39.9 41.5 113.9 97.5 147.3 134.4 150.0 69.9 22.9 441.4 83.0 146.9 330.6 351.3 404.6 105.7 93.8 123.8 141.2 93.8 38.4 392.7 356.7 112.3 52.5 90.3 104.6 130.8 107.1 277.3 237.2 33.7 31.9 162.5 160.7 122.1 148.4 472.8 139.1 92.5 199.3 33.7 168.5 119.7 113.3 30.7 44.8 393.6 143.7 125.3 69.9 158.0 173.6 484.7 135.7 61.6 85.5 133.8 221.2 330.6 190.4 60.4 218.9 488.7 81.4 135.8 181.2 201.3 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 290000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 85.3 86.1 106.8 64.7 117.3 96.1 77.9 105.3 131.0 73.7 105.8 110.2 52.2 89.9 62.5 88.7 69.0 44.0 172.1 107.8 106.3 73.8 117.7 76.2 65.3 108.6 114.7 58.2 81.4 74.1 55.4 78.8 111.0 74.2 59.1 30.9 73.0 69.8 292.0 103.4 64.0 77.5 104.6 67.8 87.7 74.7 115.2 90.6 69.4 162.9 76.5 80.8 71.7 107.0 223.7 248.2 233.5 173.3 109.6 117.3 226.5 181.5 267.4 445.7 313.8 223.3 126.8 179.5 110.1 230.1 195.7 218.3 206.7 237.7 199.0 269.4 268.1 173.1 301.1 218.5 141.4 203.7 177.0 131.4 126.1 181.6 202.5 98.4 253.8 182.7 249.2 164.7 276.0 497.0 259.5 258.4 229.5 280.7 296.1 269.3 458.8 157.3 209.5 165.2 170.0 147.1 148.7 206.9 116.2 98.2 255.7 209.8 181.3 253.7 321.1 363.8 474.7 176.5 220.0 209.2 262.4 201.7 325.1 111.5 154.3 121.8 160.8 194.6 146.7 146.8 132.9 147.8 160.6 122.4 116.5 118.6 33.9 173.3 211.6 160.0 191.0 254.7 106.8 117.3 105.3 131.0 107.8 106.3 108.6 114.7 111.0 104.6 115.2 107.0 81.5 57.7 42.0 3.9 59.5 86.3 112.8 198.5 50.7 41.2 61.4 64.1 217.6 81.5 103.7 68.0 16.7 265.9 60.0 143.9 152.6 199.2 152.5 72.0 75.7 96.0 64.5 136.6 6.4 202.6 257.9 100.4 54.0 70.1 75.3 79.2 77.1 144.2 158.2 37.0 5.3 111.5 75.3 62.4 80.0 217.6 88.6 62.5 99.6 1.9 132.0 120.2 74.2 3.0 5.2 214.2 110.8 100.1 96.3 102.8 127.7 191.3 76.9 47.4 118.3 75.1 193.3 147.0 63.6 51.3 77.3 352.9 61.8 74.1 117.6 101.6 PSME1 "IFI5111, PA28alpha" ENSG00000092010 "Proteasome activator subunit 1" Q06323 14 24136163-24138967 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006632 Approved Approved "Nuclear bodies,Cytosol" NA NA 7500000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "Nuclear bodies" "HPA006632: AB_1079686" "prognostic favorable (8.87e-5)" "unprognostic (1.02e-2)" "unprognostic (9.90e-2)" "unprognostic (2.84e-1)" "unprognostic (2.65e-1)" "unprognostic (1.97e-1)" "unprognostic (5.16e-1)" "unprognostic (7.04e-2)" "unprognostic (9.63e-3)" "unprognostic (5.06e-3)" "unprognostic (1.49e-2)" "unprognostic (1.38e-2)" "unprognostic (1.14e-2)" "unprognostic (1.45e-1)" "unprognostic (4.50e-1)" "prognostic favorable (4.60e-4)" "unprognostic (1.62e-3)" 163.2 231.2 36.4 102.1 37.3 120.3 157.1 37.1 47.1 159.0 36.4 182.2 133.9 128.6 85.0 177.6 139.6 68.3 145.2 35.7 38.9 224.5 219.7 184.1 156.8 40.5 37.6 154.3 131.0 84.6 115.0 72.4 39.0 146.3 119.9 24.5 151.6 85.9 140.7 142.9 211.6 79.8 39.6 272.6 160.4 30.7 38.2 129.1 150.6 67.3 150.7 135.2 157.1 40.3 98.6 79.0 59.8 115.9 127.6 146.0 91.6 61.5 199.0 193.2 274.8 51.9 233.5 252.1 44.8 102.7 101.7 139.1 86.8 127.3 128.7 211.2 52.5 112.9 34.9 289.6 280.0 144.8 137.6 128.2 80.4 87.4 76.3 182.6 147.4 158.1 17.5 218.5 76.3 249.3 376.0 175.1 5.8 162.3 135.9 293.2 123.4 182.9 246.8 259.8 37.7 67.3 78.0 200.7 124.6 35.5 131.9 139.5 85.1 52.8 61.0 60.6 92.7 201.8 224.5 120.9 71.9 128.0 86.6 394.8 441.9 552.3 484.5 570.1 484.8 399.4 448.4 463.2 425.0 370.1 318.6 395.7 653.9 515.6 575.2 408.3 537.9 978.6 36.4 37.3 37.1 47.1 35.7 38.9 40.5 37.6 39.0 39.6 38.2 40.3 305.5 208.3 172.7 7.5 353.8 156.4 241.6 570.7 199.2 28.2 159.6 169.2 59.6 248.8 296.5 283.3 10.4 393.3 406.7 347.8 318.9 500.0 3.5 171.4 250.5 228.0 189.7 244.9 1.4 549.8 293.2 184.8 138.6 223.9 240.1 124.7 242.4 266.6 313.7 6.7 1.9 397.6 280.8 295.3 294.2 16.5 189.2 275.4 188.5 4.7 930.4 98.3 620.0 3.0 6.6 373.6 461.2 124.8 422.0 280.6 754.3 700.5 236.3 23.5 105.2 121.4 283.6 3.5 24.9 200.0 156.0 304.4 424.6 243.6 406.6 301.3 PSMG2 "CLAST3, HCCA3, HsT1707, MDS003, MGC15092, PAC2, TNFSF5IP1" ENSG00000128789 "Proteasome assembly chaperone 2" Q969U7 18 12658043-12725740 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 537.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 436.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041517, HPA046741" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 21: OE19 - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA041517: AB_2677530, HPA046741: AB_2679780" "unprognostic (2.28e-2)" "unprognostic (9.44e-3)" "unprognostic (9.68e-2)" "unprognostic (1.15e-1)" "unprognostic (4.40e-1)" "unprognostic (1.43e-1)" "unprognostic (4.66e-2)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.09e-4)" "unprognostic (5.91e-2)" "unprognostic (2.27e-1)" "unprognostic (1.73e-1)" "unprognostic (9.04e-2)" "unprognostic (1.23e-1)" "unprognostic (4.82e-2)" "unprognostic (6.75e-3)" 65.6 50.3 43.5 44.8 43.4 91.9 65.2 47.0 54.8 53.0 43.2 56.3 48.3 49.0 67.5 63.5 47.7 53.2 47.3 43.5 44.9 57.2 65.6 44.3 65.1 44.7 42.8 60.6 55.9 31.1 31.8 52.9 44.4 42.5 60.5 25.1 46.6 47.9 50.9 56.0 47.8 53.0 46.9 43.8 53.7 89.7 42.9 67.6 49.6 39.5 63.7 63.8 52.0 49.2 82.6 51.3 58.2 74.0 100.1 142.5 75.0 81.3 115.7 131.1 147.8 89.1 84.6 90.6 64.6 86.2 108.3 49.8 93.7 99.9 112.2 48.6 52.4 50.1 43.0 101.8 100.7 170.7 78.7 116.8 76.0 80.7 107.6 81.3 92.5 78.7 77.4 112.9 102.4 83.0 109.9 226.1 46.2 436.4 67.8 78.8 87.5 130.2 121.0 106.3 69.6 52.5 77.5 88.1 78.1 56.3 75.8 136.2 63.5 148.9 203.3 131.3 89.4 101.1 142.9 111.1 90.1 88.5 63.3 84.9 89.3 87.6 65.3 95.1 77.6 70.3 84.0 74.8 80.5 62.5 74.6 72.2 30.9 73.9 111.6 65.7 108.2 91.7 43.5 43.4 47.0 54.8 43.5 44.9 44.7 42.8 44.4 46.9 42.9 49.2 96.1 51.3 50.1 42.7 76.4 91.0 98.8 145.2 80.8 25.1 81.4 99.2 36.0 82.9 80.9 82.8 22.9 183.0 80.9 70.8 154.6 110.5 537.7 59.8 75.8 83.9 68.6 97.2 50.1 110.8 140.3 99.3 59.1 53.3 60.9 74.9 101.7 53.1 147.6 25.2 50.3 87.8 54.9 133.0 88.7 140.8 134.2 100.2 72.9 26.2 130.7 63.8 50.4 34.7 38.5 103.2 84.2 97.0 67.1 126.1 120.6 193.8 68.7 21.4 85.5 78.4 89.8 344.9 216.8 119.5 90.1 186.3 78.8 122.3 103.6 130.7 PSTK "C10orf89, MGC35392" ENSG00000179988 "Phosphoseryl-tRNA kinase" Q8IV42 10 122954381-122997513 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 31.3;Spermatocytes: 37.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037780, HPA037781" Approved Approved "Nucleoli,Nuclear bodies,Actin filaments" No No "Cluster 24: B-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Actin filaments" "Nucleoli, Nuclear bodies" "HPA037780: AB_2675662, HPA037781: AB_10670530" "unprognostic (8.95e-3)" "unprognostic (5.51e-3)" "unprognostic (1.37e-1)" "unprognostic (7.39e-4)" "unprognostic (5.21e-2)" "unprognostic (4.08e-3)" "unprognostic (1.60e-2)" "unprognostic (5.92e-4)" "unprognostic (3.55e-2)" "unprognostic (1.16e-1)" "unprognostic (6.22e-3)" "unprognostic (7.10e-3)" "unprognostic (2.39e-1)" "unprognostic (4.50e-2)" "unprognostic (4.92e-2)" "unprognostic (3.02e-2)" "unprognostic (5.55e-4)" 0.9 2.2 1.3 0.6 1.5 6.1 2.9 1.5 2.2 1.9 0.3 1.6 1.9 1.9 3.5 1.5 1.9 0.7 1.7 1.5 1.6 2.0 4.1 1.0 0.9 1.6 1.5 1.3 2.1 1.1 2.6 1.3 2.5 2.0 1.5 0.5 1.9 1.1 3.5 1.6 1.0 1.9 1.3 1.1 1.3 3.2 1.4 1.8 2.4 0.9 1.2 1.3 1.3 2.8 4.1 3.4 1.7 0.8 1.6 3.2 2.1 2.0 3.5 3.0 3.7 4.6 3.4 4.4 3.9 2.5 2.0 2.3 0.7 3.1 3.4 2.4 8.7 2.7 1.2 4.0 4.3 6.7 3.6 3.3 5.2 2.9 5.2 2.7 2.3 3.9 4.3 6.0 4.3 6.6 2.0 3.9 3.3 1.6 4.3 4.5 3.0 4.4 4.3 2.6 1.6 2.1 3.9 3.8 5.3 1.4 1.8 0.4 3.1 2.8 2.6 1.2 4.5 2.6 1.6 5.8 2.4 4.3 0.9 0.0 5.0 6.0 7.4 3.1 8.8 6.2 5.7 7.0 6.7 5.9 7.5 7.7 0.6 6.8 3.6 6.7 3.8 5.3 1.3 1.5 1.5 2.2 1.5 1.6 1.6 1.5 2.5 1.3 1.4 2.8 3.0 9.6 7.3 14.4 4.6 4.5 5.0 11.0 5.2 8.3 7.1 11.7 5.9 10.0 7.5 5.5 8.4 7.7 8.0 1.6 9.8 4.6 31.3 5.7 5.2 3.2 4.2 3.4 18.8 6.3 3.1 6.0 1.5 11.6 2.5 8.1 3.6 6.3 4.8 5.0 20.3 2.6 14.2 2.1 4.3 5.4 5.3 3.0 5.4 4.7 6.1 8.8 5.2 12.5 29.4 3.7 3.8 5.7 3.3 3.5 3.0 7.7 8.3 11.4 0.0 5.6 8.6 37.5 20.6 5.5 4.7 9.6 6.9 10.8 4.3 3.5 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537376 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 109.4;skin 1: 53.9;vagina: 43.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies, Plasma membrane, Cytosol" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.5 0.1 0.6 3.6 1.7 0.8 3.8 2.9 1.7 19.8 0.0 26.5 28.9 0.4 0.1 109.4 0.4 3.5 0.2 0.6 0.9 0.8 5.2 2.6 0.6 1.6 1.0 0.3 3.6 0.0 0.2 0.3 1.7 3.1 15.7 0.8 19.1 0.6 0.6 53.9 22.2 0.8 0.6 0.8 26.2 0.3 1.1 0.3 0.2 0.0 6.4 9.8 43.2 5.4 22.1 2.6 0.3 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.5 41.4 0.1 7.2 0.0 0.1 33.9 0.0 0.1 0.0 5.4 0.4 0.0 10.2 0.1 0.1 0.0 6.7 0.0 45.0 0.0 0.2 0.2 0.0 0.1 0.2 2.5 0.2 12.5 0.0 0.2 0.2 57.0 15.5 0.1 1.2 0.5 0.0 26.4 0.3 2.2 2.6 8.1 0.0 0.1 25.2 1.6 0.2 0.3 0.4 0.8 0.3 0.5 0.1 0.1 0.4 0.5 1.1 0.4 0.7 0.1 0.1 0.5 0.5 0.3 0.1 0.0 1.3 0.3 0.1 0.1 0.3 0.0 0.4 0.1 0.1 0.3 0.6 1.7 2.9 1.7 0.6 0.9 1.6 1.0 1.7 0.6 1.1 5.4 0.3 12.8 25.6 0.3 1.4 5.9 2.6 7.7 5.2 2.2 7.0 4.3 0.4 12.8 14.9 0.0 2.1 0.2 0.2 132.1 0.0 1.4 0.2 0.4 0.5 3.2 5.4 0.0 0.1 1.6 0.2 1.4 59.1 1.3 9.5 0.2 0.4 1.7 0.6 0.0 0.1 42.5 2.0 2.2 2.0 0.0 0.3 2.6 0.0 0.0 1.0 1.6 1.0 0.0 0.8 17.6 97.6 0.0 0.1 1.5 80.2 0.2 8.9 3.7 0.0 2.3 1.1 0.2 0.3 48.0 15.5 0.1 2.0 0.2 32.1 15.9 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase non-receptor type 23" Q9H3S7 3 47381011-47413435 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear bodies" Vesicles "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favorable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 18.5 19.1 6.2 12.6 9.2 14.7 17.4 5.8 10.5 23.3 5.1 16.3 14.3 20.9 7.5 19.0 19.2 8.4 13.2 7.1 7.2 17.5 14.0 18.7 9.1 8.8 7.2 23.5 20.2 23.5 30.9 11.6 8.5 18.7 6.5 8.5 20.0 11.4 30.0 26.4 18.4 8.8 5.5 20.0 16.1 15.6 7.7 8.0 27.1 8.9 7.3 18.5 20.4 14.4 21.5 29.9 16.4 21.4 21.0 16.0 15.8 19.2 18.9 17.5 14.8 25.0 20.7 15.1 17.2 21.9 31.2 19.0 14.3 20.8 8.5 14.3 15.1 21.0 22.2 24.0 23.0 12.3 27.5 21.4 20.9 22.9 23.2 12.4 21.7 12.5 15.9 20.3 19.0 30.2 11.5 10.4 17.5 14.9 20.1 7.2 7.9 18.5 13.2 40.9 8.6 20.6 17.1 35.6 13.6 9.8 20.3 12.0 22.4 26.7 22.2 37.7 27.5 28.8 20.4 8.7 29.0 11.6 19.5 0.8 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.3 0.3 6.2 9.2 5.8 10.5 7.1 7.2 8.8 7.2 8.5 5.5 7.7 14.4 11.1 9.6 7.0 17.0 8.2 8.0 5.2 6.9 13.6 11.7 9.5 8.0 8.7 8.6 9.5 5.5 14.6 10.6 11.0 15.7 1.9 10.5 2.1 10.3 13.7 12.4 7.3 2.5 9.8 8.9 7.9 9.1 26.5 21.1 2.5 14.9 11.4 12.7 13.9 16.8 12.0 16.3 20.3 10.4 5.5 3.1 19.3 9.5 12.4 7.5 8.7 8.8 6.2 9.5 14.3 13.5 10.4 13.5 15.4 9.3 14.6 9.4 12.6 14.2 6.6 10.2 8.8 13.6 13.3 13.2 10.9 9.3 8.9 9.4 12.8 8.2 PUS10 "CCDC139, FLJ32312" ENSG00000162927 "Pseudouridine synthase 10" Q3MIT2 2 60940222-61018259 "Enzymes, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044736, HPA049582" Approved Approved "Nucleoplasm,Nuclear bodies,Mitochondria" No No "Cluster 18: Basophils - Vesicular transport" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA044736: AB_2679066, HPA049582: AB_2680824" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (3.49e-2)" "unprognostic (2.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.25e-1)" "unprognostic (1.72e-2)" "unprognostic (2.90e-2)" "unprognostic (8.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-1)" "unprognostic (1.16e-4)" "unprognostic (1.07e-1)" "unprognostic (6.60e-2)" "unprognostic (9.45e-2)" "unprognostic (1.15e-3)" 3.6 3.7 2.7 4.1 2.7 5.1 5.4 2.9 3.4 3.0 3.2 3.6 7.5 3.3 6.4 2.7 3.7 4.1 3.7 2.7 2.5 4.8 15.0 4.9 6.8 2.7 2.6 4.8 4.0 3.9 2.9 3.2 3.0 4.8 4.4 3.9 3.8 2.6 3.1 4.9 9.3 2.7 2.9 4.8 3.4 4.5 2.9 4.5 6.9 1.8 6.8 2.6 1.6 3.6 3.2 1.7 4.9 8.4 4.1 4.6 5.3 6.1 5.5 6.0 5.6 4.8 4.4 12.8 6.3 3.4 5.4 4.2 5.7 4.9 7.4 10.0 2.9 9.0 2.5 15.9 7.6 10.6 5.8 5.3 6.0 4.2 9.4 7.7 7.9 9.1 9.2 6.4 4.6 2.7 8.0 8.7 4.4 3.0 3.5 7.7 6.6 4.7 4.3 6.3 2.8 3.9 5.0 9.7 9.9 3.5 3.4 6.3 5.9 5.7 4.6 3.9 4.7 8.1 3.8 23.6 5.0 6.8 6.5 9.1 1.2 1.1 2.3 1.3 2.5 3.0 1.4 1.6 0.9 1.7 1.7 1.9 2.3 3.1 4.8 3.0 1.0 1.1 2.7 2.7 2.9 3.4 2.7 2.5 2.7 2.6 3.0 2.9 2.9 3.6 6.6 0.0 14.3 20.5 6.8 2.4 3.5 3.3 1.8 6.6 5.9 2.8 5.1 1.5 4.3 3.7 0.0 7.0 8.1 11.9 7.9 3.7 1.6 6.2 4.3 5.8 1.2 5.9 28.3 5.1 4.7 3.1 5.1 8.5 0.0 9.9 4.6 16.3 5.8 1.7 21.7 2.5 4.1 5.7 2.1 1.8 3.1 4.6 1.8 14.0 9.0 7.0 7.2 19.1 24.4 3.5 3.0 1.5 4.6 3.8 26.7 6.3 7.7 7.1 6.6 3.1 3.0 13.9 13.4 3.9 2.3 12.4 6.6 8.2 4.5 10.6 RAB38 NY-MEL-1 ENSG00000123892 "RAB38, member RAS oncogene family" P57729 11 88113251-88175443 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 48.6;skin 1: 44.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.4;Basal respiratory cells: 74.8;Cytotrophoblasts: 94.5;Melanocytes: 131.6;Suprabasal keratinocytes: 98.5;Syncytiotrophoblasts: 54.7" "Cancer enhanced" "Detected in all" "melanoma: 73.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 4 "NK-cell: 18.0" "Lineage enriched" "Detected in many" 4 "NK-cells: 18.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 87.7;hTCEpi: 308.0;hTERT-HME1: 271.4;SK-MEL-30: 175.6" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.1" HPA071701 Uncertain "Nuclear bodies,Mitochondria" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear bodies, Mitochondria" "HPA071701: " "unprognostic (2.85e-1)" "unprognostic (1.30e-1)" "unprognostic (4.40e-2)" "unprognostic (2.66e-2)" "unprognostic (1.36e-2)" "unprognostic (7.95e-2)" "unprognostic (3.96e-4)" "unprognostic (2.36e-1)" "unprognostic (1.44e-1)" "unprognostic (9.34e-2)" "unprognostic (1.00e-2)" "unprognostic (8.23e-2)" "prognostic favorable (8.26e-4)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-2)" 2.6 27.8 0.4 1.4 0.4 1.6 8.6 0.3 0.8 11.8 6.3 1.9 2.4 4.7 6.7 48.6 5.6 6.0 1.1 0.7 0.6 4.5 1.8 5.8 1.7 0.5 0.7 3.3 1.6 1.8 2.8 14.7 0.5 2.4 1.3 2.9 7.7 6.4 0.6 44.3 2.3 3.6 0.4 1.6 1.6 2.5 0.8 3.5 7.9 0.4 17.9 8.7 23.5 0.6 10.7 1.4 0.3 0.5 0.4 2.4 0.6 6.5 26.1 10.4 19.0 4.7 4.8 0.5 6.3 6.9 1.2 71.2 5.7 87.7 14.1 1.3 5.1 54.0 6.2 0.0 1.0 0.6 0.6 2.2 308.0 1.4 271.4 13.0 12.3 1.0 0.3 0.9 0.0 0.0 0.7 18.4 8.2 0.7 0.1 0.5 0.1 0.8 20.0 40.6 1.9 1.2 0.3 0.1 175.6 6.2 15.7 4.6 6.7 0.0 4.6 0.0 1.1 1.5 6.5 0.2 1.7 2.2 1.2 0.0 0.8 0.1 1.5 0.6 0.8 0.0 0.4 1.8 1.6 0.0 0.1 0.8 0.6 18.0 1.3 4.4 1.0 0.7 0.4 0.4 0.3 0.8 0.7 0.6 0.5 0.7 0.5 0.4 0.8 0.6 1.0 0.0 6.7 0.7 0.1 46.4 15.9 74.8 21.1 0.1 6.9 9.7 0.2 8.6 25.0 0.0 0.0 94.5 2.7 0.5 3.9 1.7 0.0 2.1 0.9 2.7 0.0 5.5 0.6 1.1 10.5 9.1 3.1 2.3 16.5 5.3 1.1 0.0 17.5 0.0 0.4 0.3 14.2 1.6 21.2 0.1 3.4 3.9 131.6 3.7 6.3 0.6 1.0 2.0 0.1 2.6 2.6 1.2 0.1 9.5 2.1 5.3 7.4 6.4 0.0 0.6 5.3 0.1 5.9 38.1 98.5 54.7 2.7 5.9 2.5 23.3 RAD18 RNF73 ENSG00000070950 "RAD18 E3 ubiquitin protein ligase" Q9NS91 3 8775402-8963773 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006716, HPA006724, HPA008752" Supported Approved Enhanced "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" "HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-3)" "unprognostic (2.73e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.01e-1)" "unprognostic (9.76e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.73e-4)" "prognostic unfavorable (3.65e-5)" "unprognostic (1.97e-2)" "unprognostic (1.51e-1)" "unprognostic (7.92e-2)" "unprognostic (1.89e-2)" 2.7 2.3 1.2 3.3 1.5 5.2 5.3 1.3 1.7 3.2 0.5 3.8 10.1 2.8 1.9 3.4 2.3 3.1 1.8 1.5 0.9 1.6 2.7 2.7 4.6 1.6 1.0 2.8 1.7 2.0 1.3 3.0 1.5 3.2 4.9 2.6 3.2 1.6 1.3 4.5 6.5 2.8 1.2 3.5 2.2 2.9 1.1 5.8 3.7 1.0 4.4 2.5 2.9 2.3 16.2 15.2 12.3 7.4 3.0 6.4 14.9 25.0 8.5 23.5 16.1 13.7 10.1 19.8 4.7 14.2 13.8 5.6 13.1 13.0 23.8 12.2 17.2 16.9 16.1 8.2 1.9 22.7 13.9 2.4 4.6 23.3 15.7 6.3 7.7 17.1 18.2 19.0 20.9 18.6 22.9 15.9 17.2 12.7 28.5 18.0 13.6 15.6 6.9 12.2 5.1 11.5 11.2 10.5 8.2 9.7 11.0 9.8 6.4 19.4 10.5 16.8 21.7 9.6 16.1 43.7 14.3 24.5 14.6 6.4 1.6 5.1 1.5 1.7 2.8 1.9 2.1 2.7 2.0 1.9 2.2 1.6 0.7 2.8 1.1 3.6 3.0 0.8 1.2 1.5 1.3 1.7 1.5 0.9 1.6 1.0 1.5 1.2 1.1 2.3 5.7 16.0 9.8 6.2 7.7 11.1 7.5 6.4 5.7 4.6 7.3 11.7 2.2 4.3 7.5 3.7 2.1 9.0 8.6 5.2 1.9 9.6 4.2 4.0 5.8 4.6 1.8 7.2 20.9 8.2 12.4 6.8 3.6 4.9 13.9 14.8 6.1 3.1 7.1 3.3 15.7 6.5 2.0 5.2 5.6 3.0 4.1 4.6 3.6 14.0 7.1 3.2 8.2 16.1 14.3 10.2 4.3 2.6 8.7 6.4 4.0 3.1 4.1 2.3 6.6 4.3 6.9 26.2 14.0 6.0 11.8 6.7 7.5 9.3 6.3 3.6 RAD51B "hREC2, R51H2, RAD51L1, REC2" ENSG00000182185 "RAD51 paralog B" O15315 14 67819779-68730218 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 10 "Astrocytes: 150.8;Microglial cells: 263.3;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 375.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB016191, HPA051869" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Nucleoplasm "CAB016191: AB_2238209, HPA051869: AB_2681644" "unprognostic (9.10e-3)" "unprognostic (5.45e-2)" "unprognostic (4.92e-1)" "unprognostic (6.65e-2)" "unprognostic (2.38e-2)" "unprognostic (4.85e-2)" "unprognostic (6.42e-3)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (6.80e-3)" "unprognostic (1.47e-1)" "unprognostic (6.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.49e-2)" "unprognostic (6.79e-2)" "unprognostic (8.13e-3)" 3.1 2.3 3.0 2.9 5.7 7.3 5.5 3.8 3.3 5.8 5.8 3.0 1.1 4.4 9.0 3.7 3.9 4.3 1.7 3.4 3.7 2.7 2.1 2.7 4.8 5.7 4.7 6.3 2.1 4.9 2.0 4.1 5.7 2.5 2.6 3.0 13.1 2.3 1.2 4.2 2.4 4.4 4.3 2.6 2.6 1.8 5.0 5.9 2.5 1.2 4.3 3.6 4.5 7.3 15.3 5.9 6.5 3.9 5.9 10.0 4.0 7.6 5.8 8.2 10.5 4.2 20.1 18.6 4.8 4.7 9.4 13.4 4.1 12.1 11.1 8.4 4.2 8.9 5.4 3.3 3.2 7.6 8.6 5.1 9.0 9.4 9.9 3.8 7.4 13.5 7.3 8.4 6.7 11.9 14.9 2.7 3.8 14.6 5.9 16.6 7.7 6.8 6.3 4.3 4.4 2.9 6.0 2.2 13.1 7.6 10.1 6.8 2.0 9.9 9.6 7.8 6.3 4.0 4.4 14.9 5.5 13.1 5.7 17.4 5.7 5.7 8.1 4.8 6.6 14.2 7.6 8.6 6.5 11.8 9.4 8.9 0.7 8.5 4.7 6.4 9.4 4.5 3.0 5.7 3.8 3.3 3.4 3.7 5.7 4.7 5.7 4.3 5.0 7.3 5.1 0.0 1.1 150.8 13.3 6.6 5.1 6.4 5.7 1.8 8.4 5.1 1.6 0.0 4.0 1.8 8.4 5.4 3.5 1.1 3.9 1.9 3.0 5.3 3.7 4.5 4.8 4.6 21.5 1.4 6.7 4.2 3.1 3.6 4.5 6.8 1.8 0.8 6.5 1.7 22.0 3.8 2.0 3.4 3.5 1.9 3.7 4.2 8.8 263.3 6.8 5.8 3.1 157.3 375.2 1.0 0.6 4.5 8.9 2.4 2.7 1.8 8.4 6.0 0.0 3.6 7.0 6.2 3.2 5.6 7.0 4.0 7.0 4.4 1.8 4.6 RAD9A RAD9 ENSG00000172613 "RAD9 checkpoint clamp component A" Q99638 11 67317871-67398410 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006725, HPA048155, CAB079979" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies" "CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290" "unprognostic (7.64e-2)" "prognostic favorable (6.95e-4)" "unprognostic (8.83e-3)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (2.12e-3)" "unprognostic (9.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (9.19e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (2.82e-5)" "unprognostic (6.16e-2)" "unprognostic (3.72e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.52e-6)" 5.8 5.0 3.3 6.9 3.6 10.2 6.9 2.1 6.0 9.2 2.9 7.3 10.9 7.4 2.1 9.0 10.9 5.7 4.2 3.8 2.4 7.1 6.6 6.7 8.3 2.9 3.6 8.0 8.0 3.4 10.1 4.4 2.2 10.8 3.0 1.8 9.8 6.1 5.2 11.4 11.1 2.4 2.2 9.4 8.4 8.6 2.5 6.1 9.7 2.1 3.7 6.5 8.5 2.2 10.8 15.8 9.5 13.8 2.8 1.1 12.0 5.7 4.9 8.0 7.1 23.2 20.9 11.1 12.4 1.8 13.0 18.7 6.0 5.5 0.9 13.0 16.3 16.8 8.5 10.4 3.8 12.3 20.3 3.2 5.3 7.2 3.5 6.1 5.5 23.2 14.7 15.6 2.3 33.2 21.9 21.8 13.2 15.9 12.1 18.8 12.5 13.6 2.2 9.0 9.8 10.6 9.9 27.2 21.1 2.4 19.1 10.9 4.2 11.7 14.3 23.3 8.7 14.6 14.2 11.5 7.5 11.6 9.6 5.3 1.8 6.0 5.2 2.3 3.8 4.3 4.1 4.3 1.2 3.1 2.9 3.2 2.8 3.1 2.5 3.4 2.4 1.5 3.3 3.6 2.1 6.0 3.8 2.4 2.9 3.6 2.2 2.2 2.5 2.2 16.0 22.4 17.1 10.1 31.0 17.1 17.7 17.9 23.3 19.6 19.7 18.4 1.1 12.8 22.2 20.2 70.9 27.9 31.3 54.2 13.7 11.3 27.3 32.1 13.4 16.3 14.3 17.7 8.5 13.1 22.4 13.8 27.0 14.9 20.3 26.0 11.0 6.6 15.1 21.9 6.0 48.9 10.2 10.3 31.4 13.2 10.5 14.0 19.6 11.2 8.9 15.0 56.7 2.5 5.3 11.6 31.6 12.4 38.5 16.6 61.8 10.9 44.0 32.1 13.1 10.5 14.5 32.0 17.6 18.3 17.3 40.6 30.3 15.3 38.7 18.0 RANBP17 ENSG00000204764 "RAN binding protein 17" Q9H2T7 5 170861870-171300015 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.3" "Cell type enhanced" "Detected in many" "Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 4.0;SK-BR-3: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029568, HPA029569" Uncertain Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol" Yes No "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nuclear bodies" "Nuclear membrane, Cytosol" "HPA029568: AB_10599825, HPA029569: AB_10601571" "unprognostic (4.63e-2)" "unprognostic (2.63e-3)" "unprognostic (1.06e-1)" "unprognostic (8.28e-2)" "unprognostic (1.75e-3)" "unprognostic (5.12e-3)" "unprognostic (1.50e-1)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" "unprognostic (1.64e-2)" "unprognostic (2.19e-3)" "unprognostic (2.72e-1)" "unprognostic (1.35e-1)" "unprognostic (2.56e-3)" 0.2 0.8 0.3 0.1 0.2 0.1 0.2 2.3 0.6 0.2 0.8 0.2 0.2 0.5 0.2 0.0 0.4 0.5 0.2 0.1 1.1 0.4 0.3 0.8 0.3 0.9 0.9 0.2 1.4 0.8 0.4 0.8 1.3 0.4 0.4 0.8 0.8 0.5 0.0 0.1 0.3 0.3 0.6 0.0 0.3 1.4 0.6 0.2 1.0 0.0 0.1 0.1 0.1 1.1 0.0 0.7 4.0 3.3 1.3 0.3 2.4 2.6 1.2 1.8 1.1 1.5 0.0 0.1 2.0 2.5 0.0 0.0 0.0 1.2 3.5 0.0 2.4 0.7 1.4 0.0 1.1 0.0 0.0 2.6 0.2 0.2 0.0 0.2 1.7 0.0 0.3 0.0 1.0 1.7 0.0 0.0 0.3 0.6 0.2 0.0 2.4 0.0 0.6 1.0 0.2 1.4 0.0 3.9 1.5 1.7 0.7 1.2 2.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.3 0.6 0.1 1.1 0.9 0.9 1.3 0.6 0.6 1.1 9.4 9.6 2.0 12.7 0.0 0.3 6.2 5.8 1.8 24.8 6.1 2.8 1.3 7.2 4.8 0.0 14.6 10.4 1.7 2.3 0.0 7.3 112.7 22.4 17.5 7.9 5.4 5.5 100.6 1.4 3.2 4.9 5.1 59.5 0.0 15.6 4.2 1.6 1.9 0.0 152.9 3.7 2.0 0.6 1.4 46.5 2.8 1.0 1.8 9.4 1.2 5.5 5.2 65.4 87.1 5.3 2.9 3.0 0.8 13.0 3.9 0.9 2.4 26.9 0.0 3.0 5.1 27.2 26.7 1.4 0.0 2.5 0.8 7.5 6.3 7.6 RAPGEF5 "GFR, KIAA0277, MR-GEF" ENSG00000136237 "Rap guanine nucleotide exchange factor 5" Q92565 7 22118236-22357154 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 152.1;parathyroid gland: 387.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057821, HPA076772" Uncertain Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA057821: AB_2683538, HPA076772: AB_2686814" "unprognostic (1.00e-1)" "unprognostic (1.57e-1)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.44e-4)" "unprognostic (5.22e-2)" "prognostic favorable (3.52e-5)" "unprognostic (1.16e-1)" "unprognostic (2.10e-2)" "unprognostic (1.64e-1)" "unprognostic (2.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-1)" "unprognostic (3.76e-2)" "unprognostic (6.36e-3)" "unprognostic (6.57e-2)" "unprognostic (2.55e-1)" "unprognostic (8.26e-3)" 21.0 12.7 30.7 7.0 82.9 0.9 16.4 76.1 58.5 8.9 2.9 9.5 7.5 8.8 4.8 13.9 8.3 16.8 16.8 45.7 46.9 16.7 21.8 37.5 14.3 115.3 71.8 6.5 20.1 387.8 7.4 67.2 107.1 5.1 11.0 4.2 7.6 5.7 5.1 9.2 8.3 12.1 82.0 50.9 7.0 6.4 59.8 15.7 11.7 11.1 10.7 9.3 11.9 152.1 2.8 0.0 4.6 0.0 0.2 0.2 0.0 0.0 0.3 0.0 0.0 5.5 1.4 21.1 1.1 0.3 0.7 13.0 2.8 1.9 0.0 0.0 4.2 0.3 0.0 5.4 0.1 0.0 0.1 0.5 2.4 1.3 0.7 0.7 45.0 5.9 4.8 0.1 0.0 1.2 3.0 0.1 3.6 5.4 4.0 5.2 0.0 7.4 4.2 1.9 34.1 9.0 0.5 6.0 0.1 0.7 3.0 0.1 25.8 0.0 1.0 0.4 1.1 10.9 2.5 37.4 0.5 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 82.9 76.1 58.5 45.7 46.9 115.3 71.8 107.1 82.0 59.8 152.1 125.5 9.6 16.5 13.4 3.1 11.0 4.2 2.4 86.0 30.6 8.8 5.5 10.0 15.7 3.8 0.0 0.0 0.3 0.6 16.0 1.9 6.5 61.5 3.3 1.2 70.1 7.2 0.4 504.6 7.0 0.1 5.3 16.3 10.8 8.2 0.1 86.0 6.3 0.2 23.5 193.4 18.3 2.0 3.1 2.0 65.2 1.8 0.9 7.2 138.7 0.0 0.6 0.0 28.1 640.8 5.0 20.3 4.9 12.9 3.0 18.1 0.3 0.5 1.6 85.5 1.4 21.5 1.2 1.6 19.8 11.2 0.3 2.4 1.9 10.1 4.4 RAPH1 "ALS2CR18, ALS2CR9, KIAA1681" ENSG00000173166 "Ras association (RalGDS/AF-6) and pleckstrin homology domains 1" Q70E73 2 203394345-203535335 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 61.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 84.0;Hepatic stellate cells: 103.5;Microglial cells: 92.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016744, HPA020027" Approved Approved "Nuclear bodies,Plasma membrane,Cytosol" NA NA 69000000 "Cluster 7: Monocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" "Nuclear bodies, Plasma membrane" Cytosol "HPA016744: AB_1844781, HPA020027: AB_1844782" "unprognostic (9.78e-2)" "unprognostic (9.05e-2)" "unprognostic (7.17e-4)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.83e-1)" "unprognostic (8.32e-2)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (1.31e-1)" "unprognostic (1.24e-4)" "unprognostic (1.92e-1)" "unprognostic (1.40e-2)" "unprognostic (5.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.19e-2)" "unprognostic (2.79e-1)" 11.1 6.5 1.5 5.2 4.6 3.1 13.3 1.3 7.9 9.4 0.3 7.0 7.8 5.6 4.6 8.8 5.1 8.9 5.9 5.0 8.5 7.2 61.6 14.3 3.7 2.4 7.0 2.0 6.4 5.6 3.6 13.0 4.1 6.6 7.3 7.3 8.6 4.3 6.6 8.9 7.9 7.8 0.1 16.9 8.8 9.4 2.7 2.6 30.0 6.2 4.9 7.7 6.6 2.2 11.1 7.5 15.6 9.0 12.0 15.4 14.7 15.1 11.0 15.3 19.1 35.0 11.4 0.0 3.7 23.1 11.2 5.8 8.2 12.9 31.7 2.2 4.6 0.0 17.9 6.2 30.0 0.1 0.2 21.5 10.7 28.1 29.4 16.8 24.2 1.7 0.8 8.2 31.0 6.2 0.1 0.0 9.2 5.7 10.0 0.2 22.0 6.9 11.2 34.9 5.5 7.5 10.3 9.8 12.5 20.4 5.5 0.5 29.0 37.5 12.5 18.2 16.1 3.8 7.7 0.1 30.9 0.2 8.4 0.0 0.2 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.7 0.0 0.1 0.0 1.5 4.6 1.3 7.9 5.0 8.5 2.4 7.0 4.1 0.1 2.7 2.2 36.3 16.0 8.4 12.7 1.2 49.1 20.7 10.3 16.5 11.3 21.6 9.4 1.1 15.7 9.7 14.7 14.6 8.9 0.8 32.9 7.9 6.3 14.4 24.4 17.7 29.0 2.4 3.2 84.0 9.3 7.6 23.4 47.9 65.7 1.3 6.2 103.5 79.6 18.1 10.1 56.7 8.6 4.1 17.8 51.1 4.9 4.7 28.8 12.4 92.8 3.3 18.6 0.0 41.2 9.1 20.5 21.3 4.9 0.1 19.0 22.4 2.8 5.2 4.4 19.7 26.8 33.4 29.3 19.6 26.9 40.9 10.9 2.8 0.9 13.3 28.4 RASL11A ENSG00000122035 "RAS like family 11 member A" Q6T310 13 27270830-27275192 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "ASC diff: 42.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA004859, HPA053296" Supported Approved "Nuclear bodies" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nuclear bodies" "HPA004859: AB_2667270, HPA053296: AB_2682106" "unprognostic (1.59e-1)" "unprognostic (9.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (6.65e-2)" "prognostic favorable (5.43e-4)" "unprognostic (3.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.65e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.52e-4)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (3.71e-2)" "unprognostic (3.34e-1)" 32.9 4.1 1.9 3.1 3.2 2.3 21.8 3.1 3.1 21.4 2.1 20.4 7.7 21.6 3.9 9.8 22.0 3.8 11.3 3.2 1.7 30.4 12.9 13.0 10.8 1.8 2.2 9.5 4.9 1.4 10.6 2.9 2.0 20.3 12.5 0.1 5.3 5.6 3.5 10.1 20.9 5.5 2.2 14.8 13.4 2.9 3.3 1.2 12.1 1.7 10.0 19.1 15.9 2.4 0.3 1.3 0.3 0.6 42.4 4.3 0.2 1.9 1.8 0.1 0.1 8.1 0.8 0.3 0.5 1.4 0.9 0.1 2.5 0.8 0.1 1.7 8.8 1.8 0.2 0.5 6.8 0.6 0.6 5.0 0.7 0.1 0.1 1.7 0.6 0.7 0.3 0.1 0.0 0.8 0.0 2.4 1.5 8.0 10.2 0.5 0.0 0.2 1.4 6.2 0.7 0.3 0.7 3.3 0.2 1.0 0.2 0.8 0.3 0.1 0.3 2.9 0.4 0.1 0.0 0.0 0.4 1.9 0.1 0.4 0.4 0.4 0.0 0.5 0.1 0.1 0.0 0.0 0.2 1.2 0.1 0.1 0.2 0.1 1.3 0.1 0.0 0.1 1.9 3.2 3.1 3.1 3.2 1.7 1.8 2.2 2.0 2.2 3.3 2.4 29.6 16.0 11.2 0.3 6.0 4.6 3.2 0.9 17.6 0.0 6.2 11.9 1.4 0.0 8.6 7.3 0.0 0.7 4.5 9.3 3.9 1.8 0.0 5.1 9.8 5.9 0.0 4.0 0.6 2.4 0.2 30.1 42.3 6.1 0.0 2.1 2.5 0.2 1.4 0.0 0.6 5.6 4.1 0.8 6.5 0.0 0.3 6.1 1.8 1.9 1.7 0.3 0.0 0.5 1.8 0.5 12.7 1.5 17.1 1.1 11.4 1.7 10.3 0.2 32.9 11.6 112.0 0.0 0.0 13.5 4.4 0.8 4.5 1.2 6.7 1.1 RASL11B ENSG00000128045 "RAS like family 11 member B" Q9BPW5 4 52862317-52866835 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.6;ovary: 66.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057803 Uncertain Approved "Nuclear bodies" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear bodies" "HPA057803: AB_2683533" "unprognostic (1.60e-1)" "unprognostic (1.95e-1)" "unprognostic (7.32e-3)" "unprognostic (1.19e-1)" "unprognostic (2.47e-1)" "unprognostic (6.87e-3)" "unprognostic (1.22e-1)" "unprognostic (7.66e-2)" "unprognostic (7.45e-3)" "unprognostic (4.95e-2)" "unprognostic (9.71e-2)" "unprognostic (8.72e-2)" "unprognostic (7.20e-4)" "unprognostic (7.17e-2)" "unprognostic (1.35e-1)" "unprognostic (5.00e-6)" "unprognostic (1.10e-1)" 2.0 2.0 3.1 0.5 3.8 0.0 1.1 2.8 5.8 4.5 0.1 0.9 0.0 9.8 2.7 0.5 4.1 0.9 14.7 5.2 3.2 17.9 0.6 1.0 0.8 0.3 0.4 66.4 0.9 7.9 0.7 4.7 0.2 2.0 0.1 0.3 1.4 9.1 0.4 3.8 0.9 1.9 0.2 27.6 4.1 5.9 1.4 0.1 1.0 0.1 0.9 2.2 4.9 3.2 0.3 0.0 5.9 0.0 5.2 2.4 14.1 0.1 0.1 0.3 0.0 11.1 0.0 0.0 0.5 0.0 0.1 0.0 0.7 3.5 0.0 0.0 1.4 0.5 0.0 0.0 1.0 0.0 0.4 2.5 6.2 0.0 0.2 0.0 0.0 0.3 0.7 0.0 0.0 1.3 1.1 0.0 15.2 1.3 0.2 0.0 6.8 0.0 10.2 1.5 3.2 38.5 0.2 2.6 1.3 10.1 1.5 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.2 0.0 0.0 3.1 3.8 2.8 5.8 5.2 3.2 0.3 0.4 0.2 0.2 1.4 3.2 1.1 6.4 0.0 0.3 0.9 0.9 1.5 2.8 0.0 4.9 7.5 6.5 5.3 0.0 1.8 33.1 0.0 102.6 1.5 7.1 0.0 1.5 0.4 1.6 6.9 1.2 0.0 0.0 2.7 0.5 62.2 4.6 9.7 2.7 0.0 26.6 1.1 0.0 8.0 0.0 1.1 3.6 0.0 0.3 1.7 3.3 24.2 0.8 0.0 4.7 0.6 1.9 0.0 0.5 0.9 0.5 5.6 68.4 0.1 0.5 1.6 0.1 0.1 1.2 0.0 5.8 5.7 4.6 10.9 1.2 0.4 23.1 0.9 6.1 2.8 0.2 REXO1 "EloA-BP1, KIAA1138, TCEB3BP1" ENSG00000079313 "RNA exonuclease 1 homolog" Q8N1G1 19 1815248-1848483 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 161.2;Late spermatids: 214.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042155, HPA042552" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies" "HPA042155: AB_10806233, HPA042552: AB_10794280" "unprognostic (1.36e-1)" "unprognostic (3.86e-3)" "unprognostic (7.52e-2)" "unprognostic (3.70e-3)" "unprognostic (4.21e-2)" "unprognostic (2.38e-3)" "unprognostic (7.15e-2)" "unprognostic (5.10e-2)" "unprognostic (1.88e-1)" "unprognostic (2.39e-2)" "unprognostic (6.12e-3)" "unprognostic (3.75e-2)" "unprognostic (2.87e-2)" "unprognostic (1.10e-2)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-2)" 13.3 27.8 15.0 10.4 21.3 18.9 12.7 2.2 18.5 10.5 0.0 14.5 9.9 14.0 2.5 12.8 11.7 6.2 12.7 16.8 1.6 12.2 16.4 12.5 13.1 3.7 2.3 13.5 13.3 5.6 9.5 10.0 2.0 11.7 4.2 4.8 10.5 5.2 16.2 18.6 14.0 4.5 0.3 23.6 12.2 30.1 7.2 9.2 11.4 6.2 5.6 12.3 10.9 8.4 20.8 13.1 11.8 18.4 4.6 6.0 23.7 14.7 7.8 10.5 9.4 17.1 11.2 17.6 9.7 10.3 6.8 17.9 9.0 16.5 4.6 28.2 13.8 18.6 15.3 10.1 10.4 16.5 29.3 10.6 9.3 13.9 9.2 6.0 9.7 24.8 28.4 29.8 5.5 13.0 27.5 18.6 26.6 8.3 12.8 24.3 9.8 16.7 7.0 11.6 17.3 19.0 9.2 15.3 19.3 7.8 13.4 24.1 16.9 16.6 14.3 27.9 24.8 47.9 24.8 15.1 13.3 19.7 21.7 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 15.0 21.3 2.2 18.5 16.8 1.6 3.7 2.3 2.0 0.3 7.2 8.4 17.1 0.0 5.9 7.2 12.6 15.9 8.0 6.9 14.2 19.5 11.3 9.1 1.3 5.7 7.3 18.4 8.4 21.9 20.8 27.9 1.9 7.3 161.2 14.2 13.8 13.2 18.4 10.8 7.9 8.5 10.6 9.7 23.4 23.8 5.7 20.1 13.2 14.2 11.0 47.1 6.2 16.4 2.0 8.8 10.5 214.3 7.5 12.7 7.2 10.3 7.3 7.3 11.3 6.6 6.9 14.0 17.2 7.5 15.9 11.8 11.4 8.7 3.9 20.0 0.0 15.1 10.2 14.8 18.3 17.9 16.8 20.5 14.6 33.7 18.9 12.0 RFX8 FLJ42986 ENSG00000196460 "Regulatory factor X8" Q6ZV50 2 101397359-101475112 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.7" "Cell type enhanced" "Detected in some" "Early spermatids: 16.6;Excitatory neurons: 11.5;Inhibitory neurons: 4.5;Late spermatids: 10.2;Spermatocytes: 8.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.6;hTEC/SVTERT24-B: 16.8;LHCN-M2: 6.9;U-87 MG: 9.6;U-937: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA059745 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "Nuclear bodies" "HPA059745: AB_2684120" "unprognostic (1.02e-1)" "unprognostic (1.88e-2)" "unprognostic (1.24e-1)" "unprognostic (5.55e-2)" "unprognostic (2.56e-3)" "unprognostic (8.14e-2)" "unprognostic (3.63e-2)" "unprognostic (6.04e-2)" "unprognostic (4.93e-2)" "unprognostic (9.55e-2)" "unprognostic (1.51e-2)" "unprognostic (4.76e-2)" "unprognostic (4.73e-5)" "unprognostic (4.96e-2)" "unprognostic (1.74e-1)" "unprognostic (3.14e-1)" "unprognostic (1.09e-2)" 0.6 0.1 0.0 0.1 0.0 3.7 0.8 0.0 0.3 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.7 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 5.6 0.0 2.1 1.7 1.3 1.7 0.0 3.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 2.0 0.0 16.8 0.1 0.0 0.0 0.6 0.0 0.0 6.9 0.0 0.7 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.2 0.2 0.0 1.9 3.1 0.0 0.0 0.0 9.6 4.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.7 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 16.6 1.4 0.1 1.0 0.0 0.0 11.5 0.0 0.7 2.6 0.0 0.5 0.0 0.1 0.7 0.0 0.1 0.0 4.5 0.0 0.0 0.3 1.6 10.2 0.3 0.4 0.0 2.8 0.0 0.0 0.0 0.5 1.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 1.3 8.5 1.5 0.0 0.0 1.4 0.1 0.0 0.0 0.1 RIBC1 FLJ32783 ENSG00000158423 "RIB43A domain with coiled-coils 1" Q8N443 X 53422690-53431120 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 27.5;testis: 39.3" "Group enriched" "Detected in many" 5 "Early spermatids: 249.1;Late spermatids: 609.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 6.1;T-47d: 7.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA001150 Approved "Nuclear bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" "HPA001150: AB_2666211" "unprognostic (1.08e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.25e-1)" "prognostic favorable (9.66e-4)" "unprognostic (1.11e-1)" "unprognostic (2.39e-3)" "unprognostic (9.88e-2)" "unprognostic (3.97e-4)" "unprognostic (2.25e-2)" "unprognostic (7.89e-3)" "unprognostic (3.79e-2)" "unprognostic (4.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.07e-1)" "unprognostic (1.25e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" 0.7 3.9 3.2 0.7 3.1 0.6 1.5 2.9 3.4 2.7 10.2 1.1 0.9 2.4 2.9 0.7 27.5 1.4 1.1 3.1 3.9 3.2 0.7 3.3 0.8 7.5 6.5 2.6 1.9 2.6 6.6 0.3 4.7 1.8 0.5 11.4 2.0 1.6 0.7 1.2 0.8 0.6 5.4 0.9 0.9 39.3 3.4 1.7 3.5 0.5 0.6 0.8 0.9 4.8 1.3 3.5 1.3 0.9 0.4 0.9 0.8 0.4 0.2 0.7 0.7 1.3 2.1 1.3 2.3 0.1 2.3 2.4 0.3 0.7 0.9 0.8 2.3 0.8 6.1 0.6 0.2 0.8 1.3 0.3 0.3 2.0 0.5 1.7 0.6 1.0 0.6 1.5 0.5 0.9 1.5 0.7 1.7 0.6 0.9 1.1 0.9 1.0 2.0 0.7 2.9 0.5 3.4 1.2 0.8 4.1 7.8 0.3 0.2 0.3 1.7 1.0 0.5 1.4 1.1 0.7 1.3 0.3 0.6 0.0 0.2 0.0 0.0 0.3 0.6 0.0 0.2 0.5 0.3 0.3 0.1 0.1 0.8 1.2 0.4 0.2 0.5 0.2 3.2 3.1 2.9 3.4 3.1 3.9 7.5 6.5 4.7 5.4 3.4 4.8 0.3 0.0 0.5 1.0 0.2 1.3 2.1 3.7 1.8 2.2 1.7 2.2 1.2 2.8 6.5 0.0 4.2 0.5 0.2 0.3 1.9 1.4 249.1 73.2 1.0 0.8 1.2 0.0 0.2 0.2 0.5 0.9 0.0 1.6 2.5 0.5 0.0 0.7 0.1 1.7 0.3 0.1 10.2 0.6 0.3 609.6 2.5 0.5 1.8 0.0 0.0 5.5 0.0 0.0 0.5 0.5 0.1 1.9 0.0 0.8 0.7 7.2 71.4 11.3 0.0 1.6 1.0 14.2 6.4 0.4 0.9 0.4 0.6 2.1 0.3 0.7 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 6.1 5.0 4.4 7.4 8.4 21.7 10.0 13.8 7.0 6.5 2.6 5.6 4.3 8.2 4.0 5.6 5.6 5.6 3.5 4.6 5.1 5.5 6.7 5.1 8.5 4.4 5.1 11.2 7.0 6.8 3.5 8.0 5.4 6.0 6.1 8.2 7.7 5.0 7.5 7.2 4.6 6.2 4.9 6.5 6.1 11.0 4.5 10.7 9.1 9.5 7.9 7.3 4.6 13.8 20.8 17.4 26.8 20.5 10.7 13.8 25.9 24.8 18.0 21.6 25.5 28.9 16.4 39.2 21.7 17.3 17.9 21.3 41.2 17.1 36.1 27.8 19.8 63.4 21.4 21.0 11.2 64.7 20.2 10.3 11.3 38.8 28.7 12.3 21.3 23.5 52.2 32.6 22.1 13.8 38.3 22.9 43.2 11.2 22.9 38.4 42.1 26.1 11.6 24.9 24.2 18.8 32.0 14.6 16.5 18.8 12.9 23.1 27.0 32.9 22.8 20.3 26.7 16.0 29.6 55.4 15.3 25.5 22.5 6.3 2.5 3.0 4.3 1.7 4.9 4.0 3.6 3.2 1.8 3.1 4.8 3.7 2.8 7.7 3.5 1.6 2.8 1.7 4.4 8.4 13.8 7.0 4.6 5.1 4.4 5.1 5.4 4.9 4.5 13.8 53.1 96.1 49.7 41.1 43.5 49.3 47.5 21.9 33.0 48.2 30.4 29.8 38.2 28.6 38.0 14.7 31.3 39.2 40.3 19.6 1.9 38.5 22.6 38.0 61.7 48.0 25.0 84.3 68.5 21.9 35.9 51.3 34.7 65.0 34.1 88.6 27.1 19.7 23.0 47.1 72.4 30.9 14.2 26.4 27.0 14.0 43.8 37.6 30.2 48.7 44.1 35.8 32.0 73.9 126.3 29.9 23.5 34.3 45.1 53.2 14.9 12.9 21.3 42.8 85.5 106.5 51.2 122.8 113.1 28.9 41.6 40.9 45.3 58.9 34.6 45.4 RMI1 "BLAP75, C9orf76, FLJ12888" ENSG00000178966 "RecQ mediated genome instability 1" Q9H9A7 9 83980798-84004074 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 70.0;Late spermatids: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021661 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" "HPA021661: " "unprognostic (9.59e-2)" "unprognostic (7.96e-2)" "unprognostic (6.72e-3)" "unprognostic (3.03e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (2.65e-1)" "unprognostic (3.39e-3)" "unprognostic (1.32e-1)" "unprognostic (5.55e-2)" "unprognostic (2.26e-1)" "unprognostic (1.53e-1)" "unprognostic (3.68e-3)" "unprognostic (3.42e-1)" "unprognostic (2.42e-1)" "unprognostic (9.24e-2)" 2.5 8.3 2.9 6.0 3.2 3.9 4.5 4.6 3.4 3.2 6.0 6.6 6.2 3.5 5.6 4.9 5.8 2.8 3.4 2.4 5.8 4.4 5.8 3.3 10.2 3.3 3.3 4.4 5.8 7.7 3.7 3.6 3.5 4.8 7.4 7.0 6.0 3.1 3.7 5.1 6.8 3.3 3.2 6.4 6.2 8.9 3.8 10.2 6.0 3.9 9.6 3.6 2.4 3.8 25.2 14.9 33.6 12.4 5.5 7.7 33.9 24.1 13.6 20.7 19.4 7.5 17.0 55.4 8.5 12.4 21.7 36.9 22.0 12.3 25.3 29.2 6.1 23.0 12.1 11.8 7.7 42.6 23.1 7.4 7.8 17.6 12.6 6.7 11.1 28.2 16.7 26.3 23.2 18.1 54.4 17.4 31.3 31.6 15.7 47.8 33.9 21.0 10.8 10.4 30.4 19.3 21.3 18.6 9.8 15.4 19.4 20.8 6.6 22.9 14.7 23.2 20.1 11.6 25.6 20.2 14.6 19.7 26.4 14.2 4.5 8.8 1.8 5.5 2.2 2.8 2.1 1.9 7.2 2.6 2.2 2.5 7.8 2.8 6.5 2.2 3.0 2.6 2.9 3.2 4.6 3.4 2.4 5.8 3.3 3.3 3.5 3.2 3.8 3.8 5.4 9.6 5.1 10.1 5.9 2.7 3.2 4.3 4.0 4.1 4.3 3.3 8.5 2.8 9.0 1.8 4.2 7.9 2.1 6.1 5.9 5.5 70.0 13.9 6.5 3.8 6.7 24.4 7.1 3.0 16.2 3.3 8.2 10.2 4.5 9.0 5.0 13.3 8.1 10.1 11.2 9.8 0.0 10.7 4.3 62.1 2.1 7.4 12.4 8.4 8.5 7.7 5.2 26.2 12.6 2.7 5.6 2.2 7.8 4.2 8.9 4.9 11.1 5.2 0.0 3.3 3.4 34.0 22.6 6.9 4.8 4.2 4.4 7.7 10.1 2.4 RNF168 FLJ35794 ENSG00000163961 "Ring finger protein 168" Q8IYW5 3 196468783-196503768 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 199.9;Late spermatids: 459.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046109 Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA046109: AB_2679540" "unprognostic (6.15e-3)" "prognostic favorable (8.21e-4)" "unprognostic (3.11e-1)" "unprognostic (1.11e-2)" "unprognostic (4.22e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (6.81e-3)" "unprognostic (5.30e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (4.83e-3)" "unprognostic (2.80e-3)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.95e-2)" "unprognostic (6.65e-2)" 8.6 4.8 3.9 6.0 4.2 20.6 6.8 5.9 4.3 9.3 4.4 6.1 6.1 6.0 4.0 7.9 5.9 4.5 6.8 3.2 6.3 4.7 10.4 8.1 7.2 6.1 5.2 7.4 4.8 4.0 3.5 5.4 6.5 5.3 5.7 4.9 5.8 4.1 13.1 11.5 5.6 5.3 4.9 6.8 5.8 10.7 6.0 7.7 4.9 8.3 8.7 6.7 9.3 6.0 21.6 8.5 14.8 19.5 13.6 9.8 21.1 12.9 8.1 8.5 13.3 16.6 10.4 22.7 29.1 10.8 11.9 21.3 21.0 15.4 13.0 10.9 10.3 43.0 22.2 20.7 7.0 13.3 10.3 9.8 5.8 13.3 11.7 6.0 12.6 18.4 13.1 23.1 8.7 36.4 44.6 7.8 17.6 11.6 10.8 19.7 17.2 18.4 7.2 29.2 12.3 12.4 14.6 17.7 11.1 10.9 26.8 11.7 12.4 14.6 11.4 15.7 17.2 19.6 19.7 33.2 14.3 15.8 11.9 30.0 7.3 8.8 12.2 8.0 10.9 6.3 10.1 8.8 6.6 6.6 8.8 9.4 8.0 8.7 12.2 6.2 7.0 7.5 3.9 4.2 5.9 4.3 3.2 6.3 6.1 5.2 6.5 4.9 6.0 6.0 34.4 16.0 37.5 16.0 37.7 100.1 49.8 30.8 52.3 36.0 17.3 15.0 21.7 12.8 20.0 14.7 60.5 14.6 76.4 25.3 17.6 14.0 199.9 17.0 20.8 33.3 14.4 14.1 33.5 8.9 26.6 27.9 23.9 24.0 50.1 24.0 24.3 25.9 17.9 15.2 36.0 18.5 28.5 32.4 98.8 459.7 20.2 33.9 26.6 28.1 38.2 12.7 42.2 25.1 27.4 10.5 17.3 20.7 37.9 27.7 11.4 10.3 17.1 39.8 13.1 23.6 25.7 13.8 54.9 55.5 126.6 10.7 63.7 20.3 22.4 50.3 RNF169 KIAA1991 ENSG00000166439 "Ring finger protein 169" Q8NCN4 11 74748849-74842413 "Enzymes, Predicted intracellular proteins" "DNA damage, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038505, HPA046138, HPA047952" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Nucleoli, Nucleoli rim, Cytosol" "HPA038505: , HPA046138: AB_2679553, HPA047952: " "unprognostic (1.71e-1)" "unprognostic (4.18e-2)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (3.86e-2)" "unprognostic (3.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (2.68e-1)" "unprognostic (6.47e-2)" "prognostic unfavorable (8.04e-4)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (3.23e-1)" "unprognostic (2.34e-1)" "unprognostic (9.55e-3)" "unprognostic (1.21e-1)" 4.2 2.8 3.8 6.7 6.2 14.4 5.6 6.2 4.4 5.5 5.4 4.4 4.0 7.6 4.2 10.1 5.6 4.8 3.2 4.0 4.4 4.6 5.0 5.9 6.3 5.4 5.0 7.6 4.4 5.6 2.1 4.7 5.4 5.2 5.3 6.1 4.5 4.3 6.8 5.5 4.4 7.6 4.4 7.3 4.6 2.9 4.6 7.7 5.8 5.8 6.7 5.2 5.4 9.2 10.2 7.7 9.1 9.0 5.8 7.7 3.7 7.9 7.4 8.6 7.4 13.0 7.5 18.2 7.9 9.5 5.8 9.6 12.4 9.3 11.2 9.1 8.0 12.6 15.3 5.1 6.6 6.8 10.1 7.1 7.2 9.8 22.1 9.6 14.0 12.2 11.4 14.1 8.7 8.6 11.6 12.0 3.6 12.9 5.0 10.7 21.7 9.9 5.5 10.6 4.1 7.4 10.6 8.0 16.6 7.3 9.9 8.6 9.4 14.2 11.8 9.0 7.1 10.2 5.8 21.1 2.8 7.3 8.4 1.2 0.5 0.4 0.4 0.3 0.3 0.0 0.4 0.2 0.2 0.1 0.3 0.2 1.4 0.3 0.3 0.2 0.3 0.2 3.8 6.2 6.2 4.4 4.0 4.4 5.4 5.0 5.4 4.4 4.6 9.2 18.8 9.6 11.4 51.6 18.4 19.9 30.6 7.1 20.5 58.2 12.6 9.8 3.0 17.2 8.3 3.7 52.1 5.5 24.6 9.8 5.9 10.2 2.8 30.5 26.7 17.2 12.0 18.3 40.8 11.1 6.4 16.0 14.8 30.1 7.0 24.4 10.8 12.3 8.5 37.0 43.2 8.7 2.0 15.6 19.9 3.1 7.5 16.6 10.6 25.3 12.6 22.9 26.8 42.7 68.7 10.1 6.8 10.5 18.5 49.7 6.3 12.1 8.9 33.7 26.3 31.9 18.7 9.4 11.7 16.4 18.6 8.1 22.2 14.0 10.4 42.2 RNF2 "BAP-1, BAP1, DING, HIPI3, RING1B, RING2" ENSG00000121481 "Ring finger protein 2" Q99496 1 185045526-185102603 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 83.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026803 Uncertain Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA026803: AB_10602086" "unprognostic (1.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (1.35e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.08e-5)" "unprognostic (5.85e-2)" "unprognostic (3.56e-3)" "unprognostic (1.62e-2)" "unprognostic (2.01e-2)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.94e-7)" "unprognostic (2.08e-1)" "unprognostic (5.51e-2)" "unprognostic (9.89e-3)" "unprognostic (2.52e-1)" 9.5 8.1 5.4 10.2 6.7 13.8 12.5 6.1 7.0 10.3 3.7 9.3 8.4 10.7 8.5 8.4 8.6 9.4 7.4 7.0 7.5 9.6 8.3 8.3 11.5 4.0 4.8 9.3 9.6 8.7 5.6 21.7 4.8 8.5 9.7 11.8 9.6 10.4 8.2 6.4 6.5 10.9 4.5 10.4 9.6 21.9 7.9 12.3 10.8 9.0 12.3 16.5 8.7 5.1 34.0 18.6 62.8 25.4 17.8 30.3 65.3 24.0 28.4 35.5 28.3 29.9 53.3 10.2 29.2 29.0 24.4 11.5 43.7 32.7 41.7 31.1 28.4 54.9 10.2 25.8 27.5 56.1 29.7 29.7 19.6 29.6 36.4 27.9 36.6 34.4 44.7 22.5 25.1 21.2 48.5 17.6 86.3 27.4 11.0 55.1 41.3 9.8 25.7 23.6 18.9 33.4 17.3 9.9 46.7 67.8 19.7 27.5 28.4 25.4 33.6 25.1 29.8 39.0 26.2 36.3 16.1 25.7 28.9 31.0 22.4 27.7 17.1 27.7 24.4 20.1 15.5 15.8 25.7 21.9 15.1 15.6 9.8 24.4 29.9 13.4 17.8 16.3 5.4 6.7 6.1 7.0 7.0 7.5 4.0 4.8 4.8 4.5 7.9 5.1 22.6 3.2 6.4 11.4 23.6 23.2 27.6 10.2 26.7 10.3 18.2 11.8 8.4 7.2 6.6 9.2 4.2 25.4 24.5 11.2 23.5 11.5 6.1 11.2 10.8 20.3 29.5 29.4 23.1 12.6 53.0 17.9 12.8 10.3 12.7 16.9 23.2 8.8 20.1 6.7 20.5 9.2 8.2 21.4 55.2 5.6 9.6 22.0 21.4 20.6 25.4 13.3 10.3 18.6 15.1 11.3 16.9 11.7 15.5 30.2 4.1 16.4 8.8 7.2 0.0 11.7 13.4 35.6 83.1 15.8 20.3 28.5 20.7 15.6 11.3 38.0 RNF32 "FKSG33, HSD15, LMBR2" ENSG00000105982 "Ring finger protein 32" Q9H0A6 7 156640281-156677130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 60.9" "Group enriched" "Detected in many" 9 "Early spermatids: 325.5;Late spermatids: 487.1;Spermatocytes: 243.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 12.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 12.6" "Cell line enhanced" "Detected in many" "CACO-2: 11.8;HDLM-2: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019516, HPA073560" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA019516: , HPA073560: AB_2686616" "unprognostic (9.23e-2)" "unprognostic (3.01e-2)" "prognostic unfavorable (2.21e-4)" "unprognostic (7.85e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "unprognostic (5.73e-3)" "unprognostic (1.71e-2)" "unprognostic (8.72e-3)" "unprognostic (6.08e-4)" "unprognostic (4.64e-2)" "unprognostic (2.06e-1)" "unprognostic (8.15e-3)" "unprognostic (1.25e-1)" "unprognostic (3.60e-2)" "unprognostic (3.81e-3)" "unprognostic (1.44e-1)" 1.9 1.3 1.6 1.5 2.3 1.7 1.1 1.3 2.2 0.9 1.0 1.9 1.6 0.9 11.0 0.9 3.2 2.4 0.6 1.7 2.3 2.2 1.1 1.6 2.1 2.1 1.7 2.6 2.0 0.7 1.7 1.4 2.1 2.1 1.6 2.7 0.9 0.9 1.1 2.2 1.3 0.3 2.0 1.4 3.0 60.9 2.7 1.1 2.5 0.1 1.2 0.7 0.9 3.5 4.5 2.3 0.5 1.2 1.0 0.6 0.8 0.7 0.2 1.1 0.9 11.8 5.0 7.2 5.5 0.7 1.2 0.1 0.0 0.2 2.2 13.2 3.0 0.9 1.1 0.5 1.0 2.1 4.1 1.7 0.8 0.6 2.3 0.7 0.5 6.3 10.7 2.0 3.5 7.8 2.9 5.2 2.5 7.6 5.6 2.9 0.1 3.4 1.6 1.5 7.2 5.4 4.3 0.4 2.3 1.1 1.3 1.5 1.9 0.0 0.2 0.9 0.6 10.2 4.8 4.2 0.8 4.8 1.7 12.6 0.4 1.4 0.4 0.2 1.5 2.6 1.5 0.4 1.0 1.6 0.3 0.5 0.0 0.4 0.5 2.6 2.0 0.6 1.6 2.3 1.3 2.2 1.7 2.3 2.1 1.7 2.1 2.0 2.7 3.5 0.9 6.4 2.6 2.3 1.9 0.3 2.2 2.8 2.8 2.3 1.7 2.2 1.1 4.3 5.4 3.7 0.0 0.0 0.3 2.4 5.9 2.0 325.5 12.7 0.9 1.1 4.2 0.4 2.0 3.2 0.5 0.7 4.6 2.9 5.7 0.6 2.5 2.9 0.4 1.7 1.9 2.5 2.0 0.0 0.9 487.1 6.5 2.1 1.8 1.0 0.1 2.5 0.0 5.0 5.3 3.1 0.5 4.1 2.4 1.3 2.8 6.4 35.4 2.2 0.0 1.4 1.1 243.4 35.6 2.0 0.6 0.1 1.1 0.2 2.1 1.5 RNF34 "FLJ21786, RIF, RIFF" ENSG00000170633 "Ring finger protein 34" Q969K3 12 121400041-121430623 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074151 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA074151: AB_2686668" "unprognostic (3.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.90e-1)" "unprognostic (6.10e-2)" "unprognostic (9.92e-2)" "unprognostic (2.55e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (3.39e-1)" "unprognostic (9.99e-2)" "unprognostic (1.60e-2)" "unprognostic (5.87e-3)" "unprognostic (2.80e-2)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.55e-3)" "prognostic favorable (3.02e-4)" 13.7 10.8 25.5 23.6 29.7 13.4 13.4 31.6 32.2 11.6 21.8 19.2 19.5 13.7 13.5 14.9 12.5 17.3 18.4 26.8 28.6 11.3 13.0 12.9 34.3 26.0 26.6 14.7 13.8 13.3 13.7 11.5 26.7 10.5 15.6 19.0 13.9 13.5 59.5 15.7 18.3 16.7 24.7 23.3 18.4 24.6 26.6 26.8 13.9 36.8 26.4 19.0 11.9 32.7 45.4 53.8 34.7 36.3 26.8 24.5 43.2 47.5 42.2 46.3 35.3 67.3 16.9 64.9 35.3 51.3 24.6 31.8 52.6 29.8 41.0 95.3 30.8 75.4 37.7 62.5 32.1 65.7 50.4 21.9 39.6 40.2 34.7 26.4 49.3 37.9 58.0 29.3 46.0 35.7 57.5 95.7 44.5 26.6 48.4 54.0 45.1 38.1 32.0 53.2 50.7 33.0 59.4 21.8 36.6 31.6 38.0 49.1 39.5 39.5 28.4 34.6 37.8 51.2 92.8 70.5 28.2 45.4 40.6 83.7 42.1 91.2 72.4 48.4 74.1 77.1 83.2 76.8 40.4 65.0 71.1 71.1 65.2 76.2 53.3 34.3 106.3 68.3 25.5 29.7 31.6 32.2 26.8 28.6 26.0 26.6 26.7 24.7 26.6 32.7 14.5 16.0 16.2 15.3 22.9 17.5 18.7 23.4 13.6 13.9 16.5 13.2 22.0 27.1 18.9 9.2 4.2 26.1 30.9 19.0 37.2 32.7 23.5 13.7 15.3 17.3 40.8 24.8 34.3 27.3 38.8 16.1 15.8 13.9 17.7 19.0 17.2 11.2 21.2 13.5 32.7 15.8 30.5 18.0 14.9 10.7 17.1 14.0 17.8 13.1 35.0 23.6 46.4 9.5 45.5 26.2 17.2 18.0 27.9 17.0 20.5 19.9 18.7 21.4 19.7 11.1 25.0 134.0 73.9 15.3 16.1 24.2 34.3 18.5 21.2 25.7 RNF4 "RES4-26, SLX5, SNURF" ENSG00000063978 "Ring finger protein 4" P78317 4 2462220-2625320 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022047, HPA049356" Approved Supported "Nucleoplasm,Nuclear bodies,Microtubule ends" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Microtubule ends" "HPA022047: , HPA049356: AB_2680726" "unprognostic (8.38e-3)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (9.31e-3)" "unprognostic (9.03e-3)" "prognostic unfavorable (6.38e-4)" "unprognostic (1.34e-1)" "unprognostic (6.79e-2)" "unprognostic (2.58e-1)" "unprognostic (5.64e-2)" "unprognostic (1.93e-2)" "unprognostic (6.40e-2)" "unprognostic (4.70e-2)" "unprognostic (8.67e-2)" "unprognostic (1.54e-1)" 30.2 30.9 24.0 36.0 24.9 46.4 29.2 26.0 25.1 29.4 26.5 27.9 29.0 29.5 28.3 30.7 28.5 28.3 27.0 24.5 25.5 32.6 25.9 27.8 49.9 26.0 25.9 31.0 31.2 33.6 26.8 28.4 25.2 28.2 27.4 24.0 28.0 28.1 27.7 29.7 30.4 33.1 23.9 40.3 30.1 31.9 26.3 50.1 30.7 23.2 50.0 35.0 26.8 25.5 60.9 57.0 57.9 42.0 50.6 52.2 65.6 73.3 83.4 77.3 70.0 65.1 56.8 77.6 42.0 76.0 101.5 39.7 63.5 58.6 72.7 37.6 38.5 92.4 54.6 62.6 76.6 66.7 77.8 61.0 69.7 72.3 59.4 53.6 73.1 64.8 50.0 103.2 80.4 43.5 105.0 92.5 89.8 52.3 70.9 76.6 55.3 40.8 52.6 74.5 54.3 51.0 50.5 40.4 52.1 62.9 63.1 50.6 60.0 65.8 32.0 64.2 115.4 131.3 189.5 82.6 64.6 72.7 69.5 44.7 70.0 104.6 97.7 95.4 97.2 85.0 82.2 97.0 84.1 59.1 78.8 80.3 77.2 99.2 103.8 56.5 98.8 128.6 24.0 24.9 26.0 25.1 24.5 25.5 26.0 25.9 25.2 23.9 26.3 25.5 31.1 22.4 17.5 17.0 36.0 27.5 18.4 17.7 31.3 11.9 24.0 16.0 20.7 12.8 21.3 22.0 16.7 21.3 45.9 16.5 21.5 22.2 14.0 17.0 22.8 21.7 12.1 15.4 15.9 23.3 35.0 19.5 23.0 23.9 14.5 22.7 16.4 20.4 19.7 13.5 17.8 16.8 8.2 34.0 28.5 22.4 17.1 27.8 7.2 18.7 35.1 11.5 43.3 13.0 16.3 29.8 14.3 20.7 47.8 27.1 23.1 21.2 17.6 17.7 26.3 18.2 22.0 31.2 48.6 27.0 32.1 21.8 39.7 16.4 18.9 32.9 RNF41 "NRDP1, SBBI03" ENSG00000181852 "Ring finger protein 41" Q9H4P4 12 56202179-56221933 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Autophagy, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016812 Approved Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nuclear bodies" "Midbody ring" "HPA016812: AB_1856370" "unprognostic (1.14e-2)" "unprognostic (6.30e-2)" "unprognostic (4.04e-2)" "unprognostic (6.86e-2)" "unprognostic (9.59e-2)" "unprognostic (8.22e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (6.93e-2)" "unprognostic (4.18e-2)" "unprognostic (1.67e-1)" "unprognostic (5.80e-2)" "unprognostic (5.90e-2)" "prognostic favorable (2.52e-5)" "unprognostic (1.64e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-1)" "unprognostic (1.43e-1)" 32.2 24.6 22.5 18.0 23.3 19.6 21.4 15.7 23.8 21.2 13.0 23.8 12.4 22.3 13.2 23.1 24.3 25.5 32.7 24.6 24.8 19.7 15.1 23.8 23.4 16.8 19.1 22.9 23.0 27.4 22.8 21.3 21.2 33.9 19.0 23.8 15.0 20.7 34.0 15.0 16.1 28.5 15.3 20.6 17.0 15.9 23.5 26.5 28.6 40.8 25.1 28.2 17.0 19.2 21.6 32.6 34.7 55.2 71.0 51.3 25.8 70.8 69.5 62.2 50.2 40.0 27.6 41.6 36.7 60.2 20.6 24.3 47.4 34.1 44.9 43.8 25.7 55.8 22.3 23.2 148.3 61.6 58.3 66.0 78.6 52.0 91.0 81.7 61.3 34.5 40.4 41.3 35.1 34.9 35.6 27.6 41.9 21.6 37.8 38.2 24.9 25.3 33.3 31.3 62.9 38.1 61.9 35.0 55.4 34.3 49.2 71.3 37.3 31.3 32.9 40.6 27.8 29.6 36.6 37.5 37.2 36.4 38.0 59.1 27.2 99.9 27.6 26.7 24.9 50.3 23.0 24.3 30.6 55.1 23.4 24.0 36.2 33.1 28.3 23.7 29.4 31.0 22.5 23.3 15.7 23.8 24.6 24.8 16.8 19.1 21.2 15.3 23.5 19.2 18.9 44.8 22.6 11.1 42.2 12.0 19.9 8.6 19.9 30.7 22.2 21.1 24.6 24.3 18.8 16.5 22.9 15.2 17.0 10.2 17.6 15.3 92.8 13.9 14.2 20.7 20.4 11.1 15.0 21.3 18.5 22.7 9.7 14.2 25.9 16.8 30.0 16.7 19.3 28.6 15.7 13.9 8.2 34.9 22.7 58.0 23.0 25.0 7.2 9.4 33.5 26.2 15.5 14.6 12.3 20.8 20.3 25.9 14.6 33.5 12.3 19.6 18.0 18.3 26.3 23.2 27.4 10.4 14.2 14.4 16.6 16.8 16.6 17.1 14.3 23.1 RNPEPL1 ENSG00000142327 "Arginyl aminopeptidase like 1" Q9HAU8 2 240565804-240581372 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036772, HPA036773" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies" "HPA036772: AB_10670848, HPA036773: " "unprognostic (3.92e-2)" "unprognostic (7.28e-2)" "unprognostic (1.20e-2)" "unprognostic (2.39e-1)" "unprognostic (5.24e-3)" "prognostic favorable (7.43e-4)" "prognostic unfavorable (5.06e-4)" "unprognostic (3.72e-3)" "unprognostic (9.10e-2)" "unprognostic (1.66e-3)" "unprognostic (3.10e-1)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (5.33e-2)" "unprognostic (1.57e-1)" "unprognostic (5.31e-2)" "unprognostic (9.86e-2)" 40.3 31.4 29.1 14.1 29.6 21.7 32.0 29.0 38.7 15.6 27.0 39.6 20.2 16.8 5.6 52.4 17.0 12.1 79.4 27.9 27.8 42.7 50.6 35.9 23.8 31.5 30.0 12.0 64.2 10.9 9.1 10.6 30.3 34.7 9.5 0.8 28.9 13.1 63.7 35.3 39.8 9.4 31.0 56.4 48.4 9.9 31.4 15.9 19.2 17.1 12.1 34.1 23.2 31.1 13.7 22.4 4.9 13.2 17.6 18.1 16.6 8.6 21.1 9.5 11.6 6.3 39.3 3.9 4.3 21.8 13.3 14.6 5.5 16.1 0.9 23.9 7.7 9.0 7.3 37.2 44.1 5.9 15.5 21.6 25.5 4.9 9.6 15.1 32.8 15.2 6.8 25.7 6.5 19.3 7.5 22.4 6.5 26.5 9.0 15.5 7.4 33.3 39.3 18.5 4.6 9.8 5.8 19.7 39.9 5.6 13.9 26.8 22.7 10.2 10.4 14.4 10.0 24.1 3.9 4.8 20.9 16.6 15.7 9.2 11.2 30.5 14.8 9.9 12.7 8.2 11.3 13.4 8.2 8.7 6.4 9.5 20.0 10.7 10.1 9.5 14.7 7.9 29.1 29.6 29.0 38.7 27.9 27.8 31.5 30.0 30.3 31.0 31.4 31.1 27.9 22.4 25.7 10.4 27.8 7.8 15.0 8.4 2.8 6.4 18.8 9.1 35.6 24.3 12.9 12.9 0.0 7.1 80.4 138.9 17.6 24.6 3.1 12.1 11.0 22.7 26.4 22.3 9.5 49.6 6.8 12.3 104.5 27.4 34.2 31.8 30.0 42.2 43.8 3.3 8.6 58.7 8.2 74.3 21.0 5.9 8.7 47.1 23.2 9.4 52.0 15.9 79.3 5.5 10.3 65.0 70.0 13.5 20.5 20.2 77.1 35.6 7.2 6.9 13.1 14.8 16.4 1.3 8.2 13.0 9.2 5.1 47.9 17.4 60.5 23.0 RORC "NR1F3, RORG, RZRG, TOR" ENSG00000143365 "RAR related orphan receptor C" P51449 1 151806071-151831845 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.2;skeletal muscle: 128.0" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2;Hepatocytes: 47.8;Proximal enterocytes: 32.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 4.1" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 50.3" "Lineage enriched" "Detected in many" 44 "T-cells: 50.3" "Cell line enhanced" "Detected in some" "HDLM-2: 23.8;Karpas-707: 11.5;MOLT-4: 6.3;RPMI-8226: 6.0;SK-BR-3: 5.7;T-47d: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065620 Supported "Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 44: HDLM-2 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" "Nuclear bodies" "HPA065620: AB_2685521" "unprognostic (6.51e-2)" "unprognostic (7.78e-2)" "prognostic favorable (1.83e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-4)" "unprognostic (6.29e-5)" "unprognostic (1.13e-3)" "unprognostic (8.94e-2)" "unprognostic (1.67e-1)" "unprognostic (7.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.94e-5)" "unprognostic (2.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.80e-2)" 2.9 4.9 0.2 1.8 0.1 0.4 7.5 4.1 0.3 6.5 5.2 9.3 11.6 1.9 4.6 5.4 21.2 3.7 11.6 0.2 0.4 18.8 86.2 12.7 0.9 0.9 1.6 0.3 59.2 33.5 18.3 0.0 0.7 15.8 9.2 0.0 41.0 11.0 128.0 24.7 13.9 0.3 0.8 1.3 19.8 10.7 0.4 52.7 26.4 58.8 2.4 3.0 3.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.1 0.0 0.0 0.0 23.8 0.0 0.0 2.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 11.5 0.0 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.1 0.0 0.0 0.2 0.1 5.7 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 50.3 0.0 8.0 7.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 5.8 1.2 0.2 0.1 4.1 0.3 0.2 0.4 0.9 1.6 0.7 0.8 0.4 0.4 0.1 6.4 6.0 0.3 0.8 2.0 4.4 3.1 3.4 0.0 18.4 9.8 5.9 21.5 5.3 16.5 0.0 0.0 1.8 12.0 35.2 8.3 0.4 15.3 2.6 0.7 9.6 5.3 0.1 7.0 0.0 0.3 17.3 18.9 0.0 0.3 1.8 47.8 0.1 0.0 0.0 20.0 16.2 2.7 0.3 0.9 0.6 0.6 3.6 0.0 0.2 0.0 0.0 0.0 0.0 3.2 16.0 0.4 0.3 5.0 32.9 17.1 10.5 0.0 0.0 4.2 0.5 0.2 0.0 5.0 3.0 0.0 6.8 0.1 15.3 3.5 RP2 "NM23-H10, NME10, TBCCD2" ENSG00000102218 "RP2 activator of ARL3 GTPase" O75695 X 46837043-46882358 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 49.5" "Cell type enhanced" "Detected in many" "Kupffer cells: 62.8;Langerhans cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000234, HPA000909" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA000234: AB_1079831, HPA000909: AB_2666140" "unprognostic (2.26e-1)" "unprognostic (6.01e-3)" "unprognostic (2.79e-2)" "unprognostic (2.98e-1)" "unprognostic (1.69e-1)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (2.58e-2)" "unprognostic (9.76e-3)" "unprognostic (3.10e-2)" "unprognostic (3.79e-3)" "unprognostic (9.75e-2)" "unprognostic (6.15e-3)" "unprognostic (2.96e-2)" "unprognostic (9.66e-2)" "unprognostic (1.61e-1)" "unprognostic (4.28e-3)" 10.9 8.9 1.9 15.6 2.3 49.5 7.2 2.6 2.3 7.9 3.6 10.1 10.6 6.9 4.0 12.9 6.8 12.7 4.8 1.7 2.7 6.7 13.2 11.8 12.9 3.3 2.8 6.5 4.6 7.4 1.7 25.2 3.5 6.7 10.5 4.2 4.4 5.3 2.0 5.3 11.0 9.0 3.5 13.2 8.1 4.0 2.3 9.8 6.1 3.6 11.2 10.4 4.2 4.6 21.8 10.3 20.4 11.0 15.7 19.4 48.0 27.4 21.5 23.8 23.9 44.6 18.2 25.8 10.7 29.3 20.1 14.0 19.8 20.0 32.1 11.5 11.5 13.9 11.7 10.7 17.9 29.2 46.4 15.1 13.0 18.8 10.1 13.3 30.5 11.4 6.2 13.1 27.0 1.9 18.1 26.8 12.5 14.8 19.5 22.9 27.9 13.8 15.3 22.0 7.4 10.0 24.4 14.9 12.4 36.2 16.8 27.1 27.1 18.3 13.6 29.1 9.8 4.9 6.8 15.4 9.5 20.4 19.5 62.6 22.6 35.5 6.1 30.8 5.0 10.3 4.9 5.3 22.6 9.6 6.0 5.7 43.5 7.6 36.3 7.6 6.1 12.2 1.9 2.3 2.6 2.3 1.7 2.7 3.3 2.8 3.5 3.5 2.3 4.6 9.6 9.6 7.4 3.9 18.9 15.8 3.2 6.1 15.4 3.1 7.8 6.1 1.7 7.2 5.1 9.2 2.1 23.2 12.0 28.6 0.0 4.7 2.8 15.8 14.5 8.6 3.6 10.3 3.1 5.3 6.4 10.3 12.8 14.9 12.0 4.0 12.5 20.1 24.3 0.0 4.0 9.4 2.0 62.8 72.9 1.7 5.6 44.7 21.4 6.5 36.6 3.6 6.2 12.1 5.9 11.6 13.4 5.7 13.2 8.2 9.8 3.6 14.5 5.5 6.6 7.7 10.5 7.8 4.6 36.4 14.9 38.2 11.4 4.7 10.5 13.6 RPA2 ENSG00000117748 "Replication protein A2" P15927 1 27891524-27914746 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, DNA replication" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 162.3;Spermatogonia: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016538, HPA026306, HPA026309" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572" "unprognostic (2.59e-1)" "prognostic favorable (4.33e-4)" "unprognostic (8.98e-2)" "unprognostic (6.89e-2)" "unprognostic (1.04e-1)" "prognostic favorable (8.12e-4)" "unprognostic (4.29e-3)" "unprognostic (2.03e-2)" "unprognostic (8.62e-3)" "unprognostic (1.68e-1)" "unprognostic (1.58e-2)" "unprognostic (2.31e-1)" "unprognostic (3.59e-2)" "unprognostic (9.13e-2)" "unprognostic (2.30e-1)" "unprognostic (2.18e-3)" "unprognostic (2.82e-2)" 28.4 25.0 33.3 39.7 35.1 40.7 43.8 33.4 42.4 32.0 37.4 26.6 18.5 33.7 43.4 32.3 49.1 30.6 39.2 34.5 36.1 32.4 31.8 28.7 75.1 33.7 33.2 52.0 21.0 40.7 31.3 30.2 33.9 28.7 30.2 43.8 24.0 31.3 72.3 40.3 26.1 30.7 36.7 42.3 25.6 63.7 34.0 53.4 52.9 63.2 67.6 30.3 24.9 36.7 60.9 57.4 86.4 68.5 59.3 52.8 57.2 106.1 70.3 130.0 113.5 80.2 72.7 148.9 69.4 41.1 48.4 55.8 126.5 60.3 122.4 121.0 126.0 174.3 73.0 71.3 30.9 229.7 115.1 24.6 33.2 123.8 62.3 40.3 59.1 133.1 196.2 127.1 75.7 63.6 163.9 105.1 181.7 115.1 122.0 115.0 128.7 74.2 49.1 65.2 78.3 75.8 123.3 47.3 100.7 68.1 50.9 71.8 36.6 32.2 73.0 186.2 76.3 105.8 251.0 135.8 81.4 213.5 64.3 322.3 97.4 290.0 279.7 80.0 304.4 272.5 252.9 257.4 112.1 232.0 287.4 282.7 100.1 294.1 106.5 172.3 255.5 435.5 33.3 35.1 33.4 42.4 34.5 36.1 33.7 33.2 33.9 36.7 34.0 36.7 26.5 22.4 15.7 10.4 64.0 21.0 28.5 47.1 16.5 28.4 25.7 27.8 29.0 24.3 30.4 22.0 2.1 95.2 77.8 10.1 35.2 35.0 49.0 14.6 18.8 27.9 13.8 39.1 8.8 20.6 67.3 34.8 7.1 15.1 60.9 33.3 26.4 16.6 51.9 8.4 8.4 14.0 71.2 31.5 27.6 22.6 41.3 34.1 37.4 7.5 86.7 100.0 95.8 9.5 14.3 29.5 10.4 46.3 32.6 19.3 11.2 23.6 28.8 34.5 32.9 48.0 24.7 162.3 183.5 20.6 22.4 55.7 59.9 33.9 19.3 20.1 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Approved "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" Yes No 1300000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 831.6 565.7 367.7 738.6 404.0 1928.0 2030.6 377.1 545.7 1385.7 370.7 970.8 451.2 1276.0 1088.2 1289.4 1454.2 776.9 914.1 385.6 388.6 751.5 914.9 666.3 1630.2 376.4 380.9 3022.1 1740.5 954.0 504.0 746.1 386.6 709.1 1143.5 350.6 1234.8 1092.1 1314.7 1327.1 507.9 1353.5 383.2 776.9 643.8 296.4 373.4 1883.4 1289.5 1921.7 2451.3 1322.4 782.5 406.8 1192.9 2343.4 973.0 1646.3 4272.4 7697.6 1710.1 1416.1 2899.7 2143.0 1648.1 2611.3 2025.2 4676.6 1572.3 3396.6 1011.9 2105.0 7026.5 5476.3 2352.2 1301.4 4208.3 2872.9 1955.7 2201.2 6007.7 3042.0 1376.1 7627.4 6980.3 2334.4 9237.8 2620.8 3489.1 2180.2 2682.6 1785.2 3252.1 1956.0 2044.2 1348.1 2136.9 2634.2 1661.9 2256.2 2213.4 4588.3 2958.1 2321.4 1718.4 1794.6 872.3 2447.5 3515.4 2022.2 1812.5 4303.4 2059.2 1111.1 1662.1 1048.4 2297.9 1736.5 2937.8 3118.9 1368.2 4015.4 1281.7 46.4 455.3 62.2 359.4 370.9 668.1 711.1 698.6 506.5 586.8 644.5 888.5 721.6 26.9 478.1 361.3 372.8 589.8 1758.0 367.7 404.0 377.1 545.7 385.6 388.6 376.4 380.9 386.6 383.2 373.4 406.8 393.9 451.9 1004.9 28.1 1553.4 2423.4 2769.6 2082.8 1295.3 122.6 1594.0 1140.4 403.3 760.7 1165.2 342.1 81.3 2059.9 1055.8 364.9 1651.3 1162.8 672.5 337.9 821.0 840.2 761.1 1195.8 26.2 2141.0 3735.7 879.7 467.9 430.0 945.5 899.2 711.0 715.5 1211.2 40.4 23.9 1089.8 636.8 1281.3 2031.3 1392.4 1334.0 991.6 1088.5 27.2 1920.9 417.7 1196.8 15.1 30.0 1239.9 737.1 996.0 1019.5 2031.3 370.6 1572.3 603.9 169.9 460.2 1196.4 934.7 376.4 454.9 1632.1 2583.2 2398.3 1289.5 1184.6 1371.2 2628.6 RSBN1 "FLJ11220, ROSBIN" ENSG00000081019 "Round spermatid basic protein 1" Q5VWQ0 1 113761832-113812476 "Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042124, HPA049484" Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear bodies, Vesicles" "HPA042124: AB_10794644, HPA049484: AB_2680787" "unprognostic (3.26e-2)" "unprognostic (1.32e-1)" "unprognostic (1.15e-3)" "unprognostic (2.13e-1)" "unprognostic (3.66e-2)" "unprognostic (2.30e-2)" "unprognostic (5.06e-2)" "unprognostic (6.60e-2)" "unprognostic (1.06e-1)" "unprognostic (1.97e-2)" "unprognostic (1.56e-1)" "unprognostic (3.96e-1)" "unprognostic (1.51e-2)" "unprognostic (4.67e-2)" "unprognostic (1.43e-1)" "unprognostic (1.24e-1)" "unprognostic (1.15e-3)" 6.4 6.0 4.6 7.7 4.7 34.4 8.2 12.7 6.1 7.9 2.8 8.4 6.2 10.3 6.5 7.3 7.9 6.4 5.2 4.2 5.3 8.0 6.4 7.5 10.6 3.1 3.7 14.2 11.0 11.0 5.1 6.6 3.2 7.9 8.6 13.7 6.8 6.9 8.0 7.5 7.5 7.0 3.9 9.2 6.8 10.7 4.3 12.3 9.0 7.9 10.5 6.4 5.5 5.2 14.6 4.1 13.7 8.2 8.0 9.2 6.6 5.1 10.9 10.1 10.5 4.9 4.3 12.7 7.9 6.3 4.6 6.2 9.8 6.2 16.4 12.3 7.1 9.6 4.4 5.6 6.0 18.1 9.9 7.0 6.7 8.6 8.2 8.6 8.1 14.0 14.7 7.7 7.5 14.9 14.7 10.8 11.6 4.6 6.9 26.3 13.4 6.6 6.0 6.2 13.8 11.0 9.7 9.4 8.7 6.8 4.5 12.1 9.7 9.0 9.7 13.5 8.3 10.3 8.2 15.9 9.3 10.9 15.4 53.3 14.5 25.6 29.1 11.7 29.3 32.2 31.2 27.2 12.8 33.1 31.9 26.2 29.0 25.4 13.4 27.3 30.6 12.6 4.6 4.7 12.7 6.1 4.2 5.3 3.1 3.7 3.2 3.9 4.3 5.2 37.4 35.3 20.1 16.0 52.7 74.7 39.2 26.9 45.5 90.0 35.0 46.7 21.5 24.3 29.6 25.8 66.7 26.3 68.0 55.5 19.6 22.3 25.6 26.2 39.4 38.9 49.4 37.5 34.3 26.0 24.1 41.5 17.9 28.8 36.1 23.4 32.5 18.7 19.2 97.6 34.2 58.5 28.5 26.3 37.7 9.0 50.4 25.7 40.9 30.9 35.0 56.7 62.8 33.7 34.6 21.2 54.0 49.7 34.7 44.3 40.2 17.2 27.8 106.5 39.5 43.8 54.9 96.8 37.0 34.3 65.1 31.5 84.8 24.2 52.7 37.8 RTEL1 "bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL" ENSG00000258366 "Regulator of telomere elongation helicase 1" Q9NZ71 20 63657810-63696253 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Helicase, Hydrolase" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "B-cells: 1.0;Erythroid cells: 3.8;Gastric mucus-secreting cells: 3.1;Plasma cells: 3.0;Squamous epithelial cells: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020622, HPA067329, HPA078328" Approved "Nuclear speckles,Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 39: CACO-2 - Unknown function" "Cluster 59: Non-specific - Transcription" "Nuclear speckles, Nuclear bodies" "HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380" "unprognostic (3.63e-2)" "unprognostic (8.08e-3)" "unprognostic (4.80e-2)" "unprognostic (1.12e-1)" "unprognostic (4.27e-1)" "unprognostic (9.30e-3)" "unprognostic (2.59e-1)" "unprognostic (3.64e-2)" "unprognostic (3.30e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (9.50e-2)" "unprognostic (8.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.55e-1)" "unprognostic (2.80e-2)" "unprognostic (8.84e-2)" 4.9 7.0 1.3 6.1 1.6 8.2 5.2 5.7 4.7 6.8 0.5 8.5 4.8 10.0 3.0 4.6 6.2 3.0 3.9 1.2 0.9 4.1 4.8 6.0 4.2 2.9 0.6 6.4 8.6 2.8 12.2 4.2 1.8 6.7 2.1 2.5 6.3 4.5 5.4 4.5 5.8 3.1 0.2 6.1 6.6 7.6 1.2 4.8 7.8 2.3 2.4 6.5 6.0 1.5 8.3 11.7 7.9 15.5 1.6 1.7 14.5 16.8 4.5 26.0 6.6 22.2 7.0 11.0 8.6 5.2 9.8 15.3 5.5 11.1 6.1 5.5 11.0 13.8 21.2 21.5 5.7 13.4 24.1 2.2 6.0 6.4 7.9 4.9 9.0 19.6 17.4 10.4 5.8 8.7 21.3 17.5 7.8 7.1 22.3 17.2 7.4 11.6 4.1 9.7 15.7 9.3 9.3 27.5 2.2 3.6 7.2 15.2 12.1 29.4 9.5 10.1 13.2 9.4 4.2 7.1 7.1 9.5 10.4 0.0 1.0 0.0 0.9 1.1 0.5 0.3 0.5 0.6 1.3 0.5 0.9 0.4 0.0 0.1 1.0 1.1 0.5 0.8 1.3 1.6 5.7 4.7 1.2 0.9 2.9 0.6 1.8 0.2 1.2 1.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.6 0.0 3.8 0.0 0.0 0.0 0.4 3.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.2 0.0 1.1 0.1 0.0 0.7 0.0 0.0 0.0 RTN1 NSP ENSG00000139970 "Reticulon 1" Q16799 14 59595976-59870776 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 160.6;pituitary gland: 60.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7" "Cancer enhanced" "Detected in many" "glioma: 19.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4" "Group enriched" "Detected in many" 14 "dendritic cells: 5.4;monocytes: 3.1" "Group enriched" "Detected in some" 4 "HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002745, HPA040945, HPA044249" Enhanced Supported "Nuclear bodies,Endoplasmic reticulum" NA NA 150000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Endoplasmic reticulum" "Nuclear bodies" "CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874" "unprognostic (9.40e-3)" "unprognostic (1.43e-3)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (4.24e-2)" "unprognostic (3.04e-3)" "unprognostic (8.67e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (2.79e-1)" "prognostic favorable (3.69e-4)" "unprognostic (5.79e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.75e-1)" "unprognostic (6.71e-2)" "unprognostic (1.62e-2)" 11.1 12.0 111.1 9.3 127.5 0.4 7.2 57.0 134.7 2.2 0.0 7.6 2.5 1.3 0.4 1.6 12.8 5.5 0.9 133.0 160.6 1.6 1.0 6.4 2.7 37.5 24.9 0.7 4.0 17.4 60.1 2.4 46.7 6.4 2.8 34.1 3.4 1.9 0.8 3.2 4.1 2.4 10.8 18.3 3.9 2.3 68.3 1.0 2.5 0.7 1.8 1.9 3.6 50.2 0.0 0.0 0.7 1.0 2.9 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.9 0.1 0.4 0.0 2.1 61.7 0.0 0.0 3.4 0.1 0.2 0.0 0.1 0.0 2.1 0.0 0.5 0.4 0.0 0.3 0.7 0.3 0.0 0.0 4.9 0.0 0.0 0.0 0.6 0.1 0.0 0.0 71.8 115.1 14.9 0.0 0.0 0.2 0.0 0.0 0.0 9.9 2.8 0.1 5.6 0.0 0.0 0.0 19.4 4.4 0.7 0.0 2.9 0.0 0.0 3.1 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.7 111.1 127.5 57.0 134.7 133.0 160.6 37.5 24.9 46.7 10.8 68.3 50.2 1.0 0.0 1.1 64.3 0.5 4.8 0.4 0.0 0.0 34.1 11.4 4.3 1.0 1.5 0.6 0.0 25.0 1.2 1.4 0.8 0.0 0.0 16.2 23.5 0.3 2.9 54.2 0.8 495.8 0.0 5.0 1.5 5.6 0.4 0.0 0.2 0.0 0.5 17.8 240.6 394.3 3.6 0.0 14.4 59.7 21.4 2.8 23.8 10.6 87.1 22.8 14.3 0.0 188.0 247.7 1.4 0.1 1.2 0.1 5.8 0.8 0.9 0.7 33.3 0.0 10.7 2.5 2.3 3.8 0.2 6.5 2.5 0.7 0.1 0.5 0.3 RXRG NR2B3 ENSG00000143171 "Retinoid X receptor gamma" P48443 1 165400922-165445355 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;pituitary gland: 29.9;retina: 24.3;skeletal muscle: 49.7" "Group enriched" "Detected in some" 4 "Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9" "Group enriched" "Detected in many" 13 "melanoma: 25.7;thyroid cancer: 34.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "SK-MEL-30: 39.4" "Region enriched" "Detected in many" 5 "basal ganglia: 100.2" "Low region specificity" "Detected in many" "CAB002615, HPA012933" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear bodies" "CAB002615: , HPA012933: AB_2732406" "unprognostic (2.29e-1)" "unprognostic (1.08e-2)" "unprognostic (1.51e-1)" "unprognostic (1.66e-1)" "unprognostic (4.29e-2)" "unprognostic (6.19e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-2)" "unprognostic (9.13e-2)" "unprognostic (6.86e-2)" "unprognostic (2.95e-2)" "unprognostic (5.41e-3)" "unprognostic (2.52e-2)" "unprognostic (6.12e-3)" "unprognostic (1.18e-1)" "prognostic favorable (9.40e-5)" "unprognostic (5.03e-2)" 2.4 3.2 14.6 0.4 16.6 0.0 1.0 11.7 17.4 3.0 11.7 4.1 0.7 1.1 0.7 1.0 2.8 0.6 5.3 12.4 21.5 0.2 0.3 2.8 0.3 25.6 14.8 1.0 2.1 0.1 29.9 0.7 22.2 1.1 2.0 24.3 1.2 1.4 49.7 2.3 1.6 1.2 13.6 0.4 1.4 1.0 32.1 0.1 0.7 7.6 0.0 1.6 2.1 15.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 39.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 16.6 11.7 17.4 12.4 21.5 25.6 14.8 22.2 13.6 32.1 15.6 0.9 0.0 0.0 13.4 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 1.8 0.0 0.0 0.0 25.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.3 0.0 0.0 4.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.3 2.8 5.0 0.0 28.4 0.0 0.0 16.8 0.0 1.0 1.3 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.5 13.1 35.9 3.4 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 3719.5;vagina: 1174.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA 260000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 2.2 0.8 1.5 24.9 1.6 0.2 78.3 1.5 2.0 530.8 1.3 241.0 265.4 5.4 14.7 3719.5 20.4 18.5 4.2 1.5 1.5 70.1 16.3 82.7 0.6 1.5 1.5 1.4 17.7 125.2 5.1 1.1 1.5 19.6 240.0 0.0 550.3 39.0 2.2 608.0 209.0 13.1 1.4 1.3 119.2 0.7 1.7 149.0 98.6 0.0 449.7 32.9 1174.2 1.5 798.6 0.2 0.1 0.2 0.2 0.3 7.4 0.2 0.1 0.2 0.1 97.6 140.1 0.6 2.3 0.2 0.5 1072.9 0.0 1527.6 0.1 0.5 0.3 0.1 10.8 7.3 0.0 0.0 0.9 0.6 2232.0 0.5 20.7 0.3 0.3 0.1 0.6 1.1 0.2 140.0 0.7 1.1 0.4 1675.1 1.9 0.6 0.6 2.8 8.1 51.2 0.7 0.7 2.2 1579.1 2.1 36.5 3.9 1.7 0.0 0.7 0.8 1.1 2.0 0.4 0.8 0.9 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.6 1.5 2.0 1.5 1.5 1.5 1.5 1.5 1.4 1.7 1.5 2.7 60.9 162.6 2.3 4.2 2340.8 448.6 770.5 657.9 0.0 256.2 178.3 5.3 270.2 387.7 35.0 0.0 2.7 2.2 1058.2 49.0 197.5 0.0 37.3 6.4 21.5 153.4 0.0 0.0 65.8 1.5 22.8 85.6 80.3 28.0 0.2 1.1 9.5 0.3 0.0 0.0 660.1 126.1 0.3 213.7 0.0 0.0 3.0 241.9 0.0 2.0 0.0 0.0 0.0 0.1 343.0 1098.9 0.0 7.5 619.3 1549.1 4.9 56.2 0.0 0.0 1.3 27.1 0.0 0.0 3205.8 3612.0 0.3 8.7 13.6 580.9 824.9 SAFB2 KIAA0138 ENSG00000130254 "Scaffold attachment factor B2" Q14151 19 5586999-5624046 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050894 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" NA NA 48000 "Cluster 38: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Vesicles" "HPA050894: AB_2681266" "unprognostic (7.46e-2)" "unprognostic (3.09e-1)" "unprognostic (7.69e-3)" "prognostic favorable (7.10e-4)" "unprognostic (7.95e-2)" "unprognostic (6.76e-3)" "unprognostic (4.19e-3)" "unprognostic (5.93e-2)" "unprognostic (2.11e-1)" "unprognostic (5.14e-2)" "prognostic favorable (2.53e-4)" "unprognostic (2.23e-2)" "unprognostic (2.82e-3)" "unprognostic (1.17e-2)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "prognostic favorable (2.12e-4)" 26.8 35.8 23.3 22.4 23.8 35.2 25.8 28.0 30.3 48.4 21.0 35.3 22.2 38.2 21.0 23.1 44.0 15.6 30.8 21.7 29.6 40.6 30.7 27.8 24.4 24.2 23.9 56.2 30.5 18.0 48.6 14.2 23.1 43.0 16.1 34.7 27.6 18.6 41.5 25.8 34.3 19.3 17.5 39.9 27.8 32.5 23.9 22.3 38.9 20.4 21.2 31.5 35.0 27.5 44.9 54.8 38.8 30.4 36.7 23.7 47.6 40.9 21.3 24.4 23.3 69.9 31.4 84.9 36.9 19.9 19.6 39.9 47.2 24.9 39.2 59.8 53.5 64.4 59.5 54.6 21.2 53.0 58.2 23.5 25.4 35.2 26.9 23.9 24.6 29.3 63.6 40.6 28.7 48.9 65.7 53.1 69.9 33.1 59.9 82.2 34.2 47.6 27.7 70.5 37.6 35.3 54.7 25.3 35.3 24.4 36.5 33.0 40.5 30.7 32.7 39.3 57.6 55.2 52.2 58.6 31.2 47.1 52.2 42.8 12.6 22.0 14.6 10.8 16.8 13.9 13.2 11.7 11.3 14.9 14.5 11.7 23.4 9.4 12.3 12.5 13.4 7.9 23.3 23.8 28.0 30.3 21.7 29.6 24.2 23.9 23.1 17.5 23.9 27.5 40.6 41.7 45.1 79.7 69.7 46.7 58.1 41.4 47.3 70.2 39.1 30.6 28.7 20.0 39.3 33.1 75.0 46.8 63.0 46.4 23.5 49.7 7.6 44.5 92.6 49.0 43.0 45.8 36.2 44.4 44.7 47.3 44.4 58.3 42.3 45.4 26.7 23.3 30.6 43.7 42.7 46.5 57.0 27.6 49.5 13.3 72.4 46.6 26.6 32.8 52.2 77.5 52.5 29.7 34.6 42.2 48.6 65.8 70.0 50.3 54.1 61.5 55.3 78.4 46.0 75.4 47.9 68.3 78.8 37.3 41.9 32.3 79.1 59.7 44.8 54.2 SAGE1 "CT14, SAGE" ENSG00000181433 "Sarcoma antigen 1" Q9NXZ1 X 135889205-135913061 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 4.8" "Cell type enriched" "Detected in some" 9 "Spermatogonia: 9.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 20.5;K-562: 15.6;Karpas-707: 25.5;U-2 OS: 7.0;U-266/70: 8.9;U-266/84: 23.8" "HPA003033, HPA003208" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA003033: AB_1079865, HPA003208: AB_1079863" "unprognostic (1.11e-1)" "unprognostic (5.26e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (2.37e-1)" "unprognostic (7.12e-4)" "unprognostic (1.45e-2)" "unprognostic (1.10e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 25.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 8.9 23.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.3 0.4 0.5 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SAP18 "2HOR0202, MGC27131, SAP18p" ENSG00000150459 "Sin3A associated protein 18" O00422 13 21140514-21149084 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011352, CAB012273" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" Cytosol "CAB012273: , HPA011352: AB_1856563" "unprognostic (5.08e-2)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-3)" "unprognostic (2.84e-1)" "unprognostic (5.21e-2)" "unprognostic (3.02e-1)" "unprognostic (3.18e-1)" "unprognostic (8.15e-2)" "unprognostic (3.48e-1)" "unprognostic (1.01e-1)" "unprognostic (4.14e-2)" "unprognostic (2.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.70e-2)" "unprognostic (3.70e-3)" "unprognostic (2.78e-2)" 125.7 164.3 140.9 122.9 152.2 242.3 121.6 149.6 198.9 120.4 137.8 141.8 137.4 123.8 97.5 159.2 112.9 82.4 195.8 147.4 160.7 190.4 171.1 106.5 118.0 154.7 153.8 109.5 134.6 114.2 129.6 111.7 157.7 109.7 58.5 89.5 126.3 73.0 297.9 119.5 127.5 51.7 164.1 107.6 119.5 194.3 155.7 115.5 110.7 156.3 64.8 131.7 118.5 170.7 182.1 99.3 159.5 173.1 169.0 140.5 246.9 227.1 167.2 205.5 151.3 181.1 342.4 187.3 272.0 189.1 223.4 186.5 198.1 142.4 231.5 288.0 100.4 267.6 121.2 305.9 191.8 367.1 207.5 143.0 159.7 157.5 187.1 158.4 157.3 223.1 128.8 103.6 188.2 231.0 417.0 599.0 200.7 501.5 109.7 261.1 251.4 187.1 295.7 160.7 185.0 161.1 145.7 213.8 296.5 176.5 206.8 528.0 192.6 126.0 141.9 230.1 268.9 159.6 243.6 536.7 122.5 214.9 236.4 433.0 431.5 540.0 344.1 485.0 349.3 493.7 418.2 410.9 427.8 443.6 405.9 402.9 430.5 395.3 547.4 568.8 517.5 909.3 140.9 152.2 149.6 198.9 147.4 160.7 154.7 153.8 157.7 164.1 155.7 170.7 638.0 134.6 143.5 15.0 291.7 458.6 336.3 640.9 310.7 101.5 298.9 594.9 592.9 194.5 383.8 233.6 41.7 566.2 397.4 353.6 759.2 396.5 1259.5 334.1 231.1 273.1 234.5 214.4 20.8 365.6 528.0 374.0 170.2 256.2 258.6 176.6 180.2 242.0 396.0 119.5 23.4 364.5 468.0 189.5 440.9 206.0 342.3 260.4 407.4 17.8 385.0 370.8 233.8 19.6 26.2 401.9 417.6 303.6 182.3 325.9 475.0 1100.6 446.8 132.3 203.8 362.5 438.3 547.7 319.9 271.7 422.2 908.3 338.8 254.2 344.7 419.9 SAP25 FLJ00248 ENSG00000205307 "Sin3A associated protein 25" Q8TEE9 7 100572228-100573900 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.4" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 57.8;Spermatogonia: 86.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HMC-1: 30.4;NB-4: 69.1;OE19: 117.4;U-937: 27.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA062610 Approved "Nuclear bodies" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nuclear bodies" "HPA062610: AB_2684806" "unprognostic (1.70e-1)" "unprognostic (7.87e-2)" "unprognostic (1.09e-5)" "unprognostic (6.89e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-3)" "unprognostic (9.96e-2)" "unprognostic (4.26e-2)" "unprognostic (2.83e-1)" "unprognostic (5.04e-2)" "unprognostic (6.57e-3)" "unprognostic (1.71e-2)" "unprognostic (7.52e-6)" "unprognostic (7.36e-2)" "unprognostic (1.78e-1)" "unprognostic (1.39e-1)" "unprognostic (4.18e-3)" 8.8 4.5 18.7 17.9 21.0 28.9 4.7 19.9 26.2 11.1 18.0 5.8 6.5 4.8 0.3 4.4 9.3 5.0 6.6 18.6 20.5 15.8 7.0 14.7 28.6 22.1 19.3 23.2 6.5 1.0 12.9 5.3 20.9 11.0 1.7 13.5 8.3 2.4 3.9 6.1 20.0 2.0 18.5 47.4 5.6 25.4 21.6 17.6 15.8 1.1 8.2 5.0 7.4 24.9 4.0 1.4 2.8 1.6 0.2 0.4 6.4 3.0 0.6 1.9 0.9 3.1 4.1 2.0 1.8 0.0 0.2 4.2 0.5 0.9 0.2 3.9 2.3 3.7 3.6 1.0 0.6 4.2 30.4 0.8 1.9 1.1 0.4 1.5 0.6 8.0 4.7 7.7 0.4 9.2 7.8 69.1 4.3 117.4 1.5 16.7 0.9 3.1 0.3 1.2 1.6 5.0 0.4 3.7 4.5 3.1 5.6 15.8 3.2 2.9 6.1 2.7 2.9 13.1 3.4 1.6 0.9 27.4 3.0 0.9 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.2 0.3 0.0 0.0 18.7 21.0 19.9 26.2 18.6 20.5 22.1 19.3 20.9 18.5 21.6 24.9 2.2 0.0 4.1 11.1 6.7 0.0 1.3 0.0 1.2 23.7 4.6 5.3 0.0 7.2 1.3 0.0 70.9 2.6 8.7 3.1 0.0 1.9 1.4 2.1 2.0 1.7 0.0 3.4 0.9 0.7 0.7 1.3 4.1 3.2 1.3 6.0 2.5 1.1 3.1 21.9 0.9 2.3 0.0 8.5 0.0 4.6 3.4 10.7 0.0 9.4 6.5 8.0 5.2 2.5 8.2 2.0 1.9 1.2 4.1 2.8 4.9 0.3 0.0 57.8 6.6 1.5 1.8 17.2 86.6 1.5 0.0 3.6 8.2 0.9 1.5 1.8 SASH3 "753P9, CXorf9, HACS2, SH3D6C, SLY" ENSG00000122122 "SAM and SH3 domain containing 3" O75995 X 129779949-129795201 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 108.1;intestine: 36.5;lymphoid tissue: 120.7" "Cell type enhanced" "Detected in some" "B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001085 Enhanced Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA 14000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "Nucleoplasm, Nuclear bodies" "HPA001085: AB_2184289" "unprognostic (1.88e-2)" "unprognostic (5.82e-3)" "unprognostic (1.49e-3)" "prognostic favorable (3.15e-4)" "unprognostic (1.12e-1)" "unprognostic (1.19e-3)" "unprognostic (1.67e-1)" "unprognostic (3.23e-3)" "unprognostic (7.92e-3)" "unprognostic (3.45e-1)" "unprognostic (8.75e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (3.30e-1)" "unprognostic (3.56e-2)" "unprognostic (3.17e-2)" "unprognostic (1.53e-1)" 8.6 5.6 5.2 61.8 5.6 108.1 4.3 5.4 7.4 3.2 5.1 9.4 11.6 3.1 1.8 3.6 4.9 10.2 2.7 4.8 6.4 3.7 5.9 21.3 120.6 9.6 7.0 1.8 2.5 1.5 2.2 7.5 8.4 4.2 9.9 0.2 7.9 2.2 1.3 2.1 36.5 7.5 7.5 100.3 13.6 1.3 8.4 120.7 3.9 1.7 108.2 15.4 3.0 10.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 164.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 41.7 0.0 0.0 0.0 58.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 119.4 0.2 13.6 0.0 0.0 120.6 89.1 0.0 0.0 0.0 88.5 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 24.0 0.3 0.0 0.3 0.1 0.1 0.1 35.0 150.2 0.0 117.2 0.0 41.6 135.4 245.5 192.2 195.3 159.1 79.1 108.2 178.9 121.5 90.8 76.9 120.9 128.0 153.3 209.9 55.1 145.6 343.7 5.2 5.6 5.4 7.4 4.8 6.4 9.6 7.0 8.4 7.5 8.4 10.2 0.8 0.0 3.6 0.0 69.5 0.5 0.1 0.0 0.0 0.0 0.5 1.1 1.0 1.5 0.0 0.0 0.0 0.5 66.3 0.1 0.0 0.1 0.1 0.2 0.2 1.2 0.0 13.5 0.2 0.0 0.6 0.9 2.6 0.3 22.2 0.0 3.3 0.9 51.3 0.0 0.2 0.1 0.0 58.9 19.1 0.0 0.3 40.0 0.0 7.5 45.3 0.0 101.0 0.0 0.1 0.0 0.0 0.0 39.8 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.1 1.3 0.5 60.6 0.0 0.1 0.0 SATB1 ENSG00000182568 "SATB homeobox 1" Q01826 3 18345377-18445588 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 374.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "naive CD4 T-cell: 113.7" "Group enriched" "Detected in all" 4 "NK-cells: 63.4;T-cells: 113.7" "Cell line enhanced" "Detected in many" "HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051769, CAB056144, HPA070534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies" "CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: " "unprognostic (2.16e-1)" "unprognostic (3.99e-1)" "unprognostic (7.13e-2)" "unprognostic (3.58e-1)" "unprognostic (9.15e-2)" "unprognostic (4.22e-3)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (2.90e-2)" "unprognostic (6.14e-2)" "prognostic favorable (8.97e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.96e-7)" "unprognostic (1.92e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-3)" 16.1 10.3 13.4 28.8 19.1 42.8 13.2 0.8 32.2 11.4 2.6 29.9 16.0 13.6 24.0 12.2 17.9 17.6 26.0 23.4 0.4 10.8 15.4 15.7 38.1 0.3 6.1 13.8 28.8 32.4 22.5 4.9 0.0 22.5 18.5 29.8 44.0 25.9 89.5 21.4 21.0 11.8 1.4 27.4 18.5 6.7 0.9 374.2 24.5 49.0 27.8 24.6 12.3 11.0 2.1 0.0 12.7 0.0 17.2 16.6 1.4 3.4 12.3 2.9 9.8 0.5 22.9 4.7 0.4 4.1 1.0 0.2 46.4 5.4 5.9 455.3 28.0 0.1 1.1 0.0 2.5 26.7 3.8 7.4 4.0 0.1 0.6 35.1 3.3 213.3 0.6 24.3 2.2 0.4 107.7 33.9 18.5 1.5 1.5 126.5 6.2 4.9 4.8 15.7 5.9 34.5 0.0 3.9 0.3 10.0 98.5 192.7 1.7 12.6 7.9 5.9 3.7 1.3 0.4 10.0 10.3 101.3 5.7 21.1 1.9 4.6 44.2 2.0 78.6 1.6 29.9 23.0 3.5 13.0 113.7 69.5 4.1 63.4 1.1 4.0 6.0 26.6 13.4 19.1 0.8 32.2 23.4 0.4 0.3 6.1 0.0 1.4 0.9 11.0 19.3 25.6 29.6 48.3 44.6 14.3 12.3 10.9 12.0 12.1 33.2 18.0 70.0 22.8 15.0 31.3 87.6 0.5 71.1 11.0 1.9 16.9 8.2 31.6 15.3 17.0 32.4 22.5 180.2 12.5 0.2 16.4 8.6 11.6 23.4 20.6 35.0 20.9 9.3 0.0 283.4 30.8 4.1 41.5 36.4 4.3 8.4 45.5 10.6 41.2 23.0 15.5 56.7 168.9 28.8 10.5 23.6 8.2 20.6 21.7 24.6 9.1 50.9 63.1 6.6 8.3 10.2 3.2 9.3 20.5 22.0 0.3 84.0 16.8 25.7 19.7 SBF1 "DENND7A, MTMR5" ENSG00000100241 "SET binding factor 1" O95248 22 50445000-50475035 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074004 Supported "Nuclear bodies" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Nuclear bodies" "HPA074004: AB_2732249" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (7.39e-2)" "unprognostic (4.87e-2)" "unprognostic (6.11e-2)" "prognostic favorable (3.46e-5)" "unprognostic (2.21e-3)" "unprognostic (1.14e-1)" "unprognostic (2.32e-2)" "unprognostic (3.60e-3)" "unprognostic (1.78e-1)" "unprognostic (1.75e-2)" "unprognostic (2.42e-2)" "unprognostic (3.29e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-2)" "unprognostic (2.05e-1)" 26.8 32.3 50.8 22.3 57.3 20.6 24.2 31.8 72.4 25.9 9.2 32.9 14.8 29.5 3.2 43.9 27.2 10.6 38.7 70.1 28.5 30.5 23.4 26.8 28.8 52.0 39.2 30.4 48.0 7.1 28.6 8.8 46.5 28.5 4.9 6.5 26.9 11.6 75.7 42.2 38.6 8.8 32.8 35.4 30.1 111.2 44.1 32.7 62.3 14.4 14.7 28.3 27.3 63.5 34.3 28.2 24.0 32.9 24.3 18.6 65.9 23.5 20.1 21.6 17.7 39.0 23.7 78.1 16.7 27.9 23.9 31.4 19.9 28.7 5.3 28.6 76.0 17.6 59.6 50.7 41.7 54.7 26.1 25.0 44.6 28.1 21.0 17.0 14.8 41.6 28.8 20.8 15.0 42.6 54.8 52.4 10.1 26.1 31.7 71.0 45.6 48.3 12.8 27.3 19.1 46.0 36.5 35.5 47.7 10.5 20.7 25.2 25.1 33.9 49.6 24.3 29.7 38.1 13.4 37.6 38.8 22.1 32.7 0.5 1.3 2.1 4.4 1.3 2.4 2.6 3.0 3.5 1.6 1.6 2.2 3.6 1.9 1.9 2.6 5.6 2.6 2.3 50.8 57.3 31.8 72.4 70.1 28.5 52.0 39.2 46.5 32.8 44.1 63.5 5.7 6.4 11.8 10.7 13.7 13.4 4.6 9.3 6.8 15.5 11.3 9.1 7.6 4.3 9.4 3.7 10.4 4.9 21.4 19.9 1.9 7.2 32.8 10.3 8.9 5.6 3.6 8.6 11.3 12.5 7.9 10.6 24.5 11.4 1.3 20.4 5.7 9.1 6.9 11.8 10.9 13.2 10.2 6.9 10.7 21.4 6.5 9.5 5.4 5.6 10.8 6.9 21.6 11.1 31.7 19.9 8.1 6.0 15.6 11.6 16.0 7.7 11.1 10.0 6.6 12.3 11.6 25.5 23.5 21.3 14.6 11.5 19.8 12.2 12.3 10.1 SCAF11 "CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP" ENSG00000139218 "SR-related CTD associated factor 11" Q99590 12 45919131-45992120 "Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038862, HPA045456, HPA046345" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630" "unprognostic (2.83e-2)" "unprognostic (4.10e-2)" "unprognostic (2.01e-1)" "unprognostic (5.88e-2)" "unprognostic (1.19e-1)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (9.00e-2)" "unprognostic (1.37e-2)" "unprognostic (1.30e-2)" "unprognostic (4.10e-2)" "unprognostic (2.15e-2)" "unprognostic (6.30e-3)" "unprognostic (1.68e-1)" "unprognostic (2.76e-1)" "unprognostic (4.30e-2)" "unprognostic (4.13e-2)" 31.1 21.2 22.3 41.7 29.6 89.6 40.1 38.7 23.7 28.0 36.5 31.6 29.4 34.5 41.2 26.7 26.6 30.9 30.0 19.7 25.2 29.9 42.4 31.0 54.7 30.2 26.5 37.7 23.5 39.8 17.2 31.5 32.5 29.4 34.9 60.8 27.0 24.9 35.2 40.3 31.7 29.2 25.9 43.0 29.6 29.0 26.3 44.4 34.7 38.6 49.8 31.8 23.6 38.3 56.4 49.4 60.6 50.7 41.0 55.7 56.0 64.7 52.6 54.8 39.3 180.3 60.1 116.7 71.0 69.3 32.3 54.0 62.4 52.2 61.9 62.1 42.1 108.8 64.5 47.0 32.3 115.6 70.4 46.4 54.7 47.2 71.1 62.9 57.1 50.0 85.1 62.3 70.3 51.9 87.2 63.4 47.0 0.6 67.4 70.2 81.7 57.9 52.4 70.5 34.2 35.0 71.9 60.8 35.0 47.6 56.4 123.4 71.6 55.9 46.3 42.5 34.9 44.4 36.0 187.9 47.0 245.0 21.8 39.4 19.6 29.5 21.7 19.9 19.9 28.6 20.6 21.3 16.0 28.2 22.2 20.0 51.5 21.3 23.5 30.2 20.8 12.9 22.3 29.6 38.7 23.7 19.7 25.2 30.2 26.5 32.5 25.9 26.3 38.3 180.2 176.3 164.0 91.4 200.4 128.5 127.6 87.4 132.1 134.9 101.8 96.8 187.4 88.6 131.7 79.1 127.2 86.3 229.6 96.1 54.8 117.8 57.7 133.3 148.7 146.2 103.3 118.4 75.3 107.9 72.5 135.3 69.3 152.4 222.7 224.7 114.5 138.9 109.8 107.7 81.7 123.3 67.1 158.0 160.9 39.2 121.8 157.3 67.6 141.5 211.7 105.2 185.3 119.6 122.4 103.4 103.4 103.8 126.4 121.6 97.2 83.5 149.6 198.4 124.9 176.3 129.7 157.6 82.5 116.4 120.5 61.0 170.6 114.2 107.5 145.0 SCARF2 "HUMZD58C02, SREC-II, SREC2" ENSG00000244486 "Scavenger receptor class F member 2" Q96GP6 22 20424584-20437826 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 44.8;Fibroblasts: 21.2;Leydig cells: 13.4;Peritubular cells: 17.7;Sertoli cells: 13.1;Smooth muscle cells: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 25.5;SH-SY5Y: 28.5;SK-MEL-30: 31.7;U-138 MG: 38.7;U-2 OS: 40.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035079 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 580000 "Cluster 35: T-regs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 9: U-2 OS - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035079: AB_10670287" "unprognostic (2.12e-1)" "unprognostic (2.16e-2)" "unprognostic (2.06e-2)" "unprognostic (1.06e-3)" "unprognostic (2.29e-1)" "unprognostic (2.92e-1)" "unprognostic (7.68e-2)" "unprognostic (7.87e-2)" "unprognostic (8.27e-2)" "unprognostic (2.18e-2)" "unprognostic (1.68e-1)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.38e-3)" "unprognostic (3.18e-2)" "unprognostic (3.00e-3)" "prognostic unfavorable (4.28e-4)" 15.1 5.4 2.4 1.9 2.6 0.4 10.7 0.5 3.3 19.1 4.1 10.0 1.3 22.4 0.5 3.6 15.5 3.6 10.3 2.1 3.9 10.6 3.6 23.2 1.3 5.1 3.2 20.2 4.0 0.4 5.4 3.7 2.2 15.5 0.3 0.1 4.6 4.5 3.1 10.1 6.0 2.2 2.0 9.4 7.8 2.7 4.7 0.2 11.8 0.4 0.2 13.3 13.2 1.3 0.7 0.4 5.8 10.1 3.4 4.8 2.3 25.5 10.8 6.2 3.3 0.1 0.1 0.4 14.6 12.7 0.4 0.2 3.4 0.1 0.7 0.9 21.6 2.1 0.5 4.9 21.3 0.0 1.1 8.2 0.1 3.0 1.5 3.0 3.0 0.1 0.2 0.2 2.2 1.1 0.0 0.5 7.8 0.0 3.3 0.6 16.1 0.0 0.1 0.1 2.5 28.5 0.1 0.0 31.7 1.1 0.9 0.1 3.7 38.7 40.7 1.0 5.9 1.2 0.5 0.4 0.1 0.5 19.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 2.6 0.5 3.3 2.1 3.9 5.1 3.2 2.2 2.0 4.7 1.3 3.6 0.0 0.0 1.6 0.1 2.8 1.6 0.7 0.0 2.9 0.3 0.9 44.8 0.0 0.3 0.0 2.1 0.4 0.3 0.1 0.0 0.0 0.3 2.6 8.9 10.5 0.0 0.0 1.9 0.0 1.6 21.2 1.5 1.0 0.0 0.6 3.9 0.7 0.7 0.0 5.2 0.2 0.0 0.8 2.4 0.5 13.4 0.4 3.6 6.5 0.0 0.3 1.0 3.0 1.1 0.0 0.1 17.7 0.2 7.1 0.0 0.2 4.2 0.8 13.1 1.4 19.5 1.1 0.7 0.3 2.7 0.4 1.2 2.1 0.2 0.6 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 46 "dendritic cells: 6.9;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 2.9 46.5 0.2 56.3 0.8 1.2 52.6 55.0 2.5 28.9 11.1 1.0 3.9 0.7 3.4 2.3 1.9 80.4 50.0 48.7 2.5 0.7 2.9 0.5 51.0 48.2 0.5 0.4 0.2 11.8 10.9 52.6 5.6 1.1 3.6 1.9 1.4 101.3 0.4 3.6 5.4 55.6 4.8 4.6 1.9 46.9 0.8 0.8 92.8 0.2 0.7 1.2 81.0 0.1 0.0 27.0 49.2 0.0 0.2 0.0 0.2 0.1 0.1 1.1 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 2.4 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.7 1.1 0.3 11.2 0.4 58.3 0.0 0.0 0.1 3.5 0.0 0.0 0.0 29.8 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 167.0 0.0 0.0 0.2 7.0 0.0 3.1 10.9 0.6 1.5 0.4 2.5 2.1 0.0 0.0 0.7 2.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 46.5 56.3 52.6 55.0 50.0 48.7 51.0 48.2 52.6 55.6 46.9 81.0 4.5 6.4 1.7 0.0 0.1 0.4 4.8 2.5 1.2 5.4 0.6 0.8 14.2 0.0 2.2 3.7 2.1 1.5 2.7 0.1 0.0 0.3 0.0 4.4 0.4 6.0 0.0 2.1 0.0 0.2 0.5 1.6 0.0 3.1 0.0 0.1 2.2 0.5 0.2 15.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 3.6 0.0 0.0 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.6 0.0 1.4 3.7 0.6 0.0 7.0 2.9 0.0 0.4 0.4 0.6 0.8 0.2 0.2 0.0 1.4 SCMH1 Scml3 ENSG00000010803 "Scm polycomb group protein homolog 1" Q96GD3 1 41027200-41242154 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 125.4;Excitatory neurons: 161.3;Inhibitory neurons: 213.0;Microglial cells: 102.1;Oligodendrocyte precursor cells: 154.3;Oligodendrocytes: 77.9;Spermatocytes: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048898, HPA053292" Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 43: THP-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA048898: , HPA053292: AB_2797246" "unprognostic (6.02e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (1.98e-2)" "unprognostic (8.77e-2)" "unprognostic (8.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.40e-1)" "unprognostic (7.38e-2)" "unprognostic (9.47e-2)" "unprognostic (1.63e-1)" "unprognostic (8.08e-2)" "prognostic favorable (5.80e-4)" 22.0 24.0 15.2 11.3 15.9 17.8 23.2 16.5 18.1 32.0 18.6 54.6 12.7 35.4 20.5 14.0 33.1 15.8 39.3 16.1 16.9 29.8 19.7 20.6 10.4 13.6 14.7 36.3 40.1 34.7 27.6 11.0 13.1 40.4 17.0 21.0 27.5 30.7 44.9 13.3 23.4 24.6 12.2 15.5 32.5 32.8 16.7 16.6 24.1 34.2 10.5 38.9 21.3 14.1 19.5 12.8 29.9 27.5 13.4 25.4 0.1 15.4 26.7 25.2 26.0 12.3 24.6 35.4 11.4 28.1 21.1 4.8 23.3 20.6 21.6 24.7 17.8 16.6 17.7 31.2 58.2 35.7 26.2 27.7 20.5 16.7 40.2 30.5 25.7 43.3 15.7 26.8 25.0 10.6 36.0 30.8 27.7 16.4 13.5 39.3 31.3 21.0 20.4 24.1 21.0 22.5 26.7 21.1 22.1 20.2 18.8 90.7 19.0 26.3 20.4 16.4 28.5 27.1 16.2 38.6 16.5 31.5 24.4 0.6 0.6 1.2 1.6 1.1 2.0 2.4 1.9 1.5 1.9 1.1 1.3 1.1 0.0 1.6 0.2 3.9 1.4 0.9 15.2 15.9 16.5 18.1 16.1 16.9 13.6 14.7 13.1 12.2 16.7 14.1 7.1 9.6 10.8 125.4 9.4 6.6 25.8 11.5 26.7 17.0 16.4 17.0 14.9 18.6 7.4 12.9 16.7 7.3 10.8 7.2 1.9 11.4 9.4 7.2 13.8 9.6 8.4 16.0 161.3 21.3 3.3 11.4 15.3 13.1 5.1 11.9 8.9 7.3 6.2 8.4 213.0 7.4 8.2 3.3 6.5 12.4 16.4 3.2 8.8 102.1 2.7 6.9 2.1 154.3 77.9 12.4 6.2 18.0 20.2 23.3 10.4 18.1 5.8 14.2 19.7 11.9 10.3 54.3 26.1 6.1 3.7 4.8 7.4 3.5 12.4 14.5 SCN1A "FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI" ENSG00000144285 "Sodium voltage-gated channel alpha subunit 1" P35498 2 165984641-166149214 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 24.7" "Group enriched" "Detected in some" 11 "Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC TERT1: 6.1;Hep G2: 3.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078664 Supported "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 65: Brain - Ion transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Plasma membrane" "Nuclear bodies" "HPA078664: AB_2686888" "unprognostic (9.25e-2)" "unprognostic (3.97e-2)" "unprognostic (6.88e-2)" "unprognostic (7.44e-2)" "unprognostic (1.50e-1)" "unprognostic (2.74e-1)" "unprognostic (4.70e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-1)" "unprognostic (9.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.03e-9)" "unprognostic (6.92e-2)" "unprognostic (3.69e-2)" "unprognostic (5.06e-3)" "unprognostic (6.93e-1)" 0.0 0.0 4.2 0.0 4.2 0.0 0.0 2.1 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 2.1 6.9 0.0 0.0 1.4 0.0 14.2 6.2 0.0 0.0 0.0 2.0 0.0 18.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 10.9 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.9 0.0 0.0 6.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.2 2.1 24.7 2.1 6.9 14.2 6.2 18.5 2.2 10.9 10.9 0.0 6.4 33.9 27.4 0.0 0.0 0.0 0.0 0.0 47.4 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 0.0 0.3 1.8 0.0 409.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 494.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 18.7 0.0 2.8 0.0 692.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SCRT1 "DKFZp547F072, ZNF898" ENSG00000261678 "Scratch family transcriptional repressor 1" Q9BWW7 8 144330565-144336482 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "brain: 64.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 41.2;Early spermatids: 55.6;Excitatory neurons: 10.6;Horizontal cells: 35.3;Inhibitory neurons: 14.2;Late spermatids: 11.2" "Cancer enriched" "Detected in single" 5 "glioma: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045265 Uncertain Supported "Nuclear bodies" NA NA "Cluster 65: Brain - Ion transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" "HPA045265: AB_10959521" "unprognostic (7.70e-2)" "unprognostic (7.97e-2)" "unprognostic (6.96e-3)" "unprognostic (6.88e-4)" "unprognostic (2.43e-2)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (1.97e-1)" "unprognostic (8.02e-3)" "unprognostic (1.30e-1)" "unprognostic (1.83e-4)" "unprognostic (5.02e-2)" "unprognostic (7.05e-2)" "unprognostic (2.78e-1)" "unprognostic (2.35e-1)" "unprognostic (2.66e-3)" "unprognostic (1.04e-1)" 0.0 0.5 3.4 0.0 4.8 0.0 0.0 12.5 64.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 19.4 0.0 0.0 0.0 0.0 22.9 8.5 0.0 0.3 0.0 3.4 0.0 18.1 0.0 0.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 4.8 12.5 64.2 1.6 19.4 22.9 8.5 18.1 0.1 26.2 23.6 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 41.2 0.0 0.1 1.6 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 55.6 0.0 0.0 0.3 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.3 14.2 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.1 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 SCYL3 "PACE-1, PACE1" ENSG00000000457 "SCY1 like pseudokinase 3" Q8IZE3 1 169849631-169894267 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005624 Approved Uncertain "Nuclear bodies,Microtubules" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" Microtubules "Nuclear bodies" "HPA005624: AB_1854916" "unprognostic (2.35e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (8.36e-2)" "unprognostic (7.13e-2)" "unprognostic (2.72e-3)" "unprognostic (1.31e-1)" "unprognostic (2.12e-2)" "unprognostic (2.85e-2)" "unprognostic (7.17e-2)" "unprognostic (8.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.20e-3)" "unprognostic (3.54e-1)" "unprognostic (1.75e-1)" "unprognostic (4.60e-2)" "prognostic favorable (8.85e-4)" 5.6 5.8 2.7 7.4 3.0 4.0 10.9 4.0 3.5 6.7 5.0 7.8 7.7 7.0 8.3 7.3 6.3 7.6 5.2 3.0 3.0 7.5 11.3 6.2 10.5 2.9 2.8 7.6 6.1 12.0 4.1 8.1 3.1 7.6 9.6 11.4 8.2 6.7 7.9 7.7 6.8 6.2 2.9 7.5 7.7 6.6 3.0 9.7 7.6 9.1 9.8 7.3 6.5 3.9 4.1 5.2 7.9 5.5 9.9 7.2 9.1 6.3 8.1 7.2 6.7 4.8 7.7 8.4 4.5 6.5 4.0 9.4 4.7 5.5 6.4 15.5 4.4 5.8 6.1 3.1 7.0 8.5 7.3 7.0 5.4 5.0 6.8 6.7 6.9 9.2 9.4 10.8 6.9 3.2 6.9 6.5 6.4 27.5 2.5 6.3 4.3 10.1 7.6 7.3 5.9 8.6 5.0 16.3 10.1 11.2 9.1 7.8 5.2 5.1 3.4 6.2 5.1 14.4 13.7 9.9 3.9 6.3 5.7 13.5 3.2 8.6 6.3 3.4 8.5 6.7 8.3 7.0 5.1 6.2 7.0 5.8 6.7 10.7 3.8 11.5 8.1 4.8 2.7 3.0 4.0 3.5 3.0 3.0 2.9 2.8 3.1 2.9 3.0 3.9 5.9 6.4 14.4 11.8 9.6 2.4 2.5 3.6 6.2 10.2 9.6 8.3 4.2 22.8 7.8 1.8 10.4 17.6 19.0 14.0 9.8 7.4 5.1 11.1 8.2 6.6 9.1 4.2 15.8 9.1 5.1 5.1 7.1 5.8 5.7 7.2 11.0 13.2 6.5 10.1 12.5 10.4 8.2 11.4 3.5 2.6 4.4 5.3 1.8 9.4 8.4 10.0 16.5 17.6 14.1 6.2 10.2 5.7 10.5 4.7 13.3 6.4 9.0 19.9 6.6 5.5 5.4 10.9 6.8 8.3 1.8 11.6 11.0 6.3 10.3 3.3 SEMA6A "HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ" ENSG00000092421 "Semaphorin 6A" Q9H2E6 5 116443555-116574823 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 60.1;brain: 75.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 128.9;Hepatic stellate cells: 145.6;Horizontal cells: 138.0;Oligodendrocyte precursor cells: 138.7;Oligodendrocytes: 311.3;Syncytiotrophoblasts: 348.1" "Cancer enhanced" "Detected in all" "testis cancer: 20.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 44.3;HAP1: 52.0;NTERA-2: 115.2;SuSa: 221.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031264, HPA031265, HPA031267" Approved Approved "Nucleoplasm,Nuclear bodies,Intermediate filaments" NA NA 620000 "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "Nuclear bodies, Intermediate filaments" "HPA031264: , HPA031265: AB_10610423, HPA031267: " "unprognostic (3.79e-2)" "unprognostic (3.91e-1)" "unprognostic (1.82e-2)" "unprognostic (6.81e-2)" "unprognostic (2.69e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.64e-1)" "unprognostic (4.71e-2)" "unprognostic (5.82e-2)" "unprognostic (1.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.62e-3)" "unprognostic (1.92e-1)" "unprognostic (6.21e-3)" "unprognostic (7.32e-3)" 13.4 60.1 24.1 4.9 48.6 3.5 13.1 39.9 31.9 10.0 0.3 20.6 19.9 6.0 2.8 4.4 8.2 12.9 7.1 24.5 40.3 8.6 5.6 17.9 4.5 51.9 41.0 18.1 11.2 2.0 5.8 31.9 50.0 6.0 17.5 10.4 16.6 2.5 8.2 6.9 25.5 5.8 32.9 11.2 7.0 7.5 44.1 3.6 9.1 6.5 2.2 5.6 8.1 75.2 0.3 0.1 36.9 44.3 0.2 0.0 38.2 0.7 0.4 0.2 0.2 2.2 1.5 1.6 1.7 0.6 0.7 0.4 52.0 0.0 0.1 1.6 7.7 0.7 0.7 13.1 0.5 0.5 2.6 0.7 0.0 0.0 0.0 0.5 0.2 0.3 0.3 0.4 0.2 0.8 0.7 3.9 115.2 0.2 0.3 6.9 24.2 1.8 19.0 33.7 10.3 3.7 0.2 0.7 19.7 221.1 14.4 2.6 0.9 3.6 3.1 0.4 1.5 0.6 0.7 0.8 0.6 1.8 13.8 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 24.1 48.6 39.9 31.9 24.5 40.3 51.9 41.0 50.0 32.9 44.1 75.2 64.7 0.0 0.6 71.8 1.1 6.5 0.7 13.1 34.7 17.9 17.0 8.3 8.6 61.5 3.1 14.7 2.1 128.9 0.3 73.3 0.0 42.9 13.6 12.2 4.8 60.9 28.1 2.7 26.9 1.3 8.1 15.4 1.1 10.6 0.0 9.7 145.6 0.9 12.5 138.0 62.2 30.7 0.0 14.8 4.6 2.4 6.5 1.1 24.9 54.4 0.1 5.8 0.0 138.7 311.3 2.0 46.7 1.9 2.6 1.5 40.7 4.4 0.6 3.5 0.0 36.1 8.1 0.9 1.5 11.3 4.1 348.1 0.8 3.5 40.3 2.2 SENP7 ENSG00000138468 "SUMO specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 44.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 44.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027259, HPA071998" Approved Supported "Nucleoplasm,Nuclear bodies,Centrosome,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Nuclear bodies, Centrosome, Cytosol" "HPA027259: AB_1856679, HPA071998: " "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 15.1 9.7 9.7 13.7 12.7 24.7 16.9 21.8 11.8 15.8 9.7 12.5 7.3 26.8 14.7 7.8 16.1 14.2 9.5 9.3 12.3 11.4 8.7 12.8 23.1 13.9 11.7 26.3 12.8 16.9 10.2 19.4 14.0 12.7 10.8 26.0 8.9 11.5 11.2 20.8 12.4 14.7 10.1 16.9 14.1 9.1 11.5 20.5 17.5 11.2 17.7 11.8 11.4 20.3 9.2 6.1 29.4 16.4 5.6 8.2 5.3 5.2 3.8 8.5 10.4 4.0 8.3 7.0 7.9 5.1 7.8 9.1 9.4 4.8 17.0 13.0 2.7 12.7 5.1 5.5 4.5 7.4 12.2 6.4 8.5 4.3 9.6 7.6 12.2 13.4 10.5 17.6 8.1 6.1 13.7 8.6 6.0 4.8 6.3 15.2 8.0 6.4 10.1 5.2 11.3 8.8 4.8 4.8 6.5 15.0 8.0 9.8 10.2 11.8 7.1 3.9 5.2 12.2 7.8 16.4 4.1 9.7 9.8 44.1 5.9 5.9 5.8 5.4 7.3 6.4 7.8 5.8 4.8 9.0 10.3 7.1 17.3 9.3 6.3 4.1 6.9 6.1 9.7 12.7 21.8 11.8 9.3 12.3 13.9 11.7 14.0 10.1 11.5 20.3 44.5 16.0 24.9 78.4 33.0 9.1 8.4 7.4 21.1 48.3 14.4 12.2 21.6 2.8 18.4 16.5 20.9 5.8 30.8 5.4 5.9 8.1 4.1 33.1 48.5 28.4 13.1 18.7 62.4 5.2 2.7 23.4 21.4 34.1 37.2 28.6 32.9 10.3 8.2 52.2 109.6 6.5 12.2 20.5 9.5 4.0 18.3 19.1 10.6 80.6 13.6 16.7 35.0 157.3 134.4 6.9 4.1 19.5 23.5 4.8 7.0 8.5 27.5 33.8 46.0 29.7 23.3 22.8 19.9 13.4 9.9 2.5 41.0 21.1 5.9 6.1 SERF1A "4F5, FAM2A, H4F5, SERF1, SMAM1" ENSG00000172058 "Small EDRK-rich factor 1A" O75920 5 70900669-70918530 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 64.7;testis: 43.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 92.1;Cone photoreceptor cells: 25.0;Rod photoreceptor cells: 26.9;Smooth muscle cells: 17.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SiHa: 111.9;SK-MEL-30: 80.5;WM-115: 59.8" HPA075271 Uncertain "Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.14e-1)" "unprognostic (3.00e-2)" "unprognostic (9.58e-2)" "unprognostic (3.07e-1)" "unprognostic (1.73e-1)" "unprognostic (3.81e-3)" "unprognostic (1.29e-3)" "unprognostic (1.40e-2)" "unprognostic (2.55e-2)" "unprognostic (1.03e-1)" "unprognostic (9.83e-3)" "unprognostic (4.13e-2)" "unprognostic (2.11e-1)" "unprognostic (1.98e-2)" "unprognostic (1.22e-2)" "unprognostic (9.53e-2)" 3.9 2.6 10.1 3.2 10.5 5.8 3.3 9.6 30.3 2.4 9.7 3.4 0.5 5.6 38.3 7.5 2.3 10.9 3.8 10.2 10.4 16.2 5.6 6.2 5.7 9.8 9.7 6.4 13.4 13.7 3.7 3.2 9.9 6.1 8.1 64.7 9.5 5.5 3.4 5.5 2.5 10.5 9.0 5.3 8.4 43.7 9.7 0.6 9.5 0.1 0.4 12.5 2.7 10.3 35.9 0.2 5.5 5.6 32.6 22.0 28.3 10.3 14.7 5.0 2.1 1.0 0.3 1.8 57.9 16.4 1.1 9.7 0.8 0.4 24.9 1.3 1.3 17.4 2.2 1.0 0.3 5.6 0.6 1.1 30.6 0.2 0.5 23.5 1.0 0.3 0.2 6.3 0.2 1.6 32.8 28.8 19.7 0.0 0.2 0.2 18.4 13.9 7.1 2.6 38.5 17.3 111.9 17.2 80.5 0.4 50.0 10.6 53.8 28.4 4.3 1.8 0.5 0.5 0.5 27.4 0.5 0.1 59.8 0.1 0.8 10.2 2.9 1.6 2.8 3.5 2.5 5.0 0.2 2.8 2.0 2.1 2.6 3.2 2.6 1.5 3.5 0.6 10.1 10.5 9.6 30.3 10.2 10.4 9.8 9.7 9.9 9.0 9.7 10.3 1.7 0.0 4.2 0.3 1.9 1.9 2.7 2.4 0.6 3.9 1.8 1.3 92.1 2.8 3.2 3.7 25.0 0.3 1.5 2.4 3.9 1.7 2.8 0.8 1.2 8.2 5.4 0.0 0.5 0.5 0.4 6.2 0.0 0.7 2.5 1.5 1.4 0.2 0.5 0.0 0.4 1.0 0.0 0.3 2.1 1.2 2.1 0.5 0.0 0.0 1.3 2.4 0.0 0.0 0.4 1.0 3.2 3.8 1.2 2.3 3.1 1.5 4.2 26.9 0.0 3.1 17.1 3.0 2.0 0.3 2.3 0.1 1.9 1.4 1.8 1.0 SERF1B "FAM2B, H4F5C" ENSG00000205572 "Small EDRK-rich factor 1B" O75920 5 70025247-70043113 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 154.4" "Cell type enriched" "Detected in some" 4 "Cardiomyocytes: 40.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 11.3" HPA075271 Approved "Nuclear bodies" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 71: Testis - DNA repair" "Cluster 38: EFO-21 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies" "HPA075271: AB_2686740" "unprognostic (1.00e-1)" "unprognostic (2.52e-4)" "unprognostic (2.60e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-1)" "unprognostic (2.32e-1)" "unprognostic (5.98e-2)" "unprognostic (4.92e-3)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-4)" "unprognostic (1.22e-1)" "unprognostic (2.16e-2)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (6.74e-2)" "unprognostic (3.52e-1)" 27.3 27.0 0.8 1.6 1.3 1.7 30.3 1.3 2.1 34.4 0.3 45.0 0.7 31.9 0.5 28.6 25.5 1.0 44.7 1.5 2.3 36.4 14.9 30.5 2.1 0.8 0.7 27.1 27.7 1.4 38.0 1.0 0.9 30.4 1.2 11.4 25.1 2.1 46.5 22.7 30.8 2.9 0.8 23.3 28.4 154.4 0.7 1.3 33.8 1.2 1.6 28.3 32.4 1.5 2.6 0.7 4.1 6.0 3.8 1.5 1.1 1.0 1.8 1.7 3.7 0.6 3.0 3.1 11.3 1.1 3.8 1.3 2.6 1.9 1.6 8.0 0.9 3.0 1.3 1.6 1.5 0.1 2.9 1.2 5.3 1.9 0.3 1.3 1.7 0.9 1.2 2.5 0.5 0.2 4.7 2.1 3.6 0.0 0.4 2.4 6.3 5.0 1.3 1.5 7.8 5.1 2.7 0.1 3.7 1.8 2.6 1.1 6.3 1.6 1.8 1.0 1.7 2.0 3.4 3.5 1.6 0.2 3.2 0.3 0.2 1.8 4.1 1.5 4.8 3.3 5.9 2.9 2.9 6.3 7.0 4.9 0.5 2.6 1.5 4.6 2.8 1.9 0.8 1.3 1.3 2.1 1.5 2.3 0.8 0.7 0.9 0.8 0.7 1.5 0.4 9.6 2.2 0.0 1.0 0.4 0.7 0.3 1.2 0.1 0.5 0.5 40.3 0.0 3.2 0.0 2.1 0.1 0.4 0.6 1.9 0.2 1.6 0.3 0.7 4.4 0.0 0.4 0.0 0.0 0.1 3.4 0.0 0.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.7 1.0 1.8 0.2 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.1 1.1 5.2 1.4 0.0 0.5 8.8 1.6 0.6 0.9 0.6 0.0 0.7 0.1 0.4 0.4 SETBP1 "KIAA0437, SEB" ENSG00000152217 "SET binding protein 1" Q9Y6X0 18 44680173-45068510 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 11.6" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.0;plasmacytoid DC: 2.8" "Group enriched" "Detected in many" 5 "B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0" "Cell line enhanced" "Detected in many" "AF22: 16.1;Karpas-707: 44.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049022, HPA057259" Uncertain Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 66000 "Cluster 19: B-cells - Humoral immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA049022: AB_2680602, HPA057259: AB_2683384" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.11e-1)" "unprognostic (1.97e-2)" "unprognostic (4.63e-2)" "unprognostic (1.80e-1)" "unprognostic (1.91e-1)" "unprognostic (3.57e-2)" "unprognostic (3.49e-1)" "unprognostic (2.01e-2)" "unprognostic (2.71e-3)" "unprognostic (6.52e-2)" "prognostic favorable (6.34e-8)" "unprognostic (2.18e-2)" "unprognostic (2.29e-1)" "unprognostic (6.06e-2)" "unprognostic (7.81e-5)" 7.3 1.9 2.0 3.7 3.7 1.8 6.3 11.6 5.7 11.6 0.0 10.9 1.7 8.3 7.2 4.5 7.2 5.0 4.3 2.6 0.2 7.4 4.7 6.6 5.3 0.0 0.1 7.7 5.8 3.7 2.7 7.2 0.1 7.8 3.5 3.0 4.3 9.2 10.7 4.4 4.6 7.4 0.0 3.7 5.6 1.8 0.0 4.4 5.1 9.7 4.7 8.1 8.5 3.8 0.0 2.4 16.1 0.0 4.1 1.2 1.0 1.3 3.0 1.5 1.3 0.2 0.0 1.0 0.5 1.8 1.0 4.8 1.8 4.9 1.0 1.4 0.8 0.0 1.8 1.2 0.0 0.0 0.0 3.8 2.0 0.0 3.0 2.7 0.5 0.0 0.1 44.7 0.4 0.8 0.0 0.1 2.0 0.0 1.1 5.6 0.0 5.5 4.9 3.9 8.2 4.2 0.0 0.0 0.9 7.1 2.2 0.0 0.0 9.5 3.3 0.0 7.7 8.6 0.5 0.0 5.8 0.2 5.5 0.1 0.0 0.0 0.4 0.6 0.0 2.0 0.0 0.2 0.0 3.0 0.0 0.1 0.0 0.0 1.0 2.8 0.0 0.1 2.0 3.7 11.6 5.7 2.6 0.2 0.0 0.1 0.1 0.0 0.0 3.8 7.6 0.0 1.8 85.5 42.4 15.4 8.6 8.3 7.4 12.5 11.0 12.6 3.9 14.3 4.2 16.5 18.8 1.5 25.5 1.6 3.9 4.5 1.3 12.9 15.6 8.3 12.0 0.8 349.0 3.5 1.4 29.3 4.1 14.8 0.0 0.7 17.9 16.5 2.0 3.3 548.3 4.4 10.2 2.4 8.7 3.7 62.7 4.6 3.6 88.1 1.5 10.7 6.2 170.4 62.9 3.7 9.1 39.9 29.6 8.1 0.4 10.5 5.8 18.2 6.6 18.4 28.6 0.3 0.8 4.0 15.2 0.8 5.9 0.1 4.7 1.5 SFT2D1 "C6orf83, MGC19825, pRGR1" ENSG00000198818 "SFT2 domain containing 1" Q8WV19 6 166319728-166342576 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014677 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA014677: AB_2238986" "unprognostic (8.45e-2)" "unprognostic (1.43e-3)" "unprognostic (2.29e-1)" "unprognostic (1.41e-2)" "unprognostic (6.77e-2)" "prognostic unfavorable (7.47e-4)" "prognostic unfavorable (2.19e-5)" "unprognostic (3.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.68e-1)" "unprognostic (6.53e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.59e-4)" "unprognostic (4.20e-2)" "unprognostic (5.05e-2)" "prognostic favorable (5.90e-4)" "unprognostic (2.75e-2)" 40.8 43.9 55.0 35.6 61.7 35.8 45.9 62.3 76.2 35.4 54.0 52.1 39.2 26.5 68.2 36.6 33.8 34.4 30.5 54.5 59.0 51.0 24.5 37.0 50.9 64.0 59.0 31.9 51.1 36.1 17.3 48.9 65.3 47.5 50.1 12.9 70.7 28.0 22.2 24.7 39.0 24.8 62.9 41.9 50.7 26.9 57.2 41.7 46.3 27.5 47.9 40.4 29.4 72.4 47.1 39.9 41.9 86.3 76.1 65.9 56.4 70.7 69.6 56.8 85.5 80.2 103.3 43.9 55.7 68.8 90.2 59.7 62.5 67.0 88.3 58.8 88.4 53.0 35.4 133.4 65.9 134.9 106.5 61.1 78.9 65.5 58.3 81.8 31.3 73.1 96.1 46.8 90.3 68.5 42.1 241.5 40.2 154.5 36.2 28.6 45.0 105.4 141.6 46.1 8.0 34.3 45.6 87.8 73.0 48.1 46.4 252.3 28.6 33.4 60.4 87.4 79.7 40.7 32.3 50.6 70.4 84.8 85.5 141.1 90.7 126.3 62.1 98.6 38.7 88.1 47.3 52.3 103.4 72.5 50.3 51.7 166.0 58.9 107.3 204.9 79.4 92.7 55.0 61.7 62.3 76.2 54.5 59.0 64.0 59.0 65.3 62.9 57.2 72.4 45.6 41.7 66.5 25.1 103.4 86.5 127.8 262.4 59.2 10.0 136.0 103.6 25.0 51.5 143.9 108.5 0.0 153.0 154.2 109.3 90.1 154.5 70.3 52.0 49.9 55.8 28.8 63.3 15.6 126.8 259.4 81.5 61.2 73.9 149.0 31.3 65.3 30.6 211.6 15.2 13.6 162.5 168.9 178.5 178.4 25.2 85.1 143.5 99.6 21.5 198.3 31.7 111.2 16.6 71.5 155.4 146.5 47.4 108.5 239.2 115.5 140.4 96.0 9.1 85.5 69.5 64.0 159.0 93.4 72.9 102.9 131.2 74.9 63.2 131.4 194.0 SGO2 "FLJ25211, SGOL2, TRIPIN" ENSG00000163535 "Shugoshin 2" Q562F6 2 200510008-200584096 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 14.9;testis: 32.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.6;Endometrial ciliated cells: 12.1;Extravillous trophoblasts: 31.0;granulocytes: 11.4;Granulosa cells: 23.4;Hofbauer cells: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "basophil: 16.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035163, HPA040817" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA035163: AB_10602397, HPA040817: AB_2677149" "unprognostic (3.43e-1)" "unprognostic (1.70e-1)" "unprognostic (7.06e-3)" "unprognostic (6.71e-3)" "unprognostic (1.90e-1)" "unprognostic (1.77e-1)" "unprognostic (7.55e-6)" "unprognostic (1.12e-2)" "unprognostic (1.98e-3)" "unprognostic (4.87e-2)" "unprognostic (1.37e-4)" "unprognostic (9.49e-2)" "unprognostic (8.07e-9)" "unprognostic (5.21e-2)" "unprognostic (5.43e-2)" "unprognostic (9.86e-2)" "unprognostic (2.02e-1)" 3.3 0.9 0.6 4.4 0.9 6.8 1.9 0.8 0.9 0.9 0.3 3.1 2.5 1.8 0.7 2.4 1.4 1.2 1.0 0.5 0.9 0.9 0.8 1.5 7.9 0.9 0.9 1.9 0.5 1.1 0.3 2.6 0.9 1.4 3.2 0.9 0.7 0.7 0.4 2.3 2.6 2.0 0.7 2.0 1.8 32.6 0.9 14.9 1.2 0.6 8.1 1.5 0.9 1.2 34.6 16.2 37.0 17.4 5.2 7.9 23.7 38.7 16.6 32.0 33.1 24.3 23.5 22.5 18.6 18.1 34.4 25.3 33.6 20.1 54.5 48.0 16.9 43.5 21.6 17.5 1.6 43.9 33.1 3.4 2.5 32.9 17.3 8.0 29.4 31.3 33.1 31.6 61.4 15.4 35.9 17.9 26.7 24.9 41.2 28.8 49.1 21.3 13.3 13.6 22.2 15.4 28.6 13.3 16.3 29.2 14.1 25.2 18.1 33.9 34.0 31.6 34.0 14.3 33.5 49.8 21.4 28.9 49.4 16.7 1.4 4.5 2.2 1.4 1.4 2.7 2.4 2.2 0.8 3.2 1.8 2.2 1.0 2.0 1.7 1.7 3.6 1.2 0.6 0.9 0.8 0.9 0.5 0.9 0.9 0.9 0.9 0.7 0.9 1.2 9.4 3.2 3.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.8 7.1 0.0 0.0 6.2 0.0 0.0 11.6 7.8 0.0 3.9 3.9 0.0 12.1 5.3 3.3 0.0 0.0 0.0 2.7 31.0 6.7 0.0 3.6 11.4 23.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 3.2 0.0 0.0 1.7 0.0 0.0 2.5 8.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 3.4 3.8 4.0 0.0 0.0 SH3BGRL3 ENSG00000142669 "SH3 domain binding glutamate rich protein like 3" Q9H299 1 26280086-26281522 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2516.1;Langerhans cells: 2368.4;Pancreatic endocrine cells: 2492.4;Urothelial cells: 2342.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030848, HPA076219" Enhanced Approved "Nuclear bodies" NA NA 41000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nuclear bodies" "HPA030848: AB_10602398, HPA076219: AB_2686787" "unprognostic (4.97e-2)" "unprognostic (9.57e-2)" "unprognostic (1.07e-1)" "unprognostic (4.73e-3)" "unprognostic (4.95e-2)" "unprognostic (8.68e-2)" "unprognostic (4.29e-3)" "unprognostic (3.16e-1)" "unprognostic (3.62e-2)" "unprognostic (4.32e-1)" "unprognostic (1.98e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.17e-10)" "unprognostic (1.66e-1)" "unprognostic (1.59e-1)" "unprognostic (6.35e-2)" "unprognostic (4.43e-2)" 221.9 102.0 289.8 423.0 302.9 530.2 141.8 306.0 380.2 135.5 269.7 416.3 161.9 85.8 708.2 368.2 101.4 177.5 120.8 299.4 321.7 115.9 121.6 289.5 404.4 316.2 340.4 66.7 157.4 85.5 83.2 155.4 320.6 82.5 437.9 32.2 139.6 112.3 47.6 305.9 164.7 202.6 297.0 313.1 223.2 26.2 351.0 306.7 82.9 81.0 437.0 424.5 176.3 325.7 501.1 274.9 187.5 265.7 769.3 2090.9 23.2 895.6 1315.0 959.2 611.0 220.3 460.4 120.8 297.9 1963.3 268.2 182.6 108.9 1030.2 642.6 192.0 109.3 976.3 212.1 213.3 604.8 280.1 1447.9 836.8 652.4 912.9 742.0 1115.0 1200.3 244.7 112.2 430.6 1767.3 337.8 182.1 478.2 221.6 434.8 2003.4 341.1 229.0 170.5 762.6 216.7 119.7 189.8 331.2 338.1 374.1 199.3 65.7 431.9 1451.5 1071.0 370.8 1492.9 402.3 135.7 241.6 104.0 2253.9 792.3 532.5 4277.3 7085.6 6427.9 4340.1 6247.2 3228.5 2422.2 3706.5 4249.4 5891.3 2181.2 1591.2 3072.9 7753.8 2344.8 6190.5 3152.1 5092.0 13045.6 289.8 302.9 306.0 380.2 299.4 321.7 316.2 340.4 320.6 297.0 351.0 325.7 445.2 96.1 168.0 9.8 603.5 984.1 995.1 708.3 373.9 17.1 216.7 227.1 7.8 193.0 290.5 367.8 4.2 133.1 1060.9 1614.6 313.1 1108.5 15.8 178.9 410.9 502.9 339.8 220.0 12.9 1031.5 436.1 493.8 388.4 344.0 1017.6 67.2 346.6 121.7 2516.1 16.8 8.2 1430.3 205.4 1796.4 2368.4 52.8 139.1 2209.6 779.1 16.9 1116.8 76.9 1251.3 4.0 20.2 2492.4 1309.6 162.1 397.9 1754.9 391.7 498.6 202.8 16.4 151.2 71.9 336.4 9.1 23.5 788.1 1058.7 227.1 1380.4 99.2 507.5 2342.3 SH3BP5 Sab ENSG00000131370 "SH3 domain binding protein 5" O60239 3 15254353-15341368 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 200.5" "Cell type enhanced" "Detected in many" "Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 349.3;MCF7: 118.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036445, HPA057988" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Nuclear bodies" "HPA036445: AB_10670106, HPA057988: AB_2683572" "unprognostic (1.28e-3)" "unprognostic (2.99e-2)" "unprognostic (9.50e-2)" "unprognostic (6.97e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.81e-3)" "unprognostic (4.80e-2)" "unprognostic (4.09e-2)" "unprognostic (2.76e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (4.76e-2)" "unprognostic (3.06e-2)" "unprognostic (4.34e-2)" "unprognostic (2.03e-1)" 78.3 200.5 21.2 35.2 22.7 72.6 72.0 38.4 26.1 71.1 16.0 27.4 15.7 77.5 13.5 26.9 85.6 45.7 24.1 23.3 21.0 52.8 17.3 73.2 59.9 21.4 20.0 116.2 15.9 47.9 35.7 40.8 22.4 25.0 8.4 27.4 49.9 34.1 71.7 25.6 27.0 37.3 20.8 30.9 16.1 30.9 20.9 37.4 51.1 19.1 35.7 33.0 50.6 35.1 27.4 16.5 6.4 14.1 53.1 46.8 349.3 13.6 10.9 9.3 10.4 10.8 13.4 21.3 6.2 40.8 16.1 3.6 2.9 14.2 5.9 19.5 12.8 15.7 72.3 1.9 21.9 4.4 8.6 36.9 9.3 41.6 7.9 34.2 116.0 31.3 18.4 8.5 10.3 118.1 57.6 23.2 13.6 3.5 20.6 1.1 27.2 115.6 8.8 53.5 16.8 7.8 18.6 19.2 21.7 21.6 18.1 10.9 84.3 22.8 29.5 21.9 12.0 3.3 7.6 15.2 44.7 16.3 31.5 8.1 7.8 9.1 52.9 2.5 15.9 19.1 24.1 36.1 8.9 24.3 12.9 16.6 13.9 25.4 4.6 3.9 11.1 20.4 21.2 22.7 38.4 26.1 23.3 21.0 21.4 20.0 22.4 20.8 20.9 35.1 195.9 0.0 16.3 2.3 115.2 17.0 6.0 8.2 11.4 41.3 23.5 32.1 0.7 5.7 13.9 68.0 14.6 12.5 73.7 0.6 3.9 2.7 192.2 13.1 33.0 150.7 2.4 7.0 49.5 8.7 356.3 97.5 3.6 13.7 2.5 28.1 165.0 7.0 33.1 65.6 38.4 2.5 12.2 87.2 133.3 97.8 49.0 113.1 33.8 26.2 33.3 5.1 167.9 12.5 60.6 3.2 1.1 118.5 67.1 8.5 4.7 36.2 7.5 44.4 6.6 56.8 13.4 3.0 4.5 14.2 12.1 173.2 51.5 81.6 1.4 10.2 SHCBP1 "FLJ22009, PAL" ENSG00000171241 "SHC binding and spindle associated 1" Q8NEM2 16 46578591-46621379 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.4;lymphoid tissue: 10.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA048876 Uncertain Approved "Nuclear bodies,Microtubules,Midbody,Mitotic spindle" Yes Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies" "Microtubules, Midbody, Mitotic spindle" "HPA048876: AB_2680542" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (2.98e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-2)" "unprognostic (2.35e-2)" "unprognostic (2.96e-4)" "unprognostic (2.26e-3)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.47e-5)" "unprognostic (4.81e-2)" "unprognostic (2.22e-16)" "unprognostic (3.59e-2)" "unprognostic (3.86e-2)" "unprognostic (2.66e-1)" "unprognostic (2.66e-1)" 0.7 0.5 0.5 5.1 0.5 17.4 0.9 1.2 0.6 0.6 0.4 1.9 1.2 0.6 0.6 3.5 0.2 0.6 1.0 0.4 0.2 5.4 0.2 1.0 9.8 0.4 0.3 0.3 0.2 0.2 0.2 2.4 0.4 0.3 2.2 0.2 0.8 0.2 1.5 3.3 1.5 1.7 0.1 4.4 0.9 5.2 0.5 8.8 0.3 0.2 10.6 1.2 1.2 0.7 33.8 30.8 11.9 15.3 3.1 6.2 16.2 60.7 24.6 59.2 26.8 14.6 20.8 28.0 30.2 28.8 26.8 21.0 29.3 21.7 73.8 17.7 17.2 28.2 25.8 30.3 0.1 28.5 35.4 1.2 1.6 45.9 18.1 5.9 33.0 14.9 12.7 28.3 69.7 21.5 24.0 23.7 10.0 17.2 31.6 45.4 89.9 44.8 13.7 9.4 5.0 7.2 46.0 23.7 11.1 11.4 13.0 23.4 16.1 43.9 28.7 43.5 54.0 24.9 36.7 46.7 21.4 31.3 45.8 0.2 0.3 0.6 0.2 0.5 0.0 1.7 0.3 0.1 0.3 1.2 0.0 0.1 0.4 0.1 2.4 0.7 1.2 1.1 0.5 0.5 1.2 0.6 0.4 0.2 0.4 0.3 0.4 0.1 0.5 0.7 0.2 0.0 1.1 1.3 7.1 1.7 0.7 1.2 0.0 0.3 0.6 1.1 1.9 1.5 1.4 0.0 0.0 11.3 0.8 1.9 0.0 0.2 8.4 0.7 1.7 1.7 0.0 36.2 2.1 0.0 28.7 3.7 4.1 1.5 0.0 7.6 1.8 0.3 12.6 0.0 0.7 2.2 2.0 4.5 3.3 2.3 0.6 4.0 1.8 2.8 2.8 0.8 0.0 1.0 0.5 0.1 0.1 0.4 38.3 0.5 0.4 0.1 0.1 0.3 0.0 0.5 6.3 33.7 23.7 3.6 0.6 3.7 2.2 0.8 3.4 1.1 SHISA2 "bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166" ENSG00000180730 "Shisa family member 2" Q6UWI4 13 26044597-26052016 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 12.4;skeletal muscle: 14.2;thyroid gland: 21.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 13.1;Basal prostatic cells: 14.6;Breast glandular cells: 24.1;Oligodendrocytes: 10.9;Urothelial cells: 19.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 25.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 26.7;JURKAT: 20.8;LHCN-M2: 18.7;NTERA-2: 15.5;RH-30: 46.3;U-2197: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA049752, HPA050172" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "Nuclear bodies, Vesicles" "HPA049752: , HPA050172: AB_2681041" "unprognostic (2.08e-2)" "unprognostic (3.00e-1)" "unprognostic (2.41e-1)" "unprognostic (9.71e-2)" "unprognostic (6.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.20e-1)" "prognostic favorable (3.30e-4)" "unprognostic (4.03e-2)" "unprognostic (3.10e-1)" "unprognostic (7.45e-2)" "unprognostic (2.17e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.56e-3)" "unprognostic (2.09e-1)" "unprognostic (3.46e-1)" "unprognostic (1.51e-2)" 0.5 0.0 1.1 0.2 2.3 0.1 12.4 1.5 2.0 1.7 0.9 0.1 0.7 0.1 7.8 0.2 0.2 0.5 0.2 2.0 1.5 4.7 0.0 4.3 0.5 1.9 1.5 0.3 0.3 0.1 1.6 0.0 1.6 0.5 0.1 0.0 2.7 0.3 14.2 1.1 0.7 0.1 2.2 0.2 2.1 1.2 1.6 2.5 21.0 1.2 0.7 0.7 0.0 5.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.4 4.2 1.4 0.0 0.0 1.7 26.7 1.0 20.8 0.0 0.0 18.7 1.2 2.3 0.5 15.5 8.4 8.2 0.0 46.3 0.3 1.7 6.5 0.4 0.0 0.4 0.0 5.4 2.6 0.7 0.2 1.6 0.1 0.7 30.4 7.0 0.0 0.0 0.0 0.0 0.0 4.1 0.8 0.1 0.5 0.1 0.2 0.2 0.1 0.4 0.1 0.0 0.2 1.0 1.6 0.4 0.2 0.3 0.1 0.2 0.1 1.1 2.3 1.5 2.0 2.0 1.5 1.9 1.5 1.6 2.2 1.6 5.4 4.7 0.0 13.1 0.0 0.4 5.4 14.6 2.3 0.6 0.0 24.1 6.2 0.5 0.0 1.5 3.7 0.0 0.3 0.3 0.1 0.0 6.0 2.6 1.0 0.5 5.1 0.0 0.0 0.0 0.2 0.3 2.8 3.1 2.5 0.0 2.4 1.1 0.0 0.8 0.0 1.0 0.1 8.2 0.3 2.3 1.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.5 10.9 1.2 0.0 0.4 0.2 3.9 0.0 0.3 1.1 0.0 0.0 7.6 1.6 0.7 5.1 0.4 1.7 0.1 1.1 0.7 0.0 19.6 SIM2 "bHLHe15, MGC119447, SIM" ENSG00000159263 "SIM bHLH transcription factor 2" Q14190 21 36699115-36749917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "esophagus: 31.1;kidney: 61.3" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3" "Cancer enhanced" "Detected in many" "prostate cancer: 11.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 1.2" HPA029295 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies" "HPA029295: AB_10610425" "unprognostic (1.17e-3)" "unprognostic (6.46e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (8.62e-2)" "unprognostic (1.43e-2)" "unprognostic (8.30e-2)" "unprognostic (5.46e-3)" "unprognostic (1.65e-2)" "unprognostic (1.09e-1)" "unprognostic (5.16e-3)" "unprognostic (9.18e-2)" "unprognostic (9.18e-7)" "unprognostic (2.98e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "prognostic favorable (2.88e-4)" 0.3 0.3 1.8 0.0 1.1 0.0 0.4 0.7 1.4 2.3 0.4 0.5 0.0 0.5 0.8 31.1 0.6 0.0 0.2 1.5 2.5 61.3 0.4 0.2 0.0 0.7 1.4 0.2 0.3 1.8 1.6 0.0 0.5 6.6 0.0 0.0 0.6 0.0 10.6 0.5 0.3 0.0 0.5 0.3 9.5 0.4 2.4 0.0 0.4 0.0 3.5 0.7 0.7 0.7 6.4 9.6 0.0 0.3 0.0 0.0 9.4 0.0 0.0 0.9 0.0 5.0 14.7 0.0 8.6 0.2 17.0 3.2 4.8 0.0 0.5 7.8 15.0 0.0 14.3 0.3 0.0 0.0 0.0 1.6 1.4 0.0 2.6 24.9 0.0 0.0 0.0 0.0 16.0 3.7 0.0 0.0 0.0 6.4 43.0 0.0 0.0 0.0 54.3 33.5 0.4 0.0 15.7 0.0 0.9 1.6 4.1 0.0 0.6 0.0 2.5 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.1 0.7 1.4 1.5 2.5 0.7 1.4 0.5 0.5 2.4 0.7 0.2 0.0 0.0 0.0 0.0 0.3 19.1 0.0 100.7 0.2 0.1 0.1 2.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 9.8 0.1 2.2 0.3 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.8 12.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 5.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 7.1 1.1 0.0 0.0 0.0 1.3 9.5 0.1 0.2 0.0 0.5 0.0 1.5 0.9 0.5 0.2 68.3 0.4 0.0 0.4 0.0 0.2 4.0 SIPA1L2 "KIAA1389, SPAR2" ENSG00000116991 "Signal induced proliferation associated 1 like 2" Q9P2F8 1 232397965-232630571 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024181, HPA027224" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus" No NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear membrane, Nuclear bodies" "Golgi apparatus" "HPA024181: AB_1856886, HPA027224: AB_2672165" "unprognostic (2.34e-2)" "unprognostic (9.67e-2)" "unprognostic (8.02e-2)" "unprognostic (1.71e-3)" "unprognostic (2.98e-1)" "unprognostic (5.68e-2)" "unprognostic (5.57e-3)" "unprognostic (7.79e-2)" "unprognostic (1.60e-1)" "unprognostic (1.80e-2)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (3.36e-2)" "unprognostic (2.75e-1)" "unprognostic (5.84e-3)" "unprognostic (3.45e-3)" 12.1 3.3 8.5 6.4 7.2 5.4 9.2 9.6 11.7 10.0 0.5 19.4 3.9 4.4 2.8 20.3 4.5 8.5 31.3 9.6 16.0 7.7 6.4 16.2 3.0 44.0 21.7 11.9 3.6 4.4 8.1 18.3 44.6 8.1 18.9 14.7 8.7 4.7 7.1 9.0 9.2 7.4 14.4 9.6 5.7 7.2 18.7 2.4 8.0 9.5 3.3 12.5 14.9 9.0 0.0 7.5 69.7 0.2 0.6 0.0 29.3 1.2 2.5 3.1 2.2 2.9 0.1 5.9 13.3 26.4 2.9 1.7 13.8 2.3 2.9 0.0 12.8 0.0 7.0 0.0 5.9 1.0 7.2 3.8 9.1 0.6 6.2 0.0 15.7 25.4 0.0 0.1 1.6 3.5 7.4 0.7 53.9 0.2 10.2 0.0 0.0 3.4 8.1 11.5 3.5 11.9 23.8 0.8 9.5 15.8 1.4 0.6 5.6 8.1 0.0 17.8 2.9 6.5 0.0 0.0 10.0 6.2 46.1 0.0 0.2 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.4 0.6 0.3 0.3 0.0 0.1 8.5 7.2 9.6 11.7 9.6 16.0 44.0 21.7 44.6 14.4 18.7 9.0 53.7 6.4 1.8 22.9 0.8 8.8 9.8 8.7 15.4 23.5 10.7 8.6 62.6 12.8 10.4 3.7 52.1 4.9 4.4 29.9 0.0 7.1 11.7 19.0 21.4 22.7 7.2 0.4 80.2 0.5 7.1 15.2 5.1 47.5 1.3 16.0 1.8 3.8 10.0 5.0 95.9 29.5 14.2 16.6 7.2 9.8 0.9 19.5 14.2 183.6 6.3 12.7 1.0 104.0 21.0 1.4 39.9 1.9 0.5 13.2 9.1 0.4 7.7 35.7 0.0 21.8 23.9 6.9 24.0 45.8 7.4 14.8 2.0 11.9 23.4 23.0 SIRPB2 "dJ776F14.2, PTPN1L, PTPNS1L3" ENSG00000196209 "Signal regulatory protein beta 2" Q5JXA9 20 1470741-1491587 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1" "Cell type enhanced" "Detected in some" "Hofbauer cells: 5.1;Kupffer cells: 20.0;Macrophages: 9.5;Microglial cells: 14.0;monocytes: 8.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "classical monocyte: 51.1;eosinophil: 31.7;intermediate monocyte: 30.4;myeloid DC: 21.1;neutrophil: 69.5;non-classical monocyte: 24.4" "Group enriched" "Detected in many" 329 "dendritic cells: 21.1;granulocytes: 69.5;monocytes: 51.1" "Cell line enhanced" "Detected in some" "A-431: 4.7;HBEC3-KT: 4.0;HMC-1: 7.8;hTCEpi: 8.5;HUVEC TERT2: 4.3;THP-1: 7.7;TIME: 3.7;U-937: 8.3" "Low region specificity" "Detected in all" "HPA011548, HPA048032" Uncertain Approved "Nuclear bodies" NA NA 250000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 43: THP-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nuclear bodies" "HPA011548: AB_2668514, HPA048032: AB_2680236" "unprognostic (3.22e-2)" "unprognostic (5.57e-2)" "unprognostic (2.29e-2)" "unprognostic (2.04e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-2)" "unprognostic (2.07e-2)" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.75e-1)" "unprognostic (2.38e-1)" "unprognostic (2.43e-1)" "unprognostic (3.50e-5)" "unprognostic (3.59e-3)" "unprognostic (9.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.06e-1)" 5.6 2.4 1.1 12.0 1.2 6.5 1.6 1.3 1.6 1.8 1.8 1.5 0.9 0.9 0.1 1.8 1.6 3.7 1.4 1.1 1.5 1.1 1.8 7.2 7.0 2.7 2.1 0.5 0.7 0.6 0.6 7.5 2.4 0.9 1.7 0.2 1.3 0.6 0.5 0.9 2.0 4.1 1.6 13.1 1.2 0.5 2.7 1.4 0.7 1.8 3.2 3.9 0.9 2.6 4.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.8 0.0 8.5 0.0 0.2 0.0 4.3 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 7.7 3.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 8.3 0.0 3.0 51.1 31.7 0.1 30.4 0.0 0.0 0.0 0.0 21.1 0.1 0.0 0.0 69.5 0.0 24.4 0.6 0.0 18.9 1.1 1.2 1.3 1.6 1.1 1.5 2.7 2.1 2.4 1.6 2.7 2.6 0.0 0.0 1.1 0.0 0.5 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.4 0.0 0.0 0.6 0.6 0.0 0.1 1.3 0.0 1.4 0.2 5.1 0.0 0.1 0.0 0.0 20.0 3.3 0.0 0.0 9.5 0.0 14.0 8.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.3 0.1 0.7 0.3 0.1 0.0 0.6 SKI ENSG00000157933 "SKI proto-oncogene" P12755 1 2228319-2310213 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Craniosynostosis, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010449, HPA066567" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear bodies" "CAB010449: AB_2187342, HPA066567: AB_2685692" "unprognostic (3.99e-2)" "unprognostic (3.81e-2)" "unprognostic (1.44e-1)" "unprognostic (5.42e-2)" "unprognostic (4.66e-2)" "unprognostic (7.32e-2)" "unprognostic (1.88e-1)" "unprognostic (9.14e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (4.94e-2)" "unprognostic (1.21e-1)" "unprognostic (2.56e-3)" "unprognostic (1.88e-1)" "unprognostic (7.82e-2)" "unprognostic (9.69e-2)" "unprognostic (5.24e-3)" 38.3 14.3 22.0 14.1 20.9 11.5 31.5 59.5 24.2 37.5 3.4 34.6 9.3 42.0 8.3 23.5 34.1 14.6 34.4 24.1 11.0 23.6 24.3 33.9 11.6 20.1 16.9 36.4 13.1 7.3 23.0 13.9 17.2 26.8 7.0 5.1 25.2 19.8 22.1 38.6 24.1 16.8 17.1 22.9 22.6 13.2 19.4 8.7 25.4 11.7 10.2 30.8 29.2 15.7 18.3 10.4 24.5 23.9 40.0 23.8 16.1 26.7 14.8 16.3 11.9 15.8 13.7 11.5 19.5 34.4 6.8 21.0 13.8 21.6 15.0 12.7 30.0 29.0 16.4 22.5 26.7 16.5 29.8 25.8 11.8 24.5 18.2 30.0 20.2 4.8 16.6 8.6 20.2 11.6 2.0 18.1 24.8 12.0 19.8 9.1 15.5 9.6 13.9 7.0 35.0 22.9 26.0 22.9 26.7 15.6 7.7 20.9 36.9 27.7 17.5 39.6 21.1 6.7 5.2 10.5 14.8 28.2 11.6 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 22.0 20.9 59.5 24.2 24.1 11.0 20.1 16.9 17.2 17.1 19.4 15.7 44.2 9.6 12.6 18.9 18.8 47.0 13.1 7.0 32.5 8.9 20.3 25.8 12.7 11.5 6.7 7.3 0.0 7.3 32.2 7.3 1.9 8.2 0.8 10.1 28.9 34.3 6.0 14.7 22.6 6.9 15.5 35.5 9.7 18.5 13.3 6.4 33.9 23.0 13.7 11.8 24.1 14.3 0.0 16.4 29.5 5.0 49.7 28.9 16.0 48.7 9.4 11.1 12.3 11.6 11.4 13.0 9.4 55.3 16.9 14.9 8.1 6.0 4.0 4.4 46.0 36.2 37.3 4.7 12.8 32.2 45.0 16.3 33.4 6.7 10.7 11.4 SKIDA1 "C10orf140, FLJ45187" ENSG00000180592 "SKI/DACH domain containing 1" Q1XH10 10 21513475-21526368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.1;Early spermatids: 17.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "cerebral cortex: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 26.1;AN3-CA: 6.7;BEWO: 12.1;SH-SY5Y: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039208, HPA040439" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA039208: AB_10795034, HPA040439: AB_10796122" "unprognostic (5.36e-2)" "unprognostic (1.84e-1)" "unprognostic (5.32e-3)" "unprognostic (6.45e-4)" "unprognostic (9.97e-2)" "unprognostic (3.23e-3)" "unprognostic (3.61e-2)" "unprognostic (1.12e-2)" "unprognostic (1.59e-2)" "unprognostic (4.23e-1)" "unprognostic (9.35e-3)" "unprognostic (5.93e-2)" "unprognostic (3.38e-6)" "unprognostic (8.13e-2)" "unprognostic (1.50e-1)" "unprognostic (8.20e-2)" "unprognostic (8.52e-3)" 0.3 0.6 0.4 0.1 0.6 0.6 0.2 0.4 2.3 0.5 0.0 0.6 0.1 0.2 0.2 0.2 0.5 0.1 1.2 0.5 0.0 1.3 1.4 0.3 0.1 0.1 0.0 1.3 0.5 1.1 0.5 0.8 0.0 0.3 0.2 1.5 0.5 0.6 0.2 1.0 0.2 0.3 0.0 0.1 0.2 1.7 0.0 0.2 1.2 0.2 0.1 0.3 0.3 0.9 0.5 1.1 26.1 6.7 0.5 0.3 12.1 0.5 0.4 0.0 0.1 2.5 0.2 0.2 1.0 0.4 0.2 1.6 2.4 0.5 0.0 0.0 2.9 0.1 1.3 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.4 0.2 0.2 0.1 1.1 0.9 0.1 1.6 0.0 0.0 0.4 0.8 0.0 0.5 0.7 2.9 6.0 0.9 4.5 0.1 2.1 0.4 5.4 0.4 0.2 0.8 0.2 0.6 0.1 0.0 0.3 1.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.4 2.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 1.5 5.2 0.2 1.5 1.0 0.6 6.8 19.1 1.8 2.2 6.9 4.3 1.4 1.8 0.0 5.3 0.0 0.1 7.9 0.1 17.9 0.4 1.3 4.3 0.0 0.0 2.8 0.6 3.4 2.1 0.0 0.3 1.3 3.3 4.6 10.3 3.2 1.7 2.2 0.0 0.0 2.2 0.3 10.2 1.5 0.6 0.0 1.0 0.0 6.1 0.0 3.5 2.1 0.3 0.0 2.2 0.1 0.7 0.0 8.5 0.6 4.7 6.6 1.5 1.2 6.5 5.1 4.2 1.8 3.4 0.1 5.2 0.0 0.2 SKIV2L "170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1" ENSG00000204351 "Ski2 like RNA helicase" Q15477 6 31959117-31969751 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047122, HPA051959, HPA054419" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Mitotic spindle, Cytosol" "HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482" "unprognostic (1.43e-1)" "unprognostic (5.75e-2)" "unprognostic (3.41e-2)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.36e-2)" "unprognostic (2.14e-2)" "unprognostic (7.75e-2)" "unprognostic (7.99e-3)" "unprognostic (1.53e-3)" "prognostic unfavorable (3.02e-7)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (1.20e-1)" "unprognostic (9.06e-2)" 21.9 33.1 0.0 5.2 0.3 4.1 21.6 0.0 0.4 26.5 0.0 25.1 10.5 22.6 9.4 23.0 25.0 0.0 22.0 0.0 0.1 24.0 54.7 22.2 3.4 0.0 0.5 24.6 25.7 2.4 39.7 2.6 0.0 31.9 2.4 2.1 22.4 3.2 20.4 20.2 31.2 5.7 0.0 40.6 27.6 16.6 0.1 4.3 27.7 5.3 2.7 23.6 20.9 0.0 0.2 12.7 13.3 0.0 16.5 11.8 27.1 10.9 11.7 13.6 13.2 0.4 0.0 0.0 26.0 25.5 13.2 11.9 0.0 30.8 9.9 14.8 15.7 0.0 0.0 0.2 0.0 0.1 0.2 28.3 17.9 0.1 0.0 12.7 0.0 19.3 0.0 13.6 0.0 0.0 0.0 0.3 20.6 0.0 0.0 0.3 0.0 0.0 11.2 0.0 0.0 0.0 23.6 0.0 17.6 11.5 0.0 15.7 12.8 16.0 7.2 18.7 0.2 42.2 35.7 12.0 20.4 0.1 0.0 0.3 0.5 0.2 1.5 1.4 1.1 0.2 0.7 0.3 1.1 0.9 0.8 0.8 0.1 0.0 2.2 0.5 0.2 0.4 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 6.4 16.0 11.3 10.1 13.3 2.8 5.0 7.9 11.4 5.0 9.3 5.1 8.5 10.0 8.8 7.3 8.4 12.6 12.7 19.7 1.9 9.5 3.1 7.7 7.9 7.9 12.6 6.5 7.2 8.6 7.9 7.4 28.1 6.3 8.2 10.8 8.6 19.4 9.2 0.0 5.0 13.2 8.2 6.3 4.1 1.5 9.3 7.8 7.2 2.8 10.2 4.9 18.6 3.0 4.8 9.4 16.0 6.0 20.2 5.9 25.5 6.9 16.5 8.3 0.0 4.1 10.2 4.7 7.5 6.6 3.7 12.4 14.4 12.3 11.0 5.2 SLC27A6 "ACSVL2, FACVL2, FATP6, VLCS-H1" ENSG00000113396 "Solute carrier family 27 member 6" Q9Y2P4 5 128538013-129033642 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 24.4;fallopian tube: 21.3;heart muscle: 23.5" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5" "Cancer enriched" "Detected in many" 8 "thyroid cancer: 19.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "BEWO: 43.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA008987 Approved Approved "Nuclear bodies" NA NA "Cluster 43: Testis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear bodies" "HPA008987: AB_1857065" "unprognostic (5.39e-5)" "unprognostic (4.79e-2)" "unprognostic (1.04e-1)" "unprognostic (3.15e-1)" "unprognostic (3.55e-1)" "unprognostic (1.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-1)" "unprognostic (2.78e-1)" "unprognostic (1.53e-1)" "unprognostic (2.64e-1)" "unprognostic (2.14e-1)" "unprognostic (2.54e-2)" "unprognostic (9.66e-4)" 0.4 24.4 1.8 0.3 2.4 0.1 3.0 3.0 1.4 3.9 0.7 0.9 0.4 4.3 0.2 4.2 21.3 2.7 23.5 1.2 3.6 0.0 0.1 0.8 0.2 9.7 5.2 9.7 0.1 0.0 6.0 6.7 7.5 3.6 1.7 7.4 3.5 0.3 0.4 2.0 1.1 0.8 5.8 0.1 0.5 13.0 5.5 9.6 1.8 0.9 5.7 1.1 2.9 8.4 0.0 0.0 0.1 0.0 0.0 0.0 43.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.9 0.2 0.7 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 3.5 0.0 3.3 2.0 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.3 4.4 0.0 5.1 0.0 3.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.4 3.0 1.4 1.2 3.6 9.7 5.2 7.5 5.8 5.5 8.4 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 25.0 0.6 0.2 5.5 29.6 0.0 0.0 0.0 0.0 54.8 0.0 0.0 0.0 0.0 13.2 3.8 1.0 0.3 0.0 0.0 0.4 0.0 37.3 2.7 0.0 1.9 0.0 1.7 0.0 0.0 3.8 3.3 4.6 0.0 0.0 0.0 0.4 2.8 0.3 0.2 0.0 0.0 0.0 33.0 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.9 0.0 18.0 0.3 1.1 1.0 1.8 0.9 27.5 0.0 2.3 0.1 0.1 SLC3A1 "ATR1, CSNU1, D2H, NBAT, RBAT" ENSG00000138079 "Solute carrier family 3 member 1" Q07837 2 44275458-44321494 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cystinuria, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 136.2;kidney: 649.3;pancreas: 217.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0" "Cancer enriched" "Detected in many" 7 "renal cancer: 61.9" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 22 "RPTEC TERT1: 106.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA038360, HPA071102" Enhanced Approved "Nuclear bodies,Mitochondria" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "Nuclear bodies" "HPA038360: AB_2675975, HPA071102: AB_2732171" "unprognostic (1.67e-2)" "unprognostic (1.74e-1)" "unprognostic (1.39e-1)" "unprognostic (1.43e-2)" "unprognostic (6.14e-2)" "unprognostic (9.45e-2)" "unprognostic (2.76e-2)" "unprognostic (1.34e-1)" "unprognostic (3.90e-1)" "unprognostic (8.73e-2)" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "prognostic favorable (3.67e-7)" "unprognostic (6.10e-2)" "unprognostic (1.26e-1)" "unprognostic (3.77e-1)" "unprognostic (1.58e-4)" 0.5 0.3 1.2 1.1 1.7 0.6 0.4 6.8 3.4 1.0 0.1 22.4 113.9 1.4 1.9 0.2 0.6 51.5 0.4 1.6 1.3 649.3 36.6 0.4 0.4 0.6 0.6 0.5 217.5 0.0 0.5 0.1 0.7 1.0 22.7 3.5 0.3 0.3 1.0 0.6 136.2 0.5 0.0 0.5 0.9 1.7 1.0 0.0 0.4 0.1 0.1 0.3 0.3 1.7 0.0 1.0 0.0 0.2 0.2 0.1 0.3 0.1 0.0 0.0 0.1 4.9 0.0 0.1 4.3 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.4 0.2 0.0 0.0 0.4 0.1 1.2 0.5 0.1 0.1 0.2 106.1 0.0 0.2 0.2 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.1 0.3 0.2 0.4 0.3 0.3 0.7 0.3 0.4 0.5 0.6 0.3 0.1 1.0 0.6 0.7 0.4 0.4 0.1 0.3 0.2 0.1 1.2 1.7 6.8 3.4 1.6 1.3 0.6 0.6 0.7 0.0 1.0 1.7 0.2 3.2 1.5 0.3 6.1 0.0 0.3 0.0 0.0 12.1 0.2 0.0 0.4 74.4 0.0 42.3 10.4 0.1 0.8 18.2 62.6 37.0 12.4 62.2 14.4 0.6 0.0 0.0 9.1 13.8 0.0 0.9 1.1 128.9 0.0 0.1 0.4 4.6 0.1 21.9 9.0 8.4 0.0 0.0 0.0 8.5 1.2 3.2 0.0 1.0 1.6 1.0 1.0 3.0 3.7 4.8 18.6 0.4 1.5 1.1 258.9 363.0 0.0 11.2 0.0 2.6 1.2 0.8 0.4 0.7 0.1 0.1 2.8 0.2 15.7 1.2 SLC5A7 "CHT1, hCHT" ENSG00000115665 "Solute carrier family 5 member 7" Q9GZV3 2 107986523-108013994 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport" "Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 32.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "RT4: 3.6;SCLC-21H: 1.0" "Group enriched" "Detected in many" 4 "basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2" "Group enriched" "Detected in many" 6 "basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7" HPA046105 Approved "Nuclear bodies,Cell Junctions,Intermediate filaments" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 15: RT4 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cell Junctions, Intermediate filaments" "Nuclear bodies" "HPA046105: " "unprognostic (2.98e-1)" "unprognostic (1.01e-1)" "unprognostic (1.29e-3)" "unprognostic (7.10e-2)" "unprognostic (1.66e-1)" "unprognostic (3.39e-4)" "unprognostic (1.05e-2)" "unprognostic (9.78e-3)" "unprognostic (6.42e-2)" "unprognostic (1.61e-2)" 0.1 0.7 1.1 0.5 3.0 0.0 0.1 0.0 10.3 0.7 1.0 2.6 0.7 0.1 0.1 0.3 0.1 0.1 0.3 0.2 5.3 0.3 0.0 0.2 0.0 20.2 21.2 0.2 0.1 0.0 0.0 0.0 32.9 0.3 0.7 0.9 0.3 1.1 0.0 0.0 0.8 0.7 2.8 0.0 0.5 0.1 1.6 0.0 1.2 0.1 0.0 1.3 0.6 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.0 0.0 10.3 0.2 5.3 20.2 21.2 32.9 2.8 1.6 7.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 SLTM "FLJ13213, Met" ENSG00000137776 "SAFB like transcription modulator" Q9NWH9 15 58879050-58933679 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040256, HPA040381" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA040256: AB_10674990, HPA040381: AB_2676953" "unprognostic (2.36e-1)" "unprognostic (6.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.81e-1)" "unprognostic (2.52e-3)" "unprognostic (9.65e-2)" "unprognostic (1.00e-1)" "unprognostic (2.48e-1)" "unprognostic (2.82e-3)" "unprognostic (3.44e-1)" "unprognostic (2.09e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (7.09e-2)" "unprognostic (3.69e-1)" "unprognostic (5.71e-2)" "unprognostic (3.24e-3)" 31.2 21.5 27.3 31.5 30.6 57.7 29.5 35.6 34.6 29.9 26.3 30.0 30.0 27.6 20.8 38.5 27.8 23.8 28.4 25.6 28.6 33.6 34.9 28.2 42.7 28.3 29.1 29.6 24.9 36.1 28.4 21.0 28.6 29.2 32.1 44.9 30.6 24.2 46.1 35.1 33.4 25.8 27.5 38.1 38.9 27.8 28.7 57.3 34.1 43.6 44.1 33.8 31.3 31.3 77.8 84.1 72.0 36.6 48.1 36.2 60.6 55.1 64.3 49.9 48.2 58.4 45.7 144.6 50.5 50.8 54.4 67.9 72.3 62.9 68.7 93.7 46.4 105.4 91.8 44.7 42.0 83.8 78.1 34.1 61.0 52.8 44.1 30.4 46.9 66.0 95.5 81.7 58.2 56.1 84.1 64.6 80.9 46.3 40.5 63.6 65.4 70.1 60.2 99.8 58.9 50.8 57.0 55.1 57.8 79.3 44.0 90.1 48.6 60.2 88.5 66.3 74.6 57.3 123.1 105.5 47.6 101.7 61.5 67.9 30.3 44.4 45.2 29.5 46.1 53.5 36.0 39.3 31.2 47.3 39.2 35.6 42.8 47.0 37.7 53.6 36.5 22.7 27.3 30.6 35.6 34.6 25.6 28.6 28.3 29.1 28.6 27.5 28.7 31.3 92.5 153.8 161.2 61.4 125.8 96.9 100.2 85.6 107.0 116.3 77.3 66.0 107.8 64.3 122.8 106.7 98.0 73.5 155.9 88.4 78.2 98.4 100.8 110.5 99.0 94.7 73.4 115.7 67.7 115.7 160.1 94.3 99.4 119.1 118.9 75.3 63.9 104.1 63.9 119.5 67.3 94.4 59.0 88.6 73.0 120.8 86.3 108.8 78.2 72.1 121.0 84.9 126.7 74.4 141.8 131.1 76.5 88.4 140.0 92.4 57.4 90.6 103.9 145.3 72.3 106.6 95.6 215.1 85.2 100.0 104.6 112.5 134.9 78.0 94.0 125.6 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702236-66782849 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.1;lung: 27.9" "Cell type enhanced" "Detected in many" "Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.5 2.6 5.2 1.6 4.9 0.1 7.6 4.9 4.3 6.8 8.6 3.7 1.9 6.2 0.6 2.1 5.4 1.4 30.1 3.4 4.1 8.9 6.7 27.9 0.5 7.6 5.4 5.9 2.7 1.1 3.4 7.4 5.8 7.0 1.1 0.9 2.1 3.5 1.6 2.4 3.9 0.9 4.4 2.6 5.5 1.8 6.8 0.4 15.5 1.5 0.2 8.0 5.7 4.6 1.3 10.2 1.6 3.5 6.0 1.6 9.4 7.2 0.1 1.1 0.1 2.0 4.6 0.7 29.8 6.1 0.9 18.2 2.2 0.0 0.2 2.3 8.4 16.1 28.6 1.7 0.7 0.1 1.2 2.0 0.0 0.1 0.0 3.4 1.3 5.1 1.4 1.0 0.5 2.0 0.1 4.4 3.0 10.5 3.8 0.0 1.8 2.2 3.4 8.1 3.6 1.6 3.9 4.3 0.8 5.9 1.4 2.9 6.2 4.3 5.5 17.6 1.4 0.5 1.8 0.3 3.1 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.9 4.9 4.3 3.4 4.1 7.6 5.4 5.8 4.4 6.8 4.6 19.8 12.8 6.0 5.2 0.9 0.8 1.2 2.1 0.6 0.6 0.9 1.1 4.9 4.3 3.0 1.8 2.1 0.8 0.1 4.3 3.9 4.7 3.4 8.3 5.5 25.1 0.0 0.0 0.3 5.8 0.9 4.9 5.1 6.5 4.5 5.9 91.4 4.0 1.7 0.0 0.3 2.1 0.0 10.0 0.3 1.4 2.8 1.2 0.0 57.1 0.7 10.2 0.0 0.5 0.4 8.4 1.5 8.2 0.0 1.3 2.1 1.9 0.1 0.6 0.0 0.9 1.5 0.2 3.2 0.4 0.1 0.8 0.4 0.1 5.5 0.4 SMCHD1 "FSHD2, KIAA0650" ENSG00000101596 "Structural maintenance of chromosomes flexible hinge domain containing 1" A6NHR9 18 2655726-2805017 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Hydrolase" "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 363.7;Plasma cells: 391.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 58.7" "Lineage enriched" "Detected in all" 8 "granulocytes: 58.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039441 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 2: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear bodies" "HPA039441: AB_10671042" "unprognostic (2.99e-2)" "unprognostic (5.14e-2)" "unprognostic (1.33e-2)" "unprognostic (9.03e-2)" "unprognostic (8.66e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (5.39e-4)" "unprognostic (1.32e-1)" "unprognostic (4.14e-2)" "unprognostic (3.11e-3)" "unprognostic (3.32e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (8.92e-2)" "unprognostic (2.63e-2)" 13.6 6.9 5.4 24.6 6.6 41.1 12.4 11.4 8.3 16.5 6.8 14.4 13.7 14.9 9.2 8.7 14.1 12.4 10.1 5.0 6.6 6.5 8.4 19.0 33.9 7.2 6.1 15.4 16.3 11.9 7.9 16.3 7.4 13.4 14.7 16.3 10.1 11.2 11.0 9.1 20.3 12.8 6.4 28.6 12.4 14.1 6.3 25.6 9.6 11.5 22.4 15.0 14.2 8.7 24.1 10.7 35.8 22.6 15.0 21.8 25.7 23.7 16.8 22.0 27.7 20.3 7.7 51.6 10.2 21.2 24.7 13.0 29.1 13.6 34.4 10.7 15.1 32.3 21.7 19.5 16.8 93.9 24.3 14.4 12.2 27.9 22.8 16.8 18.3 25.5 38.3 31.1 21.3 8.6 39.4 23.9 14.4 13.0 12.4 31.7 29.1 22.9 13.6 36.5 29.2 18.4 32.0 10.6 18.8 19.8 7.9 39.3 17.5 27.1 37.4 37.1 44.0 18.8 30.4 46.5 17.4 17.1 24.0 5.1 2.5 6.6 3.6 1.7 2.6 5.8 4.8 4.3 0.9 7.5 5.9 3.8 58.7 2.3 2.3 2.6 5.4 1.3 5.4 6.6 11.4 8.3 5.0 6.6 7.2 6.1 7.4 6.4 6.3 8.7 96.5 44.8 44.7 71.5 363.7 27.1 35.3 14.5 48.9 112.1 33.3 32.8 53.0 15.7 27.7 18.4 100.1 36.5 232.7 102.7 5.9 23.4 117.2 43.6 83.3 53.0 22.7 69.0 98.4 19.4 22.3 52.8 68.3 75.9 40.4 54.2 30.7 16.4 19.4 99.3 127.2 35.5 10.2 65.4 69.7 38.6 42.0 116.3 30.2 121.8 142.5 32.3 120.5 111.1 130.4 23.6 60.1 38.0 391.1 52.0 46.5 6.1 22.5 88.5 39.5 59.7 69.8 166.7 115.3 41.3 24.9 46.9 257.9 45.9 30.4 57.8 SMIM2 "C13orf44, MGC5590" ENSG00000139656 "Small integral membrane protein 2" Q9BVW6 13 44143150-44161257 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 23.4" "Cell type enriched" "Detected in some" 6 "Early spermatids: 53.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.5;OE19: 4.8" "Low region specificity" "Detected in single" "HPA026891, HPA077071" Enhanced Uncertain "Nucleoplasm,Nuclear bodies" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" "HPA026891: AB_10602924, HPA077071: " "unprognostic (4.34e-2)" "unprognostic (8.70e-2)" "unprognostic (1.07e-1)" "unprognostic (4.87e-5)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (3.26e-1)" "unprognostic (1.26e-1)" "unprognostic (2.32e-1)" "unprognostic (1.85e-2)" "unprognostic (2.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-1)" "unprognostic (4.80e-2)" "unprognostic (2.39e-2)" "unprognostic (1.05e-2)" 0.2 0.2 0.6 0.1 0.7 0.0 0.0 0.2 1.9 0.0 0.5 0.8 0.8 0.0 2.9 0.3 0.2 0.3 0.9 0.5 0.4 0.8 0.4 0.2 0.0 0.1 0.6 0.1 0.6 0.0 0.2 0.4 0.1 0.2 0.0 0.3 0.5 0.1 0.9 0.3 1.9 0.5 0.1 0.2 0.5 23.4 0.3 4.9 0.3 0.0 0.0 0.3 0.0 0.4 0.4 0.2 0.4 0.0 0.0 0.0 0.4 0.0 2.5 0.5 0.0 0.5 0.1 0.7 0.4 0.0 0.4 1.2 0.0 1.0 0.7 0.0 0.7 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.3 4.8 0.4 0.4 0.0 0.0 0.0 0.1 1.1 0.5 1.3 0.5 0.9 0.9 0.0 0.0 0.2 0.0 0.5 0.7 0.1 0.0 0.0 0.2 0.6 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.7 0.2 1.9 0.5 0.4 0.1 0.6 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 SMN1 "BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A" ENSG00000172062 "Survival of motor neuron 1, telomeric" Q16637 5 70925030-70953942 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Club cells: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 120.5;NB-4: 77.9;T-47d: 88.9;WM-115: 120.3" "CAB016324, HPA045271, CAB069888, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" "Nuclear bodies, Cytosol" "CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: " "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.18e-1)" "unprognostic (2.09e-1)" "unprognostic (2.85e-1)" "unprognostic (9.52e-3)" "unprognostic (2.10e-2)" "unprognostic (2.43e-1)" "unprognostic (9.91e-3)" "unprognostic (1.13e-2)" "unprognostic (1.01e-1)" "unprognostic (4.41e-1)" "prognostic unfavorable (6.62e-13)" "unprognostic (2.04e-1)" "unprognostic (2.17e-1)" "unprognostic (8.06e-2)" "unprognostic (4.14e-2)" 28.0 21.8 5.7 4.9 6.1 21.8 26.8 7.6 7.5 33.8 5.0 25.8 2.1 24.7 12.8 25.8 31.5 7.4 20.4 6.3 7.1 22.6 37.6 22.0 15.5 6.5 5.7 36.8 27.6 6.9 26.4 5.1 6.1 25.6 7.8 12.1 21.5 3.8 31.5 24.0 19.6 8.2 5.9 22.6 20.3 24.8 5.7 2.4 24.2 1.5 1.9 26.1 27.6 6.6 11.3 2.1 3.5 4.0 19.3 23.0 62.8 3.5 4.9 5.3 3.8 4.1 4.1 4.6 69.5 9.9 5.8 7.4 5.4 3.7 4.2 1.0 5.2 65.4 6.2 6.2 1.3 7.9 5.8 1.5 29.8 1.8 1.8 31.4 3.0 4.1 2.7 6.4 2.7 3.2 120.5 77.9 4.4 0.9 2.1 6.0 15.9 58.0 2.4 5.2 11.4 16.2 6.5 23.4 69.4 2.4 88.9 21.2 32.7 33.8 3.8 3.1 7.5 4.2 3.0 60.0 4.9 4.8 120.3 9.8 7.4 4.3 6.4 12.2 17.6 13.2 10.2 7.7 11.2 7.2 13.1 14.5 2.1 8.7 13.5 13.1 16.1 6.3 5.7 6.1 7.6 7.5 6.3 7.1 6.5 5.7 6.1 5.9 5.7 6.6 5.0 9.6 11.5 0.0 5.6 13.9 4.6 10.7 0.6 4.7 4.1 4.3 22.4 7.2 29.9 1.8 10.4 7.9 7.0 2.3 5.9 6.8 18.2 5.6 5.5 6.8 6.0 9.9 1.3 4.6 8.4 11.8 4.1 4.4 19.6 4.0 5.0 2.9 4.8 3.3 1.1 4.2 10.2 3.4 4.4 12.9 9.3 5.2 5.4 0.0 6.1 1.4 12.3 1.0 1.3 6.5 1.8 6.4 5.1 2.9 3.8 4.5 28.1 7.8 13.1 7.4 8.5 16.0 17.2 6.9 12.5 8.8 7.2 5.6 4.2 4.1 SMN2 "BCD541, GEMIN1, SMNC, TDRD16B" ENSG00000205571 "Survival of motor neuron 2, centromeric" Q16637 5 70049638-70078522 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Neurogenesis" RNA-binding "Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 41.8;Club cells: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2" "CAB009344, HPA045271, HPA073601" Supported Supported "Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear bodies, Cytosol" "CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: " "unprognostic (2.07e-2)" "unprognostic (5.70e-3)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.77e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.08e-1)" "unprognostic (1.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.21e-1)" "unprognostic (5.19e-2)" "unprognostic (2.98e-5)" "unprognostic (2.36e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-1)" "unprognostic (1.19e-1)" 19.7 15.6 1.6 4.5 1.8 13.8 19.4 1.0 2.3 20.3 1.0 19.2 0.5 20.0 16.9 17.1 15.2 13.6 16.0 1.1 7.2 14.4 23.2 16.4 13.8 1.7 2.0 25.9 18.3 8.4 20.5 3.8 2.0 18.8 5.6 3.0 15.1 5.8 26.0 17.0 13.6 14.0 1.3 14.7 14.5 16.5 1.6 0.1 17.3 0.0 0.1 16.0 20.9 2.3 61.3 0.6 0.6 0.4 16.1 20.9 122.7 31.7 21.1 42.0 44.0 0.4 0.4 1.2 86.6 31.8 1.1 28.8 0.9 0.0 50.1 0.8 1.2 68.6 0.0 2.1 0.0 1.1 0.0 0.3 36.0 0.0 1.1 14.3 0.7 0.0 0.0 0.6 0.0 0.6 125.1 106.2 0.5 0.0 0.5 0.0 45.8 55.3 31.5 0.3 30.5 70.7 60.2 6.7 89.7 0.0 41.4 25.2 53.4 27.2 1.3 0.4 0.7 0.6 1.1 72.4 0.4 0.0 76.2 8.0 9.9 5.2 12.1 16.5 14.6 16.8 14.4 10.1 16.6 20.0 17.0 14.8 1.8 10.9 11.4 16.3 12.7 13.4 1.6 1.8 1.0 2.3 1.1 7.2 1.7 2.0 2.0 1.3 1.6 2.3 2.0 6.4 7.8 0.0 2.7 13.6 3.4 9.7 1.8 0.3 2.7 2.8 41.8 0.0 20.2 1.8 0.0 6.9 4.0 1.1 5.9 2.7 14.1 3.3 4.0 6.6 1.8 3.4 0.0 1.0 3.3 10.1 2.6 3.2 8.2 1.2 2.5 3.1 2.6 1.7 0.0 3.1 6.1 2.6 6.8 8.9 7.2 3.3 1.8 0.0 2.9 0.6 2.1 0.0 0.0 2.3 1.6 5.3 2.5 1.7 2.7 3.8 14.0 1.1 0.0 5.3 6.4 12.0 11.4 3.1 12.6 7.1 5.0 1.0 2.5 2.8 SMNDC1 "SMNR, SPF30, TDRD16C" ENSG00000119953 "Survival motor neuron domain containing 1" O75940 10 110290730-110304938 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061214, HPA070666" Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nuclear bodies" "HPA061214: AB_2684451, HPA070666: " "unprognostic (4.65e-2)" "unprognostic (1.68e-2)" "unprognostic (2.64e-1)" "unprognostic (3.07e-2)" "unprognostic (3.63e-3)" "unprognostic (5.03e-3)" "prognostic unfavorable (8.08e-6)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.68e-3)" "unprognostic (6.88e-3)" "unprognostic (1.35e-1)" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (2.00e-1)" 16.3 12.0 7.0 15.1 7.5 31.8 13.7 10.8 11.1 13.8 7.7 13.4 9.9 14.4 8.7 16.2 13.3 11.6 12.4 6.5 7.2 13.6 14.9 14.2 16.9 7.1 6.9 13.5 10.2 13.1 8.9 18.4 7.0 10.0 11.1 16.6 11.5 10.2 24.8 13.2 11.5 14.6 7.5 14.7 11.5 13.1 7.1 20.4 12.1 17.9 18.3 17.3 13.7 9.4 36.2 27.0 38.9 44.9 29.6 35.1 28.9 41.0 42.6 53.3 54.6 35.1 43.7 51.2 25.7 25.9 30.5 38.5 57.8 28.2 59.9 29.0 30.6 51.1 21.9 41.2 35.3 56.9 47.2 27.4 29.7 42.2 71.1 39.5 30.0 29.0 46.8 46.5 41.9 17.1 61.0 55.0 43.5 27.8 18.4 52.0 77.9 26.8 30.0 25.7 19.4 26.0 26.6 22.4 48.9 33.3 27.7 32.3 33.0 31.2 35.2 28.9 52.9 37.8 42.4 76.7 31.4 77.9 24.6 5.7 8.9 14.5 5.2 9.2 6.4 5.4 6.8 6.7 8.6 4.8 5.9 5.9 16.6 6.3 9.8 5.2 8.1 4.3 7.0 7.5 10.8 11.1 6.5 7.2 7.1 6.9 7.0 7.5 7.1 9.4 57.7 28.9 37.1 6.8 53.4 69.6 42.5 27.2 89.4 27.3 31.7 26.7 23.4 14.3 27.9 11.0 20.9 33.0 55.7 23.9 33.2 22.8 10.7 34.2 52.0 41.5 18.6 37.0 7.8 18.0 32.0 39.1 37.8 58.8 58.3 27.3 27.1 26.5 32.4 33.7 8.0 21.4 38.7 40.9 79.7 4.4 29.2 47.7 35.6 6.5 45.8 23.0 22.6 5.0 11.2 21.7 21.0 22.2 45.7 53.3 20.6 40.9 28.6 33.0 19.7 30.8 39.7 46.2 37.7 72.4 83.4 46.1 57.4 33.5 24.1 65.8 SMS "MRSR, SPMSY, SpS, SRS" ENSG00000102172 "Spermine synthase" P52788 X 21940709-21994837 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Polyamine biosynthesis" Transferase "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 644.3;Distal tubular cells: 608.4;Syncytiotrophoblasts: 869.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029849, HPA029852" Approved Approved "Nuclear bodies,Cytosol" No No 16000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Nuclear bodies" Cytosol "HPA029849: AB_10602072, HPA029852: AB_10611521" "unprognostic (2.51e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (7.49e-4)" "prognostic unfavorable (7.79e-8)" "unprognostic (1.02e-2)" "unprognostic (2.72e-1)" "unprognostic (3.18e-3)" "unprognostic (3.95e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (7.85e-5)" "unprognostic (2.70e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-1)" "unprognostic (8.50e-2)" 29.7 94.3 52.0 34.7 53.5 50.8 49.6 56.0 61.9 42.7 43.7 52.0 54.9 44.7 63.6 30.6 28.6 40.5 53.0 53.9 50.2 119.9 44.3 36.2 47.8 48.6 46.7 91.2 24.1 28.0 31.5 114.2 49.1 136.0 50.4 49.5 39.7 42.2 34.6 21.4 50.9 39.6 47.0 41.3 39.3 30.2 53.9 50.7 55.3 32.5 47.3 55.1 32.0 49.6 664.3 161.2 265.3 107.1 71.9 121.4 86.3 174.6 102.6 261.7 249.1 204.0 213.0 239.5 59.8 180.0 722.9 142.2 265.5 318.2 508.2 111.0 128.6 124.4 201.0 145.5 129.4 242.2 103.8 76.8 93.7 266.4 497.2 189.2 254.5 93.6 270.6 32.7 366.7 139.2 181.3 244.1 474.9 149.0 244.3 176.0 188.5 182.9 354.3 90.1 131.4 105.7 143.1 181.8 489.1 687.6 163.9 101.3 232.3 194.4 193.6 405.0 294.5 23.8 52.6 142.2 378.4 107.5 275.6 9.1 57.5 102.5 18.9 59.9 23.7 34.6 29.6 33.3 51.1 22.0 19.1 22.8 55.7 31.4 73.9 10.7 55.4 37.3 52.0 53.5 56.0 61.9 53.9 50.2 48.6 46.7 49.1 47.0 53.9 49.6 43.4 25.6 21.9 33.6 61.5 65.9 203.0 206.1 42.1 35.7 116.2 66.3 36.1 81.5 115.0 110.3 12.5 644.3 46.7 61.2 608.4 246.3 1.9 126.4 70.4 61.9 58.8 95.2 45.6 152.3 313.1 86.6 57.6 215.9 40.5 249.5 59.6 49.8 364.7 21.9 40.2 103.6 146.5 157.3 200.3 7.1 95.4 153.1 92.5 21.5 250.7 46.8 48.4 22.1 8.1 165.6 63.9 103.4 45.6 276.2 137.0 466.7 78.9 43.2 65.7 76.6 114.2 6.0 181.3 54.1 50.6 869.6 63.7 271.2 119.1 153.1 SNAPC2 "PTFdelta, SNAP45" ENSG00000104976 "Small nuclear RNA activating complex polypeptide 2" Q13487 19 7920338-7923250 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049843, HPA077597" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 18: U-2197 - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nuclear bodies" Cytosol "HPA049843: AB_2680910, HPA077597: AB_2732354" "unprognostic (4.56e-3)" "unprognostic (1.89e-1)" "unprognostic (7.98e-3)" "unprognostic (8.11e-3)" "unprognostic (2.03e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (4.89e-5)" "unprognostic (1.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-1)" "unprognostic (5.45e-2)" "unprognostic (2.02e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (3.22e-1)" "unprognostic (5.30e-2)" "unprognostic (9.78e-2)" 21.2 21.6 15.4 10.4 17.7 16.7 19.6 14.7 21.4 37.1 11.0 36.1 9.7 50.7 5.7 14.3 35.0 8.3 16.6 17.1 16.0 17.2 11.9 17.1 9.1 15.6 15.2 20.7 17.8 10.1 25.5 6.5 16.4 27.0 3.8 1.8 16.6 17.2 9.0 20.5 15.2 12.4 13.8 21.4 18.7 32.6 16.3 7.6 13.1 9.7 4.9 31.7 25.1 15.3 20.6 22.9 10.8 42.0 14.7 31.1 10.0 21.4 22.6 20.5 18.5 10.6 17.4 17.6 25.8 25.0 16.4 24.7 7.7 15.9 5.9 22.7 19.7 24.5 9.6 15.4 26.6 15.4 38.7 25.5 24.0 24.3 14.9 16.6 23.5 18.1 24.5 28.3 12.7 18.1 19.9 43.6 13.9 10.4 51.8 23.4 10.7 17.6 19.1 7.1 12.7 28.7 11.0 11.8 48.6 4.8 19.2 16.6 30.9 68.8 24.5 65.2 26.8 27.4 48.1 10.8 43.1 31.6 22.2 7.0 23.8 23.5 19.0 30.8 19.2 15.7 16.1 16.5 30.1 14.5 16.6 16.9 3.5 27.7 33.4 19.9 24.0 16.4 15.4 17.7 14.7 21.4 17.1 16.0 15.6 15.2 16.4 13.8 16.3 15.3 19.8 3.2 3.7 3.3 15.4 24.3 20.0 25.1 35.9 8.6 25.8 26.2 3.2 7.2 10.7 11.0 0.0 12.2 22.9 9.8 17.6 21.2 1.9 10.7 25.0 20.7 12.0 20.2 4.1 24.5 24.2 18.5 8.6 15.0 18.4 15.4 12.5 5.2 28.6 23.5 2.6 11.9 14.2 19.6 28.0 6.0 13.7 19.2 19.6 1.0 31.3 6.0 13.4 2.0 3.0 28.9 6.6 14.3 8.4 28.5 16.7 16.1 3.0 6.1 13.1 7.3 30.1 9.5 38.6 19.0 24.3 9.9 18.4 29.2 15.5 24.1 SNAPC3 "MGC132011, MGC33124, PTFbeta, SNAP50" ENSG00000164975 "Small nuclear RNA activating complex polypeptide 3" Q92966 9 15422704-15465953 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 121.7;Late spermatids: 270.7;Spermatocytes: 113.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053145, HPA066031" Supported "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Nucleoli "HPA053145: AB_2682055, HPA066031: AB_2685600" "unprognostic (2.62e-1)" "unprognostic (4.26e-1)" "unprognostic (5.42e-3)" "unprognostic (2.09e-1)" "unprognostic (4.93e-3)" "unprognostic (6.08e-2)" "unprognostic (5.60e-3)" "unprognostic (4.15e-2)" "unprognostic (1.68e-2)" "unprognostic (1.67e-2)" "unprognostic (1.12e-2)" "unprognostic (2.64e-2)" "unprognostic (1.36e-3)" "unprognostic (3.07e-1)" "unprognostic (2.63e-1)" "unprognostic (4.38e-2)" "unprognostic (2.09e-2)" 4.1 6.6 5.5 4.0 5.2 1.7 3.8 10.4 7.6 6.5 4.9 5.8 4.2 5.9 5.4 5.5 5.1 3.8 7.0 7.7 5.5 4.6 3.4 4.3 4.4 5.4 5.5 7.1 4.3 4.9 5.1 6.2 6.2 4.8 5.1 11.3 4.5 3.7 7.9 5.0 5.3 4.5 4.5 4.9 4.8 5.5 6.4 3.5 4.4 6.2 3.9 5.1 5.9 8.0 4.7 5.9 12.3 4.7 9.6 10.0 7.2 7.2 3.1 4.2 4.9 2.8 2.0 3.3 2.7 4.6 5.9 2.8 6.6 3.4 5.1 15.5 7.7 11.9 13.4 4.0 4.8 2.7 8.9 6.5 6.6 2.9 3.3 17.7 7.8 7.7 3.4 5.3 9.7 1.4 3.2 8.5 3.9 3.5 15.4 6.6 1.5 1.8 7.3 2.8 13.1 9.2 2.5 2.2 1.7 10.7 5.3 5.5 6.5 7.0 2.7 3.0 9.3 6.9 9.0 4.2 4.4 3.5 3.3 4.9 14.2 7.8 7.6 24.6 7.6 15.2 7.6 7.0 11.2 16.5 10.9 10.5 1.7 7.8 32.2 9.2 12.2 8.9 5.5 5.2 10.4 7.6 7.7 5.5 5.4 5.5 6.2 4.5 6.4 8.0 13.8 19.2 11.9 31.6 21.1 9.6 14.1 18.1 8.6 19.7 9.7 6.9 39.5 7.2 16.8 20.2 31.3 12.4 14.5 21.3 13.7 17.6 121.7 15.2 14.8 18.7 15.0 19.4 56.0 9.2 17.3 15.3 11.2 14.7 17.2 22.2 20.3 14.8 16.1 35.3 63.9 15.7 38.7 25.0 10.7 270.7 33.8 16.3 19.6 26.2 21.5 13.8 18.6 46.8 46.3 12.4 27.9 30.5 18.0 9.8 36.4 28.4 23.9 19.0 13.1 11.6 32.0 113.3 27.1 9.1 11.9 9.7 13.4 34.6 17.7 11.7 SNRPA1 "Lea1, U2A'" ENSG00000131876 "Small nuclear ribonucleoprotein polypeptide A'" P09661 15 101281510-101295282 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045622, HPA048499" Supported Supported "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA 48000 "Cluster 39: Non-specific - mRNA processing" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear speckles, Nuclear bodies" "HPA045622: AB_2679394, HPA048499: AB_2680421" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (8.56e-5)" "unprognostic (5.80e-2)" "unprognostic (1.66e-3)" "prognostic favorable (8.83e-5)" "unprognostic (4.74e-2)" "unprognostic (6.77e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (2.84e-1)" "unprognostic (2.43e-1)" "unprognostic (1.37e-2)" 19.0 18.2 11.0 35.5 11.4 68.1 20.8 13.2 15.4 14.7 14.7 30.6 24.3 15.5 33.0 33.8 18.6 12.7 25.8 12.0 11.6 25.2 25.5 19.5 43.3 11.5 11.3 13.6 22.2 18.3 13.9 30.4 11.7 16.3 30.8 15.5 23.1 12.6 19.7 18.5 30.1 19.3 10.9 25.2 23.2 37.8 12.4 37.4 18.3 12.4 51.9 26.3 18.2 12.6 175.5 119.5 112.7 57.4 31.3 25.6 111.3 158.2 72.8 139.2 105.1 255.8 150.7 192.9 89.2 107.8 109.0 101.7 170.2 113.1 148.1 98.0 262.5 151.4 196.7 137.3 24.0 175.1 103.7 21.0 83.0 89.0 111.3 30.9 90.9 147.1 216.1 175.8 86.5 194.6 177.6 185.7 144.5 232.0 100.1 174.5 121.7 194.8 103.3 450.2 88.6 92.7 97.2 109.0 125.1 117.1 105.2 136.4 66.2 74.1 141.0 86.8 160.3 143.5 464.8 378.9 59.9 162.9 89.3 3.8 36.6 21.5 55.7 47.2 55.3 53.0 57.7 56.1 58.0 47.4 46.6 59.0 6.8 48.5 44.0 54.7 68.9 39.0 11.0 11.4 13.2 15.4 12.0 11.6 11.5 11.3 11.7 10.9 12.4 12.6 41.5 19.2 54.6 16.3 71.6 65.6 73.4 141.6 70.6 37.8 41.8 52.6 30.5 18.6 80.3 36.8 12.5 124.3 69.6 37.4 68.4 94.6 96.2 52.7 42.5 47.2 27.0 61.4 30.9 109.0 154.1 51.5 27.0 55.6 65.8 37.7 21.4 35.5 67.0 37.0 29.2 44.2 126.1 24.1 39.2 22.4 34.8 36.4 42.7 13.1 76.4 39.6 47.4 16.6 28.6 95.3 41.8 28.6 76.1 142.3 78.7 87.1 89.2 34.9 13.1 37.9 67.1 192.9 65.9 68.3 50.6 112.3 68.1 42.3 52.4 101.6 SNRPD3 "Sm-D3, SMD3" ENSG00000100028 "Small nuclear ribonucleoprotein D3 polypeptide" P62318 22 24555958-24582052 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA001170 Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 290000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA001170: AB_1080042" "unprognostic (3.30e-1)" "unprognostic (1.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.28e-3)" "unprognostic (4.49e-2)" "unprognostic (2.03e-1)" "unprognostic (4.44e-2)" "unprognostic (1.13e-3)" "unprognostic (1.20e-2)" "unprognostic (3.52e-2)" "unprognostic (3.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.87e-1)" "unprognostic (1.65e-2)" 30.5 31.1 24.7 35.2 25.7 39.2 37.5 29.6 34.8 31.8 25.7 50.5 33.2 35.5 35.5 43.5 36.7 20.2 35.3 25.0 25.8 48.0 64.9 26.9 47.7 23.7 23.9 34.3 23.7 51.2 27.0 24.7 25.5 33.8 40.7 54.1 29.7 31.9 103.7 28.8 35.7 29.5 23.6 34.3 36.5 24.7 25.0 74.4 38.9 86.2 53.3 39.5 32.3 30.7 182.5 45.7 188.6 58.5 70.1 57.7 56.1 173.1 74.8 166.1 148.1 61.4 65.8 158.7 70.1 109.2 83.0 130.7 252.1 219.3 175.5 107.9 188.8 152.4 95.4 113.9 66.2 408.0 95.7 66.5 93.8 186.3 86.6 81.8 120.6 139.8 116.2 60.5 61.5 56.8 187.0 82.6 98.9 237.8 61.9 179.5 190.7 66.6 154.5 130.0 82.2 95.6 83.4 62.7 87.7 162.7 102.3 97.5 135.5 127.0 126.3 74.3 126.2 74.3 168.2 283.7 70.1 127.1 91.4 18.5 42.9 53.9 35.6 50.2 37.6 60.5 38.4 39.2 54.2 50.7 36.6 41.3 18.6 51.1 51.1 49.7 41.1 47.4 24.7 25.7 29.6 34.8 25.0 25.8 23.7 23.9 25.5 23.6 25.0 30.7 120.0 96.1 81.8 7.5 118.2 108.6 115.3 293.1 133.1 61.1 94.2 138.8 95.9 101.5 162.9 130.6 35.5 239.5 123.1 112.6 291.6 161.9 91.0 176.6 157.7 96.8 111.0 139.4 8.1 114.8 228.8 121.0 92.2 147.9 86.2 145.3 66.0 203.3 176.4 38.7 8.7 134.2 168.9 74.5 84.8 85.1 116.2 98.1 67.6 10.3 151.0 134.3 86.5 8.0 13.4 129.4 118.2 118.5 120.7 96.8 191.7 310.5 135.2 68.9 65.7 102.8 209.6 111.1 131.4 164.9 113.7 180.3 111.9 176.2 139.0 113.3 SP100 ENSG00000067066 "SP100 nuclear antigen" P23497 2 230415942-230545606 "Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 189.2" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 255.0" "Low region specificity" "Detected in all" "HPA016707, HPA017384" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 57: B-cells - Immune response" "Nuclear bodies" Nucleoplasm "HPA016707: AB_1857398, HPA017384: AB_1857399" "unprognostic (8.04e-3)" "unprognostic (1.08e-2)" "unprognostic (3.34e-2)" "unprognostic (1.86e-3)" "unprognostic (5.48e-2)" "unprognostic (1.12e-2)" "unprognostic (1.44e-1)" "unprognostic (2.77e-2)" "unprognostic (6.25e-3)" "unprognostic (5.32e-3)" "unprognostic (1.11e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.96e-2)" "unprognostic (1.48e-2)" "unprognostic (2.33e-2)" "unprognostic (3.25e-2)" 66.3 53.1 11.0 65.5 12.3 189.2 53.8 11.3 17.9 42.4 20.7 46.1 46.1 35.1 30.8 29.4 34.9 55.9 52.9 10.9 14.0 46.0 60.9 72.4 94.3 19.6 14.3 44.3 41.1 10.5 18.3 54.5 16.7 34.9 36.1 2.5 72.7 33.0 24.3 35.7 60.4 38.7 16.2 78.8 47.9 9.2 16.5 54.2 41.0 32.1 81.6 56.1 37.1 17.1 56.9 16.9 0.8 7.5 80.8 123.2 13.3 70.3 151.0 162.4 255.0 10.6 67.9 22.9 57.0 77.0 103.0 25.9 0.8 66.6 120.7 55.2 1.9 41.8 27.9 24.0 120.0 47.3 51.4 105.6 38.8 79.8 71.4 120.2 125.1 18.9 23.9 37.9 61.7 15.9 32.0 57.6 2.4 25.6 25.6 24.4 40.7 18.2 45.9 45.3 0.4 0.7 30.0 9.5 130.3 2.8 9.1 48.3 140.3 78.7 21.4 49.4 41.8 50.3 16.0 59.8 71.6 54.8 38.1 149.7 84.4 115.8 116.3 74.9 93.9 152.0 113.0 102.4 64.6 160.5 107.5 95.3 284.6 119.8 106.0 67.0 116.0 110.1 11.0 12.3 11.3 17.9 10.9 14.0 19.6 14.3 16.7 16.2 16.5 17.1 171.9 153.8 56.6 0.3 236.6 70.7 71.2 96.5 49.5 0.6 31.2 36.7 72.3 42.9 74.4 33.1 2.1 32.9 150.6 50.5 43.0 102.9 4.7 61.6 58.3 122.7 9.0 66.9 0.6 105.5 69.4 77.9 46.4 58.9 56.8 39.3 73.5 34.5 81.0 0.0 0.7 32.5 63.1 72.9 70.9 4.8 46.6 104.1 71.2 140.5 114.3 0.2 128.8 4.5 4.8 89.7 56.9 52.6 95.6 74.2 72.8 45.4 68.4 0.8 39.5 61.2 65.9 0.8 1.1 28.4 68.2 16.1 151.5 74.0 25.2 73.7 SPAG5 "DEEPEST, hMAP126, MAP126" ENSG00000076382 "Sperm associated antigen 5" Q96R06 17 28577565-28599025 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.9;kidney: 37.8;testis: 74.0" "Cell type enhanced" "Detected in many" "Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 11.7;T-reg: 4.9" "Group enriched" "Detected in many" 6 "granulocytes: 11.7;T-cells: 4.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA022008, HPA022479, HPA024418" Approved Supported "Nuclear bodies,Mitotic spindle,Cytosol" Yes Yes "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies, Mitotic spindle" Cytosol "HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: " "unprognostic (4.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.31e-3)" "unprognostic (2.32e-3)" "unprognostic (3.50e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (5.43e-5)" "unprognostic (3.37e-3)" "unprognostic (4.84e-3)" "unprognostic (5.97e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (3.49e-2)" "prognostic unfavorable (5.43e-13)" "unprognostic (2.64e-1)" "unprognostic (1.66e-1)" "unprognostic (2.90e-2)" "unprognostic (2.01e-1)" 2.2 3.3 7.8 7.8 7.6 37.9 2.4 5.8 9.1 2.6 3.4 8.3 7.9 1.9 2.4 8.3 1.7 1.8 1.4 7.6 7.7 37.8 14.8 3.4 14.5 6.7 6.8 2.7 1.5 1.1 4.3 5.7 6.7 2.2 10.7 10.8 2.4 0.8 1.0 5.5 9.1 3.4 5.0 7.4 3.6 74.0 7.7 22.4 8.7 0.7 17.3 2.6 3.6 7.5 84.7 87.7 103.3 78.4 5.2 8.6 42.4 65.9 42.4 98.1 78.3 69.2 25.5 59.8 34.2 46.8 91.7 70.2 114.5 42.7 103.8 108.6 72.9 62.9 87.9 80.2 0.6 83.1 76.1 2.9 3.8 78.6 40.4 14.5 52.1 90.6 69.7 101.5 80.7 52.6 109.4 92.9 54.2 68.3 44.5 72.1 144.4 70.9 29.0 43.0 78.6 45.8 96.4 114.9 31.6 84.9 82.2 70.6 25.7 56.4 91.3 46.6 114.6 46.7 72.9 87.3 37.8 60.6 91.8 11.7 0.0 0.0 0.4 0.4 0.7 0.6 1.2 0.9 0.1 1.4 1.1 0.9 0.2 0.8 0.3 0.3 4.9 0.9 7.8 7.6 5.8 9.1 7.6 7.7 6.7 6.8 6.7 5.0 7.7 7.5 0.5 3.2 1.7 0.7 3.3 2.0 0.9 1.3 1.2 5.0 1.1 1.0 0.7 0.0 1.9 0.0 0.0 9.0 1.3 4.7 1.9 0.5 126.0 6.0 1.1 1.5 13.1 37.2 5.2 0.4 12.2 2.6 5.1 1.8 1.3 12.6 3.3 6.3 6.5 3.3 6.0 4.6 4.1 2.7 4.0 25.2 0.9 6.1 0.0 1.9 0.9 0.7 0.0 2.0 1.7 0.4 4.7 0.0 13.1 0.8 8.1 12.5 7.7 3.9 6.6 2.0 2.2 72.6 21.0 5.2 1.0 3.8 2.8 0.9 5.1 1.1 SRCAP "DOMO1, EAF1, KIAA0309, SWR1" ENSG00000080603 "Snf2 related CREBBP activator protein" Q6ZRS2 16 30698209-30741409 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 186.4;Club cells: 145.6;Ionocytes: 179.0;Respiratory ciliated cells: 118.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA028929 Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA028929: AB_10601265" "unprognostic (1.26e-1)" "unprognostic (1.35e-1)" "unprognostic (5.07e-1)" "unprognostic (6.57e-2)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (8.59e-2)" "unprognostic (2.34e-2)" "unprognostic (3.77e-1)" "unprognostic (6.45e-2)" "unprognostic (4.36e-2)" "unprognostic (8.57e-2)" "unprognostic (1.16e-2)" "unprognostic (2.09e-1)" "unprognostic (4.11e-2)" "unprognostic (7.71e-2)" "unprognostic (1.07e-1)" 15.4 11.9 3.6 18.9 4.8 30.1 10.1 7.1 4.2 12.8 1.7 13.2 15.7 15.5 6.4 13.5 14.2 10.9 12.1 2.9 3.4 9.6 7.1 11.6 15.3 5.9 4.3 16.9 19.4 20.2 9.5 12.6 3.5 12.6 11.2 12.5 18.0 13.1 24.5 16.2 16.1 15.0 0.8 18.7 16.0 20.6 7.7 20.2 14.0 19.4 13.6 11.3 9.9 6.8 29.5 60.1 36.9 35.9 28.3 19.5 37.7 24.0 21.1 26.2 20.7 27.8 21.9 65.9 29.7 30.5 16.9 27.8 37.7 27.5 21.9 42.2 88.1 42.5 56.2 24.3 11.4 49.8 48.0 20.8 13.2 40.3 29.0 12.8 27.8 21.7 65.4 36.5 19.7 34.5 42.2 17.4 37.6 10.8 27.7 57.7 28.7 36.4 7.5 34.2 34.5 36.5 26.6 31.0 8.4 12.2 35.4 26.0 44.1 37.0 26.5 21.0 31.6 39.8 36.7 45.9 29.7 23.2 28.9 0.3 0.7 2.9 0.8 1.2 0.6 0.7 0.4 0.9 0.5 1.0 0.5 0.4 2.2 0.6 0.3 0.9 0.9 0.7 3.6 4.8 7.1 4.2 2.9 3.4 5.9 4.3 3.5 0.8 7.7 6.8 3.0 3.2 3.7 8.8 9.8 24.6 1.9 186.4 13.1 7.5 3.3 1.8 2.4 4.3 145.6 1.8 8.4 2.3 5.3 54.3 0.0 1.4 1.2 4.6 3.0 3.4 11.3 7.6 8.6 3.1 1.4 4.2 19.9 4.7 2.5 3.0 2.2 3.0 2.3 8.4 8.6 17.7 179.0 1.9 14.3 0.9 2.8 3.4 10.6 8.4 3.0 1.7 6.2 4.5 10.6 1.9 39.1 1.2 11.1 3.1 3.1 0.6 118.3 5.8 0.0 5.0 14.3 5.6 6.0 7.8 58.2 2.5 8.9 2.0 25.6 3.1 SRP19 ENSG00000153037 "Signal recognition particle 19" P09132 5 112861188-112898371 "Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029272, HPA057315" Approved Supported "Nuclear bodies,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nuclear bodies" "HPA029272: AB_10600910, HPA057315: " "unprognostic (4.77e-2)" "unprognostic (1.36e-1)" "unprognostic (3.95e-1)" "unprognostic (1.37e-1)" "unprognostic (5.60e-3)" "unprognostic (1.17e-1)" "unprognostic (1.98e-3)" "unprognostic (5.55e-2)" "unprognostic (2.62e-2)" "unprognostic (3.62e-1)" "unprognostic (2.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (3.72e-10)" "unprognostic (1.82e-1)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (2.69e-3)" 30.2 32.5 18.9 29.0 19.8 79.2 29.0 19.2 25.8 21.6 17.7 25.1 24.6 25.2 38.2 29.3 22.0 23.1 25.4 20.0 21.4 27.7 48.1 24.4 38.4 18.4 19.1 17.9 41.7 25.4 40.5 28.6 19.0 32.6 27.2 14.5 29.6 18.0 33.9 23.8 23.4 30.2 17.5 30.0 25.8 20.2 20.4 36.0 39.9 23.9 39.9 28.7 22.3 20.6 60.1 40.7 49.3 78.6 45.2 52.4 118.7 82.0 51.8 69.2 82.3 68.0 45.8 62.3 55.0 53.2 110.0 39.0 54.6 84.5 82.2 66.0 88.8 55.1 80.5 80.6 72.4 44.7 58.5 61.2 80.5 64.9 95.6 45.5 64.7 67.1 41.9 72.3 59.5 70.1 72.6 79.0 51.1 60.5 61.6 45.6 44.3 94.4 68.6 75.5 56.1 49.6 66.4 42.4 40.3 56.5 64.7 63.2 52.1 57.1 48.6 57.3 98.3 85.2 111.4 107.9 55.4 75.4 60.3 66.7 34.1 43.6 49.3 37.3 60.9 54.9 55.0 52.7 39.9 45.8 46.3 52.4 48.1 50.9 41.3 86.8 72.2 36.3 18.9 19.8 19.2 25.8 20.0 21.4 18.4 19.1 19.0 17.5 20.4 20.6 64.7 80.1 49.9 17.9 60.6 86.4 74.8 102.2 9.1 15.6 75.1 85.9 52.0 41.5 87.8 44.1 20.9 80.0 120.2 29.6 103.7 96.4 38.9 76.0 85.0 53.4 119.0 52.2 26.7 103.2 125.0 55.9 16.3 80.4 73.5 54.6 35.7 65.3 84.5 13.5 24.6 67.6 79.3 53.3 53.8 24.0 38.8 56.6 51.6 21.5 87.8 30.7 90.6 21.6 41.1 130.4 38.9 39.5 65.7 107.5 33.5 117.1 74.1 24.6 26.3 40.8 58.3 157.4 44.7 22.6 87.8 148.2 71.3 54.2 41.2 112.7 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336236-136752403 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA035015: AB_10603117, HPA058653: AB_2683787" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 13.7 9.1 7.6 12.3 8.8 15.7 15.6 17.0 8.3 16.9 9.9 13.5 9.6 19.3 10.6 10.8 13.5 10.3 10.5 6.5 8.7 12.0 10.8 11.2 14.7 9.3 7.8 21.9 12.4 13.7 5.0 17.6 9.0 10.8 14.4 13.2 11.6 12.1 15.0 13.7 11.0 16.1 8.8 11.8 10.0 8.9 7.8 22.5 15.8 15.8 15.9 12.0 11.5 11.2 34.6 17.6 29.1 25.1 21.5 36.8 15.7 37.9 48.4 35.0 33.0 30.2 14.9 26.9 23.3 39.7 28.1 23.4 31.6 17.3 47.4 33.2 14.9 28.8 25.1 16.7 16.3 50.6 27.7 23.4 19.3 25.6 28.6 20.3 27.5 28.8 18.7 52.7 22.3 29.5 33.6 16.4 19.0 23.7 13.9 29.6 31.6 35.7 19.1 24.5 14.2 22.8 40.8 16.0 17.5 15.0 22.9 21.2 23.3 40.1 29.0 36.0 33.9 39.1 28.9 59.5 24.6 17.0 26.2 4.0 3.0 4.6 4.4 3.0 4.6 6.4 3.7 4.0 2.8 4.4 4.1 3.3 8.7 5.5 3.5 4.5 4.8 2.1 7.6 8.8 17.0 8.3 6.5 8.7 9.3 7.8 9.0 8.8 7.8 11.2 44.5 25.6 24.2 95.6 42.4 40.0 31.4 18.7 38.7 43.8 24.8 26.7 10.8 22.8 23.5 16.5 39.6 29.3 39.5 42.1 11.7 20.7 2.8 23.7 59.5 34.1 18.7 29.7 161.8 22.2 26.7 33.8 23.9 39.6 22.2 30.3 31.4 21.5 18.6 28.6 166.8 27.9 8.2 16.9 22.0 4.8 49.4 25.1 16.0 231.4 27.2 25.6 42.2 223.2 188.4 27.4 17.5 32.4 53.1 27.2 24.2 13.2 14.5 68.1 26.3 67.1 36.2 54.8 50.5 27.5 36.7 31.7 39.2 16.0 23.4 24.3 STK32B "HSA250839, STK32, STKG6, YANK2" ENSG00000152953 "Serine/threonine kinase 32B" Q9NY57 4 5051480-5500994 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 15.0;lymphoid tissue: 19.5" "Cell type enhanced" "Detected in many" "Early spermatids: 108.2;Late spermatids: 39.3;Microglial cells: 27.2;Oligodendrocyte precursor cells: 169.4" "Cancer enhanced" "Detected in many" "renal cancer: 6.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 27.5;HUVEC TERT2: 27.5;REH: 25.2;U-2197: 43.8;WM-115: 112.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015820 Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 17: WM-115 - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear bodies" Cytosol "HPA015820: AB_1858913" "unprognostic (4.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.08e-2)" "unprognostic (1.35e-1)" "unprognostic (8.12e-3)" "unprognostic (9.96e-2)" "unprognostic (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (1.27e-1)" "unprognostic (1.70e-1)" "unprognostic (2.54e-1)" "unprognostic (8.82e-2)" "prognostic favorable (1.63e-8)" "unprognostic (8.10e-3)" "unprognostic (5.04e-2)" "unprognostic (3.62e-2)" "unprognostic (1.67e-3)" 3.5 0.3 2.3 1.2 7.8 1.5 4.3 1.9 2.3 3.3 1.5 1.1 0.5 3.5 0.3 1.2 1.3 1.4 0.4 2.1 4.5 15.0 0.1 0.9 1.8 3.7 3.9 0.6 1.8 0.3 0.4 3.2 3.7 0.6 1.1 0.8 1.0 0.9 1.3 2.4 1.1 2.5 3.6 0.2 6.0 4.5 3.5 19.5 1.7 1.7 1.0 3.1 1.5 3.6 0.0 14.0 0.8 0.0 0.6 1.0 0.0 9.7 1.1 6.3 0.2 0.1 0.0 0.0 2.1 19.7 27.5 0.1 1.5 0.0 2.3 0.0 0.0 0.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.2 0.2 27.5 1.4 0.0 0.1 3.4 0.0 0.0 2.0 4.1 0.0 0.0 25.2 0.1 0.0 6.2 0.0 0.4 0.0 0.0 0.1 8.5 0.6 0.0 0.0 7.1 0.2 2.8 43.8 0.0 0.9 0.1 0.0 0.1 0.0 112.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.3 7.8 1.9 2.3 2.1 4.5 3.7 3.9 3.7 3.6 3.5 3.6 3.6 0.0 1.1 1.6 0.0 2.3 0.2 0.0 0.0 0.0 4.2 1.7 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 17.6 1.1 108.2 0.2 0.1 3.2 0.0 0.0 3.7 0.0 0.1 5.5 4.1 0.3 0.0 0.0 0.0 0.0 1.7 0.0 14.4 0.0 0.0 0.0 1.2 39.3 1.5 1.1 5.4 27.2 0.5 0.0 0.0 169.4 1.3 0.4 0.0 1.2 0.0 0.1 0.0 18.9 0.0 0.0 0.0 0.6 0.4 1.2 5.5 0.0 1.0 0.0 0.2 0.4 0.0 0.1 STK35 "bA550O8.2, CLIK1" ENSG00000125834 "Serine/threonine kinase 35" Q8TDR2 20 2101827-2177038 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "retina: 118.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 150.1;Early spermatids: 214.3;Horizontal cells: 294.4;Late spermatids: 821.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026452, HPA051673" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 30: Non-specific - Translation" "Cluster 77: Retina - Visual perception" "Cluster 39: CACO-2 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA026452: AB_2671861, HPA051673: AB_2681569" "unprognostic (2.25e-2)" "unprognostic (2.97e-1)" "unprognostic (2.87e-2)" "unprognostic (1.30e-2)" "unprognostic (3.25e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (9.46e-6)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (3.05e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-1)" "unprognostic (4.39e-2)" "unprognostic (1.74e-1)" "unprognostic (4.67e-1)" "unprognostic (1.40e-1)" "unprognostic (4.99e-2)" 9.0 11.3 9.4 6.6 8.3 8.6 7.9 6.7 13.0 7.3 5.1 10.2 7.1 9.7 5.8 15.6 8.6 7.1 10.0 9.5 8.3 6.9 8.9 8.5 6.4 6.2 10.6 8.0 9.3 7.8 9.7 6.2 7.3 8.0 8.2 118.8 8.7 6.3 6.5 11.3 9.3 7.8 5.0 8.3 8.7 18.3 15.4 6.4 8.5 5.7 7.6 8.1 8.9 8.6 23.3 19.4 14.7 25.4 6.7 9.1 17.9 9.3 11.4 12.2 12.5 25.6 17.5 15.9 7.5 11.7 19.0 34.1 17.6 21.4 13.8 6.3 8.4 15.2 7.4 28.1 8.5 13.7 6.8 7.9 18.5 19.5 16.7 11.2 11.7 15.0 14.9 12.8 8.0 10.3 17.4 19.4 27.5 18.4 12.9 14.9 13.2 10.1 11.1 22.9 24.3 11.8 16.6 29.3 15.0 17.0 14.5 13.5 10.0 20.7 14.1 10.5 14.9 11.1 15.5 10.8 11.1 14.7 9.2 0.0 0.3 0.1 0.4 0.2 0.6 0.3 0.6 0.3 0.5 0.4 0.5 0.4 0.7 0.2 0.3 0.4 0.2 0.3 9.4 8.3 6.7 13.0 9.5 8.3 6.2 10.6 7.3 5.0 15.4 8.6 8.8 12.8 9.8 4.9 6.3 11.6 4.4 7.5 13.1 111.8 10.9 9.5 12.2 2.8 9.1 3.7 150.1 7.2 7.5 15.4 1.9 6.4 214.3 15.7 7.8 9.1 6.1 12.0 11.8 6.8 11.5 11.1 11.2 12.7 9.5 8.4 7.9 10.3 5.7 294.4 11.6 7.6 10.2 6.3 4.9 821.8 6.8 5.7 7.2 11.2 4.0 124.7 5.2 9.0 11.2 10.4 9.7 6.0 8.5 6.7 8.8 3.6 10.2 96.7 0.0 10.8 7.2 15.5 14.4 12.4 11.8 5.7 6.0 4.5 10.9 6.6 STK4 "KRS2, MST1, YSK3" ENSG00000101109 "Serine/threonine kinase 4" Q13043 20 44966479-45080021 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.7" "Cell type enhanced" "Detected in all" "B-cells: 372.8;dendritic cells: 341.8;Langerhans cells: 606.9;monocytes: 367.5;Plasma cells: 336.2;T-cells: 414.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004038, HPA015270" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 45000 "Cluster 18: Basophils - Vesicular transport" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB004038: AB_2144632, HPA015270: AB_1854150" "unprognostic (2.77e-1)" "unprognostic (1.10e-1)" "unprognostic (8.83e-2)" "unprognostic (8.49e-3)" "unprognostic (2.95e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (1.70e-1)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.96e-1)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.28e-1)" "unprognostic (5.70e-2)" "unprognostic (3.96e-1)" "unprognostic (1.18e-2)" 10.0 8.5 6.9 33.8 8.0 57.7 9.1 6.2 10.8 7.9 9.9 11.1 10.2 8.5 7.6 9.1 6.2 11.7 4.6 7.2 8.7 6.0 9.2 15.9 43.1 8.7 7.6 7.0 6.0 5.9 4.1 10.4 9.2 6.7 13.0 7.3 7.4 8.0 3.3 11.2 13.5 9.3 8.3 30.4 12.7 9.7 7.5 33.1 7.6 4.9 41.7 15.0 6.9 10.3 27.8 18.7 23.3 16.1 13.5 16.9 16.0 23.6 35.7 39.4 35.6 52.7 14.6 66.6 20.4 16.9 33.4 28.5 24.3 31.8 49.7 30.8 13.8 48.6 27.8 36.8 23.8 63.5 66.4 13.8 25.6 36.7 39.6 19.4 14.6 44.6 23.5 37.0 19.9 21.7 47.6 42.3 13.9 17.7 12.5 30.2 25.2 31.2 14.4 18.7 10.9 13.2 35.6 20.0 27.0 17.2 18.3 39.1 18.7 29.2 28.6 34.4 27.8 48.4 41.7 73.2 28.6 29.5 22.0 80.6 19.7 54.8 34.4 19.9 34.3 26.2 32.2 32.0 18.4 26.9 33.1 28.0 101.8 28.5 38.0 10.0 34.3 22.3 6.9 8.0 6.2 10.8 7.2 8.7 8.7 7.6 9.2 8.3 7.5 10.3 26.2 16.0 24.6 18.9 372.8 55.7 49.3 33.8 28.5 27.3 22.9 17.4 7.6 14.3 25.2 42.3 52.1 24.1 341.8 23.7 9.8 16.3 5.9 19.1 25.1 32.1 25.7 46.3 76.7 17.6 30.3 29.7 34.1 25.1 133.6 114.0 26.0 22.0 61.1 43.7 38.2 20.7 28.5 109.3 606.9 5.0 22.7 154.4 133.4 85.3 367.5 20.2 278.1 34.2 48.1 21.6 27.9 17.0 336.2 32.6 23.2 13.4 26.1 69.9 13.1 25.5 29.2 44.2 42.4 20.9 53.0 19.4 414.5 48.1 19.5 45.5 SUDS3 "FLJ00052, SAP45, SDS3" ENSG00000111707 "SDS3 homolog, SIN3A corepressor complex component" Q9H7L9 12 118376555-118418033 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 271.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040402, HPA041972" Approved Supported "Nuclear bodies,Cytosol" "Intracellular and membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 6: T47d - Mammary gland" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA040402: , HPA041972: AB_2677776" "unprognostic (1.49e-1)" "unprognostic (4.08e-3)" "unprognostic (1.09e-1)" "unprognostic (6.60e-2)" "unprognostic (7.39e-2)" "unprognostic (1.45e-1)" "unprognostic (3.05e-3)" "unprognostic (1.22e-1)" "unprognostic (2.74e-2)" "unprognostic (2.70e-1)" "unprognostic (8.71e-2)" "unprognostic (3.03e-1)" "unprognostic (2.36e-2)" "unprognostic (1.83e-2)" "unprognostic (3.65e-1)" "unprognostic (1.02e-1)" "unprognostic (2.37e-1)" 10.8 12.3 13.3 12.0 14.2 16.9 18.7 9.6 15.2 16.6 12.1 16.5 14.3 14.9 16.0 19.9 18.1 11.7 12.8 15.8 12.9 16.1 14.0 11.9 14.7 12.7 14.6 15.0 17.3 25.3 11.6 11.5 14.1 16.2 18.3 16.3 19.2 15.7 11.3 20.1 14.1 13.7 10.6 13.7 16.2 16.4 12.2 17.9 21.7 11.9 19.5 14.4 15.2 13.2 29.4 21.9 29.4 29.4 16.1 21.1 31.5 22.5 23.2 25.8 20.4 24.1 18.6 39.8 23.5 21.8 16.0 34.3 35.3 23.8 30.3 35.3 20.9 27.7 18.4 21.6 18.4 30.9 20.5 14.6 25.0 12.8 22.7 33.5 22.2 36.9 30.8 14.1 23.9 20.2 36.7 40.2 30.5 38.8 17.0 32.9 26.4 28.3 23.7 42.7 22.9 22.7 31.9 18.7 19.9 36.7 61.1 24.9 18.7 17.5 16.6 19.7 15.5 26.2 31.4 29.2 19.4 19.4 21.4 1.8 4.3 5.9 5.0 2.8 6.1 8.8 5.4 5.7 4.7 8.4 6.4 4.4 12.6 4.3 2.8 6.8 5.5 3.9 13.3 14.2 9.6 15.2 15.8 12.9 12.7 14.6 14.1 10.6 12.2 13.2 25.5 28.9 15.9 19.6 37.8 64.7 44.7 55.0 46.1 75.4 85.6 63.0 37.5 41.5 37.1 47.8 77.2 34.6 26.9 75.1 80.3 41.5 271.9 87.6 54.4 24.6 37.3 30.3 22.4 19.3 54.5 31.5 36.7 73.2 8.2 37.5 21.0 34.1 25.0 107.7 29.1 60.2 59.0 18.2 36.1 59.4 38.5 20.8 28.4 13.1 30.5 30.0 29.9 30.2 21.6 26.4 52.6 41.0 49.1 60.5 38.3 45.7 61.9 57.3 26.3 42.8 48.5 62.6 53.4 74.1 78.7 49.1 32.9 41.6 56.8 61.9 SUGP2 "KIAA0365, SFRS14" ENSG00000064607 "SURP and G-patch domain containing 2" Q8IX01 19 18990888-19034023 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 237.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041557, HPA061111" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA041557: AB_10794301, HPA061111: AB_2684432" "unprognostic (1.35e-1)" "unprognostic (2.94e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (1.94e-2)" "unprognostic (4.60e-2)" "unprognostic (3.28e-1)" "unprognostic (4.41e-3)" "unprognostic (2.29e-2)" "unprognostic (1.00e-1)" "unprognostic (1.17e-2)" "unprognostic (1.51e-1)" "unprognostic (5.11e-2)" "unprognostic (3.60e-2)" 24.5 36.2 29.0 18.2 30.1 41.7 28.4 30.8 37.6 37.5 28.0 35.9 17.1 30.2 20.5 25.6 35.5 12.7 36.6 34.5 22.7 36.0 31.7 32.9 23.5 21.5 23.5 39.4 23.9 17.0 54.3 14.2 21.7 46.9 16.4 45.1 32.3 16.1 37.7 22.4 31.6 15.6 18.0 37.4 27.0 87.7 24.4 22.7 60.9 24.3 20.2 30.9 32.8 30.6 27.7 25.7 64.6 46.7 29.7 29.2 32.2 33.8 25.4 38.8 33.1 16.9 24.0 54.3 27.3 27.2 45.8 20.1 53.2 20.6 35.2 19.3 47.0 34.3 42.6 22.2 21.4 29.2 33.3 30.4 21.5 23.7 19.3 51.8 20.6 41.8 52.6 38.1 42.6 23.5 34.3 54.5 33.5 32.4 36.1 33.8 33.2 30.6 19.7 27.5 71.5 29.4 29.9 20.7 14.8 49.5 21.6 26.9 22.6 38.0 22.8 44.6 40.2 48.0 39.1 40.0 38.3 45.0 40.9 4.1 1.4 1.3 2.1 1.5 1.1 1.1 1.3 1.2 1.5 1.8 1.2 1.4 1.3 4.4 1.3 1.9 1.3 0.8 29.0 30.1 30.8 37.6 34.5 22.7 21.5 23.5 21.7 18.0 24.4 30.6 24.5 41.7 45.1 69.9 22.9 17.6 22.6 17.9 18.8 91.2 30.0 23.5 34.7 22.8 33.3 27.6 93.8 16.7 57.0 19.2 9.8 16.2 84.9 44.4 44.7 25.2 41.5 35.3 106.5 10.5 10.2 29.1 31.6 40.7 27.1 94.9 21.8 28.5 23.4 106.0 90.3 22.5 26.4 31.4 19.9 132.0 40.4 29.1 12.4 34.7 31.2 44.5 57.7 42.7 45.2 18.7 23.2 37.6 36.1 26.1 14.5 11.3 42.5 108.6 52.6 33.5 22.8 237.7 56.2 17.2 18.8 7.5 29.3 79.8 26.9 23.6 SUMO1 "GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1" ENSG00000116030 "Small ubiquitin like modifier 1" P63165 2 202206182-202238599 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.6" "CAB004269, HPA056956" Supported Supported "Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear membrane" "Nucleoli, Nuclear bodies" "CAB004269: AB_628300, HPA056956: AB_2683285" "unprognostic (7.15e-2)" "unprognostic (2.34e-2)" "unprognostic (1.49e-1)" "unprognostic (2.52e-3)" "unprognostic (2.89e-1)" "unprognostic (9.56e-3)" "unprognostic (1.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.78e-3)" "prognostic favorable (7.93e-4)" "unprognostic (7.06e-3)" "unprognostic (1.16e-1)" "unprognostic (4.64e-3)" "unprognostic (1.31e-2)" "unprognostic (7.58e-2)" "unprognostic (2.82e-2)" "unprognostic (2.19e-1)" 77.5 99.1 79.4 62.7 84.9 133.7 83.6 89.0 99.9 68.9 84.4 82.7 72.0 65.1 86.3 71.6 65.7 71.7 79.8 85.6 85.3 118.1 174.1 66.5 86.4 79.9 80.1 54.5 55.8 91.6 56.7 75.6 81.1 75.3 82.8 80.2 66.8 61.9 107.5 57.1 80.5 71.5 78.9 68.1 73.8 54.7 81.4 112.1 102.3 103.3 95.4 77.9 54.9 86.6 164.1 82.4 291.4 155.8 159.3 168.5 129.7 171.0 214.6 209.0 274.6 178.1 203.7 111.6 153.5 199.0 193.5 117.1 242.2 237.9 325.0 104.8 185.7 207.6 159.0 211.2 114.9 237.2 188.5 130.9 225.2 164.0 123.9 195.1 197.3 219.0 194.2 176.0 226.4 141.1 298.3 391.6 351.7 168.5 172.2 190.9 163.2 197.9 255.5 134.3 201.7 219.3 140.3 133.6 236.4 313.9 120.0 223.2 139.9 152.5 153.0 141.4 152.8 151.7 322.9 285.8 170.2 165.4 137.2 242.2 220.0 284.2 169.2 226.5 179.6 276.3 206.8 200.0 223.6 231.6 193.8 202.3 256.5 246.5 239.7 187.8 329.0 394.7 79.4 84.9 89.0 99.9 85.6 85.3 79.9 80.1 81.1 78.9 81.4 86.6 182.7 112.2 61.1 10.7 143.1 422.1 204.4 448.6 177.6 99.6 196.8 170.2 58.1 130.1 215.3 189.4 64.6 259.4 162.3 136.6 481.3 250.4 91.3 148.3 115.1 170.7 142.4 140.1 31.4 173.3 297.8 161.8 89.7 115.2 92.6 114.7 142.8 202.1 205.3 87.5 27.8 156.4 319.4 140.7 330.2 28.0 129.8 137.7 211.7 15.9 241.3 182.3 176.1 16.6 21.2 208.1 191.1 127.9 130.5 258.5 272.2 534.4 185.5 87.8 111.7 92.5 221.9 212.0 141.5 183.9 424.5 209.7 174.5 134.9 157.5 254.1 SUMO2 "SMT3B, SMT3H2" ENSG00000188612 "Small ubiquitin like modifier 2" P61956 17 75165586-75182959 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037314, HPA042123, HPA048064" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear bodies" "CAB037314: AB_796170, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (6.49e-2)" "unprognostic (1.01e-2)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.32e-1)" "unprognostic (1.23e-3)" "prognostic unfavorable (2.12e-4)" "unprognostic (9.80e-2)" "unprognostic (6.02e-3)" "unprognostic (2.58e-3)" "unprognostic (5.07e-2)" "unprognostic (2.29e-2)" "prognostic unfavorable (5.23e-6)" "unprognostic (2.15e-1)" "unprognostic (1.25e-1)" "unprognostic (1.14e-2)" "unprognostic (4.89e-3)" 198.2 205.1 176.2 203.6 186.9 229.8 174.5 214.2 239.9 219.3 168.5 190.1 161.4 205.5 158.5 240.9 186.8 134.0 156.7 185.4 193.4 205.6 185.8 171.5 214.6 175.5 177.3 231.1 161.0 130.6 146.5 130.1 177.5 158.1 143.9 205.9 160.3 122.2 229.4 182.6 169.2 154.8 187.4 174.7 205.3 182.2 187.2 271.9 149.2 152.0 228.6 188.2 205.1 191.5 742.5 299.1 1035.7 534.4 296.8 283.6 486.1 571.2 276.9 384.5 354.5 343.6 396.0 641.8 398.1 327.9 503.0 353.4 470.3 351.7 451.6 373.6 712.4 644.0 282.1 597.4 194.1 856.1 555.7 290.1 195.9 343.9 187.2 615.6 403.8 628.3 540.7 508.7 288.3 317.8 1310.8 734.0 632.8 552.5 445.5 903.2 987.1 539.5 391.9 612.0 633.4 739.0 691.1 566.8 481.4 796.9 614.6 663.0 458.1 557.2 581.7 429.4 931.3 355.4 348.1 986.8 351.2 500.6 457.3 831.1 436.4 781.2 390.9 498.9 408.8 515.7 486.8 456.8 451.6 443.6 444.0 437.1 380.1 452.3 548.3 616.0 701.6 851.5 176.2 186.9 214.2 239.9 185.4 193.4 175.5 177.3 177.5 187.4 187.2 191.5 522.1 163.5 160.6 25.5 453.3 705.4 647.4 717.6 602.2 216.4 492.1 524.1 62.3 337.5 368.2 355.0 50.1 522.8 485.0 278.1 968.5 602.7 281.8 348.6 429.0 458.5 441.9 519.9 35.7 531.7 948.9 451.1 274.2 343.5 349.0 465.0 491.2 273.4 616.3 233.9 33.0 397.9 472.0 676.9 637.0 488.6 604.9 481.5 462.4 21.5 743.4 535.4 517.0 25.1 42.6 666.5 397.3 605.2 443.0 822.3 348.7 847.5 322.6 161.3 571.9 409.5 716.6 872.2 683.2 795.2 742.7 565.2 480.3 476.1 437.0 977.2 SUMO3 "SMT3A, SMT3H1" ENSG00000184900 "Small ubiquitin like modifier 3" P55854 21 44805617-44818779 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012180, HPA042123, HPA048064" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Nuclear bodies" "CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (2.77e-2)" "unprognostic (2.52e-1)" "unprognostic (5.79e-2)" "prognostic unfavorable (7.88e-5)" "unprognostic (1.96e-1)" "unprognostic (1.21e-1)" "unprognostic (6.81e-2)" "unprognostic (7.13e-2)" "unprognostic (1.43e-1)" "unprognostic (1.32e-1)" "unprognostic (2.09e-2)" "unprognostic (7.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.00e-2)" "unprognostic (1.62e-1)" "unprognostic (7.50e-2)" "unprognostic (1.80e-2)" 68.6 58.1 58.5 56.7 64.6 118.8 63.6 50.6 75.5 55.5 55.9 55.2 55.1 52.9 50.3 57.2 52.1 44.6 74.3 64.4 71.8 64.0 59.3 61.7 68.8 53.3 59.0 57.6 49.4 44.7 38.3 49.1 58.3 46.2 45.8 72.0 66.5 47.4 106.6 51.0 58.0 39.8 54.5 61.6 56.3 28.8 68.5 63.7 54.8 73.9 57.5 50.0 53.6 50.9 226.4 88.8 131.7 80.2 105.1 147.9 86.5 152.0 177.2 211.5 173.6 133.6 137.2 78.4 234.6 165.4 122.4 53.0 96.8 123.0 166.3 110.0 106.3 322.7 78.8 123.1 113.3 184.5 172.1 126.0 139.5 123.9 89.9 87.8 109.8 164.6 188.7 215.2 173.8 293.1 220.0 127.7 254.4 223.1 174.9 239.0 8.0 217.1 120.2 111.9 98.8 153.4 136.5 196.2 126.3 48.1 190.6 218.6 172.4 99.1 151.4 151.6 172.8 155.4 234.8 198.7 77.9 265.2 138.6 2.8 123.1 52.0 78.9 130.0 79.7 84.6 74.9 76.5 133.3 77.7 88.7 81.0 14.0 70.6 122.3 162.8 91.2 157.8 58.5 64.6 50.6 75.5 64.4 71.8 53.3 59.0 58.3 54.5 68.5 50.9 83.4 64.1 50.4 5.5 76.5 96.0 121.7 127.9 74.6 72.2 99.4 88.5 59.5 67.2 66.5 95.6 20.9 122.9 98.1 95.6 166.3 121.7 63.1 36.4 51.7 101.4 59.2 113.8 14.3 112.4 107.8 76.7 52.0 37.9 29.8 63.8 92.8 116.6 200.5 62.2 13.3 91.5 81.4 143.4 172.3 114.2 72.1 137.9 97.8 10.3 280.0 132.4 111.2 3.5 6.5 148.7 112.6 72.6 58.2 150.7 129.2 130.2 33.0 60.5 59.2 43.8 68.7 90.7 77.5 82.7 77.9 136.3 78.2 43.2 99.9 145.1 SUMO4 "dJ281H8.4, IDDM5, SMT3H4" ENSG00000177688 "Small ubiquitin like modifier 4" Q6EEV6 6 149400262-149401278 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 11.1;Glandular and luminal cells: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "HPA042123, HPA048064" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 15: Liver - Metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nuclear bodies" "HPA042123: AB_2677860, HPA048064: AB_2680244" "unprognostic (1.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.16e-2)" "unprognostic (3.24e-3)" "unprognostic (8.61e-2)" "unprognostic (6.84e-2)" "unprognostic (2.24e-1)" "unprognostic (7.75e-2)" "unprognostic (4.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-2)" "unprognostic (2.44e-11)" "unprognostic (4.94e-3)" "unprognostic (5.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.19e-2)" 0.5 0.3 1.0 0.3 0.7 0.7 0.3 1.7 1.2 1.1 1.2 0.4 0.2 0.2 0.1 0.6 0.5 0.2 0.8 0.5 0.7 0.8 1.3 1.0 0.5 1.9 0.9 0.9 0.4 0.0 0.8 0.3 1.2 1.0 0.2 0.7 0.4 0.1 0.2 0.4 0.3 0.1 1.0 0.6 0.3 0.6 1.5 0.1 0.6 0.0 0.2 0.6 1.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.5 0.2 0.2 0.4 1.0 0.7 0.2 0.6 0.6 0.9 2.2 1.0 0.5 0.2 1.1 0.2 1.0 0.7 1.7 1.2 0.5 0.7 1.9 0.9 1.2 1.0 1.5 1.6 2.0 3.2 1.5 0.0 3.1 2.9 1.8 0.9 0.0 4.3 2.5 1.8 11.1 1.5 0.9 1.8 4.2 0.7 6.4 1.3 0.0 0.7 0.1 4.5 4.0 2.7 1.8 0.8 0.0 0.9 0.4 2.9 2.0 8.4 1.3 7.2 1.4 1.6 1.1 0.0 0.0 0.5 0.0 1.3 4.7 0.9 2.1 5.1 0.0 0.0 3.9 1.7 1.0 0.0 0.0 1.1 1.2 1.2 3.5 3.5 1.0 0.4 1.0 3.9 6.6 1.8 3.6 1.9 0.8 0.5 0.9 0.3 4.3 2.7 0.4 3.9 SUZ12 "CHET9, JJAZ1, KIAA0160" ENSG00000178691 "SUZ12 polycomb repressive complex 2 subunit" Q15022 17 31937007-32001038 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057436 Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli, Nucleoli rim, Nuclear bodies" "HPA057436: AB_2683439" "unprognostic (1.23e-1)" "unprognostic (1.11e-1)" "unprognostic (3.65e-3)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (7.31e-2)" "unprognostic (2.66e-3)" "unprognostic (8.05e-2)" "unprognostic (7.27e-2)" "unprognostic (3.06e-2)" "unprognostic (6.29e-2)" "unprognostic (8.70e-2)" "unprognostic (3.28e-2)" "unprognostic (2.25e-1)" "unprognostic (1.28e-1)" "unprognostic (5.91e-2)" "unprognostic (1.31e-1)" 12.3 11.8 6.3 18.8 6.3 45.4 15.0 11.1 8.5 11.6 6.8 14.9 16.0 15.2 12.0 14.0 11.0 12.0 10.3 5.4 5.8 16.4 18.1 12.6 33.0 5.4 5.9 11.4 11.5 19.8 6.6 18.7 5.6 13.3 16.4 26.5 10.5 12.2 8.1 13.0 15.3 14.7 5.2 18.4 15.2 27.4 6.1 38.5 18.3 11.0 30.0 15.6 9.0 7.1 46.5 40.4 37.2 42.9 21.1 26.8 38.2 44.2 38.8 53.0 63.7 30.9 25.5 100.7 33.2 27.7 45.4 40.1 56.0 25.5 85.7 35.8 54.0 69.9 32.9 22.3 24.8 111.5 68.7 18.7 28.1 53.1 40.4 32.1 33.1 47.3 68.8 135.6 46.2 16.2 133.3 64.4 21.3 32.4 24.4 78.5 95.3 81.9 31.1 44.6 47.5 37.1 71.3 22.7 43.3 25.8 66.0 91.5 24.7 41.9 38.0 50.8 69.3 73.5 98.4 122.5 30.7 67.4 38.7 0.6 0.7 1.6 1.4 1.1 1.1 2.4 1.6 1.6 0.6 1.8 1.5 2.1 1.6 1.8 0.7 1.9 1.8 0.4 6.3 6.3 11.1 8.5 5.4 5.8 5.4 5.9 5.6 5.2 6.1 7.1 44.5 41.7 45.8 43.1 50.1 58.5 50.2 21.8 31.9 77.6 54.2 36.8 32.3 27.1 32.6 35.0 108.4 61.5 65.2 24.0 17.6 28.3 16.2 52.8 55.8 45.1 29.4 93.6 71.6 21.9 53.1 35.1 31.1 54.2 15.8 41.4 38.2 42.3 32.9 62.2 69.5 31.8 10.2 42.1 58.2 13.9 26.8 47.3 24.9 45.0 73.1 45.7 38.1 75.4 71.3 27.8 15.4 25.6 66.2 62.8 21.5 26.6 29.6 80.9 13.1 47.2 38.4 121.7 128.9 48.6 71.7 69.5 52.5 52.8 35.6 66.7 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817397 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 149.0;Erythroid cells: 135.4;Spermatocytes: 158.0;Spermatogonia: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" Yes No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favorable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 34.7 15.1 36.4 13.7 37.7 43.1 29.9 39.1 49.9 30.9 33.6 29.3 11.6 24.9 26.2 17.7 27.2 15.2 24.7 37.1 38.4 25.6 19.1 17.4 23.0 38.2 37.3 36.3 12.1 22.1 30.6 20.6 37.5 20.3 15.7 22.6 15.9 15.4 28.0 17.7 19.9 19.2 38.2 22.1 19.0 52.9 37.1 48.3 19.0 23.5 23.5 23.9 24.8 40.3 25.9 12.9 75.2 26.9 30.9 48.3 37.2 21.5 18.1 28.8 29.7 22.8 20.2 29.1 23.5 28.6 22.6 18.3 14.3 23.7 35.2 53.6 23.7 54.5 12.1 43.9 25.6 41.3 35.2 31.2 37.4 16.2 15.4 29.7 29.1 56.0 46.2 14.3 35.3 12.0 41.5 50.8 40.8 23.7 14.5 30.9 55.8 19.2 29.9 25.3 45.5 40.4 26.8 14.9 31.7 76.9 11.3 120.1 22.7 25.4 28.1 19.6 35.6 14.9 19.1 20.7 16.1 27.5 24.4 60.5 40.2 76.5 26.8 40.8 23.5 56.4 46.5 32.3 39.2 59.8 42.8 37.2 70.3 37.3 43.8 33.0 115.7 24.7 36.4 37.7 39.1 49.9 37.1 38.4 38.2 37.3 37.5 38.2 37.1 40.3 46.2 9.6 6.3 0.0 25.0 0.0 33.0 0.0 23.9 6.2 33.1 53.1 0.0 28.6 9.3 20.2 2.1 53.8 20.0 19.5 54.8 51.7 149.0 32.2 34.6 32.3 18.2 135.4 0.0 24.5 66.0 36.6 14.3 18.2 11.4 22.8 42.8 45.6 70.4 6.7 0.0 19.6 0.0 51.8 0.0 61.6 42.9 48.4 0.0 0.0 70.2 33.1 29.9 0.0 0.0 43.1 21.7 53.8 16.9 21.9 20.5 43.2 7.3 15.5 59.2 28.1 28.4 158.0 153.8 21.4 0.0 61.6 21.4 24.1 23.6 31.1 SYCP1 "CT8, HOM-TES-14, SCP1" ENSG00000198765 "Synaptonemal complex protein 1" Q15431 1 114854863-114995370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 40.2" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 1162.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 98 "THP-1: 17.2" "Region enriched" "Detected in single" 51 "cerebellum: 14.7" "Not detected" "Not detected" HPA021083 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 43: THP-1 - Innate immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA021083: AB_1857685" "unprognostic (2.91e-1)" "unprognostic (6.89e-3)" "unprognostic (4.87e-1)" "unprognostic (8.74e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.5 0.3 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 56.7 5.3 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1162.6 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TAMALIN GRASP ENSG00000161835 "Trafficking regulator and scaffold protein tamalin" Q7Z6J2 12 52006946-52015889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 243.8;B-cells: 60.6;dendritic cells: 114.1;Macrophages: 60.6;Plasma cells: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 37.4;TIME: 27.4;WM-115: 50.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040664, HPA062028" Approved Approved "Nuclear bodies,Vesicles" No NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "Nuclear bodies" "HPA040664: AB_10794066, HPA062028: AB_2684664" "unprognostic (1.90e-1)" "unprognostic (1.29e-2)" "unprognostic (2.48e-2)" "unprognostic (2.39e-2)" "unprognostic (2.00e-2)" "unprognostic (2.38e-2)" "unprognostic (2.23e-2)" "unprognostic (1.93e-1)" "unprognostic (2.86e-1)" "unprognostic (8.71e-2)" "unprognostic (3.16e-3)" "unprognostic (7.20e-2)" "unprognostic (3.90e-3)" "unprognostic (1.99e-3)" "unprognostic (1.44e-1)" "unprognostic (3.53e-2)" "unprognostic (2.77e-2)" 31.9 6.3 9.8 4.1 14.9 23.8 26.9 3.2 21.5 17.6 0.4 9.4 2.2 22.0 1.6 7.1 22.2 9.6 24.2 10.5 3.7 12.2 4.2 46.8 3.8 5.0 4.9 14.9 5.7 2.8 6.2 8.9 4.8 13.0 1.9 0.1 6.5 3.1 10.6 10.7 9.8 6.0 4.1 18.2 8.6 2.6 7.6 3.7 16.3 8.4 2.3 12.5 17.1 7.1 0.0 0.0 4.4 0.2 1.9 3.6 1.0 0.2 1.1 0.0 1.1 0.0 0.0 0.0 10.0 0.0 0.4 0.1 1.3 0.0 0.4 0.2 1.3 0.3 0.0 6.2 7.4 0.3 3.3 7.2 0.0 0.3 0.0 0.0 37.4 1.0 1.6 0.0 0.9 0.2 3.1 10.5 4.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 1.1 1.6 0.0 0.2 7.5 2.7 0.0 0.3 27.4 0.0 2.5 0.2 0.0 0.2 0.0 0.1 0.6 0.0 50.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 9.8 14.9 3.2 21.5 10.5 3.7 5.0 4.9 4.8 4.1 7.6 7.1 243.8 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.2 114.1 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.3 5.4 0.0 0.0 0.0 TARBP2 Trbp ENSG00000139546 "TARBP2 subunit of RISC loading complex" Q15633 12 53500921-53506431 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051181, HPA061454, CAB069406" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nuclear bodies" "CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526" "unprognostic (1.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (6.61e-3)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.04e-1)" "unprognostic (4.72e-3)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (8.06e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (4.31e-1)" 9.2 13.1 9.8 9.2 10.0 6.8 8.9 13.4 11.3 8.9 9.5 9.5 9.0 8.5 7.9 13.1 11.7 6.7 9.7 9.6 10.1 18.6 20.6 10.1 10.5 10.0 10.0 8.0 18.7 8.5 8.5 13.8 9.9 11.3 5.5 6.7 11.0 5.1 9.8 9.8 9.5 6.1 9.9 15.2 12.4 13.1 10.8 10.3 12.0 7.1 9.0 10.4 8.9 10.5 25.5 69.1 26.8 29.6 15.3 20.8 35.0 22.6 19.2 34.1 20.3 61.2 33.5 24.5 44.6 24.9 22.2 20.0 32.8 34.1 19.9 30.5 54.1 28.6 26.6 43.9 33.3 48.0 31.9 24.3 21.0 35.2 16.5 23.2 41.2 36.6 37.1 38.3 24.9 102.9 32.5 62.9 53.0 19.7 37.1 23.9 14.4 31.6 22.6 26.4 34.8 24.8 11.8 28.7 58.9 19.1 40.4 63.7 22.1 31.2 29.8 11.9 27.4 19.7 39.6 26.1 34.8 24.2 35.6 2.1 11.5 5.7 13.9 11.9 13.3 10.9 13.3 12.8 14.9 15.3 13.7 13.6 0.7 13.1 7.7 13.3 11.7 12.5 9.8 10.0 13.4 11.3 9.6 10.1 10.0 10.0 9.9 9.9 10.8 10.5 5.2 0.0 8.2 4.6 10.7 6.4 10.5 15.3 17.1 9.3 12.0 10.0 6.0 15.7 11.2 9.2 10.4 46.5 7.2 9.8 21.5 20.7 10.7 7.9 8.8 11.6 5.4 9.4 2.3 26.2 48.9 9.3 13.7 7.2 10.8 10.5 12.1 18.4 25.6 1.7 3.1 10.8 18.3 9.3 4.7 23.8 5.6 7.9 14.2 1.0 12.2 10.2 10.3 4.5 6.2 16.8 9.9 4.1 15.6 11.2 11.3 28.6 7.1 14.2 0.0 4.0 10.0 11.6 13.0 14.4 4.7 32.2 9.0 9.9 14.8 10.1 TBC1D10C "Carabin, EPI64C, FLJ00332" ENSG00000175463 "TBC1 domain family member 10C" Q8IV04 11 67403915-67410089 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6" "Group enriched" "Detected in many" 4 "B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA069743 Enhanced Approved "Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA069743: AB_2686186" "prognostic favorable (3.83e-4)" "prognostic favorable (4.20e-4)" "unprognostic (9.23e-2)" "unprognostic (3.84e-2)" "unprognostic (1.28e-3)" "prognostic favorable (1.86e-5)" "unprognostic (6.22e-3)" "unprognostic (1.17e-2)" "unprognostic (3.65e-2)" "unprognostic (3.55e-2)" "unprognostic (3.28e-2)" "unprognostic (2.55e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (7.18e-2)" "unprognostic (3.81e-2)" 2.3 0.7 0.7 25.8 1.2 40.4 1.1 0.4 1.2 1.4 0.8 4.1 5.5 0.9 0.1 2.3 1.9 3.2 0.9 0.6 0.6 2.5 2.6 8.9 56.7 0.9 0.5 0.5 0.8 0.2 0.5 0.8 0.6 1.9 1.5 0.0 3.8 0.7 0.9 1.4 25.6 0.5 0.5 58.6 7.6 0.5 0.7 46.0 7.6 0.6 21.8 3.2 1.7 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.7 0.1 1.2 0.0 6.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.1 0.0 0.0 0.3 47.1 64.7 0.0 0.0 0.0 6.6 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 4.5 0.0 0.0 0.1 0.2 0.0 0.4 0.5 12.2 0.0 24.6 0.0 191.0 46.0 270.4 237.7 120.4 169.7 177.3 201.5 208.3 65.6 184.2 206.7 192.0 237.6 148.0 167.0 55.8 286.6 261.6 0.7 1.2 0.4 1.2 0.6 0.6 0.9 0.5 0.6 0.5 0.7 1.1 2.5 6.4 19.5 0.0 109.6 1.1 0.1 0.1 0.6 1.0 1.4 1.9 1.5 2.8 2.5 0.0 0.0 0.2 144.4 0.2 0.0 0.2 0.2 2.4 0.4 1.9 1.2 12.6 0.2 0.0 0.3 2.0 2.0 1.1 23.4 0.1 5.0 1.4 23.7 0.0 0.1 0.0 0.0 16.0 6.9 0.6 0.0 23.1 3.6 1.0 24.5 0.3 284.2 0.0 0.5 0.0 0.0 0.0 40.2 0.1 0.1 1.1 1.3 0.5 0.0 1.3 1.1 0.1 0.2 0.0 1.0 0.4 147.7 0.1 0.1 0.1 TBX1 "CATCH22, VCF" ENSG00000184058 "T-box transcription factor 1" O43435 22 19756703-19783593 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 61.5;tongue: 36.5" "Cell type enriched" "Detected in many" 4 "Late spermatids: 181.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 24.6;K-562: 121.6;NB-4: 28.6;TIME: 40.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA029330 Approved "Nuclear bodies,Cytoplasmic bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 1: K-562 - Erythropoiesis" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear bodies, Cytoplasmic bodies" "HPA029330: AB_2673002" "unprognostic (2.54e-1)" "unprognostic (4.28e-3)" "unprognostic (7.53e-3)" "unprognostic (1.59e-1)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (2.53e-1)" "unprognostic (5.48e-2)" "unprognostic (1.18e-1)" "unprognostic (4.42e-2)" "unprognostic (2.25e-2)" "unprognostic (8.30e-3)" "unprognostic (9.14e-2)" "unprognostic (4.44e-1)" "unprognostic (8.31e-2)" "prognostic favorable (8.90e-4)" 4.0 0.6 0.5 1.0 0.7 0.1 8.0 0.6 0.8 7.4 0.8 1.8 0.7 2.6 0.2 3.0 7.7 0.4 0.8 0.2 0.2 0.4 0.4 4.3 2.9 0.6 0.2 2.2 0.3 7.6 0.7 0.1 0.5 5.2 0.3 0.0 8.1 0.5 61.5 10.6 3.0 0.6 0.0 0.6 1.2 16.8 0.9 0.0 11.2 36.5 1.2 2.7 7.1 1.0 15.3 1.4 0.2 10.7 0.0 0.0 2.1 0.2 0.0 0.0 0.0 1.1 0.1 0.3 0.3 0.3 1.5 0.8 12.0 10.4 0.0 0.6 24.6 0.2 2.9 0.0 0.0 0.1 0.1 0.1 0.1 2.4 0.0 0.0 0.0 0.5 121.6 0.0 7.7 2.8 0.3 28.6 1.7 0.0 16.8 0.3 10.6 0.1 0.0 0.0 1.5 0.4 0.0 0.2 0.0 3.1 5.1 7.7 40.0 0.1 0.4 0.2 0.2 0.3 0.5 0.1 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.6 0.8 0.2 0.2 0.6 0.2 0.5 0.0 0.9 1.0 11.4 0.0 2.8 0.0 0.3 2.4 1.6 3.3 0.0 0.6 1.1 0.9 2.4 0.0 1.6 0.0 0.0 0.2 0.6 0.1 0.0 0.0 43.3 0.2 0.1 7.5 0.0 0.0 0.3 0.2 1.7 1.5 0.0 0.2 2.5 0.1 2.5 0.0 2.0 0.0 0.9 1.0 6.1 1.3 3.6 181.9 2.5 1.0 0.0 0.0 0.1 0.3 2.1 0.0 0.0 0.1 0.0 2.2 0.0 1.0 0.1 0.0 2.3 0.1 0.0 1.1 0.8 1.9 12.8 0.3 2.4 0.1 0.7 0.0 0.2 2.0 TC2N "C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N" ENSG00000165929 "Tandem C2 domains, nuclear" Q8N9U0 14 91779746-91867536 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 103.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 84.6" "Group enriched" "Detected in many" 47 "NK-cells: 39.2;T-cells: 84.6" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.1;OE19: 63.8;RT4: 37.3;SK-BR-3: 43.9;T-47d: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA027549 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 58: T-cells - T-cell receptor" "Nucleoplasm, Nuclear bodies" "HPA027549: AB_10603346" "unprognostic (5.36e-2)" "unprognostic (1.95e-1)" "unprognostic (4.70e-2)" "unprognostic (1.51e-1)" "unprognostic (7.17e-3)" "unprognostic (3.34e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-2)" "unprognostic (3.44e-1)" "unprognostic (8.56e-2)" "prognostic unfavorable (9.86e-4)" "unprognostic (3.00e-1)" "prognostic favorable (4.13e-5)" "unprognostic (6.82e-2)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.09e-2)" 14.3 2.3 0.1 14.2 0.7 5.1 27.7 0.2 0.5 9.5 1.4 16.5 12.1 11.4 5.1 21.6 11.8 25.2 8.5 0.2 0.3 6.9 2.9 14.4 22.0 3.1 0.5 6.5 103.0 19.8 6.9 1.5 1.6 17.2 15.2 0.5 46.5 7.8 3.1 13.7 14.5 5.8 1.4 11.1 24.9 5.9 0.7 11.5 12.5 1.2 24.5 18.4 13.9 0.7 9.2 1.5 0.0 0.0 1.6 0.0 12.2 0.0 0.2 0.0 0.0 6.5 19.1 6.0 0.4 0.1 0.2 1.0 9.0 9.0 0.0 0.1 4.7 0.0 2.4 0.0 0.0 0.0 0.0 0.2 9.3 0.0 0.5 0.0 0.0 0.5 0.1 4.7 0.0 16.3 0.0 0.0 1.3 63.8 0.0 0.1 0.0 0.0 4.3 37.3 7.0 0.0 0.8 43.9 0.0 2.4 22.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 38.4 0.1 84.6 0.7 42.0 49.0 0.1 0.2 33.6 28.7 1.3 39.2 0.2 0.2 14.8 22.5 0.1 0.7 0.2 0.5 0.2 0.3 3.1 0.5 1.6 1.4 0.7 0.7 10.0 41.7 79.6 0.7 12.4 53.4 31.3 38.1 33.6 0.4 94.3 34.3 0.9 48.6 73.1 25.8 0.0 1.0 39.6 50.2 1.9 73.3 18.5 51.4 13.6 10.9 31.8 1.7 14.4 211.7 3.6 21.2 124.4 118.6 7.0 2.5 5.7 0.6 0.3 0.0 1.8 58.5 48.8 3.0 12.7 32.7 56.8 4.0 60.5 10.3 3.1 3.5 53.5 0.5 1.6 91.7 40.0 12.8 15.6 49.1 13.6 7.5 81.0 0.1 0.0 13.2 4.5 33.8 11.8 45.4 82.5 5.5 111.0 0.1 51.7 86.8 TCAF1 "FAM115A, KIAA0738" ENSG00000198420 "TRPM8 channel associated factor 1" Q9Y4C2 7 143851375-143902198 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011732 Approved Approved "Nuclear bodies,Vesicles,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "Cell Junctions" "Nuclear bodies, Vesicles" "HPA011732: AB_2668526" "unprognostic (1.57e-1)" "unprognostic (7.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" "unprognostic (7.00e-2)" "unprognostic (5.70e-3)" "unprognostic (3.07e-2)" "unprognostic (4.93e-2)" "prognostic favorable (5.93e-4)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (3.95e-3)" "unprognostic (6.45e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.89e-1)" 29.0 46.5 22.7 12.9 51.4 4.7 21.7 15.1 30.3 27.5 2.7 18.8 12.2 32.2 15.2 15.1 22.2 19.3 23.7 29.4 42.7 14.8 29.3 19.0 8.4 15.4 13.4 39.9 19.4 35.1 27.2 81.1 19.8 36.2 20.3 28.0 15.8 19.8 17.5 16.9 15.8 30.6 11.5 11.7 21.7 9.4 31.0 17.1 26.8 55.7 9.0 14.8 13.4 20.1 47.2 29.0 90.1 93.7 57.9 55.7 55.1 54.3 64.9 42.4 56.3 60.5 33.0 0.2 25.2 63.3 54.5 29.7 34.8 35.7 46.5 25.7 26.0 25.7 15.7 54.0 39.7 0.3 16.2 58.2 31.5 50.0 18.4 66.8 53.4 32.2 43.2 4.5 83.2 70.7 42.3 15.9 27.6 52.0 17.4 26.0 60.7 6.2 33.7 37.5 25.6 153.1 55.5 34.2 25.7 63.7 51.5 4.0 48.8 44.6 28.5 42.2 32.7 14.0 19.2 0.4 81.9 7.6 62.3 0.4 1.5 0.9 4.7 1.8 3.3 1.6 2.8 3.1 2.9 1.6 2.4 3.0 0.4 4.4 3.1 1.4 2.3 2.5 22.7 51.4 15.1 30.3 29.4 42.7 15.4 13.4 19.8 11.5 31.0 20.1 36.3 44.8 37.1 30.3 7.3 0.0 15.0 0.0 16.5 47.7 29.4 38.6 43.0 31.5 14.9 3.7 25.0 251.7 15.2 18.7 0.0 30.9 2.4 27.6 62.7 35.1 19.4 22.1 71.2 35.6 43.7 54.6 20.9 40.5 7.6 167.5 34.6 83.6 32.9 30.3 63.1 29.3 0.0 10.5 0.0 3.5 53.1 12.2 0.0 29.0 10.8 27.5 20.6 57.3 43.7 49.9 15.4 56.4 8.4 27.3 20.1 8.9 8.0 26.7 13.1 72.1 53.3 13.3 11.7 14.1 0.0 521.5 10.4 377.5 23.5 24.3 TCF20 "AR1, SPBP" ENSG00000100207 "Transcription factor 20" Q9UGU0 22 42160013-42343616 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 127.0;Inhibitory neurons: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017849, HPA036786" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies" "CAB017849: , HPA036786: AB_2675313" "unprognostic (2.17e-1)" "unprognostic (2.12e-2)" "prognostic favorable (1.88e-4)" "unprognostic (2.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (4.89e-4)" "unprognostic (1.77e-1)" "unprognostic (2.36e-1)" "unprognostic (1.40e-2)" "unprognostic (2.16e-3)" "unprognostic (7.30e-2)" "unprognostic (1.17e-3)" "unprognostic (3.07e-3)" "unprognostic (4.94e-1)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" 7.1 6.5 4.2 1.7 3.1 1.6 7.5 0.0 2.9 10.2 0.0 9.1 1.6 9.0 0.2 16.3 6.9 1.0 4.9 3.7 2.4 7.6 7.4 7.1 1.6 0.9 1.0 7.6 8.2 1.2 7.4 1.2 1.1 6.9 1.3 0.9 9.9 1.0 5.7 14.3 10.0 1.4 0.0 7.3 8.0 15.3 1.8 2.3 9.6 1.3 1.6 7.8 11.0 2.1 6.6 2.3 3.2 2.1 1.0 2.1 5.5 4.2 2.8 2.1 3.5 5.0 2.5 10.9 3.6 1.1 3.1 5.4 3.9 3.3 1.2 8.5 3.9 3.4 2.2 1.6 1.5 6.0 4.7 1.2 2.9 3.0 3.0 0.9 1.0 3.1 4.1 3.9 1.6 3.0 9.4 1.8 3.4 2.2 3.1 4.7 2.0 5.7 0.5 5.2 6.2 2.0 2.7 2.0 2.7 2.0 1.2 4.8 3.9 3.8 8.9 3.9 1.9 7.0 6.2 4.5 2.3 4.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 3.1 0.0 2.9 3.7 2.4 0.9 1.0 1.1 0.0 1.8 2.1 10.0 0.0 9.6 23.5 9.1 22.6 11.3 19.4 12.0 25.1 11.5 6.9 7.3 17.2 10.1 9.2 18.8 6.3 11.0 16.6 0.0 10.8 127.0 14.2 9.9 9.3 16.8 9.9 54.0 7.5 5.5 8.1 10.7 22.2 1.3 10.0 8.9 12.6 6.2 10.1 63.5 13.8 12.2 12.4 13.3 36.2 12.5 9.4 7.2 22.5 12.0 5.6 6.2 29.7 55.0 13.3 13.5 6.4 8.7 20.9 13.0 6.0 13.4 12.6 6.6 5.8 8.5 19.1 13.4 19.5 22.9 4.5 13.0 4.3 17.9 14.6 TCF7L2 "TCF-4, TCF4" ENSG00000148737 "Transcription factor 7 like 2" Q9NQB0 10 112950247-113167678 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "brain: 244.9" "Cell type enhanced" "Detected in many" "Astrocytes: 264.8;Distal enterocytes: 260.0;Extravillous trophoblasts: 231.4;Paneth cells: 211.1" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "thalamus: 244.9" "Group enriched" "Detected in many" 10 "intermediate monocyte: 28.9;non-classical monocyte: 86.6" "Lineage enriched" "Detected in many" 14 "monocytes: 86.6" "Low cell line specificity" "Detected in many" "Group enriched" "Detected in all" 9 "midbrain: 67.2;thalamus: 86.6" "Group enriched" "Detected in all" 5 "midbrain: 146.8;pons: 97.8;thalamus: 164.3" "CAB013535, HPA038800" Supported Approved "Nucleoplasm,Nuclear bodies,Cytosol" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "CAB013535: AB_2533167, HPA038800: " "unprognostic (1.79e-2)" "unprognostic (3.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (4.59e-3)" "unprognostic (1.72e-1)" "unprognostic (2.09e-1)" "unprognostic (9.84e-2)" "unprognostic (5.09e-1)" "unprognostic (7.10e-2)" "unprognostic (6.10e-3)" "unprognostic (3.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.60e-1)" "unprognostic (1.55e-1)" "unprognostic (3.64e-1)" "unprognostic (7.36e-3)" 28.1 9.4 47.4 8.6 6.3 7.6 25.0 0.2 12.1 18.9 1.0 22.9 20.4 25.1 6.7 9.9 18.1 9.4 11.3 4.3 46.9 9.9 22.4 13.9 5.4 5.1 98.0 22.9 12.4 11.1 9.6 17.7 1.7 12.3 21.3 4.6 14.5 13.1 8.4 17.2 19.3 16.4 1.6 22.2 23.3 7.6 244.9 5.8 12.9 6.9 3.7 13.8 14.3 3.2 15.0 37.8 40.7 39.6 20.8 13.7 48.5 10.3 20.0 7.1 8.5 24.9 45.3 0.1 11.3 19.4 9.6 10.5 14.0 17.6 9.1 1.7 13.1 10.4 25.2 23.6 22.0 4.2 3.7 24.4 6.3 11.0 18.2 29.7 12.0 8.8 11.0 0.7 8.2 28.0 6.7 2.5 29.2 16.6 21.6 19.0 29.8 6.9 15.2 20.4 0.8 12.4 15.7 15.4 17.0 31.5 10.0 2.2 27.9 6.8 18.7 16.9 21.3 2.6 0.3 0.4 6.5 8.7 14.9 0.4 4.5 0.4 1.5 28.9 0.9 0.0 0.4 1.2 4.1 0.0 0.4 0.6 6.0 0.0 86.6 0.2 0.0 3.5 47.4 6.3 0.2 12.1 4.3 46.9 5.1 98.0 1.7 1.6 244.9 3.2 62.0 22.4 26.5 264.8 3.3 42.6 27.3 35.8 64.9 2.8 53.0 54.9 13.6 52.9 35.5 40.5 6.2 44.2 9.1 260.0 11.7 39.3 8.8 40.1 140.6 46.1 19.8 4.8 35.1 43.6 231.4 90.8 90.2 64.2 0.0 37.6 52.8 74.2 17.5 5.0 16.6 87.7 16.2 99.9 20.6 5.0 59.0 54.6 32.0 107.7 22.4 34.4 5.2 192.5 34.9 59.0 211.1 48.5 6.0 38.4 75.3 16.2 26.8 6.1 92.1 37.3 51.3 9.4 28.9 61.1 39.8 28.5 6.7 13.1 73.9 49.0 TDP2 TTRAP ENSG00000111802 "Tyrosyl-DNA phosphodiesterase 2" O95551 6 24649979-24666930 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Hydrolase, Nuclease" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 183.2" "Cell type enhanced" "Detected in all" "Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 75.6;neutrophil: 228.9" "Lineage enriched" "Detected in all" 7 "granulocytes: 228.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB073398, HPA074011" Enhanced Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" No No "Cluster 9: Neutrophils - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nuclear bodies" "CAB073398: , HPA074011: AB_2686651" "unprognostic (2.46e-2)" "unprognostic (2.10e-3)" "unprognostic (1.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.58e-1)" "unprognostic (4.66e-3)" "unprognostic (4.13e-3)" "unprognostic (3.24e-1)" "unprognostic (5.78e-3)" "prognostic favorable (2.53e-7)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.40e-2)" "unprognostic (1.42e-1)" "unprognostic (9.70e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.47e-5)" 24.4 23.7 27.4 34.3 28.4 21.8 27.3 30.4 36.4 20.6 30.4 141.6 120.1 19.7 25.3 18.6 22.6 28.6 28.2 28.0 28.9 77.9 51.2 24.5 38.9 28.2 29.5 21.3 29.5 25.7 20.3 20.1 28.7 56.5 127.4 18.9 21.9 21.7 21.9 21.1 183.2 24.6 28.3 27.9 26.2 25.3 32.1 37.5 21.7 26.3 37.7 27.2 16.5 28.3 47.7 37.1 41.5 48.1 63.0 64.0 32.4 41.4 53.1 38.9 51.9 50.8 26.3 57.0 70.1 43.8 90.0 34.2 51.2 47.3 52.9 73.6 53.1 53.4 37.7 84.2 40.1 82.8 49.5 43.1 43.7 40.7 36.5 46.0 63.9 54.1 48.8 23.7 59.2 34.1 64.7 52.8 37.1 54.7 31.8 55.5 43.7 61.6 67.0 66.5 52.2 29.8 33.6 84.5 71.0 42.2 38.9 47.4 48.0 37.6 31.3 28.3 61.4 33.7 107.9 77.1 26.0 107.5 61.3 75.6 13.9 29.4 25.0 14.8 30.8 20.0 28.8 27.9 13.2 14.5 24.0 26.2 228.9 29.0 16.5 12.4 31.9 22.7 27.4 28.4 30.4 36.4 28.0 28.9 28.2 29.5 28.7 28.3 32.1 28.3 24.0 6.4 16.7 23.5 24.1 14.1 25.1 37.0 18.8 12.7 19.8 20.2 23.4 37.1 29.6 22.0 6.2 18.4 23.0 530.9 49.0 35.4 140.6 19.4 16.6 22.5 52.7 20.8 25.9 36.0 23.6 18.3 14.3 19.7 24.1 15.7 27.5 31.4 68.4 6.7 25.8 168.9 30.5 28.9 20.0 80.2 18.0 33.5 12.4 15.0 61.7 19.5 38.1 11.6 21.2 21.4 428.1 23.3 10.7 37.0 637.5 175.8 30.5 15.8 32.9 19.1 20.4 9.0 32.7 10.4 16.6 44.3 28.5 15.7 119.3 31.9 TELO2 "hCLK2, KIAA0683, TEL2" ENSG00000100726 "Telomere maintenance 2" Q9Y4R8 16 1493344-1510457 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041348, HPA041473" Approved Supported "Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies, Cytosol" "HPA041348: AB_10794514, HPA041473: AB_10795593" "unprognostic (1.27e-1)" "unprognostic (2.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.91e-1)" "unprognostic (3.08e-2)" "unprognostic (2.94e-2)" "unprognostic (5.99e-3)" "unprognostic (1.47e-3)" "unprognostic (2.21e-1)" "unprognostic (6.75e-2)" "unprognostic (3.15e-3)" 12.3 13.2 7.3 7.6 7.2 11.3 13.4 8.8 11.0 15.2 5.7 12.6 8.9 14.1 1.1 14.4 15.1 3.7 13.2 6.9 6.4 13.6 14.8 11.6 8.1 10.2 7.6 14.4 12.2 4.3 12.5 4.8 7.6 15.8 1.4 1.8 11.4 4.8 17.0 14.4 14.4 2.4 6.4 18.6 11.9 10.0 7.6 5.8 13.2 4.9 3.1 13.6 13.9 8.3 19.7 28.8 8.8 16.8 3.4 3.6 33.9 30.5 5.7 14.4 10.4 37.0 18.3 28.8 25.8 4.9 7.1 20.5 6.3 11.6 2.7 16.9 55.1 16.5 36.7 21.8 5.7 21.0 23.9 7.0 4.3 13.4 2.8 4.9 8.6 24.6 43.2 10.1 5.8 66.3 24.9 56.1 28.2 6.9 23.9 73.5 12.3 29.4 5.4 18.3 36.8 20.6 26.5 24.8 9.8 3.3 23.2 25.3 13.8 31.2 21.7 30.5 25.8 18.2 12.6 53.3 9.9 29.3 26.7 0.0 5.7 2.9 4.1 7.2 3.9 4.1 2.9 3.4 6.9 6.0 3.1 2.5 0.5 3.4 10.7 4.3 2.7 4.7 7.3 7.2 8.8 11.0 6.9 6.4 10.2 7.6 7.6 6.4 7.6 8.3 15.8 0.0 2.7 18.9 15.2 6.9 7.8 10.4 10.2 13.7 12.7 9.8 1.6 11.5 6.3 9.2 12.5 25.5 9.1 19.4 5.9 8.2 2.0 8.4 11.0 9.6 2.4 10.8 5.3 7.2 20.2 11.4 15.8 9.2 2.5 21.2 8.9 12.3 19.6 18.5 6.4 17.2 8.2 11.8 7.0 1.9 7.5 8.6 8.8 10.3 13.3 17.3 8.2 8.5 7.0 6.9 5.5 14.7 8.7 8.8 13.7 6.3 5.1 20.1 13.1 9.9 11.4 9.8 8.2 10.3 6.5 22.0 9.6 19.0 23.5 5.1 TERF1 "PIN2, TRBF1, TRF, TRF1" ENSG00000147601 "Telomeric repeat binding factor 1" P54274 8 73008856-73048123 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048379 Approved "Nucleoli fibrillar center,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoli fibrillar center" "Nuclear bodies" "HPA048379: AB_2680378" "unprognostic (1.02e-2)" "unprognostic (1.66e-1)" "unprognostic (7.24e-2)" "unprognostic (2.42e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-2)" "unprognostic (1.02e-1)" "unprognostic (6.53e-2)" "unprognostic (9.55e-2)" "unprognostic (1.52e-1)" "unprognostic (8.18e-2)" "prognostic unfavorable (6.68e-4)" "unprognostic (2.34e-3)" "unprognostic (1.04e-1)" "unprognostic (9.39e-2)" "unprognostic (1.74e-1)" 13.8 15.2 6.8 4.7 7.7 8.7 13.1 10.9 8.1 13.9 7.0 13.3 8.5 13.8 6.9 9.3 14.7 7.3 11.9 7.6 7.1 14.2 11.2 9.3 7.6 6.3 6.6 17.7 10.1 12.3 11.5 6.6 6.3 12.7 7.3 9.0 10.3 9.4 11.1 10.0 9.4 8.5 7.9 8.1 14.5 10.4 6.5 7.4 11.7 4.7 4.6 18.2 12.4 8.6 17.1 15.5 14.6 12.8 11.0 7.3 14.5 18.4 7.3 10.2 10.7 10.0 13.3 9.4 27.6 9.9 22.2 13.9 19.9 11.3 10.5 14.8 31.7 13.6 3.8 6.9 9.5 7.7 15.9 11.6 7.4 11.2 18.8 14.7 11.0 23.8 14.8 12.3 9.6 10.4 31.3 8.8 60.7 37.7 14.7 21.7 7.0 9.9 17.0 8.7 11.9 15.2 13.6 49.8 14.4 42.6 19.9 5.6 7.5 7.8 13.5 17.0 15.3 15.9 16.0 18.1 10.9 12.0 16.7 11.9 6.5 10.7 11.3 6.0 10.1 12.0 10.5 11.4 7.5 10.7 12.1 12.7 3.6 9.7 7.8 11.4 11.4 6.7 6.8 7.7 10.9 8.1 7.6 7.1 6.3 6.6 6.3 7.9 6.5 8.6 41.5 28.9 29.1 39.5 47.8 27.9 39.6 45.8 35.3 77.6 22.5 32.5 23.2 21.5 27.3 31.3 85.5 53.6 109.4 27.5 25.4 35.8 16.2 24.0 41.1 38.7 92.1 31.6 52.7 37.8 62.4 52.3 24.5 27.1 36.8 44.5 41.7 31.0 34.2 70.7 58.3 26.4 36.7 25.5 26.6 8.1 74.3 27.7 30.2 22.5 32.3 85.7 72.1 48.7 55.3 25.6 21.5 85.4 34.2 30.2 17.9 65.7 24.8 55.4 59.2 63.3 49.1 117.6 131.7 23.6 24.3 31.9 52.6 62.0 28.2 27.6 TERF2 "TRBF2, TRF2" ENSG00000132604 "Telomeric repeat binding factor 2" Q15554 16 69355567-69408571 "Predicted intracellular proteins" "Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001907, HPA002735, CAB010451" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898" "unprognostic (2.61e-2)" "unprognostic (2.61e-2)" "unprognostic (3.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.13e-2)" "unprognostic (6.07e-2)" "unprognostic (3.45e-2)" "unprognostic (3.42e-1)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (1.23e-1)" "unprognostic (1.00e-1)" "unprognostic (5.79e-2)" "unprognostic (2.92e-1)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" 15.2 14.4 19.8 17.2 20.6 18.5 14.1 22.7 29.1 15.3 9.1 15.5 13.4 17.9 15.1 15.0 15.4 13.7 15.1 21.8 21.0 13.0 14.8 12.6 35.6 17.6 19.9 19.2 16.7 18.3 12.4 16.1 16.8 13.3 14.4 21.0 11.9 14.1 31.9 15.9 14.0 19.1 14.5 15.8 12.6 16.4 18.4 21.0 16.6 22.1 44.7 15.6 13.4 23.3 21.6 34.4 30.5 30.8 28.5 20.9 26.0 21.5 26.9 50.1 38.7 31.7 28.6 98.2 28.6 26.7 17.9 34.0 37.8 26.4 46.7 18.6 29.3 28.8 18.2 29.1 24.2 28.6 23.0 21.5 26.2 40.2 48.7 22.2 35.0 38.4 54.8 14.2 32.8 29.2 57.0 36.4 35.1 23.6 16.7 78.5 20.2 56.8 21.6 15.8 34.4 27.0 71.4 16.1 19.6 27.5 30.6 32.8 21.5 31.3 27.4 21.9 25.9 36.8 42.1 124.9 27.1 25.5 30.8 14.9 3.5 4.3 5.9 3.3 4.3 13.0 5.6 5.0 3.7 8.4 6.3 6.2 4.2 4.6 3.5 5.0 5.0 2.8 19.8 20.6 22.7 29.1 21.8 21.0 17.6 19.9 16.8 14.5 18.4 23.3 16.2 16.0 10.2 15.0 20.9 12.5 12.8 5.0 5.7 25.3 13.4 8.5 17.2 5.7 5.1 9.2 18.8 8.3 13.0 15.5 1.9 5.3 33.4 15.5 20.8 17.9 10.2 8.6 18.3 7.5 7.7 13.5 8.6 20.5 14.0 14.9 14.3 18.2 12.5 45.4 19.9 11.6 2.0 15.4 12.3 19.5 9.3 11.0 3.6 16.9 8.9 19.3 16.5 18.6 26.5 7.9 7.3 14.3 11.2 14.8 9.5 8.4 8.3 13.9 19.7 18.8 12.1 8.8 13.1 9.6 12.9 8.3 12.1 17.0 11.1 12.8 TERF2IP RAP1 ENSG00000166848 "TERF2 interacting protein" Q9NYB0 16 75647773-75761872 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006719, CAB018660, CAB018749" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Nuclear bodies" "CAB018660: AB_628202, CAB018749: AB_2269341, HPA006719: AB_1858267" "unprognostic (3.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.06e-3)" "unprognostic (7.83e-2)" "unprognostic (3.30e-1)" "unprognostic (1.99e-2)" "unprognostic (2.33e-1)" "unprognostic (1.59e-2)" "unprognostic (8.80e-2)" "prognostic favorable (6.14e-5)" "prognostic favorable (1.46e-4)" "unprognostic (1.81e-1)" "prognostic favorable (2.15e-5)" "unprognostic (6.26e-2)" "unprognostic (1.85e-1)" "unprognostic (5.30e-2)" "unprognostic (2.99e-1)" 56.3 93.4 151.5 41.2 152.0 89.7 51.9 146.3 186.2 52.7 112.3 48.3 27.2 51.6 57.6 37.6 50.7 36.7 67.0 146.2 189.9 46.7 42.9 51.8 68.2 142.8 154.1 72.8 38.2 71.8 144.4 27.5 155.3 48.0 26.9 168.6 38.3 44.8 58.3 48.0 41.8 39.1 146.0 57.7 37.7 55.0 174.0 71.9 55.2 47.3 61.9 44.5 46.4 156.5 25.1 23.2 51.2 39.7 56.9 59.2 16.0 74.6 63.9 62.0 45.8 25.7 26.9 127.2 97.0 50.6 30.6 35.6 51.1 21.3 52.5 48.1 74.1 64.9 36.6 59.1 74.4 88.6 88.7 50.7 59.3 49.8 76.8 68.2 42.2 82.6 77.2 52.2 71.9 73.7 107.2 112.5 25.9 32.4 53.3 119.9 33.0 106.0 46.4 22.7 123.9 74.7 96.8 22.4 61.8 18.5 51.7 86.0 46.6 59.1 31.3 51.4 57.9 216.2 202.5 179.2 62.2 59.6 57.1 56.4 21.9 101.3 28.7 19.8 35.8 46.8 44.2 47.9 21.0 65.7 53.9 33.8 33.2 39.7 31.2 20.3 48.6 19.8 151.5 152.0 146.3 186.2 146.2 189.9 142.8 154.1 155.3 146.0 174.0 156.5 109.1 48.1 69.3 30.7 160.8 195.5 114.3 82.5 163.4 388.8 73.6 77.0 95.2 68.6 74.2 93.8 93.8 76.8 172.7 33.4 135.0 81.7 7.8 68.5 81.8 102.3 97.8 421.4 46.7 51.1 38.9 115.7 39.3 74.6 124.9 81.4 84.3 58.1 60.7 282.7 54.5 50.1 120.1 70.8 138.5 23.6 115.5 89.3 120.9 18.7 96.6 320.2 125.7 38.2 68.2 46.3 46.9 130.5 162.8 101.7 45.1 74.7 66.9 176.2 138.1 79.0 106.2 255.1 116.2 94.3 194.4 122.3 215.0 140.7 32.2 116.4 TEX49 LINC00935 ENSG00000257987 "Testis expressed 49" A0A1B0GTD5 12 48727435-48765790 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "testis: 20.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "stomach cancer: 0.6;testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA066635 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 36: Testis - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA066635: " "unprognostic (2.63e-2)" "unprognostic (6.32e-3)" "unprognostic (8.28e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 20.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 THNSL1 "FLJ22002, TSH1" ENSG00000185875 "Threonine synthase like 1" Q8IYQ7 10 25016612-25026664 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 21.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 15.6;Early spermatids: 29.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037585 Uncertain Approved "Nuclear bodies,Mitochondria,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies, Cytosol" Mitochondria "HPA037585: AB_10696940" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (4.31e-2)" "unprognostic (5.26e-2)" "unprognostic (6.11e-2)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (9.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.71e-3)" "unprognostic (2.08e-1)" "unprognostic (3.21e-2)" "unprognostic (9.84e-3)" "unprognostic (3.06e-2)" 1.7 6.0 4.0 1.8 4.2 0.6 3.6 3.2 4.5 4.1 2.9 2.7 2.6 3.6 4.9 1.9 5.6 2.0 3.7 4.1 4.2 9.7 21.4 1.5 2.8 3.9 3.5 7.3 3.0 5.3 3.7 1.7 4.2 2.9 3.0 4.1 3.4 2.6 4.6 2.2 2.4 2.2 3.9 2.2 2.7 5.9 4.1 3.3 8.3 5.9 2.7 1.8 1.5 4.3 7.1 8.1 5.0 10.0 5.0 6.2 1.3 3.4 1.3 3.7 2.4 5.3 8.8 32.7 10.6 1.6 4.0 3.8 7.2 6.4 3.8 4.5 3.9 12.0 2.2 3.4 5.6 0.0 2.0 3.9 11.6 2.7 5.7 6.4 2.5 13.3 10.4 3.8 8.0 11.1 6.6 2.3 9.2 12.3 3.9 3.5 1.3 14.2 10.6 1.6 8.3 4.7 6.8 6.0 12.3 2.6 6.0 0.6 2.5 4.4 3.9 5.9 3.2 2.7 3.8 0.0 7.3 6.6 3.5 0.1 0.4 0.0 2.9 0.5 5.1 5.0 4.1 3.8 2.2 3.8 9.5 6.3 0.6 10.8 0.7 3.7 2.0 3.1 4.0 4.2 3.2 4.5 4.1 4.2 3.9 3.5 4.2 3.9 4.1 4.3 1.3 3.2 3.2 2.6 3.4 0.6 3.1 5.6 2.8 4.2 2.1 2.9 8.5 1.5 6.1 3.7 0.0 6.1 0.8 0.6 15.6 3.3 29.9 5.1 3.9 1.8 1.2 2.5 4.0 1.3 3.9 2.7 1.5 2.5 0.0 7.8 2.2 9.8 2.1 3.3 5.1 1.8 2.0 0.9 0.8 5.5 2.1 0.6 0.0 4.7 1.5 6.8 0.0 2.0 5.4 1.1 1.0 1.5 0.9 1.8 2.3 11.0 8.7 4.5 0.0 4.3 1.9 8.2 13.6 2.6 1.0 1.0 2.8 11.8 3.5 1.1 THRB "ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2" ENSG00000151090 "Thyroid hormone receptor beta" P10828 3 24117153-24495756 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Deafness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 199.2;Cone photoreceptor cells: 164.7;Excitatory neurons: 688.0;Inhibitory neurons: 631.3;Oligodendrocyte precursor cells: 329.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 7.7;basal ganglia: 15.1;cerebral cortex: 17.6;hippocampal formation: 18.5;white matter: 6.7" "Group enriched" "Detected in some" 5 "basophil: 7.2;naive B-cell: 2.2" "Group enriched" "Detected in many" 15 "B-cells: 2.2;granulocytes: 7.2" "Cell line enhanced" "Detected in many" "K-562: 45.6;RT4: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002008, CAB002009, HPA061035" Approved Supported "Nuclear bodies" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies" "CAB002008: , CAB002009: , HPA061035: AB_2684422" "unprognostic (1.82e-1)" "unprognostic (4.22e-1)" "unprognostic (2.83e-1)" "unprognostic (2.20e-6)" "unprognostic (3.37e-1)" "unprognostic (2.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-3)" "unprognostic (2.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.01e-2)" "prognostic favorable (9.46e-8)" "unprognostic (1.32e-3)" "unprognostic (6.75e-2)" "unprognostic (2.73e-2)" "unprognostic (3.34e-2)" 11.1 4.9 7.7 1.7 15.1 1.0 10.0 0.0 17.6 2.8 0.0 11.7 2.5 7.0 1.8 6.4 3.8 2.2 7.7 18.5 2.0 12.1 20.1 5.0 1.5 0.0 0.0 2.3 9.0 7.3 15.7 4.4 0.0 7.5 8.4 20.1 6.2 7.7 23.6 6.8 3.9 7.0 0.0 5.7 8.3 0.7 1.4 3.6 4.4 27.0 1.4 8.9 4.2 6.7 10.3 3.1 0.6 0.1 17.4 8.8 6.7 0.5 2.1 1.5 3.2 6.7 9.7 0.1 2.5 6.8 1.1 15.4 10.8 3.9 1.0 0.0 6.4 0.0 2.5 8.9 0.5 0.0 0.0 16.0 7.3 0.2 1.2 3.5 0.0 0.0 45.6 0.0 1.5 0.6 0.0 0.0 6.5 0.6 3.4 0.0 0.0 0.0 10.0 32.7 1.7 0.6 16.5 8.9 0.2 4.6 9.7 0.0 0.9 3.9 3.0 0.0 1.9 0.1 0.5 0.0 2.7 0.1 0.3 7.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 7.7 15.1 0.0 17.6 18.5 2.0 0.0 0.0 0.0 0.0 1.4 6.7 3.0 3.2 11.4 199.2 3.3 9.9 29.5 13.2 1.8 17.9 24.5 18.7 11.6 8.6 14.1 23.9 164.7 12.4 0.0 39.9 1.9 2.4 2.3 3.4 0.5 6.0 25.2 3.8 688.0 12.5 23.2 13.7 16.3 5.7 0.0 0.3 7.5 37.7 1.7 0.0 631.3 8.1 10.2 11.3 11.7 2.4 0.6 4.6 1.8 97.4 0.2 11.7 0.0 329.2 32.4 10.3 17.5 2.2 0.1 40.1 4.8 8.1 10.3 21.8 6.6 12.0 7.5 0.3 0.7 5.1 23.9 5.5 1.0 0.4 9.8 81.3 TIGD1 EEYORE ENSG00000221944 "Tigger transposable element derived 1" Q96MW7 2 232543883-232550557 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041717 Approved Approved "Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Cluster 32: T-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli rim, Mitotic chromosome" "Nucleoplasm, Nuclear bodies" "HPA041717: AB_2677636" "unprognostic (2.48e-1)" "unprognostic (1.77e-2)" "unprognostic (2.10e-2)" "unprognostic (1.86e-1)" "unprognostic (2.58e-2)" "unprognostic (2.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.24e-1)" "unprognostic (1.21e-2)" "unprognostic (1.20e-2)" "unprognostic (4.40e-2)" "unprognostic (6.86e-2)" "prognostic unfavorable (4.41e-5)" "unprognostic (3.77e-2)" "unprognostic (1.85e-2)" "unprognostic (2.77e-1)" "unprognostic (3.21e-3)" 1.8 2.3 6.3 2.3 5.3 6.5 2.7 13.4 7.8 3.2 5.4 2.8 1.9 2.6 2.9 2.8 3.8 1.9 2.4 5.0 4.5 7.4 2.7 2.5 3.4 3.2 2.4 5.7 2.9 1.6 5.0 2.0 4.1 4.4 2.1 10.4 2.7 1.7 4.0 4.2 3.6 1.3 1.5 6.1 3.3 5.2 4.5 3.3 4.7 1.4 2.2 2.8 3.0 9.7 3.1 2.3 4.7 7.5 1.7 2.3 3.6 2.1 1.2 2.6 2.9 2.8 3.6 5.0 1.5 1.6 2.8 3.2 4.1 1.3 3.8 3.0 3.9 4.5 7.7 3.5 1.1 3.6 2.9 2.6 1.2 2.6 1.6 2.5 1.5 6.5 3.6 5.0 2.1 5.3 4.9 8.3 2.8 1.9 2.7 4.7 6.3 2.3 1.5 3.5 6.1 6.0 2.2 2.1 2.3 3.3 3.1 3.9 2.5 4.3 4.5 2.7 2.1 4.8 3.4 4.5 2.5 3.6 2.6 1.6 1.7 1.8 1.9 1.4 1.9 1.7 2.0 1.5 1.1 2.1 3.1 2.5 2.3 1.8 1.5 1.2 1.6 0.7 6.3 5.3 13.4 7.8 5.0 4.5 3.2 2.4 4.1 1.5 4.5 9.7 2.4 9.6 3.9 4.2 5.3 1.3 4.5 2.3 1.8 4.9 2.5 2.2 2.0 1.5 2.9 3.7 8.4 2.2 3.1 1.7 0.0 3.6 4.2 1.0 3.6 1.7 1.2 6.5 4.5 1.5 1.3 3.1 7.7 1.5 0.0 6.4 1.4 0.7 1.4 6.7 5.7 1.5 2.0 1.6 1.7 0.7 4.7 2.4 1.8 1.0 2.8 7.5 5.2 5.0 8.1 2.0 2.4 1.9 5.6 2.6 3.5 1.4 1.7 7.0 6.6 3.7 2.0 3.9 5.7 3.7 2.0 1.4 4.1 4.0 3.0 2.9 TIGD2 ENSG00000180346 "Tigger transposable element derived 2" Q4W5G0 4 89111533-89114901 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 25.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 15.9;Hepatocytes: 21.0;Syncytiotrophoblasts: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 11.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 11.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054844, HPA071168" Uncertain Approved "Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear bodies" "HPA054844: AB_2682623, HPA071168: AB_2686353" "unprognostic (7.11e-2)" "unprognostic (8.02e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (5.42e-2)" "unprognostic (1.91e-1)" "unprognostic (1.01e-1)" "unprognostic (8.47e-2)" "unprognostic (4.96e-2)" "unprognostic (9.83e-3)" "unprognostic (1.16e-1)" "unprognostic (8.94e-3)" "unprognostic (2.51e-1)" "unprognostic (2.35e-1)" "unprognostic (1.11e-1)" "prognostic favorable (7.02e-4)" 2.8 1.9 1.9 3.2 1.9 2.5 10.4 4.7 2.1 3.9 3.9 3.4 6.8 2.4 4.0 2.7 1.7 2.8 1.6 1.7 2.4 5.4 25.4 3.1 4.5 2.0 2.5 2.1 3.6 7.1 3.5 8.6 2.1 3.8 4.1 13.2 10.7 2.5 1.9 2.4 4.8 1.9 1.8 3.5 4.4 3.7 2.4 5.5 5.6 3.1 4.5 3.0 2.7 2.3 15.2 7.0 7.5 9.0 8.1 6.2 3.3 9.0 11.0 8.5 7.1 14.1 14.4 7.3 4.7 3.6 6.1 4.7 8.2 13.8 11.4 12.7 2.6 8.6 7.7 6.8 24.0 4.0 5.9 15.4 13.4 3.4 12.2 7.9 3.2 9.6 11.1 12.3 10.6 5.8 7.6 4.6 9.0 16.2 2.3 11.5 13.1 10.0 7.4 28.7 35.6 7.2 8.8 27.8 11.5 9.9 9.8 8.1 2.5 10.9 10.1 3.5 6.9 19.7 6.4 5.5 9.6 7.0 9.4 11.7 1.3 0.1 1.9 1.9 0.9 1.2 0.9 1.4 1.5 1.0 0.9 1.4 0.0 2.2 1.0 0.2 1.0 0.9 1.9 1.9 4.7 2.1 1.7 2.4 2.0 2.5 2.1 1.8 2.4 2.3 1.9 0.0 0.5 1.3 1.8 0.3 5.9 1.7 7.4 4.5 4.9 3.3 3.5 7.2 5.5 3.7 10.4 15.9 1.3 1.2 1.9 2.7 1.4 6.3 3.0 2.6 2.4 1.7 1.3 5.7 10.5 1.7 4.6 6.3 0.0 2.8 2.2 21.0 4.9 0.0 1.9 2.9 0.0 2.4 1.1 0.8 1.5 3.5 0.0 0.0 4.3 2.7 1.0 1.5 2.3 3.8 1.9 1.2 2.4 2.3 8.3 10.2 1.5 7.2 0.0 1.5 2.7 2.3 8.0 3.6 0.4 39.0 2.5 2.1 3.2 1.6 TINF2 TIN2 ENSG00000092330 "TERF1 interacting nuclear factor 2" Q9BSI4 14 24239643-24242674 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 233.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059061, HPA069807" Enhanced "Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA059061: AB_2683895, HPA069807: AB_2686203" "prognostic favorable (4.96e-4)" "unprognostic (8.58e-2)" "unprognostic (1.53e-1)" "unprognostic (5.47e-2)" "unprognostic (3.20e-2)" "unprognostic (2.78e-2)" "unprognostic (4.75e-2)" "unprognostic (2.50e-1)" "unprognostic (4.70e-1)" "unprognostic (8.05e-2)" "unprognostic (1.05e-1)" "unprognostic (8.71e-2)" "unprognostic (9.59e-3)" "unprognostic (2.04e-3)" "unprognostic (2.17e-1)" "unprognostic (4.78e-2)" "unprognostic (7.44e-2)" 47.2 76.4 17.6 17.3 19.1 20.1 44.0 18.9 23.6 42.2 17.7 40.7 11.5 43.7 21.0 63.2 36.1 12.8 39.4 17.6 18.4 48.5 33.5 44.1 22.7 19.5 18.6 32.2 44.6 233.5 31.9 14.2 19.5 37.9 15.7 12.8 37.6 16.2 45.2 40.8 38.4 19.4 18.8 55.8 41.8 16.3 18.7 29.2 40.7 16.1 26.6 40.9 41.4 20.0 18.4 16.4 23.2 12.2 25.1 18.5 11.8 18.3 23.1 26.3 24.5 7.1 20.0 26.7 10.3 26.1 19.0 17.5 13.2 16.5 16.5 34.1 6.7 16.8 15.1 28.5 21.6 17.9 23.1 20.5 26.0 21.1 20.0 24.5 28.9 25.0 6.7 33.1 21.5 20.0 27.0 8.8 5.4 19.3 20.1 21.9 14.8 19.5 23.7 25.8 14.2 13.2 19.1 18.0 17.0 15.3 12.9 11.4 23.3 12.2 14.9 21.0 14.6 25.2 19.5 15.1 14.8 9.9 18.6 124.6 47.8 113.7 59.7 51.1 48.1 58.7 46.5 56.2 41.1 65.1 48.3 48.4 60.2 63.5 49.3 34.9 61.5 75.8 17.6 19.1 18.9 23.6 17.6 18.4 19.5 18.6 19.5 18.8 18.7 20.0 34.6 16.0 23.0 6.2 54.5 16.8 63.8 35.7 26.7 23.0 18.4 17.7 13.5 15.7 29.3 18.4 8.4 31.8 51.1 19.2 35.2 35.1 8.1 12.8 15.7 31.4 13.1 15.8 4.1 47.2 26.5 28.1 16.8 18.7 40.5 10.0 27.8 16.5 35.5 15.2 4.1 16.3 32.6 30.1 19.7 10.7 23.6 29.9 21.4 7.5 43.3 41.8 72.1 3.5 7.5 40.5 23.8 29.7 31.5 38.9 22.0 25.4 9.5 18.8 26.3 25.8 29.9 24.3 26.2 27.4 25.1 42.3 46.5 29.4 15.6 53.0 TLE2 "ESG, ESG2, FLJ41188, GRG2" ENSG00000065717 "TLE family member 2, transcriptional corepressor" Q04725 19 2997639-3047635 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.7" "Group enriched" "Detected in many" 11 "B-cells: 1.7;T-cells: 1.2" "Cell line enhanced" "Detected in many" "AN3-CA: 44.4;RT4: 35.2;T-47d: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049103 Enhanced Supported "Nuclear bodies,Focal adhesion sites" NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Focal adhesion sites" "HPA049103: AB_2680631" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (2.89e-1)" "prognostic favorable (2.51e-4)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (9.87e-3)" "unprognostic (6.40e-3)" "unprognostic (2.44e-1)" "unprognostic (1.81e-2)" "prognostic favorable (2.39e-6)" "unprognostic (2.12e-1)" "prognostic favorable (9.49e-6)" "unprognostic (2.66e-1)" "unprognostic (5.99e-2)" "unprognostic (2.60e-1)" "prognostic favorable (8.88e-4)" 35.6 31.5 19.4 5.2 20.6 1.6 34.2 67.6 21.2 45.0 10.5 52.4 12.5 62.6 5.2 13.5 62.2 9.0 75.6 13.4 18.9 52.0 17.1 42.5 5.5 22.0 21.5 29.3 36.7 20.4 25.9 9.3 27.2 55.5 6.6 8.7 85.5 28.0 66.4 21.9 18.4 11.1 18.5 46.9 30.2 23.0 27.9 4.9 72.5 30.9 2.1 67.4 25.7 22.2 0.5 2.8 0.2 44.4 6.7 1.1 9.5 0.4 0.0 2.1 1.1 14.0 5.1 0.2 5.9 3.2 1.3 7.6 7.7 2.7 0.5 1.2 2.1 0.0 3.4 0.6 8.6 0.0 0.4 9.6 1.2 4.9 0.1 2.6 18.0 12.6 16.2 0.2 0.3 15.0 0.4 0.2 0.1 1.3 2.9 3.9 2.2 4.4 5.5 35.2 2.3 11.1 3.0 22.0 1.1 0.9 25.1 0.1 11.7 14.0 14.4 0.8 0.5 0.5 0.5 3.0 0.3 3.3 2.8 0.0 0.0 0.1 1.1 0.0 0.9 1.7 0.7 0.4 0.0 0.1 1.2 0.7 0.0 0.0 0.0 0.0 0.2 0.3 19.4 20.6 67.6 21.2 13.4 18.9 22.0 21.5 27.2 18.5 27.9 22.2 27.1 19.2 17.6 1.6 0.7 3.6 34.2 8.3 11.4 36.9 27.0 16.5 24.9 12.8 7.0 36.8 2.1 1.8 2.8 21.7 1.9 11.3 6.5 1.8 9.6 10.3 13.8 0.4 10.3 2.7 4.4 14.8 8.2 6.0 0.0 7.2 16.1 4.0 0.7 1.7 29.3 14.9 8.2 0.3 3.1 18.8 11.8 1.1 5.4 3.7 0.1 19.2 2.1 10.6 14.6 2.7 9.8 15.1 0.3 28.2 1.3 1.1 10.0 4.4 0.0 1.5 11.2 1.2 5.8 4.6 2.3 6.7 2.3 0.7 26.5 32.5 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 252.5 276.8 498.7 220.7 507.8 434.6 241.9 504.6 588.9 236.5 500.2 253.3 192.8 179.4 344.5 310.5 181.7 117.9 355.4 502.2 514.7 317.6 273.2 208.0 279.3 511.7 510.0 259.6 230.3 309.8 302.0 146.6 505.9 239.6 229.3 295.4 215.9 142.7 511.6 215.1 220.4 132.7 513.0 272.9 235.5 216.0 511.9 388.3 232.4 287.4 297.7 213.3 239.3 514.5 565.0 398.8 634.2 456.6 514.0 497.1 435.6 454.1 355.7 425.1 419.3 326.3 395.9 365.2 315.3 397.8 553.6 215.5 559.8 512.5 471.6 452.6 475.5 689.4 910.3 845.8 399.0 792.2 443.0 459.7 538.2 402.6 388.8 414.2 546.0 641.1 376.6 379.0 615.3 581.2 929.4 1071.2 847.1 607.0 637.3 262.2 397.0 620.4 746.0 748.7 207.8 526.1 511.0 369.3 736.1 583.6 356.7 1156.3 412.1 358.0 650.8 560.5 902.6 626.1 1001.6 902.8 459.1 754.2 379.9 1923.2 1058.7 2195.0 1127.1 1022.5 1237.6 1412.6 1486.0 1377.1 1150.8 1172.2 1464.7 1408.1 2036.5 943.8 1028.9 1521.6 1652.1 2663.7 498.7 507.8 504.6 588.9 502.2 514.7 511.7 510.0 505.9 513.0 511.9 514.5 518.8 240.4 370.4 20.9 615.0 716.3 534.0 1308.9 618.6 219.6 866.8 1111.2 633.4 513.3 616.2 901.2 106.3 785.4 797.4 948.2 1717.8 566.9 653.6 524.8 511.4 474.5 635.3 609.1 25.8 1032.9 830.9 443.7 356.3 646.1 454.4 376.5 574.7 1098.6 854.5 119.5 25.4 985.5 695.8 652.4 790.5 1123.9 646.8 544.3 777.3 18.7 850.3 522.8 1080.3 10.1 28.3 872.9 980.3 464.6 593.9 584.6 1211.0 1438.8 466.4 321.9 355.0 393.6 448.4 547.4 689.4 805.5 898.4 440.1 757.1 351.9 937.2 572.2 TMEM132E DFNB99 ENSG00000181291 "Transmembrane protein 132E" Q6IEE7 17 34579487-34639318 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.9" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5" "Cancer enriched" "Detected in some" 4 "glioma: 7.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RPMI-8226: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070608 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol" NA NA 170000 "Cluster 40: NK-cells - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Golgi apparatus" "Nuclear bodies, Cytosol" "HPA070608: AB_2686286" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.29e-5)" "unprognostic (3.37e-1)" "unprognostic (1.37e-1)" "unprognostic (8.61e-2)" "unprognostic (1.06e-3)" "unprognostic (1.72e-1)" "unprognostic (1.80e-1)" "unprognostic (1.56e-2)" "unprognostic (2.16e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.67e-2)" "unprognostic (1.51e-2)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 0.3 0.1 4.6 0.0 3.0 0.0 0.1 6.1 6.4 0.4 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.5 2.6 6.2 3.6 0.4 0.1 0.1 17.9 5.1 0.2 0.0 0.0 0.1 0.1 10.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.7 0.1 8.7 0.3 0.1 1.9 6.5 0.0 0.2 0.0 0.1 0.1 0.2 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.1 4.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 4.6 3.0 6.1 6.4 2.6 6.2 17.9 5.1 10.2 8.7 6.5 11.1 0.1 0.0 0.0 2.6 0.1 0.3 0.0 0.0 0.0 1.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 6.4 0.0 0.0 1.9 0.7 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 13.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.1 0.0 0.2 0.5 1.2 2.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TMEM255A "FAM70A, FLJ20716" ENSG00000125355 "Transmembrane protein 255A" Q5JRV8 X 120258650-120311556 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.7;ovary: 19.6" "Group enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 32.6;Skeletal myocytes: 14.6" "Group enriched" "Detected in many" 10 "glioma: 21.3;melanoma: 8.0;renal cancer: 7.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 2.8" "Lineage enriched" "Detected in single" 9 "T-cells: 2.8" "Cell line enhanced" "Detected in some" "Karpas-707: 25.3;NTERA-2: 9.5;RPMI-8226: 17.1;SK-MEL-30: 27.7;U-2 OS: 11.8;U-87 MG: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048470 Approved Uncertain "Nucleoplasm,Nuclear bodies" No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nuclear bodies" "HPA048470: AB_2680406" "unprognostic (3.41e-2)" "unprognostic (8.96e-2)" "unprognostic (1.62e-2)" "unprognostic (2.04e-1)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" "unprognostic (8.55e-4)" "unprognostic (7.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (2.02e-1)" "unprognostic (1.32e-2)" "unprognostic (3.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.17e-2)" "unprognostic (2.55e-4)" 4.7 3.3 7.4 1.8 5.8 0.7 3.2 4.8 9.2 11.9 1.7 2.6 0.7 1.9 1.6 2.8 3.8 1.1 1.3 3.8 27.4 1.4 0.6 3.0 3.6 22.7 48.7 19.6 0.4 1.4 3.8 0.2 33.0 1.4 2.3 1.5 1.2 1.8 1.4 2.6 2.3 0.9 19.9 1.7 1.8 0.2 36.8 8.1 0.4 2.7 3.8 1.9 8.5 11.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.2 0.0 0.1 0.3 0.0 2.9 0.0 1.9 0.7 0.7 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 25.3 0.4 0.0 0.0 0.1 9.5 0.0 0.0 0.1 0.0 17.1 0.0 0.0 5.1 0.1 0.5 0.0 27.7 0.3 0.0 0.3 0.0 0.0 11.8 0.0 5.1 0.0 5.2 3.7 29.7 0.0 0.0 0.0 0.3 0.0 2.8 0.1 1.4 0.2 0.2 1.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 7.4 5.8 4.8 9.2 3.8 27.4 22.7 48.7 33.0 19.9 36.8 11.5 0.1 3.2 0.0 1.6 0.0 0.4 0.1 0.1 0.6 1.9 0.2 1.3 0.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.5 0.0 0.0 0.2 0.0 0.0 4.4 0.0 0.4 0.0 0.3 0.4 0.0 1.3 0.0 4.3 0.0 0.0 1.0 0.7 1.6 0.6 1.6 5.4 1.9 3.7 0.3 0.0 32.6 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 0.0 14.6 0.6 0.1 0.1 0.0 1.3 0.1 0.4 0.0 0.0 0.0 TMEM62 FLJ23375 ENSG00000137842 "Transmembrane protein 62" Q0P6H9 15 43123279-43185144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 61.0;U-266/84: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044461, HPA062359" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies" "HPA044461: AB_2678950, HPA062359: AB_2684747" "unprognostic (7.43e-2)" "unprognostic (4.96e-2)" "unprognostic (4.56e-2)" "prognostic favorable (9.72e-7)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (2.39e-2)" "unprognostic (1.41e-2)" "unprognostic (4.83e-2)" "unprognostic (3.30e-1)" "unprognostic (3.90e-2)" "unprognostic (1.77e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (6.48e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 7.1 4.6 4.8 6.0 5.0 9.0 22.9 8.2 6.7 8.1 3.6 13.1 13.1 5.4 12.3 6.2 7.5 7.9 5.1 5.3 4.8 7.6 10.3 8.8 7.2 4.5 4.5 3.2 8.1 13.7 4.6 10.3 5.0 6.1 14.4 8.9 13.6 7.1 9.4 5.2 11.7 6.5 5.0 6.1 10.2 2.0 5.4 4.0 8.5 6.6 8.0 7.6 5.4 5.6 14.9 7.9 3.5 6.8 4.3 5.5 36.4 13.9 17.6 24.1 33.3 12.5 28.5 15.0 7.9 13.2 21.7 27.6 14.8 10.9 8.7 17.7 6.8 12.2 15.4 9.5 9.4 12.7 10.5 3.9 13.0 10.6 7.4 6.8 13.6 3.7 10.9 12.7 2.8 3.5 0.0 3.0 1.2 61.0 3.2 7.5 3.7 7.9 12.9 18.6 22.2 9.6 10.9 27.2 6.7 3.9 14.6 12.9 8.0 11.9 4.9 8.5 22.7 10.6 67.1 10.7 11.0 14.0 10.4 0.5 0.7 1.1 0.8 0.3 1.0 0.7 1.1 1.0 0.7 0.8 0.7 0.9 0.2 1.6 0.4 1.7 2.0 0.4 4.8 5.0 8.2 6.7 5.3 4.8 4.5 4.5 5.0 5.0 5.4 5.6 7.7 16.0 4.6 12.1 18.8 2.3 4.1 2.8 5.7 5.6 12.3 6.3 2.6 8.6 5.0 12.9 10.4 21.9 7.0 12.5 5.9 12.9 1.6 9.6 3.7 5.6 4.2 9.1 36.3 14.8 25.2 4.8 11.2 13.9 5.1 7.0 6.1 7.3 7.5 1.7 33.4 11.4 6.1 6.5 4.8 3.7 2.5 7.1 5.4 18.7 6.4 7.8 6.2 29.1 34.5 12.2 8.1 1.2 16.5 2.7 12.8 3.4 6.1 9.9 6.6 4.1 5.2 2.2 1.0 8.6 2.8 34.1 7.4 3.8 11.0 4.8 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500452 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 43.0;Granulosa cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: AB_2681207" "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favorable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 21.3 55.9 50.3 13.9 46.4 18.4 21.7 27.7 54.9 21.9 30.5 25.1 18.8 24.4 5.4 21.1 30.7 15.8 27.8 40.7 31.5 29.7 20.2 25.6 14.1 40.1 36.8 27.7 23.7 20.3 30.1 14.2 30.5 19.9 13.6 27.7 21.1 13.2 63.4 22.9 28.2 10.7 34.8 29.7 25.0 27.1 47.1 18.0 27.4 25.8 8.6 20.5 15.3 35.8 15.3 40.7 33.6 52.6 16.1 18.8 45.6 9.2 20.0 15.4 15.4 13.7 22.6 20.6 30.3 15.9 23.6 19.9 15.8 25.6 8.8 19.4 23.1 22.0 18.4 22.9 21.2 23.7 45.2 30.9 14.5 15.0 13.4 13.9 28.1 18.3 22.6 24.4 20.7 19.1 53.3 18.8 14.4 19.3 16.2 36.2 37.2 19.2 16.0 40.7 28.1 30.5 10.2 47.4 28.7 25.3 29.8 29.3 16.0 16.5 19.0 16.5 13.8 53.2 17.2 12.2 17.2 23.8 20.8 0.1 2.6 3.0 3.5 1.6 2.6 1.0 1.6 2.5 2.5 2.5 1.3 2.2 0.7 2.4 1.4 3.3 2.1 2.9 50.3 46.4 27.7 54.9 40.7 31.5 40.1 36.8 30.5 34.8 47.1 35.8 12.8 12.8 11.1 0.0 5.8 0.0 3.3 0.0 6.2 43.0 10.9 9.1 0.0 12.8 6.2 9.2 31.3 16.1 8.8 18.0 0.0 8.1 4.7 10.1 6.8 8.2 7.3 10.7 0.0 9.5 11.0 4.4 28.1 8.6 6.3 41.5 13.9 8.9 15.4 20.2 0.0 10.5 0.0 12.4 0.0 1.9 6.8 8.9 0.0 0.0 5.6 15.2 4.1 0.0 0.0 6.0 9.1 9.1 8.1 3.3 19.6 3.4 2.9 33.6 6.6 7.5 6.0 14.9 8.8 9.7 0.0 20.1 6.9 19.0 9.3 3.1 TNKS "ARTD5, PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1" ENSG00000173273 Tankyrase O95271 8 9555912-9782346 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 149.9;Excitatory neurons: 203.2;Inhibitory neurons: 230.6;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 285.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025690 Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear membrane, Nuclear bodies" "HPA025690: AB_10602249" "unprognostic (2.07e-1)" "unprognostic (1.72e-2)" "unprognostic (5.45e-3)" "unprognostic (8.22e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-2)" "unprognostic (4.75e-2)" "unprognostic (1.13e-1)" "unprognostic (9.06e-2)" "unprognostic (8.01e-2)" "unprognostic (6.21e-2)" "unprognostic (9.10e-2)" "unprognostic (4.14e-2)" "unprognostic (1.12e-1)" "unprognostic (5.43e-1)" "unprognostic (7.76e-2)" "unprognostic (5.36e-2)" 7.3 9.3 14.2 6.5 20.5 12.2 9.9 18.5 15.8 12.1 6.9 7.5 6.0 10.5 17.5 5.9 8.2 6.2 7.0 13.4 16.8 6.1 7.5 6.6 8.5 21.5 18.5 13.1 7.5 12.5 12.6 7.9 22.2 7.8 6.8 21.0 7.1 7.7 18.4 11.4 7.8 7.1 14.7 6.5 7.2 20.3 18.3 10.5 9.7 11.8 8.6 7.9 6.9 32.2 8.8 11.5 28.8 17.4 17.8 23.7 10.7 13.4 15.1 10.7 12.0 6.9 6.9 18.9 5.4 13.2 14.3 9.2 16.5 12.5 15.4 4.9 8.6 13.3 10.7 15.6 16.0 6.9 7.9 16.9 14.8 11.1 21.6 17.3 14.6 14.5 12.7 19.6 19.9 5.8 17.5 10.4 18.9 9.7 6.7 13.9 17.8 5.5 12.8 17.8 29.1 21.4 10.5 9.9 19.3 17.3 6.6 10.2 19.7 17.4 10.6 11.9 10.0 6.7 11.8 13.3 18.7 9.5 17.1 2.4 1.1 0.9 2.0 1.1 1.0 1.9 1.6 1.9 1.4 3.2 1.8 2.2 3.5 1.5 1.4 1.8 0.8 0.7 14.2 20.5 18.5 15.8 13.4 16.8 21.5 18.5 22.2 14.7 18.3 32.2 19.7 16.0 11.7 130.9 23.1 11.5 12.8 11.4 12.0 34.1 15.8 13.6 17.0 15.7 12.0 9.2 14.6 11.2 14.9 9.2 1.9 12.4 149.9 19.9 30.6 15.5 13.8 14.5 203.2 8.5 10.9 20.3 19.9 20.9 10.1 33.7 18.9 18.0 7.1 42.1 230.6 10.8 16.2 9.4 8.5 76.3 16.8 10.3 12.4 92.8 8.4 15.1 5.2 313.1 285.7 13.4 12.8 18.0 20.7 12.8 17.2 6.9 28.1 37.0 0.0 28.7 16.6 37.7 15.4 12.9 15.5 12.3 18.1 39.5 12.2 12.8 TOE1 hCaf1z ENSG00000132773 "Target of EGR1, exonuclease" Q96GM8 1 45340052-45343973 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 36.6;Spermatocytes: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053775, HPA069119" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA053775: AB_2682259, HPA069119: AB_2686090" "unprognostic (7.20e-2)" "unprognostic (1.20e-1)" "unprognostic (7.15e-3)" "unprognostic (1.90e-2)" "unprognostic (3.33e-1)" "prognostic favorable (9.05e-4)" "prognostic unfavorable (6.12e-9)" "unprognostic (4.67e-2)" "unprognostic (4.84e-2)" "unprognostic (2.37e-2)" "unprognostic (6.03e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.71e-4)" "prognostic favorable (9.98e-4)" "unprognostic (1.81e-1)" "unprognostic (1.41e-2)" "unprognostic (2.08e-1)" 4.8 5.1 4.9 5.9 4.9 8.0 5.5 4.8 6.1 3.7 4.8 6.8 6.7 6.7 8.4 3.7 5.4 3.5 3.7 4.7 5.4 4.7 5.5 5.1 7.9 5.1 5.0 6.2 4.8 7.5 3.2 6.8 5.1 5.0 8.2 4.1 5.3 5.0 3.0 3.9 5.0 6.5 5.0 5.8 5.6 11.8 5.4 9.0 7.1 2.4 8.3 5.5 3.3 5.1 15.8 9.1 16.5 15.7 7.6 5.9 23.9 15.6 12.9 26.6 24.7 16.7 9.6 29.9 12.1 16.2 23.4 15.9 21.0 22.5 21.3 19.6 17.3 36.0 21.9 15.6 7.3 23.7 17.2 8.8 4.8 28.4 17.8 9.4 19.5 22.5 28.4 19.6 18.9 14.6 34.8 18.4 31.1 20.6 14.2 24.9 24.5 13.6 11.5 28.7 13.9 13.4 14.5 36.3 27.5 25.7 9.8 33.2 14.6 12.6 23.3 19.1 29.7 15.0 19.4 19.9 14.8 26.5 14.7 20.0 5.8 6.2 7.3 6.9 8.4 5.9 6.3 7.3 6.0 8.4 6.4 7.0 0.6 4.1 6.1 5.2 8.6 5.1 4.9 4.9 4.8 6.1 4.7 5.4 5.1 5.0 5.1 5.0 5.4 5.1 6.5 6.4 4.8 2.3 12.4 1.8 6.3 8.8 4.6 10.7 4.5 5.0 1.8 7.2 8.1 7.3 12.5 36.6 9.2 9.2 7.9 5.4 13.9 2.1 6.2 9.0 3.0 14.1 2.5 6.2 13.8 6.6 4.6 3.4 11.4 10.5 8.6 5.0 9.3 8.4 2.7 7.3 8.2 3.5 2.6 9.4 6.8 6.2 3.6 1.9 12.3 13.1 9.2 2.0 2.1 3.4 10.7 6.4 7.0 6.5 8.8 7.9 4.7 18.3 13.1 8.0 7.1 51.7 18.9 3.8 1.4 22.7 9.0 10.2 6.9 4.6 TONSL "IKBR, NFKBIL2" ENSG00000160949 "Tonsoku like, DNA repair protein" Q96HA7 8 144428775-144444440 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.5" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024679, HPA046494" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 48: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Nuclear bodies" "HPA024679: AB_1854441, HPA046494: AB_2679673" "unprognostic (6.68e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.88e-2)" "unprognostic (7.35e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.04e-3)" "unprognostic (7.81e-2)" "unprognostic (4.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.62e-7)" "unprognostic (3.24e-2)" "unprognostic (1.78e-1)" "unprognostic (9.11e-3)" "unprognostic (7.96e-2)" 1.0 2.1 0.4 2.5 0.4 8.5 1.3 0.4 1.3 1.7 0.0 3.4 3.5 1.6 0.2 3.9 1.4 0.6 1.4 0.3 0.3 1.4 1.7 1.3 2.3 1.3 0.6 1.7 1.5 0.4 0.9 1.5 1.1 1.6 0.8 0.1 1.5 0.8 0.5 3.3 4.4 0.6 0.1 3.9 2.2 3.8 0.8 2.3 2.4 0.1 1.4 2.3 2.1 0.3 21.2 18.6 13.7 21.7 1.0 1.7 33.0 17.6 3.4 10.4 8.1 15.0 17.9 19.6 17.5 2.7 4.9 14.2 13.4 10.7 2.3 20.2 26.6 46.5 26.1 15.9 0.6 14.3 28.1 1.7 1.5 10.9 2.1 2.6 5.0 26.5 53.0 14.3 4.2 43.4 35.5 24.5 19.4 20.4 26.7 42.6 8.9 20.3 5.9 22.6 22.9 13.0 18.4 12.3 7.8 5.2 17.6 13.2 5.9 12.7 52.3 14.5 21.7 5.0 9.9 12.0 12.3 30.2 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.4 0.4 1.3 0.3 0.3 1.3 0.6 1.1 0.1 0.8 0.3 2.5 6.4 22.4 1.6 2.9 8.9 5.2 1.0 1.2 3.1 3.5 2.9 2.3 8.6 3.7 1.8 2.1 4.1 1.3 20.2 0.0 0.9 0.4 4.3 2.7 4.3 2.4 7.2 2.4 1.0 5.3 3.8 11.7 6.1 2.5 8.5 2.9 11.4 4.5 1.7 1.0 14.6 0.0 0.9 16.7 0.7 0.3 3.0 14.2 1.9 1.2 1.1 1.0 0.5 0.8 1.2 7.1 1.2 4.0 3.9 76.5 7.7 4.1 3.0 6.6 6.4 2.8 4.6 7.8 3.4 11.2 1.2 3.1 3.3 15.9 3.9 TOPBP1 "Dpb11, KIAA0259, TOP2BP1" ENSG00000163781 "DNA topoisomerase II binding protein 1" Q92547 3 133598175-133662380 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 104.1;Spermatocytes: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022451, HPA036738, HPA036739" Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281" "unprognostic (7.72e-2)" "unprognostic (8.54e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.05e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (4.66e-5)" "unprognostic (8.03e-2)" "unprognostic (3.98e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (2.74e-3)" "unprognostic (8.65e-3)" "unprognostic (7.97e-2)" "unprognostic (2.52e-1)" "unprognostic (7.64e-2)" "unprognostic (1.60e-1)" 7.7 4.9 3.6 13.0 4.3 33.1 10.7 5.0 4.6 6.5 3.1 9.3 8.3 8.1 5.0 8.9 5.9 6.9 6.1 4.6 3.3 5.5 7.4 7.3 19.7 3.7 3.2 7.3 7.6 6.0 3.6 12.0 3.7 6.6 11.5 8.2 7.1 5.5 6.9 11.8 9.2 8.7 3.5 10.4 8.7 22.4 3.7 29.1 7.4 7.6 18.6 8.3 7.0 4.5 44.4 27.2 43.1 35.1 8.0 10.5 32.3 33.9 26.9 41.0 52.4 37.9 27.5 80.5 29.1 24.7 49.3 50.2 62.8 22.6 62.7 48.9 28.2 75.4 38.3 23.4 7.7 81.5 57.1 12.5 13.7 40.2 23.9 15.4 28.5 46.3 47.6 55.7 32.6 30.3 79.9 43.1 35.7 50.4 23.0 53.3 53.8 58.4 14.6 30.1 40.9 45.2 41.9 22.6 35.4 41.7 37.7 74.6 19.9 43.0 38.9 43.9 37.7 33.4 53.4 150.6 25.4 42.7 38.4 1.8 0.7 2.2 0.7 0.9 1.0 0.9 0.7 0.7 0.7 0.5 0.7 0.7 0.9 1.0 0.5 1.0 1.5 0.4 3.6 4.3 5.0 4.6 4.6 3.3 3.7 3.2 3.7 3.5 3.7 4.5 17.1 22.4 21.9 10.7 22.8 12.4 8.8 7.8 20.5 15.2 14.2 14.2 10.1 12.8 19.7 11.0 2.1 20.0 33.9 11.9 9.8 12.3 69.4 8.8 16.8 16.0 7.2 42.7 24.3 13.3 19.6 14.9 16.3 13.1 7.6 34.3 7.5 9.5 11.2 3.3 19.6 13.9 6.1 16.7 8.0 104.1 10.2 18.2 8.8 11.2 27.4 10.4 28.8 16.6 13.0 14.7 11.6 9.8 37.5 10.2 6.1 6.1 8.7 9.3 13.1 20.9 12.2 81.3 43.6 22.0 11.5 14.0 23.3 17.7 14.8 10.5 TP53BP1 "53BP1, p202, TDRD30" ENSG00000067369 "Tumor protein p53 binding protein 1" Q12888 15 43403061-43510728 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004083, HPA008788, HPA022133, CAB079980" Supported Supported "Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles" Yes No "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "Nucleoplasm, Mitotic chromosome, Vesicles" "CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382" "unprognostic (2.12e-1)" "unprognostic (7.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.85e-2)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.03e-2)" "unprognostic (3.96e-1)" "unprognostic (2.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.34e-2)" "unprognostic (4.07e-1)" "unprognostic (8.06e-2)" "unprognostic (9.11e-2)" "unprognostic (1.52e-1)" "unprognostic (6.99e-2)" "unprognostic (3.38e-2)" 6.9 11.5 17.4 10.1 16.6 11.5 10.7 19.9 14.5 17.7 21.5 9.7 6.4 16.0 15.9 6.1 14.7 10.7 8.8 15.4 26.3 9.1 4.1 8.3 8.6 13.5 16.7 16.8 7.4 22.3 24.1 12.2 15.7 12.1 10.2 22.0 10.1 12.8 7.2 9.2 6.4 16.3 9.6 8.7 7.6 21.6 23.0 15.3 17.9 11.0 12.6 11.2 8.7 12.1 13.5 22.3 63.8 40.1 25.8 31.9 15.8 22.8 33.8 31.0 39.1 19.4 15.8 14.5 19.2 39.0 66.9 32.4 46.3 27.5 36.8 38.9 15.8 27.1 40.1 11.7 16.8 30.2 37.4 24.9 19.0 41.8 31.2 51.7 37.4 24.2 26.9 12.3 36.5 9.6 23.7 14.1 41.1 24.2 13.9 25.1 23.9 9.3 22.9 31.8 57.3 26.8 33.8 14.3 8.5 48.6 29.9 16.9 27.5 33.7 22.3 27.0 20.5 9.8 22.4 33.0 27.6 14.6 17.5 1.4 0.5 1.0 1.6 0.7 1.3 1.9 1.6 1.6 1.2 1.8 1.8 1.6 0.6 0.9 0.5 1.3 1.4 0.7 17.4 16.6 19.9 14.5 15.4 26.3 13.5 16.7 15.7 9.6 23.0 12.1 11.5 22.4 22.3 53.2 17.8 6.4 10.2 10.0 13.6 32.4 17.4 13.2 14.9 5.7 20.8 29.5 47.9 13.4 11.1 7.4 9.8 14.5 38.8 47.0 44.8 16.8 41.9 8.4 66.2 7.1 11.2 23.9 14.8 26.8 26.6 47.0 15.0 3.3 10.8 47.1 81.9 15.7 12.2 3.8 6.9 17.8 23.6 9.3 1.8 17.8 4.0 11.9 7.2 62.8 50.4 7.5 5.8 17.7 17.1 11.0 2.6 8.8 60.7 51.7 13.1 35.2 20.5 33.1 36.2 14.7 5.3 18.5 17.0 29.9 13.4 8.9 TPP2 TPPII ENSG00000134900 "Tripeptidyl peptidase 2" P29144 13 102596986-102679958 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 9 "Early spermatids: 796.3;Late spermatids: 892.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021069, HPA049630" Approved Supported "Nuclear bodies,Cytosol" NA NA 280000 "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA021069: AB_1858344, HPA049630: AB_2680836" "unprognostic (4.75e-2)" "unprognostic (4.78e-2)" "unprognostic (9.97e-2)" "unprognostic (1.08e-1)" "unprognostic (2.01e-2)" "unprognostic (4.43e-2)" "unprognostic (2.45e-2)" "unprognostic (8.33e-3)" "unprognostic (5.02e-2)" "unprognostic (1.51e-1)" "unprognostic (3.12e-1)" "unprognostic (2.75e-3)" "unprognostic (6.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.95e-2)" "unprognostic (3.43e-3)" 12.6 8.1 3.5 15.6 5.5 48.0 16.4 9.7 5.3 12.9 5.7 13.9 12.3 16.3 19.7 11.6 11.5 12.5 13.8 3.0 2.3 10.0 20.4 14.6 19.9 3.7 3.1 14.1 10.9 11.3 8.3 17.7 4.4 11.3 19.2 17.4 10.6 16.7 27.7 12.1 12.5 13.1 3.3 18.6 12.2 51.8 4.9 16.1 19.9 22.1 17.1 12.8 11.4 9.8 33.8 13.7 38.0 28.7 28.9 37.5 25.5 34.9 26.6 23.8 28.0 30.7 41.0 37.3 11.9 30.3 25.7 30.0 30.5 23.7 39.3 26.4 24.9 71.2 34.0 22.8 22.9 89.3 44.6 31.5 11.2 26.4 35.6 23.6 32.7 34.8 43.4 42.9 32.0 11.3 37.2 53.4 28.5 43.7 17.6 43.5 30.3 31.8 25.7 29.7 35.8 26.7 23.2 35.0 13.7 31.9 20.0 79.9 28.5 20.9 15.1 12.9 29.0 40.7 56.2 37.0 31.1 56.6 26.8 7.4 5.5 3.7 7.1 5.9 8.4 4.8 8.2 8.4 5.2 4.5 9.7 9.8 1.0 8.9 4.9 3.3 9.6 4.5 3.5 5.5 9.7 5.3 3.0 2.3 3.7 3.1 4.4 3.3 4.9 9.8 20.9 38.5 41.6 41.8 24.5 15.4 16.4 10.6 22.8 27.5 18.5 12.7 41.8 11.5 18.5 14.7 73.0 28.5 38.7 13.3 9.8 19.8 796.3 23.0 28.9 19.3 19.8 26.1 64.1 8.8 30.7 25.8 14.3 22.7 38.6 24.8 20.3 22.4 32.1 8.4 69.8 18.5 8.2 25.7 19.9 892.8 32.0 29.5 17.8 65.6 29.3 13.8 42.2 66.4 67.3 13.3 16.3 18.8 58.9 16.5 10.2 13.2 36.4 46.5 26.3 24.3 28.8 92.7 30.0 22.9 13.4 33.1 35.6 31.6 21.8 19.6 TRAK2 "ALS2CR3, CALS-C, GRIF-1, KIAA0549, MILT2, OIP98" ENSG00000115993 "Trafficking kinesin protein 2" O60296 2 201377207-201451500 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 157.8;Erythroid cells: 181.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015827, HPA062163" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Nuclear bodies" Vesicles "HPA015827: AB_1858238, HPA062163: AB_2684702" "unprognostic (2.10e-1)" "unprognostic (1.39e-1)" "unprognostic (2.56e-2)" "unprognostic (4.31e-2)" "unprognostic (2.78e-1)" "unprognostic (1.76e-1)" "unprognostic (2.38e-2)" "unprognostic (3.08e-2)" "unprognostic (2.24e-1)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "prognostic favorable (7.42e-5)" "unprognostic (1.48e-1)" "unprognostic (3.24e-1)" "unprognostic (1.40e-2)" "unprognostic (9.82e-3)" 24.1 20.3 53.2 16.4 63.7 52.2 14.8 61.2 60.9 16.1 55.6 22.4 13.4 14.3 13.0 16.7 13.9 18.7 70.9 47.3 54.0 23.7 14.1 20.7 17.3 92.9 67.6 9.7 15.4 26.6 12.4 23.7 86.8 12.8 22.8 20.1 26.4 15.2 14.8 8.1 16.1 20.4 99.9 18.1 12.2 7.8 69.7 12.4 34.9 26.8 13.6 15.7 9.0 102.2 11.6 15.5 9.4 34.3 61.6 87.4 10.6 39.2 32.8 27.4 31.9 24.4 9.8 7.1 16.3 50.6 26.4 11.2 20.0 12.9 43.5 21.4 13.0 15.5 25.6 15.9 33.8 12.3 18.4 48.4 10.8 28.8 22.2 27.5 40.4 11.0 12.4 26.9 55.8 16.6 9.6 6.9 10.6 11.3 32.7 12.1 24.9 10.6 21.9 15.6 18.6 24.0 21.0 15.5 63.6 13.6 12.4 12.4 50.2 44.2 16.6 31.0 25.7 16.2 30.2 8.3 37.2 18.2 24.4 2.6 5.5 6.2 7.8 7.0 7.3 9.3 10.1 6.7 4.3 14.2 6.9 7.3 3.4 11.1 6.5 2.3 12.6 6.0 53.2 63.7 61.2 60.9 47.3 54.0 92.9 67.6 86.8 99.9 69.7 102.2 34.0 16.0 29.8 37.5 17.8 8.3 3.4 6.3 11.4 45.4 14.4 8.8 157.8 22.8 13.4 9.2 73.0 10.3 9.3 27.9 7.9 13.9 1.9 12.7 20.9 21.0 29.5 181.0 92.3 14.7 4.8 16.9 10.7 25.7 19.6 10.3 15.0 14.3 10.6 77.4 75.6 20.6 10.2 12.9 7.7 3.8 8.1 13.2 26.6 22.5 14.2 5.1 12.3 47.7 57.0 10.7 14.5 12.8 16.8 5.7 21.7 8.9 14.9 22.1 13.1 23.2 23.3 9.4 12.8 16.2 4.1 5.6 16.6 18.7 24.5 7.2 TRIM22 "GPSTAF50, RNF94, STAF50" ENSG00000132274 "Tripartite motif containing 22" Q8IYM9 11 5689697-5737089 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 135.9;dendritic cells: 113.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 174.6;BJ hTERT+ SV40 Large T+ RasG12V: 209.9;HSkMC: 190.6;TIME: 153.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003307, HPA003575" Approved Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA003307: AB_1080381, HPA003575: AB_1080378" "unprognostic (1.47e-2)" "unprognostic (5.27e-3)" "unprognostic (4.00e-2)" "unprognostic (4.21e-3)" "unprognostic (2.21e-1)" "unprognostic (1.21e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (1.86e-3)" "unprognostic (2.93e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" "unprognostic (1.15e-1)" "unprognostic (9.16e-2)" 54.0 21.3 13.1 101.3 18.8 90.3 50.7 16.3 23.7 42.7 25.5 36.0 25.2 50.6 70.2 37.1 49.3 78.6 22.6 14.7 16.5 21.2 72.5 83.4 139.0 17.9 16.7 60.3 17.2 8.0 12.6 21.5 16.7 43.3 53.4 11.0 65.4 52.6 13.4 18.1 53.4 52.1 17.7 143.1 39.5 15.4 12.8 101.2 21.7 40.6 120.7 61.6 22.6 29.3 2.8 1.2 13.9 2.4 88.6 174.6 5.0 53.3 93.9 89.8 209.9 1.7 8.6 111.9 13.0 80.2 20.6 10.5 34.0 56.4 10.7 2.0 0.0 6.4 5.6 1.4 107.8 18.2 11.4 190.6 54.3 18.7 9.6 124.5 128.7 1.0 2.3 4.7 111.6 1.5 54.1 16.9 40.3 0.5 4.9 62.6 3.4 2.3 51.1 14.9 1.4 2.7 4.5 4.5 2.1 56.8 4.5 17.9 153.6 56.4 29.8 2.5 2.4 4.9 4.4 11.2 67.7 28.9 7.2 108.7 118.5 79.6 109.0 143.3 145.9 149.4 118.4 117.2 138.7 158.2 106.5 102.7 103.1 61.3 181.1 177.0 197.9 181.9 13.1 18.8 16.3 23.7 14.7 16.5 17.9 16.7 16.7 17.7 12.8 29.3 54.4 67.3 57.7 2.0 135.9 12.6 17.0 42.5 56.3 0.5 17.7 14.0 6.0 7.2 60.5 29.5 0.0 1.5 113.9 4.7 5.9 11.2 0.3 16.1 27.0 40.5 4.2 16.8 4.9 8.0 4.7 36.2 20.9 23.8 17.7 5.4 33.5 4.3 18.7 1.7 0.3 9.0 30.5 87.1 46.6 2.0 36.1 67.8 5.4 52.5 59.0 6.4 83.4 1.0 0.5 5.4 6.3 30.1 18.8 9.9 4.4 3.3 52.5 1.0 13.1 35.1 24.4 0.6 0.3 14.1 8.7 2.3 89.3 13.0 5.0 18.8 TRIM25 "EFP, RNF147, ZNF147" ENSG00000121060 "Tripartite motif containing 25" Q14258 17 56836387-56914080 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Ligase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 23.5" "Lineage enriched" "Detected in all" 7 "granulocytes: 23.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005909 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA005909: AB_1078722" "unprognostic (8.73e-3)" "unprognostic (1.57e-2)" "unprognostic (2.06e-2)" "unprognostic (6.06e-2)" "unprognostic (2.69e-1)" "unprognostic (3.78e-2)" "prognostic unfavorable (9.37e-4)" "unprognostic (1.53e-1)" "unprognostic (4.23e-1)" "unprognostic (1.15e-1)" "prognostic favorable (3.36e-4)" "unprognostic (3.23e-1)" "unprognostic (3.11e-2)" "prognostic favorable (9.35e-4)" "unprognostic (5.21e-2)" "unprognostic (5.13e-2)" "unprognostic (7.39e-2)" 16.3 20.7 9.8 19.8 10.4 47.7 13.1 9.5 23.2 14.5 11.1 19.7 19.4 12.1 8.5 20.4 18.2 9.7 11.1 9.0 11.3 11.9 29.8 25.0 17.3 10.3 9.9 14.3 16.7 13.0 10.3 9.5 10.3 9.3 17.3 11.8 15.3 7.4 12.6 29.2 20.2 12.4 11.4 41.6 17.0 9.1 12.1 18.5 10.8 7.6 19.7 12.1 14.6 9.0 77.2 37.4 9.0 30.7 66.6 55.8 0.1 29.6 59.6 69.4 59.3 36.7 41.1 74.6 59.8 28.6 75.4 44.5 44.5 39.9 38.5 64.1 35.0 48.1 29.0 41.0 57.0 58.2 33.2 25.1 65.7 36.2 76.4 32.9 46.7 50.2 12.0 43.8 35.8 51.3 65.6 41.9 5.8 63.3 71.5 46.3 30.2 47.4 40.5 59.7 17.5 16.3 23.3 37.1 69.7 5.8 50.3 46.8 31.3 32.2 23.1 50.1 31.2 24.7 51.1 12.1 31.2 39.4 13.0 4.8 3.0 1.2 1.0 2.5 1.3 2.2 0.9 1.0 3.1 1.7 0.7 1.0 23.5 1.1 1.8 2.2 2.0 1.1 9.8 10.4 9.5 23.2 9.0 11.3 10.3 9.9 10.3 11.4 12.1 9.0 27.3 35.3 19.8 7.5 12.7 18.5 8.5 10.5 13.1 9.9 12.6 11.9 7.5 20.0 16.6 9.2 29.2 5.4 15.1 54.8 0.0 19.1 3.5 44.9 20.0 32.7 18.6 11.1 4.1 21.6 10.7 16.0 32.6 72.5 3.8 23.0 32.2 30.9 14.8 3.3 8.2 28.7 6.1 27.5 24.6 2.1 9.6 29.3 14.2 8.4 28.3 5.7 11.3 12.1 0.3 32.2 54.2 9.4 17.7 21.6 20.0 8.0 18.5 22.2 6.6 13.1 9.2 0.4 0.3 24.5 30.5 15.9 11.5 45.3 25.7 25.4 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235808 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 77.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (2.68e-2)" 7.9 9.6 52.7 7.5 57.8 8.1 5.8 48.3 50.8 6.9 31.3 6.6 8.4 7.6 5.8 10.1 6.4 3.2 9.4 42.2 44.1 9.5 12.2 6.2 4.9 57.3 57.3 6.0 9.9 11.7 10.9 4.1 53.2 6.8 2.7 7.0 7.6 5.6 26.1 9.8 7.2 3.5 54.5 8.2 8.8 13.2 53.8 10.1 11.7 12.7 5.2 6.8 6.7 54.7 9.3 24.0 8.7 14.6 10.1 10.0 20.6 13.3 7.2 9.6 9.0 20.4 13.8 16.0 21.4 9.1 18.0 17.3 9.1 31.9 5.2 77.8 29.2 17.8 24.9 11.7 9.7 13.3 11.8 8.8 16.1 12.0 4.2 9.3 5.6 23.8 22.7 18.8 5.3 33.8 20.0 14.7 8.3 7.0 11.3 18.7 13.2 20.9 5.5 14.7 13.5 12.7 12.3 14.3 18.7 3.8 28.7 14.8 11.7 13.1 8.9 8.0 10.3 41.2 28.1 21.9 13.7 15.3 11.3 0.2 0.3 0.6 0.6 0.3 0.9 0.5 0.6 1.1 0.4 0.6 0.6 0.8 1.0 0.6 0.7 0.7 0.9 0.4 52.7 57.8 48.3 50.8 42.2 44.1 57.3 57.3 53.2 54.5 53.8 54.7 9.1 3.2 12.4 11.4 10.1 8.0 9.5 7.5 8.0 19.1 10.5 8.9 13.2 12.8 10.0 11.0 18.8 14.6 13.6 12.3 11.7 8.5 8.0 15.8 12.9 10.4 12.7 5.9 5.2 12.1 10.0 7.5 16.8 12.4 2.5 12.3 10.4 21.0 8.8 28.6 5.3 13.1 12.2 15.1 7.3 4.0 5.3 10.1 8.8 5.6 11.8 15.0 14.4 1.5 5.8 9.9 12.3 11.7 11.1 9.5 16.0 8.0 24.1 30.4 0.0 24.4 10.7 33.2 23.7 12.3 11.2 13.0 13.6 10.2 12.6 8.3 TRIP4 "ASC-1, HsT17391, ZC2HC5" ENSG00000103671 "Thyroid hormone receptor interactor 4" Q15650 15 64387748-64455303 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016605, HPA050666" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nuclear bodies" "HPA016605: AB_1858339, HPA050666: AB_2681211" "unprognostic (1.56e-1)" "unprognostic (1.14e-1)" "unprognostic (2.62e-1)" "unprognostic (4.50e-2)" "unprognostic (5.79e-2)" "unprognostic (1.08e-1)" "unprognostic (7.16e-2)" "unprognostic (3.01e-2)" "unprognostic (4.98e-2)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.37e-2)" "prognostic favorable (6.34e-6)" "unprognostic (2.41e-1)" "unprognostic (2.96e-1)" "unprognostic (2.61e-2)" "unprognostic (1.25e-1)" 14.9 12.4 13.6 13.3 14.7 15.3 17.1 14.1 20.6 13.0 14.9 17.1 17.1 13.2 11.6 19.4 14.1 11.0 15.5 13.7 14.0 27.5 14.3 15.0 16.4 14.4 14.2 13.1 16.6 20.0 13.0 16.9 14.8 12.7 19.2 16.8 13.3 12.1 8.9 18.0 17.9 16.5 14.2 16.6 15.6 12.0 14.5 19.8 25.6 9.2 18.7 17.7 14.7 15.6 18.6 27.1 23.3 16.7 18.9 24.6 21.8 19.3 24.7 32.7 31.5 22.8 40.5 13.3 6.3 29.4 26.6 25.7 38.3 22.0 30.9 27.0 10.9 19.4 19.2 24.1 33.5 21.2 35.1 30.9 28.2 25.9 27.0 18.7 28.9 19.2 22.7 16.2 30.4 21.2 13.5 21.3 13.7 32.7 14.4 20.4 17.7 22.2 31.6 35.1 12.6 19.8 17.3 20.7 35.3 43.5 26.2 31.3 25.7 23.2 15.8 15.6 27.7 13.5 25.9 13.5 19.2 21.4 29.6 70.1 22.2 54.3 20.8 29.1 17.7 16.0 19.7 21.2 20.5 16.3 16.6 17.3 30.9 21.2 42.4 16.2 23.3 16.9 13.6 14.7 14.1 20.6 13.7 14.0 14.4 14.2 14.8 14.2 14.5 15.6 12.7 22.4 13.2 15.3 10.0 8.4 9.6 23.3 2.2 11.1 7.6 7.1 10.3 7.2 18.1 12.9 12.5 22.2 20.1 15.3 13.7 25.2 20.4 21.7 10.7 13.2 11.4 9.9 32.5 27.1 26.8 10.2 10.2 16.2 19.6 12.3 10.0 4.4 21.7 15.2 25.8 8.2 24.4 12.9 7.6 3.7 11.8 15.3 14.2 22.5 27.5 10.0 27.8 18.1 30.9 33.6 10.5 12.8 6.5 6.0 13.5 44.6 26.7 17.3 6.6 9.0 15.0 19.3 21.4 5.4 6.3 24.2 14.4 12.1 8.1 7.8 TRMT11 "C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1" ENSG00000066651 "TRNA methyltransferase 11 homolog" Q7Z4G4 6 125986479-126203817 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030473 Approved "Nuclear bodies" Yes No "Cluster 30: Non-specific - Translation" "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies" "HPA030473: AB_2673493" "unprognostic (2.55e-1)" "unprognostic (6.12e-3)" "unprognostic (1.44e-1)" "unprognostic (1.13e-2)" "unprognostic (7.62e-2)" "unprognostic (9.69e-2)" "unprognostic (2.12e-1)" "unprognostic (7.38e-2)" "unprognostic (3.54e-2)" "unprognostic (5.73e-2)" "unprognostic (7.35e-2)" "unprognostic (1.06e-2)" "unprognostic (4.74e-3)" "unprognostic (1.14e-1)" "unprognostic (1.30e-1)" "unprognostic (1.69e-1)" "unprognostic (2.06e-1)" 8.4 10.2 7.3 8.1 7.5 2.9 11.7 12.9 9.9 9.5 6.6 8.8 12.8 13.5 9.9 8.0 9.7 9.0 10.9 7.3 7.8 13.3 19.8 7.9 10.5 6.7 7.4 12.5 6.4 12.6 13.3 9.4 7.2 9.1 9.4 16.9 8.8 8.5 7.6 6.6 10.7 10.7 5.8 6.8 8.8 7.7 7.2 8.7 12.9 8.8 10.4 9.6 8.9 9.0 17.4 11.0 24.2 11.4 12.9 13.7 16.6 13.1 21.7 15.6 24.3 30.8 19.8 26.0 24.2 8.3 29.1 20.7 26.1 14.3 26.4 19.5 37.6 17.8 20.1 46.2 21.9 29.0 5.4 14.3 15.5 15.9 25.6 22.4 7.6 9.1 44.5 5.3 17.7 22.0 15.3 34.6 20.4 15.4 15.1 9.1 16.3 17.6 22.3 9.8 32.4 16.9 13.9 18.0 36.3 18.0 13.1 28.3 5.4 9.7 10.7 27.3 25.8 13.9 1.3 6.6 23.2 24.5 17.7 1.0 1.6 0.0 5.6 1.3 11.0 7.0 7.9 6.5 3.5 6.0 9.5 8.6 0.5 7.7 0.7 4.3 6.0 3.2 7.3 7.5 12.9 9.9 7.3 7.8 6.7 7.4 7.2 5.8 7.2 9.0 11.0 6.4 22.0 24.8 17.4 13.4 27.8 29.4 23.3 59.5 11.2 13.7 12.2 21.5 26.1 7.3 73.0 18.7 14.9 8.5 19.6 19.2 10.1 13.1 25.5 10.4 9.1 8.4 56.1 16.3 13.7 27.3 27.0 12.3 18.4 20.0 6.8 22.5 7.2 20.2 63.8 11.1 18.3 6.0 3.7 4.7 25.7 7.1 3.6 23.4 11.8 21.1 9.2 31.7 48.5 13.2 15.5 24.5 12.3 22.6 22.6 30.2 24.3 74.7 6.6 21.0 17.2 15.6 9.2 14.3 10.1 14.9 14.7 27.2 13.7 17.9 TRMT13 "CCDC76, FLJ10287, FLJ11219" ENSG00000122435 "TRNA methyltransferase 13 homolog" Q9NUP7 1 100133150-100150498 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028494 Approved Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane" "Nuclear bodies, Cytosol" "HPA028494: AB_10601254" "unprognostic (1.12e-1)" "unprognostic (3.33e-1)" "unprognostic (5.76e-2)" "unprognostic (2.37e-1)" "unprognostic (9.17e-3)" "unprognostic (4.97e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.16e-3)" "unprognostic (3.28e-2)" "unprognostic (8.08e-2)" "unprognostic (3.22e-1)" "unprognostic (1.02e-3)" "prognostic unfavorable (6.89e-6)" "unprognostic (3.12e-2)" "unprognostic (7.71e-2)" "unprognostic (1.99e-2)" "unprognostic (1.70e-3)" 8.8 8.7 6.9 12.2 9.8 5.2 14.5 9.6 9.6 11.2 6.7 9.3 11.2 13.9 11.8 8.5 9.2 7.2 8.0 6.5 9.7 8.8 8.7 7.8 18.2 8.5 9.0 13.5 11.5 12.9 6.8 10.7 8.7 10.4 11.3 21.7 9.1 8.1 13.1 14.7 10.7 10.1 7.0 14.1 10.0 9.4 8.5 11.3 12.0 6.2 14.6 9.5 10.3 14.9 17.5 10.0 16.5 11.5 8.7 16.9 18.0 18.0 7.1 13.4 11.1 11.9 7.0 28.7 21.8 14.4 8.9 15.4 30.6 14.0 23.1 29.0 24.2 17.2 23.1 11.6 15.7 30.0 15.4 11.9 15.5 25.5 33.3 8.4 12.4 21.0 36.6 17.9 13.6 6.7 24.6 15.6 23.0 16.7 19.9 26.0 25.0 15.7 11.1 13.6 10.7 17.9 16.6 15.8 21.6 16.1 9.3 26.1 13.0 17.8 11.9 15.1 24.3 22.8 20.0 34.0 20.1 23.5 7.0 0.2 5.8 3.1 10.5 6.1 13.0 19.9 11.3 10.6 7.0 18.7 16.8 14.0 2.5 7.9 5.1 12.8 8.6 5.6 6.9 9.8 9.6 9.6 6.5 9.7 8.5 9.0 8.7 7.0 8.5 14.9 13.1 25.6 17.0 34.0 29.0 9.7 14.2 14.2 19.9 38.9 10.7 7.9 11.1 12.8 22.2 14.7 29.2 14.2 18.9 8.0 13.7 10.5 20.9 14.3 21.0 15.7 20.4 11.3 23.1 6.1 10.2 13.7 11.7 8.0 21.5 18.7 17.9 11.4 7.6 28.6 32.1 9.9 18.3 10.1 7.0 6.0 24.8 10.3 10.6 25.3 14.7 16.6 41.2 33.7 97.4 8.5 9.6 18.4 9.0 12.6 13.0 10.7 20.4 44.7 19.7 16.0 13.4 47.6 21.9 12.2 11.9 7.3 21.5 15.8 13.6 10.0 TRMT2B "CXorf34, FLJ12687" ENSG00000188917 "TRNA methyltransferase 2 homolog B" Q96GJ1 X 101009346-101052116 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003745, HPA035120, HPA040814" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA003745: AB_2667047, HPA035120: AB_10601702, HPA040814: " "prognostic unfavorable (1.58e-5)" "unprognostic (6.72e-3)" "unprognostic (3.28e-1)" "unprognostic (1.54e-2)" "unprognostic (4.44e-1)" "unprognostic (8.74e-2)" "unprognostic (3.52e-2)" "unprognostic (8.16e-3)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (8.80e-2)" "unprognostic (2.78e-2)" "prognostic favorable (2.30e-7)" "unprognostic (4.58e-2)" "unprognostic (4.82e-1)" "unprognostic (5.03e-2)" "unprognostic (1.60e-2)" 5.4 6.4 3.3 7.1 3.3 7.8 6.3 3.7 4.0 6.8 5.6 7.8 6.1 4.7 4.0 8.2 5.3 5.4 9.1 3.3 3.8 8.7 6.2 6.5 10.3 4.3 3.9 6.7 6.4 14.7 5.8 3.9 4.7 6.6 9.2 2.4 9.9 5.3 15.0 6.9 9.2 5.0 3.4 10.6 8.7 2.5 4.0 14.7 8.6 14.4 11.3 5.2 6.1 3.3 22.4 18.9 3.8 8.9 8.7 4.5 11.6 11.4 15.4 12.6 18.7 20.6 17.5 19.9 22.3 10.6 25.6 13.7 17.5 16.0 15.7 17.2 10.9 12.6 15.6 9.9 7.6 22.5 19.6 5.8 9.3 18.2 8.4 8.8 24.8 21.2 13.0 18.3 11.7 22.5 28.5 11.6 5.2 27.7 14.0 22.8 18.2 19.1 9.2 12.8 5.5 7.4 19.4 14.0 11.7 10.4 9.1 10.8 14.5 15.7 9.4 14.8 10.3 11.5 18.7 18.1 12.2 25.3 12.4 14.9 10.0 18.8 15.8 8.0 17.0 18.7 18.6 15.8 9.3 20.4 21.8 18.3 5.7 18.7 9.5 10.0 16.8 14.8 3.3 3.3 3.7 4.0 3.3 3.8 4.3 3.9 4.7 3.4 4.0 3.3 3.0 6.4 6.3 22.2 10.5 2.3 5.5 4.1 6.2 0.8 3.0 1.5 10.3 1.5 5.0 14.7 2.1 6.1 5.7 5.4 7.9 4.0 0.1 3.3 1.9 4.0 6.7 5.7 17.2 3.4 3.0 3.4 6.1 2.9 13.3 6.9 3.6 4.1 3.6 1.7 18.5 6.8 2.0 5.3 0.6 0.8 3.4 3.4 1.8 18.7 5.6 4.8 14.4 9.5 11.6 5.3 4.8 3.8 4.2 3.8 5.5 5.7 6.0 1.8 0.0 5.3 3.0 0.2 3.8 6.2 1.6 5.1 8.7 4.4 6.1 5.3 TSACC "C1orf182, SIP, SSTK-IP" ENSG00000163467 "TSSK6 activating cochaperone" Q96A04 1 156337314-156346995 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 299 "testis: 924.9" "Group enriched" "Detected in many" 6 "Early spermatids: 6594.1;Late spermatids: 20555.9" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "basophil: 15.2" "Lineage enriched" "Detected in many" 8 "granulocytes: 15.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA029897 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA029897: AB_2756315" "unprognostic (3.95e-1)" "unprognostic (5.82e-3)" "unprognostic (8.24e-2)" "unprognostic (9.34e-2)" "unprognostic (1.04e-1)" "unprognostic (8.36e-3)" "unprognostic (1.18e-2)" "unprognostic (5.95e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (3.53e-2)" "unprognostic (4.85e-2)" "unprognostic (2.63e-6)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (2.44e-1)" "unprognostic (3.28e-2)" 0.4 1.5 1.0 0.9 1.4 0.6 1.0 1.9 1.3 0.4 1.5 0.4 0.8 0.3 2.4 0.6 0.4 0.6 0.5 1.2 1.2 0.9 1.8 0.2 1.0 1.4 1.1 0.3 0.6 0.7 0.5 0.5 1.5 1.2 0.4 2.3 0.5 0.9 0.9 0.4 0.8 0.1 1.2 0.4 0.5 924.9 1.3 0.2 1.0 0.4 0.5 0.3 0.3 3.0 2.7 3.7 1.6 1.8 1.1 2.1 2.9 1.3 0.7 1.7 1.9 3.4 1.9 4.0 2.1 0.8 1.9 3.1 3.1 0.3 1.6 2.3 6.7 2.8 6.3 3.7 0.8 2.5 2.3 0.8 5.1 1.7 2.3 1.0 0.5 3.8 7.6 2.5 0.3 4.8 2.5 1.5 5.0 6.7 4.4 2.8 0.6 4.0 4.6 1.7 2.4 1.3 1.8 5.0 2.2 6.9 2.7 2.7 1.3 1.1 1.8 0.9 1.9 4.5 7.8 6.1 0.7 1.4 1.0 15.2 0.4 0.1 1.1 0.3 0.5 1.2 0.8 1.0 0.2 1.4 1.5 1.3 0.1 1.9 0.4 1.7 1.0 0.3 1.0 1.4 1.9 1.3 1.2 1.2 1.4 1.1 1.5 1.2 1.3 3.0 0.1 0.0 0.0 0.7 1.2 0.3 0.3 1.4 0.6 0.6 1.3 1.9 0.6 0.0 1.8 3.7 0.0 4.8 0.1 0.2 1.9 0.9 6594.1 2.4 0.4 4.7 0.0 0.4 0.5 0.6 1.7 0.2 1.1 0.9 0.0 0.4 0.0 3.7 1.1 0.0 0.4 0.7 0.0 0.8 0.0 20555.9 111.6 7.6 0.0 0.0 0.0 0.4 0.0 0.5 0.9 1.0 0.1 85.7 1.2 0.3 0.6 7.9 4.5 0.8 52.6 0.1 0.3 2124.8 93.8 1.5 0.4 2.7 0.7 0.5 0.5 0.6 TSC22D1 "MGC17597, TGFB1I4, TSC22" ENSG00000102804 "TSC22 domain family member 1" Q15714 13 44432143-44577147 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 44.7" "Group enriched" "Detected in all" 5 "dendritic cells: 17.9;granulocytes: 44.7;NK-cells: 16.7" "Cell line enhanced" "Detected in many" "HEL: 247.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077414 Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Nuclear bodies" "HPA077414: AB_2686839" "unprognostic (6.61e-2)" "unprognostic (1.66e-1)" "unprognostic (4.00e-1)" "unprognostic (6.40e-2)" "unprognostic (5.22e-2)" "unprognostic (4.78e-3)" "unprognostic (6.30e-2)" "unprognostic (2.04e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (7.97e-4)" "unprognostic (4.24e-2)" "unprognostic (9.08e-2)" "prognostic favorable (4.54e-4)" "unprognostic (8.14e-2)" "unprognostic (6.52e-2)" "unprognostic (1.83e-2)" "unprognostic (4.48e-2)" 125.9 88.8 261.8 58.9 276.9 16.5 143.1 223.1 295.7 162.3 283.4 133.0 64.9 159.4 138.5 107.6 152.0 115.6 128.2 272.4 252.1 172.1 86.9 120.3 38.6 248.0 270.8 180.1 35.4 114.1 110.3 88.0 253.9 181.5 109.1 73.7 76.1 84.7 190.8 67.6 118.2 147.6 237.8 26.7 115.0 61.8 268.6 168.6 88.3 125.7 41.4 138.1 87.3 245.4 21.7 67.7 62.1 24.6 36.3 45.7 75.5 22.4 93.9 23.1 25.8 77.1 74.9 35.4 48.6 47.9 52.6 53.8 25.1 191.2 33.4 6.5 22.2 247.3 116.9 23.4 36.1 12.8 30.1 65.0 80.2 65.6 162.0 184.8 55.6 18.6 6.9 0.2 45.5 21.0 44.9 10.3 45.3 148.8 61.6 31.1 11.6 10.6 47.7 35.5 33.5 45.3 64.3 61.8 18.6 65.1 30.8 19.5 49.6 26.4 25.8 59.1 34.9 0.6 6.6 10.2 70.0 10.6 65.7 44.7 1.9 5.8 4.6 1.9 4.4 1.3 1.4 2.1 1.8 2.0 1.5 2.2 8.6 16.7 5.1 17.9 3.4 50.0 261.8 276.9 223.1 295.7 272.4 252.1 248.0 270.8 253.9 237.8 268.6 245.4 739.9 118.6 368.2 77.7 21.4 441.9 415.0 905.0 870.2 147.8 464.9 296.5 279.9 97.2 425.3 435.9 114.7 584.7 34.9 660.8 369.8 190.8 851.5 186.0 105.0 643.0 225.0 118.9 302.4 157.0 177.2 234.3 211.0 313.8 314.2 108.2 88.9 74.5 106.5 127.9 261.0 254.0 526.9 21.1 153.3 1231.0 91.6 218.4 402.0 148.0 16.2 246.2 26.8 207.1 103.8 229.5 339.6 136.5 17.2 550.9 212.0 155.1 265.8 149.9 447.0 268.2 500.9 80.9 34.6 178.2 610.0 1170.1 65.0 80.6 273.6 445.8 TSKU "E2IG4, LRRC54, TSK" ENSG00000182704 "Tsukushi, small leucine rich proteoglycan" Q8WUA8 11 76782251-76798153 "Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 237.3" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 506.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 168.0;ASC diff: 282.5;OE19: 188.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA008164 Approved Approved "Nucleoplasm,Nuclear bodies" "Secreted to blood" NA NA 6200000 "Cluster 6: Non-specific - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "Nuclear bodies" "HPA008164: AB_1853327" "unprognostic (1.07e-2)" "unprognostic (2.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (3.66e-4)" "unprognostic (7.05e-2)" "unprognostic (2.39e-1)" "unprognostic (3.08e-1)" "unprognostic (2.17e-3)" "unprognostic (4.81e-2)" "unprognostic (4.62e-2)" "prognostic unfavorable (2.87e-4)" "prognostic favorable (1.66e-4)" "prognostic unfavorable (2.80e-8)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (6.71e-2)" "unprognostic (3.88e-2)" 96.5 12.1 4.2 8.3 4.5 2.1 80.4 6.5 5.8 147.1 27.8 23.5 37.1 46.4 20.6 62.8 67.7 14.9 34.8 6.5 2.7 41.5 237.3 15.0 2.4 4.4 3.1 47.0 16.8 6.4 14.8 30.3 5.0 44.0 14.4 4.1 33.9 24.6 9.5 60.0 32.3 41.1 1.9 6.9 28.2 9.1 3.9 4.7 37.6 5.7 5.6 41.6 99.6 4.4 3.7 168.0 19.1 18.4 282.5 36.1 34.6 5.9 32.2 12.6 12.0 22.2 48.0 0.3 32.7 21.1 53.7 68.6 10.9 42.7 3.9 35.7 5.9 8.3 43.5 63.1 53.6 3.0 11.9 37.3 46.0 22.5 18.2 24.0 15.7 6.4 19.9 1.4 11.7 81.9 0.5 6.5 24.5 188.9 7.4 5.9 18.3 28.7 29.7 29.7 16.8 28.5 32.7 25.7 15.4 15.8 34.5 2.7 4.9 35.4 28.2 86.8 14.2 1.1 0.6 1.4 16.6 8.9 6.4 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.3 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.0 4.2 4.5 6.5 5.8 6.5 2.7 4.4 3.1 5.0 1.9 3.9 4.4 6.2 0.0 0.5 1.0 0.5 17.3 12.1 25.8 27.9 3.5 13.6 13.2 3.2 11.5 12.1 1.8 0.0 50.0 0.1 33.2 0.0 6.7 0.2 8.1 35.6 5.8 7.8 13.5 0.5 21.7 71.8 33.0 14.8 10.6 1.3 38.7 9.7 506.3 9.9 0.0 0.1 12.4 26.4 9.1 6.4 2.0 37.3 0.8 5.4 1.9 1.6 9.2 0.0 0.0 0.0 21.3 21.2 45.1 0.1 14.6 28.6 21.9 3.0 0.6 0.0 1.0 11.3 0.4 2.0 22.3 22.6 43.8 1.6 8.6 13.8 20.1 TSPAN15 "NET-7, TM4SF15" ENSG00000099282 "Tetraspanin 15" O95858 10 69451465-69507666 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 19.5" "Lineage enriched" "Detected in many" 6 "T-cells: 19.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044657, HPA071160" Approved Approved "Nuclear bodies,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Nuclear bodies, Plasma membrane" "Vesicles, Cytosol" "HPA044657: AB_10967927, HPA071160: " "unprognostic (2.03e-1)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (1.48e-2)" "unprognostic (9.44e-3)" "unprognostic (6.81e-3)" "prognostic unfavorable (8.00e-4)" "unprognostic (2.23e-1)" "unprognostic (3.65e-1)" "unprognostic (2.76e-1)" "unprognostic (8.22e-3)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (8.49e-2)" "unprognostic (4.66e-2)" "unprognostic (6.34e-2)" "unprognostic (3.78e-3)" 70.1 5.3 22.8 15.3 37.6 1.0 61.0 35.0 34.1 16.4 14.9 62.5 38.8 32.6 8.5 10.8 24.6 27.4 16.9 23.6 25.4 25.9 4.6 34.4 8.7 36.9 33.4 3.4 20.0 3.2 6.6 28.1 33.7 34.5 39.4 3.1 26.6 24.7 17.9 10.6 38.8 31.3 30.0 26.7 75.3 9.5 34.5 3.6 14.5 5.6 7.5 46.0 14.9 62.4 51.3 103.9 2.1 0.3 2.3 0.0 12.0 0.2 1.9 2.6 6.8 45.1 154.7 0.0 211.3 2.3 9.2 101.2 7.2 11.5 3.0 42.1 20.4 2.9 3.5 10.0 1.1 0.1 1.8 2.2 3.1 1.4 1.5 7.5 39.4 20.5 1.1 0.0 1.2 168.0 0.6 0.9 2.6 153.2 266.8 4.0 2.1 2.0 29.7 92.9 34.5 13.2 0.6 134.8 17.9 17.3 59.3 2.2 34.5 0.2 0.8 0.1 17.5 1.2 6.1 1.0 1.1 0.1 0.2 0.0 0.0 0.0 2.3 0.0 19.5 0.0 3.1 2.8 3.3 0.0 1.0 0.2 0.0 0.1 0.0 0.2 1.1 0.5 22.8 37.6 35.0 34.1 23.6 25.4 36.9 33.4 33.7 30.0 34.5 62.4 108.8 32.1 6.9 4.9 1.5 3.6 10.9 59.6 2.2 2.9 45.1 15.6 1.7 31.5 29.5 29.5 6.2 2.0 1.6 125.8 3.9 125.2 27.9 25.5 3.8 48.4 40.2 8.0 1.7 189.3 11.9 8.2 71.4 36.6 1.3 2.5 10.4 0.1 25.3 1.7 1.0 106.7 36.7 8.5 16.1 6.6 0.6 9.8 28.4 15.0 15.6 44.7 0.0 11.1 75.3 193.4 120.9 0.0 0.2 50.4 68.3 1.8 27.6 1.5 13.1 39.7 26.8 4.3 18.5 2.9 3.1 3.0 3.9 7.5 66.3 29.6 TSSK3 "SPOGA3, STK22C" ENSG00000162526 "Testis specific serine kinase 3" Q96PN8 1 32351521-32364312 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 12.7;testis: 34.0" "Group enriched" "Detected in some" 67 "Early spermatids: 335.4;Late spermatids: 1251.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA037516 Approved "Nucleoplasm,Nucleoli,Nuclear bodies" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "Nuclear bodies" "HPA037516: AB_2675517" "unprognostic (5.71e-2)" "unprognostic (1.42e-1)" "unprognostic (2.32e-1)" "unprognostic (1.37e-1)" "unprognostic (7.69e-2)" "unprognostic (2.02e-4)" "unprognostic (2.06e-1)" "unprognostic (1.98e-3)" "unprognostic (2.05e-2)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (9.20e-2)" "unprognostic (1.02e-3)" "unprognostic (1.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-1)" "unprognostic (2.68e-3)" 2.3 2.7 0.1 2.5 0.2 12.7 2.0 2.2 0.4 2.9 0.3 2.1 3.4 2.3 0.0 1.3 2.7 1.8 1.5 0.1 0.0 1.9 2.7 2.7 3.8 0.5 0.0 3.0 2.1 0.0 1.7 0.7 0.2 2.1 0.0 4.3 2.4 0.0 3.0 4.7 4.0 0.1 0.0 4.3 2.2 34.0 0.2 0.0 2.3 0.0 0.0 1.7 2.3 0.5 2.4 2.8 6.0 3.6 0.0 0.8 5.2 0.6 0.9 0.0 0.0 0.5 1.3 1.4 0.8 0.0 1.0 3.5 0.0 0.0 0.0 3.6 6.8 2.8 14.1 4.3 3.3 1.3 3.2 0.1 0.7 0.0 1.0 6.7 0.0 4.5 3.5 5.5 0.0 0.7 1.5 1.5 1.1 0.5 1.6 2.1 1.6 4.7 0.0 2.4 1.7 3.8 0.8 3.0 3.9 4.5 1.8 2.4 2.4 2.1 2.9 3.0 2.4 7.6 3.3 1.9 3.5 4.3 0.7 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 2.2 0.4 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.5 0.4 0.0 0.5 0.7 0.3 0.1 0.4 0.3 0.0 0.2 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.3 335.4 0.4 0.6 0.5 0.0 0.0 0.0 0.7 0.1 0.3 0.0 0.5 0.0 1.4 0.7 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 1251.0 9.3 0.3 0.0 0.0 0.5 0.6 0.0 0.0 0.1 0.3 0.1 9.4 0.0 0.2 0.7 0.8 0.8 1.2 6.6 0.2 0.2 11.7 3.7 0.0 0.0 0.3 0.2 0.5 0.3 0.3 TTC9 "KIAA0227, TTC9A" ENSG00000133985 "Tetratricopeptide repeat domain 9" Q92623 14 70641916-70675366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.1" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 36.0;Respiratory ciliated cells: 38.1;Urothelial cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.2;Daudi: 15.9;RH-30: 21.3;SK-BR-3: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079473 Approved "Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies" "HPA079473: " "unprognostic (2.37e-2)" "unprognostic (6.01e-2)" "unprognostic (9.29e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.81e-2)" "unprognostic (2.38e-2)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.18e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.10e-8)" "unprognostic (1.22e-2)" "unprognostic (1.01e-1)" "unprognostic (3.16e-2)" "unprognostic (9.38e-2)" 1.4 1.2 6.4 4.0 6.8 0.9 3.7 3.3 9.8 5.4 1.5 0.8 0.8 1.2 1.4 60.1 10.2 3.4 2.1 6.4 5.9 2.9 1.1 4.4 9.3 5.7 3.9 0.1 1.5 2.9 3.7 4.0 5.5 2.5 0.8 6.0 12.6 1.6 9.5 5.9 2.5 0.8 3.7 5.7 4.1 0.5 4.3 5.1 4.0 5.2 15.4 4.4 13.7 6.5 18.2 2.1 6.7 0.3 0.0 0.0 7.1 0.3 0.1 0.5 2.2 0.4 8.9 15.9 2.4 0.1 1.5 6.6 5.0 0.6 0.3 0.5 1.9 2.2 0.7 5.2 0.0 0.0 4.4 0.6 1.2 0.0 0.1 0.3 0.0 3.5 0.0 1.4 7.3 9.0 0.4 0.2 3.7 13.0 2.3 3.7 21.3 0.1 11.0 4.1 4.1 2.0 2.0 36.4 0.0 4.0 12.7 0.6 0.0 0.0 3.2 0.0 0.3 0.0 0.2 4.9 0.0 0.4 0.1 0.0 0.0 0.6 0.4 0.3 0.9 0.6 0.7 0.5 0.0 1.2 1.1 0.7 0.8 0.0 1.5 0.0 0.4 0.2 6.4 6.8 3.3 9.8 6.4 5.9 5.7 3.9 5.5 3.7 4.3 6.5 3.8 3.2 7.2 1.3 11.3 1.0 4.7 16.3 1.2 3.8 13.7 10.5 1.8 14.3 24.8 9.2 6.2 24.1 1.5 0.2 1.9 21.0 0.4 8.3 2.3 5.9 1.2 0.0 10.5 5.8 2.5 1.2 4.1 19.1 1.3 15.2 0.4 2.2 2.8 0.0 13.6 0.5 16.2 4.1 0.8 0.7 0.0 2.1 7.2 3.7 3.0 15.8 4.1 9.0 0.7 36.0 0.5 0.0 4.4 13.0 0.0 0.3 38.1 5.4 0.0 0.7 2.1 0.1 2.6 9.0 1.7 7.4 7.6 0.2 0.5 56.9 TYMP "ECGF1, MNGIE" ENSG00000025708 "Thymidine phosphorylase" P19971 22 50525752-50530032 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Glycosyltransferase, Growth factor, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 643.9;Hofbauer cells: 477.4;Macrophages: 561.7;monocytes: 2174.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 135.8;eosinophil: 74.9;intermediate monocyte: 98.4;myeloid DC: 39.5;neutrophil: 114.1;non-classical monocyte: 77.1" "Group enriched" "Detected in all" 10 "dendritic cells: 39.5;granulocytes: 114.1;monocytes: 135.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.0;HHSteC: 95.2;Karpas-707: 68.6;U-266/70: 68.6" "Not detected" "Not detected" "HPA000530, HPA001072, CAB002518" Enhanced Approved "Nuclear bodies,Golgi apparatus,Cytosol" NA NA 11000000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nuclear bodies, Golgi apparatus" Cytosol "CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274" "unprognostic (7.02e-3)" "unprognostic (1.00e-1)" "unprognostic (3.61e-1)" "prognostic favorable (4.34e-5)" "unprognostic (7.60e-2)" "unprognostic (1.16e-2)" "unprognostic (2.40e-1)" "unprognostic (7.17e-2)" "unprognostic (4.64e-2)" "unprognostic (1.33e-1)" "unprognostic (3.31e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (3.50e-8)" "unprognostic (1.32e-1)" "unprognostic (4.02e-2)" "unprognostic (1.52e-2)" "unprognostic (4.60e-2)" 46.8 19.5 6.1 77.7 6.0 22.0 37.9 7.1 7.9 32.2 12.7 20.4 26.1 7.8 0.5 58.5 30.0 7.2 26.7 6.4 8.6 38.2 82.0 63.4 31.5 22.1 18.3 4.0 13.8 4.5 8.8 15.4 15.9 21.0 3.6 0.0 40.0 5.6 10.7 24.5 32.5 9.1 10.9 86.1 31.2 3.0 18.0 15.6 25.4 1.6 15.3 22.9 27.0 12.2 27.0 2.5 0.4 0.8 1.8 2.2 5.1 3.7 0.5 6.1 17.4 0.1 40.0 1.8 4.1 5.8 1.3 21.0 0.2 1.0 0.0 9.0 16.5 1.8 3.9 3.5 95.2 1.3 26.9 4.7 4.6 5.4 0.0 0.1 0.1 0.5 2.8 68.6 0.9 1.9 1.5 9.9 0.6 1.9 9.1 5.7 0.4 35.1 0.3 1.2 0.7 5.6 22.9 17.3 6.5 0.2 4.2 13.8 6.7 0.8 4.7 1.5 1.5 68.6 15.9 5.7 1.9 1.5 1.6 19.5 135.8 74.9 2.0 98.4 1.2 6.7 2.9 1.2 39.5 6.9 1.6 1.3 114.1 9.5 77.1 9.3 3.1 10.1 6.1 6.0 7.1 7.9 6.4 8.6 22.1 18.3 15.9 10.9 18.0 12.2 122.6 12.8 29.0 0.3 122.9 58.5 57.4 169.9 53.5 3.4 101.5 90.8 3.2 50.1 88.6 33.1 4.2 17.2 65.8 154.8 29.4 340.2 2.2 55.7 56.0 55.7 16.8 19.6 0.3 643.9 300.8 81.9 38.7 59.2 53.4 3.0 38.2 93.0 477.4 0.0 0.4 50.2 24.4 371.8 409.4 8.7 5.0 561.7 113.8 4.7 2174.6 2.9 71.1 0.5 0.2 364.0 86.4 1.9 102.1 109.8 214.5 105.1 78.0 6.6 26.3 93.3 62.4 1.5 8.0 71.7 56.7 33.5 62.5 3.7 51.1 76.0 TYW5 "C2orf60, FLJ37953" ENSG00000162971 "TRNA-yW synthesizing protein 5" A2RUC4 2 199928913-199955736 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 123.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028294, HPA045803" Uncertain Approved "Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies" "HPA028294: AB_2672549, HPA045803: AB_10964878" "unprognostic (3.44e-3)" "unprognostic (3.74e-1)" "unprognostic (2.11e-1)" "unprognostic (3.03e-2)" "unprognostic (9.22e-3)" "unprognostic (4.95e-2)" "unprognostic (1.47e-3)" "unprognostic (9.72e-2)" "unprognostic (6.55e-3)" "unprognostic (6.30e-3)" "unprognostic (9.54e-2)" "unprognostic (6.98e-3)" "unprognostic (2.87e-3)" "unprognostic (8.67e-2)" "unprognostic (4.46e-1)" "unprognostic (2.08e-1)" "unprognostic (5.42e-3)" 1.0 2.1 2.7 1.4 2.9 3.6 2.1 4.4 3.9 1.0 2.7 1.3 1.8 1.5 1.9 0.9 1.2 1.0 0.9 2.9 2.6 1.6 2.5 1.4 2.3 2.5 2.5 1.7 1.0 1.6 0.5 1.1 2.6 1.4 1.5 7.0 1.7 1.1 1.8 3.7 2.1 1.1 2.2 2.5 1.6 1.1 2.7 1.2 1.7 0.9 1.5 1.0 0.5 4.0 1.3 1.6 2.0 1.7 1.5 1.8 2.3 1.9 1.2 1.5 1.3 1.8 1.6 1.1 1.2 1.3 1.7 1.7 3.1 1.5 2.2 2.0 1.3 2.1 2.7 2.3 3.6 2.4 1.5 1.9 3.5 0.9 3.1 3.5 1.3 1.5 1.7 1.4 0.9 1.9 1.7 3.9 2.4 1.5 2.6 1.5 1.7 1.3 2.8 1.7 1.7 1.3 1.4 2.8 4.2 3.7 1.4 2.7 1.5 1.4 1.2 1.6 1.5 2.4 2.2 1.0 2.3 2.2 1.6 0.5 0.3 0.6 0.3 0.3 0.3 0.3 0.4 0.4 0.2 0.4 0.5 0.4 0.3 0.3 0.3 0.2 0.4 0.1 2.7 2.9 4.4 3.9 2.9 2.6 2.5 2.5 2.6 2.2 2.7 4.0 6.4 6.4 15.5 17.6 8.4 8.3 14.7 9.7 3.4 24.4 4.5 3.7 5.6 4.3 9.6 12.9 123.0 10.4 8.2 6.0 3.9 8.5 2.6 5.4 5.7 7.8 2.4 7.8 17.7 6.2 9.3 8.7 6.6 5.2 6.3 17.1 10.0 8.9 6.0 8.4 15.8 6.7 12.2 8.5 13.9 1.1 6.2 5.7 7.2 14.0 12.1 39.0 14.4 13.0 27.0 10.0 6.7 5.7 5.5 16.5 20.1 10.6 8.5 33.7 6.6 9.7 10.5 10.5 12.4 5.2 6.0 8.3 9.4 12.3 10.3 17.0 UBAP1L ENSG00000246922 "Ubiquitin associated protein 1 like" F5GYI3 15 65092760-65115200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 14.5;retina: 26.4" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 241.8;Rod photoreceptor cells: 167.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 2.5;U-266/70: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 15.8" HPA065334 Uncertain "Nuclear bodies" NA NA "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies" "HPA065334: AB_2685472" "unprognostic (6.89e-3)" "unprognostic (2.62e-1)" "unprognostic (2.66e-3)" "unprognostic (2.73e-2)" "unprognostic (1.64e-1)" "unprognostic (2.98e-3)" "unprognostic (6.59e-2)" "unprognostic (7.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.56e-1)" "unprognostic (5.62e-5)" "unprognostic (6.40e-3)" "unprognostic (3.11e-6)" "unprognostic (5.03e-2)" "unprognostic (1.39e-1)" "unprognostic (3.70e-1)" "unprognostic (6.11e-3)" 1.2 1.1 8.2 0.3 9.1 0.4 1.3 14.5 13.5 2.9 4.4 1.6 0.2 2.0 0.3 1.1 2.6 0.2 1.0 7.0 10.1 1.2 2.1 1.0 0.4 11.8 7.8 3.4 1.0 0.1 2.1 0.2 10.5 2.0 0.1 26.4 0.8 0.5 2.2 1.2 1.3 0.4 6.1 1.6 0.8 1.7 9.6 0.5 2.1 0.3 0.2 1.6 1.7 11.0 0.0 0.0 0.2 0.7 0.2 0.0 0.6 0.4 0.0 0.2 0.2 0.4 0.1 0.3 0.5 0.0 0.1 0.5 0.4 0.0 0.0 0.6 0.3 0.0 0.4 0.1 0.2 0.3 0.3 0.2 0.3 0.1 0.1 0.5 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.5 0.1 0.4 0.0 0.1 0.3 0.2 0.2 0.0 2.5 0.3 0.1 0.3 0.0 0.2 0.1 0.2 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 9.1 14.5 13.5 7.0 10.1 11.8 7.8 10.5 6.1 9.6 11.0 2.1 0.0 1.1 6.2 1.0 0.6 1.7 1.2 2.2 35.3 2.5 1.9 5.0 0.0 1.5 3.7 241.8 0.8 2.4 0.3 1.9 0.5 0.6 1.7 1.9 2.3 1.2 0.4 18.4 0.9 0.3 1.4 1.1 1.7 0.0 3.3 1.8 2.0 0.3 3.3 18.3 1.2 2.0 0.6 0.8 1.3 3.4 1.0 1.8 3.7 0.0 21.8 0.0 5.5 19.9 1.0 1.1 3.4 1.4 1.3 3.1 9.9 0.3 167.3 6.6 1.8 2.2 2.0 3.4 0.8 0.9 0.7 1.9 1.5 0.8 0.6 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655722-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038606, HPA038607" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 23000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Nucleoplasm, Nuclear bodies" "HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112" "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 3.4 0.7 1.1 4.8 1.5 6.7 1.1 15.0 1.9 3.0 0.1 1.2 1.3 1.0 0.2 1.1 0.5 1.9 0.9 1.2 5.5 1.7 1.3 4.6 5.7 10.3 7.1 0.2 0.6 0.4 0.3 13.8 10.2 0.7 1.4 1.9 0.7 0.7 1.1 3.4 1.7 1.9 1.2 15.6 1.4 1.2 2.8 15.1 2.3 0.3 3.2 4.4 0.5 1.4 13.1 31.5 5.6 7.5 2.4 4.4 29.1 45.6 25.1 18.1 13.9 12.5 6.8 5.3 3.5 24.3 17.2 6.4 0.1 16.3 28.7 0.2 0.9 122.2 1.0 10.8 6.7 15.0 88.9 3.9 1.0 72.9 26.9 19.7 12.4 5.3 0.1 0.1 17.8 0.5 18.5 9.6 2.5 13.3 7.4 73.3 3.3 0.7 28.6 10.9 12.7 0.2 12.1 0.9 10.1 11.7 0.2 4.0 32.3 23.4 12.6 13.9 19.1 1.0 0.0 15.1 12.4 20.6 43.4 0.0 1.3 9.9 1.8 6.3 1.9 0.3 2.3 1.7 1.7 1.1 2.6 1.4 2.7 6.4 11.1 0.2 4.7 1.8 1.1 1.5 15.0 1.9 1.2 5.5 10.3 7.1 10.2 1.2 2.8 1.4 2.2 0.0 4.7 9.1 4.6 7.1 4.2 3.4 2.8 1.8 1.2 1.3 1.1 0.0 2.0 3.7 0.0 32.5 10.0 0.6 0.0 8.4 2.4 0.6 4.0 4.5 0.0 1.7 24.8 9.7 54.9 4.9 2.0 1.5 12.7 11.5 5.0 0.6 35.7 11.8 166.3 0.5 4.1 26.0 51.2 3.9 0.0 26.5 1.8 30.0 9.1 0.2 17.5 26.2 2.7 26.3 0.3 0.4 11.4 4.7 0.2 0.6 2.5 1.1 0.0 3.8 3.4 0.1 0.8 2.4 6.0 47.6 16.8 0.1 0.4 3.1 UBE2M "hUbc12, UBC12" ENSG00000130725 "Ubiquitin conjugating enzyme E2 M" P61081 19 58555712-58558954 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 1197.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004993, HPA054551, HPA057800" Approved Enhanced "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" Yes No 49000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531" "unprognostic (1.42e-1)" "unprognostic (1.99e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.35e-2)" "unprognostic (1.77e-1)" "unprognostic (1.17e-3)" "unprognostic (3.90e-3)" "unprognostic (4.86e-2)" "unprognostic (1.09e-2)" "unprognostic (3.05e-3)" "unprognostic (1.96e-1)" "unprognostic (1.81e-1)" "unprognostic (8.63e-3)" "unprognostic (1.76e-1)" "unprognostic (5.85e-2)" "unprognostic (8.42e-3)" 46.3 66.1 133.2 39.2 138.8 82.2 42.8 116.7 199.7 48.9 104.0 72.5 41.7 48.1 36.3 61.8 51.3 30.9 111.0 141.2 129.3 63.2 45.6 46.3 43.4 123.5 124.4 46.0 47.5 84.5 69.7 45.0 127.7 48.3 32.5 49.7 48.5 46.1 174.0 56.6 41.6 39.5 111.9 49.3 55.8 81.0 124.4 51.7 44.3 104.5 43.7 58.3 45.8 139.1 161.8 272.1 119.3 124.8 61.7 71.9 112.2 166.0 117.4 97.8 82.8 162.7 109.7 161.9 135.5 93.4 198.1 105.9 130.1 138.6 69.2 207.3 1197.4 235.5 163.7 113.7 154.4 197.3 192.9 82.1 107.1 145.9 167.3 102.6 117.8 146.3 119.6 179.4 127.3 158.2 177.2 223.7 87.1 155.1 306.5 171.7 106.7 204.5 111.6 166.8 239.5 205.5 133.1 149.7 163.3 41.6 94.4 188.4 105.2 333.4 80.5 110.6 281.3 262.3 411.9 169.6 206.0 177.6 220.5 6.7 3.6 4.2 3.0 2.6 2.2 2.8 3.2 3.2 2.8 3.8 3.3 2.2 10.1 1.7 2.7 6.7 2.9 1.9 133.2 138.8 116.7 199.7 141.2 129.3 123.5 124.4 127.7 111.9 124.4 139.1 75.1 6.4 13.0 14.7 32.7 40.4 36.3 15.9 6.2 100.0 74.5 81.3 38.5 20.0 11.6 18.4 20.9 21.0 72.9 63.9 7.9 17.3 25.7 89.6 68.0 40.1 41.2 39.8 22.9 30.6 22.4 38.9 21.9 63.3 19.7 103.3 28.5 38.0 35.4 109.4 20.8 43.8 20.3 27.0 33.5 34.0 17.4 42.5 35.6 15.9 21.1 142.3 14.4 8.5 17.9 41.8 21.4 13.9 35.4 59.1 37.9 33.9 18.6 81.1 26.3 41.5 55.4 27.1 7.9 17.0 56.8 52.5 41.0 156.1 41.6 56.2 UBE2O E2-230K ENSG00000175931 "Ubiquitin conjugating enzyme E2 O" Q9C0C9 17 76389456-76453152 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.7;Inhibitory neurons: 63.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023605 Uncertain Supported "Nucleoplasm,Nuclear bodies" No No 220000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 62: Horizontal cells - Visual perception" "Nuclear bodies" Nucleoplasm "HPA023605: AB_2671257" "unprognostic (8.75e-2)" "unprognostic (2.04e-1)" "unprognostic (7.44e-2)" "unprognostic (8.68e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "prognostic unfavorable (6.84e-8)" "unprognostic (3.54e-1)" "unprognostic (2.68e-1)" "unprognostic (7.61e-2)" "unprognostic (1.32e-3)" "unprognostic (1.18e-2)" "prognostic unfavorable (4.34e-9)" "unprognostic (7.22e-2)" "unprognostic (9.64e-2)" "unprognostic (9.12e-2)" "unprognostic (2.07e-1)" 9.1 9.7 12.9 10.1 14.0 21.2 9.7 8.0 24.9 12.8 1.4 10.7 9.4 11.5 7.0 12.8 11.0 6.5 20.3 15.4 11.7 8.4 10.5 8.7 13.1 21.7 9.0 15.1 17.4 10.9 18.2 9.1 21.7 11.6 5.3 10.5 12.9 8.7 28.3 16.1 10.6 7.1 4.4 13.9 11.0 16.6 11.6 12.0 16.1 13.4 8.6 10.8 12.5 14.5 25.8 29.2 29.1 35.5 17.7 11.3 25.2 11.8 12.8 18.9 18.3 25.6 12.7 36.4 8.3 14.8 29.7 25.2 34.2 20.4 13.2 10.5 42.2 36.9 20.6 42.9 14.7 22.6 22.0 11.4 16.2 18.1 15.3 16.2 25.7 19.9 31.5 31.4 9.6 21.3 44.7 26.0 27.0 15.5 38.9 43.3 37.6 40.2 8.5 22.1 43.0 38.5 17.4 43.9 23.6 26.3 25.4 16.1 15.4 21.9 20.5 18.8 19.9 25.8 9.2 30.8 24.1 18.8 14.6 0.0 0.7 1.0 1.4 0.3 0.8 0.9 0.9 0.7 0.4 1.6 0.7 1.1 0.1 0.5 0.4 1.5 0.9 0.8 12.9 14.0 8.0 24.9 15.4 11.7 21.7 9.0 21.7 4.4 11.6 14.5 7.9 3.2 7.7 24.8 19.6 8.7 6.1 7.2 13.1 45.8 9.7 9.1 23.2 5.7 7.3 7.3 41.7 6.4 15.2 6.5 0.0 6.0 1.8 8.6 13.7 8.3 23.4 33.2 54.7 9.4 7.4 8.3 17.9 10.1 7.0 18.9 7.1 8.5 8.1 45.4 63.0 9.3 2.0 5.3 11.0 1.8 9.6 11.6 5.4 19.7 10.0 7.3 18.6 27.2 24.7 7.2 5.7 7.9 22.9 9.8 5.2 3.3 5.6 23.8 6.6 12.2 10.9 19.6 23.2 12.9 12.4 5.2 14.7 13.3 8.7 6.2 UBN1 ENSG00000118900 "Ubinuclein 1" Q9NPG3 16 4846665-4882401 "Predicted intracellular proteins" "Host-virus interaction" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 153.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 14.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 14.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061029, HPA069036, HPA069045" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072" "unprognostic (8.20e-2)" "unprognostic (1.01e-1)" "unprognostic (8.99e-3)" "unprognostic (1.75e-1)" "unprognostic (1.65e-1)" "unprognostic (1.33e-1)" "unprognostic (1.47e-3)" "unprognostic (6.53e-3)" "unprognostic (1.35e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.38e-1)" "unprognostic (1.10e-1)" "unprognostic (1.25e-1)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (6.89e-2)" 14.7 12.3 8.3 14.5 7.9 48.9 12.9 10.5 8.3 14.9 12.4 13.9 14.7 12.4 6.5 25.0 11.9 11.8 20.8 9.1 5.9 10.5 13.6 13.5 15.4 6.6 6.9 13.3 14.1 12.2 10.1 11.5 5.8 11.6 14.3 20.1 15.7 9.6 22.9 15.8 14.6 13.8 6.2 21.5 12.7 37.4 8.0 22.5 11.4 19.5 15.5 11.6 16.5 8.0 21.0 26.0 29.5 29.3 25.3 23.6 23.7 25.7 24.5 29.6 28.4 21.7 24.4 39.2 23.1 25.3 32.1 27.2 38.2 23.6 25.0 38.4 19.0 32.2 35.0 17.1 24.3 39.4 33.6 15.8 30.6 34.4 36.7 22.5 39.3 38.3 53.6 32.5 22.0 30.1 43.6 18.0 25.1 21.8 19.3 67.5 36.6 37.5 15.5 24.0 39.9 22.0 44.7 36.4 22.3 21.8 36.0 34.6 39.7 31.3 29.5 102.5 32.4 30.4 34.7 77.5 18.5 24.5 53.9 1.7 1.2 0.9 1.4 1.1 1.0 0.9 1.0 1.3 0.8 1.0 1.1 0.7 14.2 1.0 0.9 1.7 0.9 0.9 8.3 7.9 10.5 8.3 9.1 5.9 6.6 6.9 5.8 6.2 8.0 8.0 31.2 9.6 15.9 17.3 31.9 18.0 22.0 7.5 30.1 59.9 23.6 20.3 25.5 22.8 9.8 9.2 110.5 28.1 51.3 41.1 7.9 16.7 46.2 39.2 36.8 36.4 30.9 32.4 17.9 18.2 23.3 22.9 29.6 29.8 7.6 27.9 28.5 31.0 23.2 50.5 16.8 27.4 8.2 33.2 21.5 57.8 29.2 37.0 26.6 30.0 28.9 27.9 61.8 19.6 20.3 27.7 33.4 22.6 44.0 33.4 27.4 13.3 16.4 100.8 13.1 26.8 21.8 153.8 128.4 30.9 22.3 29.1 40.4 35.2 26.8 27.3 UIMC1 RAP80 ENSG00000087206 "Ubiquitin interaction motif containing 1" Q96RL1 5 176905005-177022633 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 132.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 64.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 64.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037503, HPA037504" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies" Nucleoplasm "HPA037503: AB_10671373, HPA037504: AB_10671760" "unprognostic (2.96e-1)" "unprognostic (9.57e-2)" "unprognostic (2.48e-3)" "unprognostic (4.40e-2)" "unprognostic (1.69e-1)" "unprognostic (9.88e-3)" "prognostic unfavorable (7.67e-6)" "unprognostic (1.85e-1)" "unprognostic (1.12e-2)" "unprognostic (6.62e-2)" "unprognostic (1.30e-1)" "unprognostic (5.91e-2)" "unprognostic (1.33e-3)" "unprognostic (8.51e-2)" "unprognostic (5.52e-1)" "unprognostic (7.23e-2)" "unprognostic (1.44e-1)" 28.2 24.6 15.8 14.0 15.9 60.2 27.2 22.3 19.1 31.1 19.1 32.5 9.5 29.4 11.2 18.8 26.6 10.8 27.1 15.1 15.4 21.9 18.6 26.4 22.8 14.0 14.4 35.8 27.2 9.1 19.6 12.7 14.4 23.0 12.4 15.0 17.1 13.3 32.6 23.8 23.3 18.9 12.6 31.4 22.5 62.3 14.9 27.6 23.5 12.0 22.0 29.2 23.8 17.6 27.6 26.6 26.9 33.1 25.8 22.7 38.3 28.1 31.4 35.5 37.0 30.6 30.7 79.1 33.8 23.3 37.8 21.1 27.9 62.7 41.8 91.4 25.4 35.4 30.9 25.7 28.5 43.8 22.7 15.9 29.0 27.0 74.0 26.9 41.6 47.1 30.9 26.1 26.6 25.7 43.1 29.4 19.6 22.2 16.2 39.5 38.8 46.1 38.0 17.4 29.1 23.2 62.3 20.1 30.4 28.3 17.5 24.2 31.6 20.1 20.3 17.7 37.6 39.1 49.8 50.8 19.6 43.2 22.1 15.8 11.8 33.0 9.0 7.0 9.4 11.8 10.3 8.9 7.4 13.9 10.0 8.3 64.5 14.5 4.5 9.5 14.7 6.5 15.8 15.9 22.3 19.1 15.1 15.4 14.0 14.4 14.4 12.6 14.9 17.6 24.8 12.8 21.0 36.9 31.3 10.5 18.0 11.8 23.3 19.3 10.9 11.8 20.6 8.6 17.3 9.2 14.6 13.9 22.5 7.8 7.9 13.7 27.4 19.4 23.1 17.0 13.1 47.8 59.5 12.9 12.7 17.1 12.2 22.8 18.3 20.6 13.2 8.8 9.9 16.8 53.3 7.9 8.2 14.8 14.1 13.2 15.5 19.8 1.8 44.0 18.0 8.9 19.6 43.7 51.1 17.0 9.1 12.4 24.2 12.9 8.1 8.9 19.2 33.7 13.1 17.7 18.8 132.1 73.8 13.2 11.9 6.8 23.0 35.4 8.7 13.9 UNC80 "C2orf21, FLJ33496, KIAA1843, UNC-80" ENSG00000144406 "Unc-80 homolog, NALCN channel complex subunit" Q8N2C7 2 209771832-209999300 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.0;pituitary gland: 13.6;retina: 18.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5" "Cancer enhanced" "Detected in some" "glioma: 0.8;prostate cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042472, HPA050959" Enhanced Approved "Nuclear bodies,Vesicles" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear bodies" Vesicles "HPA042472: AB_10965318, HPA050959: " "unprognostic (7.91e-3)" "unprognostic (2.25e-4)" "unprognostic (1.44e-2)" "unprognostic (3.20e-4)" "unprognostic (1.92e-1)" "unprognostic (3.40e-2)" "unprognostic (3.31e-3)" "unprognostic (5.36e-2)" "unprognostic (5.16e-1)" "unprognostic (7.85e-2)" "unprognostic (5.24e-3)" "unprognostic (8.94e-2)" "unprognostic (1.50e-2)" "unprognostic (1.51e-2)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" "unprognostic (7.40e-3)" 0.0 3.9 6.4 0.0 9.9 0.0 0.0 15.6 21.0 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.4 1.1 0.0 6.9 4.9 0.1 0.0 0.1 0.0 6.7 1.5 0.5 1.0 0.2 13.6 0.0 5.8 0.9 0.1 18.9 0.1 0.2 0.0 0.1 0.1 0.2 1.1 0.2 0.4 3.5 2.6 0.1 0.3 0.0 0.0 0.2 0.0 5.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 9.9 15.6 21.0 6.9 4.9 6.7 1.5 5.8 1.1 2.6 5.0 0.2 0.0 1.1 49.0 0.0 0.8 0.3 1.9 0.0 117.7 0.2 0.1 2.1 0.0 0.7 0.0 66.7 0.0 0.0 0.0 0.0 0.0 31.9 1.1 1.7 0.5 0.0 0.0 432.0 0.0 0.0 1.1 0.0 0.1 1.3 0.6 0.0 0.0 0.1 52.2 354.7 0.0 0.0 0.0 0.0 10.5 0.9 0.3 0.0 10.3 0.0 26.6 0.0 290.5 12.8 0.1 0.0 1.9 0.0 1.2 0.0 0.2 0.8 75.6 0.0 0.2 0.1 7.5 3.8 0.0 0.1 0.0 0.0 15.1 0.0 0.3 UPK3A UPK3 ENSG00000100373 "Uroplakin 3A" O75631 22 45284949-45295874 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5" "Group enriched" "Detected in many" 6 "prostate cancer: 35.3;urothelial cancer: 78.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "myeloid DC: 86.6" "Group enriched" "Detected in many" 16 "dendritic cells: 86.6;monocytes: 32.0" "Group enriched" "Detected in some" 5 "Hep G2: 29.9;RT4: 48.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA018407, HPA018415" Enhanced Uncertain "Nuclear membrane,Nuclear bodies" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Nuclear membrane" "Nuclear bodies" "HPA018407: AB_1858641, HPA018415: AB_1858640" "unprognostic (1.27e-2)" "unprognostic (3.20e-3)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (3.98e-5)" "unprognostic (1.69e-2)" "unprognostic (4.82e-4)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-5)" "unprognostic (2.01e-2)" "unprognostic (5.45e-2)" "unprognostic (1.83e-1)" "unprognostic (6.05e-3)" 0.2 0.1 0.1 0.5 0.1 1.5 0.2 0.1 0.4 0.0 0.3 1.0 0.0 0.1 0.1 0.3 0.3 0.9 0.1 0.1 0.2 0.1 0.0 0.2 0.9 0.2 0.1 0.1 0.2 4.9 0.7 0.0 0.2 21.3 0.7 0.0 2.8 0.2 35.0 0.0 1.3 0.1 0.1 1.1 0.1 0.1 0.1 0.7 2.3 4.5 0.8 48.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 4.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 4.6 0.0 0.1 0.0 0.2 0.0 48.9 0.1 0.0 0.2 0.8 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.0 0.0 21.2 0.0 0.0 25.8 0.0 1.2 0.0 0.1 86.6 0.5 0.0 0.0 3.6 0.4 32.0 32.9 0.0 7.4 0.1 0.1 0.1 0.4 0.1 0.2 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.0 0.0 0.7 1.2 0.1 15.0 0.1 0.0 0.1 4.6 3.6 0.2 2.8 0.1 0.0 0.0 0.0 4.0 3.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.1 3.5 0.0 4.8 8.7 1.7 0.3 6.4 0.0 0.0 22.6 0.8 2.1 0.0 0.0 0.0 9.3 0.0 0.1 54.1 29.8 0.0 0.1 0.0 0.0 1.6 0.5 0.0 0.4 0.0 0.4 0.1 0.2 0.0 4.4 24.5 UQCC2 "bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1" ENSG00000137288 "Ubiquinol-cytochrome c reductase complex assembly factor 2" Q9BRT2 6 33694293-33711727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 911.7;Late spermatids: 1207.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039111 Uncertain Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 38: Heart - Muscle contraction" "Cluster 43: THP-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Mitochondria "Nuclear bodies" "HPA039111: AB_2676352" "unprognostic (3.58e-2)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (1.93e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.50e-1)" "unprognostic (2.35e-3)" "unprognostic (2.43e-2)" "unprognostic (5.93e-2)" "unprognostic (2.33e-2)" "unprognostic (7.43e-2)" "unprognostic (5.77e-2)" "unprognostic (3.88e-1)" "unprognostic (1.07e-1)" 38.9 69.6 100.5 37.3 102.8 45.3 45.3 103.3 140.9 48.4 97.6 43.3 34.3 61.5 58.4 59.2 40.0 20.8 267.2 100.1 106.6 66.9 83.3 33.9 35.6 102.5 102.2 33.4 61.2 46.8 78.0 29.3 102.9 55.4 44.0 104.3 53.0 28.6 228.8 42.9 28.5 52.4 102.4 43.2 49.5 104.1 104.4 45.7 42.9 197.9 40.8 46.1 42.8 107.9 207.7 144.2 162.8 139.4 130.9 129.8 125.5 116.4 117.3 167.7 162.6 233.9 84.5 84.4 180.3 143.5 244.1 109.0 111.7 164.5 138.6 108.0 187.7 163.3 87.3 327.6 215.9 153.8 127.2 136.2 257.4 131.7 204.7 91.0 120.4 158.9 178.4 165.9 190.4 220.9 149.0 315.9 97.3 158.4 167.6 106.5 130.7 279.9 116.2 191.5 273.1 97.1 127.9 191.7 165.6 84.1 168.3 382.2 110.5 178.0 151.1 115.9 242.0 126.8 193.1 146.6 53.7 229.7 211.0 32.7 88.5 18.2 76.1 141.6 93.6 152.4 95.0 87.6 108.6 116.1 98.7 88.0 8.4 81.6 120.9 133.2 110.7 123.8 100.5 102.8 103.3 140.9 100.1 106.6 102.5 102.2 102.9 102.4 104.4 107.9 18.5 28.9 29.3 8.1 54.2 58.5 96.8 193.0 61.5 108.7 96.0 100.3 911.7 74.4 119.8 77.3 50.1 134.7 34.0 112.4 391.3 103.4 342.3 46.6 78.7 54.1 99.7 105.0 8.9 179.7 124.4 88.5 90.7 39.1 59.5 90.0 41.4 166.1 218.8 70.7 10.2 94.5 154.6 67.8 55.6 1207.0 78.6 64.8 83.6 3.7 63.6 79.1 46.4 9.0 10.0 95.6 64.2 83.8 88.3 122.1 44.6 257.2 87.1 123.8 0.0 32.9 269.4 155.9 96.0 103.3 76.3 95.4 43.5 159.3 102.3 118.5 USP15 "KIAA0529, UNPH4" ENSG00000135655 "Ubiquitin specific peptidase 15" Q9Y4E8 12 62260338-62417431 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 176.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 297.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 297.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006237, HPA006428, HPA071014" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 300000 "Cluster 1: Neutrophils - Mixed function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Nucleoplasm, Nuclear bodies" "HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333" "unprognostic (8.18e-2)" "unprognostic (3.22e-1)" "unprognostic (9.63e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (6.59e-2)" "unprognostic (7.70e-3)" "unprognostic (2.19e-1)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (9.28e-2)" "unprognostic (5.81e-3)" "unprognostic (1.11e-2)" "unprognostic (1.26e-1)" 29.0 21.6 4.5 29.4 4.8 176.2 22.9 12.3 6.7 17.6 10.2 18.0 13.8 14.6 9.2 19.7 17.8 13.7 19.8 5.2 5.5 14.9 27.2 31.5 33.3 6.0 5.4 26.7 19.7 14.9 13.9 18.4 5.7 14.3 16.7 45.8 19.7 8.3 35.5 29.9 24.6 12.6 4.6 44.3 18.8 30.2 5.5 26.5 17.1 14.8 24.9 18.1 19.4 8.0 18.3 16.5 14.2 17.7 25.7 25.1 27.0 29.0 21.2 22.3 16.1 19.6 21.6 15.5 16.6 17.8 10.1 18.5 18.4 23.1 27.6 18.5 15.0 25.2 15.1 14.1 18.8 35.6 61.8 15.0 19.2 27.2 20.7 20.7 26.1 16.3 80.8 36.0 20.0 23.5 26.4 19.3 25.4 16.5 24.0 17.2 19.1 32.3 17.9 22.8 17.9 8.9 30.9 21.6 17.3 17.4 34.7 18.8 37.2 21.2 22.2 32.0 18.2 16.4 24.0 21.9 25.7 26.7 23.5 163.4 60.0 64.3 13.5 31.1 14.9 28.5 19.6 14.0 23.7 20.5 23.5 13.8 297.9 14.7 26.8 26.6 58.8 26.1 4.5 4.8 12.3 6.7 5.2 5.5 6.0 5.4 5.7 4.6 5.5 8.0 57.1 38.5 36.4 68.6 130.3 58.8 40.8 26.2 40.5 54.9 32.3 28.1 74.9 21.5 48.9 23.9 110.5 31.7 142.5 50.2 11.7 36.4 172.2 26.3 46.5 45.4 42.0 248.3 124.8 41.5 43.3 52.5 57.6 38.9 88.6 53.5 21.0 45.3 46.2 42.1 104.2 33.2 12.2 101.3 97.6 172.0 61.8 120.6 53.4 135.9 195.8 25.6 90.6 100.0 108.8 55.1 47.6 29.3 94.3 36.0 30.9 25.9 31.9 151.5 39.5 66.1 60.5 83.7 43.3 49.3 77.0 65.8 130.0 27.0 29.5 60.8 USP28 KIAA1515 ENSG00000048028 "Ubiquitin specific peptidase 28" Q96RU2 11 113797874-113875570 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.7;skeletal muscle: 68.3;tongue: 66.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 152.2;Excitatory neurons: 57.0;NK-cells: 73.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 20.1" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006778, HPA006779" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 38: Heart - Muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Nuclear bodies" "HPA006778: AB_1080520, HPA006779: AB_1080517" "unprognostic (2.54e-1)" "unprognostic (2.72e-1)" "unprognostic (2.99e-2)" "unprognostic (3.72e-2)" "unprognostic (5.51e-2)" "unprognostic (2.30e-1)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.04e-3)" "unprognostic (1.82e-3)" "unprognostic (3.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.11e-2)" "unprognostic (2.06e-2)" "unprognostic (9.03e-2)" "unprognostic (1.35e-3)" "unprognostic (5.03e-2)" 5.8 6.7 3.2 9.5 4.3 5.8 10.4 20.1 9.5 21.1 0.6 10.4 9.6 11.5 11.3 9.6 9.8 7.7 62.7 4.6 1.8 9.9 11.3 7.5 15.6 2.1 1.7 14.1 8.2 15.5 7.4 8.0 3.4 11.3 11.7 27.1 12.0 14.2 68.3 7.0 10.4 13.1 1.2 13.8 9.2 9.2 1.9 9.0 10.1 66.5 15.5 9.8 8.4 5.3 18.3 20.2 26.7 35.4 21.3 20.9 18.8 13.2 18.0 17.5 29.7 30.2 25.6 24.2 29.3 18.0 40.1 35.1 37.9 24.8 24.1 27.1 17.2 12.9 13.8 16.3 13.0 16.8 12.4 12.6 18.5 20.2 23.8 25.4 32.0 11.9 22.7 15.3 18.5 9.3 12.9 27.1 32.0 33.6 14.4 31.3 37.1 29.4 19.3 17.8 11.6 12.6 31.4 10.7 10.1 82.7 25.8 5.8 17.1 19.2 28.3 17.8 13.8 10.4 15.9 20.1 1.9 32.1 12.8 0.2 5.0 3.4 23.2 3.7 12.1 15.5 5.7 16.8 6.4 12.3 3.8 13.1 1.4 28.6 6.4 1.9 9.2 10.3 3.2 4.3 20.1 9.5 4.6 1.8 2.1 1.7 3.4 1.2 1.9 5.3 7.3 9.6 8.8 18.3 17.8 1.7 7.3 9.9 13.6 18.7 9.7 9.8 152.2 5.7 9.9 5.5 18.8 4.4 32.1 3.3 5.9 6.7 1.7 6.6 11.6 7.9 4.9 2.5 57.0 3.9 4.7 12.2 11.7 8.7 1.3 18.9 7.5 8.8 4.4 5.0 34.1 9.6 4.1 6.5 2.5 2.0 6.8 7.4 1.8 10.3 8.2 10.3 73.2 29.1 21.3 3.5 5.3 13.9 21.7 7.1 7.3 7.1 14.6 21.5 6.6 10.3 11.0 15.8 11.4 7.7 2.0 1.1 18.6 9.0 8.9 5.8 USP7 HAUSP ENSG00000187555 "Ubiquitin specific peptidase 7" Q93009 16 8892097-8975328 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Developmental protein, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 282.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008108, HPA015641, CAB079904" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA 16000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700" "unprognostic (6.73e-2)" "unprognostic (1.59e-1)" "unprognostic (3.36e-3)" "unprognostic (1.94e-2)" "unprognostic (9.64e-2)" "unprognostic (8.09e-2)" "unprognostic (4.69e-2)" "unprognostic (4.56e-2)" "unprognostic (4.81e-1)" "unprognostic (2.49e-1)" "unprognostic (2.35e-1)" "unprognostic (9.93e-2)" "prognostic favorable (8.56e-5)" "unprognostic (1.35e-1)" "unprognostic (1.07e-1)" "unprognostic (7.31e-2)" "unprognostic (2.69e-1)" 22.3 16.1 17.6 27.0 19.8 54.6 20.5 20.5 20.7 20.1 15.1 33.1 21.8 21.5 10.1 29.6 19.0 19.9 23.8 21.4 18.1 19.5 25.1 19.3 39.9 16.9 20.1 19.8 26.7 34.8 13.9 23.7 17.5 20.7 32.5 21.7 18.7 18.7 45.2 25.4 25.9 25.7 18.7 24.2 25.5 58.8 18.8 51.1 22.8 41.0 44.9 26.3 17.7 20.8 39.9 73.5 62.2 46.9 34.9 42.9 42.9 53.6 44.7 48.1 40.4 66.6 46.7 94.6 33.8 61.0 27.7 48.8 95.2 61.9 79.6 63.1 38.1 78.4 49.5 132.9 49.0 87.6 48.8 37.3 37.7 52.6 61.0 37.0 69.7 139.8 77.7 101.5 49.6 75.4 130.8 16.9 43.9 49.8 41.4 114.5 69.7 86.2 33.4 77.9 58.8 35.5 59.4 55.3 28.7 62.3 55.0 39.4 60.4 52.1 54.1 80.3 40.4 49.1 134.3 145.1 48.5 49.6 43.5 5.2 2.1 2.8 4.5 2.2 5.7 4.0 4.1 5.3 2.2 4.9 4.9 4.3 3.4 2.8 6.1 6.5 5.1 1.1 17.6 19.8 20.5 20.7 21.4 18.1 16.9 20.1 17.5 18.7 18.8 20.8 40.4 35.3 54.5 22.2 38.0 46.5 23.1 17.9 22.8 51.1 29.7 28.8 74.3 21.5 36.4 29.5 25.0 21.9 51.4 39.8 5.9 22.5 282.4 38.5 50.9 35.8 42.2 46.5 31.4 33.4 14.5 34.4 31.1 57.6 26.6 47.8 25.0 37.5 19.8 43.7 34.9 49.3 10.2 29.2 31.0 112.2 25.4 43.8 19.6 21.5 36.3 29.2 24.7 24.1 30.2 35.6 39.0 34.6 46.8 34.1 31.3 13.7 37.8 44.2 6.6 58.4 39.4 33.8 39.4 41.3 50.0 21.1 40.4 47.6 54.8 35.0 VIRMA "DKFZP434I116, fSAP121, KIAA1429" ENSG00000164944 "Vir like m6A methyltransferase associated" Q69YN4 8 94487689-94553529 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 26.4;Endometrial stromal cells: 32.2;Granulosa cells: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031530 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear bodies" Nucleoplasm "HPA031530: AB_10600818" "unprognostic (2.51e-2)" "unprognostic (7.41e-3)" "unprognostic (3.43e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (7.83e-2)" "unprognostic (7.54e-3)" "unprognostic (1.98e-3)" "unprognostic (1.27e-1)" "unprognostic (2.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (7.90e-4)" "unprognostic (2.48e-1)" "unprognostic (1.68e-1)" "unprognostic (3.82e-2)" "unprognostic (9.87e-2)" 12.5 7.8 6.9 11.6 8.5 27.3 17.5 11.5 7.2 13.1 7.1 9.9 8.1 13.7 8.6 9.7 11.4 8.9 9.9 6.1 7.4 10.8 12.5 10.7 14.4 7.1 7.2 16.7 10.3 14.8 6.3 13.2 7.2 10.7 11.7 12.3 9.5 10.3 8.7 9.7 9.1 13.9 7.2 11.4 11.6 16.5 7.3 20.0 13.3 9.3 15.2 10.5 8.0 9.2 40.5 25.2 26.8 14.9 32.4 42.5 17.1 27.5 27.9 29.4 29.9 17.9 33.2 43.6 25.5 36.1 23.0 25.9 36.2 33.5 42.9 38.7 20.0 52.0 19.6 17.6 23.6 25.9 17.9 32.8 13.4 35.4 33.7 30.1 37.5 28.2 54.0 26.6 30.0 23.8 50.7 14.6 17.5 41.4 19.1 29.9 24.4 24.3 19.1 27.6 20.9 28.9 21.6 5.5 23.8 26.3 31.2 20.7 37.3 26.9 15.9 23.1 25.7 20.8 27.8 51.0 26.4 33.7 26.2 14.2 5.0 8.7 6.7 6.4 10.7 6.6 7.4 9.1 5.2 5.0 9.0 7.9 6.0 9.5 13.8 3.3 6.9 5.8 6.9 8.5 11.5 7.2 6.1 7.4 7.1 7.2 7.2 7.2 7.3 9.2 24.2 25.6 21.5 0.0 6.3 0.0 0.0 0.0 0.0 0.0 16.9 16.4 0.0 0.0 14.9 7.3 0.0 26.4 20.0 0.0 7.9 14.4 0.0 23.8 32.2 9.8 0.0 0.0 0.0 12.2 23.7 10.6 0.0 22.4 5.1 28.5 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 14.7 0.0 0.0 5.2 0.0 0.0 6.9 8.7 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 16.8 9.9 25.0 0.0 0.0 WDR31 FLJ35921 ENSG00000148225 "WD repeat domain 31" Q8NA23 9 113313222-113340298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 18.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 69.6;Cone photoreceptor cells: 29.2;Early spermatids: 29.5;Late spermatids: 27.2;Rod photoreceptor cells: 42.0;Spermatocytes: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019340, HPA019347" Approved Approved "Nuclear bodies,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "Nuclear bodies" "HPA019340: AB_1858800, HPA019347: AB_2215267" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.78e-3)" "prognostic favorable (1.85e-4)" "unprognostic (4.54e-2)" "unprognostic (1.59e-1)" "unprognostic (2.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.48e-1)" "unprognostic (2.59e-1)" "unprognostic (7.67e-2)" "unprognostic (2.64e-1)" "prognostic favorable (1.90e-9)" "unprognostic (9.11e-2)" "unprognostic (1.65e-1)" "unprognostic (7.96e-3)" "unprognostic (8.50e-2)" 1.2 3.4 2.6 0.5 2.9 1.0 2.8 1.9 2.4 1.9 4.8 1.5 1.1 1.5 1.9 1.4 3.9 1.4 5.7 2.3 2.8 3.4 1.6 1.4 0.4 2.5 3.0 2.2 1.8 11.1 2.9 0.6 2.3 2.0 1.3 18.0 3.8 2.0 0.9 1.5 0.6 1.1 2.2 0.4 1.3 4.9 3.1 0.9 3.7 1.0 0.4 1.3 1.1 1.9 3.6 2.6 0.9 1.8 3.1 3.6 0.8 0.8 1.7 0.9 1.1 0.4 2.3 1.3 0.6 1.3 2.5 2.2 0.8 1.7 1.7 2.2 0.2 1.1 1.4 0.4 3.5 0.6 0.1 1.9 2.2 3.6 3.2 2.4 0.7 1.9 3.0 1.2 0.9 2.4 1.1 0.9 0.5 3.4 3.3 1.3 0.7 1.6 2.3 0.7 2.2 1.6 4.2 0.7 2.0 0.7 5.5 0.5 0.4 1.1 1.3 3.1 0.9 2.4 2.5 0.2 1.7 0.8 1.2 1.7 0.2 0.3 0.2 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.9 0.4 0.2 0.2 0.2 0.2 2.6 2.9 1.9 2.4 2.3 2.8 2.5 3.0 2.3 2.2 3.1 1.9 0.9 6.4 8.2 11.1 0.2 5.4 5.3 2.2 3.4 5.5 3.5 2.4 69.6 4.3 8.1 1.8 29.2 0.4 1.5 1.1 5.9 2.0 29.5 12.3 2.9 3.8 0.0 4.4 7.9 0.2 0.3 7.6 0.0 2.3 5.1 3.4 1.4 3.0 0.8 6.7 8.8 1.4 0.0 1.2 2.2 27.2 1.8 1.3 0.0 1.9 0.2 8.2 1.0 2.0 3.2 1.0 0.6 1.5 0.1 2.8 0.2 5.5 24.6 42.0 0.0 6.0 4.1 25.1 8.6 1.7 4.3 0.3 1.1 2.8 2.1 3.3 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0" "Group enriched" "Detected in some" 5 "Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 24 "dendritic cells: 2.9;monocytes: 2.7" "Cell line enhanced" "Detected in some" "AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 9.5" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.1 0.1 10.2 0.4 8.2 2.0 0.1 16.6 3.4 0.3 29.3 0.1 2.0 0.4 0.0 0.9 10.0 0.2 2.1 7.0 15.6 0.3 0.0 1.9 0.3 30.1 27.0 0.1 0.3 0.0 0.5 0.0 23.8 0.2 0.1 0.0 0.2 0.0 0.0 0.1 4.6 0.1 31.3 0.4 0.2 0.6 15.5 0.4 0.0 0.2 0.3 0.2 0.2 23.4 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 2.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.5 10.2 8.2 16.6 3.4 7.0 15.6 30.1 27.0 23.8 31.3 15.5 23.4 0.2 0.0 0.6 79.0 0.1 0.0 0.9 1.7 9.1 0.0 0.1 0.1 1.1 0.0 10.9 0.0 0.0 0.0 1.6 0.1 0.0 0.1 2.4 43.4 0.3 0.2 0.0 1.7 4.5 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 4.1 1.6 2.5 0.8 0.0 1.8 0.0 0.0 4.0 0.0 0.0 2.5 3.0 0.0 0.0 0.0 0.1 0.4 3.3 0.0 47.7 0.0 6.6 0.3 0.6 0.1 0.2 1.0 0.1 0.0 0.1 0.0 0.2 0.8 WDR76 FLJ12973 ENSG00000092470 "WD repeat domain 76" Q9H967 15 43826980-43868412 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.1;lymphoid tissue: 21.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 35.3;Spermatocytes: 23.5;Spermatogonia: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039804, HPA040626" Uncertain Approved "Nucleoli fibrillar center,Nuclear bodies" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies" "Nucleoli fibrillar center" "HPA039804: AB_10795297, HPA040626: AB_10795527" "unprognostic (2.26e-1)" "unprognostic (7.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.85e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (6.98e-4)" "prognostic unfavorable (8.02e-5)" "unprognostic (4.24e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.91e-2)" "prognostic unfavorable (1.35e-8)" "unprognostic (7.71e-2)" "unprognostic (9.42e-2)" "unprognostic (4.02e-2)" "unprognostic (3.28e-2)" 2.6 1.2 1.0 8.4 1.1 19.1 3.5 4.8 1.7 3.0 0.8 4.8 3.2 3.3 0.9 4.5 1.7 1.9 1.1 0.7 1.1 1.5 2.2 2.4 19.8 1.3 1.1 2.2 3.1 2.7 1.1 3.9 1.3 1.9 6.0 6.3 2.4 2.0 0.8 4.1 3.3 3.9 1.0 3.6 2.9 5.3 1.3 19.5 2.5 1.3 21.3 2.8 2.8 1.2 35.1 17.5 40.7 31.3 4.5 10.7 11.1 57.3 33.9 61.5 76.8 22.1 17.8 51.4 24.8 26.9 31.0 49.4 42.4 20.5 53.1 80.4 25.2 63.3 52.1 7.3 2.5 65.0 27.0 3.4 3.3 33.8 7.7 8.9 19.9 54.7 48.6 86.9 42.6 12.2 63.4 15.4 14.6 11.0 18.1 66.9 70.1 32.4 11.4 35.5 31.3 30.9 36.1 22.5 7.0 12.6 35.0 31.0 9.1 56.3 26.5 63.5 58.9 42.7 114.6 129.1 40.4 56.7 31.5 0.0 0.6 0.3 3.8 0.5 4.1 1.8 4.6 3.4 1.0 2.2 3.8 2.9 0.0 4.8 0.2 1.2 6.6 2.0 1.0 1.1 4.8 1.7 0.7 1.1 1.3 1.1 1.3 1.0 1.3 1.2 4.1 3.2 1.3 2.6 8.2 7.4 3.2 2.4 4.6 3.7 3.7 2.8 1.2 1.5 2.3 1.8 10.4 12.8 6.2 3.5 1.9 2.9 1.7 1.8 3.9 4.8 0.0 35.3 2.5 4.2 13.0 3.9 4.6 3.3 5.7 12.2 2.9 0.9 8.9 1.7 3.3 3.7 0.0 3.5 5.3 0.9 1.8 3.9 3.6 2.8 3.3 8.0 10.3 0.5 1.9 1.1 3.1 2.2 16.1 1.5 1.4 0.9 0.4 16.2 6.6 5.8 5.7 23.5 35.9 7.4 5.8 3.6 11.6 1.5 9.0 1.8 WRAP53 "FLJ10385, TCAB1, WDR79" ENSG00000141499 "WD repeat containing antisense to TP53" Q9BUR4 17 7686071-7703502 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Chaperone, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 29.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023026, HPA028130, HPA029928" Enhanced Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear bodies" "Nucleoplasm, Cytosol" "HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257" "unprognostic (1.45e-1)" "unprognostic (3.50e-3)" "unprognostic (6.81e-2)" "unprognostic (2.53e-3)" "unprognostic (3.86e-1)" "unprognostic (2.10e-1)" "prognostic unfavorable (4.70e-4)" "unprognostic (8.69e-2)" "unprognostic (3.29e-1)" "unprognostic (1.41e-1)" "prognostic favorable (8.26e-4)" "unprognostic (2.68e-2)" "unprognostic (5.67e-2)" "unprognostic (7.23e-2)" "unprognostic (2.47e-1)" "unprognostic (2.93e-2)" "unprognostic (4.04e-1)" 4.1 3.7 3.4 4.5 3.5 7.6 4.0 3.4 3.5 4.3 5.0 4.2 2.7 4.5 2.3 4.5 14.5 3.0 4.2 3.4 3.5 4.0 3.6 4.1 6.9 3.9 5.0 3.3 4.5 3.1 4.1 3.4 3.8 3.0 3.5 3.4 3.6 3.0 6.2 4.4 4.7 3.9 4.0 6.9 4.3 5.2 3.5 8.0 3.5 4.5 6.5 3.8 3.6 4.0 22.7 40.6 28.9 29.5 9.2 8.0 16.5 14.3 14.9 45.6 42.1 24.2 13.2 23.3 15.0 13.1 18.7 24.0 33.8 24.5 35.2 14.4 41.4 12.0 22.6 20.5 7.9 8.1 14.7 6.8 9.3 39.9 8.9 6.8 28.8 27.4 12.0 7.7 18.7 21.1 27.0 22.2 15.4 16.7 20.5 35.0 19.3 14.0 17.2 7.7 13.3 19.4 23.1 11.9 12.1 14.0 16.7 10.3 10.1 17.4 19.0 0.1 36.6 5.3 15.9 13.1 16.8 15.2 21.4 29.4 5.8 5.0 5.3 6.3 6.1 3.0 4.2 6.2 5.3 4.2 3.8 4.2 2.5 5.0 2.8 7.4 8.9 3.8 3.4 3.5 3.4 3.5 3.4 3.5 3.9 5.0 3.8 4.0 3.5 4.0 4.6 3.2 3.4 2.3 7.0 3.8 5.2 12.9 2.8 5.6 4.1 4.6 3.6 2.8 7.0 11.0 6.2 12.3 9.2 4.5 3.9 10.1 3.9 22.4 3.4 5.8 3.0 10.8 2.0 10.4 17.0 4.4 4.1 4.1 1.3 7.3 5.3 4.6 7.7 1.7 2.1 5.6 18.3 7.2 3.1 1.9 2.5 5.4 3.6 1.0 8.7 7.2 12.3 5.0 2.8 6.9 3.7 2.2 8.8 2.2 5.2 6.5 51.0 6.3 0.0 6.4 6.3 13.3 6.7 3.5 4.5 4.1 5.7 5.8 7.2 2.9 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 229.3;Endothelial cells: 221.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 41.6 13.8 19.2 22.4 20.8 0.2 37.2 18.9 19.6 41.8 32.6 74.9 8.0 42.1 13.4 35.8 33.7 39.6 36.4 20.7 53.9 45.9 19.0 41.2 7.2 52.6 39.9 43.9 31.8 14.1 13.6 44.0 35.9 34.5 13.5 4.2 27.6 32.1 13.2 24.8 21.6 43.7 37.1 19.5 32.7 7.2 23.0 4.7 31.6 15.0 6.1 59.2 34.3 41.0 58.9 80.5 40.6 48.7 48.6 86.8 43.0 32.6 57.5 17.7 17.8 46.7 53.2 0.1 212.1 45.0 53.3 36.1 28.4 28.5 17.9 22.0 19.3 0.0 18.6 37.8 27.3 0.0 0.1 45.3 7.4 61.8 26.6 65.4 136.3 0.0 0.0 0.2 61.7 9.2 0.2 0.2 8.2 0.2 96.6 0.0 50.6 0.4 151.1 9.4 0.0 0.4 21.1 17.2 160.2 31.5 26.5 1.6 94.2 29.0 16.2 24.8 67.4 0.6 0.5 0.8 66.8 0.1 78.8 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.1 19.2 20.8 18.9 19.6 20.7 53.9 52.6 39.9 35.9 37.1 23.0 41.0 125.7 64.1 89.7 60.4 1.1 51.7 229.3 34.6 60.9 2.2 58.1 56.8 46.8 141.5 87.8 49.7 4.2 12.2 2.0 0.5 7.9 72.0 21.9 136.3 89.1 221.2 0.0 3.2 8.7 27.1 82.3 77.9 10.2 144.4 7.6 45.0 111.4 21.9 4.1 0.0 6.1 1.2 10.2 6.0 32.3 7.9 57.8 4.6 30.2 94.6 2.1 11.0 0.0 7.5 12.7 45.8 0.0 126.4 2.9 86.7 1.2 59.8 53.9 2.0 59.2 76.1 58.0 2.2 0.8 46.3 35.5 14.8 6.5 48.4 2.4 93.5 XRRA1 FLJ00225 ENSG00000166435 "X-ray radiation resistance associated 1" Q6P2D8 11 74807739-74949200 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 19.4" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 139.7;Spermatocytes: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 36.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039263 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "Nuclear bodies" "HPA039263: AB_2676419" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" "unprognostic (7.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.71e-1)" "unprognostic (3.31e-1)" "unprognostic (1.23e-1)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (5.94e-3)" "unprognostic (2.13e-1)" "unprognostic (3.31e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-1)" 3.4 3.8 2.3 1.1 2.9 1.6 3.4 2.4 2.5 5.1 1.9 4.5 2.6 4.8 3.8 4.1 4.4 2.9 4.4 2.1 2.7 4.2 5.0 3.8 1.9 2.6 2.7 4.9 4.5 3.2 4.2 2.4 2.7 5.0 2.3 2.3 5.5 3.0 6.0 3.6 2.9 4.8 2.3 4.2 3.8 19.4 3.2 2.6 7.1 11.6 2.7 4.6 3.9 4.3 5.4 3.0 0.7 4.9 7.5 4.9 2.1 2.3 2.5 1.3 1.3 1.6 2.8 2.2 8.3 2.5 11.1 4.3 6.1 3.0 2.8 8.8 0.5 1.9 2.0 3.1 2.2 1.2 0.9 4.7 3.4 5.6 36.1 10.5 2.7 7.2 5.1 5.0 6.5 2.0 2.0 2.8 1.7 6.5 2.7 0.9 3.9 1.7 1.1 4.1 4.7 3.9 10.7 4.5 14.2 2.3 2.8 5.6 1.8 7.8 5.0 5.7 2.2 7.0 6.7 6.1 1.8 1.1 2.7 1.4 2.0 1.9 2.9 2.5 3.2 1.6 2.1 2.2 1.7 1.5 2.1 2.0 3.3 1.0 1.7 1.2 4.4 1.5 2.3 2.9 2.4 2.5 2.1 2.7 2.6 2.7 2.7 2.3 3.2 4.3 22.8 9.6 8.8 40.5 27.7 11.0 10.4 15.7 10.8 56.7 18.3 15.0 5.9 8.6 12.3 22.0 139.7 12.3 15.1 13.9 15.6 8.2 51.9 18.7 19.5 13.8 12.1 9.0 38.4 8.0 10.6 16.0 11.2 13.6 12.0 14.7 15.0 14.0 7.8 48.8 39.1 16.3 8.2 10.3 11.0 78.9 29.8 8.9 28.4 30.0 7.7 19.9 25.7 36.7 55.5 6.5 16.2 30.5 29.8 10.5 17.6 22.1 22.5 76.6 26.3 23.4 13.9 125.2 37.7 6.5 7.5 10.9 21.1 7.1 18.4 7.8 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755897 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavorable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 6.1 6.0 4.1 6.5 3.8 7.8 6.6 4.3 4.5 5.9 3.9 5.8 4.8 5.8 5.0 7.1 5.2 4.4 6.2 3.9 3.3 4.8 6.0 4.3 8.1 3.7 3.0 6.1 5.8 6.5 3.7 7.8 4.3 4.6 6.4 4.6 8.1 4.5 7.3 5.4 5.2 5.3 3.1 6.1 5.8 4.6 3.2 7.9 4.6 8.5 8.3 7.4 5.1 4.3 19.8 23.3 13.3 15.8 14.3 16.6 42.0 14.8 15.0 17.9 17.4 58.8 24.6 35.4 23.6 15.0 25.8 24.9 26.7 38.9 20.0 15.5 41.8 23.6 16.4 33.0 20.6 25.3 13.2 15.6 24.4 16.9 30.5 23.0 28.5 18.4 33.7 15.9 19.1 16.1 18.9 30.4 73.5 13.0 28.2 21.0 28.4 21.1 22.9 27.8 20.5 10.0 22.7 19.5 14.7 51.5 36.5 22.7 19.5 16.9 17.7 27.8 25.3 9.4 10.7 37.0 15.7 18.6 14.3 10.2 6.1 3.7 8.4 8.0 8.8 7.3 8.8 8.7 8.5 9.6 9.0 10.5 1.0 11.9 9.6 8.2 8.4 5.1 4.1 3.8 4.3 4.5 3.9 3.3 3.7 3.0 4.3 3.1 3.2 4.3 14.5 6.4 4.4 25.5 16.1 10.1 20.1 27.0 14.2 16.8 11.4 8.4 7.7 1.5 15.1 11.0 20.9 34.7 15.9 5.4 7.9 19.9 6.5 19.7 17.7 10.2 7.2 21.2 22.2 16.5 36.9 12.5 6.6 24.6 7.0 18.9 6.8 5.6 20.1 15.2 31.2 7.3 16.2 9.3 6.0 4.6 10.5 10.4 5.4 18.7 16.0 12.3 16.5 26.7 44.1 14.2 7.6 8.6 9.3 13.9 7.9 11.5 9.0 19.9 13.1 10.5 19.1 6.3 12.8 12.9 8.4 17.9 13.9 24.3 12.8 12.6 YME1L1 YME1L ENSG00000136758 "YME1 like 1 ATPase" Q96TA2 10 27110111-27155266 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066953 Approved Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear bodies" "HPA066953: AB_2685753" "unprognostic (2.28e-3)" "unprognostic (3.00e-2)" "unprognostic (1.34e-1)" "unprognostic (7.19e-2)" "unprognostic (8.12e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (8.25e-6)" "unprognostic (7.08e-2)" "unprognostic (2.91e-1)" "unprognostic (9.24e-2)" "unprognostic (9.43e-3)" "unprognostic (1.64e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-1)" "unprognostic (5.53e-2)" "unprognostic (1.44e-2)" "unprognostic (7.09e-2)" 48.8 52.6 17.7 51.7 18.4 95.1 47.5 23.3 21.7 52.4 36.4 52.2 46.0 50.3 53.3 59.1 43.7 46.0 61.4 17.8 22.7 54.0 65.5 39.8 56.6 18.2 22.1 50.8 52.0 54.5 33.3 61.1 19.9 48.4 52.4 42.0 44.7 44.5 111.4 40.1 46.3 49.2 16.6 46.4 48.8 51.2 19.7 65.9 62.2 97.7 62.5 56.8 35.0 24.4 146.6 105.3 125.5 62.0 118.3 123.9 100.7 143.3 79.7 139.7 157.6 143.3 171.9 152.1 90.8 154.8 100.5 135.6 152.8 122.6 152.9 143.4 89.0 144.4 91.0 98.3 124.6 100.4 114.5 104.7 143.3 123.4 121.6 122.5 146.7 138.8 173.8 150.5 154.4 95.1 189.1 53.7 97.4 119.3 49.4 160.4 199.7 143.0 107.7 68.2 95.6 121.9 138.4 105.2 138.9 102.8 101.5 115.1 146.9 83.4 117.3 140.8 126.7 75.1 121.9 196.1 119.4 178.8 65.8 195.0 146.4 165.4 147.5 128.5 149.4 143.0 142.4 138.8 121.9 149.7 129.3 136.8 204.0 135.6 143.1 222.6 156.7 155.5 17.7 18.4 23.3 21.7 17.8 22.7 18.2 22.1 19.9 16.6 19.7 24.4 105.4 67.3 81.8 40.5 108.3 70.1 96.7 55.6 92.2 53.1 76.8 90.9 103.6 32.9 66.4 29.5 83.4 61.2 121.0 179.4 15.6 52.2 62.3 141.4 152.5 86.1 50.3 63.1 67.0 48.6 74.4 101.1 136.6 224.3 110.8 75.0 58.5 70.0 73.2 50.5 68.1 121.2 32.6 98.9 133.2 27.0 57.8 125.4 56.9 41.2 63.7 63.8 47.4 66.9 75.2 66.8 109.3 43.2 93.8 83.7 156.5 47.3 70.1 65.7 72.3 156.6 94.5 143.4 57.4 92.5 64.9 94.8 122.1 102.2 104.4 75.0 YTHDC2 "DKFZp564A186, FLJ10053, FLJ2194" ENSG00000047188 "YTH domain containing 2" Q9H6S0 5 113513694-113595285 "Enzymes, Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 129.8;Inhibitory neurons: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037364, HPA072678" Approved Approved "Nucleoplasm,Nuclear bodies,Cytoplasmic bodies" NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nuclear bodies, Cytoplasmic bodies" "HPA037364: AB_10672788, HPA072678: AB_2686548" "unprognostic (2.09e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.82e-5)" "unprognostic (4.33e-3)" "unprognostic (1.45e-1)" "unprognostic (6.48e-3)" "unprognostic (1.96e-1)" "unprognostic (7.82e-3)" "unprognostic (3.55e-2)" "unprognostic (8.56e-3)" "unprognostic (4.61e-2)" "unprognostic (2.03e-1)" "unprognostic (4.15e-2)" "unprognostic (3.05e-1)" "unprognostic (9.96e-2)" "unprognostic (1.08e-2)" "unprognostic (2.56e-2)" 8.4 9.7 5.2 11.3 5.8 9.9 10.1 8.8 6.6 8.9 7.8 8.7 9.3 9.2 8.6 9.4 8.3 8.0 7.6 6.1 5.1 8.5 12.6 7.4 13.8 5.3 5.8 11.0 8.7 15.5 8.7 6.9 5.3 8.1 10.0 18.3 8.9 7.4 11.5 11.3 10.1 7.9 5.1 11.4 9.2 14.8 4.7 10.2 9.2 10.9 12.9 9.8 8.9 7.1 16.0 14.2 18.1 30.7 9.8 12.9 19.7 12.1 13.4 15.2 23.6 10.0 8.8 29.1 8.5 10.2 19.5 15.3 22.0 27.2 19.8 12.6 19.9 15.8 25.8 13.6 14.5 12.8 13.4 10.6 10.3 9.6 17.4 14.3 21.5 13.0 15.8 13.0 13.6 5.3 17.8 9.1 8.4 4.7 9.2 7.4 15.6 22.7 12.7 20.9 14.4 12.0 16.3 11.7 12.7 11.3 16.6 11.4 18.8 23.2 8.1 12.1 16.7 13.3 18.0 18.0 13.3 14.4 10.1 0.0 2.8 2.9 2.8 1.9 3.3 7.3 3.2 3.0 2.4 5.1 3.4 2.9 1.0 4.3 3.3 3.6 2.6 1.2 5.2 5.8 8.8 6.6 6.1 5.1 5.3 5.8 5.3 5.1 4.7 7.1 27.4 28.9 32.8 61.0 39.6 13.3 21.8 14.7 15.9 59.9 17.6 17.7 17.7 14.3 25.3 12.9 83.4 13.7 34.0 12.3 0.0 17.8 47.5 15.5 24.5 24.0 7.2 16.6 129.8 18.6 8.3 22.4 34.1 17.2 12.6 69.0 20.0 25.7 17.3 52.2 146.3 14.2 20.3 30.0 13.2 44.2 19.9 26.8 12.4 95.5 23.9 21.4 16.5 94.5 97.6 18.0 7.8 14.7 20.0 14.4 16.0 17.8 24.9 88.9 26.3 34.0 26.6 93.8 37.8 19.2 14.3 18.1 33.0 33.4 16.7 18.5 YY2 ZNF631 ENSG00000230797 "YY2 transcription factor" O15391 X 21855987-21858740 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 5.7" "Group enriched" "Detected in many" 6 "Spermatocytes: 23.6;Spermatogonia: 57.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001119, HPA030335" Enhanced Approved "Nuclear bodies" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 18: U-2197 - ECM organization" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nuclear bodies" "HPA001119: AB_1858930, HPA030335: AB_2673434" "unprognostic (1.90e-2)" "unprognostic (3.34e-2)" "unprognostic (2.75e-2)" "unprognostic (8.39e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-2)" "unprognostic (4.62e-2)" "unprognostic (1.99e-1)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (2.21e-2)" "unprognostic (2.03e-1)" "unprognostic (8.78e-4)" "unprognostic (4.04e-1)" "unprognostic (9.38e-2)" "unprognostic (1.44e-1)" "unprognostic (2.05e-1)" 1.2 1.2 0.5 1.1 0.6 0.4 1.0 1.5 0.8 1.2 0.5 0.8 0.4 1.7 1.2 0.9 1.0 0.9 0.7 0.5 0.6 1.0 1.6 0.9 0.7 0.6 0.6 1.7 0.8 0.7 1.3 1.5 0.6 1.2 0.7 0.7 0.9 1.0 0.8 1.2 0.7 1.3 0.5 0.8 0.6 5.7 0.6 0.9 0.9 0.6 0.6 0.8 0.9 0.8 3.2 2.9 1.9 6.2 2.3 1.0 0.2 3.4 2.0 3.8 4.4 2.3 5.1 3.6 1.9 4.5 5.0 1.7 4.2 4.6 6.7 2.6 4.1 1.0 7.5 1.9 4.1 3.9 1.9 1.9 3.4 2.9 4.7 3.0 2.4 1.3 3.8 4.2 6.9 2.2 2.1 4.0 3.6 1.6 3.7 2.0 3.2 5.5 2.1 1.3 1.1 2.7 2.0 1.7 5.7 5.0 3.0 1.3 2.7 7.0 1.4 12.4 4.0 2.8 3.5 2.2 4.6 1.9 5.7 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.5 0.6 1.5 0.8 0.5 0.6 0.6 0.6 0.6 0.5 0.6 0.8 1.8 0.0 2.6 0.0 0.7 0.9 0.9 1.5 0.6 2.7 1.6 1.3 1.0 1.5 0.7 1.8 4.2 2.9 0.4 0.4 0.0 0.9 0.4 1.0 2.1 2.6 1.2 0.4 0.0 0.7 1.4 1.9 0.0 1.0 1.3 4.4 1.4 2.9 2.3 6.7 0.0 0.9 0.0 1.6 0.6 1.4 6.2 1.0 0.0 0.0 3.4 1.5 2.1 0.0 0.0 1.4 0.5 3.8 1.1 1.5 0.7 0.9 0.8 3.3 0.0 2.7 1.4 23.6 57.5 0.7 1.4 2.1 0.8 3.7 0.8 1.1 Z82206.1 ENSG00000225528 "Novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7" 22 39960397-39964718 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 1.3;lymphoid tissue: 4.3" "Cell type enhanced" "Detected in some" "Distal tubular cells: 7.9;granulocytes: 3.8;Proximal tubular cells: 3.2;T-cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "K-562: 12.5" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (8.48e-4)" "unprognostic (2.95e-6)" "unprognostic (3.67e-1)" "unprognostic (5.90e-2)" "unprognostic (4.27e-1)" "unprognostic (6.95e-3)" "unprognostic (3.74e-1)" "unprognostic (5.41e-4)" "unprognostic (2.33e-1)" "unprognostic (2.13e-2)" "unprognostic (1.18e-3)" "unprognostic (8.77e-2)" "unprognostic (6.53e-5)" "unprognostic (1.89e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (6.58e-3)" 0.1 0.0 0.0 0.2 0.0 1.3 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.0 1.1 0.1 0.1 0.0 4.3 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.4 12.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 1.1 2.7 2.9 1.3 2.5 2.3 3.5 3.2 1.6 2.0 3.6 4.4 2.4 1.3 1.2 1.7 2.6 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.9 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595346 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 47.6;thyroid gland: 71.0" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 44.8" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" No No "Cluster 24: B-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.2 0.0 0.0 1.7 0.4 0.3 0.2 0.0 0.1 5.4 0.0 0.1 0.1 0.1 0.2 12.8 20.0 0.3 0.1 0.0 0.0 0.2 0.0 10.4 6.9 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 2.8 0.4 0.0 2.2 0.5 0.0 0.0 0.3 0.5 0.0 0.0 47.6 71.0 0.0 12.9 0.4 9.9 0.0 15.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 54.8 0.5 37.4 0.0 0.0 53.1 0.0 119.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.3 1.2 0.2 0.1 0.0 2.1 0.6 0.8 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 1.1 0.0 0.6 4.5 0.3 3.1 4.6 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 3.8 0.0 4.5 0.0 0.1 0.2 ZBTB20 "DKFZp566F123, DPZF, ODA-8S, ZNF288" ENSG00000181722 "Zinc finger and BTB domain containing 20" Q9HC78 3 114314500-115147288 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.5" "Cell type enhanced" "Detected in many" "Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4" "Cancer enhanced" "Detected in some" "stomach cancer: 1.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015551, HPA016815" Approved Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 43: B-cells - Humoral immune response" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear bodies" "HPA015551: AB_2669217, HPA016815: AB_1858947" "unprognostic (1.79e-1)" "unprognostic (1.50e-2)" "unprognostic (5.51e-2)" "unprognostic (2.33e-3)" "unprognostic (5.72e-3)" "unprognostic (3.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-3)" "unprognostic (6.94e-2)" "unprognostic (1.41e-1)" "unprognostic (7.83e-3)" "unprognostic (1.81e-1)" 4.1 3.9 24.5 1.1 43.8 2.5 3.4 66.5 43.7 3.4 5.7 1.7 0.8 3.6 9.6 1.2 2.4 2.3 3.5 65.9 30.9 5.2 5.4 1.8 1.8 43.8 42.6 6.8 3.4 2.3 1.4 1.0 32.9 5.4 1.4 8.5 3.0 4.9 7.9 2.3 0.8 2.9 29.9 2.5 1.7 15.8 39.4 1.9 5.0 8.9 1.7 1.6 0.7 41.1 1.4 2.7 1.0 2.8 4.2 1.8 0.0 1.3 2.5 0.8 0.6 1.7 0.5 0.4 3.7 3.2 0.8 0.0 4.0 0.6 0.7 0.3 0.1 0.4 1.7 1.3 0.8 0.1 0.0 1.8 0.2 1.4 0.4 2.4 0.8 0.2 0.1 0.6 4.4 0.0 0.1 0.1 0.3 0.0 0.1 0.1 3.4 0.0 2.9 0.0 0.3 0.7 0.5 0.0 0.9 0.1 0.0 0.3 4.8 1.0 3.5 0.2 1.8 0.9 0.0 0.1 1.7 0.2 1.3 9.7 1.5 6.4 6.8 2.3 4.6 20.4 6.4 6.4 1.9 11.3 8.3 6.8 3.5 5.3 4.6 4.9 3.6 3.5 24.5 43.8 66.5 43.7 65.9 30.9 43.8 42.6 32.9 29.9 39.4 41.1 278.1 160.3 122.6 1998.0 115.4 25.7 38.2 11.3 22.2 123.6 103.7 81.8 48.5 108.7 25.2 294.3 60.5 0.2 56.1 10.3 49.0 231.4 450.3 109.8 628.3 106.4 31.8 20.4 72.3 82.9 0.6 174.5 36.7 170.5 80.6 194.5 56.0 106.0 4.3 80.8 462.3 14.5 40.7 20.4 28.5 111.1 105.6 36.0 32.0 855.4 29.3 127.7 36.0 1908.5 2090.4 107.8 10.5 120.7 58.4 28.0 19.2 198.4 36.4 108.6 85.5 301.2 124.6 6.9 8.7 14.2 18.5 0.5 67.4 140.7 17.2 25.0 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 34.8 36.1 22.1 7.4 20.6 3.0 31.4 19.9 23.1 41.9 11.7 47.2 6.3 40.3 16.2 26.4 40.5 9.6 38.8 21.2 21.0 24.1 7.8 30.0 8.3 27.1 21.7 48.4 23.1 36.1 28.6 10.8 27.0 33.1 6.6 23.1 28.0 21.4 32.4 27.2 23.0 16.4 19.7 22.1 27.3 15.9 23.3 9.5 43.9 14.8 9.0 42.3 33.9 21.5 10.7 14.4 3.6 6.9 37.1 19.1 6.5 14.7 21.0 13.0 12.9 4.8 5.1 1.1 11.4 28.0 9.5 16.7 3.6 20.6 9.5 17.0 6.2 5.3 12.3 3.4 10.4 1.0 12.2 13.4 21.1 12.5 15.9 30.6 11.5 4.0 1.8 3.4 14.5 7.1 3.7 2.2 1.5 4.3 6.8 6.8 6.2 1.6 15.9 8.9 2.1 5.3 6.5 4.6 6.9 6.3 8.6 2.4 16.1 14.6 5.7 13.9 12.3 6.1 4.5 0.7 15.7 3.3 7.7 0.4 0.3 0.5 1.0 0.5 1.0 0.5 0.8 0.8 0.2 0.5 1.0 1.0 0.2 0.6 1.7 0.4 0.4 0.6 22.1 20.6 19.9 23.1 21.2 21.0 27.1 21.7 27.0 19.7 23.3 21.5 27.4 51.3 53.1 33.6 14.6 30.7 16.3 18.4 18.8 86.6 23.6 20.6 92.6 20.0 24.8 20.2 68.8 10.3 24.5 4.6 3.9 14.4 40.8 21.1 25.2 26.1 17.4 9.5 36.9 14.4 2.2 24.8 7.1 26.0 13.9 25.7 23.9 8.1 13.5 74.0 37.3 10.1 14.2 30.0 34.6 57.0 51.9 18.6 17.8 15.9 12.0 27.0 24.7 21.6 26.7 19.0 5.3 70.0 9.5 16.2 8.2 11.2 32.2 39.9 32.9 37.8 27.4 7.3 4.3 17.3 23.4 5.2 21.1 16.3 9.0 14.7 ZBTB45 "FLJ14486, ZNF499" ENSG00000119574 "Zinc finger and BTB domain containing 45" Q96K62 19 58513530-58538911 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 55.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035754, HPA075485" Uncertain Approved "Nuclear bodies,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "Nuclear bodies" "HPA035754: AB_10603461, HPA075485: " "unprognostic (1.38e-1)" "unprognostic (7.12e-2)" "unprognostic (2.31e-1)" "unprognostic (7.34e-2)" "unprognostic (2.60e-1)" "unprognostic (4.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.19e-2)" "unprognostic (2.63e-2)" "unprognostic (3.02e-1)" "unprognostic (1.79e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.38e-4)" "unprognostic (2.08e-1)" "unprognostic (1.06e-1)" "unprognostic (5.47e-2)" "unprognostic (1.40e-1)" 7.9 8.5 6.5 5.1 6.7 4.9 8.6 5.2 11.4 9.9 1.9 10.3 6.1 12.0 1.1 10.1 9.5 3.1 9.1 7.1 4.9 7.7 6.9 6.1 4.2 8.9 6.4 9.3 8.2 4.2 7.1 3.1 8.3 9.5 1.6 2.1 9.0 4.1 10.3 12.7 7.6 2.4 4.5 8.0 8.3 4.9 6.7 3.3 8.3 3.0 2.3 10.5 9.0 7.4 21.3 29.7 7.6 11.7 7.7 6.6 9.6 11.8 4.8 3.0 2.9 5.8 13.4 31.9 15.6 6.6 8.4 13.2 4.2 10.7 1.1 21.4 55.3 17.3 15.1 7.1 4.9 11.1 11.1 6.3 7.4 4.7 3.9 5.6 6.2 32.1 16.0 1.8 4.6 14.2 17.4 11.6 10.6 12.5 26.1 13.8 4.7 19.4 6.2 19.4 23.4 16.7 8.7 22.5 6.1 4.6 33.4 7.6 13.1 12.9 5.6 4.3 11.7 34.8 27.2 15.9 14.7 4.6 8.4 5.8 5.0 10.2 5.7 7.6 6.8 4.4 3.9 5.3 5.3 5.0 4.6 3.4 4.4 5.5 9.1 6.4 3.7 4.7 6.5 6.7 5.2 11.4 7.1 4.9 8.9 6.4 8.3 4.5 6.7 7.4 3.3 9.6 0.5 2.9 5.6 1.7 3.7 5.5 2.2 4.2 4.5 4.6 3.3 1.5 4.0 12.9 0.0 8.9 5.1 6.3 5.9 10.6 0.6 3.4 4.6 5.0 10.3 7.4 1.9 8.9 8.0 3.9 8.6 3.8 0.0 5.6 8.6 4.5 6.6 6.7 2.0 4.6 8.2 6.8 2.4 1.3 5.9 3.7 7.2 0.0 12.3 3.7 7.2 1.5 1.6 8.8 2.6 9.8 3.6 3.8 5.9 5.6 3.8 3.0 13.1 2.5 5.1 5.2 5.9 3.5 2.7 5.6 3.1 4.8 6.0 2.6 ZBTB5 KIAA0354 ENSG00000168795 "Zinc finger and BTB domain containing 5" O15062 9 37438102-37465450 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021521 Approved Approved "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nuclear bodies" "Golgi apparatus" "HPA021521: AB_2670736" "unprognostic (2.36e-2)" "unprognostic (2.78e-2)" "unprognostic (5.22e-2)" "unprognostic (6.35e-2)" "unprognostic (1.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.96e-3)" "unprognostic (5.81e-2)" "unprognostic (3.95e-2)" "unprognostic (1.43e-1)" "unprognostic (4.72e-2)" "unprognostic (2.12e-2)" "unprognostic (1.27e-3)" "unprognostic (5.73e-3)" "unprognostic (2.30e-1)" "unprognostic (2.77e-3)" "unprognostic (1.80e-1)" 4.9 6.2 4.9 5.6 5.8 13.6 7.4 5.9 5.0 6.3 5.0 6.1 6.3 6.3 7.7 17.8 5.9 5.4 5.5 4.7 5.0 7.4 12.9 7.9 9.0 5.7 5.3 8.4 8.4 7.6 4.7 6.2 5.5 7.2 5.8 9.2 7.8 6.7 5.2 11.9 7.2 5.3 5.0 7.2 7.2 8.8 5.2 9.5 10.3 7.2 12.1 5.6 9.3 7.8 9.3 10.5 26.6 16.6 6.7 4.7 11.4 7.5 5.8 9.0 7.4 7.8 6.7 18.8 7.9 5.6 6.6 11.1 17.5 6.2 6.9 13.9 9.1 6.9 28.7 9.1 6.5 8.6 5.8 4.5 15.5 4.5 9.5 10.2 10.2 14.8 16.6 15.6 6.8 5.9 18.2 6.3 6.8 10.0 5.3 16.3 12.8 7.2 8.7 8.2 12.2 21.9 7.3 11.7 5.8 13.3 18.7 8.3 7.0 6.3 17.3 3.7 7.2 8.3 9.8 16.3 5.8 7.3 6.8 0.1 0.4 0.0 0.6 0.2 0.7 0.9 0.5 0.5 0.8 0.7 0.8 0.9 0.0 0.3 0.0 0.2 0.5 0.3 4.9 5.8 5.9 5.0 4.7 5.0 5.7 5.3 5.5 5.0 5.2 7.8 4.0 16.0 6.5 12.7 5.1 14.3 8.8 5.0 11.4 2.0 8.4 6.6 3.2 7.2 9.3 1.8 6.2 3.9 3.7 6.5 0.0 4.0 2.2 7.3 4.2 5.6 8.4 2.1 8.9 3.2 2.2 4.2 5.1 7.3 1.3 6.6 3.6 8.6 2.4 13.5 9.1 5.2 4.1 1.9 4.8 5.3 4.1 3.4 3.6 10.3 3.7 3.3 1.0 13.6 15.5 4.1 3.7 3.8 4.2 12.6 3.1 3.5 6.0 5.1 0.0 5.4 4.0 7.5 7.9 17.9 18.2 5.7 2.7 4.4 5.1 8.2 ZC3H8 "Fliz1, ZC3HDC8" ENSG00000144161 "Zinc finger CCCH-type containing 8" Q8N5P1 2 112211529-112255136 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034803, HPA034804" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA034803: AB_2674338, HPA034804: AB_10670284" "unprognostic (2.45e-1)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.29e-3)" "unprognostic (8.76e-2)" "unprognostic (1.20e-2)" "unprognostic (5.04e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.74e-2)" "unprognostic (3.49e-2)" "unprognostic (8.02e-3)" "unprognostic (4.88e-3)" 3.6 3.9 4.7 5.7 4.8 6.2 8.0 6.5 6.2 5.4 3.1 4.6 5.2 4.6 4.4 8.6 5.1 2.6 8.6 5.0 4.7 5.7 5.9 2.9 8.5 4.5 4.1 6.0 9.0 11.2 6.6 3.7 4.5 5.6 6.0 5.9 7.1 3.9 11.0 7.6 4.6 4.4 4.0 6.1 4.4 9.0 4.1 9.1 7.2 11.0 8.6 4.9 6.1 4.8 22.1 10.5 13.2 13.7 7.4 8.0 20.6 6.8 5.8 9.5 7.9 25.3 8.3 45.6 12.4 4.8 13.3 13.1 19.4 13.7 12.5 16.2 9.0 30.3 11.8 12.9 11.7 28.6 13.4 10.0 27.0 18.4 28.4 7.0 7.2 27.3 39.2 12.2 7.5 14.6 31.0 25.7 12.2 23.1 29.2 21.2 22.5 18.8 8.7 9.7 19.8 15.4 12.9 13.7 29.9 11.5 10.9 15.1 9.6 12.3 15.9 8.8 17.4 21.9 27.9 44.4 8.8 23.4 4.9 2.7 2.5 0.8 4.0 2.0 8.4 5.9 4.2 4.3 2.5 6.1 7.1 5.9 1.4 7.2 2.6 4.1 4.7 2.4 4.7 4.8 6.5 6.2 5.0 4.7 4.5 4.1 4.5 4.0 4.1 4.8 15.5 9.6 15.2 17.0 35.6 12.6 18.2 16.6 30.7 50.2 28.7 28.6 35.4 12.8 22.8 7.3 41.7 18.1 38.7 13.4 27.4 15.2 30.9 25.5 28.0 15.4 14.9 19.8 35.8 18.6 16.8 16.4 12.2 15.1 35.4 20.2 13.6 11.3 11.4 38.7 46.2 27.4 22.4 15.7 7.8 40.6 22.1 13.7 1.8 12.2 18.1 16.1 43.3 41.2 27.8 19.5 11.3 20.3 14.3 21.2 12.7 24.3 17.4 53.5 13.1 20.9 16.2 60.9 39.0 34.3 17.8 14.2 31.6 24.4 24.0 12.5 ZCCHC12 "FLJ16123, PNMA7A, SIZN, SIZN1" ENSG00000174460 "Zinc finger CCHC-type containing 12" Q6PEW1 X 118823824-118826968 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 281.2;endometrium 1: 101.5;fallopian tube: 132.2;smooth muscle: 141.6" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 4.6;Spermatogonia: 5.6" "Cancer enriched" "Detected in many" 76 "thyroid cancer: 256.3" "Group enriched" "Detected in all" 5 "hypothalamus: 281.2;thalamus: 156.5" "Immune cell enriched" "Detected in single" 6 "naive CD8 T-cell: 1.2" "Lineage enriched" "Detected in single" 7 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HAP1: 3.9;HEK 293: 10.1;NTERA-2: 3.2;SH-SY5Y: 2.5;SuSa: 2.0" "HPA031016, HPA034940" Uncertain Approved "Nuclear bodies" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies" "HPA031016: AB_2673698, HPA034940: AB_10671098" "unprognostic (1.29e-1)" "unprognostic (7.48e-3)" "unprognostic (1.96e-1)" "unprognostic (1.28e-1)" "unprognostic (1.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.66e-2)" "unprognostic (1.47e-1)" "unprognostic (1.22e-1)" "unprognostic (3.44e-1)" "unprognostic (8.36e-3)" "unprognostic (5.34e-4)" "unprognostic (9.18e-13)" "unprognostic (4.14e-3)" "unprognostic (1.63e-1)" "prognostic favorable (3.42e-5)" "unprognostic (1.18e-1)" 0.2 7.7 35.8 0.8 24.5 0.0 0.4 19.4 30.0 32.1 0.4 1.2 0.3 101.5 8.7 0.0 132.2 0.4 0.1 22.2 281.2 0.1 0.1 0.5 0.6 26.5 48.1 3.1 0.1 0.0 26.9 0.0 37.8 0.4 0.4 4.2 0.0 0.5 0.0 0.0 0.9 141.6 12.4 0.2 0.9 0.5 156.5 0.6 3.1 0.0 0.7 0.0 6.1 5.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.0 3.9 0.0 0.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 2.5 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 35.8 24.5 19.4 30.0 22.2 281.2 26.5 48.1 37.8 12.4 156.5 5.5 0.2 0.0 0.0 0.7 0.6 0.0 0.1 0.0 0.6 0.9 0.2 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 1.2 0.2 1.2 0.0 0.4 0.0 0.0 0.3 0.0 0.9 0.0 0.5 0.0 0.0 0.1 0.0 4.6 0.5 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.5 1.4 1.2 5.6 0.1 0.1 0.0 0.7 0.5 0.1 0.0 ZFAND5 "ZA20D2, ZFAND5A, ZNF216" ENSG00000107372 "Zinc finger AN1-type containing 5" O76080 9 72351413-72365235 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 591.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 450.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018129, HPA077824" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nuclear bodies, Cytosol" "HPA018129: AB_1859012, HPA077824: " "unprognostic (1.97e-1)" "unprognostic (5.79e-2)" "unprognostic (1.91e-1)" "prognostic favorable (4.43e-4)" "unprognostic (1.53e-1)" "unprognostic (2.24e-1)" "unprognostic (3.39e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (3.34e-1)" "unprognostic (2.47e-1)" "unprognostic (3.90e-2)" "unprognostic (6.85e-2)" "unprognostic (3.92e-2)" "unprognostic (3.86e-2)" "unprognostic (7.03e-2)" 312.2 187.7 99.9 55.3 112.7 145.7 150.0 105.5 136.0 97.6 70.9 88.1 39.4 91.0 115.7 99.8 120.6 87.3 117.7 103.9 107.8 114.9 204.7 108.5 46.9 93.9 113.3 250.4 73.6 69.1 138.8 79.2 105.6 76.8 49.2 50.7 69.8 121.4 591.1 75.4 69.0 94.9 100.5 60.4 95.5 88.5 105.9 52.3 79.2 273.9 59.1 108.9 87.1 110.8 115.9 113.0 138.8 59.4 156.5 77.3 104.3 131.9 178.9 71.1 55.1 14.5 112.6 60.4 81.3 194.5 105.2 122.4 305.1 50.4 103.4 450.1 43.1 53.5 57.7 70.1 120.4 74.7 71.1 99.0 87.6 72.7 79.2 156.3 122.1 60.4 49.8 82.1 82.6 31.3 96.3 38.8 178.9 107.2 74.3 74.1 72.4 70.5 218.4 109.3 101.2 86.4 85.2 91.2 117.2 142.1 42.1 64.3 97.1 57.4 71.7 104.7 90.9 113.9 110.3 38.1 77.2 49.1 146.3 39.0 35.9 37.3 11.2 52.1 12.0 17.0 14.6 14.1 33.6 15.1 13.2 12.2 27.7 19.2 81.6 6.2 11.2 23.9 99.9 112.7 105.5 136.0 103.9 107.8 93.9 113.3 105.6 100.5 105.9 110.8 370.7 176.3 192.1 102.8 125.8 339.2 573.2 130.6 376.7 93.9 267.0 207.1 322.6 92.9 132.6 132.4 75.0 145.1 118.6 213.3 148.7 145.8 91.8 257.1 291.9 195.3 136.7 155.6 45.7 142.6 164.8 270.8 145.2 527.6 109.2 116.1 97.5 308.3 198.0 40.4 38.6 119.8 126.1 290.6 320.1 44.5 118.4 470.1 208.1 31.9 268.8 84.2 53.5 38.7 67.2 185.9 221.3 93.3 149.3 329.9 87.2 127.1 109.2 70.6 85.5 674.9 285.2 148.7 116.4 298.1 291.2 226.3 165.5 102.9 109.4 528.2 ZFAT "KIAA1485, ZFAT1, ZNF406" ENSG00000066827 "Zinc finger and AT-hook domain containing" Q9P243 8 134477788-134713049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 31.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.5;dendritic cells: 35.6;Early spermatids: 49.3;Late spermatids: 53.0;Syncytiotrophoblasts: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 24 "plasmacytoid DC: 34.5" "Lineage enriched" "Detected in many" 24 "dendritic cells: 34.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020989, HPA063592" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 2: Karpas-707 - Immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Nuclear bodies" Nucleoplasm "HPA020989: AB_2670552, HPA063592: AB_2685051" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (4.62e-3)" "unprognostic (5.91e-3)" "unprognostic (2.45e-1)" "unprognostic (5.12e-2)" "unprognostic (1.31e-4)" "unprognostic (6.27e-2)" "unprognostic (2.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.90e-2)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (1.33e-1)" 2.2 1.4 0.8 2.8 0.9 1.2 2.1 0.5 1.4 1.8 1.7 4.7 2.3 2.5 2.0 2.6 2.0 1.2 2.2 1.0 0.9 9.7 1.5 2.2 3.7 1.3 0.6 2.1 2.3 2.7 1.5 31.1 0.8 2.2 1.7 2.7 1.8 2.1 7.5 1.9 2.1 2.6 0.5 2.5 1.9 2.3 0.7 3.2 1.6 4.3 2.9 2.8 1.8 0.7 4.1 6.5 2.3 2.9 4.4 4.3 2.1 4.4 3.8 3.9 4.0 4.5 5.2 4.7 3.8 4.6 2.3 3.2 4.7 5.6 5.1 3.9 6.0 8.7 5.7 3.3 3.4 4.9 4.3 3.5 2.8 4.3 5.7 3.6 4.9 1.7 3.4 8.4 3.4 5.6 5.1 0.8 3.2 4.2 3.9 3.1 3.0 2.0 3.8 6.2 2.8 2.1 4.5 3.4 3.7 2.6 2.8 4.6 5.4 2.3 3.4 3.3 5.0 3.0 4.4 4.5 2.8 3.6 4.9 1.1 0.6 1.4 0.4 0.8 0.4 0.9 0.4 0.7 0.5 1.1 0.6 0.4 1.0 0.1 0.5 34.5 0.3 0.9 0.8 0.9 0.5 1.4 1.0 0.9 1.3 0.6 0.8 0.5 0.7 0.7 3.5 3.2 3.3 14.4 7.0 1.5 1.2 1.0 1.8 5.3 4.0 1.4 2.0 1.5 3.1 1.8 4.2 74.5 35.6 1.5 0.0 2.1 49.3 2.6 5.0 2.8 0.0 0.8 24.4 1.5 17.2 2.7 3.6 3.1 2.5 2.9 0.7 1.4 8.4 1.7 18.9 1.4 0.0 3.8 2.1 53.0 3.4 4.2 8.8 14.0 3.5 2.1 4.1 9.5 12.6 3.3 0.5 2.6 17.0 1.6 1.1 12.2 1.1 6.0 0.0 3.7 2.5 2.9 5.5 1.9 1.7 126.7 3.6 3.2 1.3 1.5 ZIC2 HPE5 ENSG00000043355 "Zic family member 2" O95409 13 99981784-99986765 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "brain: 123.4;choroid plexus: 35.2" "Cell type enhanced" "Detected in some" "Astrocytes: 28.1;Cone photoreceptor cells: 6.2;Microglial cells: 29.0;Muller glia cells: 10.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 123.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 86.2;HDLM-2: 43.5;HEK 293: 66.1;NTERA-2: 80.5;SCLC-21H: 179.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 113.3" HPA055031 Supported "Nuclear bodies" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 64: Astrocytes - Nervous system maintenance" "Nuclear bodies" "HPA055031: AB_2682676" "unprognostic (6.43e-6)" "prognostic favorable (2.64e-4)" "unprognostic (5.73e-2)" "unprognostic (1.99e-2)" "unprognostic (4.39e-1)" "unprognostic (3.12e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (4.66e-2)" "unprognostic (3.10e-1)" "unprognostic (1.59e-1)" "unprognostic (9.36e-3)" "unprognostic (7.42e-2)" "unprognostic (0.00e+0)" "unprognostic (3.26e-1)" "unprognostic (2.11e-1)" "unprognostic (5.36e-3)" 0.0 0.2 17.0 0.0 19.0 0.0 0.0 123.4 16.2 0.0 35.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 16.0 10.4 0.1 0.0 0.0 0.0 20.9 14.8 0.0 0.0 0.0 1.2 0.0 22.5 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.5 4.9 86.2 5.5 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.5 5.8 0.0 7.3 0.0 4.6 0.1 3.9 0.0 0.0 43.5 66.1 6.4 4.0 4.4 0.0 0.0 4.3 0.0 6.2 0.0 3.9 0.4 0.0 2.2 6.5 0.0 0.0 2.9 0.4 34.3 80.5 0.0 2.0 19.8 3.3 0.1 0.4 2.2 179.7 0.0 2.8 0.5 0.0 3.3 4.2 33.5 0.0 20.2 0.0 3.6 5.8 0.6 0.0 0.0 4.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 19.0 123.4 16.2 16.0 10.4 20.9 14.8 22.5 8.8 27.1 11.3 0.2 0.0 0.0 28.1 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.3 0.7 0.0 0.0 1.8 6.2 0.0 0.0 0.7 0.0 0.0 0.4 0.2 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 29.0 0.0 10.3 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 1.5 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 272.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" Yes No "Cluster 18: Basophils - Vesicular transport" "Cluster 15: Liver - Metabolism" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 12.0 18.4 20.2 11.6 29.1 8.7 22.7 17.2 22.1 16.4 7.4 21.5 18.2 15.5 17.1 18.8 21.7 13.9 10.1 14.4 23.8 13.3 52.8 10.9 11.7 21.3 23.2 19.0 26.1 16.5 10.9 11.0 23.4 23.0 23.5 15.8 25.3 10.8 10.4 32.6 16.9 13.7 13.9 13.5 32.6 11.1 24.1 14.2 11.9 8.8 11.9 12.2 17.4 37.5 17.0 12.3 31.8 34.6 32.0 38.7 12.0 18.6 22.5 10.9 11.0 7.4 15.7 19.1 23.0 20.9 19.1 13.7 18.4 16.1 20.6 18.4 11.3 15.5 15.8 19.3 18.0 29.9 17.7 26.1 25.1 14.7 49.0 29.5 24.4 22.2 36.2 16.3 21.7 22.4 28.4 17.6 12.8 31.6 15.2 16.7 16.2 17.3 18.2 26.4 36.8 44.0 28.9 37.4 32.4 17.8 19.1 19.6 36.8 23.7 23.0 27.9 18.9 18.7 35.3 19.5 16.2 20.8 31.7 16.0 4.0 4.1 5.0 3.1 4.9 3.8 3.9 4.9 5.8 4.8 5.3 3.9 4.2 8.8 9.0 3.9 3.5 3.8 20.2 29.1 17.2 22.1 14.4 23.8 21.3 23.2 23.4 13.9 24.1 37.5 45.3 25.6 55.4 57.5 37.0 15.0 45.7 43.4 71.7 93.9 77.6 38.7 42.8 140.2 61.4 46.0 150.1 41.1 40.1 84.8 15.6 55.9 46.5 89.2 90.9 52.2 220.9 24.6 70.1 43.8 15.3 47.9 103.5 68.0 35.4 120.5 44.6 140.8 19.8 89.2 77.7 99.2 77.3 32.7 18.6 18.4 51.3 31.2 40.9 62.8 45.8 61.2 34.0 102.1 272.5 46.6 81.3 53.4 27.1 93.1 70.4 32.4 153.6 70.1 19.7 87.4 43.9 32.8 16.7 62.9 21.5 65.9 32.3 74.0 114.4 62.0 ZNF143 "pHZ-1, SBF, STAF" ENSG00000166478 "Zinc finger protein 143" P52747 11 9460319-9528524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003263, HPA003264, HPA074818" Supported Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus, Vesicles" "HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (5.51e-2)" "unprognostic (9.72e-2)" "unprognostic (5.09e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (1.76e-5)" "unprognostic (4.87e-3)" "unprognostic (2.57e-3)" "unprognostic (9.56e-2)" "unprognostic (1.26e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.20e-3)" "unprognostic (1.92e-2)" "unprognostic (1.06e-2)" "unprognostic (7.55e-2)" 9.0 6.1 8.6 11.4 10.1 18.6 9.6 17.3 9.9 10.0 10.8 9.7 9.5 10.5 14.4 9.8 10.1 8.4 9.3 7.9 9.3 8.6 9.6 9.1 15.7 9.9 8.8 13.7 7.7 7.9 7.1 10.4 11.2 8.7 9.9 16.1 8.9 8.0 17.3 10.2 8.2 9.5 9.8 11.1 7.7 16.9 9.0 18.9 14.6 11.5 14.1 11.2 8.4 14.9 20.0 18.8 23.4 15.2 18.9 17.4 21.5 21.8 17.3 16.4 17.9 26.7 24.3 19.6 9.7 17.7 14.0 22.5 23.1 17.3 24.5 20.0 27.7 18.5 27.7 18.7 15.6 25.9 17.8 15.3 20.4 22.2 19.4 21.4 16.3 17.9 20.5 23.3 18.3 17.1 24.1 10.6 26.3 23.0 19.9 21.4 21.2 12.3 14.7 24.0 16.1 15.8 24.0 16.0 14.3 20.6 14.9 14.6 15.6 21.4 15.3 15.1 19.6 11.5 21.6 33.4 13.8 14.8 12.5 39.1 24.6 57.3 28.0 24.9 25.0 23.0 24.6 22.9 20.9 18.2 22.8 19.6 45.1 19.4 28.2 10.1 29.7 19.6 8.6 10.1 17.3 9.9 7.9 9.3 9.9 8.8 11.2 9.8 9.0 14.9 17.9 6.4 12.1 6.2 14.7 26.6 34.1 12.1 17.6 9.3 8.7 13.2 15.5 7.2 10.3 5.5 8.4 10.0 17.1 10.1 3.9 12.5 20.3 18.7 14.9 13.0 6.6 25.4 8.1 11.5 16.2 14.5 9.7 16.3 14.0 7.7 6.8 7.6 9.9 5.0 7.4 6.9 14.2 8.3 22.0 10.0 11.8 15.8 10.6 12.2 16.3 15.5 17.5 7.5 9.8 14.1 7.7 6.8 15.4 20.1 6.3 7.7 15.0 14.3 59.2 18.3 16.7 50.5 21.3 12.8 23.4 18.3 18.1 7.3 7.9 26.9 ZNF174 ZSCAN8 ENSG00000103343 "Zinc finger protein 174" Q15697 16 3401215-3409364 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009656, HPA070692" Approved Supported "Nucleoli fibrillar center,Nuclear bodies" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli fibrillar center" "Nuclear bodies" "HPA009656: AB_1080679, HPA070692: " "unprognostic (4.33e-2)" "unprognostic (6.81e-3)" "unprognostic (2.08e-1)" "unprognostic (7.68e-2)" "unprognostic (1.94e-3)" "unprognostic (5.19e-2)" "unprognostic (2.03e-3)" "unprognostic (6.39e-3)" "unprognostic (2.41e-1)" "unprognostic (4.25e-3)" "unprognostic (2.06e-3)" "unprognostic (4.35e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (2.55e-1)" "unprognostic (1.83e-1)" 6.7 7.0 7.8 5.5 8.3 4.0 6.8 8.0 9.1 8.1 7.1 10.4 6.1 9.5 11.5 6.1 10.8 5.6 10.0 7.4 9.0 6.6 6.6 5.4 8.2 8.0 8.1 12.6 5.8 14.1 9.3 5.0 8.3 8.8 7.1 9.9 7.9 10.9 9.9 7.4 6.4 10.3 7.8 7.3 6.8 9.5 8.3 9.5 7.5 10.6 8.4 9.0 6.8 9.4 7.1 11.6 13.1 14.9 15.8 11.3 8.4 6.1 16.2 14.2 12.7 8.8 12.3 23.0 9.3 11.9 12.7 10.1 12.4 11.0 13.1 14.0 11.7 12.2 11.2 11.4 11.3 14.5 13.9 13.3 12.6 11.9 11.9 13.6 11.7 16.8 18.9 10.8 14.7 12.2 14.7 12.4 13.9 10.5 14.2 19.8 14.3 19.3 10.0 3.6 12.0 9.1 12.7 14.1 11.0 12.2 13.7 15.4 9.1 10.4 10.8 8.3 8.5 12.9 14.9 19.5 5.6 9.1 10.1 17.4 6.4 27.0 9.6 7.5 9.1 10.3 10.0 11.0 7.9 8.0 12.0 8.9 7.8 8.5 5.1 4.2 10.2 7.6 7.8 8.3 8.0 9.1 7.4 9.0 8.0 8.1 8.3 7.8 8.3 9.4 4.3 3.2 2.0 4.9 4.1 1.9 1.4 2.6 6.2 6.4 3.3 4.3 5.3 4.3 1.8 0.0 6.2 6.1 5.6 3.0 3.9 5.0 7.1 5.4 4.4 5.2 3.6 5.5 3.4 4.3 3.8 4.7 1.5 2.5 1.3 4.9 2.9 3.5 4.5 3.3 4.3 2.2 8.2 2.5 0.9 4.0 8.7 2.6 3.6 1.0 2.4 7.7 8.2 3.5 10.6 4.0 5.0 9.8 4.6 2.2 4.7 4.7 1.6 8.8 0.0 4.7 4.0 15.1 10.3 4.7 1.8 2.9 4.0 5.8 3.4 0.8 ZNF202 "ZKSCAN10, ZSCAN42" ENSG00000166261 "Zinc finger protein 202" O95125 11 123723914-123741675 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 14.7;Spermatogonia: 14.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059229 Approved "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No "Cluster 32: T-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoli rim, Mitotic chromosome" "Nuclear bodies" "HPA059229: " "unprognostic (3.12e-2)" "unprognostic (7.75e-2)" "unprognostic (2.20e-2)" "unprognostic (4.49e-2)" "unprognostic (2.10e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.52e-6)" "unprognostic (1.23e-1)" "unprognostic (1.74e-3)" "unprognostic (2.80e-1)" "unprognostic (9.48e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (9.93e-7)" "unprognostic (2.61e-2)" "unprognostic (2.11e-2)" "unprognostic (1.17e-1)" "unprognostic (1.35e-2)" 5.7 4.7 5.9 6.7 5.9 5.2 7.6 5.9 6.5 8.1 5.7 6.3 4.4 9.7 9.3 6.0 6.8 4.6 4.5 5.7 5.9 6.2 5.1 5.1 8.9 5.4 5.8 10.4 9.7 5.2 5.9 6.2 5.4 7.2 7.9 6.1 6.0 5.3 6.2 8.4 6.5 7.3 4.8 9.9 6.2 9.8 5.8 6.7 6.9 3.9 8.7 6.9 6.4 6.8 6.0 9.3 15.3 18.5 6.6 10.1 11.9 9.3 7.4 8.5 7.6 10.5 15.7 17.7 8.6 7.2 13.7 14.3 15.9 10.6 11.7 7.3 8.9 31.5 6.6 10.2 9.0 18.5 8.9 7.2 21.0 9.7 28.7 7.3 10.0 14.8 17.1 11.8 11.2 6.3 16.0 25.3 25.2 21.0 12.8 19.2 9.5 6.5 8.3 11.4 11.3 12.6 7.8 9.4 6.2 12.5 17.8 12.8 8.7 16.3 10.5 11.8 9.5 7.6 5.9 12.1 4.3 20.2 10.8 0.0 1.2 0.0 1.7 1.8 1.6 1.6 2.3 2.5 1.9 1.9 2.6 2.4 0.0 1.6 0.7 1.2 2.2 1.7 5.9 5.9 5.9 6.5 5.7 5.9 5.4 5.8 5.4 4.8 5.8 6.8 3.1 6.4 0.5 7.8 3.8 2.9 3.8 1.9 0.6 3.1 3.4 3.2 3.1 2.8 9.7 3.7 0.0 2.2 2.1 1.5 1.9 2.2 5.1 1.4 3.3 3.1 3.0 1.7 8.9 3.5 1.7 2.8 4.6 2.0 3.8 6.0 2.2 1.9 1.8 6.7 8.3 3.9 0.0 2.0 2.0 5.0 1.8 3.1 0.0 3.7 1.6 2.4 1.0 6.6 11.0 3.2 2.4 1.2 3.6 2.5 1.0 1.4 1.3 3.1 6.6 5.0 2.2 14.7 14.5 3.6 3.0 0.8 3.0 3.1 3.2 2.9 ZNF221 ENSG00000159905 "Zinc finger protein 221" Q9UK13 19 43951223-43967709 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA059435 Uncertain Approved "Nuclear bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "HPA059435: AB_2684016" "unprognostic (2.06e-1)" "unprognostic (8.35e-2)" "unprognostic (2.65e-2)" "unprognostic (1.63e-1)" "unprognostic (3.17e-3)" "unprognostic (2.11e-1)" "unprognostic (1.81e-2)" "unprognostic (3.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.17e-2)" "unprognostic (5.02e-2)" "unprognostic (1.91e-1)" "unprognostic (1.84e-2)" "unprognostic (3.67e-2)" "unprognostic (1.50e-1)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" 0.9 1.2 1.3 0.6 1.5 0.6 1.2 4.8 1.5 1.0 1.0 0.7 0.5 1.1 0.8 0.8 1.3 0.6 1.2 1.1 1.5 1.1 1.1 1.0 0.7 1.1 1.3 1.9 0.7 2.3 0.9 1.3 1.7 1.5 0.8 3.0 0.7 1.1 0.4 1.2 0.8 1.3 0.8 1.0 0.8 1.1 1.5 1.2 1.8 0.7 0.7 1.0 0.7 3.5 1.4 1.2 3.6 2.8 1.2 2.4 1.0 1.5 2.3 1.3 2.0 1.6 0.5 0.0 0.8 1.5 0.9 0.6 1.4 1.0 2.3 0.0 2.9 3.8 5.1 0.6 1.2 0.4 1.6 3.5 0.9 2.2 0.8 2.7 2.4 0.0 0.2 0.0 1.7 0.1 0.0 0.6 3.3 0.5 1.2 0.1 4.0 0.4 0.8 4.6 2.9 2.5 3.0 0.2 0.3 2.1 1.0 3.5 4.1 1.6 3.6 0.8 1.2 1.9 2.6 0.0 0.5 1.5 1.9 0.3 0.1 0.2 0.2 0.2 0.2 0.1 0.3 0.3 0.3 0.2 0.2 0.1 0.3 0.6 0.1 0.3 0.1 0.1 1.3 1.5 4.8 1.5 1.1 1.5 1.1 1.3 1.7 0.8 1.5 3.5 1.4 0.0 2.0 1.0 0.2 0.0 0.1 1.1 0.6 2.8 0.5 0.3 0.7 0.0 0.4 0.0 2.1 0.3 0.2 0.1 0.0 0.4 0.3 0.8 1.8 0.8 0.0 1.3 2.7 0.4 0.2 1.4 1.5 0.8 1.3 1.3 0.7 0.1 0.3 0.0 2.1 0.0 0.0 0.0 0.3 0.5 1.2 0.2 1.8 0.0 0.0 1.3 1.0 2.5 2.6 0.5 0.0 0.4 0.4 0.1 0.0 0.4 0.3 2.3 0.0 0.9 1.1 0.9 0.7 0.7 0.1 0.3 0.4 1.3 0.1 0.4 ZNF222 ENSG00000159885 "Zinc finger protein 222" Q9UK12 19 44025342-44033110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Early spermatids: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA004086 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Nuclear bodies" "HPA004086: AB_2273259" "unprognostic (1.91e-3)" "unprognostic (3.41e-2)" "unprognostic (8.08e-2)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (7.45e-2)" "unprognostic (1.75e-3)" "unprognostic (6.75e-2)" "unprognostic (1.58e-2)" "unprognostic (7.58e-2)" "prognostic favorable (5.56e-7)" "unprognostic (2.19e-3)" "unprognostic (1.36e-1)" "unprognostic (2.44e-1)" "unprognostic (8.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.16e-3)" 2.8 4.1 3.7 3.0 3.7 5.3 4.5 6.0 5.3 3.2 3.6 2.5 1.6 2.8 3.9 1.9 2.9 3.4 4.3 3.6 4.5 3.8 2.8 3.2 4.4 4.3 4.5 4.7 3.1 3.7 5.1 3.1 4.4 3.5 2.7 6.8 2.6 3.3 2.3 2.6 2.7 3.2 3.4 4.6 3.1 9.1 4.2 5.8 4.1 2.3 4.3 3.8 2.0 4.9 3.8 4.5 7.4 6.7 5.5 5.5 0.3 4.1 7.3 4.7 7.4 2.1 2.4 1.2 6.1 4.4 5.5 1.3 5.2 3.6 5.9 4.9 4.7 6.4 6.5 3.8 7.0 0.2 5.2 4.2 5.4 3.9 6.5 7.4 4.5 5.2 1.2 2.4 5.9 0.5 4.3 2.4 4.5 1.8 1.7 0.1 7.7 2.1 3.8 12.1 4.0 9.0 6.4 1.2 5.4 6.3 1.6 6.2 3.3 5.1 4.9 2.9 5.0 10.6 9.1 0.1 2.7 0.1 5.8 7.7 2.4 5.0 5.9 1.6 4.8 4.7 5.4 5.7 2.5 5.9 6.2 4.6 4.8 4.9 2.0 2.9 4.2 2.8 3.7 3.7 6.0 5.3 3.6 4.5 4.3 4.5 4.4 3.4 4.2 4.9 2.1 0.0 1.5 1.0 1.9 2.5 1.9 2.3 0.0 5.3 2.1 2.0 1.9 0.0 1.8 5.5 0.0 1.8 3.1 0.8 7.9 2.4 78.5 1.6 1.7 2.4 3.0 4.8 3.7 1.2 1.1 3.0 1.5 2.7 4.5 3.5 3.3 1.1 2.3 6.7 4.2 2.1 6.1 1.3 1.5 6.9 1.8 1.5 1.8 1.0 1.7 6.3 3.1 3.5 3.6 0.8 0.4 2.2 1.5 0.8 1.1 1.3 0.3 2.8 0.0 2.8 3.0 9.9 3.5 0.7 1.7 1.1 3.7 3.5 1.2 1.1 ZNF226 ENSG00000167380 "Zinc finger protein 226" Q9NYT6 19 44165073-44178381 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006145, CAB034353" Uncertain Approved "Nuclear bodies" No No "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies" "CAB034353: AB_2219110, HPA006145: AB_10696203" "unprognostic (1.30e-2)" "unprognostic (5.53e-2)" "unprognostic (3.06e-1)" "unprognostic (3.41e-3)" "unprognostic (1.79e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favorable (8.34e-4)" "unprognostic (4.09e-2)" "unprognostic (6.60e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (2.46e-1)" "prognostic favorable (2.37e-5)" 13.5 31.5 14.5 12.2 18.6 11.7 20.5 23.1 20.6 13.4 18.5 14.1 13.8 13.9 25.6 10.6 16.1 16.9 16.5 15.0 18.0 18.5 17.9 12.8 20.2 16.5 16.4 20.1 9.4 21.8 32.9 12.1 18.0 21.2 14.5 31.1 12.4 15.7 10.0 12.7 14.8 12.3 18.0 18.7 16.2 17.2 16.4 20.7 23.8 7.2 15.9 15.1 11.4 26.0 18.6 20.3 22.4 16.5 20.8 33.1 10.1 19.0 42.6 20.9 38.0 14.3 22.5 6.6 23.5 24.5 28.9 10.1 9.9 18.8 25.1 10.6 23.7 26.3 25.8 10.8 18.2 17.1 17.1 37.6 24.3 25.4 50.9 40.2 27.7 19.6 5.6 6.3 40.4 6.1 18.7 7.2 10.9 10.8 15.0 11.2 17.9 13.3 20.5 50.9 16.0 25.5 38.2 13.9 9.1 21.9 22.6 24.6 21.7 19.1 23.4 10.5 22.8 31.0 30.6 19.7 17.4 11.7 20.9 53.8 14.7 10.1 22.1 15.6 25.1 19.8 22.2 21.8 17.9 28.2 25.9 22.9 11.4 26.4 13.6 19.3 26.8 13.4 14.5 18.6 23.1 20.6 15.0 18.0 16.5 16.4 18.0 18.0 16.4 26.0 15.1 16.0 13.8 20.5 19.6 4.0 17.0 48.2 8.6 39.8 14.2 14.7 27.6 14.3 30.9 11.0 27.1 13.5 19.8 13.0 35.2 22.7 20.2 24.4 12.3 17.1 12.1 19.1 13.4 27.7 7.5 15.6 16.3 17.0 11.4 25.2 16.1 24.8 18.0 21.9 14.2 18.5 30.5 16.0 7.4 7.4 19.3 12.1 21.4 9.4 22.9 29.3 36.0 17.1 35.8 26.1 19.3 22.2 7.7 20.4 20.9 47.4 37.1 30.7 6.6 13.6 15.0 15.0 21.8 9.2 5.8 12.9 18.4 36.6 10.6 20.5 ZNF234 "HZF4, ZNF269" ENSG00000263002 "Zinc finger protein 234" Q14588 19 44141554-44160313 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA001664 Approved Approved "Nuclear bodies" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "HPA001664: AB_1080694" "unprognostic (9.03e-2)" "unprognostic (8.56e-2)" "unprognostic (5.31e-2)" "unprognostic (4.97e-2)" "unprognostic (2.53e-2)" "unprognostic (2.96e-1)" "unprognostic (7.77e-3)" "unprognostic (2.22e-1)" "unprognostic (5.07e-2)" "unprognostic (3.43e-1)" "unprognostic (3.77e-2)" "unprognostic (2.57e-2)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (1.70e-1)" "unprognostic (7.31e-2)" "prognostic favorable (4.34e-5)" 3.5 4.8 2.1 4.0 2.9 0.7 4.8 3.7 3.0 3.6 3.2 3.6 3.7 3.7 2.7 3.0 3.2 3.3 4.5 2.1 2.6 3.7 3.1 3.2 4.7 2.4 2.5 5.2 2.9 4.7 3.5 4.7 3.1 4.0 3.6 5.3 3.6 3.5 3.3 4.4 4.0 4.2 1.8 5.7 3.9 2.1 2.7 4.8 4.2 2.9 5.1 3.3 3.3 4.5 5.1 3.5 8.4 8.0 9.8 9.9 3.8 6.5 4.7 5.0 8.3 4.4 3.1 0.1 4.3 5.9 4.7 3.8 6.4 4.1 6.0 0.0 7.7 10.1 8.1 5.8 4.6 0.0 6.8 5.7 9.1 5.4 6.2 6.9 5.7 0.0 0.6 0.1 7.6 1.6 6.8 2.4 5.6 3.3 3.3 0.0 9.6 1.6 3.1 9.7 4.7 7.8 4.7 3.8 3.4 8.6 4.3 4.1 5.8 9.3 7.6 1.7 6.0 5.2 4.7 0.1 1.0 0.0 7.6 1.4 2.0 3.1 3.6 2.6 3.0 2.2 2.1 2.5 2.4 3.4 3.9 3.8 0.7 4.4 1.8 1.6 1.2 1.7 2.1 2.9 3.7 3.0 2.1 2.6 2.4 2.5 3.1 1.8 2.7 4.5 5.0 0.0 2.0 6.2 4.7 3.1 2.4 3.1 2.8 4.8 2.8 2.8 8.3 0.0 4.7 1.8 2.1 5.8 4.2 2.2 5.9 4.1 11.0 3.2 4.7 4.5 3.6 9.1 5.6 2.0 2.5 6.6 3.6 2.5 3.8 7.5 6.8 0.9 2.8 5.0 4.1 2.8 2.0 2.7 2.8 6.3 6.8 2.3 1.8 8.4 3.4 2.9 10.3 7.5 14.2 2.3 5.0 5.7 0.9 2.4 3.3 2.2 2.1 5.7 6.6 4.7 4.3 4.0 4.8 2.7 2.8 3.1 4.8 7.9 2.2 2.2 ZNF239 "HOK-2, MOK2" ENSG00000196793 "Zinc finger protein 239" Q16600 10 43556344-43574618 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 49.2;Late spermatids: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 2.8;T-cells: 6.4" "Cell line enhanced" "Detected in many" "NTERA-2: 24.4;T-47d: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030843, HPA046679" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" "HPA030843: AB_2673632, HPA046679: AB_10960498" "unprognostic (1.74e-2)" "unprognostic (1.59e-1)" "unprognostic (1.40e-1)" "unprognostic (1.45e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.05e-7)" "unprognostic (2.98e-1)" "unprognostic (1.84e-1)" "unprognostic (5.90e-3)" "unprognostic (4.13e-2)" "unprognostic (5.59e-3)" "prognostic unfavorable (4.70e-7)" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.60e-1)" "unprognostic (1.34e-1)" 2.5 2.3 4.3 1.9 4.3 0.3 5.3 4.1 4.9 3.8 3.1 3.3 1.3 4.4 2.1 1.1 4.3 1.4 1.4 4.1 4.0 6.2 1.5 1.4 2.9 3.8 3.8 3.9 5.0 4.3 4.5 0.9 3.7 5.2 2.7 1.5 1.9 4.5 2.9 0.7 2.0 4.9 3.9 1.5 2.5 8.2 4.2 1.7 3.2 2.7 2.6 4.3 1.7 4.3 0.0 4.3 5.0 4.9 6.8 5.2 0.0 8.9 1.0 10.6 9.3 11.1 9.7 0.0 3.3 4.9 3.9 0.3 0.0 0.5 13.5 0.1 7.2 0.0 8.0 0.0 5.3 0.0 3.2 5.7 0.2 8.3 0.0 3.2 0.4 0.0 14.7 0.0 8.8 4.9 1.4 1.5 24.4 4.8 5.0 0.0 0.0 0.3 8.8 3.9 9.3 12.7 4.0 0.1 0.6 6.9 19.1 6.1 1.1 0.0 10.8 0.3 11.6 1.2 8.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 1.5 0.0 3.7 2.6 3.5 2.4 0.0 2.8 6.4 3.8 0.0 0.4 0.0 0.0 2.0 1.4 4.3 4.3 4.1 4.9 4.1 4.0 3.8 3.8 3.7 3.9 4.2 4.3 0.5 0.0 0.5 3.6 1.4 0.0 1.7 0.3 4.0 3.1 1.8 2.4 0.7 0.0 1.3 3.7 0.0 0.3 0.2 0.2 1.9 2.0 49.2 0.5 2.2 0.3 0.0 0.4 5.6 0.4 1.2 1.6 1.5 0.7 0.0 2.1 0.4 0.2 0.4 0.0 6.7 0.9 0.0 0.0 0.3 16.4 0.3 0.2 0.0 1.0 0.6 1.3 3.1 7.5 4.3 0.9 0.2 1.5 0.1 0.9 0.0 1.5 0.0 0.5 0.0 1.9 1.6 6.1 8.2 0.4 0.0 0.1 0.8 2.8 1.1 0.2 ZNF26 "FLJ20755, KOX20" ENSG00000198393 "Zinc finger protein 26" P17031 12 132986365-133032952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA018329, HPA042406" Uncertain Approved "Nuclear bodies,Mitochondria" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "Nuclear bodies" "HPA018329: AB_1859157, HPA042406: AB_2677982" "unprognostic (7.31e-3)" "unprognostic (7.60e-3)" "unprognostic (7.26e-4)" "unprognostic (5.52e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-2)" "unprognostic (1.52e-3)" "unprognostic (3.00e-2)" "unprognostic (9.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.11e-1)" "unprognostic (3.67e-3)" "unprognostic (2.66e-12)" "unprognostic (8.24e-2)" "unprognostic (7.20e-2)" "unprognostic (1.94e-3)" "unprognostic (7.64e-4)" 0.8 0.7 1.2 0.9 1.2 1.6 0.8 1.9 1.7 1.0 2.2 0.7 0.8 0.9 1.5 0.6 1.2 0.5 0.6 1.4 0.9 0.8 0.6 1.0 0.9 1.2 0.9 0.9 0.8 0.4 0.7 0.5 0.9 0.7 0.6 1.4 0.8 0.5 1.1 1.4 0.8 0.6 0.4 0.9 0.8 1.1 1.4 0.6 0.8 0.2 0.8 0.7 0.8 2.0 1.3 0.3 1.0 2.0 0.4 0.5 3.4 0.9 0.7 0.9 0.5 0.4 1.0 0.9 1.8 0.8 0.6 1.4 0.4 0.4 0.5 1.1 3.1 2.0 1.2 0.4 0.2 2.7 3.2 0.8 0.7 0.6 1.3 0.8 0.4 1.4 1.3 0.3 0.6 1.4 2.5 1.7 2.2 0.4 2.4 3.0 2.6 2.7 0.3 2.5 2.6 4.2 0.8 1.3 1.1 0.5 2.9 2.4 2.4 1.5 1.1 0.7 1.2 0.7 0.1 3.5 0.9 1.6 1.8 5.9 1.2 3.2 4.0 1.4 4.0 2.1 3.4 2.9 1.8 3.8 4.3 3.8 0.9 3.4 1.3 1.5 3.3 2.8 1.2 1.2 1.9 1.7 1.4 0.9 1.2 0.9 0.9 0.4 1.4 2.0 10.7 22.4 16.0 6.5 15.7 0.0 9.0 0.1 7.4 26.6 9.1 6.7 5.2 11.5 8.2 5.5 25.0 6.4 18.9 3.3 3.9 7.5 1.1 8.8 9.5 10.1 8.4 3.8 11.6 5.7 4.2 8.2 9.2 8.4 9.5 20.3 11.4 5.6 5.3 26.9 8.8 7.0 0.0 6.6 0.0 1.5 8.1 7.5 0.0 11.2 6.5 5.6 17.5 9.5 10.3 8.4 4.9 6.0 10.7 8.1 5.9 2.8 3.0 23.2 0.0 19.1 7.4 12.1 10.9 5.3 0.0 4.8 15.8 14.0 7.2 7.8 ZNF300 ENSG00000145908 "Zinc finger protein 300" Q96RE9 5 150894392-150904983 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 13.3;Granulosa cells: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 36.1" "Low region specificity" "Detected in all" "HPA028975, HPA051777" Uncertain Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Nucleoli, Nucleoli rim, Nuclear bodies" "HPA028975: AB_2672851, HPA051777: AB_2681606" "unprognostic (5.06e-2)" "unprognostic (1.05e-2)" "unprognostic (8.41e-2)" "unprognostic (2.31e-1)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.15e-1)" "unprognostic (6.23e-3)" "unprognostic (4.21e-2)" "unprognostic (3.23e-1)" "unprognostic (8.62e-2)" "unprognostic (6.85e-3)" "prognostic unfavorable (3.21e-6)" "unprognostic (3.62e-3)" "unprognostic (2.99e-1)" "unprognostic (3.46e-1)" "unprognostic (1.50e-2)" 3.6 1.0 2.3 2.6 3.2 2.7 4.5 3.8 2.8 6.5 2.3 3.6 2.7 7.4 2.3 5.1 4.4 3.3 3.2 2.3 2.9 7.4 1.2 2.4 3.0 3.0 3.1 10.2 5.5 0.8 2.4 1.5 3.1 5.4 2.7 9.1 2.8 2.3 0.9 4.4 3.8 4.0 2.6 3.9 4.7 6.4 2.9 2.8 6.9 1.5 2.9 4.5 4.9 3.5 2.1 4.7 28.2 0.0 2.4 5.8 0.0 7.1 5.6 6.1 8.7 2.4 3.5 0.0 6.1 5.9 18.3 4.2 0.0 16.2 9.5 0.0 9.3 0.0 36.1 3.9 5.0 0.2 0.1 8.9 5.0 12.7 14.7 8.6 10.4 0.1 0.0 15.1 6.1 0.0 0.0 1.5 27.2 0.0 0.0 0.0 4.1 8.5 4.4 5.3 15.9 26.2 16.7 14.3 9.8 17.1 9.4 0.0 4.6 8.1 3.4 5.9 12.9 0.5 0.2 0.0 0.8 0.1 17.1 0.0 0.1 0.3 0.1 0.4 0.0 0.2 0.2 0.0 0.3 1.3 0.1 0.1 0.0 0.5 0.0 0.0 0.0 0.2 2.3 3.2 3.8 2.8 2.3 2.9 3.0 3.1 3.1 2.6 2.9 3.5 2.0 0.0 0.5 0.3 1.8 1.5 3.1 2.3 7.4 4.0 2.3 1.7 0.6 1.5 2.7 7.3 0.0 0.7 1.9 0.3 1.9 2.5 3.2 1.8 5.3 2.3 3.0 4.0 0.8 1.6 2.2 3.8 13.3 1.9 0.0 11.5 1.8 0.2 0.5 0.0 1.9 1.4 2.0 1.0 1.2 0.9 2.5 0.8 0.0 5.6 1.5 3.3 3.1 5.5 6.7 1.8 0.1 1.2 0.3 2.0 0.6 1.8 0.8 4.3 6.6 4.1 2.8 7.2 3.7 5.9 2.3 0.8 1.2 2.7 1.8 3.0 ZNF32 "KOX30, Zfp637, ZNF637" ENSG00000169740 "Zinc finger protein 32" P17041 10 43643860-43648881 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039148 Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear bodies" Nucleoplasm "HPA039148: AB_2676365" "unprognostic (1.05e-2)" "unprognostic (2.04e-3)" "unprognostic (1.15e-3)" "unprognostic (9.76e-2)" "unprognostic (1.04e-2)" "unprognostic (5.26e-2)" "prognostic unfavorable (7.08e-4)" "unprognostic (7.39e-2)" "unprognostic (9.94e-3)" "unprognostic (2.90e-3)" "prognostic favorable (3.02e-4)" "unprognostic (1.39e-1)" "unprognostic (5.73e-3)" "unprognostic (6.66e-2)" "unprognostic (4.57e-2)" "unprognostic (2.89e-1)" "unprognostic (1.15e-1)" 33.2 33.2 69.4 13.2 71.9 8.3 45.9 71.0 101.5 46.0 69.0 56.7 12.7 42.9 57.5 23.1 40.0 23.4 60.0 69.0 70.8 49.9 32.4 26.5 22.1 71.3 71.0 52.8 48.1 47.7 45.1 16.6 70.4 48.5 23.4 40.8 31.0 38.1 84.3 31.5 29.6 36.8 70.1 36.0 37.8 16.2 70.9 32.8 41.9 72.9 25.9 41.2 32.9 73.3 25.0 21.8 32.3 48.9 58.1 62.1 10.6 21.9 65.5 39.9 35.8 14.8 12.5 0.1 37.7 46.7 18.8 14.5 20.7 21.2 29.2 27.5 23.0 6.6 13.2 17.2 54.4 0.7 19.7 64.1 48.0 24.7 29.7 38.2 30.6 86.8 19.5 0.0 50.9 22.8 25.2 22.8 25.2 25.2 11.3 38.5 36.3 5.7 40.8 9.7 41.2 36.7 18.1 13.3 35.4 35.3 49.0 23.0 13.1 22.3 26.8 16.4 5.4 14.3 40.2 0.1 8.0 15.9 21.1 14.0 13.9 18.2 36.5 12.9 36.8 26.0 29.2 41.1 22.9 27.2 37.0 41.6 1.1 50.4 11.6 19.3 22.8 20.7 69.4 71.9 71.0 101.5 69.0 70.8 71.3 71.0 70.4 70.1 70.9 73.3 26.1 9.6 14.3 14.0 18.8 11.0 24.4 28.6 33.0 23.2 41.4 57.8 11.7 22.8 16.9 18.4 8.4 18.0 31.9 7.5 105.7 44.7 2.3 16.2 25.6 23.8 27.7 16.8 9.7 47.4 17.1 27.3 16.3 11.5 30.4 34.1 25.7 25.5 29.4 16.8 11.1 16.0 22.4 22.3 10.1 2.1 42.3 19.0 17.8 9.4 15.8 52.7 58.7 16.6 23.0 28.4 10.3 54.5 9.5 36.2 10.0 53.1 12.6 24.1 32.9 38.3 34.2 17.0 14.3 26.4 15.3 6.7 27.1 33.0 17.9 17.9 ZNF341 dJ553F4.3 ENSG00000131061 "Zinc finger protein 341" Q9BYN7 20 33731657-33792269 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023240, HPA024607, HPA067108" Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Cluster 34: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Vesicles" "Nuclear bodies" "HPA023240: AB_1859207, HPA024607: AB_1859208, HPA067108: AB_2685780" "unprognostic (1.74e-1)" "unprognostic (2.18e-1)" "unprognostic (3.73e-1)" "unprognostic (2.10e-1)" "unprognostic (9.31e-2)" "prognostic favorable (3.93e-4)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.44e-1)" "unprognostic (1.70e-1)" "unprognostic (1.80e-1)" "unprognostic (7.38e-2)" "unprognostic (9.31e-2)" "unprognostic (8.17e-5)" "unprognostic (4.84e-2)" "unprognostic (2.90e-1)" "unprognostic (8.67e-3)" "unprognostic (3.68e-2)" 1.2 0.9 1.0 1.9 1.1 2.4 0.9 0.8 2.2 1.1 0.0 1.5 1.4 1.3 1.0 1.3 1.3 0.9 1.0 1.6 0.2 0.6 0.6 1.1 1.9 0.3 0.1 1.3 1.6 0.9 0.6 1.4 0.4 1.3 1.1 0.7 1.5 1.0 3.3 2.1 1.0 1.2 0.2 1.9 1.4 1.5 0.5 1.8 0.9 3.3 1.2 1.2 1.1 1.3 2.4 6.4 2.2 4.7 2.1 1.7 9.5 2.3 1.2 1.9 1.2 4.6 5.4 3.7 3.8 1.7 2.2 3.7 2.4 4.1 0.8 3.3 2.2 3.6 3.6 3.7 1.2 2.1 4.3 1.4 3.0 1.6 1.0 1.7 2.3 3.4 1.9 1.7 2.0 2.9 1.9 1.6 3.0 3.5 3.1 2.4 1.4 2.1 1.3 5.2 1.9 2.1 6.1 5.6 1.4 1.7 5.0 1.7 2.9 3.4 1.4 2.5 2.2 1.3 1.9 3.4 3.3 1.7 2.4 2.6 1.3 2.9 1.1 1.8 1.0 2.2 0.8 0.7 1.0 1.2 0.5 1.5 2.5 1.3 1.2 0.7 0.6 0.9 1.0 1.1 0.8 2.2 1.6 0.2 0.3 0.1 0.4 0.2 0.5 1.3 1.8 3.2 5.1 5.5 2.9 0.4 1.0 1.5 0.6 2.2 1.9 1.4 2.7 2.8 4.7 1.8 2.1 2.6 0.9 7.0 0.0 1.5 0.6 1.6 1.4 1.4 1.2 0.8 11.3 1.4 3.3 1.6 6.6 2.1 2.5 1.8 1.4 1.0 1.4 1.7 8.0 2.0 2.0 1.6 2.0 0.1 0.6 2.4 0.0 3.7 1.2 0.6 2.1 6.0 7.7 1.7 2.5 0.4 2.6 2.5 4.2 0.4 4.6 2.3 0.0 1.9 1.1 1.6 2.4 1.6 1.0 2.1 1.9 1.5 2.4 2.5 ZNF350 "ZBRK1, ZFQR" ENSG00000256683 "Zinc finger protein 350" Q9GZX5 19 51964340-51986856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001521 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nuclear bodies" "HPA001521: AB_1080705" "unprognostic (7.26e-3)" "unprognostic (4.02e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "unprognostic (1.03e-2)" "unprognostic (4.17e-2)" "unprognostic (7.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.08e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-1)" "unprognostic (3.25e-3)" "unprognostic (6.64e-3)" "unprognostic (1.19e-2)" "unprognostic (3.16e-1)" "unprognostic (8.30e-2)" "prognostic favorable (2.54e-4)" 6.6 4.4 5.8 5.4 7.3 26.2 13.8 8.6 6.7 5.5 4.1 6.6 5.4 6.4 8.2 4.7 5.8 5.2 5.1 6.4 6.5 7.0 5.3 6.3 9.7 6.0 5.7 8.3 4.5 9.2 4.8 9.3 6.1 27.5 9.1 9.7 6.4 6.3 4.5 7.5 6.1 5.8 5.8 9.0 7.3 6.3 6.5 9.0 9.8 5.9 9.1 6.2 5.2 7.2 0.8 4.4 5.6 6.8 7.5 6.7 1.1 4.6 6.5 4.8 9.5 0.0 3.5 2.1 3.6 5.5 8.8 5.8 4.9 6.5 6.6 0.0 10.5 8.6 7.5 3.9 6.3 2.2 10.1 9.5 9.9 6.4 6.6 9.4 5.5 3.5 2.3 0.1 5.8 2.8 8.5 10.2 3.7 0.5 6.8 4.0 8.0 6.9 7.6 11.9 4.7 6.3 0.0 6.0 5.0 7.9 9.8 7.7 5.9 5.2 3.7 3.1 4.7 1.6 2.8 2.7 1.0 0.1 5.6 65.3 11.2 26.9 16.2 12.7 16.4 16.8 15.3 15.6 13.6 17.2 17.7 14.2 30.8 21.5 16.2 8.8 13.4 8.1 5.8 7.3 8.6 6.7 6.4 6.5 6.0 5.7 6.1 5.8 6.5 7.2 9.1 0.0 7.3 4.6 13.1 5.9 11.0 11.1 5.7 9.9 6.0 5.3 6.6 2.8 10.7 9.2 12.5 12.2 12.9 5.1 7.9 6.7 13.0 4.5 4.7 8.0 7.3 2.5 4.2 5.3 9.9 7.1 3.6 6.7 12.0 9.7 6.4 3.1 7.8 6.7 4.1 5.9 16.2 9.5 12.0 3.4 11.1 10.8 12.4 6.5 11.6 7.9 23.7 4.0 9.1 6.0 5.7 6.0 7.5 14.5 7.6 3.9 7.8 13.1 0.0 7.2 8.4 10.2 5.7 3.5 7.0 23.1 15.1 6.8 3.8 13.4 ZNF410 "APA-1, APA1" ENSG00000119725 "Zinc finger protein 410" Q86VK4 14 73886617-73932521 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002871 Approved "Nuclear bodies" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Nuclear bodies" "HPA002871: AB_1080712" "unprognostic (5.84e-2)" "unprognostic (5.04e-2)" "unprognostic (9.29e-2)" "unprognostic (6.36e-3)" "unprognostic (5.86e-4)" "unprognostic (4.91e-2)" "unprognostic (2.83e-3)" "unprognostic (2.10e-2)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (1.86e-3)" "unprognostic (1.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.79e-2)" "unprognostic (2.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.19e-1)" 29.0 33.0 26.8 18.7 30.4 57.7 29.4 30.9 33.9 30.0 28.9 30.6 19.0 27.5 43.7 33.4 28.1 22.6 21.0 26.3 28.0 33.0 28.8 27.6 25.6 29.1 27.5 38.7 20.6 27.1 27.0 32.2 29.6 29.5 24.4 22.8 24.4 27.3 21.1 37.6 25.2 28.4 26.7 26.1 25.7 44.7 28.3 29.9 24.6 18.3 30.7 29.1 28.7 37.0 46.7 35.8 42.4 45.2 44.8 39.8 52.4 51.4 56.9 88.2 82.0 37.6 40.1 38.4 21.7 65.7 28.2 42.1 42.9 52.8 83.2 56.2 26.9 36.2 31.6 29.9 67.4 30.6 45.6 37.0 72.4 44.5 83.1 39.5 47.5 43.9 38.2 33.0 43.3 88.6 45.8 51.2 15.5 56.3 41.7 40.7 48.5 24.7 57.0 43.7 39.0 50.3 57.2 52.5 54.6 35.5 48.3 52.2 30.7 62.7 59.0 37.1 47.2 45.2 83.4 48.0 40.1 34.1 53.7 65.9 45.3 74.8 47.5 43.1 51.9 37.7 49.0 49.0 45.6 43.0 42.3 43.5 34.4 60.5 50.1 30.8 46.7 55.9 26.8 30.4 30.9 33.9 26.3 28.0 29.1 27.5 29.6 26.7 28.3 37.0 4.3 0.0 3.1 27.7 10.8 0.6 1.5 1.0 10.8 1.5 2.2 1.7 1.1 0.0 2.9 0.0 4.2 1.8 5.0 1.7 0.0 1.0 3.8 4.7 5.6 2.6 0.0 5.9 22.7 0.9 1.5 5.3 10.7 6.7 10.8 2.9 1.8 0.4 1.2 1.7 23.8 1.1 0.0 2.2 3.1 1.1 1.2 5.4 1.8 18.7 1.1 2.4 2.1 18.1 31.0 1.3 1.4 0.4 13.4 1.0 2.4 0.7 0.2 4.7 0.0 4.0 5.1 3.3 1.9 10.1 1.1 2.6 10.5 4.1 0.8 1.4 ZNF416 FLJ20557 ENSG00000083817 "Zinc finger protein 416" Q9BWM5 19 57571566-57578911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 8.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA063318 Approved "Nuclear bodies,Cytosol" No No "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nuclear bodies" "HPA063318: AB_2684983" "unprognostic (1.40e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.14e-2)" "unprognostic (7.57e-3)" "unprognostic (3.66e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" "unprognostic (6.62e-3)" "unprognostic (5.37e-2)" "prognostic favorable (1.20e-5)" "unprognostic (1.31e-1)" "unprognostic (2.62e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-1)" 2.2 2.2 2.6 1.6 3.0 2.6 3.7 4.3 3.7 2.7 2.2 2.3 1.4 2.3 3.9 3.2 3.4 1.8 2.7 2.7 2.5 2.6 2.0 2.5 2.8 2.0 2.2 4.4 1.4 4.4 2.0 2.9 2.0 2.7 2.1 3.7 2.2 3.1 2.6 5.1 1.7 2.8 2.2 2.8 2.1 4.2 2.6 4.0 3.6 3.0 4.1 2.4 2.4 2.9 3.2 3.1 6.5 5.2 3.9 5.6 4.3 3.2 5.8 6.2 4.0 2.2 1.7 2.2 2.3 4.1 4.5 1.2 3.8 5.5 7.6 3.5 15.5 5.3 3.5 1.8 7.0 4.7 3.3 5.6 5.6 3.9 8.2 4.9 4.3 5.3 0.7 1.7 8.4 1.3 9.9 2.2 7.7 3.8 5.7 4.9 9.7 4.8 4.3 6.8 4.7 5.3 5.8 3.0 2.9 7.3 2.7 5.6 3.2 6.7 3.2 2.2 4.8 5.4 9.5 5.9 1.5 3.1 4.1 1.1 2.6 1.9 4.3 1.9 7.7 6.6 5.9 6.3 4.1 10.4 8.0 5.8 0.8 9.0 1.7 3.7 2.9 3.7 2.6 3.0 4.3 3.7 2.7 2.5 2.0 2.2 2.0 2.2 2.6 2.9 1.1 0.0 0.5 1.3 2.9 1.7 1.6 1.6 1.2 3.5 1.6 1.8 1.8 1.5 1.6 0.0 0.0 2.1 1.0 0.6 3.9 2.8 5.0 0.9 0.9 1.8 0.0 3.6 1.5 0.9 0.8 1.1 1.5 1.1 2.5 2.6 0.7 1.2 1.7 8.4 1.4 1.1 0.0 1.0 0.6 2.0 0.9 0.6 0.0 1.0 0.5 3.2 3.1 3.0 0.2 1.4 1.2 0.7 0.8 1.3 1.1 1.3 0.6 2.8 6.6 1.5 1.2 3.1 4.1 1.3 2.4 1.9 1.3 2.4 0.9 2.2 ZNF433 FLJ40981 ENSG00000197647 "Zinc finger protein 433" Q8N7K0 19 12014732-12035741 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 198.4;Late spermatids: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA073724 Enhanced Approved "Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "HPA073724: AB_2686631" "unprognostic (3.48e-2)" "unprognostic (1.24e-1)" "unprognostic (9.90e-2)" "unprognostic (6.84e-2)" "unprognostic (2.67e-1)" "unprognostic (3.92e-2)" "unprognostic (1.13e-1)" "unprognostic (4.16e-2)" "unprognostic (3.66e-3)" "unprognostic (1.52e-1)" "unprognostic (1.43e-2)" "unprognostic (1.36e-3)" "prognostic favorable (8.33e-15)" "unprognostic (1.06e-2)" "unprognostic (6.95e-2)" "unprognostic (9.20e-2)" "unprognostic (2.69e-2)" 4.1 3.8 5.1 2.3 5.2 11.8 7.8 10.9 5.2 5.7 5.3 3.6 2.1 4.9 9.4 6.9 4.7 3.8 5.3 6.1 5.2 14.2 5.3 4.0 3.2 5.2 5.4 5.7 9.2 9.1 4.9 5.1 5.0 6.3 3.6 9.9 7.2 4.7 5.6 9.0 2.5 3.2 4.3 4.6 4.8 27.6 5.1 1.8 9.1 3.9 2.9 4.5 5.3 6.0 5.5 0.4 4.1 11.5 3.9 3.7 6.0 4.8 3.5 5.3 5.6 3.1 1.1 1.7 2.6 4.1 3.6 2.2 0.0 5.3 5.0 0.8 1.4 4.0 1.1 3.4 4.1 3.7 9.0 4.3 4.9 3.7 1.8 3.3 0.0 6.4 1.0 0.8 5.9 2.3 4.9 4.7 1.6 0.1 4.5 2.6 2.8 0.4 7.7 11.3 3.4 2.8 0.0 3.0 2.3 4.4 6.2 5.5 3.4 6.0 2.5 10.3 3.4 8.1 10.6 4.8 1.1 4.2 3.7 6.5 1.1 5.1 1.3 0.9 1.1 1.5 1.2 1.7 4.1 2.6 1.8 2.2 2.0 5.9 1.4 3.9 0.9 1.1 5.1 5.2 10.9 5.2 6.1 5.2 5.2 5.4 5.0 4.3 5.1 6.0 3.8 3.2 2.8 7.5 1.7 1.8 3.4 3.7 1.8 4.9 4.8 4.3 7.2 5.7 4.1 5.5 16.7 10.5 1.7 0.8 7.9 4.2 198.4 7.1 3.8 2.2 0.0 3.6 6.7 3.8 4.5 3.1 3.6 9.5 3.8 3.3 1.4 3.1 6.9 6.7 5.9 0.5 4.1 2.2 1.6 134.4 3.1 1.5 5.4 0.0 0.0 4.7 1.0 10.1 3.7 3.0 1.1 4.1 0.6 2.1 0.0 6.1 6.1 8.1 6.6 1.9 2.9 35.1 5.7 4.5 2.6 3.4 0.9 2.4 0.8 2.5 ZNF470 "CZF-1, FLJ26175" ENSG00000197016 "Zinc finger protein 470" Q6ECI4 19 56567468-56588911 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatogonia: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 11.0" "Low region specificity" "Detected in all" HPA029000 Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nuclear bodies" "HPA029000: AB_10603843" "unprognostic (1.40e-2)" "unprognostic (5.51e-2)" "unprognostic (5.91e-2)" "unprognostic (9.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.40e-2)" "unprognostic (7.11e-2)" "unprognostic (4.58e-2)" "unprognostic (6.91e-3)" "unprognostic (2.39e-2)" "unprognostic (3.45e-3)" "unprognostic (3.33e-3)" "unprognostic (3.89e-2)" "unprognostic (2.82e-2)" "unprognostic (4.68e-1)" "unprognostic (2.76e-3)" "unprognostic (2.88e-3)" 2.0 3.0 8.2 1.0 8.2 0.4 1.9 9.0 12.2 3.0 5.8 3.8 0.9 2.8 3.0 1.8 2.3 1.5 3.6 8.5 8.5 4.4 3.2 1.8 1.4 8.4 8.6 2.6 2.0 2.3 5.3 1.6 8.6 3.7 1.1 12.3 1.7 2.4 1.3 1.8 2.0 1.9 7.7 2.1 2.3 4.6 8.6 1.9 2.5 1.1 1.7 3.5 2.3 8.7 0.0 1.6 5.4 2.3 2.8 2.6 4.5 2.6 1.2 2.0 3.8 0.3 1.3 0.0 1.6 2.9 3.5 0.1 2.3 1.2 2.4 0.0 11.0 4.8 0.1 0.4 2.7 1.0 5.4 3.2 1.8 2.3 0.6 2.1 1.2 0.2 0.0 0.1 3.0 0.0 1.1 1.8 4.4 0.0 0.6 0.2 3.8 0.9 2.2 3.3 2.0 5.1 0.0 0.4 0.7 3.7 1.8 3.0 1.2 0.2 2.2 1.8 3.5 1.7 2.5 0.2 0.0 3.2 0.9 0.5 0.2 0.9 0.6 0.1 1.2 0.7 0.6 0.3 0.4 0.8 0.8 0.8 0.6 0.7 0.3 0.6 0.4 0.3 8.2 8.2 9.0 12.2 8.5 8.5 8.4 8.6 8.6 7.7 8.6 8.7 3.4 3.2 3.6 10.4 1.1 1.0 1.4 1.0 1.2 8.6 2.1 2.0 7.4 2.8 1.7 0.0 10.4 1.1 0.8 0.7 1.9 2.6 2.1 2.1 3.1 4.2 0.0 2.1 10.1 0.6 0.9 3.1 0.5 1.9 7.0 4.1 3.6 2.4 1.2 11.8 9.6 0.8 0.0 0.6 2.1 1.7 2.1 1.6 1.8 2.8 1.8 4.2 1.0 6.6 11.9 1.2 1.5 3.0 0.4 1.9 2.1 2.7 1.5 7.1 6.6 3.9 2.6 7.4 13.4 1.5 0.6 0.3 1.4 2.5 1.9 0.9 ZNF511 "MGC30006, Zfp511" ENSG00000198546 "Zinc finger protein 511" Q8NB15 10 133308914-133313162 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035360 Uncertain Approved "Nucleoplasm,Nuclear bodies,Vesicles" "Intracellular and membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931" "unprognostic (3.35e-2)" "unprognostic (2.19e-1)" "unprognostic (1.91e-1)" "unprognostic (8.84e-2)" "unprognostic (1.31e-1)" "unprognostic (1.16e-1)" "unprognostic (3.04e-1)" "unprognostic (1.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (1.40e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.94e-2)" "unprognostic (3.91e-2)" "unprognostic (2.55e-1)" "unprognostic (4.52e-2)" 12.7 11.6 15.9 8.7 16.2 17.1 11.3 15.5 17.2 15.8 17.5 19.7 16.1 15.7 10.7 10.8 15.4 9.4 21.2 15.4 15.4 10.4 21.3 11.4 12.6 16.7 15.9 20.4 15.5 14.7 12.7 8.7 15.7 16.1 12.8 5.8 16.7 10.7 49.1 7.9 13.2 11.1 16.4 12.5 12.5 9.6 16.8 11.4 10.9 31.9 9.7 13.6 12.5 16.5 54.1 54.0 30.3 43.8 25.6 21.6 32.6 25.2 39.3 53.3 44.4 88.0 50.9 48.2 24.4 29.5 33.9 48.8 41.9 36.0 23.2 38.8 92.1 29.1 22.1 53.4 21.0 57.5 52.1 22.0 19.2 43.7 26.5 30.6 24.3 22.7 40.0 22.4 18.6 71.2 27.5 76.1 37.3 50.2 74.6 37.1 37.1 12.4 28.3 18.6 16.9 37.0 16.8 30.0 38.2 18.7 23.2 33.1 23.3 23.1 35.4 26.5 68.5 31.3 36.4 66.1 37.5 26.8 12.9 40.2 61.1 68.6 45.4 52.6 35.6 66.6 37.0 46.6 61.0 51.8 41.6 40.8 8.5 41.0 51.1 65.9 36.2 47.3 15.9 16.2 15.5 17.2 15.4 15.4 16.7 15.9 15.7 16.4 16.8 16.5 16.3 16.0 14.5 7.5 33.6 29.6 45.6 40.7 39.3 19.5 37.3 52.6 23.6 25.8 21.9 22.0 8.4 61.2 36.7 33.3 70.5 39.5 29.5 18.5 22.4 20.9 53.4 40.2 10.7 41.2 62.9 34.0 20.4 15.2 78.1 40.6 20.3 54.4 47.4 21.9 7.6 128.8 22.4 33.9 38.0 8.8 41.7 39.9 16.0 5.6 64.3 27.4 41.2 3.5 12.3 38.6 44.0 30.5 40.4 43.0 60.8 72.1 23.2 23.6 26.3 27.3 34.5 58.1 48.0 36.3 35.9 28.2 33.0 38.6 65.9 41.5 ZNF511-PRAP1 ENSG00000283496 "ZNF511-PRAP1 readthrough" 10 133309410-133352529 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 9.2;kidney: 8.4;liver: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.3;RPMI-8226: 1.0" "HPA035360, HPA038713, HPA052451" Supported Uncertain "Nucleoplasm,Nuclear bodies,Vesicles" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 2: Karpas-707 - Immune response" "Cluster 11: Alveolar cells - Smell perception" "Nuclear bodies" "Nucleoplasm, Vesicles" "HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839" 0.2 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 6.2 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 30.4 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 0.0 9.2 0.0 0.1 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.0 0.6 0.0 0.8 0.0 0.1 0.1 1.0 0.0 0.1 0.0 0.7 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF514 FLJ14457 ENSG00000144026 "Zinc finger protein 514" Q96K75 2 95145000-95165413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 44.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028974 Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" "HPA028974: AB_10603845" "unprognostic (8.79e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-1)" "unprognostic (5.99e-2)" "unprognostic (1.11e-2)" "unprognostic (1.80e-2)" "unprognostic (4.68e-2)" "unprognostic (1.42e-2)" "unprognostic (1.73e-1)" "unprognostic (5.17e-2)" "unprognostic (1.80e-3)" "unprognostic (4.33e-2)" "unprognostic (1.91e-1)" "unprognostic (1.00e-1)" "unprognostic (1.79e-2)" 9.3 9.3 13.5 5.9 13.5 2.5 13.2 14.5 14.4 18.3 12.6 14.1 10.2 15.7 26.8 7.8 14.5 5.9 9.6 13.9 13.1 14.2 6.6 9.0 8.7 13.5 12.7 23.3 10.2 12.7 17.2 8.1 14.3 14.8 9.9 29.9 11.7 11.3 14.4 15.0 9.8 10.5 10.9 10.1 10.8 11.2 13.8 10.1 17.9 13.3 8.2 11.4 13.0 15.9 16.7 5.5 16.0 11.5 11.1 15.0 12.2 6.6 7.2 11.0 11.2 9.3 6.5 2.8 3.3 7.1 16.8 10.7 8.6 6.3 12.2 5.5 11.1 3.2 8.8 7.6 4.6 1.9 8.3 8.9 18.9 6.9 4.7 16.4 5.1 9.5 9.3 3.4 8.9 8.2 5.0 10.3 5.3 5.4 6.0 8.5 5.8 6.1 7.1 6.6 14.8 11.2 7.1 3.5 7.6 21.6 6.3 6.4 5.9 7.9 9.9 2.7 5.6 8.5 6.9 4.9 8.2 3.7 5.2 12.7 4.3 8.4 3.9 2.3 4.7 6.8 5.1 3.7 4.2 7.0 8.5 7.0 1.4 6.1 2.6 3.5 6.2 4.2 13.5 13.5 14.5 14.4 13.9 13.1 13.5 12.7 14.3 10.9 13.8 15.9 8.0 9.6 7.9 20.2 4.6 5.6 9.9 8.0 2.2 13.9 9.4 11.9 14.0 12.8 6.7 0.0 18.8 6.3 4.9 6.3 27.4 6.6 44.1 7.1 7.9 8.0 9.6 7.0 22.8 5.2 3.5 7.2 4.6 5.3 1.3 27.9 7.1 9.4 8.3 15.2 22.3 10.6 10.2 5.1 2.2 43.2 10.5 5.4 7.2 13.1 5.9 12.9 8.2 15.1 34.3 4.9 5.1 7.5 3.1 10.0 10.3 18.2 10.3 31.5 6.6 7.9 8.0 20.6 12.5 3.8 6.3 3.7 4.7 8.2 8.7 10.7 ZNF565 FLJ36991 ENSG00000196357 "Zinc finger protein 565" Q8N9K5 19 36182276-36246257 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 23.3;Late spermatids: 16.1;Oligodendrocytes: 21.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 16.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 16.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA044123 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 21: OE19 - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" "HPA044123: AB_10794395" "unprognostic (1.51e-1)" "unprognostic (3.77e-2)" "unprognostic (6.80e-2)" "unprognostic (7.46e-3)" "unprognostic (6.08e-3)" "unprognostic (7.97e-3)" "unprognostic (2.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.90e-2)" "unprognostic (5.73e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-3)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (3.35e-2)" "unprognostic (1.55e-3)" "unprognostic (1.93e-4)" 2.9 2.6 4.6 2.0 7.0 3.7 3.4 5.7 5.8 2.8 2.5 2.5 2.1 3.2 3.0 2.4 3.1 2.2 2.3 4.9 5.5 2.5 3.0 2.2 2.3 6.9 6.3 5.0 2.5 2.9 2.7 2.2 6.4 3.1 2.7 3.5 3.7 2.5 4.2 3.1 2.0 2.9 4.4 2.2 3.0 6.8 5.6 2.2 3.1 4.6 2.8 2.7 2.5 12.1 2.7 4.1 4.7 3.2 7.2 4.9 1.3 2.8 4.5 3.3 5.6 2.2 2.4 2.2 3.4 3.6 1.5 1.6 2.4 2.0 5.3 3.7 0.9 3.8 3.6 3.2 3.0 2.7 2.5 5.4 5.8 2.1 5.5 3.5 3.9 2.5 2.6 2.6 4.0 3.6 3.2 0.7 1.8 6.4 1.8 2.5 2.8 2.0 3.3 3.8 3.5 3.7 2.3 2.5 2.6 2.9 1.6 2.7 3.3 4.3 2.6 3.4 3.9 0.8 1.3 1.4 4.4 2.1 2.2 16.3 2.7 4.3 2.7 2.7 3.0 2.1 3.2 2.7 3.1 2.0 3.6 2.7 1.2 3.1 3.3 1.6 1.8 1.9 4.6 7.0 5.7 5.8 4.9 5.5 6.9 6.3 6.4 4.4 5.6 12.1 3.3 3.2 1.1 5.9 1.6 2.2 7.1 2.3 4.6 4.2 2.0 1.8 2.9 0.0 1.0 1.8 6.2 1.4 1.9 1.1 0.0 2.5 23.3 2.6 3.8 3.4 1.2 0.0 10.2 2.9 2.1 3.8 7.1 3.9 0.0 3.7 2.9 1.1 1.6 1.7 12.4 0.9 2.0 2.7 0.6 16.1 5.3 1.6 0.0 5.6 1.7 2.9 6.2 5.5 21.2 2.6 0.4 2.6 1.5 5.2 1.6 1.6 3.2 4.6 6.6 7.7 3.3 10.8 8.1 2.7 1.4 2.1 2.8 2.5 1.8 4.3 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75678660-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 47.7" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 5.1 5.7 7.6 3.3 9.6 2.8 7.3 7.7 9.5 5.7 4.4 5.1 5.7 5.9 15.4 5.4 7.2 4.5 5.9 7.2 8.1 9.9 7.9 4.6 4.8 9.0 8.5 7.9 8.9 8.3 9.3 5.0 9.2 6.7 6.6 7.8 7.2 4.7 4.2 9.9 5.2 4.2 8.5 7.1 7.4 8.2 8.7 4.7 9.3 4.4 7.1 5.8 5.4 12.3 11.4 5.8 5.2 3.6 6.1 8.5 3.9 3.5 5.2 5.1 5.9 9.4 9.8 5.2 4.6 6.0 5.0 6.3 6.8 4.5 4.2 0.5 7.0 8.6 9.4 0.9 15.9 0.5 8.6 10.4 4.8 12.8 17.4 4.3 0.7 0.5 47.7 11.6 5.7 1.8 0.6 17.1 5.2 8.9 6.3 7.7 4.5 27.0 7.6 3.8 4.2 17.4 3.5 6.6 14.6 5.1 16.8 4.6 1.6 9.3 10.9 6.4 1.4 12.0 19.9 5.2 4.7 1.3 6.0 1.3 2.6 5.1 2.1 3.8 1.2 5.1 3.3 2.0 2.7 6.1 6.3 3.7 0.7 3.0 3.8 4.1 1.1 2.0 7.6 9.6 7.7 9.5 7.2 8.1 9.0 8.5 9.2 8.5 8.7 12.3 6.6 3.2 3.1 28.1 6.0 3.2 4.2 3.4 5.2 8.5 9.1 8.3 5.6 8.6 4.2 7.3 2.1 5.2 5.8 2.2 11.7 4.6 5.0 3.4 4.8 5.1 5.3 7.4 21.7 4.4 1.8 5.7 4.6 2.6 8.9 11.4 7.9 8.2 7.3 10.1 27.2 7.0 4.1 5.7 4.1 2.1 2.5 4.5 1.8 16.9 5.0 5.2 5.2 25.6 35.4 3.9 2.0 3.0 0.7 5.1 6.3 17.5 6.3 8.1 0.0 5.1 5.3 11.1 8.6 7.0 4.4 3.4 3.1 7.9 5.0 3.9 ZNF778 FLJ31875 ENSG00000170100 "Zinc finger protein 778" Q96MU6 16 89217703-89237141 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 35.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 10.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA052057, HPA057151" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 6: T47d - Mammary gland" "Cluster 51: Myeloid cells - Hemostasis" "Nuclear bodies" Nucleoplasm "HPA052057: AB_2681710, HPA057151: AB_2683352" "unprognostic (3.63e-2)" "unprognostic (1.42e-1)" "unprognostic (4.75e-3)" "unprognostic (7.04e-2)" "unprognostic (2.43e-1)" "unprognostic (1.66e-3)" "unprognostic (5.34e-2)" "unprognostic (1.29e-2)" "unprognostic (1.91e-1)" "unprognostic (3.57e-1)" "unprognostic (3.53e-7)" "unprognostic (2.51e-1)" "unprognostic (2.85e-7)" "unprognostic (3.22e-2)" "unprognostic (3.67e-1)" "unprognostic (8.46e-2)" "unprognostic (3.63e-2)" 2.1 2.2 2.3 1.9 2.5 1.6 2.5 3.7 2.8 2.1 2.4 2.3 1.1 2.2 1.7 2.0 2.1 1.5 2.3 2.4 2.0 3.2 2.1 2.1 1.8 2.4 2.8 2.1 5.0 8.1 2.5 1.4 4.5 2.3 1.9 3.9 2.5 2.9 3.8 3.2 1.7 2.6 2.0 2.3 2.4 5.2 2.7 2.0 3.1 4.3 2.6 2.1 1.7 2.8 4.2 2.3 6.8 5.6 4.2 3.5 8.4 3.3 5.2 4.7 2.8 6.7 2.8 2.2 6.4 4.2 2.5 4.0 9.4 4.6 7.9 0.8 8.4 5.8 4.6 3.2 2.4 1.7 3.2 3.0 3.3 6.2 4.6 3.0 4.2 3.7 6.5 1.1 4.1 10.5 3.5 2.4 9.9 3.4 3.9 9.7 15.6 0.6 2.4 3.8 14.0 10.1 8.2 4.1 2.6 6.2 10.8 3.2 4.4 5.3 3.7 3.5 4.0 4.0 6.0 4.6 7.3 3.3 3.3 10.9 1.2 3.1 3.0 1.9 1.7 0.9 1.5 1.4 1.5 1.2 1.1 1.9 0.3 1.4 2.1 0.5 1.8 1.4 2.3 2.5 3.7 2.8 2.4 2.0 2.4 2.8 4.5 2.0 2.7 2.8 2.9 12.8 4.4 3.6 2.2 1.7 2.8 1.8 9.1 8.6 4.5 4.6 5.1 2.8 2.8 5.5 14.6 2.4 8.4 1.3 0.0 3.3 16.4 4.2 4.6 4.7 3.0 6.1 6.3 5.6 2.2 3.1 5.6 7.7 0.0 5.2 4.6 5.5 2.5 21.9 5.7 2.9 2.0 5.0 0.7 35.3 2.5 6.2 1.8 1.0 4.3 4.3 11.3 2.0 5.9 3.2 1.8 3.0 9.6 5.4 3.4 3.5 0.5 10.5 13.1 11.7 3.4 15.1 12.7 8.2 1.6 2.3 4.7 3.0 2.0 3.3 ZNF786 DKFZp762I137 ENSG00000197362 "Zinc finger protein 786" Q8N393 7 149069641-149090782 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 18.8;Horizontal cells: 18.5;Inhibitory neurons: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021518, HPA053459" Uncertain Approved "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear speckles" "Nucleoplasm, Nuclear bodies" "HPA021518: AB_2670734, HPA053459: AB_2682159" "unprognostic (3.13e-2)" "unprognostic (2.72e-1)" "unprognostic (5.61e-2)" "unprognostic (5.39e-2)" "unprognostic (1.87e-1)" "unprognostic (2.84e-2)" "prognostic unfavorable (1.09e-4)" "unprognostic (5.62e-2)" "unprognostic (1.09e-3)" "unprognostic (8.85e-2)" "prognostic favorable (2.01e-4)" "unprognostic (3.97e-2)" "unprognostic (1.39e-2)" "unprognostic (8.86e-3)" "unprognostic (1.31e-1)" "unprognostic (3.44e-1)" "unprognostic (1.47e-2)" 2.0 2.2 2.9 2.8 2.6 1.5 2.6 3.9 4.3 3.5 1.1 3.1 2.0 3.3 2.4 3.8 3.1 2.0 2.0 2.8 2.6 2.9 3.1 1.9 3.8 1.6 1.7 3.2 2.6 2.3 3.8 1.6 1.5 3.7 1.4 1.9 3.0 2.2 2.0 5.6 3.1 1.9 0.9 3.9 2.3 1.6 2.8 3.5 2.9 2.3 2.8 3.3 3.5 2.8 4.5 8.1 6.1 10.4 3.7 1.5 8.7 2.7 2.8 2.9 2.3 4.3 4.0 6.3 6.3 1.9 5.1 5.0 3.8 3.6 1.9 6.9 5.9 3.2 5.1 5.4 3.1 6.3 4.1 2.2 4.0 3.6 2.6 3.0 2.7 4.5 5.6 3.5 2.7 13.9 10.7 10.5 11.4 4.1 6.0 7.7 3.0 4.1 2.4 6.1 7.3 11.5 6.6 6.1 5.0 3.8 3.9 3.0 3.6 3.4 2.0 6.0 3.9 12.7 10.0 3.5 5.7 3.9 3.8 1.8 3.4 2.9 10.4 4.7 8.8 6.4 7.5 9.4 4.3 5.9 9.7 8.3 1.1 8.5 4.0 3.7 5.0 5.0 2.9 2.6 3.9 4.3 2.8 2.6 1.6 1.7 1.5 0.9 2.8 2.8 2.4 0.0 1.1 3.6 3.5 2.7 2.6 4.2 2.8 10.1 2.3 1.3 2.7 1.5 1.6 3.7 2.1 2.4 5.9 2.0 3.9 4.1 0.4 0.9 2.1 3.1 4.8 0.8 18.8 1.5 2.5 2.6 6.6 1.1 4.5 4.5 1.8 2.4 2.2 18.5 15.8 1.6 2.0 1.9 2.6 0.4 3.1 2.1 0.0 3.7 3.6 2.8 13.4 7.1 5.4 1.8 3.3 4.1 2.9 1.4 1.7 2.5 2.3 6.0 0.0 3.3 2.5 4.9 8.3 2.3 1.7 1.9 6.0 1.8 2.7 1.7 ZNF792 FLJ38451 ENSG00000180884 "Zinc finger protein 792" Q3KQV3 19 34956354-34964229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 7.0;Endothelial cells: 7.5;Hepatic stellate cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 12.8;HMC-1: 16.1;HUVEC TERT2: 11.0;OE19: 9.7;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "HPA035157, HPA035158" Supported Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA035157: AB_2674497, HPA035158: AB_10603010" "unprognostic (1.31e-1)" "unprognostic (7.31e-2)" "prognostic favorable (2.72e-4)" "unprognostic (1.24e-1)" "unprognostic (2.15e-1)" "unprognostic (7.91e-2)" "unprognostic (2.41e-5)" "unprognostic (2.49e-2)" "unprognostic (4.30e-2)" "unprognostic (1.22e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-1)" "unprognostic (6.88e-3)" "unprognostic (3.88e-1)" "unprognostic (2.48e-1)" "unprognostic (6.02e-2)" "unprognostic (2.77e-3)" 3.8 1.3 1.1 2.2 1.6 1.3 3.6 3.6 1.3 2.4 1.1 1.9 2.1 2.2 1.9 1.0 2.6 1.7 2.0 0.9 1.2 1.6 1.3 4.1 3.8 1.2 1.4 2.3 1.8 2.8 1.1 3.4 1.2 1.8 2.3 2.5 2.2 2.2 1.2 1.5 2.4 2.6 0.9 3.6 2.5 0.9 1.3 4.0 1.9 2.1 2.8 2.3 1.4 0.9 1.1 3.8 1.8 2.7 1.8 1.4 0.0 1.1 2.0 1.3 1.6 1.5 1.8 1.6 3.4 1.5 0.6 0.7 2.6 2.0 2.0 4.6 0.6 12.8 1.1 2.9 1.3 1.1 16.1 1.6 0.6 1.1 0.5 2.3 11.0 1.1 3.4 0.0 2.2 0.9 4.5 1.1 1.3 9.7 0.8 2.9 0.0 0.2 1.0 3.5 0.9 10.2 1.0 1.0 1.3 1.6 1.2 3.4 4.5 1.9 2.4 0.8 1.2 0.3 1.0 0.9 2.1 0.2 0.9 5.4 0.5 4.1 1.9 0.4 2.3 1.3 3.0 2.7 0.7 0.9 3.3 2.8 0.1 3.0 0.3 0.1 3.2 1.7 1.1 1.6 3.6 1.3 0.9 1.2 1.2 1.4 1.2 0.9 1.3 0.9 7.0 0.0 1.1 0.7 2.1 0.5 0.1 0.6 0.6 0.8 1.2 0.9 2.0 0.0 0.2 0.0 2.1 0.1 2.9 0.7 0.0 1.8 0.2 0.7 0.7 7.5 1.8 3.4 0.3 2.6 0.4 1.0 2.0 0.8 1.3 1.4 6.4 0.6 1.5 0.0 0.6 1.7 0.0 3.5 1.4 0.4 1.5 1.6 0.0 1.0 1.6 0.5 2.1 2.5 0.3 2.7 1.0 0.0 1.6 0.2 0.5 0.5 0.2 1.8 0.0 0.9 0.6 0.0 1.5 0.4 0.4 0.1 3.0 0.7 1.4 0.1 ZNF8 "HF.18, Zfp128" ENSG00000278129 "Zinc finger protein 8" P17098 19 58278955-58302791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEK 293: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034797, HPA034798" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA034797: AB_10696364, HPA034798: AB_10602785" "unprognostic (1.41e-1)" "unprognostic (7.27e-2)" "unprognostic (6.66e-2)" "unprognostic (3.03e-2)" "unprognostic (1.52e-2)" "unprognostic (4.16e-3)" "unprognostic (1.09e-2)" "unprognostic (9.20e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (4.14e-3)" "unprognostic (4.98e-2)" "unprognostic (7.16e-3)" "unprognostic (8.56e-2)" "unprognostic (7.65e-2)" "unprognostic (1.52e-1)" "unprognostic (1.28e-2)" 1.5 1.8 2.3 1.1 1.8 3.6 1.6 4.6 3.2 1.5 1.0 1.7 1.1 1.8 1.5 1.6 1.7 1.1 2.2 2.8 1.5 1.9 1.1 2.1 1.4 1.7 1.7 1.8 1.6 2.0 2.3 1.5 1.7 1.6 1.1 4.0 1.7 1.3 0.9 2.5 1.7 1.4 0.9 1.8 1.6 1.4 2.1 2.1 1.8 1.4 1.3 1.6 1.6 2.8 1.8 2.6 3.7 6.9 2.3 1.9 3.1 0.9 1.4 0.9 1.0 2.8 1.3 2.3 1.1 1.5 0.8 1.6 2.7 3.0 1.2 1.8 11.4 4.5 6.0 2.5 2.1 1.5 3.5 3.7 1.8 1.6 3.1 2.7 1.7 3.7 2.4 0.9 1.9 2.1 3.5 2.0 3.3 1.3 1.8 3.9 3.5 1.6 1.8 6.3 6.5 3.5 2.8 1.9 0.9 2.8 1.9 2.8 2.5 6.9 1.7 1.0 1.9 3.4 2.9 3.0 1.1 0.0 1.8 1.4 0.7 0.4 0.4 0.3 0.5 0.4 0.3 0.3 0.4 0.5 0.3 0.4 1.3 0.5 0.3 0.3 0.2 0.7 2.3 1.8 4.6 3.2 2.8 1.5 1.7 1.7 1.7 0.9 2.1 2.8 4.2 0.0 4.1 2.3 2.3 0.0 2.9 0.0 2.8 11.0 2.5 2.3 3.1 0.0 1.8 5.5 12.5 2.1 1.2 1.4 3.9 4.0 4.0 4.7 5.3 4.5 5.4 10.3 4.2 2.3 1.6 2.8 4.1 3.9 1.3 5.9 6.8 1.7 2.5 11.8 4.3 2.1 0.0 1.9 0.0 0.9 4.1 2.4 0.0 1.9 3.0 3.5 2.1 3.0 3.3 3.1 0.5 1.9 1.7 4.4 1.0 2.5 2.2 10.2 6.6 6.6 2.6 8.0 3.4 2.8 0.0 2.6 3.4 5.1 1.9 2.8 ZNF829 DKFZp779O175 ENSG00000185869 "Zinc finger protein 829" Q3KNS6 19 36888124-36916291 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 10.4" "Cell type enriched" "Detected in many" 4 "Early spermatids: 278.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 13.0" "Low region specificity" "Detected in all" HPA073073 Approved "Nucleoplasm,Nuclear bodies" No No "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies" "HPA073073: AB_2686567" "unprognostic (4.55e-2)" "unprognostic (2.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.44e-4)" "unprognostic (1.32e-1)" "unprognostic (6.46e-2)" "unprognostic (8.20e-2)" "unprognostic (1.33e-2)" "unprognostic (9.35e-4)" "unprognostic (1.20e-2)" "unprognostic (3.57e-2)" "unprognostic (3.39e-2)" "unprognostic (3.48e-4)" "unprognostic (5.47e-3)" "unprognostic (1.64e-1)" "unprognostic (1.73e-1)" "unprognostic (8.92e-4)" 1.1 0.9 0.7 1.2 0.6 1.1 2.0 1.9 1.0 1.1 0.1 0.9 0.9 1.6 1.0 0.9 1.3 0.9 1.2 0.6 0.7 1.2 0.8 1.0 1.5 0.3 0.5 2.4 0.9 1.9 0.5 1.5 0.4 1.3 0.7 1.9 1.1 1.2 0.5 1.8 0.7 1.4 0.3 1.5 0.9 10.4 0.8 1.5 1.7 0.8 1.4 1.0 0.9 0.9 0.0 0.8 2.9 0.1 1.5 2.2 1.2 3.3 1.9 3.9 5.5 0.0 0.5 0.1 3.9 2.1 3.7 0.6 0.0 2.3 4.6 0.0 4.1 1.6 0.1 0.1 1.6 0.0 4.2 2.3 2.1 4.3 0.0 1.3 0.4 1.2 0.0 0.1 3.9 0.7 0.7 0.8 5.1 0.0 0.0 0.0 3.7 1.5 1.1 4.5 3.2 4.7 0.1 0.0 2.8 3.8 3.0 0.2 1.1 2.4 3.4 3.3 3.4 7.9 13.0 5.0 0.0 0.0 6.1 1.4 0.2 0.9 0.9 0.1 1.4 0.8 1.0 1.4 0.3 1.2 1.4 1.5 0.4 0.7 0.2 0.5 1.0 0.3 0.7 0.6 1.9 1.0 0.6 0.7 0.3 0.5 0.4 0.3 0.8 0.9 3.0 0.0 3.4 2.0 4.7 1.5 1.9 1.2 1.2 6.8 2.5 2.0 5.6 2.8 3.7 3.7 4.2 4.0 5.5 0.6 0.0 2.7 278.1 3.1 4.4 3.7 0.0 1.3 4.2 1.0 2.5 3.9 0.5 3.1 1.3 5.5 2.9 0.6 1.5 11.8 3.8 1.0 0.0 1.0 4.6 58.9 5.9 1.4 3.6 1.0 1.7 2.6 5.2 6.0 4.1 0.8 0.1 7.2 1.3 1.9 0.3 1.3 1.6 11.1 0.0 5.9 4.6 10.6 11.2 1.1 2.7 4.2 3.8 3.1 0.5 1.1 ZSCAN12 "dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96" ENSG00000158691 "Zinc finger and SCAN domain containing 12" O43309 6 28378955-28399734 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006637, HPA007018" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Nuclear bodies, Cytosol" "HPA006637: AB_1080646, HPA007018: " "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (2.22e-1)" "unprognostic (8.35e-4)" "unprognostic (1.51e-2)" "unprognostic (9.99e-2)" "unprognostic (1.00e-3)" "unprognostic (4.73e-2)" "unprognostic (9.96e-2)" "unprognostic (1.91e-2)" "unprognostic (2.35e-1)" "unprognostic (4.44e-2)" "unprognostic (1.71e-1)" "unprognostic (6.25e-3)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (8.71e-2)" 2.4 2.3 1.8 2.6 2.0 2.2 5.6 3.6 2.5 3.6 1.6 2.9 2.5 4.3 3.6 1.8 3.0 2.3 2.4 1.8 2.2 2.9 1.6 2.9 4.7 1.7 2.1 5.5 3.2 4.0 2.0 3.6 1.6 4.3 2.9 6.8 3.1 3.7 0.9 1.8 2.7 3.6 1.6 3.9 2.9 4.1 2.2 5.1 5.1 1.7 4.1 3.1 2.9 2.0 5.5 1.8 8.1 0.1 4.1 3.2 5.7 3.7 5.1 5.5 7.6 1.2 2.0 5.3 6.8 2.6 2.8 2.4 0.0 4.6 5.6 0.0 6.6 7.6 5.6 3.8 3.8 2.7 1.8 4.2 4.3 5.5 9.9 6.0 1.5 0.0 11.4 1.1 3.5 0.6 0.0 6.1 5.1 0.5 0.9 9.2 7.3 1.4 4.1 3.5 9.8 10.0 1.9 4.3 6.4 8.0 1.7 6.7 1.5 2.2 4.6 1.7 3.0 3.1 3.4 1.0 1.9 0.7 3.4 2.4 0.7 1.5 1.5 0.4 1.4 1.8 1.1 1.8 1.0 2.7 1.8 1.6 0.2 1.8 0.8 0.9 0.9 0.8 1.8 2.0 3.6 2.5 1.8 2.2 1.7 2.1 1.6 1.6 2.2 2.0 2.1 6.4 5.1 4.6 4.0 0.4 1.1 0.9 0.6 6.1 2.6 2.5 3.2 1.5 6.5 0.0 4.2 1.5 3.6 0.3 1.9 1.7 31.8 0.6 2.4 1.9 1.2 2.1 6.9 2.6 1.0 2.7 1.5 0.9 1.3 5.5 3.3 1.0 1.0 6.7 7.0 1.2 0.0 1.3 1.1 9.7 1.8 1.1 1.8 1.0 1.8 4.9 2.1 10.1 6.2 1.3 0.3 3.4 2.4 1.5 1.5 1.2 0.6 6.0 6.6 1.7 2.4 12.6 3.9 1.2 0.3 0.5 1.5 4.2 2.1 0.7 ZWINT "KNTC2AP, SIP30, Zwint1" ENSG00000122952 "ZW10 interacting kinetochore protein" O95229 10 56357227-56361273 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.6;lymphoid tissue: 43.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 17.0" "Lineage enriched" "Detected in many" 5 "T-cells: 17.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005757, HPA022264" Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" Cytosol "HPA005757: AB_10600224, HPA022264: AB_10600995" "unprognostic (5.59e-2)" "unprognostic (1.71e-2)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (9.38e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.77e-8)" "unprognostic (6.36e-3)" "unprognostic (5.88e-2)" "unprognostic (1.45e-2)" "unprognostic (1.58e-3)" "unprognostic (1.86e-2)" "prognostic unfavorable (3.72e-12)" "unprognostic (1.40e-2)" "unprognostic (1.48e-1)" "unprognostic (5.47e-2)" "unprognostic (3.46e-1)" 2.6 2.5 1.2 15.7 1.3 41.6 6.5 1.1 1.8 3.9 1.0 18.8 13.7 3.2 1.7 12.4 2.8 2.4 1.5 1.5 1.2 4.4 4.8 2.9 26.5 1.2 1.3 1.5 2.4 5.4 0.8 10.8 1.2 2.5 22.4 0.5 3.3 1.4 0.3 10.8 14.8 6.8 1.2 5.0 12.5 26.1 1.6 43.5 3.9 0.7 33.0 5.0 4.3 1.4 199.8 154.8 107.9 120.9 7.5 10.8 88.1 143.1 108.0 169.6 153.4 275.4 116.1 102.0 53.2 49.6 79.1 99.9 153.2 108.3 156.7 259.9 80.2 101.6 120.8 129.4 0.7 169.6 131.0 5.1 6.8 157.7 64.9 20.8 86.8 134.2 140.2 121.4 151.1 160.1 150.7 108.3 77.0 135.9 188.7 151.7 209.5 54.0 53.5 87.5 99.8 61.2 135.2 304.2 35.3 62.2 197.3 163.4 47.4 73.6 189.4 76.9 223.2 105.8 55.3 176.0 103.8 210.0 94.7 0.0 0.8 0.7 2.4 3.0 0.3 1.6 5.3 3.6 1.4 0.3 6.3 3.6 0.0 3.5 2.3 1.1 17.0 3.1 1.2 1.3 1.1 1.8 1.5 1.2 1.2 1.3 1.2 1.2 1.6 1.4 0.9 3.2 1.7 0.3 11.1 18.4 6.0 20.2 4.6 2.0 9.4 5.5 1.4 2.8 7.3 5.5 0.0 73.7 3.3 17.9 0.0 9.7 74.0 7.0 4.3 5.7 0.0 133.0 1.3 13.3 108.6 10.3 16.8 8.0 0.0 27.6 7.9 3.5 49.4 0.0 0.3 22.8 14.2 8.5 8.8 208.8 5.0 9.2 7.2 0.0 2.6 1.3 0.0 0.0 0.6 8.6 16.4 2.6 42.4 1.9 8.7 6.0 2.5 0.9 0.0 1.4 10.6 121.0 100.3 24.5 8.2 23.1 7.9 6.5 39.4 8.4